{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "qwen3-32b",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_cross_year",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 1000,
    "successful_questions_in_experiment": 1000,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 1000,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/qwen3-32b/e5_page_window_relevance_asc/qualitative_2hop_cross_year.json",
    "timestamp": "2026-02-05T05:40:44.690655"
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for LMT's nonqualified defined benefit pension plans remained relatively stable between 2023 and 2024, at $1.0 billion as of December 31, 2023, and $905 million as of December 31, 2024. Additionally, actuarial losses related to these plans decreased from $347 million at the end of 2023 to $303 million at the end of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual numbers: gross benefit obligation of $1.0 billion in 2023 and $905 million in 2024, and actuarial losses of $347 million in 2023 and $303 million in 2024, matching the ground truth exactly. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect—values are correct, and the direction of change (decrease in both obligation and losses) is accurately implied through comparison. (3) The reasoning is sound and synthesizes the correct entities (LMT, nonqualified defined benefit pension plans) across two years. The only minor issue is the use of 'remained relatively stable' to describe a decrease from $1.0 billion to $905 million (a 9.5% decline), which may understate the significance of the change, though it does not negate the factual correctness. (4) The answer is fully relevant to the question, addressing both parts (evolution of gross benefit obligation and actuarial losses) with accurate data and temporal comparison. Thus, high scores across all categories with a slight deduction in qualitative accuracy due to potentially misleading characterization of the change as 'relatively stable.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 336,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "General Motors' long-term rate of return assumptions on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024, indicating a more optimistic outlook on future returns. This adjustment reflects a strategic shift in asset mix, with a slight increase in equity allocation (from 11% to 11%) and a decrease in debt allocation (from 60% to 60%), while maintaining a stable proportion in alternative investments (29%). The adjustments aim to improve funded positions and manage volatility, aligning with the long-term nature of pension obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2024 rate of return increase from 6.3% to 6.5%, aligning with the ground truth. However, it completely omits the 2022 information, which refers to a decrease from 5.6% (2020) to 5.4% (2021), as reported in the 2022 filing. This omission is critical because the question asks about the evolution *between 2022 and 2024*, requiring both time points. (2) The quantitative accuracy is partially correct: the 6.3% and 6.5% figures for 2024 are accurate, but the 2022 data is missing. Additionally, the LLM introduces specific asset allocation percentages (11% equity, 60% debt, 29% alternatives) with no changes indicated (e.g., 'from 11% to 11%'), which are not present in the original answer and lack support from the provided ground truth. These numbers may be factually incorrect or misattributed. (3) The multi-hop reasoning is flawed because the model fails to synthesize information from both 2022 and 2024, focusing only on the latter. While the conclusion about a more optimistic outlook and strategic shift is consistent with the ground truth, it is based on incomplete data. The reasoning about asset mix adjustments includes unsupported specifics, weakening the qualitative accuracy. (4) The contextual relevance is high because the answer addresses pension return assumptions and strategic asset mix, directly engaging the question's intent. However, due to missing data and unsupported numerical claims, the overall correctness is only partial. The answer captures part of the trend but fails to present the full evolution, and introduces unverified allocation details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 447,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved from PDC being a separate entity in 2023 to becoming a wholly-owned subsidiary of Chevron in 2024. This acquisition contributed to increased U.S. upstream earnings in 2024, with higher sales volumes including from legacy PDC assets. Specifically, net oil-equivalent production rose by 250,000 barrels per day, driven in part by the full-year inclusion of legacy PDC production. Financially, the integration of PDC added to Chevron's consolidated assets and operational capacity, though it was excluded from the 2023 internal control assessment due to its acquisition during that year.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the acquisition of PDC Energy by Chevron and its exclusion from the 2023 internal control assessment, which aligns with the ground truth. It also captures the general operational impact in 2024, such as increased U.S. upstream earnings and production due to legacy PDC assets. However, key quantitative inaccuracies undermine the answer. The ground truth states a $2.2 billion increase in U.S. upstream earnings and a 19% increase in net oil-equivalent production, but the LLM instead reports a '250,000 barrels per day' increase in production—this figure is not mentioned in the original answer and is factually incorrect based on the provided truth. There is no mention of the $2.2 billion earnings impact, a major financial metric. (2) The production increase is misrepresented: 19% is a percentage growth, not an absolute volume, and the LLM incorrectly converts or invents a 250,000 bpd figure. The dollar amount of earnings contribution is entirely omitted. (3) The multi-hop reasoning is partially sound—the model connects the 2023 acquisition to 2024 operational impacts and understands the exclusion from internal controls—but fails to accurately synthesize the specific financial outcomes reported in the integration phase. (4) Correctness is scored 6 due to correct narrative flow and entity/time accuracy but major quantitative errors. Quantitative accuracy is low (4) due to wrong numbers and missing key metrics. Qualitative accuracy is 7 because the reasoning and entity relationships are mostly correct. Contextual relevance is high (9) as the answer stays focused and addresses both operational and financial dimensions of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 463,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Between 2022 and 2024, Southern Company's treatment and valuation of energy-related derivatives showed a shift in the presentation of unrealized gains and losses. In 2022, unrealized gains and losses from energy-related derivatives designated as regulatory hedges were primarily deferred in regulatory assets and liabilities, with significant unrealized gains reported (e.g., $155 million for Southern Company at December 31, 2021). By 2024, the presentation shifted to a more detailed breakdown of current and non-current positions, with unrealized gains and losses reflected in both \"Other\" and \"Risk Management Activities\" sections of the balance sheets. Additionally, the net amounts recognized in the balance sheets for 2024 showed a reduction in overall exposure compared to 2022, indicating a more conservative or settled position in derivative valuations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in Southern Company's treatment of energy-related derivatives from deferral of unrealized gains/losses in regulatory accounts (2022) to a more detailed balance sheet presentation under 'Other' or 'Risk Management Activities' by 2024, which aligns with the ground truth. However, the LLM introduces a specific dollar amount—$155 million unrealized gain as of December 31, 2021—that is not present in the original answer and cannot be verified from the provided ground truth, making it a factual overreach. (2) The date reference to December 31, 2021, is consistent with the original answer’s backward-looking disclosure in the 2022 report, but the inclusion of a precise figure without support reduces quantitative accuracy. No other numbers are provided in the ground truth for comparison, so the claim of 'reduction in overall exposure' in 2024 lacks verifiable support and appears as inference beyond the data. (3) The multi-hop reasoning is sound: the model correctly infers a change in presentation and valuation approach over time, synthesizing information across years and disclosure practices. It accurately captures the conceptual shift from deferral under regulatory accounting to fair value presentation in financial statements. (4) While the core qualitative shift and contextual framing are accurate and relevant, the unsupported numerical claim lowers confidence in factual precision. The answer remains largely aligned with the original in meaning and relevance, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 432,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Between 2022 and 2024, Chevron's investment carrying value in Tengizchevroil increased from $23,727 million in 2022 to $27,368 million in 2024. However, Chevron's equity earnings from Tengizchevroil declined during this period, dropping from $4,386 million in 2022 to $3,033 million in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Chevron's equity earnings decline from $4,386 million in 2022 to $3,033 million in 2024, matching the ground truth exactly. It also accurately states the 2024 investment and advances value of $27,368 million. However, it introduces a figure of $23,727 million as the 2022 carrying value, which is not present in the original answer. The ground truth does not specify the total carrying value in 2022 but notes that it was about $100 higher than Chevron’s underlying equity in TCO’s net assets, with a $4,500 million loan being a significant component. The LLM’s specific $23,727 million figure is unsupported by the provided truth and appears to be either inferred or sourced incorrectly. (2) While the 2023 investment value of $26,954 million is mentioned in the original, the LLM omits it, simplifying the trend. This omission does not invalidate the answer but reduces completeness. The earnings numbers are quantitatively accurate. (3) The multi-hop reasoning is partially sound—Chevron’s growing investment value and declining earnings are correctly contrasted. However, the LLM fails to explain the composition of the investment (e.g., the $4.5B loan for FGP/WPMP), which is a key qualitative aspect of the financial relationship evolution. (4) Despite missing some contextual nuance and introducing an unverified 2022 carrying value, the core financial trend—rising investment value and falling equity earnings—is correctly conveyed. The answer is highly relevant and mostly accurate, warranting a score of 8 for correctness, with slightly lower quantitative and qualitative scores due to the unsupported figure and missing detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 460,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart acquired a 100% ownership stake in Alert Innovation during fiscal 2023 through a $0.4 billion acquisition. However, the entity was subsequently sold and deconsolidated in fiscal 2025, marking the end of Walmart's ownership in Alert Innovation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Walmart acquired a 100% stake in Alert Innovation for $0.4 billion in fiscal 2023 and later sold and deconsolidated the entity, ending its ownership. However, it incorrectly states the sale occurred in fiscal 2025, while the ground truth specifies fiscal 2024. This is a critical error in temporal accuracy that affects the correctness of the multi-hop timeline. (2) Quantitatively, the $0.4 billion acquisition amount and 100% ownership are accurate, and no calculations are required beyond these figures. The dollar amount and percentage are correctly reported. (3) The reasoning is partially sound: the model captures the acquisition and subsequent divestiture, showing understanding of ownership transformation. However, the misplacement of the sale into fiscal 2025 breaks the correct sequence of events within the specified fiscal years (2023 to 2024), undermining the multi-hop synthesis across the two fiscal periods. (4) The answer is contextually relevant and addresses both parts of the question—ownership evolution and transaction type—but the fiscal year error reduces factual accuracy significantly. While the nature of the transactions is correct, the timing misalignment leads to an incomplete and slightly misleading narrative. Hence, correctness is penalized more heavily, though not fully incorrect due to strong performance on other elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 391,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "Starbucks' foreign currency - other derivative asset positions increased from $55.3 million in fiscal 2022 to $920 million in fiscal 2023, while liability positions remained relatively low. This significant increase in asset positions indicates a more active use of hedging instruments to manage foreign currency exposure, reflecting the company's strategy to mitigate risks from currency fluctuations on anticipated cash flows and intercompany transactions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It claims Starbucks' foreign currency - other derivative assets increased from $55.3 million in 2022 to $920 million in 2023, which is factually wrong. According to the ground truth, by 2023, Starbucks reported only $1.9 million in current assets and $1.7 million in long-term assets for foreign currency - other derivatives—totaling $3.6 million, not $920 million. Additionally, the LLM completely omits the liability side of $4.7 million (current) and $4.1 million (long-term), falsely stating liabilities remained 'relatively low' without accurate reference. (2) The numbers are grossly inaccurate: the claimed $920 million is over 250 times higher than the actual total asset position in 2023. There is no indication in the ground truth of any $920 million figure related to this metric. The 2022 figure of $55.3 million is correctly cited, but the comparison is invalid due to the erroneous 2023 value. (3) The reasoning is flawed: the LLM concludes that the increase reflects a more active hedging strategy, but the actual data shows a dramatic reduction in exposure—from a $55.3 million unrealized gain in AOCI in 2022 to small, balanced asset and liability positions in 2023—indicating de-risking or unwinding of positions, not increased hedging. The model fails to recognize the shift from equity-based unrealized gains to on-balance-sheet assets and liabilities. (4) The contextual relevance is moderate because the answer addresses the right topic (hedging strategy and foreign currency derivatives), but the factual foundation is so incorrect that the conclusion is misleading. Due to severe quantitative and reasoning errors, the correctness score is low at 2, with similarly low scores for quantitative (1) and qualitative accuracy (2). Contextual relevance receives a 5 because the structure and intent align with the question, even if the content does not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 531,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Between fiscal years 2022 and 2024, Medtronic's treatment of A Preferred Shares remained consistent, as no A Preferred Shares were outstanding in either year. In 2022, the company redeemed the previously outstanding 1,872 A Preferred Shares for $0.075 million, leaving no A Preferred Shares outstanding as of April 29, 2022. This status continued through fiscal year 2024, with no A Preferred Shares issued or outstanding as of April 26, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic redeemed 1,872 A Preferred Shares for $0.075 million in fiscal year 2022, and no shares were outstanding as of April 29, 2022. This status persisted through fiscal year 2024, with no reissuance. The dates (April 29, 2022, and April 26, 2024) match the expected reporting periods. (2) Quantitative accuracy is perfect: the number of shares (1,872), dollar amount ($0.075 million), and fiscal years (2022, 2024) are all correct and match the original answer. Format variations (e.g., $0.075 million) are acceptable and standard. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across fiscal years and inferred continuity of the 'no outstanding shares' status from 2022 to 2024. (4) The only minor difference is semantic: the original emphasizes 'discontinuation' of the shares, while the LLM states 'remained consistent'—a slightly less strong characterization but still factually accurate. The LLM could have explicitly noted that no reissuance occurred, but the absence of outstanding shares in 2024 implies this. Thus, the answer is complete and correct in substance, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 354,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Comcast's financial relationship with Atairos evolved significantly between 2022 and 2023 in terms of equity income driven by fair value adjustments on underlying investments. In 2023, Atairos contributed $1.1 billion in income, a substantial improvement from a $434 million loss in 2022. This shift reflects a marked turnaround in the fair value adjustments of Atairos' underlying investments during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: the $434 million loss in 2022 and $1.1 billion income in 2023 from Atairos are correctly stated, with proper sign and magnitude (the original uses $(434) million, which is equivalent to a $434 million loss). (2) Quantitative accuracy is perfect—both numbers match the ground truth exactly, and the comparison correctly highlights the turnaround. (3) The multi-hop reasoning is sound: the answer synthesizes Comcast's equity income from Atairos across two years and correctly attributes the change to fair value adjustments on underlying investments, as required by the question. (4) The response is contextually relevant, directly addressing the evolution of the financial relationship in terms of equity income driven by fair value changes. Wording differs slightly but meaning is preserved, and no critical information is omitted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 276,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 312 BCF at the end of 2023 to 296 BCF at the end of 2024, reflecting a slight decline. This indicates a modest reduction in the company's direct natural gas reserves in the region, although the company remains active through equity affiliates, which saw an increase from 50 BCF to 62 BCF. This suggests that while COP's direct reserves have slightly decreased, its strategic positioning in the region is maintained through investments in equity affiliates, highlighting continued interest in the Asia Pacific/Middle East market.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that reserves increased from 312 BCF to 296 BCF, which is factually wrong—the correct trend is a decrease from 312 to 296 BCF. This misstatement undermines the core quantitative claim. While the 312 BCF (2023) and 296 BCF (2024) figures are correctly cited in value, the directional characterization ('increased') is erroneous. Additionally, the LLM introduces new data—equity affiliate reserves rising from 50 BCF to 62 BCF—that is not present in the original answer or ground truth, making it hallucinated information. (2) The individual numbers for 2023 and 2024 reserves are accurate (312 and 296 BCF), so quantitative accuracy is partially correct, but the comparison (increase vs. decrease) is flawed, and the added equity affiliate data lacks support. (3) The multi-hop reasoning fails because the model misinterprets the direction of change and injects unsupported data about equity affiliates, which were not part of the original knowledge graph answer. The conclusion about strategic positioning through affiliates goes beyond the provided evidence, which only suggests 'limited growth or strategic reallocation' based on the decline. (4) Despite the factual errors, the answer remains contextually relevant by addressing both the evolution of reserves and strategic implications. However, due to the incorrect trend description and hallucinated data, the correctness and qualitative accuracy scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 410,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL's revenue performance in Canada declined from $73 million in 2022 to $47 million in 2023, representing a 36% decrease, and further dropped to $28 million in 2024, a 40% decrease from 2023. This consistent decline indicates a deteriorating market trajectory for ENBREL in Canada, likely driven by factors such as lower net selling prices and increased competition, as noted in the disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue figures for 2023 ($47 million) and 2024 ($28 million), which match the ground truth. However, it incorrectly states the 2022 revenue as $73 million instead of the correct $113 million, a significant factual error. This affects the accuracy of the percentage decline calculations: while the 40% drop from 2023 to 2024 is approximately correct (from $47M to $28M is a 40.4% decrease), the claimed 36% decrease from 2022 to 2023 is based on the wrong baseline and is therefore inaccurate (actual decline from $113M to $47M is about 58.4%). (2) The quantitative inaccuracies are critical because they misrepresent the magnitude of the initial revenue and the rate of decline, undermining the financial analysis. (3) The qualitative reasoning is sound—the conclusion of a deteriorating market trajectory due to declining revenues is consistent with the actual trend and logically follows from the data. The mention of potential drivers like lower net selling prices and increased competition adds context supported by typical 10-K disclosures, even if not part of the original answer. (4) Contextual relevance is high as the response directly addresses both parts of the question: revenue evolution and market trajectory. Despite incorrect starting revenue, the overall narrative of sustained decline remains valid. However, the major numerical error in 2022 revenue prevents a higher correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 404,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "Qualcomm's approach to linking human capital advancements with executive compensation in fiscal 2024 evolved to make progress toward human capital advancements a non-financial performance modifier for executives' bonus payouts. Specifically, for fiscal 2024, this modifier could adjust the executives' bonus payout by a multiple ranging from 0.9 to 1.1.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and matches the ground truth in all key aspects. (1) It accurately states that Qualcomm evolved its approach in fiscal 2024 to use human capital advancements as a non-financial performance modifier for executive bonuses, which aligns with the ground truth. (2) The specific performance modifier range of 0.9 to 1.1 is correctly reported with no numerical errors. (3) The multi-hop reasoning is sound: the LLM correctly identifies the evolution from fiscal 2023 (where human capital was a general consideration) to fiscal 2024 (where it became a quantified modifier), though it omits explicit mention of fiscal 2023 context. This omission slightly reduces completeness but does not affect factual correctness. (4) All entities—Qualcomm, fiscal 2024, executive compensation, bonus modifier—are accurately identified and used. The answer is semantically equivalent to the ground truth, with only minor conciseness compared to the original. Thus, high scores across all categories, with a 9 in correctness due to partial omission of the comparative evolution detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 311,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Between 2022 and 2024, the therapeutic scope of Breyanzi expanded significantly. In 2022, Breyanzi was in Phase III trials for 3L+ Chronic Lymphocytic Leukemia (CLL) and 3L+ Follicular Lymphoma (FL). By 2024, Breyanzi received FDA approvals for treating adult patients with relapsed or refractory CLL/SLL who had received at least two prior lines of therapy and for relapsed or refractory FL after two or more lines of systemic therapy. Additionally, it was approved for relapsed or refractory mantle cell lymphoma (MCL) in patients with prior Bruton tyrosine kinase inhibitor exposure. These approvals demonstrate Breyanzi's expanded use across a broader range of B-cell malignancies.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of Breyanzi's therapeutic scope from Phase III trials in 2022 for 3L+ CLL and FL to FDA approvals in 2024 for relapsed or refractory CLL/SLL and FL after at least two prior lines of therapy. However, it introduces a significant factual error by stating that Breyanzi was approved for mantle cell lymphoma (MCL) in 2024, which is not supported by the ground truth and is incorrect. The original answer only mentions approvals for CLL/SLL and FL, with no reference to MCL. (2) The dates of approval (March and May 2024) are not explicitly mentioned in the LLM answer, though the year 2024 is correct. The requirement of prior Bruton tyrosine kinase inhibitor and BCL-2 inhibitor for CLL/SLL is partially captured but not fully detailed. The LLM correctly notes 'two or more lines of therapy' for FL, aligning with the ground truth. (3) The multi-hop reasoning is partially sound—correctly linking 2022 trial status to 2024 approvals—but fails in accuracy due to the inclusion of an unmentioned indication (MCL), which reflects a failure in entity and factual synthesis. (4) The contextual relevance is high as the answer addresses the evolution of therapeutic scope and uses appropriate terminology. However, the addition of an incorrect approval significantly undermines factual correctness, warranting a mid-range score. Quantitative and qualitative accuracy are reduced due to the erroneous indication and missing approval details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 413,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "Disney's Resorts and Vacations segment revenue grew by 5% from 2023 to 2024, driven by higher average ticket prices for cruise line sailings, increased hotel room rates, and more occupied room nights, partially offset by lower Disney Vacation Club unit sales. This growth aligns closely with the overall 5% revenue increase for the Parks & Experiences segment, indicating that the Resorts and Vacations segment performed in line with the broader segment's performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states a 5% growth for both the Resorts and Vacations segment and the overall Parks & Experiences segment, which aligns with the ground truth. However, it omits the actual revenue figures ($7,949M and $8,375M for Resorts and Vacations; $32,549M and $34,151M for Parks & Experiences), which are key quantitative details from the original answer. While the percentage growth is accurate, the absence of absolute values reduces completeness and quantitative precision. (2) The calculation of 5% growth is consistent with the ground truth: (8,375 - 7,949) / 7,949 ≈ 5.36%, which rounds to about 5%, and similarly for the overall segment: (34,151 - 32,549) / 32,549 ≈ 4.92%, also approximately 5%. Thus, the percentage figures are reasonably accurate. (3) The reasoning is sound in concluding that Resorts and Vacations grew in line with the overall segment, but the original answer notes that its growth was 'slightly below' due to the marginal difference in growth rates (5.36% vs 4.92%), whereas the LLM portrays them as 'in line', which slightly misrepresents the comparative performance. This reflects a minor flaw in multi-hop synthesis and interpretation. (4) The LLM provides relevant qualitative drivers (higher prices, occupancy, offset by DVC sales), which add context not in the ground truth, enhancing relevance. However, the omission of exact figures and slight mischaracterization of the comparative growth relationship prevents a higher score. Scores justified as: 7 for correctness (core facts right, but missing key data and nuanced comparison), 8 for quantitative accuracy (percentages correct but no absolute values), 7 for qualitative accuracy (logical but slightly flawed comparative reasoning), and 10 for contextual relevance (fully addresses the question scope with added useful context).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 499,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "Between 2023 and 2024, the structure and value of CVS's forward contracts associated with ASR transactions evolved as follows: In 2023, the $2.0 billion ASR with Citibank resulted in an initial 80% share delivery (17.4 million shares) and a forward contract of $0.4 billion. In 2024, the $3.0 billion ASR with Morgan Stanley involved an initial 85% share delivery (31.4 million shares) and a forward contract of $0.4 billion. This reflects a shift to a higher initial share delivery percentage in 2024, reducing the forward contract value relative to the notional amount compared to 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2.0 billion 2023 ASR with Citibank and the $3.0 billion 2024 ASR with Morgan Stanley, as well as the $0.4 billion forward contract value in both years, which matches the ground truth. It accurately notes the forward contract value remained constant despite the larger ASR size, indicating a shift in allocation—this aligns with the original answer’s conclusion. However, the LLM introduces specific share numbers (17.4 million and 31.4 million) and initial delivery percentages (80% and 85%) that are not present in the ground truth. While the 80% initial delivery in 2023 can be inferred from the $1.6B/$2.0B split (which is 80%), the 2024 split of $2.6B/$3.0B is ~86.7%, not 85%, making the 85% figure inaccurate. Additionally, the ground truth states 20% of shares were received in February 2023 (i.e., 80% initially delivered), and 15% in March 2024 (i.e., 85% initially delivered), so the percentage inference is directionally correct but slightly misstated. (2) The dollar amounts ($0.4B forward contract, $2.0B and $3.0B total ASRs) are correct. The share counts (17.4M, 31.4M) are not in the original and cannot be verified, suggesting potential hallucination. The 85% initial delivery is close but not exact (actual is ~86.7%). (3) The multi-hop reasoning is sound: the model correctly infers that a constant $0.4B forward contract on a larger ASR implies a smaller relative forward component, and it draws the correct qualitative conclusion about structural evolution. (4) The correctness score is 8 due to accurate core facts and valid reasoning, but docked for introducing unverified share numbers and slightly inaccurate percentages. Quantitative accuracy is 7 due to the incorrect percentage and unsupported share figures. Qualitative accuracy is 9 due to strong synthesis and correct interpretation. Contextual relevance is 10—fully on point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 517,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology in 2024 shows increased transparency around fair value categorization compared to 2023. In 2024, the company provided a more detailed breakdown of assets by fair value hierarchy levels (Level 1, Level 2, Level 3, and Not Categorized), including specific amounts for each category. Additionally, the 2024 disclosure explicitly explained the categorization of certain investments, such as those measured using the net asset value per share practical expedient, which were not included in the fair value hierarchy. In contrast, the 2023 disclosure offered similar data but with less clarity on the categorization rationale and fewer specific details on the composition of Level 3 and Not Categorized assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains significant inaccuracies. The ground truth states that in 2024, Duke Energy added a reconciliation of beginning and ending balances for Level 3 assets in the Master Retirement Trust, which represents increased transparency. However, the LLM incorrectly claims that in 2024, Duke Energy provided a 'more detailed breakdown of assets by fair value hierarchy levels (Level 1, Level 2, Level 3, and Not Categorized), including specific amounts for each category' — this level of granular categorization breakdown is not mentioned in the original answer and is therefore unsupported. Additionally, the LLM states that the 2023 disclosure 'offered similar data but with less clarity,' which contradicts the ground truth: the original answer does not indicate that 2023 included any breakdown by Level 1/2/3 at all, only that certain NAV-based investments were not categorized. (2) There are no explicit numbers in the original answer (e.g., percentages or dollar amounts), so the LLM’s implication of specific quantitative disclosures (like exact amounts per level) introduces false precision. The absence of such numbers in the ground truth makes the LLM’s quantitative claims inaccurate. (3) The multi-hop reasoning is partially sound — the model correctly identifies that transparency increased from 2023 to 2024 and correctly notes the treatment of NAV-based investments as 'not categorized' in the hierarchy. However, it fabricates the existence of a full fair value hierarchy breakdown in 2024 and overstates the detail in both years, failing to accurately reflect the nature of the incremental change (i.e., the addition of a Level 3 reconciliation, not a full hierarchy disclosure). (4) The correctness score is 5 due to partial factual alignment but significant overstatement of disclosure detail; quantitative accuracy is low (4) because of unsupported claims about specific amounts and categorizations; qualitative accuracy is moderate (6) as core concepts like fair value hierarchy and NAV expedient are handled correctly; contextual relevance is high (9) because the response stays focused on the evolution of disclosure and pension asset valuation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 593,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial obligations and revenue recognition related to Paxlovid shifted significantly due to the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile (SNS). In 2023, a non-cash revenue reversal of $3.5 billion was recorded, reflecting the expected return of 6.5 million EUA-labeled Paxlovid treatment courses by the U.S. government. In 2024, a favorable final adjustment of $771 million was recorded after 5.1 million courses were returned by February 29, 2024. Additionally, in the third quarter of 2024, Pfizer supplied 1.0 million treatment courses to create the U.S. SNS at no cost, recognizing $442 million in revenue. Deferred revenues related to Paxlovid decreased from $3.4 billion in 2023 to $2.2 billion in 2024, as products were delivered and obligations satisfied.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key financial figures and events from the ground truth: the $3.5 billion non-cash revenue reversal in 2023 due to expected return of 6.5 million Paxlovid courses, the $771 million favorable adjustment in 2024 based on the actual return of 5.1 million courses, and the $442 million revenue recognized in 2024 related to the U.S. Strategic National Stockpile (SNS) for 1.0 million treatment courses. All dollar amounts and quantities are accurate. (2) Quantitative accuracy is perfect: $3.5B, $771M, $442M, 6.5M, 5.1M, and 1.0M all match the original answer. The mention of deferred revenues decreasing from $3.4B to $2.2B is an additional detail not in the ground truth but does not contradict it and may reflect supplementary data; it does not detract from accuracy. (3) The multi-hop reasoning is sound—correctly linking the 2023 reversal to the 2024 adjustment based on actual returns, and identifying the shift in revenue recognition due to SNS creation. The only minor shortcoming is the claim that Pfizer supplied the SNS 'at no cost'—while revenue was recognized, the phrasing could imply a donation, but in context, the recognition of $442M in revenue aligns with proper accounting, so this is likely a wording nuance rather than a factual error. (4) The answer is highly relevant, complete, and semantically equivalent to the ground truth, with excellent synthesis across years and financial events. The correctness score is 9 instead of 10 due to the slight ambiguity around 'at no cost' despite revenue recognition, which could confuse readers about the nature of the transaction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 450,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA's financial performance improved significantly between 2022 and 2023, with sales increasing by 26.9% to $2.387 billion in 2023 from $1.881 billion in 2022. This growth was driven by continued share gains and market expansion in the treatment of metastatic castration-resistant prostate cancer. This strong performance highlights ERLEADA's growing importance within J&J's oncology portfolio, which saw overall sales growth of 10.5% in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: ERLEADA sales increased from $1.881 billion in 2022 to $2.387 billion in 2023, representing a 26.9% growth. These figures match the ground truth exactly, with acceptable format variation (e.g., $1.881 billion = $1,881 million). The overall oncology portfolio growth of 10.5% in 2023 is also accurately cited. (2) All calculations are correct—26.9% growth is accurate based on the provided figures: (2387 - 1881) / 1881 ≈ 0.269. (3) The reasoning is sound and captures the multi-hop synthesis: ERLEADA’s strong growth within a growing oncology segment indicates its increasing strategic importance. However, the LLM answer omits a key contrast mentioned in the ground truth: the decline in other oncology products like IMBRUVICA and ZYTIGA, which strengthens the conclusion that ERLEADA is becoming a more central revenue driver. This omission slightly weakens the qualitative depth but does not invalidate the core conclusion. (4) Despite this, the answer remains factually correct, contextually relevant, and semantically aligned with the ground truth. The missing comparative context prevents a perfect 10, but the response is otherwise excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 345,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA's global sales increased significantly from 2022 to 2023, with worldwide sales growing by 70.0% to $1,291 million in 2023 from $760 million in 2022. This growth was driven by strong performance in both the U.S. and international markets, with U.S. sales rising by 39.3% and international sales surging by a substantial margin. This indicates a positive market trajectory for ERLEADA, reflecting strong market acceptance and continued share gains in its indication for metastatic castration-resistant prostate cancer.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in numbers and timeframes. It incorrectly states that ERLEADA's 70.0% growth was from 2022 to 2023, when in fact the 70.0% growth occurred from 2021 to 2022, with 2022 sales at $1,291 million. The LLM claims 2023 sales were $1,291 million, but the ground truth shows 2023 sales were $2,387 million. It also fabricates a 2022 sales figure of $760 million, which is incorrect (actual 2021 sales were ~$760 million). The actual 2023 growth rate was 26.9%, not mentioned in the LLM response. (2) Calculations are fundamentally wrong: the LLM misattributes the 70% growth to the wrong year comparison and invents figures not present in the ground truth. The correct progression is $760M (2021) → $1,291M (2022, +70%) → $2,387M (2023, +26.9%). (3) Multi-hop reasoning fails: the model does not correctly trace the sales evolution across years and confuses the direction of growth. It omits the actual 2023 sales figure and growth rate, instead recycling the prior year’s growth metric incorrectly. (4) Contextual relevance is moderate—it addresses market trajectory and growth drivers—but the severe quantitative inaccuracies undermine the qualitative insights. The conclusion about positive trajectory is directionally correct but based on false premises. Scores reflect major factual errors in core data, especially in financial figures and temporal logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 391,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "NVDA's debt management strategy regarding the 0.584% Notes Due 2024 evolved between fiscal years 2023 and 2024 by repaying the notes in fiscal year 2025 as planned. In the 2023 filing, the notes had a remaining term of 0.4 years and a carrying value of $1,250 million, indicating they were due shortly. By the 2024 filing, the notes were fully repaid, as noted in the statement that repayment occurred in fiscal year 2025. This reflects a proactive approach to managing short-term debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $1,250 million carrying value in fiscal year 2023 is accurately reported, and the repayment in fiscal year 2025 is consistent with the original answer. The interest rate (0.66%) is not mentioned in the LLM answer, which is a minor omission, but no incorrect numbers are presented. (2) The timeline is correctly interpreted: the note was outstanding in FY2023, and repayment occurred in FY2025, as disclosed in the FY2024 10-K. The statement about the remaining term of 0.4 years adds contextual precision and is logically sound, though not in the original answer. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers from the filings that the debt was repaid rather than refinanced, indicating a shift in strategy. The characterization as a 'proactive approach' is a reasonable interpretation. (4) The only minor gap is the omission of the effective interest rate (0.66%), which was included in the ground truth and relevant to debt management strategy. However, this does not undermine the core correctness. The answer is contextually relevant, directly addressing the evolution in strategy with accurate evidence. Thus, the correctness score is 9 due to high accuracy with a small detail missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 377,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Honeywell's investment in Mortgage/Asset-backed securities decreased significantly between 2022 and 2023. In 2022, the total value of Mortgage/Asset-backed securities was $1,119 million for U.S. plans and $31 million for non-U.S. plans, totaling $1,150 million. In 2023, this dropped to $676 million for U.S. plans and $10 million for non-U.S. plans, totaling $686 million. The magnitude of the change was a decrease of $464 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Honeywell reported $982 million in Mortgage/Asset-backed securities in 2022 under U.S. Plans and only $10 million in 2023 under Non-U.S. Plans, representing a reduction of $972 million. However, the LLM claims total investments of $1,150 million in 2022 ($1,119M U.S. + $31M non-U.S.) and $686 million in 2023 ($676M U.S. + $10M non-U.S.), which are not supported by the ground truth. These numbers are entirely incorrect and lead to an erroneous decrease of $464 million instead of the correct $972 million. (2) The calculation of the change ($1,150M - $686M = $464M) is mathematically correct based on the LLM's numbers, but since the inputs are wrong, the result is invalid. The ground truth shows a >98% reduction, which the LLM fails to reflect. (3) The multi-hop reasoning is flawed: the LLM incorrectly attributes 2022 investments to both U.S. and non-U.S. plans and does not recognize that the 2023 amount is solely under Non-U.S. Plans after a near-complete divestment. It also fails to identify that the investment dropped from $982M to $10M, missing the strategic shift emphasized in the original answer. (4) Scores are low due to major quantitative and qualitative errors. The contextual relevance is moderate because the answer addresses the general trend (decrease), but the magnitude and entity-specific details are wrong, undermining the core of the multi-hop analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 411,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations remained a key component of its funding mix, with the fair value of securitized debt obligations classified under Level 2 of the fair value hierarchy in both years. In 2023, the fair value of securitized debt obligations was $18.067 billion, compared to $16.918 billion in 2022, indicating a slight increase. These obligations were primarily used to support the company's long-term funding strategy and were not subject to nonrecurring fair value adjustments, as they were measured at fair value on a recurring basis.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative data. The ground truth states that in 2023, the carrying value of securitized debt obligations was $18,043 million with a fair value of $18,067 million, all classified under Level 2. The LLM correctly reports the 2023 fair value as $18.067 billion (equivalent to $18,067 million), which is accurate. However, it incorrectly claims the 2022 fair value was $16.918 billion — this figure is not present in the original answer and is therefore unsupported. The original answer does not provide any 2022 fair value or carrying value for securitized debt obligations, only a qualitative description of their role in the funding mix. Thus, the comparison between years is fabricated. (2) The calculation of a 'slight increase' from $16.918B to $18.067B is based on incorrect data and therefore invalid. No numerical comparison can be made between 2022 and 2023 per the ground truth. (3) The qualitative reasoning partially aligns: the LLM correctly identifies that securitized debt obligations remained a key part of the funding mix and that they were classified under Level 2 in 2023. However, it fails to note that the shift from 2022 to 2023 involved increased transparency and disclosure — a key point in the original answer. The LLM also introduces the claim that these instruments were 'measured at fair value on a recurring basis' and 'not subject to nonrecurring adjustments' — details not present in the ground truth and thus unverifiable. (4) The contextual relevance is high because the answer addresses the evolution in funding mix and fair value classification. However, due to the invention of a 2022 fair value figure and unsupported comparisons, the quantitative accuracy is low. The correctness score is pulled down primarily due to this major factual error, despite some correct elements like the 2023 fair value and Level 2 classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 528,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules showed a decline in the CECL-related capital benefit from 2023 to 2024. Specifically, the benefit was $1.4 billion as of December 31, 2023, and reduced to $720 million as of December 31, 2024. This indicates a quantitative decrease of $680 million in the CECL-related capital benefit during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the CECL-related capital benefit amounts for both 2023 ($1.4 billion) and 2024 ($720 million), matching the ground truth exactly. The quantitative decrease of $680 million ($1.4B - $720M) is accurately calculated. (2) All numeric values and dates (December 31, 2023 and December 31, 2024) are correct and consistent with the original answer. Format variations (e.g., $1.4 billion vs $1.4B) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly infers a decrease in the benefit over time due to the phase-in of U.S. capital rules, though it omits the forward-looking detail that the benefit was fully phased in by January 1, 2025. This omission is minor and does not detract from the core factual accuracy. (4) The answer is contextually relevant, directly addressing both parts of the question—evolution of treatment and quantitative change. The qualitative accuracy is slightly reduced only because the explanation of the regulatory phase-in is less detailed than in the ground truth, but the core logic remains correct. Overall, the answer is factually precise and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 340,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolved as follows: In fiscal 2023, the Credit Facility had a capacity of $3.0 billion and was set to mature in December 2025. By fiscal 2024, the Credit Facility was increased to $5.0 billion and extended to mature in October 2029. Additionally, the administrative agent for the facility changed from Citibank, N.A. to Bank of America, N.A. No outstanding borrowings were present under the facility in either year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $3.0 billion capacity in fiscal 2023 maturing in December 2025, and the $5.0 billion facility in fiscal 2024 maturing in October 2029 are correctly reported. These numbers match the original answer exactly, and formatting is consistent. (2) Quantitative accuracy is perfect—dollar amounts and dates are correct, and no calculations were required. (3) The reasoning is sound and correctly synthesizes the evolution of the credit agreement across fiscal years. The LLM adds an extra detail—the change in administrative agent from Citibank, N.A. to Bank of America, N.A.—which is not in the ground truth. While this additional information may be factually correct based on external filings, it is not part of the provided knowledge graph and slightly exceeds the scope of the original answer. However, it does not contradict it. The note about no outstanding borrowings is also not in the original answer but is contextually relevant and does not introduce error. (4) The answer is fully relevant to the question and addresses both terms and capacity changes. The only reason for not giving a perfect 10 is the inclusion of unverified (though plausible) details not present in the ground truth, which slightly affects qualitative accuracy. Overall, the core multi-hop synthesis—comparing the two fiscal years’ credit facilities—is executed correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 400,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "UPS divested its Coyote business in the third quarter of 2024, resulting in a pre-tax gain of $156 million ($152 million after tax) for the year ended December 31, 2024. Between 2022 and 2024, Coyote was part of UPS's Supply Chain Solutions segment, providing truckload brokerage services in the U.S. and Europe. The divestiture marked the end of this relationship, and the financial impact in 2024 was a gain, which UPS excluded from ongoing operations in its non-GAAP financial reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the pre-tax gain of $156 million and after-tax gain of $152 million match the original answer exactly. The timing of the divestiture in 2024 is correctly stated, and while the original answer does not specify the quarter, the LLM adds the detail of 'third quarter'—this is a minor addition but not contradicted by the ground truth and commonly reported in financial disclosures, so it does not reduce accuracy. (2) The financial impact in 2024 is correctly identified as a gain, and the note that it was excluded from non-GAAP ongoing operations adds useful context not in the original but consistent with typical reporting practices. (3) Qualitatively, the evolution of the relationship is accurately described: Coyote operated as part of UPS’s supply chain solutions, providing truckload brokerage in the U.S. and Europe during 2022–2024, and was fully divested by 2024. The reasoning correctly synthesizes the transition from integration to divestiture as a strategic shift. (4) The only minor shortcoming is that the LLM does not explicitly mention Coyote being a 'branded subsidiary' or its integration with UPS fleet and third-party carriers, which are details present in the original. However, the core facts and implications are preserved. The answer is fully relevant, directly addressing both the relationship evolution and financial impact. Overall, this is a semantically equivalent, factually correct response with excellent multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 431,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Between 2023 and 2024, Union Pacific's relationship with chassis has undergone significant changes in terms of total units and ownership structure. In 2023, the company owned 30,635 chassis and leased 17,705, totaling 48,340 units. By 2024, the number of owned chassis dropped to 4,356, while leased chassis increased to 1,197, resulting in a total of 5,553 chassis. This represents a substantial reduction in both total chassis units and a shift from a primarily owned structure to a largely leased model.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values: 2023 owned (30,635), leased (17,705), and total (48,340) are accurate. 2024 figures — owned (4,356), leased (1,197), and total (5,553) — are also correct. However, the LLM incorrectly states that leased chassis 'increased' to 1,197 in 2024, when in fact leased units decreased from 17,705 in 2023 to 1,197 in 2024. This is a qualitative error in interpretation. (2) All calculations are correct: 30,635 + 17,705 = 48,340 and 4,356 + 1,197 = 5,553. The quantitative accuracy is high, with only a minor misstatement in directional change for leased units. (3) The multi-hop reasoning is sound — the model correctly synthesizes data across two years and ownership types, identifying the significant reduction in total units. However, the conclusion that there was a shift to a 'largely leased model' is incorrect; in both years, owned units dominate the mix, and the overall trend is a massive reduction in scale, not a structural shift toward leasing. The original answer correctly frames it as a reduced footprint with a still mixed but much smaller ownership structure. (4) The answer is highly relevant and addresses both parts of the question — total units and ownership structure — with accurate data. The error in interpreting the ownership shift prevents a perfect score, but core facts and numbers are correct, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 395,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Between 2022 and 2024, Boeing has consistently classified its aluminum agreements as derivative instruments for accounting purposes but has not designated them for hedge accounting treatment. In 2022, these agreements were described as addressing long-term strategic sourcing objectives and non-U.S. business requirements, with changes in their fair value recorded directly in earnings. By 2024, the disclosure expanded to clarify that these agreements involve quantities offset at prevailing market prices and include both purchase and sale commitments. However, the time horizon for these agreements remained consistent, with commodity contracts hedging forecasted transactions through 2028. No significant changes in classification or time horizon were observed in the provided disclosures.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Boeing classified aluminum agreements as derivatives without hedge accounting treatment in both 2022 and 2024, and accurately describes the 2022 disclosure regarding strategic sourcing and non-U.S. business requirements. It also correctly notes that changes in fair value were recorded in earnings. However, it incorrectly claims that 'the time horizon for these agreements remained consistent' and that 'commodity contracts hedging forecasted transactions through 2028' were already in place in 2022. The ground truth indicates that the 2028 time horizon and structured hedging strategy were a new development by 2024, representing an evolution from the 2022 disclosures. This misrepresents a key aspect of the change over time. (2) Quantitatively, the year 2028 is correctly cited, and no other numerical data (e.g., dollar amounts) is involved, so quantitative accuracy is high. (3) The multi-hop reasoning is partially flawed: while the model synthesizes information across years, it fails to correctly identify the evolution in time horizon and strategic intent. The original answer emphasizes a shift from strategic sourcing to structured hedging with a defined 2028 horizon as a change, whereas the LLM answer treats the 2028 horizon as pre-existing. (4) Contextual relevance is strong—the response addresses classification, accounting treatment, and time horizon as asked—but the incorrect portrayal of continuity undermines the core of the question about 'evolution' between years, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 434,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble's exposure to currency rate risk remained relatively stable between the fiscal years ended June 30, 2023, and June 30, 2024. The Company continues to leverage its diversified portfolio of exposures as a natural hedge and prioritizes operational hedging over financial instruments. Hedging activities for currency rate risk primarily involve forward contracts and currency swaps with maturities of less than 18 months. The Company maintains confidence in its ability to mitigate near-term exchange rate fluctuations, as it believes the impact of such fluctuations on its financial statements would not be material at a 95% confidence level based on historical currency rate movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Procter & Gamble's currency risk exposure remained stable between FY2023 and FY2024, aligning with the ground truth's 'materially unchanged' characterization. It accurately identifies the use of forward contracts and currency swaps with maturities under 18 months and correctly notes the 95% confidence level assessment regarding near-term exchange rate impacts. The only minor discrepancy is the addition of 'diversified portfolio of exposures as a natural hedge' and 'prioritizes operational hedging over financial instruments,' which are not present in the original answer. While these may reflect broader P&G strategy, they are not mentioned in the ground truth for this specific time comparison and slightly extend beyond the provided facts. (2) All quantitative elements—fiscal years (June 30, 2023, and June 30, 2024), 18-month maturity horizon, and 95% confidence level—are factually accurate and match the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two fiscal years, identifies consistent hedging instruments, and maintains the correct conclusion about financial statement impact. The added detail on operational hedging does not contradict but slightly over-enriches the response. (4) The correctness score is 9 due to high factual accuracy and semantic equivalence; the quantitative accuracy is 10 as all numbers and timeframes are correct; qualitative accuracy is 9 due to minor unverified additions; contextual relevance is 10 as all parts of the question are directly addressed with appropriate focus on evolution, instruments, and confidence level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 457,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Between 2022 and 2024, Adobe has expanded Frame.io's functional scope and integration with its ecosystem. Frame.io is described as a cloud-native creative collaboration platform that supports video workflows beyond post-production, including casting, location scouting, and marketing campaign management, as well as still images and design files. In 2024, Frame.io is highlighted as being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, enabling seamless, frame-specific feedback. Additionally, Frame.io is part of Adobe GenStudio, which allows for scalable content production, indicating a stronger integration with Adobe's generative AI tools and broader creative workflows. This evolution reflects Adobe's strategy to position Frame.io as a central hub for collaborative creative production within its integrated product suite.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io evolved from a trademarked asset in 2022 to a cloud-native creative collaboration platform by 2024 with expanded functionality. The listed integrations with Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront are accurate, as is its inclusion in Adobe GenStudio. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound—correctly inferring increased integration and functional expansion over time based on changes in product description and ecosystem embedding. The LLM adds slightly more detail (e.g., casting, location scouting, marketing campaign management) not explicitly stated in the ground truth, but these are reasonable inferences given the 'expanded capabilities' and 'scalable content production' context, and do not contradict the original. (4) The answer fully addresses the question about evolution in functional scope and integration, and the semantic meaning matches the ground truth. The only minor deviation is the extrapolation of use cases beyond post-production, which is plausible but not explicitly confirmed—hence a 9 instead of 10 on qualitative accuracy. Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 404,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between the 2022 and 2023 fiscal years, AMD's carrying value of its investment in the ATMP JV increased from approximately $83 million to $99 million, reflecting a rise in the equity method investment's value. Financial disclosures related to the ATMP JV became more detailed in 2023, with specific mention of purchases from and resales to the JV, as well as the amounts payable and receivable. Additionally, AMD reported equity income gains from the ATMP JV in both years, with a slight increase in 2023 compared to 2022.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that in the 2022 filing, AMD reported carrying values of $69 million (as of December 25, 2021) and $63 million (as of December 26, 2020), but the LLM falsely claims values of $83 million and $99 million, which are not supported by the data. Furthermore, the LLM asserts that financial disclosures became more detailed in 2023, when in fact the opposite is true: the 2023 filing omits carrying values and specific transaction figures entirely, indicating reduced disclosure. The LLM incorrectly states that AMD reported equity income gains from the JV in both years and that there was a slight increase in 2023—this information is not present in the ground truth and contradicts the actual trend of reduced disclosure. (2) All numeric values provided by the LLM ($83M, $99M, 'slight increase') are fabricated and do not match the original answer. There are no correct numbers in the LLM response. Calculations or comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is fundamentally flawed. The question requires comparing the extent and nature of financial disclosures across two years, particularly regarding carrying values and transaction details. The LLM incorrectly infers increased transparency and investment value, when the correct inference is a reduction in disclosure despite an unchanged equity stake. The model fails to recognize that omission of data in the 2023 filing signifies less detailed reporting. (4) The contextual relevance is moderate because the LLM addresses the right topic (AMD's relationship with ATMP JV) and mentions relevant aspects like investment value and disclosures, but the factual inaccuracies and incorrect synthesis render the answer misleading. Due to complete failure on quantitative and qualitative accuracy, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 522,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a slight contraction in its original equipment manufacturing activities within the aerospace sector, potentially due to market conditions or shifts in demand. However, the overall Aerospace Technologies segment still showed growth in net sales, indicating that other areas, such as the aftermarket and defense, are compensating and reinforcing Honeywell's broader position in the aerospace industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue figures for Commercial Aviation Original Equipment—$2,397 million in 2023 and $2,223 million in 2024—matching the ground truth exactly. The decrease is accurately implied, and no calculation is required beyond the comparison, which is correctly interpreted as a decline. (2) All numeric values are correct and presented in a consistent format; minor phrasing differences (e.g., 'decreased from...to...') do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies the decline in the specific segment while contextualizing it within the broader growth of the Aerospace Technologies division, which requires synthesizing information across different parts of the business. The inference about other areas (aftermarket, defense) compensating is a reasonable extension supported by the ground truth’s mention of overall division growth. (4) The only minor difference from the ground truth is that the LLM attributes the decline to 'market conditions or shifts in demand,' whereas the original answer suggests 'potential weakening in original equipment demand or supply constraints.' These are semantically similar and both speculative but plausible; the slight broadening of causes does not undermine factual correctness. Overall, the answer is factually accurate, complete, and contextually appropriate, warranting a high score with only a small deduction in qualitative accuracy due to slightly less precise diagnostic language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 419,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased from $1,161 million in 2023 to $1,279 million in 2024, representing a 10.2% increase. Excluding the impact of foreign exchange, the growth was 10.3%.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the global revenue for Heart Failure Devices as $1,161 million in 2023 and $1,279 million in 2024, matching the ground truth. The percentage change is accurately calculated as 10.2%, which aligns with the ground truth ((1,279 - 1,161) / 1,161 ≈ 0.1016 → 10.2%). The additional detail about 10.3% growth excluding foreign exchange is plausible and consistent with the ground truth's note on minimal exchange rate impact, though this specific figure is not in the original answer. (2) All numeric values and the percentage increase are correct; the minor discrepancy in the FX-adjusted growth rate (10.3% vs. not mentioned) does not contradict the original but adds a detail not present in the ground truth. (3) The multi-hop reasoning is sound—revenue figures across two years are correctly compared and synthesized into a percentage change. The addition of FX-adjusted growth shows deeper contextual understanding, though it slightly exceeds the provided data. (4) The answer is highly accurate, complete, and relevant. The only reason for not scoring a 10 is the introduction of a specific FX-adjusted growth figure (10.3%) not present in the original, which, while reasonable, is not verifiable from the ground truth. Otherwise, all key facts, calculations, and context are correct and well-synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 377,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "The 0.300% Notes due 2028 (trading symbol IBM 28B) are listed in IBM's 2023 10-K (page 1) as securities registered under Section 12(b) of the Exchange Act, traded on the New York Stock Exchange. In the 2022 10-K (page 31), there is no specific mention of these notes, suggesting they were either newly issued or newly registered for trading between 2022 and 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: the 0.300% Notes due 2028 are correctly identified with their trading symbol (IBM 28B), and the 2023 10-K does list them as registered under Section 12(b) and traded on the NYSE. The 2022 10-K reference is partially incorrect—while the notes are not explicitly listed in a table, they *are* referenced via incorporation by reference to the February 10, 2020 Form 8-K in Exhibit 4.1, as stated in the ground truth. The LLM incorrectly states there is 'no specific mention' in the 2022 filing, which is not accurate; the notes were disclosed through incorporation by reference, a standard and legally valid method. This omission affects qualitative accuracy, as it mischaracterizes the nature of the 2022 disclosure. However, the overall evolution—increased prominence and formal listing in 2023—is correctly inferred. Quantitative accuracy is perfect: no incorrect numbers, dates, or symbols. Contextual relevance is high, as the response directly addresses the evolution question. The reasoning is mostly sound but misses the nuance of incorporation by reference, weakening the multi-hop synthesis. Thus, correctness is reduced to 7 due to this key factual inaccuracy in characterization, despite correct entity and symbol identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 360,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple's financial performance in the Rest of Asia Pacific region from 2022 to 2023 showed modest growth in both net sales and operating income. Net sales increased from $29,375 million in 2022 to $29,615 million in 2023, while operating income rose from $11,569 million in 2022 to $12,066 million in 2023. This indicates a slight improvement in both revenue and profitability for the region during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key numerical values: net sales of $29,375 million in 2022 and $29,615 million in 2023, and operating income of $11,569 million in 2022 and $12,066 million in 2023 are all correctly reported. The quantitative accuracy is perfect, with no errors in dollar amounts or years. The answer correctly identifies the upward trend in both net sales and operating income, indicating growth. However, the LLM omits the specific percentage increases (0.8% for net sales and 4.3% for operating income) and the absolute dollar changes ($240 million and $497 million), which were included in the original answer and directly address the 'evolution' aspect of the question. While the qualitative assessment of 'modest' or 'slight' growth is reasonable and aligns with the small percentage changes, the lack of explicit calculation details represents a minor incompleteness in multi-hop synthesis—particularly the failure to compute and report the changes. This prevents a perfect score, but the core facts, entities, and trends are correct, and the response is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 323,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed between grants made prior to 2022 and those made after December 31, 2021. Stock options granted prior to 2022 generally vested pro rata over a five-year period, while stock options granted after December 31, 2021 generally vest pro rata over a four-year period. Both types of grants terminate ten years from the grant date, though specific terms for executive officers and certain employees may vary.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. (1) Quantitative accuracy: The vesting periods—five years for grants prior to 2022 and four years for grants after December 31, 2021—are accurately reported. The mention of a ten-year termination period is additional but consistent with typical option terms and does not contradict the ground truth. (2) Completeness: The answer addresses the core evolution in vesting periods as requested. However, it does not explicitly reference the 2024 10-K confirmation mentioned in the original answer, which slightly reduces completeness. The ground truth emphasizes that both the 2022 and 2024 10-Ks confirm the same pattern, reinforcing consistency over time—a nuance omitted in the LLM response. (3) Entity accuracy: The plan name (2007 Omnibus Incentive Plan), time periods (prior to 2022, after December 31, 2021), and vesting terms are correctly identified. (4) Reasoning: The multi-hop synthesis between pre- and post-2021 grants is sound and correctly infers a structural change. The LLM correctly interprets the shift from five- to four-year vesting, demonstrating valid reasoning. (5) Semantic equivalence: The meaning conveyed is substantively the same, though the LLM omits the reaffirmation in the 2024 filing, which slightly weakens the longitudinal confirmation. Overall, the answer is highly accurate with only minor contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 395,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "From 2022 to 2023, CVS maintained a consistent approach to validating fair value estimates for its Level 2 debt securities, with no adjustments made to the prices obtained for these securities in either year. However, in 2023, the Company experienced net realized and unrealized capital losses, which were partially offset by purchases and transfers out of Level 3, indicating a shift in asset classification and valuation adjustments. The process of comparing prices with secondary sources and internal estimates remained unchanged, but the 2023 data reflects a more active reclassification of assets between levels, particularly with significant net transfers out of Level 3.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that CVS maintained a consistent approach to validating fair value estimates for Level 2 debt securities from 2022 to 2023, with no price adjustments made in either year, and that price comparisons to secondary sources remained unchanged—this aligns with the ground truth. However, the LLM introduces information not present in the original answer or context: specifically, the mention of 'net realized and unrealized capital losses' and 'significant net transfers out of Level 3' in 2023. These details, while potentially true in a broader financial context, are not part of the ground truth response and misrepresent the focus of the question, which was on Level 2 validation methodology, not Level 3 reclassifications or overall capital gains/losses. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not heavily penalized, but the inference of valuation adjustments due to Level 3 transfers implies numerical shifts not supported in the ground truth, reducing confidence in quantitative fidelity. (3) The multi-hop reasoning is flawed: the question asks about evolution in validation approach for Level 2 securities, and the correct answer is that there was no change. The LLM incorrectly infers that activity in Level 3 classifications indicates a shift in Level 2 validation, which is a logical error—movement between levels does not imply a change in pricing validation methodology for Level 2. (4) The contextual relevance is moderate because the core process (single price, no adjustments, secondary source checks) is accurately described, but the inclusion of extraneous Level 3 dynamics distracts from and distorts the actual evolution (or lack thereof) in Level 2 validation. Thus, while partially correct, the answer misleads by implying change where the ground truth emphasizes consistency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 518,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "Between 2022 and 2023, CVS maintained its classification of privately-placed equity securities in Level 3 of the fair value hierarchy due to the absence of active markets. The valuation methodology remained consistent, relying on internal analysis of each investment's financial statements and cash flow projections. Unobservable inputs such as earnings and revenue multiples, discounts for lack of marketability, and comparability adjustments continued to be significant in determining fair value. However, in 2023, there were net transfers out of Level 3 for certain financial assets, indicating a reduction in the use of unobservable inputs for some securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that CVS classified privately-placed equity securities as Level 3 in both 2022 and 2023 and used internal financial analysis and cash flow projections for fair value determination. It accurately lists the unobservable inputs (earnings and revenue multiples, discount for lack of marketability, comparability adjustments) consistent with the ground truth. However, the LLM introduces a fact not present in the original answer: 'net transfers out of Level 3 for certain financial assets' in 2023. This claim is unsupported by the ground truth, which makes no mention of Level 3 transfers or a reduction in unobservable inputs. Instead, the original answer notes an increased emphasis on sensitivity analysis regarding unobservable inputs, not a decrease in their use. This misrepresents the evolution of the methodology. While the core valuation approach and inputs are correctly described, the erroneous addition about Level 3 transfers undermines the accuracy of the reasoning and suggests a flawed synthesis. The answer is contextually relevant and mostly factually aligned, but the incorrect inference lowers the correctness and qualitative accuracy scores. No numerical data is incorrect (hence high quantitative score), but the reasoning misstep is significant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 361,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue from Alphagan/Combigan decreased by 21.4% between 2023 and 2024. Internationally, the revenue for Alphagan/Combigan increased by 4.9% in 2024 compared to 2023, indicating a positive trend in international markets during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the revenue change and international revenue trend. The total net revenue decreased from $272M to $248M, a decline of 8.8%, not 21.4% as claimed. The international revenue increased from $151M to $153M, a 1.5% growth, not 4.9% as stated. These numerical errors severely undermine the factual correctness. (2) Calculation verification: (272 - 248)/272 = 24/272 ≈ 8.8%, not 21.4%. International growth: (153 - 151)/151 ≈ 1.32%, which rounds to 1.5% in the ground truth, not 4.9%. Both percentages are incorrect. (3) Multi-hop reasoning is partially present—LLM attempts to compare two time points and assess trends—but fails in synthesizing the correct values across years and geographies. It identifies the right product (Alphagan/Combigan) and the right dimensions (total net revenue, international revenue), but uses incorrect data points. (4) Correctness and quantitative accuracy are low due to major numerical errors. Qualitative accuracy is slightly higher because the model recognizes the direction of change (decrease in total, increase in international), though magnitudes are wrong. Contextual relevance is high as the answer addresses the right question structure and entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 355,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "Chevron's relationship with PDC Energy transitioned from an external entity in 2023 to a wholly-owned subsidiary in 2024. This acquisition had a notable operational impact, contributing to a seven percent increase in Chevron's worldwide oil-equivalent production in 2024 compared to 2023, primarily due to the full-year inclusion of PDC's production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the acquisition of PDC Energy by Chevron and its impact on production, with accurate representation of the 7% increase in worldwide oil-equivalent production in 2024. The timing of the acquisition (2023) and its operational impact in 2024 are correctly conveyed. (2) Quantitatively, the 7% production increase is accurately reported, and the reference to full-year contribution aligns with the ground truth. No calculation errors or incorrect numbers are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes that PDC was acquired in 2023 (transitioning from external to subsidiary) and became a contributor to 2024 production growth. The only minor shortcoming is that the LLM does not explicitly mention PDC's exclusion from internal control assessment in 2023, which is part of the original answer but not critical to the operational impact focus of the question. (4) The answer is semantically equivalent to the ground truth, with slightly simplified wording but no loss of key factual content. The relationship evolution and operational impact are both accurately addressed, making the response highly relevant and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 342,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "From 2023 to 2024, UPS enhanced its cold-chain logistics capabilities primarily through the acquisition of MNX Global Logistics in 2023 and Frigo-Trans and Biotech & Pharma Logistics in 2024. These acquisitions, reported under Supply Chain Solutions, expanded UPS's international complex cold-chain logistics services, particularly in healthcare and temperature-sensitive logistics.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key acquisitions in both years—MNX Global Logistics in 2023 and Frigo-Trans and Biotech & Pharma Logistics in 2024—and links them to the expansion of cold-chain logistics, particularly in healthcare and temperature-sensitive sectors. However, it omits the 2023 acquisition of Bomi Group, which is mentioned in the ground truth as a key part of UPS's strategy that year, making the 2023 coverage incomplete. (2) There are no numeric values in the LLM answer that contradict the ground truth; it does not mention the $440 million acquisition cost for the 2024 German deals, but it also does not misstate any figures. Since it avoids quantification, it neither gains nor loses points for quantitative inaccuracy—hence a high score of 9. (3) The multi-hop reasoning is mostly sound: the model connects acquisitions across years to demonstrate evolution in strategy and correctly infers a focus on international, complex cold-chain logistics. The omission of Bomi Group weakens the completeness of the synthesis, but the core trajectory from 2023 to 2024 is logically presented. (4) Contextual relevance is perfect—the answer directly addresses how UPS's investment evolved and which acquisitions contributed, even if not exhaustively. The focus on healthcare and temperature-sensitive logistics aligns with the ground truth. The correctness score is 8 due to the missing Bomi Group acquisition, which is a notable but not critical omission affecting completeness more than overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 424,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Between 2022 and 2024, Linde plc's non-employee director restricted stock unit (RSU) award program has evolved through amendments to its long-term incentive structure. In 2022, the 2021 Linde plc Long-Term Incentive Plan governed the RSU awards, with specific forms for non-employee directors. By 2024, the company introduced a new Non-Employee Director Deferral Program, adopted on July 30, 2024, indicating a shift in governance structure to enhance flexibility in compensation deferral. Additionally, the 2021 Long-Term Incentive Plan was amended on January 29, 2024, to refine long-term shareholder alignment mechanisms, emphasizing performance-based metrics and deferral options to align director incentives with long-term shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 RSU award under the 2021 Long-Term Incentive Plan, the introduction of the Non-Employee Director Deferral Program on July 30, 2024, and the governance intent of enhancing long-term shareholder alignment are all accurately reported. (2) Quantitative accuracy is perfect: dates (July 30, 2024, and January 29, 2024) are correct; no financial figures are misstated. The mention of the January 29, 2024 amendment to the 2021 plan adds detail not in the original answer but does not contradict it and is plausible within the context—this may reflect additional data but does not introduce error. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the evolution from a basic RSU framework to a more advanced deferral structure, linking governance changes to shareholder alignment. (4) The only minor gap is that the original answer emphasizes the 'strategic emphasis on board accountability and sustained governance standards,' which the LLM answer implies but does not explicitly state. However, the core evolution, entities, dates, and intent are all correctly conveyed. Wording differs but semantic meaning is equivalent. No factual inaccuracies; slight under-elaboration on the strategic governance implications keeps it just below perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 378,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors' financial and legal relationship with Stellantis remained primarily defined by indemnification obligations stemming from the 2017 sale of the Opel/Vauxhall business to PSA Group (now Stellantis). GM agreed to indemnify Stellantis for certain losses related to emissions claims, product liabilities, and recalls for vehicles sold prior to the sale. In 2024, GM disclosed ongoing consumer lawsuits in Europe related to alleged emissions violations by former Opel/Vauxhall vehicles, as well as indemnification for immaterial amounts related to Takata inflator recalls in legacy Opel vehicles. While GM noted it was unable to estimate potential material losses from these obligations, it emphasized that certain indemnifications are subject to time limitations, thresholds, and/or caps. There was no indication of significant investment gains from Stellantis during this period, with the relationship centered on legal and financial risk management rather than financial returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core indemnification obligations from the 2017 Opel/Vauxhall sale and notes GM's liability for pre-sale emissions claims, product liabilities, and recalls—key elements from the ground truth. It accurately reflects the shift from financial gains in 2022 to legal and contingent liabilities in 2024. However, it omits the specific $0.2 billion gain from Stellantis warrants in 2022, which is a significant financial detail in the original answer. This omission reduces completeness but does not distort the overall narrative. (2) Quantitatively, the LLM does not mention the $0.2 billion gain, which is a factual gap. All other qualitative financial references (e.g., 'immaterial amounts' for Takata recalls, inability to estimate losses) align with typical SEC disclosure language and are consistent with the ground truth’s emphasis on uncertainty. Dates (2017 sale, 2022–2024 timeline) are correct. (3) The multi-hop reasoning is sound: the model connects the 2017 sale to ongoing liabilities, links GM’s indemnification to Stellantis, and contextualizes the evolution of the relationship over time. It correctly infers that the relationship became risk-focused rather than gain-driven, even without explicitly citing the 2022 gain. (4) The answer is highly contextually relevant, directly addressing the evolution of financial and legal ties. The qualitative accuracy is high due to correct entity identification (GM, Stellantis, Opel/Vauxhall, PSA Group), accurate characterization of indemnification scope, and appropriate framing of uncertainty. The main deduction is for missing the $0.2 billion gain, which is a material fact in assessing the financial relationship’s evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 473,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024 by introducing a more detailed categorization based on hedge designation and regulatory treatment. In 2024, the company explicitly separated energy-related derivatives into those designated as hedging instruments for regulatory purposes and those not designated as hedges, providing a clearer financial presentation. Additionally, the 2024 disclosures included more granular data on the net volumes of derivative contracts, their hedge maturity dates, and the impact of collateral requirements, reflecting enhanced transparency and alignment with evolving accounting standards and regulatory expectations.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth indicates a shift from income statement reporting (pre-tax effects in 2022 for prior years) to balance sheet presentation (fair value categorized under 'Other' or 'Risk Management Activities' in 2024). However, the LLM claims a new categorization based on hedge designation and regulatory treatment in 2024 with granular data on net volumes, maturity dates, and collateral—none of which are mentioned or supported in the original answer. (2) There are no numeric values in either response, so quantitative accuracy cannot be penalized for missing numbers, but the LLM invents details (e.g., 'net volumes', 'hedge maturity dates', 'collateral requirements') not present in the ground truth, implying false precision. (3) The multi-hop reasoning is flawed: the actual evolution is from income-focused to balance-sheet-focused disclosure; the LLM instead fabricates an enhancement in granularity and regulatory alignment that isn't in the original. It fails to identify the core shift in financial presentation (income statement → balance sheet). (4) While the answer is contextually relevant—addressing derivative disclosures and framing them as evolving—the specific claims lack factual basis. Thus, correctness, quantitative, and qualitative scores are low due to invention of details; contextual relevance is moderate because it stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 399,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, GILD's strategic relationship with Arcus evolved significantly in terms of equity ownership and governance influence. As of December 31, 2023, GILD owned approximately 19.9% of Arcus and had two designees on Arcus' board of directors. In January 2024, GILD increased its equity investment in Arcus by $320 million, raising its ownership to 33%. Concurrently, GILD paid the $100 million fourth-anniversary option continuation fee and increased its board representation to three designees. These actions reflect a deepening strategic commitment and enhanced governance influence over Arcus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: GILD's ownership increased from 19.9% in 2023 to 33% in January 2024 following a $320 million equity investment, and board representation expanded from two to three designees. These details align exactly with the original answer. (2) Quantitative accuracy is perfect: percentages (19.9%, 33%), dollar amounts ($320 million), and timing (January 2024) are all correct. The mention of a $100 million 'fourth-anniversary option continuation fee' is not present in the ground truth and appears to be extraneous or incorrectly inferred, but it does not contradict the core facts about ownership and governance. (3) Multi-hop reasoning is sound—LLM correctly synthesized changes over time in both equity stake and governance, demonstrating evolution in the strategic relationship. (4) The answer is contextually relevant and fully addresses the question. The only minor issue is the inclusion of the $100 million fee, which lacks support in the ground truth, but it doesn't undermine the correctness of the main claims. Hence, a score of 9 is warranted for overall correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 336,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "The maturity date of the 2021 Multicurrency Credit Facility was extended from June 30, 2025, in 2022 to July 1, 2026, in 2023. The borrowing capacity remained unchanged at $6.0 billion during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the maturity date in 2022 was correctly stated as June 30, 2025, and the 2023 maturity date as July 1, 2026; the borrowing capacity of $6.0 billion is correctly reported as unchanged between years. (2) Quantitative accuracy is perfect—dates and dollar amounts match the original answer exactly, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesized information across two time points (2022 and 2023) for the same credit facility, identifying both continuity (borrowing capacity) and change (maturity date). (4) While the LLM answer is more concise than the original, it captures all key information required by the question—evolution of both maturity date and borrowing capacity—without omissions or inaccuracies. The slight lack of interpretive context (e.g., 'strategic move to maintain financial flexibility') does not detract from factual correctness, as such commentary was not required to answer the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 306,
        "total_tokens": 1461
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron's utilization of imported crude oil in U.S. refining operations remained stable at approximately 60 percent of total refinery inputs in both 2023 and 2024. However, the average crude unit distillation capacity utilization at U.S. refineries declined from 90.8 percent in 2023 to 86.6 percent in 2024, indicating a reduction in operational efficiency or demand during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron's utilization of imported crude oil remained stable at approximately 60% in both 2023 and 2024, matching the ground truth. It also accurately reports the decline in crude unit distillation capacity utilization from 90.8% in 2023 to 86.6% in 2024. All numeric values and years are correct. (2) Quantitative accuracy is perfect: percentages and years are precisely aligned with the original answer, and no calculation errors are present. (3) The multi-hop reasoning is sound—information about imported crude oil dependency and refinery utilization across two years is correctly synthesized. The only minor issue is the interpretation that the decline 'indicates a reduction in operational efficiency or demand,' which introduces an inference not present in the ground truth (which remains neutral, stating only that operational intensity declined). While plausible, this slight interpretive leap reduces qualitative accuracy by one point. (4) The answer is fully contextually relevant, addressing both parts of the question—evolution of imported crude use and changes in refinery utilization—with accurate data and appropriate scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 337,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS's hedging position in British Pound Sterling decreased from £663 million in 2023 to £536 million in 2024, indicating a reduction in exposure to this currency. This shift suggests a more conservative approach to currency risk management, potentially reflecting a reassessment of exposure levels or improved confidence in the stability of the British Pound relative to other currencies. The company continues to prioritize hedging against major foreign currency risks, including the British Pound, as part of its broader strategy to manage the impact of currency fluctuations on its international operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the hedging positions in GBP for both 2023 (£663 million) and 2024 (£536 million), matching the ground truth exactly. The reduction of 127 million units is implied (663M - 536M = 127M), though the percentage decrease (19.15%) is not explicitly mentioned, which is a minor omission. 2) All numeric values are accurate and properly formatted; the calculation of the difference is correct even if not stated outright. 3) The reasoning is sound: the decrease in hedge position is correctly interpreted as a reduction in exposure and linked to a more conservative risk management strategy, which aligns with the ground truth's interpretation. The mention of 'improved confidence in stability' adds a plausible nuance not in the original but does not contradict it. 4) The answer fully addresses both parts of the question—evolution of the hedging position and its strategic implication—and maintains semantic equivalence with the original answer. The only reason for not scoring a 10 is the missing explicit percentage change, which was present in the ground truth and adds precision to the 'evolution' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 326,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at the end of 2023 to $1.3 billion at the end of 2024. This slight increase suggests a stable or slightly more aggressive short-term investment strategy, with the company maintaining or slightly expanding its allocation to short-term, highly liquid money market instruments during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the fair value of money market investments increased from $1.2 billion at the end of 2023 to $1.3 billion at the end of 2024, matching the ground truth exactly in both values and time periods. There are no numerical or date inaccuracies. (2) All numeric values are accurate and correctly formatted; the increase of $0.1 billion (or $100 million) is implied and consistent. (3) The reasoning is sound: the model correctly infers that the increase indicates a shift in short-term investment strategy, interpreting it as a slight expansion in liquidity management, which aligns with the ground truth's conclusion. The LLM uses slightly different phrasing—'stable or slightly more aggressive' versus 'modest growth'—but the semantic meaning is equivalent and reasonable given the small increase. (4) The answer fully addresses both parts of the question: the evolution of fair value and its implication for strategy. The only minor difference is in tone of interpretation (e.g., 'slightly more aggressive' may imply a marginally stronger strategic shift than 'modest growth'), but this does not constitute a factual error. Thus, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy due to interpretive nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 376,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell-back options for Southern Company's subsidiaries decreased from 2022 to 2024. In 2022, the total was 26 million mmBtu (6 million for Alabama Power, 8 million for Georgia Power, 4 million for Mississippi Power, and 8 million for Southern Power), while in 2024, it was 15 million mmBtu (4 million for Alabama Power, 6 million for Georgia Power, 2 million for Mississippi Power, and 3 million for Southern Power).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values for both 2022 and 2024 are accurate: total volumes (26 million mmBtu in 2022, 15 million mmBtu in 2024) and subsidiary breakdowns (Alabama Power: 6→4, Georgia Power: 8→6, Mississippi Power: 4→2, Southern Power: 8→3 million mmBtu) are exactly correct. (2) The quantitative accuracy is perfect—no calculation errors, and the totals are consistent across years and subsidiaries. (3) The multi-hop reasoning is sound: the model correctly synthesized data across Southern Company and its four subsidiaries for two different years, capturing the downward trend company-wide and at the subsidiary level. (4) The answer conveys the same semantic meaning as the original—highlighting the decrease over time and providing complete breakdowns—without unnecessary details or omissions. Wording differs slightly but remains factually and contextually equivalent. All entities, metrics, and time periods are correctly identified. No errors in reasoning, completeness, or relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 303,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "Between 2023 and 2024, the Firefly Vector Model has seen expanded integration across Adobe's product suite. In 2023, it was introduced in Adobe Illustrator for generating editable vector graphics from text prompts. By 2024, it was further integrated into Adobe Express, enabling quick generation of custom vector graphics and text effects, and was also available in Adobe Photoshop and Adobe Stock. Additionally, Firefly Vector Model became part of Adobe Firefly Services and Custom Models, allowing enterprises to leverage it for scalable content generation while maintaining brand consistency.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the Firefly Vector Model was introduced in Adobe Illustrator in 2023, when the ground truth confirms it was first integrated into Adobe Express in 2023. Conversely, it claims integration into Adobe Express occurred in 2024, which is backwards. (2) The ground truth confirms expansion to Adobe Illustrator in 2024 with Generative Recolor, but the LLM incorrectly attributes initial Illustrator integration to 2023 and adds unsupported integrations into Adobe Photoshop and Adobe Stock, which are not mentioned in the original answer. (3) The mention of 'Adobe Firefly Services and Custom Models' and enterprise use for brand consistency is not present in the ground truth and appears to be fabricated or conflated with other Firefly features. (4) While the answer correctly identifies a trend of expansion across Adobe’s suite, the multi-hop reasoning fails because it misrepresents the timeline, direction of integration, and specific product features. The qualitative and quantitative accuracy is low due to incorrect years, products, and features. Contextual relevance is moderate because the answer addresses the general theme of Firefly Vector Model expansion, but the specifics are largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 367,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "From 2023 to 2024, the commercial significance of Biktarvy for Gilead (GILD) increased, with product sales rising from $11,850 million in 2023 to $18,175 million in 2024. This growth underscores Biktarvy's continued dominance in Gilead's HIV portfolio, representing a significant portion of total HIV product sales. The sustained performance of Biktarvy reinforces Gilead's HIV business strategy, which focuses on maintaining leadership in the HIV treatment market through differentiated, well-tolerated regimens. However, the company must continue to innovate and address competitive pressures, including the potential impact of generics and evolving treatment paradigms, to sustain this momentum.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies, particularly in the 2024 sales figure for Biktarvy. The original answer states that in 2023, Biktarvy generated $11,850 million in sales (up from $10,390 million in 2022), but does not provide any 2024 sales figure. The LLM incorrectly claims sales rose to $18,175 million in 2024, which is not supported by the ground truth and represents a fabricated number. This invalidates the core quantitative claim of growth in commercial significance. (2) The calculation and comparison of sales figures are therefore entirely incorrect. There is no evidence in the original answer that sales increased in 2024; on the contrary, the implication is of growing risk to Biktarvy's dominance. The LLM’s assertion of a sharp sales increase contradicts the original answer’s emphasis on increasing risks from generics and treatment shifts. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that Biktarvy is central to GILD's HIV portfolio and that competitive pressures exist, it fails to synthesize the key strategic implication: that GILD faces pressure to diversify due to overreliance on TAF-based products like Biktarvy. Instead, it asserts continued growth and dominance, which misrepresents the strategic outlook. (4) Contextually, the answer addresses the right topic—Biktarvy’s role in GILD’s HIV strategy—and mentions relevant factors like generics and innovation needs. However, due to the false sales data and resulting incorrect conclusion about increasing commercial significance, the overall correctness is very low. The qualitative reasoning would score higher if not for the foundational error in numbers. Minor positive: correct entity identification (GILD, Biktarvy, HIV portfolio) and general awareness of market dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 493,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "The Series 2018-1A Securities had an outstanding principal amount of $496.8 million as of December 31, 2023, unchanged from $496.1 million as of December 31, 2022. The interest rate for the Series 2018-1A Securities remained at 3.652% during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the principal amounts. According to the ground truth, the outstanding principal in 2022 was $500.0 million, not $496.1 million as stated by the LLM. In 2023, the principal was $496.8 million, which the LLM correctly reports. However, the LLM incorrectly claims the principal was 'unchanged' from 2022 to 2023, when in fact it decreased from $500.0 million to $496.8 million—a reduction of $3.2 million. The interest rate of 3.652% is correctly reported as unchanged, which matches the ground truth. (2) Quantitative accuracy is low because two of the three numeric values are wrong: the 2022 principal is misstated, and the implication of no change is incorrect. Only the 2023 principal and interest rate are accurate. (3) The reasoning is partially sound in noting that the interest rate remained constant, but the model fails to correctly synthesize the change in principal over time, undermining the multi-hop comparison between 2022 and 2023. The claim of 'unchanged' principal contradicts the actual reduction. (4) Contextual relevance is high because the answer addresses the right securities, time frame, and requested metrics (principal and interest rate), but factual correctness is severely compromised by incorrect numbers and an erroneous conclusion about stability in principal.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 380,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "From 2023 to 2024, UPS's relationship with Coyote evolved significantly in terms of financial impact and strategic direction. In 2023, UPS recorded a $111 million impairment charge for the Coyote trade name due to declining revenues and challenging market conditions, signaling a strategic reevaluation. By 2024, UPS finalized the divestiture of Coyote in September, resulting in a $156 million gain and a $949 million reduction in Forwarding operating expenses due to lower activity levels and the divestiture. This marked a strategic shift away from the truckload brokerage business, with the focus shifting to growth in other Supply Chain Solutions segments like freight forwarding and logistics.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $111 million impairment charge in 2023 and the September 2024 divestiture of Coyote, aligning with the ground truth. However, it introduces two significant numerical inaccuracies: a $156 million gain and a $949 million reduction in Forwarding operating expenses, which are not present in the original answer and cannot be verified from the provided ground truth. These figures may be hallucinated or derived from external data not in the knowledge graph. (2) The original answer emphasizes the financial impact of Coyote's exit on Supply Chain Solutions revenue as a decrease, but the LLM shifts focus to a gain and cost reduction, altering the narrative of financial impact. There is no mention in the ground truth of a $156M gain or $949M expense reduction, so these numbers fail verification. (3) The multi-hop reasoning is partially sound—correctly linking 2023 impairment to 2024 divestiture as a strategic evolution—but extends beyond the evidence by attributing specific financial outcomes (gain, expense reduction) not supported in the original. The strategic shift narrative is plausible and contextually appropriate, but the added financial details undermine factual correctness. (4) Correctness score is 6 due to correct timeline and core strategic direction, but major quantitative errors reduce accuracy. Quantitative accuracy is low (4) due to unsupported numbers. Qualitative accuracy is 7 because reasoning and entity identification (UPS, Coyote, 2023–2024 timeline) are strong. Contextual relevance is high (9) as the response directly addresses the evolution in financial and strategic terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 455,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "Linde plc's Performance Share Unit Awards, beginning in 2019, were structured under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan and later the 2021 Linde plc Long Term Incentive Plan. These awards utilized two primary performance metrics: Return on Capital and Total Shareholder Return. By 2024, the structure remained consistent, with the 2021 Plan continuing to incorporate these same performance metrics for Performance Share Unit Awards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution (or lack thereof) in Linde plc's Performance Share Unit Awards structure between 2022 and 2024. It correctly identifies the two performance metrics—Return on Capital and Total Shareholder Return—and notes their continuity from grants beginning in 2019 through 2024. The mention of the transition from the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan to the 2021 Linde plc Long Term Incentive Plan adds context not explicitly in the original answer but is factually plausible and does not contradict the ground truth. However, the LLM omits specific exhibit references (e.g., Exhibits 10.11k, 10.11l in 2022 and 10.10l, 10.10m in 2024) that anchor the claims in the original answer and support the multi-hop verification across filings. While the overall conclusion about structural consistency is accurate, the absence of these document-level details slightly weakens the qualitative accuracy and completeness, particularly in demonstrating direct evidence from the filings. There are no numerical inaccuracies (dates and plan names are correct), so quantitative accuracy is high. The reasoning is sound and semantically equivalent in intent, though less precise in evidentiary support. Contextual relevance is excellent as it directly addresses the question’s focus on structural evolution and performance metrics over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 389,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "Between 2023 and 2024, the regulatory status of Trodelvy (sacituzumab govitecan-hziy) advanced significantly. In 2023, it received approval for HR+/HER2- breast cancer in the U.S. and EU and was being evaluated for additional indications, including lung and gynecological cancers. In 2024, Trodelvy was granted Breakthrough Therapy designation for extensive-stage small cell lung cancer, highlighting its potential to improve outcomes compared to existing therapies. This regulatory progression indicates a strong development trajectory, with Trodelvy expanding into new cancer indications and receiving recognition for its therapeutic promise.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory advancement of Trodelvy in 2024—Breakthrough Therapy designation for extensive-stage small cell lung cancer—which aligns with the ground truth. It also accurately reflects the 2023 indications, specifically mentioning HR+/HER2-negative breast cancer (implied in 'HR+/HER2-'), and notes ongoing evaluation in other cancers like lung, which is consistent with development trajectory. However, the original answer specifies that in 2023, Trodelvy was already approved for triple-negative breast cancer, HR+/HER2-negative breast cancer, and urothelial cancer—this full scope is not explicitly stated in the LLM answer, which omits urothelial cancer and does not clarify that approvals (not just evaluations) were already in place. (2) There are no numerical values requiring calculation, but the years (2023, 2024) and regulatory milestones (approval, Breakthrough Therapy designation) are correctly dated and characterized. The mention of EU approval is an addition not in the ground truth, but not contradicted by it—this may be accurate but is not verifiable from the provided truth. (3) The multi-hop reasoning is sound: the model connects 2023 approvals with 2024 designation to infer an expanding development trajectory, correctly interpreting the significance of Breakthrough Therapy status as indicating high unmet need and therapeutic promise. (4) The correctness score is 8 due to minor incompleteness (missing urothelial cancer indication and overemphasis on 'evaluation' rather than established approvals in 2023), but core facts and trajectory interpretation are accurate. Quantitative accuracy is 9 because all dates and designations are correct. Qualitative accuracy is 8 due to slight overreach on EU approval and incomplete listing of indications. Contextual relevance is 10—answer directly addresses the question’s focus on regulatory evolution and development implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 528,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "From 2023 to 2024, the Vertex AI platform within Google Cloud has evolved significantly in terms of capabilities and integration with generative AI models. In 2023, Vertex AI enabled developers to train, tune, augment, test, and deploy applications using generative AI models. By 2024, Vertex AI expanded its offerings by providing access to Gemini, Imagen, and Veo models, along with pre-packaged AI agents that assist developers in writing, testing, and operating software. This advancement reflects a stronger integration with Google's latest and most capable generative AI models, enhancing the platform's utility for developers and enterprises.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Vertex AI from 2023 to 2024. It correctly identifies that in 2023, Vertex AI supported training, tuning, augmenting, and deploying generative AI applications. The 2024 enhancements are accurately portrayed with expanded capabilities, including access to Gemini and other models (Imagen, Veo), which aligns with the ground truth's mention of 'Gemini and other leading generative AI models.' The addition of pre-packaged AI agents, while not explicitly mentioned in the ground truth, is contextually plausible and consistent with the trend toward enhanced developer support. However, the LLM omits specific 2024 services highlighted in the original answer—vector search, grounding, and distillation—which are key aspects of the platform's evolution in optimizing model cost and quality. These omissions prevent a perfect score but do not undermine the core accuracy. All dates and entity names (Vertex AI, Google Cloud, Gemini) are correct. The reasoning is sound and multi-hop, connecting changes across years and capabilities. Wording differs but maintains semantic equivalence on major points. Quantitative accuracy is perfect as no numerical data is involved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 352,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "From 2022 to 2024, the treatment and valuation of weather derivatives in SO's financial disclosures remained consistent in terms of being excluded from derivative valuations as immaterial. In 2022, the disclosures explicitly noted that immaterial premium and intrinsic value associated with weather derivatives were excluded. In 2024, similar language was used, stating that net amounts of derivative instruments excluded immaterial premium and intrinsic value related to weather derivatives. There is no indication of a material change in how these items were treated or valued during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that SO consistently treated weather derivatives as immaterial and excluded their premium and intrinsic value in both 2022 and 2024, which aligns with the ground truth. However, it fails to mention the key quantitative addition in the 2024 disclosures: the specific cash collateral amounts of $17 million and $62 million at the end of 2024 and 2023, respectively. This omission significantly affects quantitative accuracy. (2) The ground truth includes precise dollar figures related to broker margin accounts, which the LLM answer omits entirely—there are no numbers mentioned, making the response less informative and factually incomplete in a quantitative sense. (3) The reasoning is sound in noting consistency in treatment and exclusion of weather derivatives due to immateriality, demonstrating correct synthesis across years. However, it misses the multi-hop element that while the weather derivatives themselves remained immaterial, SO enhanced disclosure transparency by including collateral details, indicating a more structured approach. This reflects a partial failure in deeper contextual synthesis. (4) The correctness score is 6 due to accurate core facts but major omission of key numerical data; quantitative accuracy is low (4) due to missing dollar amounts; qualitative accuracy is 7 because reasoning and entity identification (SO, weather derivatives, immateriality) are correct; contextual relevance is high (9) as the answer addresses the main theme of disclosure treatment over time, just lacks specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 434,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Between 2023 and 2024, Biktarvy's regulatory and market positioning evolved with an expanded FDA-approved indication to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the label was updated with new safety and efficacy data supporting its use in pregnant individuals with HIV-1 and suppressed viral loads, enhancing its therapeutic versatility and patient applicability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key regulatory developments for Biktarvy in 2024—expanded indication for patients with M184V/I resistance and updated labeling for use in pregnant individuals with HIV-1. These are accurately presented and align with the ground truth. However, the LLM omits the 2023 patent expiration detail (2033 U.S. patent expiry), which is a significant part of the market positioning context from the original answer. This omission reduces completeness, particularly in addressing the evolution *between* 2023 and 2024. (2) There are no numeric values, dates, or calculations in the LLM answer that conflict with the ground truth. The absence of the 2033 patent date is a missing fact, not an incorrect one, so quantitative accuracy remains high. (3) The multi-hop reasoning is partially sound—the model correctly synthesizes the 2024 regulatory updates from GILD's disclosures and links them to broader patient eligibility and therapeutic use. However, it fails to contrast this with the 2023 positioning (patent protection), weakening the comparative evolution aspect of the question. (4) The answer is contextually relevant and well-phrased, but the missing 2023 patent information prevents a top score in correctness and qualitative accuracy. The core facts presented are accurate and relevant, warranting a strong but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 385,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "AMT's utilization of the 2021 Multicurrency Credit Facility changed between 2022 and 2023 in terms of borrowing amounts and facility amendments. In 2023, AMT borrowed an aggregate of $3.0 billion and repaid $6.1 billion, including 842.6 million EUR ($919.1 million as of the repayment date), under the 2021 Multicurrency Credit Facility. Additionally, the facility was amended to extend its maturity date to July 1, 2026, and the LIBOR pricing benchmark was replaced with an Adjusted Term SOFR pricing benchmark.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: $3.0 billion borrowed and $6.1 billion repaid in 2023, including the 842.6 million EUR (converted to $919.1 million), and correctly notes the extension of the maturity date to July 1, 2026, the replacement of LIBOR with SOFR (specified as Adjusted Term SOFR, which is a more precise and acceptable detail). The mention of SOFR instead of 'Adjusted Term SOFR' in the ground truth is a minor specificity difference but does not constitute an error. (2) All numbers and dates are accurate and match the ground truth exactly. The conversion of EUR to USD is correctly cited as $919.1 million, and the dollar amounts for borrowings and repayments are precise. (3) The multi-hop reasoning is sound: the model synthesizes changes in borrowing activity between 2022 and 2023 and correctly identifies both quantitative usage changes and structural amendments to the facility. However, the LLM omits the 2022 net borrowing of $850.0 million, which was explicitly part of the original answer and directly responsive to the question about changes between 2022 and 2023. This omission reduces completeness, though the focus on 2023 is still highly relevant. (4) The answer is contextually excellent, well-structured, and semantically aligned with the ground truth. The only reason for not scoring a 10 is the missing reference to 2022 borrowings, which is a meaningful but not central omission given that the 2023 activity and amendments are fully covered. Thus, correctness is 9 due to partial incompleteness, not inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 436,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "Between 2023 and 2024, Google Ad Manager remained a central platform for advertising inventory management and revenue recognition across Alphabet's advertising ecosystem. In both years, it was highlighted as one of the primary channels through which customers purchase advertising inventory, alongside Google Ads, Google Display & Video 360, and Google Marketing Platform. The integration with revenue reporting models remained consistent, with Alphabet evaluating whether it acts as a principal or agent for ads placed on Google Network properties. In 2024, no significant changes were noted in the role or integration of Google Ad Manager in Alphabet's advertising revenue recognition strategy compared to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that no significant changes occurred in Google Ad Manager's role in revenue recognition between 2023 and 2024. The ground truth states there was a clear strategic evolution: in 2023, revenue recognition was based on a gross reporting model tied directly to Google Ad Manager, while in 2024, Alphabet shifted to emphasizing a control-based evaluation (principal vs. agent) with specific criteria—control of inventory, primary responsibility, and pricing discretion—justifying gross reporting. This reflects a meaningful change in the justification and integration with revenue reporting models, which the LLM incorrectly dismisses as unchanged. There are no numeric values to evaluate, so quantitative accuracy is not applicable (scored 10 by default for absence of errors). However, the qualitative accuracy is low due to failure in multi-hop reasoning: the model did not synthesize the shift in accounting rationale over time, misrepresenting the evolution as static. Contextual relevance is moderate—the response addresses the right topic and entities (Google Ad Manager, revenue recognition, Alphabet) and mentions the correct framework (principal vs. agent), but fails to report the actual change, undermining the answer’s usefulness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 359,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "Between 2023 and 2024, UPS's financial exposure and strategic positioning regarding Roadie evolved as follows: In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial stress, while in 2024, no impairment was recorded, suggesting improved performance or valuation. However, as of 2024, Roadie remained one of three reporting units with limited excess of fair value over carrying value, exposing it to a higher risk of future impairment if business forecasts or cost of capital assumptions deteriorate. This highlights ongoing strategic and financial risk for Roadie despite the absence of impairment in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $56 million goodwill impairment charge in 2023 and the absence of an impairment in 2024, accurately reflecting the financial exposure evolution. It also correctly states that Roadie remained a reporting unit with limited excess of fair value over carrying value in 2024, signaling ongoing risk. The only minor omission is that the original answer specifies Roadie was 'among the reporting units' (plural), while the LLM says 'one of three', which, while consistent with known data, adds specificity not present in the ground truth. This does not constitute an error but a slight over-precision. (2) Quantitative accuracy is perfect: $56 million, 2023, 2024, and the absence of further impairment are all correctly reported. No calculations are required. (3) The multi-hop reasoning is sound—linking the 2023 impairment to 2024 risk assessment shows synthesis across years and financial concepts (goodwill, fair value, carrying value, impairment risk). The conclusion about continued sensitivity due to forecasts and cost of capital is logically derived and aligns with the original. (4) Scores reflect near-perfect factual alignment, with full quantitative accuracy and high qualitative accuracy due to correct entity identification (UPS, Roadie), time periods, and financial concepts. Contextual relevance is complete as all aspects of the question—financial exposure, strategic positioning, goodwill impairment, and risk assessment—are addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 415,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "From 2022 to 2024, Linde's relationship with helium shifted from lower volumes in 2024 to higher costs impacting operating profit. In 2024, global helium volumes declined, contributing to a $32 million sales decrease in the \"Other\" category. However, operating profit for \"Other\" increased by $19 million (44%) due to insurance recovery for LAMT, partially offset by higher helium-related costs. Thus, while helium negatively impacted sales, it had a mixed quantitative effect on operating profit.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies a shift in Linde's relationship with helium from 2022 to 2024 and mentions the 'Other' segment, it fabricates specific dollar amounts not present in the ground truth: a '$32 million sales decrease' and a '$19 million (44%) operating profit increase'. These figures are not supported by the original answer and are therefore incorrect. The ground truth states only a 2% underlying sales decrease due to lower helium volumes, with no dollar value provided. Similarly, the operating profit impact is described qualitatively (increased costs partially offset by insurance recovery), but no numerical profit increase is stated. (2) The quantitative accuracy is low because both the sales and operating profit figures are invented. Even if the direction of impact (sales down, profit up) were plausible, the specific numbers and percentage (44%) are unsupported. The original answer does not mention any profit increase, only cost pressures and partial offset from insurance. (3) The reasoning partially captures the multi-hop evolution—helium shifting from a supply component to a cost pressure—but misrepresents the financial impact. It incorrectly implies that operating profit improved significantly due to helium-related factors, when the ground truth suggests helium contributed to cost pressures, not profit growth. The synthesis across time and segments is present but flawed in conclusion. (4) Contextual relevance is high because the answer addresses the right company, time frame, segment ('Other'), and business elements (helium volumes, LAMT, insurance recovery). However, the inclusion of false quantitative data severely undermines correctness. Overall, the answer gets the general direction of change right but fails on key facts and numbers, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 511,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long-term credit protection agreements with FNMA and FHLMC increased from $8.7 billion in 2023 to $8.0 billion in 2024. This indicates that the Corporation's credit risk exposure on residential mortgage loans remained stable, as these agreements provide full credit protection on severely delinquent loans, and all covered loans are individually insured, eliminating the need for an allowance for credit losses.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the value of loans increased from $8.7 billion in 2023 to $8.0 billion in 2024, when in fact it decreased. This is a critical factual error that inverts the trend. The correct evolution is a decrease of $0.7 billion, not an increase. (2) Quantitative accuracy is severely compromised: while the dollar amounts themselves ($8.7B and $8.0B) are correctly cited, the direction of change is wrong. A correct answer must reflect that $8.0B is less than $8.7B, indicating a decline. The LLM misrepresents this as an increase, which is a fundamental numerical reasoning failure. (3) The qualitative reasoning is partially sound in explaining that these agreements provide full credit protection and eliminate the need for an allowance for credit losses. However, the conclusion that risk exposure 'remained stable' contradicts the ground truth implication—that a decline in covered loans suggests reduced reliance on credit protection and potentially lower volume of high-risk loans. The LLM fails to infer the correct implication of the decrease. (4) Contextual relevance is moderate because the answer addresses the right entities (FNMA/FHLMC, credit protection, credit risk) and the general framework of risk exposure, but the incorrect trend undermines the validity of the analysis. The synthesis across time points and implications is flawed due to the inverted quantitative claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 397,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024 by enhancing its competitive differentiation through deeper integration of generative AI capabilities into its product suite and emphasizing commercial safety for users. In 2023, Firefly was highlighted as a standalone web app with AI models for generating images, text effects, and design templates, while in 2024, it was further embedded into core products like Photoshop, Illustrator, and Adobe Express, with expanded language support and enterprise indemnification. However, regulatory risks increased due to evolving AI legislation, such as the EU AI Act, which could impose compliance costs, limit monetization strategies, and require costly changes to Firefly's development and deployment practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe emphasized Firefly's generative AI integration and commercial safety in 2023, and by 2024, deepened integration into Photoshop, Illustrator, and Adobe Express, which reflects competitive differentiation. The mention of enterprise indemnification and expanded language support adds contextual detail not in the original but does not contradict it. Regulatory risks tied to the EU AI Act are correctly identified, including compliance costs and potential changes to development practices. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2023, 2024) and references to the EU AI Act in 2024 are accurate. (3) Multi-hop reasoning is sound: the answer synthesizes Firefly’s evolving product integration (competitive differentiation) with emerging regulatory challenges, correctly linking strategic positioning shifts across years and external regulatory developments. (4) The only minor gap is that the original emphasizes a 'shift from purely competitive emphasis to a more risk-aware positioning,' which the LLM captures implicitly but doesn’t explicitly frame as a strategic pivot. Still, the core information is semantically equivalent. Wording differences are acceptable and do not affect factual correctness. All parts of the question—competitive differentiation and regulatory risks across 2023–2024—are fully addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 420,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "Between 2023 and 2024, Trodelvy's financial performance showed strong growth, with product sales increasing by 56% in 2023 compared to 2022, reaching $1.1 billion. In 2024, Trodelvy received Breakthrough Therapy designation from the FDA for the treatment of adult patients with extensive-stage small cell lung cancer whose disease has progressed on or after platinum-based chemotherapy, marking a significant regulatory milestone. This designation aims to expedite the drug's development and regulatory review, highlighting its potential to improve clinical outcomes compared to existing therapies.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures both the financial performance and regulatory developments for Trodelvy between 2023 and 2024. The 56% sales increase in 2023 is accurately reported, and the $1.1 billion figure is a reasonable rounding of the exact $1,063 million stated in the ground truth (common in financial reporting). The 2024 Breakthrough Therapy designation for extensive-stage small cell lung cancer after platinum-based chemotherapy is correctly described, including patient population and regulatory implications. (2) Quantitatively, the $1.1 billion is a rounded but acceptable representation of $1,063 million; no calculation errors are present. The 56% growth is correctly attributed to 2023 vs. 2022. (3) The multi-hop reasoning is sound—financial data from 2023 and regulatory news from 2024 are correctly synthesized to show evolution across both dimensions. (4) The answer is contextually complete and relevant, addressing both financial and regulatory aspects as required. The minor rounding of sales is not a material inaccuracy, hence the 9/10 on correctness and quantitative accuracy. All entities (FDA, Trodelvy, indication, year) are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 334,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "Chevron's financial involvement and strategic positioning in Angola LNG declined from 2022 to 2024. In 2022, Chevron reported equity in earnings from Angola LNG of $1,857 million, which dropped significantly to $405 million in 2023 and further to $405 million in 2024. Additionally, the carrying value of Chevron's investment in Angola LNG decreased from $1,762 million in 2023 to $1,665 million in 2024, indicating a reduction in the company's financial stake or valuation of the investment during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The original answer states that Chevron reported improved income from equity affiliates in 2022, with Angola LNG contributing to a total of $5,657 million in income from equity affiliates—not $1,857 million specifically from Angola LNG. The LLM falsely claims specific earnings from Angola LNG of $1,857M in 2022, $405M in 2023, and $405M in 2024, which are not supported by the ground truth. There is no mention of earnings declining or specific figures per year for Angola LNG in the original answer. Additionally, the LLM introduces a 'carrying value' decrease from $1,762M to $1,665M, which is entirely absent from the original and cannot be verified. (2) The quantitative inaccuracies are severe: none of the dollar amounts or trends match the ground truth. The only correct number indirectly referenced in the original is the 2022 total income from equity affiliates ($5,657M), but the LLM misattributes a portion of it to Angola LNG without justification. (3) The multi-hop reasoning is flawed—the original answer traces evolution from general earnings contribution in 2022 to a defined 36.4% ownership stake in 2024, showing strategic clarification and stability. The LLM incorrectly infers a decline in strategic positioning based on fabricated financials, failing to recognize that disclosure of a precise ownership percentage indicates increased transparency, not reduced involvement. (4) The contextual relevance is low because the answer contradicts the core trend (evolution toward stronger, more defined positioning) and invents data. Scores are low due to complete factual inaccuracy, especially in financial figures and directional trends, with only minimal relevance in discussing Angola LNG and Chevron over the correct time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 497,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, the value of META's Fixed-Rate Senior Unsecured Notes increased from $18.50 billion to $29.0 billion, primarily due to the issuance of $10.50 billion in new Notes in August 2024. The 2024 Notes have maturities ranging from 2029 to 2064 with stated interest rates between 4.30% and 5.55%. This issuance reflects an expansion of META's long-term debt portfolio to support general corporate purposes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the increase in total value from $18.50 billion (end of 2023) to $29.0 billion (end of 2024), and the $10.50 billion issuance in August 2024. These figures match the ground truth exactly. It also correctly identifies the timing and nature of the issuance. However, it omits the 2023 issuance of $8.46 billion in net proceeds from Fixed-Rate Senior Unsecured Notes in May 2023, which is a relevant part of the evolution of issuance activity. (2) All numbers and dates are accurate: $18.50B → $29.0B total; $10.50B issued in August 2024. The calculation of the increase ($29.0B - $18.50B = $10.50B) is correct and consistent. (3) The reasoning is sound—correctly inferring that the increase is due to new issuances and reflecting growth in long-term debt. The multi-hop synthesis across 2023 and 2024 is mostly accurate, though the lack of mention of the 2023 issuance weakens the full picture of issuance activity evolution. (4) The answer is highly relevant and factually precise, missing only a minor but notable detail about 2023 issuance activity. Hence, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 356,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "LIN's financial exposure to helium as a raw material increased from 2023 to 2024, as evidenced by its shift from categorizing helium as a \"supply\" to labeling it a \"dependency.\" In 2023, helium costs were included in raw materials and supplies inventory at $614 million, while in 2024, the inventory value for raw materials and supplies dropped to $529 million. This decline, combined with the increased dependency classification, suggests a higher strategic and operational reliance on helium in 2024, likely due to sourcing constraints or cost volatility, even as inventory levels decreased.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that helium costs were 4.2% of total raw material expenses in 2023 and increased to 6.8% in 2024. However, the LLM claims absolute inventory values of $614 million in 2023 and $529 million in 2024 for 'raw materials and supplies,' which are not mentioned in the original answer and contradict the percentage-based metric. These dollar amounts are unsupported by the ground truth and appear fabricated. (2) There is no verification of calculations because the numbers themselves are incorrect. The LLM attempts to infer increased exposure from a drop in inventory value, but this reasoning is based on false premises. The actual increase in exposure is due to a rise in helium's cost share from 4.2% to 6.8%, not inventory changes. (3) The multi-hop reasoning is partially sound in identifying the shift from 'supply' to 'dependency' as signaling increased strategic importance, which aligns with the original answer. However, the synthesis fails because it uses incorrect financial data to support the conclusion. The model misinterprets or invents inventory figures instead of reporting the disclosed percentage of raw material expenses. (4) The contextual relevance is moderate because the answer addresses the change in categorization and attempts to explain increased exposure, but the use of incorrect quantitative data severely undermines factual correctness. The qualitative reasoning is plausible but built on false numbers, leading to a misleading conclusion. Correctness score is low due to major factual and quantitative errors despite some correct conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 457,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities decreased between 2022 and 2023, with the approved amount dropping from $3.8 billion in 2022 to $3.0 billion in 2023, representing a 21.1% decrease.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers: $3.8 billion in 2022 and $3.0 billion in 2023, which match the ground truth. The calculated percentage decrease of 21.1% is accurate: (3.8 - 3.0) / 3.8 ≈ 0.2105 or 21.05%, which rounds to 21.1%. (2) However, the LLM omits the contextual detail about the percentage of European customer balances—37% in 2022 and 39% in 2023—which is a key nuance in the original answer. While the absolute amount decreased, the proportion of available balances used increased slightly, indicating a more conservative utilization strategy. This qualitative insight is missing, reducing completeness. (3) The reasoning is sound in terms of trend and calculation, but fails to synthesize the full multi-hop insight: the contrast between declining absolute funding and rising relative utilization rate. (4) Despite the omission, the core quantitative facts and trend are correct, and the answer directly addresses the main question about evolution and percentage change. Hence, high scores for quantitative accuracy and contextual relevance, with a slight deduction in qualitative accuracy and overall correctness for missing key contextual interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 337,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Between 2023 and 2024, Starbucks' exposure to foreign currency - other instruments decreased significantly in terms of fair value. The fair value of derivative assets for foreign currency - other dropped from $32.0 million in 2023 to $1.9 million in 2024, while derivative liabilities increased slightly from $2.0 million to $4.7 million. Additionally, the expected reclassification impact on earnings for foreign currency - other decreased from $39.6 million in 2023 to $11.5 million in 2024, indicating a reduced anticipated impact on earnings in the next 12 months.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Starbucks' fair value for foreign currency - other instruments was $1,164 million in 2023 and $920 million in 2024. However, the LLM incorrectly reports derivative assets as $32.0 million and $1.9 million and liabilities as $2.0 million and $4.7 million, which do not match the total fair values provided in the original answer. These figures appear to represent only a subset (possibly net derivatives or a specific instrument type), but the LLM misrepresents them as the overall fair value. (2) The expected reclassification impact is partially correct: the LLM states it decreased from $39.6 million to $11.5 million, but this misattributes the 2023 reclassification amount. The ground truth specifies that $39.6 million was the net gain in AOCI in 2023, not the reclassification amount. The correct reclassification amounts are $55.3 million in 2023 and $9.5 million in 2024—both of which the LLM gets wrong. Only the 2024 reclassification figure ($11.5M) is close but still incorrect. (3) The multi-hop reasoning is flawed. The question asks about evolution in fair value and reclassification impact; the LLM fails to correctly synthesize the full fair value trend and misidentifies key metrics (confusing AOCI gains with reclassification expectations). It also introduces derivative assets/liabilities not mentioned in the original answer, suggesting a misinterpretation of the data source. (4) Despite incorrect numbers and misattributed metrics, the LLM captures the general direction of change—decreasing exposure and reduced earnings impact—so some contextual relevance remains. However, due to major quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 484,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Alabama Power decreased from $18 million to $15 million, while Georgia Power's decreased from $75 million to $13 million. Both companies experienced a reduction in their asset positions. Additionally, their liability positions increased, with Alabama Power's energy-related derivative liabilities rising from $11 million to $110 million and Georgia Power's increasing from $8 million to $124 million. This indicates a significant shift from asset to liability positions for both companies.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that Alabama Power's energy-related derivative assets decreased from $18 million in 2022 to $15 million in 2023, but the ground truth reports $55 million in assets for Alabama Power in 2022, not $18 million. This is a major factual error. Georgia Power’s 2022 asset value is correctly stated as $75 million, and its 2023 value is correctly given as $13 million. Liability figures are accurate for both companies: Alabama Power increased from $11M to $110M, and Georgia Power from $8M to $124M. (2) The calculation of directional changes is correct—both companies saw decreases in asset values and large increases in liabilities—but the incorrect baseline for Alabama Power’s 2022 assets undermines the accuracy of the summary. The claim that Alabama Power’s derivatives decreased from $18M to $15M implies a small drop, whereas the truth is a dramatic reversal from a $44M net asset position ($55M–$11M) to an $95M net liability ($110M–$15M). (3) The multi-hop reasoning is partially sound: the model correctly identifies the need to compare both asset and liability positions across two companies and two years, and it draws the correct qualitative conclusion about a shift toward liability exposure. However, due to the incorrect input data for Alabama Power’s 2022 assets, the synthesis is flawed. (4) Scores reflect that core trends and some numbers are correct (especially for Georgia Power and liability increases), but the major error in Alabama Power’s 2022 asset value reduces factual reliability. Contextual relevance is high as the structure and intent align well with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 459,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "From 2022 to 2023, the asset allocation strategy for the U.S. Retiree Health Care Plan shifted significantly, with the percentage of fixed income securities and cash equivalents increasing from 65% to 80%, while the percentage of equity securities decreased from 35% to 20%. This change reflects a more conservative allocation strategy, aligning with the plan's target allocation ranges updated in 2023 to 75%-85% for fixed income and 15%-25% for equity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for both years are accurate: 65% fixed income and 35% equity in 2022, shifting to 80% fixed income and 20% equity in 2023. These numbers exactly match the original answer. (2) The answer is complete, addressing the evolution of asset allocation between the two years and the shift in distribution between fixed income and equity securities as required by the question. (3) Entity accuracy is correct—'U.S. Retiree Health Care Plan' is properly identified, and the years 2022 and 2023 are correctly referenced. (4) The reasoning is sound and adds value by noting that the 2023 allocation aligns with updated target ranges (75%-85% for fixed income, 15%-25% for equity), which is consistent with the direction of the shift and enhances the explanation without contradicting the ground truth. This additional context does not introduce error and supports the conclusion of a more conservative strategy. All information is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 306,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, Trodelvy received new regulatory approvals in 2023 for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This expansion of Trodelvy's indication reflects its evolving regulatory approval status, with the drug also previously approved for triple-negative breast cancer and urothelial cancer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and captures the key evolution in Trodelvy's regulatory approval status between 2022 and 2023. It correctly identifies the new indication granted in 2023: for adult patients with unresectable or metastatic HR+/HER2-negative breast cancer who have received endocrine-based therapy and at least two prior systemic therapies. It also accurately references the pre-existing 2022 indications (triple-negative breast cancer and urothelial cancer), though it does not explicitly mention that these were already approved by both FDA and EMA in 2022. The answer correctly notes the 2023 approvals included both FDA and EMA (EC) authorization, but slightly omits specifying that the 2023 approvals were granted by both agencies—though 'regulatory approvals' plural implies multiple jurisdictions. All entities (disease types, patient criteria, drug name) are accurate. There are no numerical values requiring calculation, so quantitative accuracy is 10. The reasoning is sound and synthesizes multi-hop information across time and indications. The answer is contextually complete and relevant, with only minor omission of explicit agency names (FDA/EMA) for the 2023 approvals preventing a perfect 10. Semantic equivalence to the original answer is high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 356,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Meta's disclosure regarding user perception as a risk factor evolved between 2023 and 2024 by emphasizing increased regulatory and legal challenges impacting user data practices and platform trustworthiness. In 2023, the focus was on how user behavior and regulatory changes (e.g., GDPR, CCPA) could reduce engagement and ad effectiveness. By 2024, the risks highlighted expanded to include broader concerns about user well-being, content moderation, and legal actions (e.g., COPPA violations, biometric technology use), reflecting a shift toward the potential reputational and operational impacts of user dissatisfaction and regulatory scrutiny on business operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of Meta's risk disclosures, particularly misrepresenting the shift in focus between 2023 and 2024. (1) What was correct: The answer correctly identifies that in 2023, Meta highlighted user perception risks related to privacy, regulatory changes (e.g., GDPR, CCPA), and their impact on engagement and ad effectiveness. It also appropriately notes growing concerns around content moderation and legal issues in 2024, which aligns with broader regulatory scrutiny. (2) Quantitative accuracy: There are no numeric values in the question or answers, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The model fails in synthesizing the correct directional shift in Meta’s disclosures. According to the ground truth, the key evolution was a *reduction* in emphasis on user perception as a direct risk factor in 2024, with a pivot toward operational and financial risks (e.g., acquisition integration, tax liabilities, investor sentiment). However, the LLM answer claims the opposite — that risks *expanded* to include more user-centric concerns in 2024 — which contradicts the ground truth. This reflects a failure in reasoning across time periods and misinterpretation of the strategic shift. (4) Justification for scores: Correctness is scored 5 due to partial factual alignment but major error in the core trend (increased vs decreased focus on user perception). Qualitative accuracy is 5 because while some risk themes are valid, the synthesis and directionality of change are incorrect. Quantitative accuracy is 10 by default (no numbers involved). Contextual relevance is 8 because the answer addresses the right domain (risk disclosures, user perception, regulation) and is well-structured, even if factually flawed in key aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 503,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "The notional amount of Lockheed Martin's variable interest rate swaps increased from $500 million in 2021 to $1.3 billion in 2024. This increase indicates that the company has expanded its use of interest rate swaps as part of its interest rate risk management strategy, likely to hedge against potential fluctuations in interest rates and manage the balance between fixed and variable rate debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the notional amounts of $500 million in 2021 and $1.3 billion in 2024, matching the ground truth exactly. These figures are critical multi-hop data points from SEC filings across years, and their accuracy is confirmed. (2) All numeric values are correct and properly formatted; no calculation errors exist. The increase from $500M to $1.3B is accurately represented. (3) The reasoning is sound: the LLM correctly infers that the increase reflects an expanded use of swaps for interest rate risk management. While the original answer specifies a strategy shift toward converting fixed-rate to variable-rate debt, the LLM captures the essence—managing the balance between fixed and variable rate debt and hedging rate fluctuations—though with slightly less specificity on the directional shift (fixed-to-variable conversion). This minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing both the evolution of notional amounts and the strategic implication. Overall, the response is factually complete and semantically equivalent to the ground truth with only a slight reduction in strategic nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 344,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "Between 2022 and 2023, PayPal's financial provisions for transaction losses related to its Seller Protection Programs remained relatively stable. The allowance for transaction losses was $66 million at December 31, 2022, and $64 million at December 31, 2023. The provision for transaction losses increased slightly from $1,170 million in 2022 to $1,192 million in 2023, while realized losses also decreased slightly from $1,417 million in 2022 to $1,313 million in 2023. Recoveries were $170 million in 2022 and $125 million in 2023. Overall, the ending balance of the allowance remained consistent at $278 million in 2022 and $282 million in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the allowance for transaction losses was $66 million in 2022 and $64 million in 2023 (matching the ground truth), it introduces incorrect figures such as a $278 million ending allowance balance in both years, which contradicts the $66M/$64M figures. The provision for transaction losses is falsely reported as $1,170M in 2022 and $1,192M in 2023, and realized losses of $1,417M and $1,313M—none of which appear in the ground truth and are likely confused with unrelated TPV or other metrics. Recoveries of $170M and $125M are also unsupported. (2) The only correct numbers are the $66M and $64M allowances, but all other financial figures are incorrect or fabricated. The calculation of stability based on these wrong totals is invalid. (3) The multi-hop reasoning fails: the ground truth emphasizes a shift from qualitative risk disclosure in 2022 to more structured, quantified disclosures in 2023. The LLM misses this conceptual evolution and instead invents detailed financials not present in the source, indicating a failure to synthesize the actual evolution in PayPal's approach. (4) The contextual relevance is moderate because it discusses the right topic (Seller Protection financial provisions) and gets the direction of change in allowance ($66M to $64M) correct, but the overwhelming number of fabricated metrics and lack of focus on the qualitative-to-quantitative shift severely undermine correctness. Quantitative accuracy is very low due to pervasive incorrect numbers; qualitative accuracy is low due to flawed reasoning and missing conceptual evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 456,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks' derivative asset positions for foreign currency - other decreased from fiscal year 2023 to fiscal year 2024. In fiscal 2023, foreign currency - other derivative assets totaled $32.0 million in prepaid expenses and other current assets and $22.9 million in other long-term assets, for a total of $54.9 million. In fiscal 2024, these positions were $1.9 million in current assets and $1.7 million in long-term assets, totaling $3.6 million. This represents a decrease of $51.3 million in the balance sheet value of foreign currency - other derivative assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. According to the ground truth, Starbucks reported a derivative asset of $1,164 million (not $54.9 million) under 'Foreign currency - other' in fiscal year 2023. The LLM incorrectly breaks this into $32.0 million in current assets and $22.9 million in long-term assets, which contradicts the ground truth. In 2024, the correct derivative asset value is $1.9 million, which the LLM does report, but again with incorrect component values ($1.9M current + $1.7M long-term = $3.6M total, which is inconsistent with the ground truth total of $1.9M). The LLM also completely omits any mention of the derivative liability, which increased from $2.0 million in 2023 to $4.7 million in 2024 — a key part of the original answer. (2) Calculations are internally consistent but based on false inputs: $54.9M - $3.6M = $51.3M decrease is mathematically correct but irrelevant because the starting values are wrong. The actual decrease in derivative assets is $1,164M - $1.9M = $1,162.1M, which the LLM fails to report. (3) The multi-hop reasoning is flawed — the model fails to correctly extract and synthesize the correct asset values across years and entirely misses the liability dimension, which is required for completeness. (4) Scores reflect major factual inaccuracies in numbers and omissions in liability data, though the direction of change (decrease in assets) is correct, and some fiscal year references are accurate, preserving partial relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 420,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "From 2022 to 2023, the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions shifted significantly. In 2022, energy-related derivatives contributed a gain of $37 million to Southern Company's cost of natural gas and a neutral impact on Southern Power's cost of natural gas. However, in 2023, energy-related derivatives resulted in a loss of $44 million for Southern Company and $23 million for Southern Power, indicating a deterioration in the hedging effectiveness or market conditions affecting these positions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The original answer states that in 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on cost. In 2023, there was a $59 million gain on cost and $0 impact on revenue. The LLM instead claims a $37 million gain on Southern Company's cost in 2022 and neutral impact for Southern Power, which is not mentioned in the ground truth. In 2023, it reports losses of $44M and $23M for Southern Company and Southern Power respectively—none of which appear in the original. (2) All numeric values are incorrect and do not match the ground truth; there are no valid calculations or corroborated figures. (3) The reasoning is flawed: the LLM introduces specific entities (Southern Company, Southern Power) not referenced in the question or original answer, fails to address the correct multi-hop evolution of hedging impacts on both cost and revenue across years, and draws an incorrect conclusion about deteriorating effectiveness when the actual data shows improvement in cost hedging. (4) The contextual relevance is low because it discusses unrelated companies and incorrect financial impacts, though it does attempt to address the general theme of change over time in hedging performance, which provides minimal relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 383,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Between the 2023 and 2024 10-K filings, Walmart's Deferred Compensation Matching Plan was amended and restated effective November 8, 2023, as documented in the 2024 filing. In the 2023 filing, the plan was not specifically referenced, indicating that the plan was either not previously disclosed or was newly formalized in the 2024 filing with an effective date in late 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error in the timeline and documentation status of Walmart's Deferred Compensation Matching Plan. According to the ground truth, the plan was introduced in the 2023 10-K as 'amended and restated effective November 8, 2023'—meaning it was explicitly documented in the 2023 filing. However, the LLM incorrectly states that the plan was 'not specifically referenced' in the 2023 filing, which contradicts the original answer and misrepresents the evolution of the plan. This undermines the core multi-hop reasoning required to assess how the treatment changed between years. The effective date (November 8, 2023) is correctly noted, earning partial credit for quantitative accuracy. However, the qualitative error is severe: the LLM reverses the chronology, suggesting the plan appeared in the 2024 filing with retroactive effect, rather than being newly introduced in 2023 and then normalized in 2024. The shift from 'newly introduced' to 'incorporated by reference'—a key indicator of institutionalization—is entirely missed. As such, while the answer addresses the question's general topic and gets the effective date right, it fails to accurately describe the documentation status in either year, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the response stays on topic but misinterprets the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 387,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, the disclosure of LTIP Units remained consistent in stating that no securities had a material dilutive effect for either year. In both years, LTIP Units were included as potentially dilutive securities, but they did not impact earnings per share or unit calculations. The accrual policy also remained unchanged, with distributions being accrued when declared. There was no notable evolution in the treatment or dilutive effect of LTIP Units during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core information from the ground truth. (1) All factual elements are correct: LTIP Units are consistently described as potentially dilutive with no material dilutive effect in both 2023 and 2024, and the accrual policy (distributions accrued when declared) is correctly reported as unchanged. (2) There are no numeric values requiring calculation, but the years referenced (2023, 2024, and prior years) are correctly aligned with the disclosure periods in the original answer. (3) The multi-hop reasoning is sound—comparing disclosures across two years and synthesizing treatment changes (or lack thereof) in both dilutive effect and accrual policy. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the expansion of the lookback period in 2023 (which included 2021) versus 2024 (which included 2022), though this detail is contextual and does not alter the conclusion of no material change. The answer correctly concludes no notable evolution, which aligns with the ground truth. Wording differs slightly but maintains semantic equivalence. Thus, the answer is excellent with only a slight omission of a minor contextual nuance, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 354,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024 by implementing steps to comply with regulatory corrective orders following engagement with the Irish Data Protection Commission (IDPC). In 2023, the European Commission adopted an adequacy decision regarding the United States under the EU-U.S. DPF, which replaced invalidated prior frameworks. Meta has taken actions to align with this decision and the broader regulatory landscape, including addressing the IDPC's findings. However, potential invalidation of the EU-U.S. DPF by the Court of Justice of the European Union (CJEU) remains a risk that could significantly impact Meta's operations in Europe.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but misses key aspects of Meta's evolving compliance approach between 2023 and 2024, particularly regarding specific regulatory actions and business model changes. (1) Correctly notes Meta's engagement with the Irish Data Protection Commission (IDPC) and the 2023 adequacy decision for the EU-U.S. DPF, which aligns with the ground truth. It also correctly identifies ongoing legal risks, such as potential CJEU invalidation, which is contextually relevant. (2) Quantitatively, no specific numbers (e.g., the €1.2 billion fine) are mentioned, which were present in the original answer and are significant factual markers. The absence of this key penalty weakens the response’s factual completeness. (3) The multi-hop reasoning is partially sound but incomplete: while it references regulatory engagement and framework adoption, it omits critical developments in 2024, such as Meta’s implementation of corrective measures, the introduction of the 'subscription for no ads' model in November 2023, and the European Commission’s July 2024 preliminary findings of non-compliance under the DMA. These omissions represent a failure to fully synthesize the evolution from foundational DPF compliance to active scrutiny of new business models. (4) The answer remains contextually relevant and uses accurate terminology, but lacks depth in tracing the actual progression of Meta’s compliance strategy as required by the question. It focuses more on external risks than on Meta’s internal strategic shifts. Thus, while factually plausible in parts, it does not fully reflect the nuanced evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 451,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Between 2023 and 2024, Linde has increased its emphasis on green hydrogen production by advancing its technology portfolio and promoting renewable energy sources. In 2023, the company described green hydrogen as being produced through electrolysis using renewable energy or via steam methane reformation of biomethane. By 2024, Linde further highlighted its state-of-the-art sustainable technologies in its Engineering business, which support the transition to clean energy by covering the entire value chain for hydrogen production, including production, liquefaction, storage, and distribution. This reflects a stronger strategic focus on renewable energy integration and clean energy solutions in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Linde's 2023 production methods—green hydrogen via electrolysis using renewable energy and steam methane reforming of biomethane—which matches the ground truth. It also accurately reflects the increased strategic emphasis on green hydrogen in 2024, including integration across the value chain. However, it omits a key evolution noted in the original answer: the rebranding and clearer differentiation of green hydrogen as 'renewable hydrogen' produced specifically from water and renewable energy, and the explicit distinction from blue hydrogen. Additionally, the LLM answer fails to mention the introduction of carbon intensity as a metric to differentiate production methods in 2024, which is a significant qualitative shift in Linde’s framing. (2) There are no numerical values in this question, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly referenced, satisfying temporal accuracy. (3) The reasoning is sound in recognizing a strategic shift between the two years and synthesizing Linde’s expanding focus on clean energy infrastructure. However, it falls short in capturing the full multi-hop nuance—the evolution in terminology, feedstock specification (water), and use of carbon intensity metrics—which are critical to fully answering how the approach evolved. (4) The correctness score is 7 because the core facts about production methods and increased emphasis are accurate, but important details about conceptual refinement in 2024 are missing. Quantitative accuracy is 10 due to correct use of years and absence of numerical errors. Qualitative accuracy is 7 due to partial but incomplete synthesis of the strategic framing evolution. Contextual relevance is 9 as the response stays focused and relevant throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 495,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company completed the sale of Sequent to Williams Field Services Group on July 1, 2021, for a total cash purchase price of $159 million, resulting in a pre-tax gain of approximately $121 million ($92 million after tax). By 2023, Sequent was no longer part of Southern Company Gas' reportable segments, as noted in the 2023 10-K. The financial implications included a one-time gain from the sale in 2021, as well as additional tax expenses of $85 million due to changes in state apportionment rates.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has a critical factual error in the sale date. The ground truth states the sale occurred in 2022, but the LLM claims it was completed on July 1, 2021—this incorrect timing undermines the core of the multi-hop analysis between 2022 and 2023. The financial figures—$159 million sale price, $121 million pre-tax gain, and $85 million additional tax expense—are all factually correct and match the ground truth. The post-divestiture status in 2023 is accurately reflected, with Sequent no longer in Southern Company Gas' reportable segments. (2) Quantitative accuracy is partially correct: all dollar amounts are accurate, but the date of the transaction is wrong, which affects the temporal alignment of financial implications. The after-tax gain of $92 million is mentioned in the LLM answer but not in the original; while plausible, it introduces unverified detail. (3) The reasoning correctly identifies the evolution from ownership to divestiture and recognizes the financial impacts, but fails on the key multi-hop requirement of tracking the change *between 2022 and 2023* due to misplacing the sale in 2021. This breaks the logical timeline and misattributes when the financial impacts occurred. (4) Contextual relevance is high—the answer addresses both the relationship evolution and financial implications. However, the incorrect year reduces the correctness score significantly despite otherwise solid synthesis of financial outcomes and entity relationships. Minor flexibility is allowed in wording, but not in event timing, especially for year-over-year analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 449,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Between 2023 and 2024, Walmart has continued to expand and emphasize the Allswell brand within its private brand portfolio, indicating a strategic focus on enhancing its offerings in home and wellness categories. The Allswell brand is specifically highlighted in the Walmart U.S. segment's merchandise strategy, underscoring its role in providing high-quality, affordable products under Walmart's private label. This evolution reflects Walmart's broader strategy to strengthen its private brand portfolio by investing in recognizable and trusted names that align with customer needs and preferences, thereby reinforcing its position as a value-driven retailer.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the timeline (2023–2024) and the general strategic positioning of Allswell within Walmart's private brand portfolio. It correctly identifies Allswell as part of Walmart’s private label strategy and links it to customer value and brand trust. However, it misses the specific evolution detail that Allswell was *introduced* in 2023 and then *listed alongside mature brands* like 'bettergoods' and 'Great Value' in 2024—a key multi-hop signal indicating progression from new to established status. While the LLM captures the strategic implication (strengthening private brands), it does not reference this concrete evidence from the knowledge graph, leading to a less precise qualitative reasoning chain. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no numbers were involved), and the response remains contextually relevant and well-aligned with the question’s intent. The omission of specific brand comparisons and the lack of explicit transition from 'new' to 'established' prevent a higher score on qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 325,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "From 2022 to 2023, the strategic importance of Embedded Processing products for Texas Instruments (TXN) remained significant but showed mixed performance. Revenue for Embedded Processing increased by 3% in 2023 compared to 2022, driven by a favorable product mix. However, operating profit declined by 20% due to higher manufacturing costs. Despite the revenue growth, the operating profit margin dropped from 38.4% in 2022 to 29.9% in 2023, indicating margin pressure. This suggests that while Embedded Processing maintained its strategic relevance, its profitability became more challenging in 2023 due to cost factors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that no specific revenue figures for Embedded Processing were disclosed in 2022, and there is no mention of a 3% revenue increase or a 20% decline in operating profit. Additionally, the operating profit margins of 38.4% in 2022 and 29.9% in 2023 are not present in the original answer and are therefore unsupported. These numbers appear fabricated or misattributed. (2) Quantitatively, the LLM introduces precise percentages and margin figures that are not in the ground truth and cannot be verified from the provided information. The ground truth emphasizes the role of Embedded Processing in offsetting Analog revenue decline and contributing to a total revenue of $17.52 billion in 2023, but does not break down Embedded Processing revenue or profitability. The LLM incorrectly shifts focus to profitability and margin pressure, which is absent in the original. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that Embedded Processing remained strategically important, it fails to connect the key point that it played a compensatory role in the revenue mix during a period of overall decline—this synthesis is central to the ground truth but missing. Instead, it introduces unverified financial metrics that distort the conclusion. (4) Despite the factual errors, the answer is contextually relevant—it addresses the evolution of strategic importance and focuses on the correct company (TXN) and product segment. However, the incorrect data severely undermines correctness. The qualitative reasoning about strategic relevance has partial merit but is undermined by unsupported numbers. Hence, low scores on quantitative and overall correctness, moderate on contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 489,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "Chevron's involvement in Angola LNG has seen a decline in equity in earnings, dropping from $1,857 million in 2022 to $405 million in 2024. This significant decrease suggests a strategic shift or challenges in the project's performance during this period, potentially indicating a reduced focus or financial commitment to Angola LNG as part of Chevron's broader strategic positioning in the LNG market.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and interpretation. The ground truth states that Chevron's involvement evolved from operational participation in 2022 to a clearly defined 36.4% equity stake in Angola LNG Limited by 2024, indicating a strategic deepening of commitment. In contrast, the LLM claims a drop in 'equity in earnings' from $1,857 million to $405 million, which is not supported by the original answer and introduces financial figures absent from the ground truth. These numbers appear fabricated or misattributed, as no such earnings data is present in the provided knowledge. (2) Quantitative accuracy is very low: the dollar amounts and the implied financial trend (sharp decline) are not found in the original answer and contradict the narrative of increasing strategic commitment. There is no mention of earnings in the ground truth—only stake percentage (36.4%) and production context. (3) The multi-hop reasoning is flawed. Instead of synthesizing the evolution from operational role to formal ownership stake as evidence of strategic positioning, the model infers a reduction in strategic focus based on invented financial data. This misrepresents the direction of Chevron’s strategic intent. (4) Contextual relevance is moderate because the answer addresses Chevron, Angola LNG, and the 2022–2024 timeframe, and attempts to discuss strategic positioning. However, due to factual inaccuracies and incorrect reasoning, the conclusion is opposite to the ground truth. The model fails to capture the core fact of a 36.4% stake in 2024 and the significance of formalized investment. Thus, correctness and qualitative accuracy are severely penalized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 465,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "The CH-53K program has seen a notable increase in production and financial contribution within Lockheed Martin's RMS division between 2021 and 2024. In 2021, the program contributed to higher net sales and operating profit for RMS due to increased production volume and risk retirements. By 2024, the CH-53K program's production ramp-up further boosted RMS product sales, indicating its growing importance as a key driver of revenue and profitability within the division. This evolution highlights the program's increasing strategic and financial significance for RMS.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the overall evolution of the CH-53K program from increased production and financial contribution between 2021 and 2024, and accurately identifies its growing strategic role within Lockheed Martin's RMS division. However, it omits specific quantitative figures that are central to the ground truth. In 2021, the program contributed to a $540 million increase in RMS net sales and a $140 million increase in operating profit—these exact figures are missing in the LLM response. By 2024, the program contributed $1.1 billion to higher product sales, a key metric that the LLM fails to include. (2) While the qualitative description of 'production ramp-up' and 'growing importance' aligns with the ground truth, the absence of precise dollar amounts significantly reduces quantitative accuracy. The LLM uses vague terms like 'higher net sales' and 'boosted product sales' without anchoring them to the actual data. (3) The multi-hop reasoning is sound in that the model correctly infers a progression from early production with risk retirements to a mature, high-volume production phase driving revenue growth. It synthesizes the program’s evolving role across time, though without numerical support. (4) The contextual relevance is perfect—the answer directly addresses the question’s focus on financial contribution, production status, and strategic role. The qualitative accuracy is high because the logic and entity identification (CH-53K, RMS, Lockheed Martin) are correct, but the correctness score is limited by the lack of key financial data, which is essential in financial multi-hop evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 451,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "Between 2022 and 2023, PayPal updated its expected credit loss models for revolving consumer credit products, incorporating macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales, in addition to unemployment rates (used through the first quarter of 2023). In 2022, the reasonable and supportable forecast period for revolving products was 2 years, while in 2023, it was extended to approximately 5 years. These changes reflect a more comprehensive and extended macroeconomic outlook applied to the revolving consumer credit portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core evolution in PayPal's use of macroeconomic factors in its loss curves between 2022 and 2023, correctly noting the addition of household disposable income and retail e-commerce sales and the use of unemployment rates only through Q1 2023. However, it introduces a detail not present in the ground truth: the extension of the forecast period from 2 years in 2022 to 5 years in 2023. This specific quantitative claim about the forecast horizon is unsupported by the original answer and cannot be verified from the provided ground truth, making it a significant factual overreach. While the qualitative shift in macroeconomic indicators is accurately described (adding new factors and phasing out unemployment), the original answer states that unemployment was *replaced* after Q1 2023, whereas the LLM says the factors were added 'in addition to' unemployment, which slightly misrepresents the nature of the change. This implies unemployment was still used alongside new factors, contrary to the replacement described in the ground truth. Despite this, the answer remains contextually relevant and reflects a sound understanding of the model updates. The multi-hop reasoning is partially correct—synthesizing changes in inputs to the loss models—but introduces unverified quantitative details. Thus, the correctness score is reduced due to unsupported numerical claims and a minor mischaracterization of the factor replacement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 400,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks' foreign currency debt-related gains or losses included in AOCI increased significantly from 2023 to 2024, with the net gains in AOCI for foreign currency debt rising from $140.2 million in 2023 to $135.2 million in 2024. This indicates that the company's exposure to foreign currency fluctuations remained high, and the changes in foreign currency values had a material impact on the valuation of its foreign currency-denominated debt. The continued presence of substantial gains or losses in AOCI suggests that Starbucks is actively managing its foreign currency risk through hedging instruments, but it remains sensitive to exchange rate movements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative data. According to the ground truth, Starbucks reported a foreign currency debt-related *loss* of $6.3 million in 2023, not a gain of $140.2 million as stated by the LLM. The 2024 figure of $135.2 million gain is correct. The LLM incorrectly states that gains increased from $140.2M to $135.2M, which is both numerically wrong and directionally incorrect (the actual change was from a loss to a large gain). (2) The calculation and comparison are fundamentally flawed: the actual change is a swing from a $6.3M loss to a $135.2M gain—an improvement of $141.5M—not a decrease in gains as implied. The LLM misrepresents the magnitude and direction of the change. (3) While the LLM correctly identifies the metric (foreign currency debt-related gains/losses in AOCI) and the years (2023 to 2024), and attempts multi-hop reasoning about foreign currency exposure and hedging, the conclusions are based on incorrect data. The assertion that exposure 'remained high' misses the key point of a reversal in position (from loss to gain), which suggests a shift in currency dynamics, not just persistent exposure. (4) Contextually, the answer addresses the question's intent regarding AOCI and foreign currency exposure, so relevance is moderate. However, due to severe quantitative inaccuracies and resulting flawed interpretation, the correctness score is low. The qualitative reasoning would be acceptable if based on correct data, but it is undermined by factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 424,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "For 2023, the fair value of energy-related derivative liabilities for Alabama Power was $110 million (Level 2), and for Georgia Power, it was $124 million (Level 2). In 2022, Alabama Power's energy-related derivative liabilities were $199 million (Level 2), and Georgia Power's were $124 million (Level 2). Thus, Alabama Power's liabilities decreased by $89 million, while Georgia Power's remained unchanged. The combined liabilities for both companies decreased from $323 million in 2022 to $234 million in 2023, indicating an overall downward trend.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Alabama Power's 2022 net liability was $144 million, not $199 million as stated. The LLM incorrectly reports Georgia Power's 2022 derivative liabilities as $124 million, but the original answer does not provide Georgia Power's 2022 liabilities at all, making this an unsupported fabrication. The LLM also fails to account for derivative assets: Alabama Power had $15 million in assets in 2023 and Georgia Power had $13 million, which are critical for calculating net liabilities. Instead, the LLM uses only liability figures, leading to incorrect net assessments. (2) Calculations are therefore flawed: the LLM claims combined liabilities decreased from $323M to $234M, but the correct combined net liability decreased from $255M (Alabama Power's $144M only in 2022, as Georgia Power's 2022 data is not provided) to $206M in 2023. The LLM's calculation of a $323M total in 2022 assumes Georgia Power had $124M in liabilities in 2022, which is not supported by the original answer. (3) Multi-hop reasoning is partially present— the model attempts to compare two companies across two years and draw a trend—but it fails due to incorrect data synthesis. It does not properly net assets against liabilities, misrepresents 2022 figures, and invents data for Georgia Power in 2022. (4) Contextual relevance is high because the structure and intent align with the question, discussing fair values, liabilities, trends, and both companies. However, factual and quantitative errors severely undermine correctness, warranting a low overall score despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 458,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, gaining approximately 100% ownership. However, by fiscal 2025, the company had sold and deconsolidated Alert Innovation, indicating a disposition of the asset. There is no explicit mention of the acquisition or sale occurring specifically in fiscal 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion acquisition of Alert Innovation in fiscal 2023 and Walmart's ~100% ownership, which matches the ground truth. However, it incorrectly states the disposition occurred in fiscal 2025 instead of fiscal 2024, which is a critical factual error in timing. The original answer clearly states the sale and deconsolidation happened in fiscal 2024, marking a one-year evolution from acquisition to divestiture. (2) Quantitatively, the $0.4 billion figure is accurate and properly formatted. There are no calculation errors, but the misplacement of the fiscal year for the sale undermines the temporal accuracy. (3) The reasoning is partially sound—LLM captures the acquisition and disposition trajectory but fails on the multi-hop synthesis of timing, which is central to the question about the evolution between fiscal 2023 and 2024. By placing the sale in fiscal 2025, it misses the rapid turnaround implied in the original answer. (4) Contextual relevance is high as the response addresses the core financial relationship and uses appropriate terms like 'deconsolidated' and 'disposition.' However, the incorrect fiscal year for the sale significantly reduces factual correctness, warranting a moderate score of 6 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 361,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's regulatory approval status expanded significantly, with the FDA approving it for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. Additionally, the European Commission granted approval for Trodelvy as monotherapy for similar indications. This expansion indicates that Gilead is actively pursuing broader therapeutic applications for Trodelvy, reflecting a strategic focus on expanding its oncology portfolio and addressing unmet medical needs in breast cancer treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Trodelvy received FDA and European Commission (EC) approval in 2023 for unresectable locally advanced or metastatic HR+/HER2- breast cancer in patients who had prior endocrine-based therapy and at least two additional systemic therapies. The answer correctly notes no specific regulatory updates in 2022, only that it was already marketed. (2) There are no numeric values requiring calculation, but the dates (2022–2023) and regulatory bodies (FDA, EC) are correctly identified. (3) The multi-hop reasoning is sound—synthesizing the evolution of approval status across years and jurisdictions to infer Gilead’s oncology strategy. The LLM correctly infers strategic expansion in oncology, particularly in breast cancer, based on expanded indications. (4) The only minor shortcoming is that the LLM does not explicitly state that no regulatory updates occurred in 2022 (though it implies it by focusing on 2023 developments), slightly reducing completeness compared to the original answer. However, the core information and strategic interpretation are semantically equivalent. Wording differs but meaning is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 377,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's financial relationship with ABG evolved significantly through capital transactions. In 2023, Simon sold a portion of its interest in ABG, resulting in a pre-tax gain of $157.1 million and a dilution of its ownership to approximately 9.6%. By early 2024, Simon fully divested its remaining stake in ABG, generating a substantial pre-tax gain of $414.8 million from the $1.2 billion cash proceeds. This strategic move reflects Simon's shift in capital allocation priorities, focusing on core real estate assets and optimizing returns by exiting non-core investments like ABG.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) did not sell a portion of its interest in ABG for a $157.1 million gain in 2023, nor did it fully divest its remaining stake in early 2024 for $414.8 million. Instead, SPG recognized non-cash pre-tax gains from dilution events: $36.4 million in Q2 2023 and $145.8 million in Q3 2023 due to SPARC Group issuing equity, which diluted SPG’s ownership. There is no mention in the original answer of a $1.2 billion cash proceeds transaction or a full divestiture in 2024. The 2024 filing only referenced historical transactions, not new divestitures. (2) Quantitative accuracy is severely lacking: the LLM invents numbers ($157.1M, $414.8M, $1.2B) that do not appear in the ground truth. The actual gains were $36.4M and $145.8M in 2023, totaling $182.2M, not $157.1M. The 9.6% ownership figure is not mentioned in the original answer and cannot be verified. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a strategic exit from ABG in 2024, while the ground truth indicates that SPG simply stopped reporting active capital transactions and only referenced past deals. The strategic partnership involving Forever 21, Brooks Brothers, and Eddie Bauer is omitted entirely, weakening the qualitative analysis. (4) Contextual relevance is moderate because the answer addresses the evolution of the financial relationship and capital transactions, but the incorrect facts and invented transactions undermine the overall correctness. The conclusion about shifting capital allocation is speculative and unsupported by the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 459,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Between 2022 and 2024, Chevron's relationship with Chevron Phillips Chemical Company LLC remained stable in terms of financial reporting and investment value. In 2022, Chevron's investment in Chevron Phillips Chemical was $7,765 million, generating $608 million in equity earnings. By 2024, the investment increased to $8,571 million, with equity earnings rising to $903 million, indicating a stronger financial performance and increased value of the investment during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct numbers but misrepresents the core evolution of Chevron's relationship with Chevron Phillips Chemical Company LLC. While the 2024 investment value of $8,571 million and the 2023 value of $7,765 million are accurate, the LLM incorrectly states that the $7,765 million was the 2022 investment value. The ground truth does not specify the 2022 investment value, only that the entity was consolidated in 2022. The equity earnings figures ($608M in 2022, $903M in 2024) are fabricated and not present in the ground truth. (2) Quantitatively, the $8,571 million figure is correct for 2024, but the attribution of $7,765 million to 2022 is wrong—it is the 2023 value. The earnings numbers are entirely unsupported. (3) The multi-hop reasoning is flawed: the key point is the shift from consolidation (2022) to equity method reporting (2024), indicating a change in control or ownership structure. The LLM completely misses this critical transition and instead frames the relationship as stable, which contradicts the ground truth. This failure to identify a structural accounting change undermines the qualitative accuracy. (4) Contextual relevance is moderate because the answer discusses financial reporting and investment value as asked, but it omits the most important aspect—the change in consolidation status—and invents earnings data, leading to a low correctness and qualitative score despite some accurate numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 407,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "Between the end of 2023 and the end of 2024, Meta's Facilities Consolidation Strategy, part of the 2022 Restructuring, saw completion of all initiatives by December 31, 2024. In 2023, the strategy had already been substantially completed, with most activities finalized. Financially, the 2024 impact was limited to $389 million in pre-tax charges, all related to facilities consolidation, compared to $2.255 billion in charges in 2023. This reduction reflects the winding down of the multi-year initiative.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the financial figures. The ground truth states that the 2024 disclosure included a retrospective summary of total pre-tax charges across 2022–2024, but does not specify the 2023 and 2024 charges as $2.255 billion and $389 million, respectively. These numbers are not present in the original answer and appear to be fabricated or misattributed. There is no mention in the ground truth of a $389M charge in 2024 or a $2.255B charge in 2023, nor any comparison between annual charges. (2) The quantitative accuracy is low because the dollar amounts and implied calculations (e.g., reduction from 2023 to 2024) are unsupported by the original answer. The original does not provide annual breakdowns of charges for those years, so the LLM's specific figures and their comparison are incorrect. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that the facilities consolidation was substantially completed by end-2023 and fully completed by end-2024, which aligns with the multi-hop progression in status. It also correctly ties the initiative to the 2022 Restructuring. However, it adds financial details not present in the ground truth, failing to accurately reflect that the 2024 financial impact was a retrospective summary, not new charges. (4) Contextual relevance is high because the answer addresses the evolution of the strategy and attempts to discuss both status and financial impact. However, the inclusion of false quantitative data undermines correctness. The core status progression is accurate, but the financial claims are not, leading to a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 460,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2024 has shown a strategic shift from initial development to more focused execution. In 2022, the company highlighted its participation in hypersonics programs with the U.S. Air Force and Army as part of its Missiles and Fire Control segment, emphasizing design and development. By 2024, the company's hypersonics programs were mentioned under both the Missiles and Fire Control and Space segments, indicating expanded collaboration and integration with other advanced systems. The 2024 report also noted progress in advancing hypersonic capabilities, aligning with broader strategic goals in next-generation strike weapons and multi-domain solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lockheed Martin's evolving involvement in hypersonics from 2022 to 2024, noting a shift from development to more advanced stages. It accurately references the U.S. Air Force and Army programs and mentions the Missiles and Fire Control segment, which aligns with the ground truth. However, it omits the critical detail that in 2022, the program's continuation was explicitly described as dependent on U.S. Government authorization and funding, which is a key indicator of its uncertain, early-stage status. In 2024, the ground truth emphasizes that Lockheed Martin was actively producing hypersonic strike weapons, whereas the LLM answer only states 'progress in advancing hypersonic capabilities'—a vaguer and less definitive characterization. The LLM also introduces the claim that hypersonics were mentioned in both the Missiles and Fire Control and Space segments in 2024, which is not present in the ground truth and may be an overstatement or misattribution. (2) There are no numerical values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic evolution over time and connects the programs to military branches and business segments. However, it fails to fully capture the significance of the shift from 'funding-dependent development' to 'active production,' which is the core of the evolution described in the ground truth. (4) The answer is contextually relevant and well-structured, but lacks precision in conveying the program status transition. The correctness score is 7 due to accurate framing and entities but missing key qualitative distinctions about program maturity and funding dependency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 486,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "From 2022 to 2023, Southern Company's treatment and disclosure of energy-related derivatives showed a shift in financial impact and designation. In 2022, energy-related derivatives contributed a gain of $34 million to Southern Company's AOCI, while in 2023, this turned into a loss of $81 million. Additionally, Southern Power's energy-related derivatives moved from a $12 million gain in 2022 to an $18 million loss in 2023. These changes reflect a more negative financial impact in 2023 compared to the prior year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The original answer focuses on the evolution of Southern Company's disclosure practices regarding energy-related derivatives—specifically, a shift from reporting only regulatory hedging instruments in 2022 to including non-designated derivatives in 2023 with expanded retrospective disclosure. However, the LLM answer fabricates specific financial figures ($34M gain in AOCI in 2022 turning to $81M loss in 2023, Southern Power’s $12M gain to $18M loss) that are not present in the ground truth and misrepresents the nature of the change. There is no mention of AOCI or Southern Power in the original answer, nor are any specific dollar amounts provided about gains or losses. (2) The numbers cited in the LLM response (e.g., $34M, $81M, $12M, $18M) have no basis in the provided ground truth and cannot be verified—this constitutes a severe quantitative inaccuracy. (3) The multi-hop reasoning is flawed: instead of identifying the change in accounting disclosure and designation policy, the model incorrectly infers a shift in financial performance based on nonexistent data. It fails to recognize that the core evolution is in transparency and scope of disclosure, not in the financial results themselves. (4) While the answer is framed around the correct company and time period (2022–2023), and attempts to address changes in derivative treatment, it fundamentally mischaracterizes the information, leading to a low correctness score. The contextual relevance is moderate because it discusses derivatives and time-based changes, but the substance is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 454,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Between 2022 and 2023, Gilead's intellectual property strategy regarding Truvada did not involve significant new patent disclosures related to Truvada itself, as the product had already lost exclusivity in the United States in October 2020. However, Gilead continued to focus on strengthening its overall portfolio through strategic collaborations, in-licensing, and acquisitions in virology, oncology, and inflammation. These efforts included entering into new collaborations and expanding existing ones to develop novel therapies, which indirectly supported the company's long-term IP strategy by diversifying its pipeline and reinforcing its position in key therapeutic areas.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly notes that Truvada lost U.S. exclusivity in October 2020, which aligns with the ground truth and addresses the timeline context. However, it fails to capture the core evolution in Gilead's disclosure strategy between 2022 and 2023. In 2022, Gilead acknowledged the loss of exclusivity as a transitory headwind, and in 2023, it shifted to structured disclosures of patent expiration dates for key products including Truvada—this key shift is entirely missing from the LLM response. Instead, the LLM discusses Gilead's broader IP strategy through collaborations and pipeline development, which, while potentially true, is not responsive to the specific question about Truvada's patent disclosures. (2) Quantitatively, the October 2020 date is accurate and correctly referenced, earning high marks for date accuracy. There are no numerical errors in the information provided. (3) The multi-hop reasoning is flawed: the question requires comparing Gilead’s disclosure approach in two consecutive years regarding Truvada’s IP, but the LLM does not identify or contrast these reporting differences. It does not mention the 2023 structured disclosures of expiration timelines in the U.S. and EU, which is a central element of the ground truth. (4) While the answer is factually plausible and contextually related to IP strategy, it misses the specific evolution in transparency and disclosure format, leading to a low correctness score despite accurate dates and reasonable phrasing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 417,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "Between 2022 and 2024, SPG's use of the Supplemental Facility evolved significantly in terms of borrowing and repayment activities. In 2022, SPG had $1.05 billion outstanding under the Supplemental Facility, and on January 12, 2022, it repaid $1.05 billion outstanding under the Supplemental Facility using proceeds from the issuance of senior unsecured notes. By 2024, SPG had repaid the €750.0 million ($815.4 million U.S. dollar equivalent) outstanding under the Supplemental Facility on November 17, 2023, using proceeds from the issuance of €750.0 million senior unsecured bonds. As of December 31, 2024, SPG had an aggregate available borrowing capacity of $8.2 billion under the Credit Facilities, with no outstanding balance under the Commercial Paper program.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the sequence and nature of borrowing and repayment activities. According to the ground truth, in January 2022, SPG *borrowed* $1.05 billion under the Supplemental Facility to repay $1.16 billion in mortgages, and this borrowing was repaid shortly after. However, the LLM incorrectly states that SPG *repaid* $1.05 billion on January 12, 2022, using proceeds from senior unsecured notes, reversing the actual flow of funds and misrepresenting the purpose and timing. This is a critical error in financial reasoning. (2) The €750.0 million ($815.4 million) borrowing in November 2023 and repayment on November 17, 2023, is correctly reported in terms of amount and date, which supports a partial quantitative accuracy score. However, the LLM implies the repayment occurred in 2024, while the borrowing and repayment both occurred in late 2023, which affects temporal accuracy. (3) The LLM introduces new information—issuance of €750.0 million senior unsecured bonds to repay the Supplemental Facility—that is not in the original answer and may be inferred, but the original answer does not confirm this specific funding source for the repayment. Additionally, the LLM omits the key point from the ground truth that SPG issued new senior unsecured notes in 2024 to redeem other notes at maturity, indicating a shift in financing strategy, which is a crucial part of the 'evolution' asked in the question. (4) While the LLM attempts to describe the evolution and includes relevant context like available capacity under Credit Facilities, it fails to accurately portray the causal and temporal logic of the financing activities. The answer is contextually relevant and well-structured, but the core multi-hop reasoning—linking borrowing, repayment, and strategic shifts—is flawed due to incorrect event sequencing and missing strategic insight. Thus, correctness and qualitative accuracy are significantly penalized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 535,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife's capital management strategy has emphasized maintaining sufficient liquidity and cash buffer levels to support its financial strength ratings, regulatory requirements, and risk management objectives. In 2022, the company highlighted its focus on maintaining capital consistent with ratings objectives, including managing dividends and deploying financial resources as needed, while also addressing liquidity needs through a rolling 12-month forecast and stress testing. By 2024, MetLife continued to emphasize the importance of liquidity, noting that cash buffer needs could limit capital available for other uses such as innovation or shareholder returns. Additionally, the company acknowledged that regulatory and market uncertainties, including potential moratoriums on captive reinsurance and volatility in capital markets, could impact its ability to deploy excess capital and manage liquidity effectively.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the qualitative evolution in MetLife's capital management strategy from 2022 to 2024 correctly, noting the continued emphasis on liquidity and the emerging trade-off between cash buffers and other capital uses like innovation and shareholder returns. However, it omits the specific quantitative figures from 2022—$12.4 billion in short-term liquidity and $223.0 billion in total liquid assets—which are central to the ground truth and expected in a complete answer. These numbers are not mentioned at all, representing a significant gap in quantitative completeness. (2) No incorrect numbers are stated, but the absence of key dollar amounts from 2022 reduces quantitative accuracy. The LLM does not attempt any calculations, so no errors there. (3) The multi-hop reasoning is sound: the model correctly synthesizes the shift in tone and strategic consideration over time, connecting liquidity management in 2022 with capital allocation constraints in 2024. It also appropriately contextualizes external factors like regulatory uncertainty and market volatility as influencing capital deployment, which aligns with the broader narrative. (4) Despite missing specific figures, the answer remains contextually relevant and conveys the core strategic evolution. The qualitative reasoning and entity accuracy (MetLife, years 2022–2024, capital allocation concepts) are correct. The correctness score is 7 because the key facts are partially missing (quantitatively), but the overall direction and logic of the answer are accurate and well-structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 435,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Between 2022 and 2023, Starbucks' exposure to 'Foreign currency - other' derivatives shifted significantly in terms of asset and liability classifications. In 2022, these derivatives were primarily classified as assets, with $39.9 million in prepaid expenses and other current assets and $33.5 million in other long-term assets. By 2023, the exposure was largely reclassified, with $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets, indicating a reduction in asset exposure. Additionally, liabilities related to 'Foreign currency - other' increased, with $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities in 2023, compared to minimal liabilities in 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Starbucks had a 'Foreign currency - other' derivative liability of $0.3 million and no asset, but the LLM incorrectly states there were assets of $39.9 million and $33.5 million with no mention of the $0.3 million liability. In 2023, the correct figures are a $1.9 million asset and $4.7 million liability; the LLM correctly identifies the $1.9 million asset but adds a non-existent $1.7 million in other long-term assets and a $4.1 million long-term liability not present in the ground truth. (2) The quantitative inaccuracies are severe: the LLM invents large asset values in 2022 that do not exist in the original data and introduces long-term liability classifications absent from the ground truth. The only correct numbers are the 2023 $1.9 million asset and $4.7 million liability. (3) The reasoning is flawed: the LLM suggests a reclassification from large asset positions to smaller ones and the emergence of long-term liabilities, but the actual evolution is from a small liability-only position to a balanced asset and liability structure—this misrepresents the nature and direction of change. The model fails to correctly synthesize the multi-hop information across years and classifications. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—it addresses the right topic, time frame, and general concept of shifting exposure between asset and liability classifications—hence a moderate relevance score. However, due to major factual and quantitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 449,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "The Coca-Cola Company's relationship with Coca-Cola FEMSA from 2023 to 2024 remained stable in terms of strategic engagement and financial stake. As of December 31, 2024, The Coca-Cola Company owned 28% of Coca-Cola FEMSA, maintaining its equity method investment. Coca-Cola FEMSA continued to be one of The Coca-Cola Company's largest bottling partners, operating in key markets such as Mexico, Brazil, and parts of Central and South America. There were no significant changes in the financial stake or strategic partnership during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that the relationship remained stable between 2023 and 2024. The ground truth states a significant evolution — Coca-Cola FEMSA transitioned from being a top independent bottler to becoming an equity method investee with a 28% ownership stake in 2024, indicating a strategic shift. The LLM incorrectly asserts there were 'no significant changes,' which contradicts the ground truth. (2) Quantitatively, the 28% ownership stake is correctly reported, and the geographic operations (Mexico, Brazil, Central and South America) are consistent with the original answer. However, the LLM omits the key 2023 context that Coca-Cola FEMSA was one of the five largest bottlers contributing to 42% of global unit case volume — a critical multi-hop data point. (3) The reasoning is flawed: the model fails to recognize the transition from traditional bottler to equity investee as a strategic evolution, which is the central point of the original answer. This indicates a failure in multi-hop synthesis — connecting the change in financial structure with strategic implications. (4) While the answer includes relevant entities and some correct numbers, the conclusion misrepresents the nature of the relationship change, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer discusses the right companies and timeframe but misses the key transformation in the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 411,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Intel's strategic positioning of FPGAs between 2022 and 2024 has emphasized their role as a key component in programmable solutions across adjacent products and advanced computing architectures. In 2022, FPGAs were highlighted as part of Intel's broader portfolio of programmable logic devices (PLDs) and adjacent products, supporting diverse applications such as networking, data centers, and autonomous driving. By 2024, FPGAs were explicitly positioned within the \"xPU\" category—processors tailored for CPU, GPU, accelerators, and FPGAs—showcasing their integration into Intel's cross-architecture strategy. Additionally, FPGAs were increasingly aligned with high-performance computing and AI initiatives, reflecting a broader production focus on enabling flexible, performance-optimized solutions for cloud, communication, and edge computing markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges from the ground truth in key aspects of strategic positioning. (1) Correct elements: The answer accurately reflects that FPGAs were part of a broader product ecosystem in 2022 and became more integrated into advanced computing architectures by 2024. It correctly identifies FPGAs as increasingly important in AI, cloud, and edge computing. (2) Quantitative accuracy is high: no specific numbers are cited, and the years (2022, 2024) are correctly used. (3) However, the qualitative accuracy suffers because the LLM introduces the 'xPU' category and positions FPGAs within a cross-architecture strategy, which is not supported by the ground truth. The original answer emphasizes a structural shift—from being classified as 'adjacent products' in 2022 under CCG, DCG, and IOTG to being listed as a direct product in 2024—indicating a move from supplementary to core status. The LLM answer misses this organizational and classification shift entirely and instead focuses on technological integration (e.g., xPU, AI), which may be contextually relevant but does not reflect the specific evolution in strategic positioning as defined in the ground truth. (4) The answer is contextually relevant and well-articulated but fails to capture the core factual evolution—classification within product groups—making it only partially accurate despite plausible-sounding details. Thus, correctness is scored at 6 due to significant omission of the actual structural and strategic repositioning documented in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 427,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips significantly increased its capital expenditures in the Lower 48 region, with $6,487 million in 2023 compared to $5,630 million in 2022, reflecting active asset acquisition and development. Additionally, depreciation, depletion, and amortization (DD&A) expenses for the Lower 48 rose to $5,729 million in 2023 from $4,854 million in 2022, indicating increased asset utilization and investment in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the DD&A expenses for the Lower 48 region as $4,854 million in 2022 and $5,729 million in 2023, matching the ground truth exactly. The increase of $875 million is accurate (5,729 - 4,854 = 875), though not explicitly stated, the rise is correctly implied. However, the LLM introduces 'capital expenditures' of $6,487 million in 2023 and $5,630 million in 2022, which are not present in the original answer or supported by the provided ground truth. Since the question asks about asset acquisition and DD&A, and the original answer only references the Concho acquisition as the driver in 2022 (with no specific capex numbers), this addition of quantitative capex data is extraneous and potentially misleading. (2) All provided numbers related to DD&A are correct and properly formatted; no calculation errors. The capex figures, while possibly true, are not in the ground truth and thus represent unverified additions. (3) The multi-hop reasoning is sound in linking increased DD&A to continued investment and asset utilization post-acquisition, aligning with the original answer’s logic. The mention of ongoing asset acquisition is consistent with the Concho acquisition context, though the 2023 capex figures go beyond the provided information. (4) The answer is highly relevant and accurately captures the evolution in DD&A expenses. The only deviation is the inclusion of unsupported capex numbers, which slightly affects qualitative accuracy but does not undermine the core factual correctness of the DD&A trend. Hence, a score of 9 is justified—excellent but with minor overreach in unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 453,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Between 2022 and 2024, Emerson's financial and strategic relationship with AspenTech evolved significantly. In 2022, Emerson completed a business combination with Heritage AspenTech, creating \"New AspenTech,\" in which Emerson owned 55% of the shares on a fully diluted basis. By 2024, Emerson increased its ownership to approximately 57% and proposed to acquire the remaining shares for $240 per share, valuing AspenTech at $15.3 billion. Financially, the Heritage AspenTech acquisition in 2022 positively impacted gross margins by 0.6 percentage points in 2023, but by 2024, acquisition-related inventory step-up amortization negatively affected margins by approximately 1.3 percentage points.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Emerson increased its ownership from 55% in 2022 to 57% by 2024 and proposed to acquire the remaining shares for $240 per share, valuing AspenTech at $15.3 billion—this is not supported by the ground truth, which confirms Emerson owned 55% in 2024 and there was no mention of a $240/share offer or $15.3B valuation. Second, the ground truth specifies that the $87.69 per share payment was made in 2022, but the LLM omits this and instead introduces a fictional later offer. Third, while the LLM correctly notes the 0.6 percentage point gross margin improvement in 2023 and the 1.3 percentage point negative impact from inventory step-up amortization in 2024, it fails to mention the key outcome that gross margins reached 50.8% in 2024 (a 1.8 percentage point increase), which is central to the financial impact. (2) Quantitative accuracy is low: correct numbers include the 0.6 pp margin boost in 2023 and the $231M amortization impact (implied by 1.3 pp reduction), but the $240/share, $15.3B valuation, and 57% ownership are incorrect. The 2022 cash payment of $6.0B and $87.69/share are omitted. (3) The reasoning partially follows a logical multi-hop structure—linking acquisition to margin impacts—but introduces false progression in ownership and exit attempt not present in the truth. It also fails to connect the net margin effect in 2024 (positive 1.8 pp despite negative 1.3 pp drag), indicating incomplete synthesis. (4) Contextual relevance is high as the answer addresses ownership evolution and margin impacts directly, but factual correctness undermines overall accuracy. The core financial cause-effect is partially captured, but with significant factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 485,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the 2015 Director Stock Plan's share availability evolved as follows: in 2022, 34,073,114 shares were available for future issuance, while by 2024, this number decreased to 30,660,961. This reduction reflects the issuance of shares for awards and reinvested dividends, partially offset by share recoveries from forfeitures, cancellations, and other adjustments. Share recovery mechanics remained consistent, with shares becoming available again due to award terminations, cash settlements, or tax withholdings, and issuance mechanics continued to use either treasury shares or newly issued shares.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of share availability between 2022 and 2024, noting a decrease from 34,073,114 to 30,660,961 shares available. However, the original answer does not mention the 2022 figure of 34,073,114—this number is absent from the ground truth, which only provides cumulative data as of January 1, 2015, and activity through 2024. Thus, this specific 2022 availability number is unsupported by the original data and appears to be an addition or inference not present in the source. The 2024 figure of 30,660,961 is correct and matches the ground truth. (2) The ground truth states that 37,608,213 shares were recovered and 42,343,146 were issued or used for dividends, resulting in a net reduction. The LLM correctly describes the dynamic of issuance offset by recoveries but does not cite these exact cumulative totals, missing an opportunity for completeness. The absence of these key figures reduces quantitative accuracy. (3) The reasoning is sound: the LLM correctly infers that share recovery mechanisms (from forfeitures, cash settlements, etc.) remained consistent and that issuance used treasury or new shares. It synthesizes the ongoing balance between new awards and recovered shares, aligning with the multi-hop requirement. (4) Contextual relevance is perfect—the response directly addresses the evolution of treatment and availability, focusing on mechanics and trends. The qualitative accuracy is high due to correct logic and terminology, despite missing some original data points. The correctness score is 8 because core facts are accurate and the explanation is coherent, but the unsupported 2022 number and omission of key cumulative figures (37.6M recovered, 42.3M issued) prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 480,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "Starbucks' relationship with the Global Coffee Alliance (GCA) showed increased strategic emphasis and revenue contribution from fiscal year 2022 to 2023. In fiscal 2022, the GCA contributed to a $216 million increase in \"Other\" revenue, driven by higher product sales and royalty revenue. By fiscal 2023, the GCA remained a key strategic focus, with continued growth in the global ready-to-drink business and ongoing innovation, indicating a stronger alignment with Starbucks' long-term growth strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details. The ground truth states that the Global Coffee Alliance contributed to a $250 million increase in revenue in fiscal year 2022 within the Channel Development segment, but the LLM incorrectly reports a $216 million increase in 'Other' revenue, which is both numerically and categorically incorrect. This discrepancy undermines the quantitative accuracy. (2) While the LLM correctly identifies that the alliance remained strategically important in fiscal 2023 and mentions continued growth in ready-to-drink products and innovation, it fails to capture the key evolution described in the original answer: the shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler through the Nestlé licensing relationship. This deeper strategic repositioning is a core part of the ground truth and is missing in the LLM response. (3) The multi-hop reasoning is partially sound—the model connects the alliance to revenue and strategic focus across two years—but it does not fully synthesize the evolution in strategic emphasis as defined in the original answer. It also misattributes the revenue figure and segment, indicating a failure to correctly pull and align data across the required sources. (4) Despite these issues, the answer remains contextually relevant, addressing both strategic emphasis and revenue contribution across the two fiscal years, and uses appropriate terminology (e.g., royalty revenue, product sales, global reach). Hence, it earns moderate scores in qualitative accuracy and contextual relevance, but the incorrect dollar amount and missing strategic nuance limit the overall correctness to a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 479,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "Between 2022 and 2023, NEE's financial stake in the Mountain Valley Pipeline (MVP) significantly declined, as reflected in the equity method investment tables. In 2022, NEE's investment carrying amount for the principal entities included MVP, with a value of $4,968 million, while by 2023, this amount dropped to $3,963 million. Additionally, a substantial impairment charge of approximately $2.4 billion in 2023 primarily related to MVP, indicating a significant write-down in its value. This evolution suggests that NEE faced challenges with MVP's performance or regulatory hurdles, prompting a strategic reassessment of its investment in the project. The impairment and reduced carrying value reflect a more cautious approach to high-risk infrastructure projects, aligning with a broader strategy to prioritize more stable and profitable ventures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, there is no mention of a $4,968 million or $3,963 million carrying amount for the Mountain Valley Pipeline (MVP) in 2022 or 2023, nor is there any reference to a $2.4 billion impairment charge related to MVP in 2023. The original answer only states that MVP was an equity method investee with ownership stakes ranging from 32%–55% in 2022 and 32.8%–52.6% in 2023, and that in 2023 it was noted under Nonrecurring Fair Value Measurements. The LLM invented specific dollar figures and an impairment event not present in the source data. (2) The quantitative inaccuracies are severe: the claimed carrying amounts and impairment charge are entirely fabricated. The total equity method investments for NEE were $6,159M in 2022 and $6,156M in 2023—only a $3M decrease overall—not the $1,005M drop the LLM attributes to MVP alone. There is no support for any $2.4B impairment. (3) The multi-hop reasoning is flawed. While the LLM attempts to infer strategy from financial changes, it does so based on false data. The actual answer suggests a slight refinement in ownership ranges and a change in financial disclosure treatment, not a major write-down or strategic retreat. The LLM misidentifies the nature of the evolution. (4) The contextual relevance is moderate because it addresses the right topic (NEE’s stake in MVP and investment strategy) and time frame, and attempts to interpret strategic implications. However, due to major factual and quantitative errors, the qualitative reasoning is unsound. Correctness and quantitative accuracy are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 452,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Medtronic's InterStim Therapy product line expanded its neurostimulator offerings and therapeutic applications. In 2022, the product line included the InterStim II, InterStim Micro, and InterStim X neurostimulators for treating overactive bladder, urinary retention, and bowel incontinence. By 2024, the InterStim Therapy portfolio continued to include the InterStim X and InterStim II recharge-free neurostimulators, alongside the InterStim Micro rechargeable neurostimulator, emphasizing expanded treatment options for similar indications. Additionally, the 2024 report highlights the Inceptiv closed-loop rechargeable SCS system receiving U.S. FDA approval in April 2024, indicating a broader focus on integrating advanced neurostimulation technologies for chronic pain and related conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the neurostimulator offerings in 2022 (InterStim II, InterStim Micro, InterStim X) and the indications (overactive bladder, urinary retention, bowel incontinence), which aligns with the ground truth. It also correctly notes that by 2024, InterStim II and InterStim X were labeled as 'recharge-free,' which matches the original answer. However, the LLM incorrectly states that the InterStim Micro remained part of the portfolio as a 'rechargeable neurostimulator' in 2024, which is not supported by the ground truth—there is no mention of InterStim Micro being retained, and the focus shifted to InterStim II and X only. Additionally, the LLM introduces the Inceptiv closed-loop SCS system receiving FDA approval in April 2024, which is factually unrelated to the InterStim Therapy product line (Inceptiv is for spinal cord stimulation for chronic pain, not sacral neuromodulation for bladder/bowel indications). This represents a significant factual misalignment and confusion between product lines. (2) Quantitatively, the dates (2022, 2024) and product names are accurate, and no numerical calculations are required, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound—information is synthesized across years and product features—but fails in entity disambiguation by conflating InterStim with Inceptiv, a different therapeutic system. The expansion to 'chronic fecal incontinence' as a refined indication in 2024 is omitted, which is a key evolution per the ground truth. (4) The correctness score is 5 due to partial factual accuracy but major omissions and one significant error (introducing Inceptiv). Qualitative accuracy is reduced due to incorrect product-line attribution and missing indication expansion. Contextual relevance is moderate as the core topic is addressed but with extraneous information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 511,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "From 2022 to 2024, Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolved significantly. In 2022, Simon sold a portion of its interest in ABG for $65.5 million and later acquired additional interests for $100.0 million, resulting in a noncontrolling interest of approximately 10.4%. In 2023, Simon further reduced its stake through a capital transaction that diluted its ownership to approximately 9.6%, resulting in a non-cash gain. Finally, in 2024, Simon sold all of its remaining interest in ABG for $1.2 billion, generating a pretax gain of $414.8 million, effectively exiting its strategic relationship with ABG.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Simon held a 1.37% interest in ABG and was involved in merging Forever 21 operations into SPARC Group with ABG after increasing its stake to 50%. However, the LLM claims Simon sold part of its stake for $65.5M and acquired $100M in interests in 2022—events not supported by the original answer. The LLM also states Simon sold all remaining interest in ABG in 2024 for $1.2B with a $414.8M gain, but the ground truth reports only a partial sale with an $18.8M pre-tax gain and a subsequent $100M cash acquisition—indicating continued investment, not exit. (2) Quantitative accuracy is very low: none of the dollar amounts ($65.5M sale, $1.2B final sale, $414.8M gain) or ownership percentages (10.4%, 9.6%) match the ground truth. The only correct number is the $100M acquisition, which aligns with the original answer. (3) The multi-hop reasoning is flawed—the LLM incorrectly infers a complete divestment and exit, contradicting the ground truth's indication of an evolving, ongoing relationship. It fails to mention the SPARC Group merger or the 50% joint stake in Forever 21 operations, which are key strategic elements. (4) Contextual relevance is moderate because the answer addresses the evolution of the financial stake between Simon and ABG over time and mentions cash transactions, but the core facts are incorrect. Due to major factual and numerical errors, especially in financial figures and ownership trajectory, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 431,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased significantly from 2021 to 2023. In 2021, DD&A expenses for the Lower 48 were $4,067 million, rising to $4,854 million in 2022, and further to $5,729 million in 2023. This upward trend reflects increased investment activity and asset utilization in the region during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key numbers are correct: $4,067 million in 2021 and $5,729 million in 2023 match the original answer exactly. The LLM adds $4,854 million for 2022, which is not contradicted by the ground truth and provides additional granularity, enhancing completeness without introducing error. (2) Quantitative accuracy is perfect—values are correctly stated with proper units and consistent formatting. (3) The reasoning is sound: the upward trend in DD&A expenses is correctly interpreted as reflecting increased investment activity and asset utilization, which logically supports the conclusion about ConocoPhillips' growing emphasis on the Lower 48 region. (4) The answer is fully contextually relevant, directly addressing the evolution of investment activity through DD&A expenses from 2021 to 2023. The only minor limitation is that the original answer emphasizes the strategic shift ('growing emphasis on the Lower 48 as a core operational area'), which the LLM implies but does not explicitly state, slightly reducing qualitative completeness. However, the core facts, trends, and implications are accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 335,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon's treatment and valuation approach for international bonds in 2024 shows a reduction in holdings compared to 2023. In 2023, international bonds were valued at $341 million (Level 1: $3 million, Level 2: $338 million), while in 2024, they were valued at $113 million (Level 2: $113 million). Additionally, the valuation methodology remained consistent, relying on matrix prices from independent third-party valuation sources for fixed income securities, including international bonds.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, Verizon did not disclose a specific dollar value for international bonds; instead, they were included in a broader category and valued using matrix pricing from third-party sources. The LLM incorrectly states that international bonds were valued at $341 million in 2023 (with $3M Level 1 and $338M Level 2), which contradicts the original answer. In 2024, the ground truth reports a total value of $12 million ($10M Level 1, $2M Level 2), but the LLM claims $113 million (all Level 2), which is factually wrong. These numerical discrepancies are severe and undermine the entire response. (2) The calculations and comparisons are therefore incorrect: the claimed reduction from $341M to $113M is not supported by the data. The actual evolution is not in magnitude but in disclosure granularity—from a general description in 2023 to a specific, segmented disclosure in 2024. (3) The reasoning is flawed: the LLM asserts that the valuation methodology remained consistent, but the ground truth emphasizes a shift toward greater transparency and segmentation in 2024, indicating a change in disclosure and possibly valuation approach. The multi-hop synthesis failed—instead of identifying the evolution in reporting detail, the model fabricated quantitative figures and inferred a trend in holdings size that is not present in the source. (4) While the answer is relevant to the question’s topic and attempts to compare two years, the complete absence of correct numbers and mischaracterization of the methodological evolution justify a low correctness score. The contextual relevance is moderate because it addresses the right company and general theme, but the factual foundation is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 489,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Between 2022 and 2024, Emerson's relationship with AspenTech evolved significantly. In 2022, Emerson acquired Heritage AspenTech, owning 55% of its outstanding shares on a fully diluted basis. By 2024, Emerson increased its stake to approximately 57% and proposed to acquire the remaining shares for $240 per share, valuing AspenTech at $15.3 billion. Operationally, AspenTech continued to operate under Emerson's strategic portfolio, contributing to Emerson's Software and Control sales growth, particularly in 2023 and 2024. The integration was marked by financial synergies and strategic alignment, with Emerson maintaining significant influence over AspenTech's operations and future direction.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of Emerson's relationship with AspenTech between 2022 and 2024. (1) Quantitatively, the answer incorrectly states that in 2022, Emerson owned 55% of AspenTech on a fully diluted basis; the ground truth indicates that Emerson had a financial stake valued at $8,326 million on its balance sheet, not a 55% ownership at that time. The claim that Emerson increased its stake to 57% by 2024 and proposed to acquire the remaining shares for $240 per share, valuing AspenTech at $15.3 billion, is incorrect. The actual event in 2024 was a strategic restructuring where Emerson contributed the AspenTech Industrial Software Business and $6.0 billion in cash to form 'New AspenTech', in which it retained a 55% ownership stake—not an acquisition of the remaining shares. (2) The financial figures are largely fabricated: no mention of a $15.3 billion valuation or $240 per share offer exists in the ground truth. The $6.0 billion cash contribution is omitted entirely. (3) Qualitatively, the reasoning is flawed: the answer frames the relationship as a gradual equity increase and pending acquisition, whereas the truth is a complex multi-hop transformation involving divestiture, contribution of assets, and creation of a new entity with majority control. The LLM fails to capture the operational integration via the formation of 'New AspenTech' and instead vaguely references 'strategic portfolio' integration. (4) Contextually, the answer addresses the general theme of deepening integration, so it retains partial relevance, but the core facts, entities, and financial mechanics are incorrect. The synthesis across years and financial events is unsound, leading to a mostly incorrect narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 480,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' position in interest rate swaps evolved in terms of classification and associated liabilities. In 2023, the interest rate swap liabilities were classified as \"Other long-term liabilities\" with a total of $41.4 million as of October 1, 2023. In 2022, the interest rate swap liabilities were also classified under \"Other long-term liabilities,\" but with a higher amount of $34.0 million as of October 2, 2022. This indicates an increase in liabilities related to interest rate swaps from 2022 to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Starbucks had a long-term liability of $34.0 million for interest rate swaps. In 2023, the liability was split into $0.4 million (current, under accrued liabilities) and $19.2 million (long-term), totaling $19.6 million—representing a decrease. However, the LLM incorrectly states that in 2023 the liability was $41.4 million under 'Other long-term liabilities' alone, which contradicts the ground truth. It also falsely claims an increase from $34.0 million to $41.4 million, when in fact there was a net decrease. (2) The numbers are largely incorrect: the 2023 figure is wrong ($41.4M vs actual $19.6M total), and the classification is oversimplified—failing to mention the split between current and long-term liabilities. The 2022 number ($34.0M) is correct, but the classification is misrepresented as 'Other long-term liabilities' only, while the ground truth confirms it was long-term but does not specify the exact label. (3) The multi-hop reasoning is flawed: the model fails to synthesize the change in classification (from solely long-term to both current and long-term) and incorrectly infers an increase in liability. It misses the nuanced evolution in accounting treatment and overall reduction in exposure. (4) Scores reflect major quantitative errors and poor qualitative reasoning, though the response is contextually relevant by addressing the right topic (classification and liability changes over time).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 422,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "NextEra Energy Resources' (NEER) financial commitment and involvement in the Mountain Valley Pipeline (MVP) significantly declined from 2022 to 2023. In 2022, NEER recorded an impairment charge of approximately $0.8 billion ($0.6 billion after tax) due to continued legal and regulatory challenges that led to a very low probability of MVP completion. This charge fully wrote off NEER's equity method investment of $0.6 billion and established a liability of $0.2 billion for future abandonment and removal (ARO) costs. By 2023, there is no indication of further impairment charges or increased financial commitments related to MVP, suggesting that NEER's involvement remained at the level established in 2022, with no significant new financial commitments reported.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the $0.8 billion impairment charge in 2022 and attributes it to the low probability of pipeline completion, which aligns with the ground truth. It also accurately notes that this charge included a write-off of the equity investment and recognition of $0.2 billion in ARO liabilities, which is consistent with the original data. However, the LLM answer incorrectly implies that NEER's involvement declined or stagnated in 2023, stating 'no indication of further impairment charges or increased financial commitments' and 'no significant new financial commitments reported.' This contradicts the ground truth, which states that in 2023, NEER maintained its 32.8% equity investment and committed to a 20-year transportation agreement with an annual obligation of ~$70 million. This is a significant financial commitment that the LLM answer omits, leading to an incomplete and misleading conclusion about reduced involvement. While the quantitative details for 2022 are accurate (allowing for format variation: $0.8B = $800M), the failure to report the 2023 transportation agreement and ongoing equity stake constitutes a major omission in both completeness and qualitative reasoning. The model fails to synthesize the multi-hop fact that despite the write-off, NEER continued its financial involvement through contractual obligations. Thus, while contextually relevant and partially accurate, the answer misses a key evolution in NEER's commitment, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 413,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts increased from $1,643 million as of December 31, 2023, to $1,883 million as of December 31, 2024. This represents an increase of $240 million over the one-year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1,643 million (2023) and $1,883 million (2024) are accurately reported with correct dates (December 31, 2023, and December 31, 2024), and the implied $240 million increase is correctly calculated ($1,883M - $1,643M = $240M). (2) The answer is complete, addressing the evolution of the investment between 2023 and 2024 as required by the question. (3) Entities are accurate: The Coca-Cola Company, its captive insurance company, and the context of reinsuring group annuity insurance contracts are correctly referenced. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by identifying the relevant financial data across years and correctly interpreting the change as an increase. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (explicit mention of $240M increase), which enhances clarity without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 298,
        "total_tokens": 1474
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node evolved significantly from 2022 to 2024. In 2022, Intel 4 was in the ramp-up phase, with period charges associated with its development and production. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and was used for the Intel Core Ultra processor, marking its entry into high-volume client product production. Intel 4 is positioned as a key node in Intel's product roadmap, expected to represent an increasing share of processor production in 2025 and beyond, with a 20% performance-per-watt improvement over Intel 7.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Intel 4 was in ramp-up in 2022 with associated period charges, transitioned to high-volume manufacturing in Ireland by 2024, and is used for the Intel Core Ultra processor. The strategic positioning as a key node in the roadmap is correctly conveyed. (2) Quantitative accuracy is excellent: the 20% performance-per-watt improvement over Intel 7 is factually correct and consistent with Intel's public disclosures, even though this specific metric was not in the original answer; no incorrect numbers or dates are present. (3) Multi-hop reasoning is sound—information is synthesized across time (2022 to 2024) and domains (production status, strategic roadmap). The only minor gap is that the original answer emphasizes the shift from investment/ramp-up to full integration, which the LLM captures implicitly but could have made more explicit. (4) The answer is fully relevant, directly addressing the evolution in production status and strategic positioning. The addition of forward-looking context (increasing share in 2025) enhances completeness without introducing inaccuracies. Minor deduction in qualitative accuracy due to slight expansion beyond the original scope, but no factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 361,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved significantly in terms of ownership and financial integration. In 2022, Emerson acquired Heritage AspenTech, gaining 55% ownership of the combined entity, \"New AspenTech.\" By 2024, Emerson had increased its ownership to approximately 57% and proposed to acquire the remaining shares for $240 per share in cash, signaling full integration. Financially, AspenTech's results were consolidated into Emerson's operations, contributing to revenue and earnings growth, particularly in the Software and Control segment. However, in 2024, Emerson recorded a loss on the Copeland note receivable and incurred higher amortization costs from acquisitions, which impacted earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Emerson acquired Heritage AspenTech and gained 55% ownership in 2022, whereas the ground truth indicates that in 2022, AspenTech was merely a strategic partner with no ownership stake mentioned. The 55% ownership stake was acquired in 2024 as part of the merger to form 'New AspenTech,' not in 2022. Additionally, the claim that Emerson increased ownership to 57% by 2024 and proposed to acquire remaining shares at $240 per share is unsupported by the original answer and introduces fabricated details. (2) Quantitative inaccuracies include the false $240 per share offer and the 57% ownership figure; the ground truth specifies a stable 55% stake. The mention of a loss on the Copeland note and higher amortization costs is not present in the original answer and appears irrelevant or invented. (3) The multi-hop reasoning is flawed: the model fails to correctly trace the evolution from partnership (2022) to partial ownership (2024), instead inventing an acquisition timeline and financial events. It also misattributes financial integration effects, such as gross margin improvement (0.6 percentage points in 2023) and SG&A impacts in 2024, which are omitted or misrepresented. (4) While the answer correctly identifies financial integration and mentions consolidation into Emerson's results, this is outweighed by major factual and chronological errors. Contextual relevance is moderate because it addresses ownership and financial integration but does so with incorrect data and reasoning, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 446,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "From 2022 to 2024, Intel's approach to the Intel 4 process node evolved significantly in terms of manufacturing readiness and performance. In 2022, Intel introduced the new naming structure for its process nodes, and by 2024, Intel 4 had moved to high-volume manufacturing in Ireland and was used for the Intel Core Ultra processor, which began shipping in 2023. Intel 4, as the company's first EUV lithography node, delivered significant density scaling and approximately 20% performance-per-watt improvement over Intel 7. By 2024, it was expected to represent an increasing portion of Intel's processor production in 2025, indicating improved readiness and integration into mainstream product offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel 4 was introduced in 2022 as part of a new naming convention; by 2024, it reached high-volume manufacturing in Ireland; it is Intel's first EUV node; it delivers ~20% performance-per-watt improvement over Intel 7; and it was used in the Intel Core Ultra processor, which began shipping in 2023. (2) Quantitative accuracy is perfect: the 20% performance-per-watt improvement is correctly cited, and all dates (2022 naming, 2023 shipments, 2024 manufacturing ramp) match the original. Format variations are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the answer synthesizes information across time (2022 to 2024), technology (EUV, performance gains), and production (Ireland, Core Ultra) correctly. (4) The only minor shortcoming is the addition of forward-looking commentary about 2025 production share, which is plausible but not present in the ground truth. This does not introduce inaccuracy but adds a slight extrapolation. Otherwise, the answer is complete, factually correct, and contextually appropriate, capturing the evolution in manufacturing readiness and performance as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 344,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "Between 2022 and 2024, the role and positioning of InterStim Micro within MDT's Pelvic Health therapies remained consistent as a key product offering for treating overactive bladder, non-obstructive urinary retention, and chronic fecal incontinence. In 2022, it was listed among Pelvic Health products alongside InterStim X and InterStim II. By 2024, it was highlighted again as part of the Pelvic Health therapies, emphasizing its role as a rechargeable neurostimulator within the broader portfolio of InterStim therapies. No significant changes in its strategic positioning were noted during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies InterStim Micro as a rechargeable neurostimulator within MDT's Pelvic Health portfolio in 2024 and notes its presence alongside InterStim X and InterStim II in 2022. However, it incorrectly states that there was 'no significant change' in strategic positioning, which contradicts the ground truth that by 2024, InterStim Micro was specifically differentiated as the rechargeable option, indicating a more defined and evolved strategic role. This misrepresents the core evolution the question asks about. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the product's presence across years and its technical attribute (rechargeable). However, it fails to infer the strategic shift—positioning InterStim Micro distinctly as the rechargeable variant—as a meaningful evolution, which is central to the ground truth. (4) Contextual relevance is high because the answer addresses the product, timeframe, and portfolio context. Qualitative accuracy is moderate due to correct entity and attribute identification but flawed conclusion about positioning stability. Correctness score is reduced due to this key misinterpretation of strategic evolution, though core facts are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 388,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The disclosure around the dilutive effect of LTIP Units in the 2024 10-K shows a consistent pattern with prior years, indicating no material impact on earnings per share or unit across the reporting periods. Specifically, for the years ended December 31, 2024, 2023, and 2022, the company explicitly states that no securities, including LTIP units, had a material dilutive effect. This is consistent with the 2022 10-K, which similarly noted no material dilutive effect for 2021, 2020, and 2019. Thus, while LTIP units are included as potentially dilutive securities, their impact has remained immaterial across all periods disclosed.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: in both the 2022 and 2024 disclosures, no securities—including LTIP Units—had a material dilutive effect for the respective three-year periods (2019–2021 in 2022 filing; 2022–2024 in 2024 filing). The dates and entities are accurate, and the conclusion about immaterial dilutive impact is consistent with the ground truth. However, the LLM omits a key qualitative evolution noted in the original answer: the reduction in disclosure detail regarding the exchangeability of LTIP Units into common stock. While the 2022 filing explicitly mentioned that LTIP Units were exchangeable for common stock, the 2024 filing dropped this detail, signaling a change in disclosure granularity. The LLM correctly synthesizes the consistent conclusion on dilution impact but fails to highlight this change in narrative detail, which is central to the question about *evolution* in disclosure. This omission reduces the qualitative accuracy slightly but does not undermine the core factual correctness. The answer remains contextually relevant and quantitatively precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 316,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "From 2022 to 2024, MetLife's approach to managing cash buffer needs in relation to stock repurchases has emphasized balancing liquidity and capital return to shareholders while adhering to regulatory requirements. In 2022, the company had a $3.0 billion repurchase authorization, with $1.5 billion remaining as of year-end. By 2024, MetLife continued to highlight the importance of maintaining a cash buffer to meet liquidity needs and regulatory capital requirements, which could limit the capital available for repurchases. The company also noted that external factors, such as market volatility, regulatory changes, or public health events, could affect its ability to repurchase shares, reflecting a more cautious and adaptive approach to managing repurchase programs within evolving financial and regulatory environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that in 2022, MetLife had $1.5 billion remaining out of a $3.0 billion repurchase authorization as of year-end, which aligns with the ground truth (note: the original answer clarifies this authorization was as of December 31, 2021, but referenced in 2022 context—this nuance is minor and reasonably interpreted). The LLM accurately reflects the 2024 shift toward caution regarding cash buffers limiting repurchases. (2) All numeric values—$3.0 billion authorization and $1.5 billion remaining—are factually correct and match the ground truth; no calculations are required, but the representation is precise. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022 and 2024 time points, correctly identifying the evolution from active repurchase capacity to a more conservative liquidity posture influenced by regulatory and market factors. It captures the core shift in strategy even if it doesn't explicitly label it as a 'shift from active to conservative'—the implication is clearly conveyed. (4) The answer is contextually fully relevant, addressing both remaining authorization and liquidity considerations in relation to repurchases. The only minor shortcoming is a slightly less explicit articulation of the strategic evolution compared to the original answer, but the substance and factual accuracy are preserved. Thus, high scores across all dimensions with a 9 on correctness due to near-perfect alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 412,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "From fiscal year 2022 to 2023, Starbucks' foreign currency - other derivative asset positions decreased from $156.2 million (2022) to $153.0 million (2023), while derivative liability positions remained minimal. In terms of balance sheet classifications, foreign currency - other derivative assets were primarily categorized under \"Prepaid expenses and other current assets\" and \"Other long-term assets.\" In 2023, $1.9 million was classified as a current asset, and $1.7 million as a long-term asset, compared to $39.9 million current and $33.5 million long-term in 2022, indicating a significant shift toward short-term classification in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The reported asset values of $156.2 million in 2022 and $153.0 million in 2023 are incorrect; the ground truth states that Starbucks had $103.9 million in foreign currency - other derivative assets recognized in OCI before reclassifications in 2022, with $22.0 million reclassified from AOCI to earnings. The 2023 balance sheet amounts are $1.9 million (current assets) and $1.7 million (long-term assets), totaling $3.6 million — not $153.0 million. The liability figures are also missing entirely in the LLM response; the ground truth specifies $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities in 2023. (2) The LLM incorrectly claims a shift toward short-term classification in 2023 by comparing $1.9 million current and $1.7 million long-term in 2023 to $39.9 million current and $33.5 million long-term in 2022 — these 2022 classification numbers are not supported by the ground truth, which does not provide such a breakdown for 2022. Thus, the comparison is fabricated. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution from OCI reporting in 2022 to balance sheet classification in 2023 and omits the reclassification from AOCI to earnings. It incorrectly implies that the derivative assets were directly carried forward at a similar magnitude, when in fact there was a dramatic reduction. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant — it attempts to address the evolution of derivative positions and balance sheet classifications — hence a moderate contextual relevance score. However, due to major quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 478,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Procter & Gamble's global cash management strategy between fiscal 2022 and fiscal 2024 evolved to support its restructuring activities and maintain strong financial performance. In fiscal 2022, the company focused on managing liquidity through operating cash flow, which generated $16.7 billion, while using cash for dividends, share repurchases, and debt management. Adjusted free cash flow decreased to $13.8 billion due to lower operating cash flows. By fiscal 2024, operating cash flow improved significantly to $19.8 billion, and adjusted free cash flow increased to $16.9 billion, reflecting enhanced efficiency and productivity from restructuring efforts. The company also expanded its restructuring program in 2024, incurring higher costs, including impairment charges and foreign currency translation losses, but this was offset by cost savings and improved gross margins driven by lower commodity costs and pricing strategies. Overall, the company maintained a robust liquidity position, supported by strong credit ratings and effective cash flow management.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding financial figures and the nature of Procter & Gamble's restructuring and earnings performance. While it correctly identifies that restructuring activities occurred and that cash flow management was a focus, the specific numbers cited (e.g., operating cash flow of $16.7B in FY2022 and $19.8B in FY2024, adjusted free cash flow of $13.8B and $16.9B) are not present in the ground truth and cannot be verified from the provided data. The ground truth emphasizes restructuring costs and corporate net earnings changes, not operating or free cash flow figures. (2) The ground truth states that in FY2022, restructuring costs were within the $250–$500M range with $147M in accruals, and corporate net earnings improved by $872M to $485M. In FY2024, restructuring costs rose to $659M before tax, including $216M in non-cash foreign currency losses, and corporate net earnings decreased by $1.0B due to a $1.4B impairment charge on Gillette intangibles. None of these key quantitative points are accurately reflected in the LLM answer. Instead, the LLM fabricates cash flow metrics not mentioned in the original. (3) The multi-hop reasoning is partially sound in linking restructuring to financial performance and cash management, but fails to correctly synthesize the actual data across years and metrics. It incorrectly implies that improved cash flow offset restructuring costs, while the ground truth shows a decline in earnings due to significant impairment and restructuring charges. The mention of 'Enterprise Markets like Nigeria' in the original is entirely missing, weakening the contextual depth. (4) The correctness score is low due to major quantitative errors and omission of key facts (impairment charge, accruals, net earnings changes). Quantitative accuracy is poor because the LLM invents financial figures not in the source. Qualitative accuracy is moderate as the general theme of restructuring impacting finances is correct. Contextual relevance is fair since the answer addresses cash management and restructuring, but misses the core financial indicators that define the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 587,
        "total_tokens": 2111
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's positioning and application of Omniverse evolved significantly in terms of enterprise integration and simulation technologies. In 2022, Omniverse was described as a virtual world simulation and collaboration platform for 3D workflows, primarily used for digital design mirroring reality and deployed in applications like virtual car showrooms and architectural walkthroughs. By 2023, Omniverse had expanded into a more robust development platform and operating system for building virtual world simulation applications, with industrial enterprises adopting it for digital twins, real-time 3D product configurators, and testing autonomous systems. Additionally, Omniverse was integrated into NVIDIA's DRIVE Sim solution for autonomous vehicle simulation, highlighting its role in enterprise-scale simulation and validation workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual information is correct: the positioning of Omniverse in 2022 as a collaboration platform for 3D workflows with use cases like virtual car showrooms and architectural walkthroughs is accurately described. The evolution in 2023 into a development platform and operating system for virtual world simulations is correctly stated. Key applications such as digital twins, real-time 3D configurators, and integration with DRIVE Sim for autonomous vehicle simulation are properly included. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2023), application domains (enterprise, industrial, simulation), and technological integrations (DRIVE Sim, digital twins). The only minor omission is that the 2023 evolution could have more explicitly mentioned Omniverse’s tighter integration with NVIDIA’s accelerated computing infrastructure (on-premises and cloud), which is a key part of the ground truth and reinforces enterprise-grade AI workflow integration. This is a small but relevant detail in the context of enterprise solution integration. (4) Despite this slight omission, the answer captures the core evolution and maintains semantic equivalence. The response is fully relevant, well-structured, and addresses all aspects of the question with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 425,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "From 2023 to 2024, AMT's financial commitments related to communications sites showed a slight decrease in anticipated spending. In 2023, capital expenditures were $1.8 billion, with $849.3 million allocated to discretionary capital projects, including the construction of 3,198 communications sites. By 2024, the projected capital expenditures were estimated between $1,545 million and $1,655 million, with $790 million to $820 million allocated to discretionary projects, including the construction of 2,500 to 3,500 communications sites. This suggests a reduction in the scale of new site construction and related capital investments in 2024 compared to 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both factual content and interpretation. The original answer states that in 2023, AMT anticipated spending $450 million on data center assets as part of construction plans for 2,500 to 3,500 communications sites, and in 2024, disclosed a $4.5 billion future cash outlay for asset retirement obligations (AROs) on leased sites. The LLM instead claims capital expenditures of $1.8 billion in 2023 and $1.545–1.655 billion in 2024, with discretionary spending of $849.3 million and $790–820 million respectively—none of which appears in the ground truth and contradicts it. (2) The numbers provided in the LLM answer (e.g., $1.8B capex, $849.3M discretionary) are not present in the original answer and are therefore factually inaccurate. The only overlapping figure is the 2,500 to 3,500 site range, which the LLM attributes to 2024, while the original answer cites it in the context of 2023 construction plans. The LLM also misrepresents the nature of the financial commitment: the $4.5 billion in 2024 is not capex but a long-term undiscounted ARO liability, a critical distinction the LLM misses entirely. (3) The multi-hop reasoning is flawed—the question asks about evolution in financial commitments, particularly anticipated spending and future obligations. The original answer correctly contrasts near-term capex planning (2023) with long-term liability recognition (2024). The LLM incorrectly frames both years in terms of capex and discretionary project spending, failing to recognize the shift from construction spending to retirement obligations. It also draws the opposite conclusion (decrease in spending) when the ground truth shows a tenfold increase in financial exposure. (4) The correctness score is 1 due to almost complete factual inaccuracy and mischaracterization of financial metrics. Quantitative accuracy is low (2) because most numbers are fabricated or misattributed. Qualitative accuracy is 2 because the reasoning and entity usage (e.g., confusing capex with AROs) are incorrect. Contextual relevance is 3 because the answer discusses AMT and communications sites, but misidentifies the type and timing of financial commitments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 592,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil's characterization of asset divestitures shifted in emphasis regarding the use of proceeds. In 2023, the focus was on aligning asset sales with strategic objectives by divesting assets no longer meeting these goals or worth more to others. In 2024, the language expanded to highlight the increased proceeds from asset sales (e.g., $4,987 million in 2024 vs. $4,078 million in 2023) as part of a disciplined review process, emphasizing their role in funding investments and shareholder distributions. The 2024 description underscores the strategic and financial utility of these proceeds more explicitly.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($4,987 million in 2024 vs. $4,078 million in 2023) that are not present in the original answer (ground truth), and there is no indication in the ground truth that these figures were disclosed or used to support the characterization of language evolution. These numbers appear to be fabricated or sourced from outside the provided knowledge, making them factually unsupported. (2) Quantitative accuracy is low because the financial figures cited in the LLM response cannot be verified against the ground truth and are likely incorrect or misleading in this context. The original answer does not mention any specific proceeds, so including them undermines factual correctness. (3) Qualitatively, the LLM captures part of the evolution—ExxonMobil’s continued emphasis on strategic alignment and disciplined review—but misrepresents the nature of the linguistic shift. The original answer highlights a *streamlining* of terminology (from detailed categories like subsidiaries and PPE to a broader 'proceeds from asset sales'), whereas the LLM frames it as an expansion of emphasis toward funding investments and shareholder distributions, which is not supported by the ground truth. This reflects flawed multi-hop reasoning, as the conclusion about increased strategic *and financial* utility is an inference not present in the source. (4) Contextual relevance is high because the response addresses the core question about evolving language around asset divestitures and proceeds, and attempts to compare 2023 and 2024 characterizations. However, the introduction of unsupported data and mischaracterization of the narrative shift reduces overall correctness. The answer is partially aligned but contains significant factual and interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 491,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort increased from 2022 to 2023. In 2022, the consolidated balance sheet included assets and liabilities of Universal Beijing Resort totaling $9.7 billion and $8.1 billion, respectively. By 2023, these amounts rose to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a slight reduction in the net exposure (from $1.6 billion to $0.6 billion), but the overall financial involvement remains significant.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both direction and magnitude of change. It incorrectly states that financial exposure 'increased' from 2022 to 2023, when in fact it decreased. While the 2022 figures are correct ($9.7B assets, $8.1B liabilities), the 2023 figures are misstated: the LLM says 'rose to $7.8B in assets and $7.2B in liabilities', but this represents a decrease, not an increase. The LLM confuses the interpretation of the numbers. (2) Quantitatively, the 2022 numbers are accurate, and the 2023 numbers ($7.8B assets, $7.2B liabilities) are numerically correct but mischaracterized as increases. The net exposure calculation is also wrong: in 2022, net exposure is $9.7B - $8.1B = $1.6B, and in 2023 it is $7.8B - $7.2B = $0.6B — these differences are correct, but the conclusion drawn is misleading. (3) The multi-hop reasoning fails because the model incorrectly infers increasing exposure despite declining asset and liability amounts. It does not recognize that reductions in both assets and liabilities indicate reduced financial exposure, especially when both are declining. The synthesis across years is flawed. (4) Contextually, the answer addresses the right entities (Comcast, Universal Beijing Resort) and time frame (2022–2023), and attempts to interpret net exposure, so relevance is moderate. However, the core conclusion is factually incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 400,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's discussion of Customer Demand Volatility as a risk factor highlights a heightened sensitivity to macroeconomic conditions and supply chain disruptions. In 2023, the focus was on how economic weakness, commodity price volatility, and infrastructure spending trends could reduce demand for Caterpillar's products and services. By 2024, the emphasis expanded to include the compounding effects of global supply chain disruptions, material shortages, and labor inefficiencies, which not only impact Caterpillar's ability to meet customer demand but also increase operating costs and reduce profitability. This evolution reflects a broader recognition of the interconnectedness between macroeconomic uncertainties and operational execution, underscoring a more complex and immediate threat to financial performance and supply chain stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Customer Demand Volatility as a risk factor for Caterpillar from 2023 to 2024. In 2023, the focus was on economic uncertainties, commodity price volatility, and infrastructure spending affecting demand—consistent with the original answer’s mention of pandemic aftereffects, inflation, and supply chain issues. In 2024, the LLM correctly notes an expansion to include supply chain disruptions, material shortages, and labor inefficiencies, which matches the ground truth’s emphasis on supply-side challenges like material price increases and labor shortages. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years (2023 and 2024) are correctly referenced, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes how the nature of the risk evolved over time and connects it to financial performance and supply chain stability, as required. The only minor gap is that the LLM answer does not explicitly mention 'inflationary pressures' or 'broader commodity price changes' as distinct evolving elements in 2024, instead grouping them under macroeconomic conditions—this slight omission prevents a perfect 10 but doesn’t undermine the core accuracy. (4) The answer is contextually excellent, directly addressing the evolution of the risk, its drivers, and implications for financial and operational stability. Overall, the semantic meaning matches the ground truth closely, with only slight differences in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 452,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "From 2022 to 2024, the fair value of Net Derivative Assets (liabilities) evolved as follows: in 2022, the fair value was $19 million (Level 3), decreased to $5 million in 2023, and increased to $69 million in 2024. The valuation methodology consistently relied on discounted cash flows with swap rates as significant unobservable inputs, with the weighted average swap rate increasing from 2% in 2022 to 4% in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the fair value was $19 million as of December 31, 2021 (reported in 2022), not in 2022 itself, and increased to $58 million as of December 31, 2023 (reported in 2024). The LLM incorrectly states values for 2022, 2023, and 2024 as $19M, $5M, and $69M respectively—none of which match the ground truth. There is no mention of a decrease to $5 million in 2023 in the original answer, nor an increase to $69 million in 2024. (2) The calculation and timeline are fundamentally wrong. The ground truth does not provide a 2023 midpoint value but shows a rise from $19M (end of 2021) to $58M (end of 2023). The LLM introduces non-existent figures and misattributes timing. Additionally, the original answer references derivative activity (issuances, settlements, transfers) totaling $37M net change ($68M - $37M + $6M), which the LLM omits entirely. (3) Regarding methodology, the original answer states a shift *to* discounted cash flows with observable inputs (swap rates 3–5%, weighted average 4%) by 2024, implying improved transparency. However, the LLM claims the methodology 'consistently relied' on discounted cash flows with 'unobservable inputs', which contradicts the ground truth that emphasizes a move toward *observable* inputs. Also, the LLM invents a 2% swap rate in 2022 not present in the original. (4) While the LLM attempts to address both fair value evolution and methodology, it fails on quantitative accuracy and misrepresents the reasoning and entity relationships. The contextual relevance is moderate because it addresses the right metric and time frame, but with incorrect data and flawed synthesis. Thus, the correctness score is low due to major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 488,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "From 2022 to 2023, NVIDIA's GeForce NOW cloud gaming offering evolved from being a standalone service for playing PC games on underpowered devices to a more integrated component of NVIDIA's broader GPU and cloud platform ecosystem. In 2022, GeForce NOW was positioned primarily as a gaming-focused cloud service. By 2023, it was highlighted as part of NVIDIA's unified strategy to enable interactive graphics applications across devices through cloud platforms, leveraging the same GPU and software technologies used in data centers, AI, and autonomous systems. This integration reflects NVIDIA's broader vision of a software-defined, accelerated computing platform spanning gaming, professional visualization, and enterprise applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values to verify in this question, so quantitative accuracy is 10. (2) The answer correctly captures the evolution of GeForce NOW from a gaming-focused cloud service in 2022 to a more integrated component of NVIDIA’s broader GPU and cloud platform ecosystem in 2023. It accurately reflects the shift in positioning from standalone gaming access to integration within a unified accelerated computing platform. (3) The multi-hop reasoning is sound: the LLM synthesizes information about GeForce NOW’s role in 2022 (gaming access across devices) and its evolved role in 2023 (alignment with data center, AI, and enterprise technologies), correctly inferring strategic integration with NVIDIA’s broader cloud and software-defined infrastructure. (4) The only minor shortcoming is that the LLM does not explicitly mention NVIDIA DGX Cloud or vGPU as specific counterparts in the ecosystem, which were noted in the original answer as part of the broader platform narrative. However, the reference to 'same GPU and software technologies used in data centers, AI, and autonomous systems' captures the essence. Thus, qualitative accuracy is 9 due to slight omission of specific service names, but overall semantic equivalence and contextual relevance are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 374,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta's revenue increased by 3% from $1,003 million in 2022 to $1,036 million in 2023. The growth was driven by continued expansion in emerging markets and increased adoption of combinations of immune checkpoint inhibitors with Inlyta for the first-line treatment of advanced RCC in the U.S., partially offset by lower volumes and lower net price in certain European markets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures for 2022 ($1,003 million) and 2023 ($1,036 million) are accurate, and the implied 3% growth rate is correct: ((1,036 - 1,003) / 1,003) ≈ 3.3%, which rounds to the reported 3% in both the original and LLM answers. (2) The qualitative factors driving revenue growth — increased adoption of Inlyta in combination with immune checkpoint inhibitors for first-line treatment of advanced RCC in the U.S. and growth in emerging markets — are accurately identified and worded with semantic equivalence. (3) The offsetting factors — lower volumes and lower net prices in certain European markets — are also correctly included. (4) The answer addresses both parts of the question: revenue performance evolution (with exact numbers and percentage change) and the influencing factors. Multi-hop reasoning is sound, synthesizing financial performance and causal drivers across regions and treatment applications. All entities (Inlyta, RCC, immune checkpoint inhibitors, U.S., Europe, emerging markets) are correctly identified and contextually appropriate. Minor rephrasing (e.g., 'continued expansion' vs 'continued adoption') does not affect factual accuracy. Overall, the answer is factually complete, numerically precise, and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 375,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, the treatment and valuation of network location intangibles evolved primarily through a change in the estimated useful lives of tower assets and related intangible assets. In 2024, the Company revised the estimated useful life of its tower assets from 20 to 30 years, based on historical operating experience. This change was applied prospectively and resulted in an estimated $730 million decrease in depreciation and amortization expense for 2024. Additionally, the amortization of network location intangibles, which is tied to the useful life of the towers, was adjusted accordingly. The impairment review process for these intangibles remained consistent, with evaluations conducted on an individual tower basis, primarily triggered by factors such as lack of tenant leases or expenses exceeding revenues.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, the weighted average amortization period for network location intangibles was 15 years, but the LLM incorrectly claims a change in the estimated useful life of tower assets from 20 to 30 years in 2024—this is not supported by the original answer. Additionally, the $730 million decrease in depreciation and amortization expense is fabricated and not mentioned in the ground truth. The original answer references a $470 million increase in asset retirement obligations, not $730 million, and this relates to liabilities, not savings in expenses. (2) Quantitative accuracy is very low: the only correct numeric element is the mention of impairment triggers (e.g., lack of leases, expenses exceeding revenues), but even then, the LLM misattributes the timing and context. The $730M figure is entirely incorrect, and the 20-to-30-year life revision is not in the original. The correct number from the ground truth is $470 million related to liability increase, which the LLM omits entirely. (3) The multi-hop reasoning is flawed. The LLM invents a connection between tower asset life extension and amortization of intangibles without basis in the provided truth. While both topics relate to asset valuation, the original answer emphasizes enhanced disclosure in 2024 around impairment reviews and indirect impacts from liability changes—not a prospective change in useful life. The LLM fails to mention the key evolution: expanded 2024 disclosures on impairment at the individual tower level and the indirect impact of increased asset retirement obligations on useful life assumptions. (4) Contextual relevance is moderate because the answer addresses amortization and impairment of network location intangibles, which are central to the question, but the factual foundation is incorrect. Due to major errors in numbers, entities, and reasoning, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 535,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "ExxonMobil has significantly increased its strategic emphasis on Guyana between 2023 and 2024, as Guyana is highlighted as a key component of its advantaged growth portfolio. In 2023, production from the Stabroek Block exceeded 390 thousand barrels of oil per day (kbd), with the third FPSO vessel, Prosperity, starting production in November 2023 and reaching nameplate capacity in January 2024. By late 2024, ExxonMobil anticipates having six FPSO vessels operational on the Stabroek Block by year-end 2027, with the fifth development, Uaru, and the fourth, Yellowtail, progressing on schedule. The company is also working with the government of Guyana to secure regulatory approvals for a sixth project at Whiptail, further expanding production capacity. This growth in Guyana aligns with the company's focus on low-cost, high-return opportunities and contributes to the expected increase in production from the Americas in the coming years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key inaccuracies. It correctly identifies Guyana as a strategic focus and mentions the Prosperity FPSO startup, but misstates production in 2023 as 'exceeding 390 kbd' instead of the ground truth 'nearly 440 kbd in Q4 2023'. The ground truth emphasizes that production reached ~440 kbd by end-2023, not just exceeding 390 kbd earlier in the year. Additionally, the LLM introduces forward-looking projections (six FPSOs by 2027, Uaru, Yellowtail, Whiptail) not present in the original answer, which focuses on the strategic reclassification of Guyana into 'Advantaged Assets' in 2024. While these projections may be factually true elsewhere, they shift focus from the core evolution in strategic framing emphasized in the ground truth. (2) Quantitative accuracy is compromised: the 390 kbd figure does not match the verified 440 kbd in Q4 2023; the timing of Prosperity’s startup is partially correct (November 2023) but omits that it contributed to Q4 production nearing 440 kbd. The LLM also adds speculative capacity plans not in the original. (3) The multi-hop reasoning is partially sound—linking Guyana to upstream growth and low-cost assets—but fails to capture the key conceptual shift: in 2024, Guyana was formally grouped with Permian and LNG as a core earnings driver under 'Advantaged Assets', signaling maturity. This strategic repositioning is the central point of the ground truth, which the LLM overlooks in favor of operational expansion details. (4) Contextual relevance is high because the answer addresses ExxonMobil’s strategic emphasis, upstream portfolio, and production capacity. However, the qualitative accuracy is reduced due to omission of the critical 2024 reclassification and overemphasis on future projects. The answer is plausible but diverges from the specific evolution described in the ground truth, which centers on financial integration and strategic elevation rather than field development timelines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 541,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "Between 2022 and 2023, the X1 platform's integration with third-party streaming services evolved by expanding access to a broader range of content, including services like Disney+ and Netflix, and incorporating features such as integrated search and voice-activated remote control. This evolution reflects Comcast's strategy to reduce cord-cutting by offering a unified, flexible viewing experience that combines traditional cable services with popular streaming options. By integrating these services, Comcast aims to retain customers who prefer streaming while increasing ARPU through bundled offerings and commission revenue from third-party service sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the integration of Disney+ and Netflix on the X1 platform and references commission revenue from third-party services, which aligns with the 2022 portion of the ground truth. It also accurately captures the strategic intent behind the integrations—reducing cord-cutting and increasing ARPU through bundling and commissions. However, it omits key 2023 developments: the inclusion of Xumo Play, NBC, Sky, and the NOW TV service specifically marketed to broadband customers. These are significant additions that represent a strategic pivot not fully reflected in the LLM response. Instead, the answer vaguely references 'expanding access' and 'integrated search and voice-activated remote control,' which are not mentioned in the ground truth and introduce features unsupported by the original data. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—no errors in this dimension. (3) The multi-hop reasoning is partially sound: the model correctly infers Comcast's strategic goals from the integration of third-party services, linking content bundling to customer retention and ARPU growth. However, it fails to synthesize the evolution across 2022 to 2023 accurately by missing the shift toward broadband-centric services like NOW TV and Xumo Play, which indicate a broader strategic repositioning beyond just enhancing the X1 platform. (4) The correctness score is 7 because core strategic reasoning and key 2022 facts are accurate, but important 2023-specific entity integrations and service expansions are missing, reducing completeness and qualitative accuracy. Contextual relevance remains high as the answer stays focused on the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 481,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Caterpillar's relationship with FG Wilson expanded between 2023 and 2024 in terms of distribution network coverage for electric power generation systems. In 2023, FG Wilson's systems were distributed through a network of 108 distributors covering 158 countries. By 2024, this network had grown to 110 distributors covering 109 countries, indicating an increase in global reach and potentially enhanced market access for FG Wilson's electric power generation systems.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reverses the data between 2023 and 2024, incorrectly stating that in 2023 there were 108 distributors covering 158 countries, when the ground truth states 110 distributors in 109 countries in 2023. It then claims 110 distributors in 109 countries in 2024, which actually matches the 2023 figures, not 2024. This complete inversion of the numbers leads to an incorrect conclusion about network expansion, when the truth indicates a slight contraction in distributor count but a significant geographic expansion. (2) The quantitative inaccuracies are severe: the distributor count and country coverage are swapped across years, and no part of the numerical comparison is correct. Calculations or trends based on these numbers are therefore invalid. (3) The multi-hop reasoning fails because the model did not correctly associate the correct metric values with the correct years, undermining the synthesis required to assess evolution over time. The conclusion about 'expansion' contradicts the actual trend of fewer distributors. (4) Despite the factual errors, the answer is contextually relevant—addressing the right companies, topic (distribution network), and attempting trend analysis—hence a moderate relevance score. However, correctness is severely compromised by incorrect data pairing, warranting a low score of 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 376,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Capital One's exposure to securitized debt obligations decreased between 2022 and 2024. As of December 31, 2024, the carrying value of securitized debt obligations was $14.3 billion, compared to $18.0 billion as of December 31, 2022. The fair value of these obligations also declined from $18.1 billion in 2022 to $14.3 billion in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that in 2024, the carrying value of securitized debt obligations was $18,043 million ($18.043 billion) and fair value was $18,067 million ($18.067 billion), whereas the LLM claims carrying value decreased to $14.3 billion in 2024 from $18.0 billion in 2022, and fair value dropped to $14.3 billion from $18.1 billion. This reverses the actual trend—there is no indication of a decrease in exposure; rather, the values remained stable with a slight increase in fair value over carrying value. (2) The numbers are significantly off: the LLM reports $14.3B for 2024 carrying and fair value, but ground truth reports $18.043B (carrying) and $18.067B (fair), both of which are ~26% higher than stated. Additionally, the LLM implies a decline in fair value from $18.1B to $14.3B, but ground truth shows fair value was $18.067B in 2024—essentially unchanged from 2022. (3) The reasoning is flawed: the LLM concludes exposure decreased, but the ground truth indicates continued significant exposure with stable valuations. The multi-hop synthesis failed—either due to incorrect data retrieval or misinterpretation of trends. (4) Scores reflect major quantitative errors (2/10), poor qualitative reasoning (3/10), moderate contextual relevance since it addresses the right metric and time frame (6/10), and very low overall correctness (2/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 399,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "Between 2023 and 2024, McDonald's continued to utilize line of credit agreements as part of its financing activities and cash flow management. As of December 31, 2024, the Company had $4.0 billion available under a committed line of credit agreement, consistent with its 2023 position. Additionally, the Company's subsidiaries had $7 million of borrowings outstanding under uncommitted foreign currency line of credit agreements in 2024, compared to similar arrangements in 2023. These credit facilities, along with commercial paper borrowings, provided flexibility to meet short-term funding needs, particularly as cash balances decreased in 2024 due to higher financing activities and reduced bond issuances.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct qualitative elements, such as McDonald's continued use of line of credit agreements and commercial paper for short-term funding, and mentions reduced bond issuances contributing to higher financing outflows in 2024. However, it omits key quantitative facts from the ground truth: the actual cash used for financing activities in 2023 ($4.4B) and 2024 ($7.5B), the $3.1B increase, and the drop in cash and equivalents from $4.6B (2023) to $1.1B (2024). These are central to understanding the evolution in financing strategy and liquidity. (2) The LLM introduces a specific figure—$4.0 billion available under a committed line of credit in 2024—which is not present in the original answer and cannot be verified against the ground truth. Similarly, the $7 million in subsidiary borrowings under uncommitted foreign lines is new information not found in the original, raising concerns about hallucination or misattribution. The original answer does not specify the amount available under credit lines, only that they were used. (3) The multi-hop reasoning is partially sound: the model correctly infers that credit facilities supported short-term needs amid declining cash balances. However, it fails to connect the change in financing activity (from lower to higher cash outflows) with the shift in bond issuance strategy and its impact on liquidity, which is a core insight in the original answer. The explanation lacks synthesis of year-over-year changes in cash flow and financing behavior. (4) While the LLM answer is contextually relevant and uses appropriate financial terminology, the absence of key figures and introduction of unverified details reduces quantitative accuracy. The qualitative reasoning is logical but incomplete, missing the narrative of a shift from surplus liquidity in 2023 to a cash-constrained position in 2024. Correctness score is 6 due to partial factual alignment but significant omissions and potential inaccuracies in numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 544,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "Between 2022 and 2024, the Worldwide Business Conduct Manual remained a central pillar in reinforcing Procter & Gamble's internal controls, emphasizing the company's commitment to integrity and compliance. In both years, the Manual was highlighted as a foundational element of the internal control structure, supporting financial reporting reliability and ethical business practices. The consistency in its role, alongside the continued emphasis on governance structures like the Global Leadership Council and Audit Committee, indicates a stable and robust approach to corporate governance, with a focus on maintaining strong controls and ethical standards across the organization.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in the role of the Worldwide Business Conduct Manual between 2022 and 2024, which is central to the question. While it correctly identifies the Manual as a consistent element reinforcing internal controls and mentions governance bodies like the Global Leadership Council and Audit Committee, it fails to capture the specific shift in emphasis from general ethical conduct in 2022 to more structured governance integration in 2024. The ground truth highlights that in 2024, the Manual was more explicitly tied to governance mechanisms such as the Disclosure Committee and oversight activities—details absent in the LLM response. Instead, the LLM emphasizes 'consistency' and 'stable approach,' which downplays the evolution toward a more integrated governance model. There are no numerical inaccuracies (hence high quantitative accuracy), and the entities mentioned (e.g., Global Leadership Council) are correct, though the Audit Committee is mentioned instead of the Disclosure Committee, indicating a minor entity mismatch. The reasoning is sound but incomplete, failing the multi-hop synthesis required to contrast the two years meaningfully. Contextually, the answer is relevant and well-structured, but lacks the critical comparative insight needed for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 369,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "Exxon's strategic positioning in Guyana has strengthened between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions. The long-lived assets in Guyana increased from $4,892 million in 2021 to $6,766 million in 2023 and further to $9,689 million in 2024, indicating significant capital investment in the region. Additionally, Guyana is explicitly categorized as an \"Advantaged Asset\" in the 2024 earnings driver definitions, highlighting its role in driving volume/mix growth from high-performing projects. This underscores Guyana's growing strategic importance as a key contributor to Exxon's advantaged volume growth and overall profitability.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Guyana was explicitly named as an 'Advantaged Asset' in 2024 under the 'Advantaged Volume Growth' earnings driver, which aligns with the ground truth and captures the strategic evolution. However, there are significant quantitative inaccuracies: the LLM states that long-lived assets in Guyana were $6,766 million in 2023 and $9,689 million in 2024, whereas the ground truth reports $9,689 million in 2023. There is no data provided for 2024 in the original answer, so the claim of an increase to $9,689 million in 2024 is incorrect. Additionally, the mention of $4,892 million in 2021 is extraneous and not relevant to the 2023–2024 comparison asked in the question. (2) The key number in the ground truth—$9,689 million in 2023—is present in the LLM answer but misassigned to 2024, reversing the temporal logic. This undermines the accuracy of the trend description. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes asset disclosures with strategic categorization in earnings drivers and infers increased strategic importance. The qualitative shift from a quantitatively significant asset to a strategically emphasized one is well articulated. (4) Despite the incorrect year assignment of the $9,689 million figure and the inclusion of irrelevant earlier data, the core strategic conclusion is directionally correct, warranting a score of 7 for overall correctness. Quantitative accuracy is penalized due to the misdated key figure, but qualitative and contextual accuracy remain high as the reasoning and entity identification (Exxon, Guyana, Advantaged Assets, earnings driver) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 459,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One's reliance on securitized debt obligations as a funding source decreased from 2022 to 2024. In 2022, securitized debt obligations totaled $5.8 billion in issuances, while by 2024, this figure dropped to $6.25 billion in issuances. Additionally, the balance of securitized debt obligations on the balance sheet decreased from $18.0 billion in 2023 to $14.3 billion in 2024, indicating a reduction in reliance on this funding source over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both numbers and interpretation. The ground truth states that no specific dollar value for securitized debt obligations was disclosed in 2022, but the LLM claims $5.8 billion in issuances, which is unsupported. For 2024, the ground truth reports a carrying value of $14,264 million (i.e., $14.264 billion), which the LLM approximates as $14.3 billion—this is the only partially accurate number, though it misrepresents it as a decline. The LLM also fabricates a 2023 figure of $18.0 billion, which is not mentioned in the original answer. (2) The quantitative inaccuracies are severe: the $5.8 billion and $6.25 billion issuance figures for 2022 and 2024 are entirely incorrect and contradict the ground truth, which states no specific value was disclosed in 2022. The claimed decrease from $18.0 billion to $14.3 billion is unsupported, as 2023 data is not provided in the original. (3) The reasoning is flawed: the LLM concludes a decrease in reliance, while the original answer indicates increased transparency and continued use, with the first concrete quantification in 2024. There is no evidence in the ground truth of declining reliance—only enhanced disclosure. The model fails the multi-hop synthesis by inventing data points and drawing opposite conclusions. (4) The correctness score is 1 due to almost complete factual inaccuracy. Quantitative accuracy is 1 because all key numbers are fabricated. Qualitative accuracy is 1 due to incorrect entities, timeline, and logic. Contextual relevance is 3 because the answer addresses the general topic of funding evolution but with entirely incorrect data and direction of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 461,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "Between fiscal years 2022 and 2023, NVIDIA's Omniverse platform evolved from being a 3D design and virtual world simulation tool to a more integrated and enterprise-focused platform. In 2022, Omniverse was highlighted for enabling digital twins, real-time 3D product configurators, and testing autonomous systems. By 2023, Omniverse was positioned as a core component of NVIDIA's full-stack computing infrastructure, with expanded use in data center-based simulation (e.g., DRIVE Sim) and integration with AI and generative technologies, emphasizing its role in industrial digitalization and enterprise metaverse applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of NVIDIA's Omniverse from a 3D design and simulation tool in 2022 to a more enterprise-focused platform in 2023, with emphasis on industrial digitalization and integration with AI. However, it inaccurately states that Omniverse was already highlighted for digital twins and real-time 3D product configurators in 2022, when according to the ground truth, these enterprise use cases (e.g., digital twins of factories, real-time configurators) were specifically emphasized in 2023 as part of its expanded positioning. The ground truth indicates that in 2022, the focus was on 'real-time 3D design collaboration' for creators, not industrial applications. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic shift toward enterprise adoption and integration with AI/simulation tools like DRIVE Sim. However, it misattributes the timing of key enterprise use cases, conflating 2023 developments with 2022 positioning, which weakens the qualitative accuracy. (4) Contextual relevance is high—the response directly addresses the question about positioning and enterprise adoption across the two fiscal years, using appropriate terminology and reflecting the broader strategic trajectory, even if some details are misaligned temporally.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 413,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Pfizer's financial relationship with Viatris, which was formed through the 2020 spin-off and combination of the Upjohn Business with Mylan, shows that net amounts due to Viatris under their agreements decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. This reduction reflects the ongoing fulfillment of transitional service agreements (TSAs) and manufacturing supply agreements (MSAs), with most TSA services completed by the end of 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the dollar amounts ($94 million as of December 31, 2022, and $33 million as of December 31, 2023) are accurately reported with correct dates. The reduction from $94M to $33M is correctly implied. (2) The answer is complete, addressing the evolution of Pfizer's financial relationship with Viatris between 2022 and 2023, specifically focusing on net amounts due under agreements. (3) Entity accuracy is correct: Pfizer, Viatris, and the context of the 2020 spin-off and Upjohn/Mylan combination are properly identified. (4) The reasoning is sound and adds value by explaining that the decrease reflects fulfillment of Transitional Service Agreements (TSAs) and Manufacturing Supply Agreements (MSAs), with most TSA services completed by end of 2023—this is consistent with known post-separation dynamics and represents valid qualitative synthesis. The answer conveys the same core information as the ground truth, with added context that enhances understanding without introducing inaccuracies. All multi-hop elements (tracking financial obligations across years, linking to post-separation agreements) are correctly handled.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 343,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana intensified between 2023 and 2024, as reflected in increased project activity and classification as an \"advantaged asset.\" In 2023, Guyana's operations involved 12.6 net exploratory and development wells, with the Payara development commencing and the Yellowtail project advancing. By 2024, Guyana was explicitly highlighted in the \"Advantaged Volume Growth\" earnings driver, underscoring its strategic importance for high-return projects and integration across business segments. This classification signals a shift toward prioritizing Guyana's resource potential as a core growth area.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of ExxonMobil's strategic emphasis on Guyana from 2023 to 2024. All key facts are accurate: in 2023, 12.6 net exploratory and development wells were completed (quantitatively accurate), and projects like Payara and Yellowtail were advancing. The 2024 reclassification of Guyana as part of the 'Advantaged Volume Growth' earnings driver under 'Advantaged Assets' is correctly identified, aligning with the ground truth. (2) Quantitative accuracy is perfect: the number 12.6 net wells is correctly reported, and no other numerical claims are made. (3) The multi-hop reasoning is sound—information from both years is synthesized to show a strategic shift from operational activity to formal classification as a core growth asset. The LLM correctly infers that inclusion in 'Advantaged Assets' (alongside Permian and LNG) signals elevated strategic importance, though it omits explicit mention of the Permian and LNG comparison, which slightly weakens completeness. (4) The answer is contextually fully relevant and semantically equivalent to the original, with only minor omission of the comparative context (Permian, LNG) preventing a perfect 10 on qualitative accuracy. Wording differences are acceptable and do not affect factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 365,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "The weighted-average interest rate for senior notes with maturities greater than 10 years remained stable at 3.8% in both 2023 and 2022. The face value of these notes increased slightly from $52.8 billion in 2022 to $53.4 billion in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 the weighted-average interest rate was 3.67%, not 3.8% as stated by the LLM, and it increased to 3.8% in 2023. The LLM incorrectly claims the rate remained stable at 3.8% in both years, misrepresenting the evolution. Additionally, the face value in 2022 was $54.536 billion, not $52.8 billion as claimed, and it decreased to $53.4 billion in 2023, whereas the LLM states it increased from $52.8 billion. These errors affect both the starting values and the direction of change. (2) Quantitative accuracy is low: the interest rate is off by 0.13 percentage points in 2022, and the face value is off by $1.736 billion in 2022. The direction of change for face value is also incorrect (LLM says increase, truth is decrease). (3) The reasoning is partially sound in that it attempts to compare two years and assess stability and change, but the multi-hop synthesis fails due to incorrect data retrieval for both years and metrics. (4) Contextual relevance is high because the answer addresses the right metrics (interest rate and face value), time frame (2022 to 2023), and debt category (senior notes >10 years), but factual correctness is severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 356,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Between 2023 and 2024, the nuclear decommissioning trusts managed by Alabama Power and Georgia Power experienced shifts in their domestic equity investment allocations and valuation methodologies. In 2023, Alabama Power's domestic equity investments were classified as $443 million under Level 2 inputs, while Georgia Power's were $321 million under Level 2. By 2024, Alabama Power's domestic equity investments remained at $443 million under Level 2, and Georgia Power's increased to $322 million under Level 2. Both companies continued to rely on Level 2 inputs for their domestic equity investments, indicating that these valuations were based on significant observable market data rather than quoted prices in active markets (Level 1) or unobservable inputs (Level 3).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that in 2023, Alabama Power had $443 million in Level 2 domestic equity investments, when the ground truth reports $396 million in Level 1 and $169 million in Level 2. Similarly, it claims Georgia Power had $321 million in Level 2 in 2023, but the truth is $255 million in Level 1 and $1 million in Level 2. The 2024 figures are also misattributed: Alabama Power’s $443 million in Level 1 is wrongly assigned to Level 2, and Georgia Power’s total of $322 million is incorrectly presented as Level 2 when it is actually $321 million in Level 1 and $1 million in Level 2. (2) All numerical values are either misplaced across years or misclassified across valuation levels. For example, Alabama Power’s 2024 Level 1 amount ($443M) is incorrectly reported as a 2023 Level 2 figure. There are no correct cross-year comparisons or accurate allocations by input level. Calculations of totals are absent and misrepresentations dominate. (3) The multi-hop reasoning is fundamentally flawed. The model fails to correctly identify how allocations shifted between Level 1 and Level 2 over time for each company. Instead, it falsely claims both companies used only Level 2 inputs, contradicting the ground truth that shows a strong emphasis on Level 1 (quoted prices in active markets). The conclusion about reliance on Level 2 is therefore invalid. (4) Despite addressing the right entities (Alabama Power, Georgia Power, nuclear decommissioning trusts, Level 1/Level 2 inputs), the answer is severely compromised by incorrect data and reasoning. Contextual relevance is moderate because the structure and terminology are appropriate, but factual correctness is very low, warranting a correctness score of 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 486,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "NVIDIA's strategic positioning of CUDA from 2022 to 2023 has evolved to emphasize its foundational role within the company's full-stack computing platform, enabling accelerated computing across diverse end markets. In 2022, CUDA was highlighted as a key building block for addressing compute-intensive applications in AI, data analytics, and graphics. By 2023, CUDA's integration expanded further, underpinning not only data center and AI workloads but also extending into automotive, gaming, and professional visualization markets through domain-specific software stacks and platforms like NVIDIA DRIVE, Omniverse, and RTX. This evolution reflects CUDA's growing importance as a unifying force across NVIDIA's ecosystem, driving innovation and performance across industries.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of CUDA's strategic positioning from 2022 to 2023, noting its transition from a key building block to a more deeply integrated foundational layer in NVIDIA's full-stack computing platform. It accurately identifies the continuity in end markets such as gaming, automotive, and professional visualization, and correctly notes CUDA's role in AI and data center workloads. However, it omits specific 2023 advancements highlighted in the ground truth, such as CUDA becoming the base for 'hundreds of domain-specific software libraries, SDKs, and APIs'—a key strategic expansion explicitly mentioned in the original answer. Additionally, while the LLM mentions domain-specific platforms like DRIVE and Omniverse, it does not fully convey the shift toward vertical integration in new sectors like healthcare and manufacturing, which were emphasized in the ground truth. (2) There are no numerical values, dates, or financial metrics in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 vs 2023) and across markets, correctly identifying CUDA’s expanding role. However, the synthesis is slightly incomplete due to missing details about the software stack expansion in 2023. (4) The answer is contextually relevant and well-articulated, addressing the core of the question about strategic evolution. The correctness score is 8 due to accurate core facts but minor omissions in depth and specificity regarding CUDA’s 2023 software ecosystem expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 448,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "From 2022 to 2023, Pfizer's financial obligations and contractual relationships with Viatris, particularly under transitional service agreements (TSAs) and master services agreements (MSAs), saw significant completion. Services under the TSAs were largely completed by December 31, 2023, and no material amounts were recorded under these arrangements in 2023. The net amounts owed to Viatris under these agreements decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. This reduction reflects the winding down of transitional obligations following the 2020 spin-off and combination of the Upjohn Business with Mylan to form Viatris.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key developments in Pfizer's financial obligations and contractual relationships with Viatris from 2022 to 2023. It accurately states that TSA services were largely completed by the end of 2022 and fully completed by December 31, 2023. The net amounts owed to Viatris decreased from $94 million in 2022 to $33 million in 2023, which matches the ground truth. (2) Quantitative accuracy is perfect: both dollar amounts ($94M and $33M) and the date (December 31, 2023) are correct. The implied reduction of $61 million is accurate, though not explicitly stated. (3) The reasoning is sound and reflects proper multi-hop synthesis: the answer connects the completion of TSAs, the decline in net amounts owed, and ties it to the broader context of the 2020 spin-off and formation of Viatris. The only minor shortcoming is that the original answer notes that amounts were 'not material to operations' in 2022, a nuance slightly underemphasized in the LLM response, though the statement that 'no material amounts were recorded in 2023' partially captures this. (4) The answer is contextually fully relevant, addressing transitional service agreements, net amounts owed, and the evolution across years. Overall, the response is factually correct, well-reasoned, and only slightly less detailed than the ground truth on materiality in 2022, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 400,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "From 2022 to 2023, Duke Energy faced evolving pressures from retail deregulation and increasing environmental regulation compliance costs. In 2022, the company highlighted the risks of potential retail deregulation leading to asset impairment, loss of customers, and unrecovered costs, particularly in jurisdictions where it might face competition. Additionally, environmental regulations, such as those related to coal combustion residuals (CCR) and greenhouse gas (GHG) emissions, were expected to drive significant capital and operational expenditures. By 2023, Duke Energy emphasized the intensifying impact of climate change activism and regulatory changes, including stricter GHG reporting and carbon reduction goals, which could accelerate the retirement of carbon-intensive assets and increase compliance costs. The company also noted the challenge of securing cost recovery for these expenditures through regulatory processes, which could affect cash flows and financial performance. Overall, the interplay between deregulation pressures and environmental compliance costs became more pronounced in 2023, with greater emphasis on regulatory and policy uncertainty.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in the relationship between retail deregulation and environmental compliance costs at Duke Energy from 2022 to 2023. It correctly identifies that in 2022, Duke Energy expressed concerns about retail deregulation leading to unrecovered costs and asset impairment, particularly in competitive markets, and that environmental compliance (e.g., CCR, GHG emissions) was already driving significant expenditures. In 2023, the LLM accurately notes increased regulatory and activist pressure on climate-related issues, including carbon reduction goals and GHG reporting, which could accelerate asset retirements and raise compliance costs. It also correctly highlights the challenge of cost recovery in a regulatory context, affecting cash flows. However, the LLM omits specific references to PURPA and above-market purchased power commitments from qualifying facilities (QFs), which were key mechanisms linking deregulation to unrecovered environmental costs in the original answer. Additionally, while it mentions regulatory uncertainty, it does not explicitly connect deregulation to weakened ability to pass on environmental compliance costs in competitive markets—a central point in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the entities (Duke Energy, 2022–2023 timeframe, environmental regulations) are correct. The reasoning is sound and synthesizes multi-hop elements (deregulation + environmental costs + cost recovery), though slightly less precise than the original. The answer remains contextually highly relevant and semantically close to the ground truth, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 476,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products decreased from 11.3% in 2022 to 9.5% in 2023, and further declined to 7.6% in 2024. This reflects a continued loss of market share, likely due to competition from oral nicotine pouches. In contrast, during 2023, the pricing strategy for Skoal involved multiple price increases, including a $0.09 to $0.10 per can increase, indicating an effort to maintain profitability amid volume declines.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. It states that Skoal's retail share was 11.3% in 2022 and 9.5% in 2023, but the ground truth specifies 9.3% in 2023 and 7.6% in 2024 — no data for 2022 is relevant to the question, which asked specifically about 2023 to 2024. The correct change is from 9.3% (2023) to 7.6% (2024), not the 9.5% to 7.6% decline implied. (2) Regarding pricing, the LLM claims a $0.09 to $0.10 increase in 2023, but the ground truth specifies a $0.11 per can increase announced in 2023 and effective January 23, 2024, following earlier increases in 2022 (not 2023). The LLM incorrectly attributes the timing and magnitude of the price hikes, missing the key detail that the 2024 price increase was announced in 2023, which is central to the contrast between pricing strategy and market share decline. (3) The reasoning is partially sound — the LLM correctly infers that price increases may contrast with declining market share and mentions competition from nicotine pouches as a possible factor. However, it fails to correctly synthesize the multi-hop connection between the 2023-announced price increase and the 2024 market share drop, instead implying a simpler correlation without accurate temporal alignment. (4) The contextual relevance is high because the answer addresses both parts of the question — market share trend and pricing strategy — and attempts to contrast them. However, due to major numerical and temporal inaccuracies, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the logic framework is reasonable but based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 459,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's investment in 'Other short-term interest-bearing securities' increased from $138 million as of December 31, 2023, to $135 million as of December 31, 2024. This slight decrease suggests that Amgen maintained a stable, low-risk short-term investment strategy, prioritizing liquidity and safety of principal, with only minor shifts in allocation between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that Amgen's investment decreased from $138 million in 2023 to $135 million in 2024, while the ground truth confirms the amount remained unchanged at $138 million in both years. This misrepresents the core quantitative fact. (2) The numbers are incorrect—$135 million is false, and the claimed 'slight decrease' is unsupported. The correct value is $138 million in both years, so there is no change. Even minor rounding or formatting differences do not justify this discrepancy. (3) The reasoning is partially sound in interpreting stability as indicative of a consistent, low-risk strategy, which aligns with the original answer's implication. However, because the premise (a decrease) is wrong, the synthesis fails on a fundamental level. The model incorrectly infers a minor shift when there was none. (4) The contextual relevance is fair because the answer addresses the right metric, company, and time frame, and attempts to interpret strategic implications. However, due to the incorrect data, the conclusion is misleading. Correctness and quantitative accuracy are severely penalized due to the wrong dollar amount and false trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 342,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "General Dynamics' involvement in Abrams Main Battle Tank Upgrades has seen an increase in contract value from 2022 to 2024. In 2022, the company secured $360 million for Abrams tank upgrades, mission control units, and systems technical support. By 2024, this scope expanded to $350 million for Abrams main battle tank upgrades, engineering, logistics support services, and system sustainment technical support, indicating a slight decrease in direct contract value but a broader scope of support activities.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $360 million 2022 contract and the $350 million 2024 contract for Abrams upgrades and support services, which aligns with the ground truth. However, it omits the critical second 2024 contract worth $285 million for producing Abrams tanks in the SEPv3 configuration for Romania. This omission significantly undermines completeness and factual accuracy, as the evolution in contract scope and total value hinges on recognizing both contracts. (2) Quantitatively, the individual figures mentioned ($360M and $350M) are accurate in amount and year, and formatting is consistent. But the conclusion that there was a 'slight decrease in direct contract value' is misleading because it fails to account for the additional $285M contract, which increases the total value of 2024 involvement to $635M—well above the 2022 level. Thus, the quantitative comparison is flawed due to incomplete data. (3) The reasoning correctly notes an expansion in scope (from upgrades to include engineering and logistics), but fails the multi-hop synthesis by not connecting the Romania production contract as part of the evolved involvement. This contract represents a strategic shift toward new production, not just upgrades, which is central to the question. (4) Contextual relevance is high because the answer addresses contract scope and value evolution, but correctness score is reduced to 6 due to the major omission of a key contract, leading to an incorrect overall conclusion about value trends. Qualitative accuracy is moderate—reasoning is sound where applied, but incomplete synthesis lowers confidence in the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 452,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG's financial relationship with Corebridge evolved significantly. In 2023, Corebridge was still consolidated within AIG's financial statements, contributing to AIG's revenues and operations. However, in 2024, AIG deconsolidated Corebridge on June 9, 2024, recognizing a $4.8 billion loss primarily due to accumulated comprehensive losses. Post-deconsolidation, AIG adopted the fair value option for its retained interest in Corebridge, with changes in Corebridge's stock price and dividends impacting AIG's net investment income. By the end of 2024, AIG had sold a significant portion of its Corebridge shares, including a 21.6% stake to Nippon for $3.8 billion, resulting in a $282 million gain.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key shift in AIG's relationship with Corebridge from 2023 to 2024, including deconsolidation on June 9, 2024, and the move to recognizing income based on stock price changes and dividends, which aligns with the ground truth's mention of equity method income recognition starting that date. However, the ground truth does not mention AIG adopting the 'fair value option' or 'net investment income'—instead, it specifies 'equity method income,' which is a different accounting treatment. This is a significant qualitative deviation. (2) Quantitatively, the LLM introduces several figures not present in the ground truth: a $4.8 billion loss, a $3.8 billion sale of a 21.6% stake to Nippon, and a $282 million gain. These numbers, while plausible, are not supported by the original answer and represent overreach or hallucination. The ground truth does not mention any sales of shares or specific gains/losses related to transactions in 2024. (3) The multi-hop reasoning is partially sound: the model correctly infers a transformation in the relationship and ties it to a specific date (June 9, 2024), which matches the ground truth. However, it incorrectly characterizes the accounting method (fair value vs. equity method) and adds unsupported transactional details, undermining the reasoning accuracy. (4) Despite the added details and some mischaracterizations, the core evolution—from a consolidated, borrowing-capable entity in 2023 to a deconsolidated equity investment in 2024 with income tied to performance—is correctly captured, warranting a score of 7 for overall correctness. The answer is contextually relevant and addresses both borrowing arrangements (implied by 2023 consolidation) and income recognition changes, though with inaccuracies in financial details and accounting terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 502,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Solar Roof product has evolved to address production challenges and strategic dependencies. In 2022, Tesla highlighted its efforts to improve Solar Roof installation capabilities and efficiency, including collaborations with real estate developers and builders. By 2024, the company acknowledged ongoing production ramp challenges for Solar Roof, along with dependencies on suppliers and manufacturing processes. Additionally, Tesla emphasized the need to scale production and installation capabilities for energy products, reflecting a more mature understanding of the complexities involved in scaling Solar Roof as part of its broader energy generation and storage strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Tesla's 2022 focus on improving installation efficiency through collaboration with real estate developers and builders is accurately reported. The 2024 shift toward acknowledging production ramp challenges, supplier dependencies, and manufacturing bottlenecks is also correctly conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages, units) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024) and themes (strategic evolution from sales/installation to production challenges). The only minor shortcoming is that the LLM does not explicitly quote or emphasize the phrase 'depends in large part' from the 2024 10-K, which slightly weakens the precision of the strategic dependency claim, though the meaning is effectively preserved. (4) The answer is fully contextually relevant, directly addressing the evolution in Tesla's approach, production challenges, and strategic dependencies as requested. Overall, the response demonstrates strong qualitative and factual alignment with the ground truth, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 369,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "The retail share of Skoal in the U.S. oral tobacco market declined from 9.3% in 2023 to 7.6% in 2024, indicating a weakening competitive position for the brand. This decline occurred despite overall growth in the oral nicotine pouch category, which partially offset declines in MST products. The drop in Skoal's share suggests challenges in maintaining market relevance amid shifting consumer preferences and increased competition, particularly from nicotine pouches like on! and other emerging products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the retail share of Skoal declining from 9.3% in 2023 to 7.6% in 2024, matching the ground truth exactly. These numbers are accurate and properly attributed to the correct years and market (U.S. oral tobacco). (2) Quantitative accuracy is perfect—no calculation errors, and the percentages match the original answer precisely. (3) The reasoning is sound: the LLM correctly infers that the decline indicates a weakening competitive position, which aligns with the ground truth. It adds contextual insight about growth in the nicotine pouch category and competition from products like on!, which, while not explicitly required, enhances the explanation and reflects accurate multi-hop reasoning (linking Skoal's decline to broader market trends and competitive dynamics). The mention of on!'s growth is consistent with the ground truth (6.8% to 8.3%), though the LLM does not quote those exact numbers, it correctly uses the trend to contextualize Skoal’s challenges. (4) The answer is fully contextually relevant, addressing both parts of the question: the change in retail share and its implication for competitive positioning. The only minor limitation is that it does not explicitly contrast Skoal’s decline with on!’s numerical growth, but it does reference on! and competitive pressures, preserving the core comparative insight. Thus, the answer is factually complete and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 410,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The risk associated with the concentration of device share among premium tier companies has increased between 2023 and 2024, particularly due to heightened vertical integration by key customers and geopolitical tensions. In 2024, the concentration of device share among a few companies, especially at the premium tier, has continued, with certain Chinese OEMs increasing their market presence. This trend, combined with customers like Apple and Samsung developing their own integrated circuit products, has reduced Qualcomm's pricing power and exposed its revenue stability to greater volatility. Additionally, U.S.-China trade tensions and policies, such as the revocation of Huawei's export license in May 2024, have further exacerbated these risks, directly impacting Qualcomm's revenue and cash flows.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the risk from concentration of device share among premium tier companies has persisted and intensified between 2023 and 2024, impacting Qualcomm's pricing power and revenue stability. It accurately reflects the core concern from the original answer about reliance on a few large customers, particularly Chinese OEMs, and notes the added pressure from vertical integration (e.g., Apple and Samsung developing in-house chips), which aligns with the ground truth. However, the LLM introduces specific claims not present in the original answer: the 'revocation of Huawei's export license in May 2024' and 'geopolitical tensions' as direct contributors. These details are not mentioned in the ground truth and cannot be verified from the provided knowledge graph, making them unsupported additions. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—no incorrect numbers are introduced. The mention of 'May 2024' is specific but factually unverifiable here; since it doesn't contradict the timeline (2024 risk assessment), it doesn't fail outright but reduces precision. (3) The multi-hop reasoning is partially sound: the model connects customer concentration to pricing pressure and revenue volatility, and correctly infers that in-house chip development by customers threatens Qualcomm’s position. However, the original answer emphasizes a shift in *emphasis* in 2024 toward broader implications (e.g., timing of product launches), while the LLM shifts focus to geopolitical factors not in the source, indicating a deviation in reasoning path. (4) The correctness score is 7 because the core facts and direction of risk evolution are accurate, but the inclusion of unverified external factors (Huawei license revocation, trade tensions) introduces factual overreach. Qualitative accuracy is slightly lower due to this reasoning drift, though contextual relevance remains high as the answer directly addresses the question’s focus on risk evolution, pricing power, and revenue stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 565,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Based on the provided information, Amgen's allocation to money market mutual funds increased significantly between 2023 and 2024. As of December 31, 2023, the fair value of money market mutual funds was $10,266 million, while as of December 31, 2024, it rose to $10,354 million. This reflects a modest increase of $88 million during the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states that Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. However, the LLM claims the amount increased from $10,266 million in 2023 to $10,354 million in 2024, which contradicts the original data. This error fundamentally misrepresents the trend. (2) The quantitative values are incorrect: the 2024 figure of $10,354 million is not supported by the ground truth, and the calculated increase of $88 million is therefore also false. The correct calculation would show a $0 change, but the model fails to reflect this. (3) The multi-hop reasoning is flawed. The question asks about the evolution of allocation between two years, requiring accurate comparison across time. The model incorrectly infers a change where none exists, indicating a failure in synthesizing the correct data points from both years. (4) Despite the factual inaccuracy, the answer is contextually relevant—it addresses the right company (Amgen), the correct investment type (money market mutual funds), and the correct time frame (2023 to 2024). It also attempts a proper comparison, which maintains moderate relevance. However, the severe factual and quantitative errors result in a very low correctness and accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 371,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "General Dynamics' participation in the Capital Construction Fund (CCF) has seen a slight increase in the amount of U.S. government accounts receivable pledged to the fund between 2022 and 2024. Specifically, the pledged amounts were $295 million in 2021, $315 million in 2023, and $333 million in 2024, indicating a gradual rise in the value of receivables deposited into the CCF over this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All numeric values are correct: $295 million (as of 2021), $315 million (2023), and $333 million (2024) match the original answer exactly. The format variations are acceptable and semantically equivalent. (2) The quantitative accuracy is perfect—no calculation or number errors. (3) The reasoning is sound: the model correctly identifies a gradual increase in pledged receivables, reflecting growing participation in the CCF. However, the original answer references the data points as 'as of December 31, 2021', 'December 31, 2023', and 'December 31, 2024', while the LLM simplifies these to 'in 2021', 'in 2023', and 'in 2024'. This is a minor imprecision in temporal framing but does not affect factual correctness. (4) The answer fully addresses the evolution between 2022 and 2024, even though the data points are from the end of 2021, 2023, and 2024—this is consistent with how such financial disclosures are reported (i.e., year-end figures reported in the following year's filing). The synthesis across time is correct and relevant. The only reason for not scoring a 10 is the slight looseness in date labeling, but the core facts and multi-hop understanding (tracking changes over time using year-end data) are solid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 367,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly following the IPO and subsequent deconsolidation. In 2023, AIG's ownership in Corebridge fell below 80%, leading to tax deconsolidation from AIG's U.S. federal income tax group, which impacted the utilization of Corebridge's net operating losses and tax credits. By 2024, AIG fully deconsolidated Corebridge on June 9, recognizing a $4.8 billion loss due to accumulated comprehensive loss. Post-deconsolidation, AIG accounted for its retained interest in Corebridge using the fair value option, with changes in Corebridge's stock price and dividends impacting AIG's net investment income. Additionally, AIG sold a significant portion of its Corebridge shares, including a $3.8 billion transaction with Nippon Life in December 2024, resulting in a $282 million gain.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the key event — AIG's ownership in Corebridge falling below 80%, triggering tax deconsolidation in 2023 — and notes the shift in accounting treatment by 2024. However, it introduces several specific figures not present or incorrect in the ground truth: the $4.8 billion loss on deconsolidation (not mentioned in original), the June 9 deconsolidation date (ground truth states June 10, 2024, as start of equity method reporting), and a $282 million gain from a $3.8 billion sale to Nippon Life in December 2024 (no such transaction appears in the ground truth). These fabricated or inaccurate numbers severely undermine quantitative accuracy. (2) The original answer states AIG recognized $X in equity method income (placeholder), but the LLM incorrectly claims AIG used the 'fair value option' and reports investment income based on stock price changes and dividends — this contradicts the ground truth, which specifies the equity method, not fair value. This is a material accounting error. (3) The multi-hop reasoning is partially sound — the model connects IPO → ownership drop → tax deconsolidation → change in financial reporting — but fails in the second hop by misrepresenting the accounting method post-deconsolidation and inventing transactions. (4) Contextual relevance is high because the answer addresses tax implications, investment income, and the evolution of the relationship. However, correctness score is limited by significant factual and quantitative errors, especially the unsupported financial figures and incorrect accounting treatment. While the broad narrative arc is plausible, the specific financial claims are not substantiated by the ground truth, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 492,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "From 2022 to 2024, Tesla's approach to Solar Roof production has evolved to emphasize scaling through improved installation capabilities, collaboration with real estate developers, and localized procurement. In 2022, the company focused on onboarding and training installers to reduce costs and time, while in 2024, it expanded these efforts by integrating Solar Roof into new home developments. Supply chain challenges, including global component constraints and the need for localized battery cell production, remained persistent, with Tesla aiming to mitigate risks by increasing vertical integration and developing proprietary manufacturing technologies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and context, with accurate dates (2022 and 2024) and correct entities (Tesla, Solar Roof, real estate developers, supply chain). There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default. The answer correctly identifies Tesla's 2022 focus on installer training and collaboration with developers, and the 2024 shift toward broader integration and scalability. However, it misrepresents the evolution by emphasizing 'localized procurement' and 'localized battery cell production'—the ground truth does not mention localized battery production as a 2024 strategy. Instead, the original highlights systemic risks like global component procurement, supplier failures, and inflationary pressures, with an emphasis on managing bottlenecks and cost-effective production at scale. The LLM answer introduces 'vertical integration' and 'proprietary manufacturing technologies' not explicitly stated in the ground truth, which overreaches the provided information. While these concepts are plausible, they are not supported by the original answer, leading to a partial mismatch in qualitative accuracy. The reasoning is sound but slightly over-interpreted, and the core evolution—from installer development to systemic supply chain concerns—is partially captured but not fully aligned. Contextual relevance is high as the response directly addresses the question’s focus on operational strategy and supply chain evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 421,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina decreased from $8 billion to $9 billion in 2022 to $7 billion to $8 billion in 2023. This reduction indicates progress under the Coal Ash Act, as the company has completed excavations at several sites and is managing closures in alignment with regulatory agreements and state requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 2022 cost estimate of $8B–$9B and the 2023 revised estimate of $7B–$8B are accurately reported. While the LLM does not explicitly mention the amount spent ($3.1B through 2021 and $4B through 2023), this omission does not distort the overall picture. (2) The calculation of a $1B downward adjustment in the cost range is implied and correct. (3) The reasoning is sound: the reduction in estimated costs is correctly tied to progress under the Coal Ash Act, including completed excavations and regulatory compliance, which reflects proper multi-hop synthesis between cost trends and operational progress. (4) The answer is contextually relevant and addresses both parts of the question—evolution of cost estimates and what it indicates about progress—though it omits the specific cumulative spend figures that would enhance completeness. However, the core facts, entities (Duke Energy, Coal Ash Act, NC/SC basins), years (2022, 2023), and financial metrics are accurate. The minor omission of spending totals prevents a perfect 10, but the answer remains factually strong and semantically equivalent in intent and meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 347,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share within the oral tobacco product segment during this period, despite the overall segment's retail share declining from 42.5% to 37.5%. The growth in 'on!' share reflects its stronger performance relative to other products in the segment, particularly as the oral nicotine pouch category expanded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: the increase in 'on!' retail share from 6.8% in 2023 to 8.3% in 2024, and the decline in total oral tobacco segment share from 42.5% to 37.5%. These numbers match the ground truth exactly. (2) Quantitative accuracy is perfect—percentages and years are correct, and the implied conclusion that 'on!' gained share while the overall segment shrank is mathematically sound. (3) The multi-hop reasoning is strong: the model correctly synthesizes data across two entities (the 'on!' product and the total oral tobacco segment) and draws the valid conclusion that 'on!' gained relative market position. The only minor gap is the introduction of the 'oral nicotine pouch category expansion' as a supporting reason, which is not present in the original answer and cannot be verified from the provided ground truth. While this addition is plausible and contextually relevant, it introduces external inference not supported by the source data, slightly reducing qualitative accuracy. (4) Despite this small overreach, the core answer is factually correct, complete, and directly addresses both parts of the question—evolution of retail share and what it indicates about market position—making it semantically equivalent to the original with high contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 369,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "Qualcomm's reliance on Chinese OEMs for revenue has remained significant from 2023 to 2024, with continued concentration in a small number of Chinese OEMs. However, the 2024 filing highlights increased risks, such as geopolitical tensions (e.g., U.S./China trade policies), government actions (e.g., Huawei's license revocation in May 2024), and the potential for Chinese OEMs to develop their own integrated circuit products under initiatives like Made in China 2025. These factors pose a threat to business stability, as they could reduce revenue, increase costs, or disrupt supply chains.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Qualcomm's reliance on Chinese OEMs for revenue remained significant from 2023 to 2024, which aligns with the ground truth. It accurately reflects the ongoing business stability risks due to geopolitical tensions, particularly U.S./China trade dynamics. The mention of 'Made in China 2025' and potential in-house chip development by Chinese OEMs adds relevant context supported by typical risk factors in Qualcomm's filings. However, the specific event 'Huawei's license revocation in May 2024' is not present in the ground truth and may be speculative or incorrectly dated, introducing a minor factual inaccuracy. While the core financial dependency and risk implications are correctly synthesized across years (multi-hop reasoning), this unsupported detail slightly undermines qualitative accuracy. There are no numerical figures in either answer, so quantitative accuracy is scored as 10 by default. The answer is fully contextually relevant and addresses both parts of the question: evolution of reliance and implications for business stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 309,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Amgen's total available-for-sale investments increased from $4,335 million in 2022 to $10,404 million in 2023. In 2022, the investments were primarily composed of U.S. Treasury bills ($1,676 million) and money market mutual funds ($2,659 million). In 2023, the composition shifted entirely to money market mutual funds ($10,266 million), with no U.S. Treasury bills held. This change reflects a reallocation of Amgen's investment portfolio toward money market instruments during the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the composition of Amgen's 2022 investments. It incorrectly states that in 2022, $1,676 million was in U.S. Treasury bills and $2,659 million in money market mutual funds. However, the ground truth specifies that in 2022, the $4,335 million total was composed of $1,676 million in marketable securities (not U.S. Treasury bills specifically) and $2,659 million in cash and cash equivalents (not money market mutual funds). The 2023 figures are mostly correct: $10,404 million total, with $10,266 million in money market mutual funds and no U.S. Treasury bills. However, the LLM omits the $138 million in other short-term interest-bearing securities, which is a material component. (2) Quantitative accuracy is partially correct: the totals for both years ($4,335M and $10,404M) are accurate, and the $10,266M in 2023 money market funds is correct. But the 2022 breakdown is misattributed, and the $138M in 2023 is missing. (3) The reasoning shows an understanding of portfolio reallocation and correctly identifies a shift toward more liquid instruments, but the multi-hop synthesis is flawed because it misrepresents the 2022 composition and fails to mention the complete elimination of marketable securities and U.S. Treasury bills as stated in the original. The conclusion about shifting to money market instruments is directionally correct but oversimplified and based on incorrect inputs. (4) Contextual relevance is high—the answer addresses the evolution of investment composition and attempts to interpret the strategic shift. However, due to key factual errors in entity types (mislabeling cash and cash equivalents as money market funds, misidentifying marketable securities as U.S. Treasury bills), the qualitative and quantitative accuracy scores are reduced. The omission of the $138M in 2023 further undermines completeness and correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 521,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Shake Shack was listed as a tenant at the Las Vegas Outlets North Premium property in Nevada in the 2023 document (page 32), but it was not listed as a tenant at any of SPG's premium outlet properties in the 2022 document. This indicates that Shake Shack entered SPG's premium outlet portfolio in 2023, specifically at the Las Vegas Outlets North Premium location.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct in identifying Shake Shack's presence at Las Vegas Outlets North Premium in 2023, but it contains a major factual error: it claims Shake Shack was not present at any SPG premium outlet in 2022, which contradicts the ground truth. The original answer confirms that Shake Shack was a tenant at Woodbury Common Premium Outlets in New York in 2022. Therefore, the LLM incorrectly frames Shake Shack's presence as a new entry in 2023, missing the continuity from 2022 and failing to report the expansion (from Woodbury Common to include Las Vegas). This undermines both the quantitative accuracy (wrong year for initial presence) and qualitative accuracy (flawed multi-hop reasoning about evolution). The contextual relevance is moderate because it discusses the right companies and properties, but the core narrative about the evolution is incorrect. The model fails to synthesize information across both years accurately, leading to an incomplete and misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 287,
        "total_tokens": 1458
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, retirement annuity contracts remained classified as Level 3 assets in the fair value hierarchy, indicating that their fair value is based on significant unobservable inputs. In 2022, these contracts had a fair value of $38 million, decreasing to $25 million in 2023 and further to $22 million in 2024. This consistent classification in Level 3 suggests that GD's valuation methodology for these assets relies on internal models or assumptions due to the lack of observable market data, reflecting the illiquid or unique nature of these contracts.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that retirement annuity contracts remained in Level 3 of the fair value hierarchy between 2022 and 2024, which aligns with the ground truth. However, it introduces specific dollar amounts ($38M in 2022, $25M in 2023, $22M in 2024) that are not present in the original answer and cannot be verified from the provided ground truth. These figures may be factually incorrect or at least unsupported by the given information, significantly undermining quantitative accuracy. (2) There are no calculations in the LLM answer, but the inclusion of unverified financial figures without sourcing from the ground truth constitutes a major error. The ground truth does not mention any values for these contracts, so their introduction is unjustified. (3) The reasoning correctly infers that Level 3 classification implies reliance on unobservable inputs and internal models, which is consistent with fair value hierarchy definitions and the original answer. However, the LLM misses the key qualitative point about improved disclosure practices in 2024—specifically, the inclusion of investments valued using NAV as a practical expedient in reconciliation tables, which was not explicitly stated in 2022. This omission represents a failure in multi-hop synthesis, as the evolution in reporting transparency (even without a classification change) is central to the question. (4) The contextual relevance is high because the answer addresses the classification stability and its implication for valuation methodology. However, the fabricated numbers reduce correctness, and the missing disclosure refinement limits qualitative accuracy. The answer captures part of the truth but lacks critical nuance and introduces unsupported data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 481,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly. In 2023, AIG held a 52.2% ownership stake in Corebridge and recognized income from its controlling interest. By June 2024, AIG deconsolidated Corebridge after reducing its ownership to 48.4% and waiving its majority board representation. This deconsolidation led to a $4.8 billion loss, primarily due to the recognition of an accumulated comprehensive loss of $7.2 billion, which was recorded as part of discontinued operations. Post-deconsolidation, AIG accounted for its retained interest using the equity method, and subsequent share sales, including a $3.8 billion transaction with Nippon in December 2024, further reduced AIG's ownership to 22.7%. These actions resulted in income recognition through Net Investment Income, reflecting changes in Corebridge's stock price and dividend receipts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly regarding key dates, ownership percentages, and the nature of AIG's financial relationship with Corebridge. (1) Quantitative inaccuracies: The claim that AIG held a 52.2% stake in 2023 and reduced it to 48.4% by June 2024 is incorrect — the original answer states that the dilution mechanism was terminated due to Corebridge's IPO on September 19, 2022, meaning the relevant ownership changes occurred before 2023. The $4.8 billion loss and $7.2 billion accumulated comprehensive loss are not mentioned in the ground truth and appear fabricated. The December 2024 $3.8 billion transaction with Nippon is also not supported by the original answer. (2) The timeline is fundamentally flawed: the IPO occurred in 2022, not after 2023, so the potential dilution (24.1 million shares in 2022, 4.4 million in 2023) was already moot by 2023. The LLM incorrectly frames deconsolidation as occurring in June 2024, while the ground truth states income recognition under the equity method began on June 9, 2024. (3) While the LLM correctly identifies a shift to the equity method and income recognition via dividends and stock price changes, this is only partially aligned with the truth and lacks the critical context of the terminated exchange right with Blackstone. (4) The reasoning fails on multi-hop synthesis: it invents a deconsolidation event and loss not present in the original, misrepresents the timeline, and omits the core mechanism of potential dilution being eliminated by the 2022 IPO. However, the answer is contextually relevant and attempts to address the evolution of the financial relationship, earning moderate points for structure and relevance despite factual failures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 474,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort decreased slightly from 2022 to 2024. In 2022, Universal Beijing Resort had $3.6 billion of debt outstanding, while in 2024, this amount was reduced to $3.4 billion. Additionally, the assets and liabilities of Universal Beijing Resort included in Comcast's consolidated balance sheets decreased from $7.8 billion and $7.2 billion in 2023 to $7.3 billion and $7.0 billion in 2024, indicating a modest reduction in overall exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeframes. According to the ground truth, the $3.6 billion debt was as of December 31, 2021 (disclosed in 2022), not 'in 2022' as the LLM states. Similarly, the $3.4 billion debt is as of December 31, 2024 (disclosed in 2025, likely in a 2024 annual report), not 'in 2024' as presented. The LLM incorrectly implies debt decreased from 2022 to 2024, but the actual data shows debt increased from $3.5B (Dec 2023) to $3.6B (Dec 2021) to $3.4B (Dec 2024), with a peak in 2023 — not a consistent decline. (2) The LLM invents figures for 2023 assets and liabilities ($7.8B assets, $7.2B liabilities), which are not in the ground truth. The ground truth only provides 2024 consolidation figures ($7.3B assets, $7.0B liabilities) and does not mention prior year consolidated balance sheet amounts. This is a major quantitative error. (3) The reasoning is partially sound in noting consolidation and debt trends, but fails the multi-hop synthesis: it misaligns disclosure years with reporting dates, omits the VIE consolidation status as a key evolution, and misrepresents the debt trajectory. The ground truth notes stabilization after reductions, while the LLM incorrectly frames it as a continuous decrease. (4) Contextual relevance is high — the answer addresses debt levels and consolidation — but correctness is low due to fabricated numbers and temporal misalignment. Quantitative accuracy is severely penalized due to incorrect debt timing and invented balance sheet data. Qualitative accuracy suffers from flawed reasoning, though the general direction (monitoring exposure via debt and consolidation) is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 465,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "Between 2022 and 2023, the structure of aircraft trade-in commitments for Gulfstream customers remained largely consistent in terms of customer eligibility, as customers with aircraft in contract backlog continue to hold options to trade in aircraft as partial consideration for new-aircraft transactions. However, there was a slight shift in risk exposure. In 2023, trade-in commitments that guarantee a predetermined trade-in value (which carry higher risk in adverse market conditions) were noted, but the company indicated that estimated changes in fair market values from the date of the commitments were not material. This suggests that while the potential for risk remained, the actual exposure did not significantly increase in 2023 compared to 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding customer eligibility. The ground truth states that in 2022, trade-in options were available to 'some customers' broadly, but in 2023 they were narrowed to 'some Gulfstream customers,' indicating a restriction in eligibility. However, the LLM claims eligibility 'remained largely consistent' and that 'customers with aircraft in contract backlog continue to hold options,' which contradicts the narrowing of eligibility described in the original answer. This is a major error in qualitative accuracy. (2) There are no numeric values, dates, or calculations in either the ground truth or LLM answer beyond years (2022, 2023), which are correctly referenced. Thus, quantitative accuracy is fully preserved. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies that risk exposure related to guaranteed trade-in values was acknowledged in 2023 and that changes in fair market value were 'not material' in both years. However, it fails to recognize the shift in customer scope as a structural change, instead asserting consistency, which undermines the core of the multi-hop synthesis required. (4) Contextual relevance is high because the answer addresses both customer eligibility and risk exposure as asked, and discusses materiality of fair value changes. However, due to the incorrect characterization of eligibility changes and missed strategic focus on Gulfstream as a concentrated risk, the overall correctness is significantly reduced. The answer captures part of the risk narrative but misrepresents the key structural change in eligibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 451,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Tesla Semi has evolved from being in the planning and development phase to entering pilot production. In 2022, the Semi was listed as a future commercial electric vehicle without specific production details. By 2024, it is noted as being in \"Pilot production\" at the Nevada Gigafactory, indicating progress toward scaling manufacturing. Strategically, the Semi remains a part of Tesla's broader product roadmap, emphasizing commercial electrification and leveraging advancements in battery and powertrain technologies. However, it has not yet reached the same production scale as Tesla's consumer vehicle models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: in 2022, the Tesla Semi was in planning/development; by 2024, it entered 'pilot production' at the Nevada facility. These details match the original answer exactly. (2) There are no numeric values requiring calculation (e.g., dates are correct: 2022 and 2024), and entity names (Tesla, Tesla Semi, Nevada Gigafactory) are accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesized the evolution across time (2022 to 2024) and assessed both production status and strategic positioning. It appropriately notes that while the Semi is advancing, it hasn't reached the scale of consumer models, which adds contextual insight not in the original but is factually reasonable. (4) Semantic equivalence is strong: the LLM conveys the same core progression from concept to pilot production and strategic intent. The only minor point preventing a perfect 10 is that the original emphasizes the strategic shift 'from planning to market entry preparation' more explicitly, while the LLM slightly generalizes the strategic positioning. However, this does not detract from factual correctness. All aspects are relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 346,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "The valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain a full or substantial valuation allowance against the deferred tax assets associated with its investment in Cronos, suggesting the company does not currently expect these assets to be realizable in the foreseeable future.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the valuation allowance increased from $379 million in 2022 to $402 million in 2024, matching the ground truth exactly in both figures and years. These numbers are factually accurate and properly formatted. (2) All numeric values are correct—$379 million in 2022 and $402 million in 2024—and the direction of change (increase) is accurately described. No calculations are required beyond comparison, which is sound. (3) The reasoning is logically sound: the increase in valuation allowance is correctly interpreted as indicating Altria’s continued lack of expectation that deferred tax assets will be realizable in the foreseeable future. The LLM captures the core implication of sustained uncertainty. However, it omits the explicit mention that the 'steady increase' suggests a 'cautious stance' over time, which slightly weakens the qualitative depth compared to the original answer. This is a minor omission, not an error. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the evolution of the allowance and its implication for realizability. The semantic meaning is equivalent to the ground truth, with only slight concision in the explanation of Altria’s strategic posture. Thus, the answer is highly accurate with negligible loss in nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 375,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "Amgen changed the method of accounting for its investment in BeiGene in the first quarter of 2023, switching from the equity method to recording the investment at fair value, with changes in fair value recognized in earnings. In 2023, this change led to gains being recognized in connection with the fair value adjustment of the BeiGene investment. In 2024, the impact of BeiGene on Amgen's financials is reflected in net unrealized losses on strategic equity investments, which contributed to the change in Other income (expense), net, for that year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Amgen changed its accounting method for the BeiGene investment in Q1 2023 from the equity method to fair value, with gains recognized in 2023 due to revaluation. In 2024, the investment resulted in net unrealized losses reported in Other income (expense), net. These points match the original answer exactly. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change in accounting method, its immediate impact (gains in 2023), and the subsequent reversal (losses in 2024), showing an understanding of the evolution over time. (4) The only minor shortcoming is that the LLM does not explicitly state the 'reversal in financial benefit' or characterize the shift as a 'change from gains to losses' in a comparative summary, which slightly reduces qualitative completeness, though the information is implied. Wording differs slightly but maintains semantic equivalence. Overall, the response is factually correct, complete in substance, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 349,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's positioning and market strategy evolved by streamlining its service structure in key international markets. In Latin America, the Company merged Disney+ and Star+ into a single Disney+ product offering by the end of June 2024, simplifying its regional branding and consolidating services to enhance user experience and operational efficiency. Additionally, Disney+ Hotstar remains a standalone service in India and Southeast Asia, emphasizing localized content and branding to cater to regional preferences. These changes reflect a broader strategy to unify and optimize the DTC portfolio while maintaining tailored approaches in critical markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the merger of Disney+ and Star+ in Latin America by the end of June 2024 is accurately stated, and the continued operation of Disney+ Hotstar as a standalone service in India and Southeast Asia is correctly noted. (2) There are no numeric values requiring calculation, but the date 'end of June 2024' matches the ground truth's timeframe. (3) The multi-hop reasoning is sound—correctly synthesizing that while Disney+ Hotstar remains regionally branded in some areas, Disney is consolidating under the Disney+ brand in others (specifically Latin America via the Star+ merger). (4) The LLM slightly omits the explicit mention that Disney+ Hotstar was described as a DTC service offering general entertainment, family, and sports programming in 2023, which adds minor contextual depth. However, this does not detract from the core accuracy. The answer effectively captures the strategic shift toward consolidation while maintaining regional localization. Wording differs but meaning is semantically equivalent. Minor deduction only for slight incompleteness in describing 2023 positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 335,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "Between 2023 and 2024, PayPal's approach to its Protection Programs evolved by increasing its focus on mitigating risk exposure and enhancing loss recovery mechanisms. In 2023, PayPal emphasized that its protection programs were designed to reduce losses for consumers and merchants from fraud and counterparty performance, but it faced challenges in recovering losses from merchants, especially in cases involving fraudulent or insolvent merchants. By 2024, PayPal acknowledged heightened risks related to fraud and abusive behaviors, and noted that evolving fraud schemes and regulatory changes could increase its exposure to losses. Additionally, PayPal highlighted the importance of refining its fraud detection and prevention measures to address new threats, while also seeking to recover transaction losses where possible, though such recoveries may not always be sufficient to offset incurred losses.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the general evolution of PayPal's Protection Programs between 2023 and 2024, noting increased risk exposure due to fraud and regulatory changes, and challenges in loss recovery from merchants. However, it misrepresents the 2023 disclosure by stating that PayPal 'faced challenges in recovering losses from merchants' in that year, while the original answer specifies that in 2023, PayPal did not provide a separate service under these programs and recorded costs in 'transaction and credit losses' without emphasizing recovery challenges at that time—this nuance is missing. The 2024 disclosures are accurately reflected, including heightened risk from fraud schemes and regulatory impacts. (2) There are no numeric values, percentages, or dollar amounts in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes changes in risk and recovery focus across years, but incorrectly projects the loss recovery challenge back into 2023, which undermines the accuracy of the comparison. The original answer shows that the detailed discussion of recovery challenges emerged in 2024, not 2023. (4) The contextual relevance is high as the response directly addresses the question’s focus on risk exposure and loss recovery evolution. The qualitative accuracy is reduced due to the misattribution of 2024-level recovery concerns to 2023, though core themes like fraud risks and regulatory exposure are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 436,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024 through a shift in ownership structure and increased financial exposure. In 2022, NextEra Energy Resources sold a significant portion of ownership interests in solar facilities to third parties and NEP subsidiaries, retaining operational control but reducing direct ownership. By 2024, NextEra Energy Resources consolidated numerous variable interest entities (VIEs) related to solar generation, owning or operating facilities with a total generating capacity of approximately 3,485 MW, with third-party debt secured by the assets. This reflects a strategic move toward maintaining operational and financial control while managing capital exposure through partnerships and structured ownership.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift from direct ownership to structured arrangements with VIEs, which aligns with the ground truth. However, key quantitative details are incorrect or missing. In 2022, the ground truth specifies the sale of a 100% stake in a 100 MW Arizona solar facility and a 90% stake in a portfolio of four solar facilities—these specific transactions and ownership percentages are omitted in the LLM answer. Instead, it vaguely states 'sold a significant portion of ownership interests' without citing the exact deals. (2) The 2024 capacity figure in the LLM answer—3,485 MW—is materially incorrect. The ground truth states that NextEra consolidated eight VIEs with approximately 765 MW of solar capacity, not 3,485 MW. This large discrepancy suggests either a data error or conflation with another portfolio (possibly wind or total renewable capacity). Additionally, the LLM introduces 'third-party debt secured by the assets' without grounding it in the original answer, which mentions guarantees and credit support but not secured debt. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic evolution from divestiture to VIE consolidation. However, it fails to accurately synthesize the specific transactions and their financial implications (e.g., gains on sale, cash proceeds) and misrepresents the scale of exposure. The shift from outright ownership to equity stakes and VIEs is conceptually correct, but the lack of precise entity-level detail (e.g., NEP subsidiaries are mentioned but not tied to specific transactions) weakens the accuracy. (4) The contextual relevance is high—the answer addresses ownership structure and financial exposure over the 2022–2024 period. However, due to significant quantitative inaccuracies and incomplete factual support, the correctness score is limited to 5. The qualitative accuracy is moderate because the reasoning direction is correct, but the quantitative accuracy is low due to the incorrect MW figures and missing percentages.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 554,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "ACN's investment in Mutual Fund Debt Securities increased from $379,989 as of August 31, 2022, to $379,989 as of August 31, 2023, showing no change in the amount invested. However, the valuation methodology changed as these securities were classified under Level 2 in 2022, relying on quoted prices for similar instruments in active markets or model-derived valuations with observable inputs. By 2023, the fair value hierarchy information was not explicitly provided for Mutual Fund Debt Securities, but the overall context suggests continued use of Level 2 inputs, with no indication of a shift to Level 3.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the investment amount remained unchanged at $379,989 in both years. According to the ground truth, the investment decreased from $379,989 in 2022 to $253,025 in 2023 — a significant reduction that the LLM completely missed. This error undermines the core of the response. (2) Quantitatively, the 2022 figure is correct, but the 2023 value is wrong, and the claim of 'no change' is false. The correct change is a decrease of $126,964. The LLM also incorrectly states that the 2023 fair value hierarchy level was not explicitly provided, while the ground truth confirms it remained entirely under Level 2, with no change in methodology. (3) The multi-hop reasoning failed: the model should have compared two data points (2022 vs 2023 values and hierarchy levels) across time, but instead asserted no change in value and uncertainty in methodology where there was none. It did not correctly synthesize the evolution of the investment. (4) Despite addressing the right entities (ACN, Mutual Fund Debt Securities, Level 2) and framing the discussion around valuation changes, the answer is fundamentally flawed due to incorrect numbers and misrepresentation of methodology changes. The contextual relevance is moderate because it discusses the right concepts but draws wrong conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 376,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron's financial stake in Tengizchevroil (TCO) increased slightly between 2022 and 2023. As of December 31, 2023, Chevron's carrying value of its investment in TCO was $26,954 million, compared to $26,534 million as of December 31, 2022. Additionally, Chevron's equity in earnings from TCO rose to $3,375 million in 2023 from $4,386 million in 2022. The difference between the carrying value and underlying equity in TCO's net assets remained relatively stable, at about $80 million in 2023 compared to $100 million in 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Chevron's carrying value in 2022 was $23,727 million, not $26,534 million as stated by the LLM. The 2023 carrying value is reported as 'approximately $80 million higher than its underlying equity' but no total carrying value is given in the original answer—certainly not $26,954 million. The LLM's claim of a $26.95B carrying value in 2023 is unsupported and incorrect. Additionally, the LLM states equity in earnings decreased from $4,386M in 2022 to $3,375M in 2023, which directly contradicts the ground truth stating $1,238M in 2022. These numbers are entirely fabricated. (2) The only partially correct element is the mention of an $80 million difference between carrying value and underlying equity in 2023, which aligns with the original answer. However, the LLM incorrectly adds a comparable $100M figure for 2022, which is not present in the ground truth. (3) The multi-hop reasoning is flawed: the LLM fails to mention the critical new $4,500 million loan Chevron provided in 2023 to fund the FGP/WPMP projects—a key indicator of deepened financial involvement. This omission severely undermines the qualitative assessment of Chevron's evolving role. Instead, the LLM invents financial figures and trends that contradict the source. (4) The contextual relevance is moderate because the answer addresses the general topic of Chevron's stake in Tengizchevroil over time, but due to pervasive numerical errors and missing key strategic developments (like the loan), the overall correctness score is very low. Quantitative accuracy is poor due to completely incorrect financial figures. Qualitative accuracy is low because the reasoning and synthesis are based on false data. Contextual relevance is acceptable only in topic selection, not in accurate portrayal of evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 510,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Between 2023 and 2024, Disney's relationship with the ABC Network has evolved to become more strategically integrated within Disney's broader entertainment ecosystem. ABC continues to serve as a key platform for Disney's primetime, news, and sports programming, with ESPN programming the sports daypart on ABC (branded as ESPN on ABC). Additionally, ABC's content is distributed to nearly all U.S. television households through its affiliated stations and owned stations, reinforcing its role in Disney's linear network strategy. The integration is further enhanced by ABC's alignment with Disney's Direct-to-Consumer platforms, such as Disney+ and Hulu, which stream ABC content, thereby strengthening cross-platform viewer engagement and monetization.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in describing ABC Network's continued role in Disney's linear and direct-to-consumer strategy, with accurate entity identification (ABC, Disney+, Hulu, ESPN on ABC) and no incorrect numeric values (no specific numbers were cited, so no inaccuracies). The answer correctly notes ABC's integration with Disney's DTC platforms and its role in primetime, news, and sports programming. However, it omits key strategic shifts emphasized in the ground truth: specifically, the 2024 change where ABC content is made available on Hulu one day after linear airing, which marks a concrete step in the shift from linear to digital distribution. Additionally, the ground truth highlights a change in emphasis from affiliate fees (2023) to streaming contribution (2024), which the LLM answer does not mention. While the LLM captures the general trend of integration, it lacks the specific year-over-year evolution in strategic positioning, particularly the reduced focus on linear revenue and increased prioritization of streaming. This missing nuance prevents a higher score on qualitative accuracy and overall correctness. Contextual relevance is high as the response stays focused on ABC's strategic role within Disney's ecosystem.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 349,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics' Combat Systems segment increased its revenue share from 18% to 20% of consolidated revenue, with military vehicle revenue rising from $4,581 million in 2022 to $5,036 million in 2023. This growth indicates a heightened focus on land systems, including the ASCOD vehicle, which is part of ELS's broader portfolio of tracked combat vehicles. The ASCOD's continued inclusion in production and modernization efforts for international clients, alongside increased investment in next-generation capabilities and upgrades, suggests a strategic shift toward expanding General Dynamics' global land combat solutions and strengthening its position in international defense markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer focuses on a shift in language from 'producing and upgrading' ASCOD in 2022 to merely 'offering' it in 2023, indicating a potential reduction in investment. The LLM instead claims increased revenue, production, and investment in ASCOD, which contradicts the ground truth. (2) The quantitative data provided—such as Combat Systems revenue rising from $4,581M to $5,036M and its share increasing from 18% to 20%—are not present in the original answer and cannot be verified against the ground truth. These figures may be fabricated or misattributed, as the original answer contains no financial data about revenue or percentages. (3) The multi-hop reasoning is flawed: the question asks about the evolution of ASCOD's positioning within the portfolio, not overall segment performance. The LLM incorrectly infers that overall growth in military vehicle revenue implies increased focus on ASCOD, while the ground truth suggests a de-emphasis. It fails to recognize that the removal of 'producing and upgrading' in 2023 is a meaningful signal of reduced activity. Additionally, the LLM does not mention the comparative emphasis on Piranha 5 and AJAX, which are key to the correct inference about shifting investment. (4) The contextual relevance is moderate because the answer discusses General Dynamics' land systems and mentions ASCOD, but it misrepresents the core insight about strategic positioning. Due to major factual inaccuracies, incorrect use of numbers, and flawed reasoning, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 445,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities decreased between 2023 and 2024, with the approved amount designated for credit activities dropping from $3.0 billion as of December 31, 2023, to $2.0 billion as of December 31, 2024. This reduction indicates a shift in the company's credit funding strategy, potentially reflecting a more conservative approach to leveraging European customer balances or a strategic reallocation of funds to other credit funding sources.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in PayPal's utilization of European customer balances for credit activities, with accurate dollar amounts ($3.0 billion in 2023 and $2.0 billion in 2024) and correct dates (December 31, 2023, and December 31, 2024). These figures match the ground truth exactly. However, the LLM omits the percentage context provided in the original answer—39% in 2023 and 26% in 2024—which is important for understanding the relative scale of the change. (2) All numeric values are correct, and no calculations are required beyond the stated figures, so quantitative accuracy is high. The format is consistent and acceptable. (3) The reasoning correctly infers a strategic shift in credit funding, which aligns with the ground truth. However, the LLM answer lacks the critical supporting evidence from the multi-hop data: PayPal’s increased sale of consumer installment receivables ($20.8 billion in 2024 vs. $5.5 billion in 2023), which directly supports the conclusion about a move toward external financing. This omission weakens the qualitative accuracy and completeness of the reasoning. (4) The answer is contextually relevant and addresses the evolution and strategic implication, but the absence of key evidence from another part of the knowledge graph (the receivables sales) makes the explanation less robust. While the conclusion is directionally correct, it lacks full multi-hop synthesis, justifying a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 417,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, the valuation and categorization of equity securities within NEE's Special Use Funds evolved in terms of both composition and transparency. In 2022, equity securities were primarily categorized under Level 1 and Level 2, with no Level 3 allocations, indicating a high degree of market observability. By 2024, equity securities were still largely in Level 1 and Level 2, but there was a notable increase in Level 3 allocations, particularly for NEE and FPL, suggesting a shift toward less observable inputs for certain equity valuations. This evolution indicates a potential decrease in transparency for a portion of the equity securities held in these funds, likely due to increased complexity or market illiquidity in some investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. It claims that in 2022, equity securities were categorized under Level 1 and Level 2 with no Level 3 allocations, but the ground truth states that in 2022, there was no detailed categorization by valuation levels at all—levels were not disclosed. This is a critical factual error. The LLM also incorrectly states that by 2024 there was a notable increase in Level 3 allocations, suggesting decreased transparency. In reality, the 2024 disclosures included Level 1, 2, and 3 valuations, but the reported amounts are specifically $2,614 million in Level 1 for NEE and $1,028 million in Level 1 for FPL—there is no indication in the ground truth that Level 3 allocations increased or that transparency decreased. On the contrary, the introduction of full Level 1-3 disclosures represents increased transparency. (2) The dollar amounts are completely missing or incorrect in the LLM answer: it fails to mention the 2022 carrying amounts ($906M for NEE, $672M for FPL) and the 2024 Level 1 amounts ($2,614M NEE, $1,028M FPL). No correct numbers are cited. (3) The multi-hop reasoning is flawed: the model incorrectly infers a decline in transparency due to 'increased Level 3 allocations,' which is unsupported by the data. The actual evolution shows greater transparency due to more granular reporting, not less. The LLM misinterprets the introduction of detailed disclosures as a sign of opacity, when it is the opposite. (4) The contextual relevance is moderate because the answer addresses the question's structure (evolution over time, transparency, composition), but the factual foundation is wrong, leading to an incorrect conclusion. Hence, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher due to correct framing of the topic, but reasoning is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 512,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Accenture's share purchase program saw a significant increase in total shares acquired under the public program, with $6,456.6 million in total consideration for fiscal 2023 compared to $2,482.1 million in fiscal 2022. In fiscal 2022, 1,964,612 shares were purchased under the public program, while in fiscal 2023, the number of shares acquired under the public program was not explicitly stated but implied to be higher given the increased total consideration. Employee-related transactions, such as share withholding for payroll tax obligations, remained a smaller component, with 97,251 shares acquired in fiscal 2022 under such transactions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Accenture spent $576 million to purchase 1,964,612 shares under the public program in fiscal 2022, and there was no mention of any public program activity in fiscal 2023. However, the LLM claims that total consideration under the public program increased to $6,456.6 million in fiscal 2023 from $2,482.1 million in fiscal 2022—both figures are completely incorrect and not supported by the original answer. The LLM also falsely implies increased activity in the public program, when in fact it likely decreased or halted. (2) The only correct numbers are the 1,964,612 shares purchased in fiscal 2022 under the public program and the 97,251 shares acquired via employee-related transactions in fiscal 2022. However, the LLM incorrectly presents these employee-related transactions as occurring only in 2022, while the ground truth indicates they continued in 2023. (3) The multi-hop reasoning is flawed: the question asks for a comparison of scope and utilization across two years, particularly public vs. employee-related transactions. The LLM fails to recognize that the public program had no reported activity in 2023 and incorrectly infers higher purchases based on fabricated figures. It also misses the key insight of a shift or reduction in public program activity. (4) The contextual relevance is moderate because the answer addresses share purchase programs and distinguishes between public and employee-related transactions, but the severe factual and quantitative errors undermine correctness. The qualitative reasoning is weak due to incorrect synthesis and unsupported implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 462,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC (CPChem) remained consistent between 2022 and 2023. In both years, CPChem was accounted for using the equity method, as Chevron held a 50% equity ownership interest. CPChem was not consolidated into Chevron's financial statements, and its summarized financial data was disclosed separately in the footnotes of Chevron's consolidated financial statements.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) It claims Chevron's reporting relationship with Chevron Phillips Chemical Company LLC (CPChem) remained consistent between 2022 and 2023, stating CPChem was accounted for using the equity method in both years and not consolidated. However, the ground truth states that in 2022, CPChem *was* consolidated into Chevron’s financial statements, as evidenced by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among consolidated subsidiaries. The shift to equity method accounting occurred in 2023, when Chevron explicitly stated it no longer consolidated CPChem. (2) There are no numeric values in the response to verify for quantitative accuracy, but the core financial reporting treatment (consolidation vs. equity method) is a critical accounting fact that is completely reversed. (3) The multi-hop reasoning fails entirely: the model should have identified the change in consolidation status by comparing the accounting treatment across the two years in the respective 10-K filings, but instead asserts continuity where there was a significant change. (4) Contextual relevance is low because the answer addresses the right entity and topic, but with the opposite and incorrect conclusion. The model misunderstands the evolution of the relationship, which is the central point of the question. Thus, the correctness score is 1 due to major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 410,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "From 2022 to 2023, the role of Hydra-70 rockets in General Dynamics' Combat Systems segment remained significant, particularly in terms of production capacity expansion. In 2023, OTS received awards to expand its Hydra-70 rocket production capacity as part of broader efforts to increase metal parts production, propellant capacity, and 155mm artillery capabilities, supporting the U.S. Army's modernization goals. While specific contract awards for Hydra-70 rockets in 2023 are not detailed, the 2022 award of $175 million for Hydra-70 rocket production highlights continued investment in this munitions program.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $175 million 2022 contract for Hydra-70 rocket production and notes the expansion of production capacity in 2023 under OTS, which aligns with the ground truth. However, it omits the specific quantitative detail that metal parts production capacity is increasing from 18,000 to 86,000 rounds per month by 2025—a key factual element in the original answer. This omission affects completeness and precision. (2) The $175 million figure is accurately reported, and the years (2022, 2023) are correct. But the absence of the 18,000 to 86,000 rounds per month expansion metric represents a significant missing quantitative claim. The LLM vaguely references 'expansion' without providing the concrete numbers, reducing quantitative accuracy. (3) The reasoning is generally sound: it connects OTS’s role in Combat Systems, acknowledges continued investment, and links capacity expansion to U.S. Army modernization. However, it fails to explicitly tie the production capacity increase to Hydra-70 rockets as part of the broader munitions portfolio, weakening the multi-hop synthesis between OTS, capacity awards, and Hydra-70 specifically. (4) The answer remains contextually relevant and captures the evolution in broad terms—contract continuity and capacity growth—but lacks the specificity needed for full factual equivalence. Hence, correctness is reduced to 7 due to missing key data points despite overall accurate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 407,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) is listed as incorporated by reference from the 10-12B/A filed on May 14, 2015, with no indication of recent amendments. In the 2024 filing, the same exhibit remains incorporated by reference from the same 10-12B/A, but a new related exhibit, 10.08+, is included, indicating an amended and restated version of the Global Performance Based Restricted Stock Unit Award Grant Notice and Agreement, filed on April 30, 2024. This suggests an update to the performance-based component of the RSU awards in 2024, while the standard RSU grant documentation remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2023 filing lists the Global Restricted Stock Unit Award Grant Notice as Exhibit 10.07+, incorporated by reference from the 10-12B/A on May 14, 2015, under the 2015 Equity Incentive Plan. In 2024, this base exhibit remains unchanged, while a new Exhibit 10.08+ (Global Performance Based RSU Award Notice) is introduced, filed on April 30, 2024, under the amended and restated plan. (2) Quantitative accuracy is perfect: dates (May 14, 2015, and April 30, 2024), exhibit numbers (10.07+, 10.08+), and filing types (10-12B/A, 10-Q) are all correct. (3) Multi-hop reasoning is sound—LLM correctly synthesizes across years, exhibits, and plan versions, noting that the standard RSU notice is static while the performance-based variant was updated. (4) The only minor omission is that the 2024 performance-based exhibit is linked to a 10-Q filing, which the LLM mentions implicitly by citing the April 30, 2024 date but does not explicitly name as a 10-Q. This does not detract significantly from accuracy. Wording differs slightly but maintains semantic equivalence. The answer fully addresses the question on documentation status and associated agreements across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 357,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within Bristol-Myers Squibb's portfolio has evolved both in terms of revenue performance and regulatory approvals. Revenue from Opdivo remained relatively stable, with $7,523 million in 2021 and consistent figures in subsequent years. However, its strategic importance has grown due to multiple new regulatory approvals in 2024, including FDA approval for Opdivo Qvantig (a subcutaneous formulation) and approvals in combination therapies for various cancers, strengthening its position in oncology. These developments highlight Opdivo's continued central role in BMS's commercial and therapeutic strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies but captures the general trend of Opdivo's stable revenue and growing strategic importance. However, it incorrectly states that the $7,523 million revenue was from 2021 instead of 2022 as per the ground truth, which affects quantitative accuracy. The answer claims 'consistent figures in subsequent years' but provides no 2024 revenue data, which is a partial omission since the ground truth also does not report a significant increase—so the stability claim is directionally correct but misattributed in time. (2) The key error is the misstatement of the year for the $7.5B revenue figure (2021 vs. 2022), which is a factual deviation. Additionally, the LLM introduces 'Opdivo Qvantig' and a 'subcutaneous formulation' approval, which are not mentioned in the ground truth. While BMS did receive FDA approval for a subcutaneous version of Opdivo in 2024, the ground truth specifically cites the approval for use in combination with cisplatin and gemcitabine for urothelial carcinoma. The LLM invents or conflates details not supported by the provided truth. (3) The multi-hop reasoning is partially sound—linking revenue performance and regulatory developments to assess portfolio evolution—but the synthesis relies on incorrect or unverified approvals. The core logic of 'stable revenue + new approvals = continued strategic importance' aligns with the ground truth, so qualitative reasoning is reasonable but based on flawed inputs. (4) Correctness is scored 6 because the central theme (Opdivo remains important due to stable sales and new indications) is correct, but key facts—especially the year of the revenue figure and the specific 2024 approval—are inaccurate. Quantitative accuracy is 5 due to the wrong year and unsupported claims about consistency without data. Qualitative accuracy is 7 because the reasoning structure is sound despite factual errors. Contextual relevance is 9 as the answer directly addresses the question's scope and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 543,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Between 2022 and 2023, Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC (CPChem) showed notable developments. In 2022, Chevron's investment in CPChem included a $387 loan to fund a portion of the Golden Triangle Polymers Project in Texas, where CPChem owns a 51% interest. By 2023, Chevron's equity earnings from CPChem increased to $608 million from $867 million in 2022, indicating a shift in performance. Additionally, Chevron's total investment in CPChem rose to $7,765 million in 2023 from $6,843 million in 2022, reflecting continued strategic financial support and project funding for CPChem's expansion and operational initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Chevron provided a $387 million loan to CPChem in 2022, while the ground truth specifies this loan occurred in 2023. Additionally, the LLM claims equity earnings decreased from $867 million in 2022 to $608 million in 2023, which contradicts the original answer and implies a performance decline, whereas the ground truth does not mention earnings at all. The increase in total investment from $6,843 million to $7,765 million is fabricated and not supported by the original answer. (2) Quantitative errors include misplacement of the $387 million loan (wrong year), incorrect earnings figures, and invented investment totals. These numbers do not align with the ground truth, which only mentions the $387 million loan in 2023 and no earnings or total investment figures. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolution of support from general project announcements in 2022 (e.g., 1-hexene unit, C3 splitter) to direct financial intervention in 2023 (the loan). Instead, it fabricates financial metrics and misattributes timing, breaking the causal and chronological logic. (4) Contextual relevance is moderate because the answer addresses Chevron’s involvement with CPChem and mentions real projects like the Golden Triangle Polymers Project, but the core financial and strategic evolution is misrepresented. Due to major factual and temporal errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 420,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, PayPal's protection programs saw an increase in financial commitments, as reflected in the allowance for transaction losses, which rose from $64 million at the end of 2023 to $86 million at the end of 2024. The allowance for negative customer balances also increased from $218 million to $256 million during the same period. The provision for transaction losses was $1,114 million in 2024 compared to $1,192 million in 2023, while realized losses decreased from $1,313 million to $1,218 million, indicating a slight improvement in loss management.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in the allowance for transaction losses from $64 million in 2023 to $86 million in 2024 and the rise in allowance for negative customer balances from $218 million to $256 million, which aligns with the ground truth. However, it introduces two figures not present in the original answer — the provision for transaction losses ($1,114M in 2024 vs $1,192M in 2023) and realized losses ($1,313M to $1,218M) — which were not disclosed in the ground truth and cannot be verified. These additions introduce factual inaccuracies or hallucinations. (2) The core dollar amounts for allowances are accurate and correctly compared year-over-year, but the inclusion of unverified provisions and losses reduces quantitative accuracy. The direction of change (decrease in provision, decrease in realized losses) may be plausible but is unsupported by the source. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the evolution of financial commitments using year-over-year allowance changes. However, the addition of non-grounded metrics weakens the reasoning chain and suggests overextrapolation. (4) Despite the hallucinated figures, the main thrust — increased allowances indicating higher financial commitments — matches the original answer’s conclusion. Hence, the answer is mostly correct but compromised by unsupported data, warranting a 7 for correctness. Quantitative accuracy is penalized more heavily (6) due to the introduction of incorrect specific figures. Qualitative reasoning and relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 439,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's has reinforced franchising as the cornerstone of its business model, emphasizing its role as a franchisor and the mutual benefits of this structure. In 2024, the company highlighted that franchising enables individuals to be their own employers while leveraging the strength of the McDonald's brand, and it underscored the importance of franchisee co-investment in driving restaurant performance and brand value. This reflects a more collaborative framing of the franchisee relationship compared to 2022, where the focus was more on the operational and financial mechanics of franchising.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's strategic framing between 2022 and 2024. It correctly identifies the shift from a more operational/structural description in 2022 to a strategic, value-laden emphasis on franchising as central to the business model in 2024. The mention of franchisee co-investment driving restaurant performance and brand value aligns with the ground truth's point about co-investment enabling high performance. The characterization of the 2022 framing as focused on 'operational and financial mechanics' is semantically equivalent to the original answer's 'neutral, structural terms' and 'division of responsibilities.' The 2024 emphasis on franchising being 'paramount' is well captured through phrases like 'cornerstone' and 'reinforced franchising as the cornerstone.' The only minor gap is that the LLM does not explicitly use the term 'food quality' or 'customer experience' as outcomes tied to franchising in 2024, which were present in the original answer. However, 'brand value' and 'restaurant performance' serve as reasonable proxies. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. The reasoning is sound, multi-hop synthesis across years is correct, and all entities (McDonald's, franchisees, 2022, 2024) are accurate. The answer is fully contextually relevant and directly addresses the question's focus on strategic framing and co-investment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 403,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "Between 2022 and 2023, the FDA's authorization of Marlboro HeatSticks advanced with the approval of three new tobacco-flavored varieties in January 2023, indicating progress in Altria's regulatory efforts for heated tobacco products. However, the products remained subject to the FDA's graphic health warnings and post-market surveillance requirements. This reflects Altria's ongoing engagement with the FDA to navigate regulatory pathways for innovative tobacco products, although continued compliance and potential enforcement actions remain critical challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key event—the FDA's authorization of three new tobacco-flavored Marlboro HeatSticks in January 2023—which aligns with the ground truth. It accurately reflects the progression from 2022, when no authorization had occurred and the FDA was evaluating the products case-by-case, particularly regarding graphic health warnings. The answer correctly notes ongoing regulatory requirements like post-market surveillance, which adds context not explicitly in the ground truth but is factually accurate and reasonable. (2) Quantitatively, the answer correctly states the January 2023 authorization of three varieties, matching the ground truth. No calculations are involved, but the date and count are precise and correctly formatted. (3) The multi-hop reasoning is sound: the model synthesizes the regulatory status change across 2022 and 2023 and infers that this represents progress for Altria, which is consistent with the ground truth’s interpretation. The only minor shortcoming is that the LLM does not explicitly mention that in 2022 the FDA was considering graphic health warnings on a case-by-case basis—a detail present in the original answer—though it does reference the health warnings, implying awareness. (4) The answer is contextually relevant, directly addressing both parts of the question: the evolution of FDA authorization and what it indicates about Altria’s regulatory progress. The slight deduction in qualitative accuracy is due to the omission of the specific 2022 evaluation status, but the overall reasoning and factual content remain highly accurate and well-aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 455,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The valuation of mutual fund equity securities held by ACN in its non-U.S. pension plans increased from $273,541 as of August 31, 2021, to $239,293 as of August 31, 2022. This decline indicates a reduction in the value of these securities, likely due to market conditions or investment reallocations. The shift suggests a more conservative investment positioning in this category, aligning with the company's broader strategy to manage risk and match asset durations with liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the valuation increased from $273,541 million in 2021 to $239,293 million in 2022, which contradicts the ground truth showing $239,293 million in 2022 with no data provided for 2021. More critically, the LLM fails to report the 2023 figure of $196,226 million, which is central to the question about the evolution between 2022 and 2023. The reported decrease of $43,067 million (from 239,293 to 196,226) is entirely missing from the LLM response. (2) The numbers cited are incorrect: the LLM references 2021 and 2022 values but mischaracterizes the trend as an increase when it should be discussing a decrease from 2022 to 2023. The $273,541 figure appears to be from a different context (possibly a different year or fund category) and is not supported by the ground truth. (3) The multi-hop reasoning is flawed — the question requires comparing ACN's mutual fund equity securities between 2022 and 2023; the LLM instead discusses 2021 to 2022 and omits 2023 entirely, failing the core requirement. It also introduces 'non-U.S. pension plans' not mentioned in the original answer, adding unsupported context. (4) While the general idea of a decline possibly indicating conservative positioning aligns thematically with the ground truth’s 'strategic shift', the conclusion is based on wrong data and timeframes. Due to major quantitative errors, omission of key data (2023), and incorrect temporal comparison, the correctness score is low at 2. Quantitative accuracy is severely compromised (score 2), qualitative reasoning is partially logical but based on false premises (score 3), and contextual relevance is moderate since it discusses the right company and general topic but wrong years and figures (score 4).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 492,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "Chevron's involvement in Angola LNG Limited remained consistent from 2022 to 2023, with the company maintaining a 36.4 percent interest in the entity, which operates an onshore natural gas liquefaction plant in Soyo, Angola. In both years, the focus was on supplying the plant with natural gas, sourced from multiple fields, including efforts to develop non-associated gas in offshore Angola to support the Angola LNG plant. There is no indication of significant changes in operational focus or investment emphasis during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron maintained a 36.4% interest in Angola LNG Limited from 2022 to 2023, which matches the ground truth. The operational description about processing natural gas from multiple fields and developing non-associated gas is factually accurate for 2022. However, the LLM fails to capture the key shift in disclosure emphasis in 2023 as noted in the original answer — that Chevron's reporting shifted from operational development to highlighting Angola LNG Limited as part of its broader portfolio of equity affiliates like Tengizchevroil and Chevron Phillips Chemical. This change in narrative focus is a critical qualitative difference that the LLM overlooks. (2) All numeric values (36.4%) and locations (Soyo, Angola) are correct; no calculations were required. (3) The multi-hop reasoning is partially sound — the model correctly identifies continuity in ownership and operational activities but misses the shift in disclosure strategy, which requires synthesizing how Chevron presented Angola LNG in its 2023 reporting versus 2022. This represents a failure in deeper contextual interpretation across years. (4) While factually accurate on surface-level details, the LLM provides an incomplete picture by not acknowledging the change in emphasis, leading to a correctness score of 5. Quantitative accuracy is perfect (10), but qualitative accuracy is reduced due to missing synthesis (5). Contextual relevance is high as the answer addresses the core topic, but lacks the nuanced evolution requested (8).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 429,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "MMM's investment in Certificates of Deposit/Time Deposits increased from $21 million in 2022 to $49 million in 2023, representing a change of $28 million. This indicates a significant rise in MMM's holdings in these types of marketable securities over the one-year period.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2022 value: it states $21 million instead of the correct $14 million from the ground truth. The 2023 value is correct at $49 million. The calculated change of $28 million is therefore incorrect; the true increase is $35 million (from $14M to $49M), which corresponds to a 250% increase, not addressed in the LLM response. (2) Quantitative accuracy is compromised due to the wrong baseline value and resulting miscalculation of the dollar change. While $49 million in 2023 is accurate, the $21 million figure for 2022 is unsupported by the ground truth and leads to an incorrect delta. Percentage change or magnitude is not fully or correctly conveyed. (3) The reasoning is partially sound—MMMs investment did increase significantly, and the direction of change (increase) is correctly identified. However, the failure to report the correct starting value undermines the multi-hop synthesis required to compute the accurate magnitude of change. (4) Despite the numerical inaccuracies, the answer is contextually relevant and addresses both parts of the question—evolution over time and magnitude of change—albeit with incorrect data. The qualitative reasoning structure is logical and uses appropriate financial terminology. Scores reflect partial correctness with major quantitative flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 379,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "Between 2021 and 2024, the percentage of franchised restaurants in McDonald's system increased from 93% to 95%. In 2021, 37,295 out of 40,031 total restaurants were franchised, while in 2024, 41,303 out of 43,477 total restaurants were franchised. This reflects McDonald's continued emphasis on and growth of its franchising model.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages (93% in 2021 and 95% in 2024) are accurate and supported by the provided absolute numbers: in 2021, 37,295 franchised out of 40,031 total restaurants equals approximately 93.17%, which rounds to 93%; in 2024, 41,303 out of 43,477 equals approximately 94.99%, which rounds to 95%. These calculations are correct. (2) The answer is complete, addressing the evolution of McDonald's relationship with franchisees through the lens of franchised restaurant percentages over the specified time period (2021–2024). (3) Entity accuracy is perfect: McDonald's is the correct company, and the years and metric (percentage of franchised restaurants) are correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—comparing two time points using absolute and relative figures to illustrate a strategic trend. (5) The semantic meaning fully aligns with the original answer, conveying the same conclusion: a slight but deliberate increase in franchised restaurants, reinforcing McDonald's strategic focus on franchising. Minor additional detail (absolute restaurant counts) enhances completeness without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 349,
        "total_tokens": 1510
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective March 31, 2021, as noted in the 2022 filing. Between 2022 and 2023, it was further amended and restated effective October 26, 2022, as detailed in the 2023 filing. These changes reflect updates to the structure of the plan during this period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reports the two effective dates: 'March 31, 2021' (as referenced in the 2022 filing) and 'October 26, 2022' (as updated in the 2023 filing), with no date or number errors. (2) Quantitative accuracy is perfect—both dates are correctly stated and reflect the evolution of the plan’s effective dates between 2022 and 2023. (3) The reasoning is sound: the answer correctly infers from the filings that the plan was amended again during the 2022–2023 period, indicating structural updates, which aligns with the multi-hop requirement to compare plan descriptions across two years. (4) The answer is contextually relevant, directly addressing how the effective date and structure evolved, and uses semantically equivalent phrasing to the original answer. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 261,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Between fiscal years 2022 and 2023, Accenture's financial relationship with Duck Creek Technologies evolved in terms of investment valuation and reported financial impact as follows: In fiscal 2023, Accenture recorded a $253 million investment gain related to its investment in Duck Creek Technologies, which was excluded from adjusted earnings per share. By August 31, 2022, the carrying amount of Accenture's equity method investment in Duck Creek was $138,902, with an estimated fair value of $223,166 for its approximately 16% ownership stake.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts: the $253 million gain in fiscal 2023, the $138,902 carrying amount, $223,166 fair value (approximately 16% ownership) as of August 31, 2022. These match the ground truth exactly in value and context. (2) Quantitative accuracy is perfect—numbers, ownership percentage, and fiscal timing are correct. The $253 million gain is accurately attributed to fiscal 2023, and the 2022 carrying and fair values are correctly stated. (3) The reasoning is largely sound and captures the evolution from a long-term equity investment (equity method accounting) to a financial realization event (gain recognition). However, the LLM states the gain was 'excluded from adjusted earnings per share,' while the original answer notes it was 'specifically called out... as impacting the adjusted earnings per share and effective tax rate.' This is a subtle but important distinction—the gain was adjusted *for* in calculating adjusted EPS, not merely excluded. The LLM slightly mischaracterizes the financial impact nuance. (4) Despite this minor qualitative inaccuracy in financial reporting terminology, the answer is factually complete, contextually relevant, and correctly synthesizes multi-hop information across fiscal years and accounting treatments. The core evolution of the relationship is accurately conveyed, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 393,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, Breyanzi's therapeutic application expanded significantly, particularly in the treatment of B-cell malignancies. In 2024, two key new indications were approved: (1) the FDA approved Breyanzi for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) who have received at least two prior lines of systemic therapy, including a Bruton tyrosine kinase inhibitor, and (2) the FDA granted accelerated approval for Breyanzi for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor. These approvals significantly broaden Breyanzi's market potential by addressing additional high-unmet-need patient populations.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the specific new indications approved for Breyanzi in 2024. According to the ground truth, Breyanzi received two approvals in 2024: one in March for relapsed or refractory CLL/SLL (correctly mentioned in part by the LLM), and another in May for follicular lymphoma (FL). However, the LLM incorrectly states that Breyanzi was approved for mantle cell lymphoma (MCL), which is not supported by the original answer. Additionally, the LLM adds specific requirements for prior therapies involving Bruton tyrosine kinase inhibitors and BCL-2 inhibitors, which are not mentioned in the ground truth and thus introduce unsupported detail. (2) The dates (March and May 2024) are not explicitly mentioned in the LLM answer, but the year 2024 is correctly referenced. No numerical values (e.g., patient counts, financials) are present, so quantitative accuracy is assessed on correctness of approval details and timing—partial credit due to one correct indication (CLL/SLL) and one incorrect (MCL). (3) The multi-hop reasoning is partially sound in that the model recognizes expansion of indications in 2024 and links it to increased market potential, but fails in accurately synthesizing the correct disease indications from the knowledge base. The inclusion of MCL and omission of FL represent critical errors in entity and factual recall. (4) Contextual relevance is high because the answer addresses the evolution of therapeutic use and market expansion, and correctly identifies CLL/SLL as a new indication. However, the introduction of an incorrect indication (MCL) and unverified treatment prerequisites undermines factual correctness, leading to a moderate score overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 476,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "Between 2022 and 2023, 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 remained consistent in its methodology but reflected updated assessments of respirator mask/asbestos liabilities. In 2023, 3M increased its accruals for these liabilities by $57 million, bringing the total accrual to $574 million as of December 31, 2023. However, the insurance receivables related to these matters were described as \"immaterial\" in 2023, indicating a reduction in expected recoveries compared to prior periods. This suggests that 3M has likely collected substantially all of its remaining insurance coverage for respirator mask/asbestos claims, aligning with its ongoing efforts to resolve coverage disputes with insolvent and other insurers.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to accurately reflect the evolution in 3M's accounting approach to insurance receivables under ASC 450 between 2022 and 2023. (1) The original answer states that in 2022, 3M did not specify its methodology for estimating insurance receivables, but in 2023 it explicitly adopted the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30, incorporating analysis of policy terms, case law, and claim nature. The LLM answer incorrectly claims the methodology remained 'consistent,' which contradicts the ground truth. (2) The LLM introduces specific dollar figures—$57 million increase and $574 million total accrual in 2023—which are not present in the original answer and cannot be verified against the provided ground truth; these numbers are therefore factually unsupported. (3) The claim that insurance receivables were 'immaterial' in 2023 and that 3M has 'likely collected substantially all' of its insurance recoveries is speculative and not mentioned in the original answer. (4) While the LLM correctly identifies the context of respirator mask/asbestos litigation, it fails the multi-hop reasoning requirement: it does not connect the increase in claimants (from 4,028 to 4,042) to the more detailed disclosure in 2023, nor does it accurately describe the evolution in accounting policy. The contextual relevance is moderate because it addresses the right topic and litigation, but the factual and qualitative inaccuracies severely undermine the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 417,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "Between 2022 and 2023, PepsiCo's relationship with Naked evolved from ownership to a reduced financial stake and operational involvement. In the first quarter of 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, Tropicana Brands Group (TBG), operating across North America and Europe. PepsiCo also acts as the exclusive distributor for TBG's portfolio for small-format and foodservice customers with chilled direct-store-delivery. By 2023, there is no indication of increased operational involvement, suggesting a continued reduced role in the management and operations of the Naked brand.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key facts: in 2022, PepsiCo sold Tropicana, Naked, and other juice brands to PAI Partners, retained a 39% noncontrolling interest in the newly formed joint venture, and acted as exclusive distributor for TBG’s portfolio for small-format and foodservice channels via chilled direct-store-delivery. The 39% stake is accurately reported, and the timeline (2022 transaction) aligns with the ground truth. However, the LLM answer states 'there is no indication of increased operational involvement' in 2023, which understates the change: the ground truth specifies that by 2023, PepsiCo *no longer directly distributed* Naked products, marking a clear cessation of operational involvement, not just a lack of increase. This omission of the definitive shift from active distribution to purely financial stake reduces completeness. (2) Quantitative accuracy is perfect: the 39% noncontrolling interest is correctly cited, and no other numbers (dates, dollar amounts) are misstated. Format and percentages match. (3) The multi-hop reasoning is mostly sound—linking the 2022 sale, retained stake, distribution role, and reduced 2023 involvement—but fails to fully synthesize the *change* in operational role between the years. The entity name 'Tropicana Brands Group (TBG)' is correctly used (ground truth abbreviates as TBG, full name matches). (4) Contextual relevance is excellent: the answer directly addresses the evolution in operational involvement and financial stake. The main shortcoming is the lack of explicit confirmation that distribution ceased in 2023, which is central to the question. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 467,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment and disclosure around the ExtraBucks Rewards program remained consistent in terms of recognizing revenue and determining performance obligations. In both years, the Company treated ExtraBucks Rewards as a separate performance obligation, allocating the transaction price based on the relative standalone selling price, which considers historical redemption patterns. Revenue related to ExtraBucks Rewards is recognized when the rewards are redeemed, and unredeemed rewards are reflected as a contract liability at the end of each period. No material changes in methodology or disclosure were noted between the two periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative changes in the accounting treatment and disclosure between 2023 and 2024, which is the core of the question. (1) What was correct: The answer accurately describes the consistent elements of the accounting treatment—namely, that ExtraBucks Rewards creates a separate performance obligation, transaction price is allocated based on relative standalone selling prices considering historical redemption patterns, revenue is recognized upon redemption, and unredeemed rewards are recorded as a contract liability. These points align with the ground truth and are factually accurate. (2) Quantitative accuracy: There are no numerical values in this question, so this dimension is not applicable beyond factual consistency; no errors here. (3) Multi-hop reasoning assessment: The model fails in synthesizing the evolution of disclosures. The ground truth emphasizes that while the core accounting treatment remained consistent, the 2024 filing included more refined language—specifically tying the performance obligation to customers who accumulate ExtraBucks based on historical spending levels and introducing more structured language around transaction price allocation and standalone selling price evaluation. These represent a maturation in disclosure and suggest a more formalized approach, which the LLM answer incorrectly dismisses as 'no material changes.' (4) Justification for scores: The correctness score is 5 because the answer gets the baseline accounting right but fails to capture the nuanced evolution in disclosure and language that constitutes the main point of the question. Qualitative accuracy is 5 due to the omission of these important refinements. Quantitative accuracy is 10 because there are no numbers and no factual inaccuracies in the statements made. Contextual relevance is 8 because the response stays on topic and addresses revenue recognition and performance obligations, but overlooks the evolution aspect that is central to the query.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 543,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Based on the information provided in the cost of revenues section, Netflix's reliance on integrated payment partners decreased slightly between 2023 and 2024. In 2023, the cost of revenues was 58% of total revenues, while in 2024, it decreased to 54% of total revenues. This decline suggests a reduced proportion of costs related to integrated payment partners and other operating expenses in 2024 compared to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that Netflix continued its relationship with integrated payment partners in 2024 but reduced the level of disclosure in the cost of revenues section. However, the LLM incorrectly infers a decrease in reliance based on overall cost of revenues as a percentage of total revenues (58% in 2023 vs 54% in 2024), which is not mentioned or supported in the original answer. These percentages are entirely fabricated and not part of the ground truth. (2) There are no correct numbers in the LLM response—neither the 58% nor 54% figures appear in the original answer, and no financial ratios or totals were provided in the ground truth to support such a calculation. This results in a major quantitative inaccuracy. (3) The multi-hop reasoning is flawed: the question asks about the evolution of reliance on payment partners based on disclosure in the cost of revenues section, not overall cost trends. The LLM conflates general cost of revenues percentages with specific disclosures about payment processing fees, failing to recognize that the change in detail (from explicit mention to less granular reporting) reflects a disclosure strategy shift, not an operational change. (4) The answer is partially contextually relevant because it addresses Netflix and the years 2023–2024 in the context of cost of revenues, but it introduces unsupported data and misinterprets the nature of the evolution. Thus, while the topic area is correct, the substance is factually and logically unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 436,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M's approach to managing PFAS contamination in Minnesota evolved in response to regulatory changes and new health-based standards. In 2022, 3M was actively addressing compliance issues, including self-reporting violations and working with the MPCA to remediate PFAS discharges at its Cottage Grove facility. By 2023, the company faced more stringent health-based values (HBVs) for PFOA and PFOS issued by the Minnesota Department of Health in January 2024, prompting 3M to evaluate the impact on its obligations under the SACO. Additionally, 3M received an alleged violation letter from the MPCA in November 2023 regarding hazardous waste shipments, and the company responded with corrective actions. These developments reflect an increased regulatory focus and 3M's ongoing efforts to comply with evolving standards.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of 3M's PFAS management approach and correctly notes the January 2024 issuance of more stringent HBVs by the Minnesota Department of Health, which is a key regulatory development. However, it incorrectly states that the HBVs were issued in January 2024 as part of the 2023 developments, when the original answer clarifies they were issued in January 2024, which is outside the 2022–2023 timeframe. This misplacement affects the timeline accuracy. Additionally, the LLM mentions an 'alleged violation letter from the MPCA in November 2023 regarding hazardous waste shipments,' which is not present in the ground truth; instead, the truth states a Notice of Violation was issued in March 2023 for stormwater discharge at the Hutchinson facility and a December 2022 order for Cottage Grove. The November 2023 date and hazardous waste shipment detail are factually incorrect. (2) Quantitative accuracy suffers due to incorrect dates: March 2023 and December 2022 events are misrepresented as November 2023, and the January 2024 HBV issuance is incorrectly framed as a 2023 regulatory change. While dollar amounts are not involved, the temporal metrics (dates) are critical and contain significant errors. (3) The multi-hop reasoning is partially sound—3M’s response to evolving standards is logically inferred—but fails in synthesizing the correct sequence and nature of regulatory actions. The model conflates different facilities (Hutchinson vs. Cottage Grove) and violation types (stormwater vs. hazardous waste shipments). It also omits key details such as the 2007 Settlement Agreement and Consent Order context, the Decatur, Alabama facility obligations, and the proposed Clean Water Act permit with stricter PFAS limits in January 2024. (4) Despite these issues, the answer remains contextually relevant, addressing the core theme of evolving regulatory pressure and 3M’s compliance response. The overall correctness is reduced due to factual inaccuracies in dates and events, but the general direction of increased scrutiny and 3M’s adaptive response is consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 576,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "PepsiCo's use of foreign currency derivatives increased from a notional value of $3.0 billion in 2022 to $3.8 billion in 2023, indicating a more aggressive approach to managing foreign exchange risk. This increase suggests that PepsiCo is expanding its hedging activities to mitigate the growing impact of currency fluctuations on its international operations, reflecting a proactive foreign exchange risk management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the notional values of foreign currency derivatives for PepsiCo in 2022 ($3.0 billion) and 2023 ($3.8 billion), matching the ground truth exactly. These figures are critical quantitative data points and are accurately reported with correct formatting. (2) The calculation of the increase (from $3.0B to $3.8B) is implied and correct, though no explicit percentage or dollar difference is computed, which is acceptable as the question does not require it. (3) The reasoning about PepsiCo's strategy is sound and aligns with the ground truth: the increase in derivative usage indicates a more proactive or expanded hedging strategy. The LLM correctly infers that this reflects a response to greater foreign exchange risk in international operations. However, the LLM omits a key qualitative point from the original answer: that these derivatives resulted in no material net impact on earnings in 2023, which strengthens the effectiveness of the strategy. This omission slightly reduces completeness and qualitative accuracy. (4) All entities—PepsiCo, foreign currency derivatives, 2022, and 2023—are correctly identified. The answer is contextually relevant and directly addresses both parts of the question: the evolution of derivative use and its implication for risk management. The omission of the 'no material net impact' point prevents a perfect score, but the core facts and interpretation remain highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 406,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil's approach to capitalizing on improving living standards has shifted to focus more on strategic capacity additions in high-growth markets and expanding its production of high-performance chemical products. In 2023, the company emphasized geographic expansion, particularly in China, with the development of a new petrochemical complex in Guangdong Province to meet domestic demand for performance chemicals. Additionally, ExxonMobil added new production capacity in the U.S., including a performance polymers line and a linear alpha olefins unit in Baytown, Texas, to support growing demand for advanced materials in sectors like automotive, construction, and renewable energy. This reflects a strategic shift toward leveraging geographic and technological advantages to align with long-term demand trends driven by population growth and rising living standards.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift in ExxonMobil's approach from 2022 to 2023, noting increased focus on high-performance chemicals and geographic expansion in China. It accurately mentions the Baytown, Texas expansions for performance polymers and linear alpha olefins. However, it omits key quantitative details from the ground truth: the 2022 completion of the Corpus Christi ethane cracker joint venture and the specific plan for up to 500,000 metric tons per year of advanced recycling capacity by 2026. Additionally, while it references a petrochemical complex in Guangdong Province, it fails to specify that the Dayawan, China complex is 100% foreign-owned and has over 2.5 million metric tons per year of polyethylene and polypropylene capacity—critical details in the original answer. (2) The LLM answer lacks specific numbers and dates that are central to the ground truth, such as '500,000 metric tons annually' and '2.5 million metric tons per year,' which significantly reduces quantitative accuracy. The mention of '2023' as the year of emphasis is acceptable, but the absence of forward-looking timelines like 'by 2026' weakens precision. (3) The multi-hop reasoning is generally sound—the model synthesizes information about geographic focus and product shifts across years and locations. It correctly infers a strategic evolution from domestic U.S. projects to international expansion and higher-value products. However, it does not fully connect the 2022 baseline (which is necessary for comparison) with the 2023 developments, missing an opportunity to contrast the two years explicitly with supporting figures. (4) Despite missing key numbers, the answer remains contextually relevant and captures the qualitative essence of the strategic shift. Wording is flexible but semantically aligned with the original, just less specific. Correctness score is 7 due to accurate core narrative but significant omissions in quantitative detail; quantitative accuracy is 6 due to missing metrics; qualitative accuracy is 8 due to sound reasoning; contextual relevance is 9 due to strong alignment with the question’s intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 580,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "From 2022 to 2023, 3M's investment in Certificates of Deposit/Time Deposits increased significantly from $21 million to $49 million, as shown in Note 12 of the 2023 10-K. This shift indicates a strategic move toward safer, short-term investments, likely reflecting a more conservative approach to liquidity management amid economic uncertainty or a desire to preserve capital in a low-risk environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in 3M's Certificates of Deposit/Time Deposits from $21 million in 2022 to $49 million in 2023, matching the ground truth exactly. The quantitative evolution — more than doubling — is accurately represented. (2) All numbers are correct: $21 million (2022) and $49 million (2023), with no calculation errors. The reference to Note 12 of the 2023 10-K adds contextual support, though not required for correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes year-over-year changes and infers strategic intent. The interpretation — a shift toward safer, short-term investments and conservative liquidity management — is logically consistent with the ground truth's interpretation of increased liquidity or reallocation to stable/higher-yielding instruments. While the LLM emphasizes 'safer' and 'conservative' motives and the ground truth mentions 'liquidity' or 'higher-yielding' instruments, these are complementary rather than contradictory perspectives. (4) The answer is fully contextually relevant, addressing both the quantitative evolution and strategic implication. The slight difference in emphasis in interpretation does not undermine factual correctness, so a score of 9 is appropriate for qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 370,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "Mastercard's approach to proprietary insights in 2023 emphasized a stronger commitment to data responsibility and trust-building compared to 2022. In 2023, the language explicitly highlights \"principled and responsible use of secure consumer and merchant data,\" reflecting a more deliberate focus on ethical data practices. In contrast, the 2022 document mentioned \"proprietary insights, drawing on Mastercard's principled use of consumer and merchant data,\" without explicitly emphasizing trust-building or data responsibility. The 2023 evolution underscores a strategic shift toward reinforcing transparency and trust in how data is leveraged for insights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: the 2022 language referencing 'principled use of consumer and merchant data' and the 2023 evolution to 'principled and responsible use of secure consumer and merchant data' are correctly quoted and contextualized. (2) There are no numeric values requiring calculation, but the years (2022 and 2023) are correctly identified and compared. (3) The multi-hop reasoning—comparing language shifts across two years to infer a strategic emphasis on data responsibility and trust—is sound and well-supported. The LLM correctly identifies the addition of 'responsible' and 'secure' as meaningful enhancements indicating stronger trust-building. (4) The answer is semantically equivalent to the original, with slightly expanded phrasing around 'transparency' and 'ethical data practices' that are reasonable interpretations consistent with the source. No factual inaccuracies, omissions, or misstatements are present. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 308,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "Between 2022 and 2023, the factors influencing the accounting estimates for pension and retiree medical plans evolved in response to the high interest rate and inflationary cost environment, as well as ongoing global conflicts. In 2022, the impact of these plans on financial results was a positive 0.3%, while in 2023, there was no reported impact, indicating potential adjustments or stabilizations in assumptions or liabilities. This shift suggests that external economic pressures, such as rising interest rates, may have led to recalibrations in discount rates or benefit obligations, reflecting a more cautious or stable outlook for these plans in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific quantitative claim—that in 2022, the impact on financial results was a positive 0.3%, and in 2023, there was no reported impact—which is not present in the original answer and cannot be verified from the ground truth. This number is likely fabricated or misattributed, as the original answer does not mention any percentage impact on financial results. This significantly undermines factual accuracy. (2) There are no correct numbers in the LLM response that align with the ground truth; the 0.3% figure and the claim of 'no reported impact' in 2023 are unsupported. The original answer focuses on qualitative shifts in risk factors (from pandemic-related to geopolitical and macroeconomic), not financial impact percentages. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies a shift in external factors—mentioning high interest rates, inflation, and global conflicts (Ukraine and Middle East)—which aligns with the original answer’s emphasis on evolving macroeconomic and geopolitical concerns. However, it fails to correctly attribute the 2022 factors to the ongoing impacts of the COVID-19 pandemic, instead implying the shift was only about interest rates and conflicts. (4) While the general direction of the answer (a shift in external risk factors affecting pension plans) is relevant and partially accurate, the inclusion of unverified quantitative data and omission of the correct primary driver in 2022 (pandemic uncertainty) reduces correctness. The answer synthesizes some correct elements but distorts the factual basis with unsupported metrics, warranting a low-to-mid score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 457,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 32,441 gross thousand acres (15,838 net) at year-end 2022 to 30,773 gross thousand acres (15,012 net) at year-end 2023, reflecting a reduction in holdings. This decline suggests a strategic consolidation or evaluation of assets, potentially leading to relinquishments where exploration potential has been assessed and deemed non-viable. The reduction does not necessarily indicate a withdrawal from the region but may signal a focus on higher-potential areas or operational efficiency.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numeric values provided. According to the ground truth, ExxonMobil's undeveloped acreage in the Other Americas region was 25,096 gross and 11,977 net thousand acres in 2022, decreasing to 24,221 gross and 11,548 net thousand acres in 2023. However, the LLM reports 32,441 gross (15,838 net) in 2022 and 30,773 gross (15,012 net) in 2023—values that are substantially higher and incorrect. These numbers do not align with the ground truth data, indicating a failure in retrieving accurate figures from the source material. (2) The calculation of the decrease is numerically consistent within the LLM’s own incorrect numbers (a drop of ~1,668 gross and ~826 net thousand acres), but since the base figures are wrong, the entire quantitative foundation is invalid. (3) The reasoning and synthesis about what the reduction might indicate—such as strategic consolidation, relinquishment of low-potential assets, or focus on higher-potential areas—are qualitatively reasonable and align semantically with the interpretation in the original answer. The LLM correctly infers plausible strategic implications from a reduction in acreage, which shows sound qualitative logic. (4) Despite this, the severe quantitative inaccuracies undermine the correctness score, as financial and operational decisions rely on precise data. The contextual relevance is moderate because the structure and intent of the response match the question, but the use of incorrect data renders the answer misleading. Thus, the correctness score is low due to fundamental errors in core facts, even though the interpretive reasoning is partially valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 462,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, the use of foreign currency contracts not designated in hedging relationships by 3M remained focused on offsetting the impacts of changes in value of non-functional currency denominated items, such as intercompany financing balances. In 2022, the gross notional amount of these contracts was $2.8 billion, with a fair value of $73 million. By 2023, the notional amount decreased to $1.0 billion, and the fair value dropped to $7 million. This indicates a reduction in both the scale and the value exposure of these contracts over the period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, the gross notional amount of foreign currency contracts not designated in hedging relationships was $3.7 billion, but the LLM incorrectly reports it as $2.8 billion. Similarly, the 2023 notional amount is stated as $1.0 billion in the LLM answer, which contradicts the ground truth that does not specify a new notional amount but instead emphasizes a strategic shift in the use of derivatives. The fair value figures ($73M and $7M) are entirely absent from the original answer and thus appear fabricated. (2) These numerical discrepancies are critical because they misrepresent the scale and trend of 3M's financial exposure management. The LLM implies a reduction in contract usage, while the ground truth describes a qualitative shift in accounting treatment and strategy—not necessarily a reduction in volume. (3) The multi-hop reasoning is partially sound in that the LLM correctly identifies the purpose of the contracts (offsetting non-functional currency items like intercompany balances) and the fact that they are not designated in hedging relationships. However, it fails to capture the key evolution described in the original: the increased emphasis on derivatives not designated as hedging instruments whose gains/losses directly impact earnings, signaling a strategic shift in financial reporting and risk management. (4) The contextual relevance is moderate because the answer addresses the right topic and entities (3M, foreign currency contracts, non-functional currency items), but the incorrect numbers and mischaracterization of the evolution undermine the overall correctness. The qualitative accuracy is low due to the failure to report the actual strategic shift and the introduction of unsupported data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 508,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, the role and emphasis of Cyber and Intelligence Solutions within Mastercard's value proposition have evolved to become a more integral component of its broader value-added services. In 2022, these solutions were highlighted as part of Mastercard's efforts to ensure secure and confident transactions. By 2023, the emphasis on Cyber and Intelligence Solutions was more pronounced, with the solutions being explicitly positioned as a key differentiator in Mastercard's offerings, underscoring their importance in addressing fraud prevention and enhancing transaction safety across its payment ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies the evolution of Cyber and Intelligence Solutions between 2022 and 2023: in 2022, it was part of broader value-added services with a focus on secure transactions; by 2023, it became more prominently positioned as a key differentiator for fraud prevention and transaction safety. This matches the original answer’s core claim of a strategic elevation in importance. (3) The multi-hop reasoning is sound—comparing the positioning and language used across two years to infer a shift in strategic emphasis. The LLM captures the progression from a supporting role to a more central, differentiating component. (4) Minor difference: the original answer notes that in 2022, Cyber and Intelligence Solutions were grouped among other services like loyalty and gateway fees, which the LLM omits. This contextual detail adds nuance about its earlier peripheral status. However, the LLM still correctly infers increased emphasis and strategic positioning in 2023. Overall, the answer is semantically equivalent with only slight omission of contextual framing—hence a 9 on correctness and qualitative accuracy. Contextual relevance is perfect as it directly addresses the evolution in role and emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 394,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "The treatment and disclosure of Income Tax Expense and Accruals in the list of critical accounting policies remained consistent between 2022 and 2023. In both years, the policies emphasized the judgment required in determining the annual tax rate, evaluating tax positions, and establishing reserves for potentially challenged tax positions. The 2023 disclosure added more detail about adjustments to reserves based on changing facts, such as tax audits or new tax laws, but the core principles and considerations were unchanged from 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key structural evolution highlighted in the ground truth. (1) There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (2) The LLM correctly identifies that income tax expense and accruals remained a critical accounting policy in both years and notes consistent emphasis on judgment in tax rate determination and reserve establishment. However, it fails to mention the key change in presentation: in 2023, the item was reorganized into a subsection under 'Our Critical Accounting Policies and Estimates' with explicit cross-referencing to Note 5 - Income Taxes, indicating a shift toward more structured and transparent reporting. This omission undermines the qualitative accuracy. (3) The multi-hop reasoning is partially sound—the model synthesizes continuity in treatment—but misses the evolution in disclosure format and organization, which is central to the question about 'evolution' in treatment or disclosure. (4) Contextually, the answer is relevant and addresses the topic appropriately, but lacks the depth of structural change described in the ground truth. Thus, correctness is reduced to 5 due to significant omission of a key factual development in presentation and transparency, despite accurate description of ongoing policy substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 381,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Between 2023 and 2024, Intel advanced the Universal Chiplet Interconnect Express (UCIe) standard as a key enabler of its systems of chips strategy. In 2023, Intel demonstrated UCIe in silicon, showcasing its capability for high-performance communication between chiplets. By 2024, the company emphasized UCIe as a foundational standard to optimize system performance and power consumption, integrating it into its broader foundry and packaging offerings to support both internal and external customers. This evolution reflects Intel's commitment to driving industry-wide adoption of systems of chips for AI and other high-growth applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: in 2023, Intel demonstrated UCIe in silicon; by 2024, it was integrated into broader packaging and foundry offerings. The evolution from demonstration to production and industry adoption is correctly conveyed. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are accurate. (3) The multi-hop reasoning is sound—linking UCIe’s development to Intel’s broader systems of chips strategy, advanced packaging, and customer enablement. The LLM correctly synthesizes the progression in Intel’s strategic positioning. (4) The only minor omission is that the original answer specifies Intel was 'actively producing' based on UCIe in 2024, while the LLM says it was 'emphasizing' and 'integrating'—slightly less strong but still semantically close. Also, the LLM adds context about AI applications and power consumption, which are reasonable inferences but not in the original. These do not detract from correctness. Overall, the answer is factually correct, complete in substance, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 345,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions remained consistent in structure but showed differences in execution timing and share delivery percentages. In 2023, ASRs were accounted for as an initial treasury stock transaction and a forward contract classified in capital surplus, with shares delivered in two tranches (80% upfront and 20% later). In 2024, the structure was similar, but the delivery percentages varied slightly (85% upfront and 15% later), and the final share delivery occurred in March 2024, compared to February 2023 in the prior year. The accounting treatment remained unchanged, with forward contracts reclassified to treasury stock upon completion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the LLM correctly identifies the 80% and 85% initial share deliveries, the February 2023 and March 2024 completion dates, and the reclassification of the forward contract from capital surplus to treasury stock. However, it omits the exact dollar amounts ($2.0 billion in 2023, $3.0 billion in 2024) and the precise number of shares (17.4M, 5.4M, 31.4M, 8.3M), which are present in the original answer. These omissions prevent a perfect score, but the percentages and timing are correct. (2) The LLM correctly notes the accounting treatment consistency and the two-tranche delivery structure. (3) The multi-hop reasoning is sound: it synthesizes information across two years, compares the structure, timing, and accounting, and correctly infers that the treatment remained consistent despite changes in scale and timing. (4) The answer is contextually excellent—directly addressing the evolution in accounting treatment and timeline. The only shortcoming is the lack of specific dollar values and exact share counts, which are important for full quantitative completeness. Thus, the correctness, quantitative, and qualitative scores are high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 353,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "From 2022 to 2023, UPS's financial exposure and reporting approach related to the Central States Pension Fund (CSPF) showed a significant shift in actuarial estimates and sensitivity analysis. In 2022, UPS recorded a $5.1 billion pre-tax gain related to a reduction in its best estimate of potential coordinating benefits for the CSPF. By 2023, this shifted to a $697 million pre-tax gain (from the sensitivity analysis) due to changes in discount rates and other assumptions, indicating a more stable or reduced exposure. Additionally, the sensitivity analysis in 2023 highlighted the impact of a 25 basis point change in discount rates and return on assets, showing increased vulnerability to interest rate fluctuations and asset returns, which could significantly affect obligations and expenses.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, UPS disclosed a $2.3 billion pre-tax actuarial *loss* related to potential coordinating benefits for the Central States Pension Fund. However, the LLM incorrectly reports a $5.1 billion pre-tax *gain*, which is both the wrong direction (gain vs. loss) and the wrong amount. In 2023, the ground truth indicates a shift in reporting focus to sensitivity analysis around a 25 basis point change in returns on assets, but the LLM invents a $697 million pre-tax gain from sensitivity analysis, which is not stated in the original answer. This number and characterization are entirely fabricated. (2) The quantitative inaccuracies are severe: $5.1B gain vs. $2.3B loss (off by $7.4B in magnitude and sign), and a fictional $697M gain in 2023. The sensitivity analysis in the LLM answer incorrectly attributes the impact to discount rates and return on assets together, while the original specifies only a 25 bps change in expected and actual returns on assets as the key assumption. (3) The multi-hop reasoning is flawed. The LLM fails to correctly synthesize the evolution from a specific actuarial loss disclosure in 2022 to a shift toward sensitivity analysis in 2023. Instead, it fabricates gains and misrepresents the nature of the sensitivity analysis, suggesting increased vulnerability when the original implies a methodological shift in disclosure, not necessarily a change in risk exposure. (4) The contextual relevance is moderate because the answer addresses the right topic (UPS, Central States Pension Fund, actuarial estimates, sensitivity analysis, 2022–2023 evolution), but the factual and quantitative errors severely undermine correctness. The qualitative reasoning is partially sound in structure but based on false premises. Hence, low scores for correctness and quantitative accuracy, slightly higher for qualitative reasoning due to structural coherence, and moderate for relevance due to correct topic framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 548,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Between 2022 and 2023, Mastercard has emphasized the role of its Cyber and Intelligence Solutions in enabling secure, efficient, and confident transactions across its global payments ecosystem. In 2022, the value proposition focused on these solutions as part of a broader set of value-added services to support stakeholders in transacting \"easily and with confidence.\" By 2023, the emphasis evolved to highlight these solutions as integral to a multi-layered approach for protecting the global payments ecosystem, while also leveraging principled and responsible data use to provide insights. This shift reflects a stronger focus on security, trust, and innovation in response to evolving risks and stakeholder expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2022 emphasis on value-added services enabling transactions 'easily and with confidence' is accurately reflected, as is the 2023 evolution toward positioning Cyber and Intelligence Solutions as integral to security and trust. The principled use of data is correctly noted in both years. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable but assumed correct by default. (3) The multi-hop reasoning is sound—information is synthesized across two years and two strategic narratives, correctly identifying the shift in emphasis. The LLM captures the core evolution: from a supporting service to a more central, strategic role in the payments ecosystem. It slightly omits the explicit 2023 linkage to strategic investments in open banking and digital identity mentioned in the original answer, which is a minor gap in completeness. (4) Despite this omission, the answer conveys the essential semantic meaning and correctly interprets the strategic shift. Wording differs but meaning is equivalent. Contextual relevance is excellent, directly addressing the evolution in value proposition to stakeholders.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 359,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In PepsiCo's 2022 SEC filing, the 4.450% Senior Note due 2046 was referenced as Exhibit 4.11, incorporated by reference to a Form 8-K filed on October 14, 2015. In the 2023 SEC filing, the same note was not explicitly listed again, indicating no new documentation was referenced for this specific note in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in the 2022 filing, the note was listed as Exhibit 4.12 (not 4.11 as stated by the LLM), and in the 2023 filing, it was reclassified as Exhibit 4.13 with a new reference to a Form 8-K filed on February 24, 2016. The LLM incorrectly claims the note was 'not explicitly listed' in 2023, which contradicts the ground truth showing a clear reclassification and updated exhibit reference. (2) The date October 14, 2015, is correctly cited for the 2022 filing’s incorporation, but the exhibit number is wrong (4.11 vs. correct 4.12). The 2023 filing omits the correct exhibit (4.13) and the correct Form 8-K date (February 24, 2016), instead asserting no new documentation—factually incorrect. (3) The multi-hop reasoning fails: the model does not recognize that the same financial instrument was reclassified across filings, which requires tracking exhibit numbering changes and updated source documents over time. Instead, it concludes no update occurred, missing the evolution entirely. (4) While the answer addresses the general topic (exhibit referencing and documentation dates), it fails on core facts and synthesis, warranting low scores in correctness, quantitative, and qualitative accuracy. Contextual relevance is moderate because the structure and intent of the response align with the question, even if the facts are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 397,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Between 2023 and 2024, Intel's engagement with Positive Technologies, a Russian IT security firm sanctioned by the U.S., remained limited to authorized activities under an OFAC license. In both years, Intel's interactions were confined to IT security research and coordinated disclosure of vulnerabilities, with no associated revenues or profits. Intel confirmed its intention to continue these communications in compliance with the OFAC license terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core evolution of Intel's relationship with Positive Technologies under OFAC licensing between 2023 and 2024. It correctly identifies that interactions were limited to IT security research and coordinated vulnerability disclosure, conducted under an OFAC license due to U.S. sanctions on the Russian firm. It accurately notes no revenues or profits were generated from these activities—matching the ground truth. The answer also correctly states Intel's intent to continue communications in compliance with the license, reflecting the forward-looking posture emphasized in the 2024 filing. However, it slightly underrepresents the qualitative shift in tone and framing between the years: in 2023, Intel disclosed past communication and resumption under the license, while in 2024, it explicitly signaled ongoing, sustained engagement. This nuance of evolving from retrospective disclosure to proactive continuation is present but not clearly emphasized. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Intel, Positive Technologies, OFAC, U.S. sanctions) and timeframes (2023–2024) are correct. The reasoning is sound and contextually appropriate, synthesizing multi-hop information across time and regulatory context. Minor deduction in qualitative accuracy for not fully articulating the shift in narrative posture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 389,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million between 2023 and 2024, as shown in the long-term debt sections of both years in Note 10 of the 10-K filings. This indicates that the company has maintained this specific long-term debt obligation without refinancing or retiring the notes during this period, reflecting stability in a portion of its long-term debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million in both 2023 and 2024, which matches the ground truth exactly. All numeric values, including the interest rate, maturity date, dollar amount, and years, are accurate. (2) Quantitative accuracy is perfect: $5,000 million is correctly reported, and no erroneous calculations are present. The format ($5,000 million) is consistent with the ground truth. (3) The reasoning is sound—the LLM correctly infers that the stability indicates no retirement or issuance of these notes, reflecting stability in that portion of the debt structure. However, the LLM answer omits the comparative context provided in the original answer about other senior notes (e.g., the 2.7% notes due 2040 decreasing from $1,250M to $367M), which adds depth to the interpretation of CVS's selective debt management. This missing contrast slightly reduces completeness and qualitative accuracy, though the core multi-hop reasoning (linking unchanged balance to debt strategy) is valid. (4) The answer is highly contextually relevant, directly addressing both parts of the question—evolution of the note balance and its implication for long-term debt. The omission of the comparative example from other notes prevents a perfect qualitative score, but the response remains factually correct and well-reasoned within the scope it covers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 399,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 (trading symbol XOM32) were listed as securities registered pursuant to Section 12(b) of the Exchange Act in both the 2022 and 2024 SEC filings, indicating their continued status as registered securities traded on the New York Stock Exchange. There is no indication of any material change in the status of these notes between the two filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.835% Notes due 2032 (XOM32) were listed in both the 2022 and 2024 filings as registered securities under Section 12(b), which is factually accurate and consistent with the ground truth. The trading symbol XOM32 is correctly noted. However, the LLM fails to address a key comparative insight present in the original answer: the disappearance of the 0.142% Notes due 2024 (XOM24B) from the 2024 filing, which provides context for changes in Exxon’s debt structure. By omitting this contrast, the LLM implies no change in the broader debt composition, which understates the evolution in the company's disclosed debt instruments. (2) All numeric values—interest rate (0.835%), maturity year (2032), trading symbol (XOM32)—are correct. No calculations are required, and dates are accurate. (3) The multi-hop reasoning is partially sound: the model correctly tracks the status of the 2032 notes across two filings but fails to synthesize the change in the 2024 notes, which is essential for fully answering how the status of the 2032 notes evolved *in context*. The absence of this comparative analysis weakens the qualitative reasoning. (4) The answer is contextually relevant and factually precise about the 2032 notes but lacks completeness in addressing the implied comparative dimension of the question—how the status evolved relative to other notes. Hence, while not factually wrong, it misses a critical analytical layer, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 418,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "American Express's investment strategy toward U.S. Government treasury obligations between 2022 and 2024 shows a significant decrease in fair value allocation, dropping from $1,704 million in 2021 to $287 million in 2024. Additionally, the maturity distribution shifted, with a larger portion of the 2024 holdings maturing within one year compared to the 2021 period, which had a more extended maturity profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It references data from 2021 ($1,704 million) and 2024 ($287 million), which are not present in the ground truth and are factually incorrect. The ground truth states that in 2022, American Express held $477 million in short-term U.S. Treasury obligations, and by 2024, the allocation was $189 million short-term and $98 million intermediate-term (totaling $287 million). While the total 2024 fair value matches by coincidence, the 2021 figure is irrelevant as the question asks about 2022–2024. The LLM incorrectly claims a 'larger portion' of 2024 holdings mature within one year, which contradicts the ground truth showing a strategic expansion into intermediate-term (1–5 year) maturities. (2) Quantitative accuracy is low: the $1,704 million figure is entirely fabricated; the correct 2022 value is $477 million. The 2024 total ($287 million) is correct as a sum of $189M + $98M, but the LLM fails to break it down or acknowledge intermediate-term holdings. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the evolution from exclusive short-term in 2022 to diversified maturities in 2024. Instead, it falsely claims a more extended maturity profile in 2021 and a concentration in short-term by 2024, which is the opposite of the truth. (4) Contextual relevance is moderate because the answer addresses investment strategy, fair value, and maturity distribution, but uses wrong years and incorrect data, undermining the analysis. The conclusion about strategy evolution is therefore invalid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 437,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced the 2.500% Note due 2050 in June 2020, as detailed in the 2022 10-K filing (page 72). By 2024, the note remained outstanding and was still listed in the exhibit descriptions in the 2024 10-K (page 75), indicating no material changes in its terms or status during the period between 2022 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitative accuracy: The 2.500% Note due 2050 was indeed introduced in June 2020 (per Officers' Certificate dated June 3, 2020), and the LLM correctly identifies its presence in both the 2022 and 2024 10-K filings. The percentages and years are accurate. (2) Completeness: The answer addresses the evolution between 2022 and 2024, noting the note's continued listing without material changes. However, it omits the detail that the note was reintroduced in Exhibit 4.6 in 2024 as an exact replication of Exhibit 4.5 from 2020, which is a minor but relevant structural detail about how Amazon maintained the instrument. (3) Entity accuracy: Amazon, the 2.500% Note due 2050, and the correct years (2020 introduction, 2022 and 2024 references) are all correctly identified. (4) Reasoning: The logic is sound—no material changes are inferred from consistent listing, which is valid. The multi-hop synthesis across years and filings is appropriate. (5) Semantic equivalence: The core message—that the note remained unchanged in status and terms—is correctly conveyed. The omission of exhibit-level detail slightly reduces qualitative accuracy but does not affect factual correctness. Hence, high scores across all dimensions with a 9 on correctness due to minor incompleteness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 374,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "Between 2022 and 2023, the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement increased from eight to twelve. In 2022 (COST_10k_2022.pdf), the agreement had been amended up to the Eighth Amendment (10.8.8). By 2023 (COST_10k_2023.pdf), four additional amendments were added, including the Ninth, Tenth, Eleventh, and Twelfth Amendments (10.8.9 to 10.8.12).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that the number of amendments increased from eight in 2022 to twelve in 2023, matching the original answer's claim that four additional amendments were filed. (2) The quantitative details are precise: the Eighth Amendment was the latest in 2022, and the Twelfth Amendment was filed in 2023, implying four new amendments (Ninth through Twelfth), which is consistent with the ground truth. Although exact dates (March 10, 2022, and October 11, 2023) are omitted, the core numerical progression and timeline are correct. (3) The multi-hop reasoning is sound—information is correctly synthesized across two years and filings (COST_10k_2022.pdf and COST_10k_2023.pdf), and the amendments are properly sequenced. (4) All entities (Citibank, N.A. Co-Branded Credit Card Agreement, amendment numbers, years) are correctly identified. The answer is concise, factually accurate, and fully addresses the evolution of the amendment count between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 300,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "Between 2022 and 2024, NVIDIA's approach to CUDA has evolved to further integrate with new computing architectures and software ecosystems, enhancing its role as a foundational element of its full-stack accelerated computing platform. In 2022, CUDA was highlighted as a key building block for GPUs and interconnects, enabling performance leaps across data center, gaming, and automotive markets. By 2024, CUDA's integration expanded to include not only GPUs but also CPUs and DPUs, supporting the NVIDIA Blackwell architecture, which is optimized for generative AI and large-scale data center workloads. Additionally, CUDA's ecosystem has grown, with over 5.9 million developers leveraging it to deploy NVIDIA's technology across diverse applications, including AI, HPC, and autonomous systems.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of CUDA between 2022 and 2024. (1) It accurately captures the shift from CUDA as a foundational GPU-centric technology in 2022 to a broader full-stack platform integrated with CPUs and DPUs by 2024, which matches the ground truth's emphasis on heterogeneous computing architectures. The mention of Blackwell architecture and generative AI workloads adds timely context consistent with NVIDIA's 2024 direction. (2) Quantitatively, the figure of 'over 5.9 million developers' is not present in the original answer, but it is a plausible and commonly cited statistic in NVIDIA's public communications; since it does not contradict the ground truth and is contextually appropriate, it does not detract from accuracy. There are no incorrect numbers, dates, or calculations. (3) The multi-hop reasoning is sound: the answer synthesizes CUDA’s expansion across hardware (GPUs to CPUs/DPUs) and software ecosystems (developer growth, AI/HPC applications), reflecting integration with new architectures and enterprise ecosystems. However, it omits specific mention of CUDA-X, APIs, SDKs, and domain-specific frameworks—key elements in the ground truth that detail the 'full-stack' expansion. (4) Despite this omission, the answer remains semantically close and contextually strong, earning high marks for relevance and qualitative accuracy. The core evolution is correctly conveyed, just with slightly less specificity on the software ecosystem components.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 422,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial relationship with Paxlovid evolved significantly in terms of revenue recognition and contractual obligations. In 2023, Paxlovid revenue was $1,279 million, but this included a non-cash revenue reversal of $3.5 billion due to the expected return of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenue increased to $5,716 million, driven by the transition to commercial market sales and a favorable final adjustment of $771 million after 5.1 million treatment courses were returned. Additionally, deferred revenues related to Paxlovid decreased from $5.1 billion in 2023 to $2.2 billion in 2024, as revenue was recognized upon product delivery. Contractual obligations also shifted, with the U.S. government's role diminishing as sales moved to traditional commercial markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the reported 2024 revenue figure of $5,716 million, which is not supported by the ground truth. The original answer does not state any total revenue for 2024, but rather describes adjustments: a favorable $771 million reversal adjustment and an additional $442 million from SNS creation, implying incremental revenue adjustments, not a total of $5.7 billion. This misrepresents the financial evolution. Additionally, the LLM claims deferred revenues decreased from $5.1 billion to $2.2 billion, which is not mentioned in the ground truth and appears fabricated. (2) The 2023 revenue of $1.279 billion is correct, and the $3.5 billion non-cash reversal is accurately cited. The 5.1 million returned treatment courses and $771 million favorable adjustment are also correct. However, the $442 million SNS revenue is omitted in the LLM answer, and the deferred revenue figures are incorrect. The calculation of total 2024 revenue as $5,716 million has no basis in the provided data. (3) The reasoning partially captures the shift from government to commercial sales, and the adjustment due to lower-than-expected returns is correctly noted. However, it fails to mention the $1 billion in remaining performance obligations as of December 31, 2024—a key contractual obligation metric in the original answer. The synthesis is incomplete and introduces unsupported figures. (4) While the answer addresses revenue recognition and contractual shifts (contextually relevant), the severe quantitative errors—especially the invented total revenue and deferred revenue numbers—undermine factual correctness. The qualitative reasoning is partially sound but based on incorrect data, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 493,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "The availability of shares under the 2003 Incentive Program decreased from 65,754,069 shares in 2022 to 47 million shares in 2024. The structure remained consistent, with awards including restricted stock, stock options, and stock appreciation rights, and vesting periods typically spanning three to ten years. The reduction in available shares reflects the issuance of awards over this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the availability of shares decreased from 65,754,069 in 2022 to 47 million in 2024, implying a net reduction due to award issuance. However, the ground truth shows that the total maximum number of shares was increased to 220 million by 2024, with 47 million remaining available. Thus, the 47 million is not the total available at the start of 2024 but the remaining balance after grants, not a decrease in authorized capacity. The LLM misrepresents the evolution as a reduction rather than an expansion in program size. (2) Quantitatively, the 65,754,069 shares in 2022 is correct, and 47 million is mentioned correctly as remaining available in 2024, but the LLM omits the critical fact that the cap was raised to 220 million, leading to a false narrative. It also fails to mention the increase in restricted stock units granted from 9,392 thousand in 2022 to 10,393 thousand in 2024. (3) The reasoning is flawed: the LLM interprets the lower remaining balance as a reduction in availability, failing to recognize the multi-hop synthesis that the program was expanded significantly despite moderate usage. This reflects a failure to correctly interpret the structural evolution of the program. (4) Contextual relevance is fair—the answer addresses share availability and structure, and correctly notes award types and vesting periods (consistent details), but misses the core dynamic of program expansion. Due to major quantitative and reasoning errors, the correctness score is low despite some accurate details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 442,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "Between 2022 and 2024, AdSense's role within Google's advertising revenue streams has evolved as part of the broader integration of AI technologies into Google's advertising portfolio. In 2022, AdSense was noted as a contributor to Google Network revenues, which saw growth driven by AdMob, Google Ad Manager, and AdSense. By 2024, Google's advertising solutions increasingly leveraged AI to enhance performance and brand advertising, with products like Demand Gen and Performance Max utilizing AI to help advertisers identify new opportunities. While AdSense remains part of Google's advertising ecosystem, its role has been complemented by AI-driven innovations that optimize ad delivery and user experience across Google's platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AdSense's role from being a highlighted growth contributor in 2022 as part of the Google Network (alongside AdMob and Google Ad Manager) to a more background, foundational component by 2024, with AI-powered tools like Demand Gen and Performance Max taking center stage. However, it omits the specific $8.6 billion year-over-year revenue increase mentioned in the ground truth for 2022, which is a quantitatively significant detail. (2) No incorrect numbers are presented; the absence of the $8.6 billion figure is a gap in completeness rather than inaccuracy. All references to years (2022, 2024) and product names (AdSense, AdMob, Google Ad Manager, Demand Gen, Performance Max) are accurate. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift based on the changing emphasis in Google’s advertising portfolio, linking the reduced mention of AdSense to the rise of AI-driven products. It synthesizes across time and product lines appropriately, though it could have more explicitly stated that AdSense was no longer specifically quantified as a growth lever in 2024. (4) The correctness score is 8 due to the omission of a key quantitative data point; qualitative accuracy is also 8 because while the reasoning is strong, the answer slightly underrepresents the degree of strategic downgrading of AdSense by not explicitly stating its transition to a mature, less-prominent offering. Contextual relevance is perfect—every part of the response addresses the question directly and appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 437,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "Between 2022 and 2023, the UPS Retirement Plan's benefit accrual structure changed significantly for non-union participants. Effective January 1, 2023, the UPS Retirement Plan ceased future benefit accruals for non-union participants. Instead, non-union employees began receiving retirement contributions of 5% to 8% of eligible compensation to the UPS 401(k) Savings Plan, based on years of vesting service. This replaced the previous structure, which provided contributions ranging from 3% to 8% for employees hired after July 1, 2016, prior to 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. (1) Correctly identifies the key change: the UPS Retirement Plan ceased future benefit accruals for non-union participants effective January 1, 2023, which aligns with the ground truth. This addresses the core of the question and maintains contextual relevance. (2) However, the quantitative and structural details are inaccurate. The LLM claims that non-union employees began receiving 5% to 8% retirement contributions to the UPS 4001(k) Savings Plan based on vesting service, replacing previous 3% to 8% contributions for post-July 2016 hires. This information is not present in the original answer and introduces new details (specific 401(k) contribution percentages and their linkage to vesting service) that are unsupported by the ground truth. The original answer does not mention any replacement plan or contribution changes to the 401(k), only that benefit accruals were frozen. (3) The multi-hop reasoning is partially sound in identifying the accrual cessation as a structural change, but it fails to accurately synthesize the full scope of the plan’s description in 2022 and 2023. The original answer emphasizes the transformation from an active to a closed plan for non-union employees, without referencing offsetting benefits. By introducing unverified details about 401(k) contributions, the LLM overreaches and injects potentially misleading information. (4) While the main event (accrual freeze) is correctly identified and dated, the addition of unsupported quantitative claims significantly undermines factual accuracy. Hence, the correctness and quantitative accuracy scores are moderate. The qualitative accuracy is limited by incorrect synthesis, though the reasoning framework is partially valid. Contextual relevance remains high as the response directly addresses the evolution of the benefit structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 510,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Between 2022 and 2024, Amazon significantly expanded its short-term credit facilities. In 2022, Amazon had a $1.0 billion secured revolving credit facility with a maturity in October 2022, bearing interest at LIBOR plus 1.40%. By 2024, Amazon had a $15.0 billion unsecured revolving credit facility with a maturity extending to November 2028, with interest at the applicable benchmark rate plus 0.45%. Additionally, in October 2024, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility, with interest at the Secured Overnight Financing Rate plus 0.45%. Outstanding borrowings under these facilities were minimal in 2024, with no borrowings under the $15.0 billion facility and only $147 million and $151 million in other short-term credit facilities as of December 31, 2023 and 2024, respectively. The structure shifted from a smaller, secured facility to larger, unsecured facilities with longer maturities and lower interest rate margins.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. Key correct elements include the $15.0 billion unsecured revolving credit facility in 2024 with interest at benchmark rate plus 0.45%, the $5.0 billion 364-day facility added in October 2024 at SOFR plus 0.45%, and the $147 million and $151 million in other short-term borrowings as of December 31, 2023 and 2024, respectively. However, the LLM incorrectly states that in 2022 Amazon had a $1.0 billion secured facility at LIBOR plus 1.40%, whereas the ground truth specifies a $7.0 billion unsecured facility at benchmark rate plus 0.50% with a 0.04% commitment fee and no outstanding borrowings. The LLM also omits the commitment fee details for both years and incorrectly characterizes the 2022 facility as secured and smaller. Additionally, the LLM fails to mention the $7.2 billion in unused letters of credit as of end-2021 and the increase to $8.3 billion by end-2024, which is a significant omission in assessing credit utilization. (2) Quantitative inaccuracies include the wrong credit capacity in 2022 ($1.0 billion vs. $7.0 billion), incorrect interest rate (LIBOR +1.40% vs. benchmark +0.50%), and missing commitment fees. The 2024 figures for the $15.0 billion and $5.0 billion facilities are correct, as are the $147M and $151M borrowings. (3) The multi-hop reasoning is partially sound—the model correctly identifies the expansion in credit capacity and improved terms in 2024, and notes minimal utilization. However, it fails to accurately synthesize the full evolution due to incorrect baseline data for 2022 and missing details on letters of credit and fee reductions. (4) The contextual relevance is high as the answer addresses the evolution of credit facilities, capacity, rates, and utilization. However, due to significant quantitative errors in the 2022 baseline and missing key metrics (commitment fees, letters of credit), the correctness and quantitative accuracy scores are moderate. The qualitative reasoning is reasonable but based on flawed input data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 555,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Costco's use of variable-priced contracts for energy purchases remained consistent between 2022 and 2023, as the company continued to enter into variable-priced contracts for some electricity, natural gas, and fuel purchases on an index basis. This approach, combined with fixed-price contracts for certain facilities, reflects Costco's strategy to partially mitigate commodity price risk while balancing cost management and operational flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly states that Costco maintained its use of variable-priced contracts for energy purchases from 2022 to 2023 on an index basis, covering electricity, natural gas, and fuel for gas stations—consistent with the original answer. There are no numeric values to verify, so quantitative accuracy is 10. (2) The answer is complete in addressing the evolution (consistency over time) and the implication for risk management strategy. However, it adds that fixed-price contracts are used for 'certain facilities,' which, while plausible, is not mentioned in the ground truth and introduces information not confirmed by the source. This slightly affects qualitative accuracy. (3) The multi-hop reasoning is sound: the model correctly infers that continued use of variable-priced contracts indicates a stable commodity price risk management strategy. The mention of 'balancing cost management and operational flexibility' is a reasonable interpretation but goes slightly beyond the original answer’s more neutral tone stating 'no significant shift.' (4) Contextual relevance is high—the response directly addresses the question’s focus on evolution and strategic implications. Overall, the answer is semantically equivalent with minor extrapolation, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 377,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "Between 2022 and 2024, NVIDIA AI Enterprise evolved from being a comprehensive software suite for developing and deploying generative AI applications to a more integrated and expanded role within NVIDIA's data center offerings. In 2022, NVIDIA AI Enterprise was positioned as a key component of its AI solutions, offering tools like NVIDIA NIM, NeMo, and AI Blueprints to streamline AI workflows. By 2024, it had become a central part of a broader, full-stack data center platform, incorporating GPUs, CPUs, DPUs, and the new Blackwell architecture, which enhanced its capabilities for generative AI and accelerated computing workloads. This evolution reflects NVIDIA's strategy to provide end-to-end AI solutions that combine hardware, software, and cloud services for enterprise and data center customers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of NVIDIA AI Enterprise from 2022 to 2024 in broad strategic terms, aligning with the ground truth that it transitioned from a foundational component to a more central, monetized offering. However, it introduces specific tools—NVIDIA NIM, NeMo, and AI Blueprints—that are not mentioned in the original answer and cannot be verified from the provided ground truth, which may over-specify capabilities. Additionally, the mention of the 'Blackwell architecture' and integration with CPUs and DPUs, while contextually plausible, extends beyond the scope of the original answer, which only notes these as part of broader data center expansions, not explicitly tied to AI Enterprise. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present, hence score of 10. (3) The multi-hop reasoning is partially sound: the model infers a strategic evolution consistent with the original answer, but adds unverified technical details and product integrations not present in the ground truth, weakening the qualitative accuracy. The core logic—that AI Enterprise became more central and integrated—is correct. (4) The answer is contextually relevant and addresses the strategic positioning and commercial evolution question directly. The correctness score is 7 because the central claim about strategic evolution is accurate and well-articulated, but the inclusion of unsupported specifics (tools, architectures) introduces minor factual overreach, preventing a higher score despite strong overall alignment in theme and direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 453,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Between 2023 and 2024, Pfizer's contractual obligations related to Paxlovid evolved significantly. In 2023, the company recorded a non-cash revenue reversal of $3.5 billion due to expected returns of EUA-labeled Paxlovid inventory, while in 2024, a favorable final adjustment of $771 million was recorded after 5.1 million treatment courses were returned. Additionally, in 2024, Pfizer supplied 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost, recognizing $442 million in revenue. These adjustments and the transition of Paxlovid to commercial markets indicate a decline in government-driven sales and a shift toward commercial revenue, suggesting that future revenue expectations for Paxlovid are likely to be lower compared to its peak in 2022 and 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the $3.5 billion non-cash revenue reversal in 2023 related to expected returns of EUA-labeled Paxlovid, it introduces a 'favorable final adjustment of $771 million' in 2024 due to 5.1 million treatment courses returned — this figure is not present in the ground truth and contradicts it. The ground truth states that as of December 31, 2024, remaining performance obligations totaled $1 billion, with no mention of a $771 million adjustment or 5.1 million returned courses. Additionally, the claim that Pfizer supplied 1.0 million treatment courses to the SNS at no cost while recognizing $442 million in revenue is not supported by the original answer and introduces unverified details. (2) Quantitative accuracy is low: the $3.5 billion reversal is correct, but the $771 million and $442 million figures are unsupported, and the 5.1 million returned courses conflict with the 6.5 million expected return mentioned in 2023. The $1 billion remaining obligation in 2024 is omitted entirely, which is a key data point. (3) The reasoning is partially sound in identifying a shift from government to commercial markets, but the conclusion that future revenue expectations are 'likely to be lower' contradicts the ground truth's interpretation — which sees the $1 billion in remaining obligations as a sign of stabilization and improved outlook, not continued decline. The multi-hop synthesis fails because the model does not connect the reversal in 2023 to the emergence of defined forward obligations in 2024. (4) Contextual relevance is high — the answer addresses contractual obligations and revenue expectations directly and uses appropriate financial and strategic language — but factual errors severely undermine correctness. The omission of the $1 billion forward-looking obligation, a cornerstone of the ground truth, results in a misleading narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 528,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google's exposure to new regulatory costs in international markets evolved in both scope and nature. In 2022, the focus was on general regulatory challenges such as foreign ownership restrictions, import/export controls, and geopolitical tensions, with a mention of evolving foreign policy landscapes affecting regulatory costs. By 2024, the scope expanded to include more specific regulatory developments, such as data privacy and AI-related regulations, with a heightened emphasis on compliance with new customer requirements and the transfer of personal data (e.g., between the EU and the UK). The nature of the challenges also shifted to include more direct impacts from AI and data governance, reflecting increased global scrutiny of technology firms and their data practices.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in the description of the nature and scope of Google's regulatory challenges in 2022 and 2024. While the ground truth states that in 2022, Google specifically highlighted 'data transfers between the EU and the UK' and 'new customer requirements' as part of evolving foreign policy impacts, the LLM incorrectly broadens this to include 'foreign ownership restrictions, import/export controls, and geopolitical tensions,' which are not mentioned in the original answer. This misrepresents the focus of 2022 risks. In 2024, the ground truth emphasizes new language about 'uncertainty regarding regulatory outcomes' and 'liabilities under local laws that may not offer due process or clear legal precedent'—critical qualitative escalations that the LLM fails to mention. Instead, the LLM cites 'AI-related regulations' and 'data governance' as new developments, which are not present in the original answer and introduce speculative content. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors here, hence a score of 10 by default. (3) The multi-hop reasoning is partially sound in that the model attempts to compare the evolution of regulatory exposure across years, but it fails to accurately synthesize the actual content from the filings. The LLM introduces elements (AI regulation, foreign ownership) not present in the ground truth, indicating a failure in faithful information retrieval and synthesis. (4) The contextual relevance is relatively high because the answer addresses the evolution of regulatory costs and attempts a year-over-year comparison with some correct elements (e.g., data transfers between EU and UK). However, the correctness score is limited to 5 due to significant factual deviations in the nature and scope of the regulatory challenges described, undermining the qualitative accuracy despite correct framing and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 537,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "Between 2022 and 2023, UPS's approach to funding postretirement medical benefits remained consistent in that expected benefit payments were primarily sourced from plan trusts and corporate assets. No significant changes were noted in the sources used for these payments during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that UPS's funding approach for postretirement medical benefits remained unchanged between 2022 and 2023, with expected benefit payments sourced from both plan trusts and corporate assets. There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense—however, the temporal references (2022 and 2023) are accurate, satisfying the date-related requirements. The answer is semantically equivalent to the ground truth: while the LLM uses the phrase 'primarily sourced' and 'no significant changes,' this does not distort the meaning, as the original answer confirms continuity in language and funding sources. The multi-hop reasoning is sound—comparing UPS's disclosures across two years—and the entities (UPS, postretirement medical benefits, plan trusts, corporate assets) are correctly identified. The only minor shortcoming is that the LLM slightly softens the certainty by saying 'primarily' and 'no significant changes,' whereas the ground truth explicitly states the language 'remained unchanged,' which is a stronger and more precise claim. Despite this, the core factual content and synthesis are correct. Thus, the answer is highly accurate with only a slight deviation in precision of phrasing, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 384,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "From its introduction in 2022, NVIDIA AI Enterprise was positioned as a comprehensive suite of enterprise-grade AI software, integrated with NVIDIA's GPU infrastructure. By 2024, its role and scope expanded significantly, with broader supply and integration across data center, cloud, and on-premises environments. The platform now includes tools like NVIDIA NIM for enhanced token throughput, NVIDIA NeMo for model customization, and AI Blueprints for secure deployment, supporting generative AI applications at scale. Additionally, NVIDIA AI Enterprise is offered alongside DGX Cloud and is optimized for use with the Blackwell architecture, enabling enterprises to develop, train, and deploy AI models more efficiently and securely.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: NVIDIA AI Enterprise was introduced in 2022 as an enterprise AI software suite and evolved by 2024 into a more comprehensive platform. The inclusion of NVIDIA NIM, NeMo, and AI Blueprints is correctly stated. The 2.5x increase in token throughput from NIM is implied through 'enhanced token throughput' though not explicitly quantified—this minor omission prevents a perfect score. (2) No incorrect numbers or dates are present; the years 2022 and 2024 are correctly used. While the ground truth specifies a 2.5x improvement in token throughput, the LLM mentions 'enhanced token throughput' without stating the exact figure—this is a slight gap in quantitative detail but not an error. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of the platform across time, integrates components (NIM, NeMo, Blueprints), and links it to broader deployment (cloud, on-prem, data center) and integration with DGX Cloud and Blackwell architecture—information consistent with the expected evolution. (4) The answer is contextually excellent, directly addressing the role and scope evolution. The mention of DGX Cloud and Blackwell optimization adds relevant, plausible context not in the original but does not contradict it. Overall, the answer is factually correct, well-reasoned, and only slightly less specific on performance metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 402,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "From 2022 to 2024, ExxonMobil's proved reserves through equity companies increased significantly, particularly in the United States and Asia. In 2022, equity companies contributed 20 net productive development wells drilled, while by 2024, proved reserves from equity companies totaled 1,481 million oil-equivalent barrels, with Asia alone accounting for 1,276 million barrels. This growth indicates a strategic focus on expanding reserves in key regions, especially in Asia, where investments and discoveries have been substantial. The increase suggests a strengthening of ExxonMobil's global footprint and a deliberate effort to leverage equity partnerships for resource development.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, ExxonMobil's proved reserves from equity companies were 14 million barrels gross (1 million net), but the LLM incorrectly cites '20 net productive development wells drilled'—a completely different metric unrelated to reserves. By 2024, the ground truth reports 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, whereas the LLM claims '1,481 million oil-equivalent barrels'—a fabricated aggregate not supported by the data and inconsistent in both magnitude and unit. The LLM's figure appears to be a miscalculated or invented number. (2) The quantitative accuracy is very low: none of the key reserve numbers match the ground truth. The LLM introduces oil-equivalent barrels without conversion methodology, and the Asia-specific figure of 1,276 million barrels has no basis in the provided data. (3) While the LLM correctly infers a strategic shift toward Asia, which aligns with the ground truth, this correct reasoning is based on false data. The multi-hop synthesis fails because it uses incorrect metrics (development wells instead of reserves) and invents reserve totals. (4) Contextual relevance is moderate because the answer addresses the evolution of reserves and regional strategy, but the core factual foundation is flawed, undermining the validity of the conclusion. The strategic interpretation is plausible but not reliably supported by the data presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 427,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "The financial relationship with Google Network Partners between 2022 and 2024 has primarily remained consistent in terms of their role in revenue generation and cost structure. Google Network Partners continue to contribute to advertising revenues through platforms like AdMob, AdSense, and Google Ad Manager, with revenues typically recognized on a gross basis, where amounts billed to customers are recorded as revenues and payments to partners are classified as cost of revenues. In 2024, there was no significant change in the nature of this relationship, although increased investments in technical infrastructure and data centers may have indirectly impacted the scale of operations involving these partners. No specific changes in the cost structure related to Google Network Partners were highlighted in the provided documents.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses a key evolution highlighted in the ground truth. While it correctly states that Google reports revenue on a gross basis and payments to partners as cost of revenues, it claims there was 'no significant change' in the relationship between 2022 and 2024. This contradicts the original answer, which notes a shift in financial reporting emphasis—from a revenue-centric view in 2022 (gross reporting) to a cost- and cash flow-centric framing in 2024, where payments to partners are highlighted as a primary use of operating cash. This evolution in narrative and financial emphasis is a critical qualitative difference that the LLM fails to capture. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the absence of numbers does not detract from the need to report a documented shift in financial framing. (3) The multi-hop reasoning is weak: the model should have synthesized the change in reporting tone and focus across years, but instead defaults to asserting consistency. The original answer reflects a nuanced shift in how the relationship is financially contextualized, which requires connecting revenue recognition practices with evolving cash flow disclosures—a synthesis the LLM does not perform. (4) Correctness is scored at 5 due to accurate description of the ongoing structure but major omission of the evolving emphasis. Quantitative accuracy is 10 because no numbers are involved and no false claims are made. Qualitative accuracy is 5 due to correct entity identification (Google Network Partners, revenue recognition) but flawed reasoning about change over time. Contextual relevance is 8 because the answer addresses the right topic and scope but lacks the temporal comparison insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 492,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "Between 2022 and 2023, UPS's financial impact from undesignated foreign currency forward contracts on earnings volatility decreased significantly. In 2023, the company recognized a loss of $7 million in \"Investment income and other\" from these contracts, compared to a loss of $69 million in 2022, indicating a substantial reduction in earnings volatility from non-hedged foreign currency exposures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) The numbers cited—$7 million loss in 2023 and $69 million loss in 2022—are not present in the original answer (ground truth) and are factually unsupported by the provided information. The original answer does not mention any specific dollar amounts related to losses or investment income from undesignated forward contracts, nor does it state any reduction in earnings volatility. (2) The LLM introduces specific financial figures and a comparison that do not appear in the source, making the quantitative claims entirely fabricated. There is no mention of 'Investment income and other' or any loss amounts in the ground truth. (3) The reasoning is flawed: the original answer describes an evolution in disclosure practices and transparency—not a change in actual financial impact or volatility levels. The LLM incorrectly interprets increased disclosure clarity as a reduction in earnings volatility, which is a misrepresentation of the information. (4) While the LLM attempts to address the question about evolution in strategy and impact on earnings volatility, it fails to capture the actual nature of the change—enhanced disclosure and structured reporting—instead inventing a narrative about decreasing losses. The contextual relevance is moderate because it addresses UPS and the topic of foreign currency forward contracts, but the core facts and reasoning are incorrect. Thus, the correctness score is low due to major factual and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 421,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Between 2022 and 2023, Costco's membership format continued to play a central role in its profitability strategy by reinforcing member loyalty and generating consistent fee revenue. In 2022, membership fee revenue increased by 9%, driven by new member sign-ups, upgrades to Executive memberships, and higher renewal rates. By 2023, membership fee revenue grew further by 5%, supported by new sign-ups and Executive upgrades, although the growth rate slowed slightly compared to the prior year. This evolution reflects Costco's ongoing focus on expanding its membership base and enhancing the value proposition for members, which in turn supports long-term profitability through recurring fee revenue and increased sales from loyal customers.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific numerical claims—9% membership fee revenue growth in 2022 and 5% in 2023—that are not present in the original ground truth answer and cannot be verified from the provided context. These figures are likely fabricated or inferred incorrectly, which severely undermines quantitative accuracy. (2) The original answer focuses on qualitative evolution in language used in filings (e.g., 'integral part of our business' in 2022 vs. 'integral part of our business and profitability' in 2023) and introduces a new concern in 2023 about lower renewal rates in newer markets affecting worldwide renewal rates. The LLM answer omits this key shift in narrative and risk disclosure, which is central to the question about how the role evolved. (3) While the LLM correctly identifies that membership drives loyalty and fee revenue, and that Executive upgrades and sign-ups contribute to growth, it fails to perform the necessary multi-hop reasoning to contrast the strategic emphasis and emerging risks between the two years as detailed in the ground truth. Instead, it introduces unsupported financial metrics, weakening the reasoning chain. (4) Despite these issues, the answer remains contextually relevant by addressing membership's role in profitability and loyalty, and it maintains correct entities (Costco, membership format, Executive memberships). However, the inclusion of unverified percentages and omission of the nuanced shift in risk reporting and language consolidation leads to a partial correctness score. The answer captures the general direction but misses the specific evolution documented in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 453,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "NVIDIA's approach to CUDA has evolved significantly between 2022 and 2024, with a stronger emphasis on integration within the broader data center platform and software ecosystem. In 2022, CUDA was highlighted as a foundational element of the accelerated computing platform, supporting diverse markets like Gaming, Data Center, and Automotive. By 2024, CUDA's role expanded as part of a full-stack innovation strategy, now complemented by new technologies such as CPUs and DPUs, and integrated with AI-specific tools like NVIDIA AI Enterprise, NIM, and NeMo. This evolution reflects CUDA's deepening integration into data center-scale infrastructure and enterprise AI workflows, enhancing its utility for generative AI, training, and deployment across industries.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of CUDA between 2022 and 2024, with accurate qualitative descriptions and strong contextual relevance. (1) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies the shift in CUDA's role from a foundational accelerated computing tool in 2022 to a more deeply integrated component of a full-stack data center platform by 2024. It accurately reflects the expansion into enterprise AI workflows and integration with data center technologies like CPUs and DPUs. (3) The LLM mentions NVIDIA AI Enterprise, NIM, and NeMo as part of the evolved ecosystem, which aligns with the broader trend described in the ground truth, though these specific tools are not mentioned in the original answer. While not incorrect, this introduces details beyond the source, slightly diluting fidelity. The ground truth emphasizes CUDA-X, acceleration libraries, APIs, and SDKs as the structural evolution—this key point is missing in the LLM response, representing a minor omission in completeness. (4) Despite this, the reasoning is sound, the multi-hop synthesis across years and strategic positioning is accurate, and the answer directly addresses the question about integration within the data center and software ecosystem. The answer is semantically close to the original and conveys the strategic shift effectively, warranting a high correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 414,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "From 2023 to 2024, Pfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly. In 2023, Paxlovid generated $1,279 million in revenue, but a $3.5 billion non-cash revenue reversal was recorded due to expected returns of EUA-labeled inventory by the U.S. government. By 2024, Paxlovid revenue increased to $5,716 million, with a favorable $771 million adjustment in Q1 reflecting fewer returned treatment courses than estimated. Additionally, in Q3 2024, Pfizer supplied 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost, recognizing $442 million in revenue. Deferred revenues for Paxlovid decreased from $5.1 billion in 2023 to $2.2 billion in 2024, with remaining obligations expected to be recognized through 2028.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies the $3.5 billion non-cash revenue reversal in 2023 related to expected returns of EUA-labeled Paxlovid from the U.S. government, it fabricates or misrepresents nearly all other financial figures. The claim that Paxlovid generated $1,279 million in revenue in 2023 and $5,716 million in 2024 is not supported by the ground truth, which does not provide annual Paxlovid revenue totals. Similarly, the $771 million favorable adjustment in Q1 2024 and the $442 million revenue from supplying 1.0 million treatment courses to the SNS at no cost are not mentioned in the original answer and appear to be hallucinated. The deferred revenue figures ($5.1 billion in 2023 down to $2.2 billion in 2024) are also not present in the ground truth. (2) The only correct number is the $3.5 billion reversal, which matches the original. However, the remaining performance obligations of $1 billion by end-2024 and their recognition from 2025–2028 are omitted in favor of incorrect deferred revenue figures. The LLM introduces new data points (e.g., SNS delivery, Q1 adjustment) with precise numbers that cannot be verified against the ground truth. (3) The multi-hop reasoning is partially sound in that it attempts to show a shift from uncertainty in 2023 to more defined obligations in 2024, but it fails to accurately reflect the nature of this evolution. The original emphasizes a shift to firm contracts with $1 billion in remaining performance obligations, while the LLM focuses on deferred revenue trends and fabricated adjustments. (4) Despite the detailed narrative, the answer is only contextually relevant and structurally aligned with the question; the core financial evolution is misrepresented. The correctness score is low due to major quantitative errors, though some conceptual framing (evolution from reversals to forward-looking revenue) is directionally accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 541,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil has significantly increased its strategic emphasis on Guyana between 2022 and 2024, as evidenced by its reporting of reserves development and the inclusion of Guyana as an \"advantaged asset\" in its 2024 disclosures. In 2022, Guyana was highlighted as a key growth area with reserves additions, particularly in the context of proved undeveloped reserves tied to large-scale projects. By 2024, Guyana is explicitly listed as one of the core components of ExxonMobil's \"Advantaged Volume Growth\" strategy, reflecting its role in driving earnings through high-impact projects and its integration into the company's long-term growth and capital allocation priorities. This evolution underscores Guyana's growing importance as a strategic and financial cornerstone for ExxonMobil.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the LLM does not repeat the exact figure of '1.3 billion oil-equivalent barrels (GOEB)' from 2022, it correctly characterizes Guyana as a significant reserves growth area with proved undeveloped reserves linked to large-scale projects—consistent with the original answer. No incorrect numbers are presented, and the absence of the specific 1.3 billion figure is a minor omission rather than an error. (2) The years 2022 and 2024 are correctly used as reference points, and the evolution in strategic framing—from reserves growth to advantaged asset status—is accurately captured. (3) The multi-hop reasoning is sound: the LLM synthesizes information across time (2022 vs 2024), identifies the shift in disclosure language (from reserves contributor to 'Advantaged Volume Growth'), and correctly infers the strategic elevation of Guyana in ExxonMobil’s portfolio. (4) Semantically, the LLM conveys the same core message: Guyana evolved from a reserves growth story to a central, earnings-driving asset. The only minor gap is the lack of explicit mention of 'proved undeveloped reserves' and the precise 1.3 GOEB figure, which slightly reduces completeness but does not affect overall correctness. Contextual relevance is excellent, directly addressing the evolution in strategic emphasis through disclosures on reserves and advantaged assets.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 396,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "The planned utilization of the ATR 72-600F aircraft decreased from 2022 to 2024, with FedEx committing to purchase 24 units in 2022 and only 10 units in 2024. This reduction indicates a diminished role for the ATR 72-600F in the company's fleet strategy, as FedEx shifted focus toward other aircraft types like the B767F and B777F, which are more fuel-efficient and better aligned with long-term operational goals.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both numbers and entities. The original answer states that the ATR 72-600F fleet was projected to decrease from 11 units in 2023 to 1 by 2026 in 2022 projections, but by 2024, the outlook shifted to maintaining 7 units in 2025 and declining to 3 by 2026. The LLM instead claims FedEx committed to purchasing 24 units in 2022 and 10 in 2024, which contradicts the ground truth and introduces a company (FedEx) not mentioned in the original. (2) Quantitative inaccuracies are severe: no mention of FedEx or purchase commitments exists in the ground truth; the numbers 24 and 10 are entirely fabricated. The actual data involves planned fleet size evolution (11 → 1 vs. 7 → 3), not purchase orders. (3) The reasoning is flawed: the LLM infers a continuous decline and strategic de-emphasis, but the ground truth shows a reversal of initial phase-out plans, indicating a more sustained role than previously expected. The multi-hop synthesis fails—instead of comparing projected fleet sizes across years from company filings, it invents a narrative around purchases by a different company. (4) Scores are low due to complete factual inaccuracy, incorrect entities, and flawed logic. Contextual relevance is moderate because the answer addresses fleet strategy and aircraft role, but with wrong data and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 379,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "NVIDIA's approach to offering Omniverse evolved significantly between 2022 and 2024 by enhancing its integration with AI and simulation platforms. In 2022, Omniverse was primarily positioned as a real-time 3D design and virtual world simulation tool for enterprise use, supporting collaboration and digital twin applications. By 2024, Omniverse had expanded its role as a foundational platform for industrial AI and digital twin applications, with deeper integration into NVIDIA's broader AI ecosystem, including the DRIVE Hyperion platform for autonomous vehicles and the Blackwell architecture for generative AI and accelerated computing. This evolution reflects NVIDIA's strategy to unify its platforms across AI, simulation, and real-time collaboration, enabling more advanced use cases such as autonomous vehicle testing and industrial digitalization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of NVIDIA's Omniverse from a 3D simulation and collaboration platform in 2022 to a more advanced, enterprise-focused digital twin and industrial AI platform by 2024. The core factual elements—shift in positioning, enterprise focus, use cases like autonomous vehicles and industrial digitalization—are all correct. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; the years 2022 and 2024 are used correctly. (3) The multi-hop reasoning is sound: the LLM synthesizes information about Omniverse’s changing role and integrates it with broader NVIDIA platforms like DRIVE Hyperion and Blackwell architecture, which reflects accurate understanding of platform integration even if not explicitly detailed in the original answer. The mention of Blackwell architecture is plausible for 2024 context and consistent with NVIDIA's trajectory, though not specified in the ground truth—this is a minor extrapolation but not factually incorrect. (4) The answer is semantically equivalent to the original, capturing the shift from general 3D collaboration to specialized simulation and AI integration. Only minor deduction in qualitative accuracy due to added specificity (e.g., DRIVE Hyperion, Blackwell) not present in the original, which, while reasonable, slightly extends beyond the provided ground truth. Overall, the response is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 425,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "Between 2022 and 2023, Google Play's role in generating non-advertising revenue continued to grow as part of Alphabet's broader strategy to expand offerings beyond advertising. In 2023, non-advertising revenues, including those from Google Play, contributed to a $19.0 billion increase in Google Services revenues. Google Play generates non-advertising revenue primarily through the sale of apps, in-app purchases, and digital content in the Google Play store. While specific revenue figures for Google Play are not provided, the overall growth in non-advertising revenue and the emphasis on platforms like Google Play indicate its increasing contribution to Alphabet's financial performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Google Play's role in generating non-advertising revenue through app sales, in-app purchases, and digital content, and notes its growing importance within Alphabet's strategy. However, it introduces a specific quantitative claim—'a $19.0 billion increase in Google Services revenues'—that is not present in the original answer and cannot be verified from the provided ground truth. This figure may be factually incorrect or misattributed, as the ground truth does not mention any such dollar increase tied to non-advertising revenue or Google Play specifically. (2) The quantitative inaccuracy significantly impacts correctness; while the original answer focuses on strategic evolution and categorization (e.g., shift to 'platforms'), the LLM introduces unsupported financial data, which undermines trust in the response. There are no calculations in the original, so the LLM's inclusion of a $19.0B figure represents a fabrication or misalignment with the source. (3) Qualitatively, the reasoning is partially sound: the LLM captures the directional trend of Google Play becoming more central to non-ad revenue and reflects the strategic intent. However, it fails to mention the key qualitative shift described in the original—namely, the transition to a 'more defined revenue stream under platforms' and the strategic re-categorization indicating monetization maturity. This omission reduces completeness in capturing the evolution. (4) Contextual relevance is high because the answer stays focused on Google Play’s revenue role and timeframe. Overall, the answer gets the general direction right but fails on key specifics and introduces unverified numbers, warranting a moderate score of 6 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 479,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods in workers' compensation reserving for guaranteed cost and excess of deductible business remained significant for recent accident years but saw some refinement. For guaranteed cost business, expected loss ratio methods are still primarily applied only in the most recent accident year, as older years rely more on development methods due to consistent historical data. For excess of deductible business, expected loss ratio methods were given significant weight in the most recent five accident years in 2022, and this approach continued into 2023. However, the 2023 disclosures emphasize adjustments for rate changes, loss trends, and market conditions more explicitly, reflecting a continued shift toward incorporating updated assumptions and external factors in reserve estimation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures that in 2022, AIG gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, and for excess of deductible business, this approach applied to the most recent five accident years—this is factually correct and consistent with the original answer. The continuation of this methodology into 2023 is also correctly stated. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the question or ground truth, so quantitative accuracy is not compromised; all time periods (e.g., 'most recent accident year', 'five accident years') are correctly referenced, earning full marks for quantitative accuracy. (3) The LLM adds that 2023 disclosures emphasized adjustments for rate changes, loss trends, and market conditions more explicitly—while this nuance is not directly stated in the ground truth, it is a reasonable interpretation of increased transparency in reporting and does not contradict the source. However, the LLM omits the key point from the ground truth that incurred and paid losses in 2023 were now presented net of reinsurance and undiscounted, which is a specific and important refinement in reporting. Additionally, the LLM fails to mention the continued impact of large deductible business slowing claims reporting patterns in 2023, a point emphasized in both years in the original answer. These omissions prevent a higher score. (4) The answer remains highly contextually relevant, directly addressing the evolution of AIG's reserving methods for the two business lines across 2022–2023. Overall, the reasoning is sound and the synthesis across years and business types is accurate, but the missing details from the 2023 update reduce completeness and qualitative accuracy slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 506,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024 by reorganizing its categories to align with strategic priorities. In fiscal 2022, the categories included \"Secure, Agile Networks,\" \"Internet for the Future,\" \"Collaboration,\" \"End-to-End Security,\" and \"Optimized Application Experiences.\" By fiscal 2024, the categories were simplified to \"Networking,\" \"Security,\" \"Collaboration,\" and \"Observability.\" Specifically, the \"Collaboration\" category remained a key segment in both years, but its composition slightly changed. In fiscal 2022, it included Meetings, Collaboration Devices, Calling, Contact Center, and CPaaS offerings, while in fiscal 2024, it included Webex Suite, Collaboration Devices, Contact Center, and CPaaS offerings. Revenue in the Collaboration category decreased by 5% in fiscal 2022 compared to 2021 and further declined by 9% in fiscal 2023, but showed a modest 2% increase in fiscal 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Cisco's product category segmentation between fiscal 2022 and 2024, noting the consolidation from six to four categories and the retention of 'Collaboration' as a key segment. It accurately states that in fiscal 2022, Collaboration was one of several categories and that by fiscal 2024, the structure shifted to include Networking, Security, Collaboration, and the new Observability category. This aligns with the ground truth regarding category restructuring and the introduction of Observability. However, the LLM introduces specific revenue performance data—'decreased by 5% in fiscal 2022', 'declined by 9% in fiscal 2023', and '2% increase in fiscal 2024'—which are not present in the original answer and cannot be verified against the provided ground truth. These quantitative claims significantly impact the correctness score because they introduce unverified financial metrics not supported by the knowledge graph. While the qualitative description of category changes is largely accurate and contextually relevant, the inclusion of unsupported percentages undermines quantitative accuracy. Additionally, the LLM provides more granular detail on Collaboration offerings (e.g., Webex Suite, CPaaS) not present in the original answer, which may reflect external knowledge but goes beyond the ground truth. The multi-hop reasoning is sound in structure—comparing category lists across years—but the added numerical claims suggest overreach beyond the source data. Thus, while the core structural evolution is correctly captured, the unsupported revenue figures reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 447,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen's disclosure for the 3.125% 2025 Notes shows a shift in the interest rate framework from 2022 to 2023. In 2022, the effective interest rate on these notes was LIBOR + 1.8%, whereas in 2023, it transitioned to SOFR + 2.1%. This change reflects the broader industry shift from LIBOR to SOFR as the benchmark interest rate. The notional amount of $1,000 million remained consistent in both years.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes but did *not* disclose any specific interest rate framework (e.g., LIBOR or SOFR). However, the LLM incorrectly states that in 2022 the interest rate was 'LIBOR + 1.8%', which is not supported by the original data. The 2023 disclosure correctly identifies the rate as 'SOFR + 2.1%', which the LLM gets right. The notional amount of $1,000 million is consistent and correctly reported. (2) Quantitative accuracy is partially correct: the $1,000 million amount is accurate, and the SOFR + 2.1% in 2023 is correct. However, the fabricated LIBOR + 1.8% in 2022 is a major error with no basis in the ground truth. (3) The multi-hop reasoning is flawed: the model assumes a transition from LIBOR to SOFR, which may be contextually plausible given industry trends, but the original data does not support that Amgen disclosed *any* rate framework in 2022. Thus, the synthesis is incorrect—there was no 'transition' disclosed, only an introduction of the rate framework in 2023. (4) Contextual relevance is moderate because the answer addresses the evolution of disclosure and mentions the correct note and amount, but the core factual claim about 2022 is invented, undermining correctness. The qualitative reasoning is misleading despite using plausible financial logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 401,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 326 BCF at the end of 2022 to 296 BCF at the end of 2024, indicating a slight decline. This suggests a potential strategic shift or reduced focus in the region, as the company has not significantly expanded its reserves there during this period. However, the company's equity affiliates in the region still hold substantial reserves, showing continued involvement in the area through partnerships.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that natural gas reserves increased from 326 BCF in 2022 to 296 BCF in 2024, when in fact the reserves decreased from 326 to 296 BCF. This misrepresents the direction of change, which is a critical factual error. The correct trend is a decline, not an increase. (2) The numerical values themselves (326 BCF and 296 BCF) are accurate and match the ground truth, and the two-year period (2022 to 2024) is correctly identified. However, the comparison is reversed, leading to an incorrect conclusion about the trend. The calculation of a 30 BCF decrease is implied but not stated, and the mischaracterization as an 'increase' invalidates the quantitative reasoning. (3) The multi-hop reasoning is partially sound in that the model attempts to interpret the reserve change in the context of strategic positioning, but the flawed premise (increase vs. decrease) undermines the logic. The mention of equity affiliates is extraneous and not supported by the original answer or ground truth, introducing unsupported information. (4) The correctness score is 4 due to accurate base numbers but a major error in trend interpretation. Quantitative accuracy is low (3) because the directional comparison is wrong. Qualitative accuracy is moderate (5) as the general idea of strategic repositioning is plausible, but reasoning is based on incorrect data. Contextual relevance is 7 because the answer addresses the geographic region, time frame, and strategic implications as required, despite factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 426,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Alphabet's repurchase activity of Class C Capital Stock increased from $52.577 billion in 2022 to $52.868 billion in 2023, indicating a slight rise in the company's commitment to returning value to shareholders. This suggests that Alphabet continued to prioritize capital allocation toward share repurchases, signaling confidence in its financial position and a strategic focus on optimizing shareholder equity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, Alphabet repurchased $59.3 billion in 2022 and $62.2 billion in 2023 across Class A and Class C shares. However, the LLM incorrectly states $52.577 billion in 2022 and $52.868 billion in 2023, which are both numerically wrong and do not match the actual figures. Additionally, the LLM focuses only on Class C shares, while the original answer specifies that repurchases included both Class A and Class C shares, indicating a misrepresentation of the scope. (2) The calculation of year-over-year change is also incorrect: the actual increase is $62.2B - $59.3B = $2.9B, whereas the LLM implies an increase of only ~$291 million, which is off by orders of magnitude. The LLM fails to mention the April 2023 $70.0 billion authorization or the $36.3 billion remaining as of year-end 2023—key elements showing strategic capital allocation expansion. (3) While the LLM correctly infers that increased buybacks signal confidence and shareholder value focus, this qualitative reasoning is based on incorrect data and incomplete synthesis. The multi-hop aspect—linking repurchase amounts across years and board authorization to capital strategy—is partially understood but poorly executed due to factual errors. (4) The contextual relevance is moderate because the answer addresses the general theme of capital allocation and shareholder returns, but the severe quantitative inaccuracies and omission of critical details (new authorization, remaining capacity) undermine the correctness. Thus, the correctness score is low at 3 due to major factual and numerical errors, despite some relevant conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 472,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "Between 2022 and 2023, AIG expanded the use of frequency/severity methods to additional lines of business, particularly in U.S. Workers' Compensation and U.S. Excess Casualty. In 2023, the frequency/severity method was explicitly mentioned as part of a combination approach for workers' compensation, reflecting the line's long-tail nature and the need for detailed segmentation due to risk-sharing features like high deductibles. In contrast, in 2022, the method was not specifically highlighted for these lines. The reasoning behind this usage centers on the need to address complex, long-tail claims with variable emergence patterns, ensuring more accurate reserve estimation by analyzing both claim frequency and severity trends.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of AIG's use of frequency/severity methods between 2022 and 2023, noting the expansion into U.S. Workers' Compensation in 2023 and the method's prior use in short-tail lines like U.S. Property in 2022. It accurately captures the reasoning—increased complexity, risk-sharing features, and long-tail claim dynamics—as drivers for broader application. However, the LLM incorrectly adds 'U.S. Excess Casualty' as a line of business where frequency/severity methods were applied in 2023, which is not mentioned in the ground truth. The ground truth only confirms U.S. Workers' Compensation as the new line. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not compromised; all temporal references (2022, 2023) are correct. (3) The multi-hop reasoning is largely sound: the model correctly infers a strategic shift from short-tail to long-tail lines and links it to risk-sharing and deductibles. The only flaw is the inclusion of an unverified line of business (Excess Casualty), which represents a minor factual overreach. (4) The correctness score is 8 due to this minor inaccuracy, but the answer remains strong in completeness, reasoning, and relevance. Qualitative accuracy is slightly reduced for the same reason, while contextual relevance and quantitative accuracy are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 391,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "From 2022 to 2023, Amgen's financial relationship with BeiGene evolved as follows:\n\n- **Cost Recovery**: Net costs recovered from BeiGene for oncology product candidates decreased from $199 million in 2022 to $109 million in 2023.\n- **Product Sales**: Product sales from Amgen to BeiGene increased from $64 million in 2022 to $125 million in 2023.\n- **Profit and Loss Sharing**: Profit and loss share expenses related to the initial product-specific commercialization period declined from $53 million in 2022 to $40 million in 2023.\n\nOverall, while product sales increased, cost recovery and profit-sharing expenses decreased in 2023 compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $199 million to $109 million in cost recovery, $64 million to $125 million in product sales, and $53 million to $40 million in profit and loss sharing expenses—each value exactly matches the original answer. (2) The answer is complete, addressing all three financial dimensions (cost recovery, product sales, profit and loss sharing) across both years as required by the question. (3) Entity accuracy is perfect: Amgen and BeiGene are correctly identified, and the financial metrics are appropriately named and contextualized (e.g., 'oncology product candidates' and 'commercialization period' align with typical SEC filing terminology). (4) The reasoning is sound and reflects correct multi-hop synthesis: the model correctly infers trends (decrease in cost recovery and P&L expenses, increase in sales) without overreaching, and the summary captures the evolution of the relationship. While the LLM omits the interpretive sentence about 'maturation of the collaboration,' this does not detract from factual correctness, as the core question focuses on financial metrics. The answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 351,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "From 2022 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region experienced significant changes. In 2022, the region had 326 BCF of reserves, which declined to 296 BCF by 2024. Key changes during this period included revisions, with 2024 showing a minor upward revision of 9 BCF. Purchases contributed 4 BCF in 2022 but were absent in 2024. Production reduced reserves by 24 BCF in 2022 and 25 BCF in 2024. Additionally, equity affiliate reserves in the region increased from 50 BCF in 2022 to 62 BCF in 2024, driven by purchases and technical revisions.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the starting and ending reserve volumes (326 BCF in 2022 and 296 BCF in 2024), which matches the ground truth. However, it introduces significant inaccuracies: it claims a 9 BCF upward revision occurred in 2024, while the ground truth states the 9 BCF revision was in 2023. It also incorrectly reports 4 BCF in purchases in 2022 and states production was 24 BCF in 2022—neither of which is supported by the original answer, which does not mention 2022 production or purchases. Additionally, the LLM introduces new information about 'equity affiliate reserves' increasing from 50 to 62 BCF, which is entirely absent from the ground truth and unsupported. (2) Number verification: 326 BCF (2022) and 296 BCF (2024) are correct; 25 BCF production in 2024 is accurate. However, 9 BCF revision misattributed to 2024 instead of 2023; 4 BCF purchases in 2022 and 24 BCF production in 2022 are fabricated. Equity affiliate data is extraneous and incorrect. (3) Multi-hop reasoning is partially sound in tracking reserve changes over time but fails in synthesis—incorrectly assigning revisions and purchases to years and introducing unverified entities. The model appears to hallucinate data points to fill gaps. (4) Correctness and quantitative accuracy are scored at 5 due to partial factual alignment but major errors in key details. Qualitative accuracy is 5 due to flawed reasoning and unsupported inferences. Contextual relevance is 8 because the answer addresses the right region, company, and general trend, but with significant factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 438,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "From 2022 to 2024, FedEx's planned usage of the B767F aircraft evolved from being a key part of its fleet modernization to a more limited role. In 2022, FedEx had committed to purchase 38 B767F aircraft through 2026, but by 2024, these commitments were reduced to only 14 B767F aircraft, all scheduled for delivery in 2025. This shift indicates a strategic fleet planning move toward prioritizing newer, more fuel-efficient aircraft like the B777F and a reduced reliance on the B767F, likely to optimize long-term operational efficiency and cost savings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, FedEx projected using 14 B767F aircraft in 2023 and 2024 in 2022, with a reduction to 10 by 2025. By 2024, projections showed 11 for 2025 and only 3 by 2026. The LLM incorrectly states that FedEx 'committed to purchase 38 B767F aircraft through 2026' in 2022 and that this was reduced to '14 B767F aircraft, all scheduled for delivery in 2025' by 2024 — this contradicts the ground truth, which discusses planned usage, not purchase commitments or delivery schedules. There is no mention of 38 aircraft or delivery timelines in the original answer. (2) Quantitative accuracy is very low: the numbers 38 and 14 are presented in a completely different context (purchases vs. planned usage), and the timeline (deliveries in 2025) is fabricated. The correct trend is a revision from 10 to 11 (2025) and then down to 3 (2026), not a reduction from 38 to 14. (3) The multi-hop reasoning is flawed — the LLM conflates fleet usage projections with purchase commitments and delivery plans, failing to correctly synthesize the evolution of projected aircraft usage over time. While it correctly infers a strategic shift toward reducing B767F reliance, the reasoning is based on incorrect data. (4) Contextual relevance is moderate because the answer addresses fleet planning strategy and reduction in B767F use, but the incorrect data undermines the conclusion. Correctness and quantitative accuracy are low due to major factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 424,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "Between 2022 and 2023, AIG's use of Expected Loss Ratio Methods evolved in terms of the lines of business and the reasoning behind their application. In 2022, the Expected Loss Ratio methods were primarily used for the latest accident year and in conjunction with ground-up claim projections for certain lines like aviation. By 2023, the Expected Loss Ratio method was applied more broadly, particularly in short-tail classes and for business written in excess of a deductible, especially in the most recent five accident years. The reasoning for this application included the need for reliable estimates when loss development patterns were inconsistent, losses emerged slowly, or there was limited historical loss data. Additionally, the expected loss ratios were adjusted for rate changes, loss trends (including inflation), and market conditions, reflecting a more dynamic and responsive approach to reserving.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but includes significant inaccuracies in the description of AIG's use of Expected Loss Ratio Methods between 2022 and 2023. While it correctly notes a broader application in 2023 and mentions use in recent accident years, it incorrectly identifies the lines of business involved. The original answer specifies that in 2023, AIG applied the method more broadly in U.S. Workers' Compensation, a long-tail line, whereas the LLM claims it was applied to short-tail classes, which contradicts the ground truth. This is a major qualitative error. (2) There are no explicit numerical values (e.g., percentages, dollar amounts) in either answer, so quantitative accuracy is not heavily applicable; however, the time periods (2022, 2023, recent five accident years) are consistent and correctly framed, warranting a high score here. (3) The multi-hop reasoning is partially sound—the model recognizes a shift in application scope and reasoning (e.g., inconsistent development patterns, slow emergence)—but fails to correctly synthesize the key evolution: from high-severity short-term contexts (like aviation) to long-tail, structurally complex lines (like Workers' Compensation). Instead, it mischaracterizes the 2023 application as being in short-tail classes, which undermines the core of the multi-hop insight. (4) Contextual relevance is fair because the answer discusses reserving methods, accident years, and reasoning like slow loss emergence, which are relevant, but the misidentification of business lines reduces its accuracy. The adjustment for rate changes and inflation is plausible but not mentioned in the ground truth, introducing unsupported detail. Overall, the answer captures some correct reasoning but misses the central factual shift in business lines, justifying a mid-range correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 508,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Cisco's positioning around Enterprise Data Center Transformation between 2022 and 2024 has evolved with a stronger emphasis on strategic alliances and addressing a more competitive landscape. In 2022, Cisco highlighted its strategic alliances with companies like Apple, Equinix, Google, IBM, Microsoft, Samsung, and AWS to drive innovation and market expansion. By 2024, the company continued to pursue these alliances but noted increased competitive pressures, particularly from entities that are both partners and competitors. This dual dynamic has intensified as the enterprise data center undergoes technological convergence, with competitors leveraging acquisitions and alliances to offer end-to-end solutions, thereby challenging Cisco's market position and necessitating a more strategic and adaptive approach to partnerships and product development.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of Cisco's evolving positioning around Enterprise Data Center Transformation between 2022 and 2024, with accurate emphasis on strategic alliances and competitive dynamics. It correctly identifies the technological convergence shaping the data center landscape and acknowledges the complexity of partner-competitor relationships. However, it introduces specific alliance partners (Apple, Samsung) not mentioned in the ground truth and not verifiable from the provided knowledge graph, which only notes that strategic partners were aligning with or acquiring competitors—reducing business with Cisco—without naming those partners. The ground truth highlights a shift in 2024 toward alliances focused on industry advancement and new market creation, and explicitly notes the emergence of Nvidia Corporation as a new competitive entrant, which the LLM answer omits. While the LLM captures the dual nature of partnerships (co-opetition) and increased competitive pressure, it fails to reflect the specific evolution in alliance strategy and the updated competitive landscape including Nvidia. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but scored as 10 by default. The reasoning is sound but not fully aligned with the multi-hop synthesis from the knowledge graph. The answer remains contextually relevant and well-structured, hence high marks for contextual relevance and qualitative accuracy despite missing key specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 421,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "The effective interest rate for the 3.125% 2025 Notes increased from LIBOR + 1.8% in 2022 to SOFR + 2.1% in 2023, reflecting a shift in the reference rate from LIBOR to SOFR. The notional amount remained unchanged at $1,000 million during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, the notional amount was $5.2 billion (not $1.0 billion), and there is no mention of LIBOR + 1.8% as the effective rate in 2022. Instead, the original answer states that new interest rate swaps were entered into on a $5.2 billion principal, but does not specify the 2022 effective rate. The LLM incorrectly claims the notional amount remained unchanged at $1,000 million, when in fact it decreased from $5.2 billion to $1.0 billion. The only correct quantitative point is the 2023 notional amount of $1.0 billion and the 2023 effective rate of SOFR + 2.1%. (2) The numbers are mostly wrong: $5.2 billion in 2022 is misrepresented as $1.0 billion, and a specific rate of LIBOR + 1.8% is fabricated with no support in the original. The shift from LIBOR to SOFR is plausible contextually but not stated in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to capture the reduction in notional amount and invents a prior rate not present in the source. It also misses the strategic context of dynamic hedging and low interest rates. (4) Correctness and quantitative accuracy are low due to major factual and numerical errors. Qualitative accuracy is low due to incorrect synthesis and missing context. Contextual relevance is moderate because the answer addresses the right topic and correctly identifies the 2023 rate and amount, but misrepresents the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 412,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "Cisco's strategic positioning of AppDynamics has evolved significantly from 2022 to 2024, with a stronger emphasis on its role within observability offerings. In 2022, AppDynamics was highlighted as a key element in Cisco's full-stack observability strategy, alongside ThousandEyes and Intersight, to provide customers with insights from applications to infrastructure. By 2024, AppDynamics was explicitly integrated into the newly established Observability product category, which saw a 27% revenue increase, driven in part by the acquisition of Splunk. This reflects Cisco's growing focus on expanding its observability suite to support customers in monitoring and optimizing cloud-native applications and hybrid environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of AppDynamics' strategic positioning from 2022 to 2024, noting its initial role in Cisco's full-stack observability strategy alongside ThousandEyes and Intersight, and its later integration into a formal 'Observability' product category. However, it introduces a significant factual error by claiming a 27% revenue increase in the Observability category 'driven in part by the acquisition of Splunk.' The Splunk acquisition was not completed until late 2024 and would not have driven revenue growth by that point, and the 27% figure is not present in the ground truth, making this a major quantitative and factual inaccuracy. (2) There are no numbers in the original answer to validate the 27% claim, and the Splunk acquisition context is misrepresented—this acquisition was not part of the 2024 Observability revenue narrative in the provided truth. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the shift from AppDynamics as a component to being subsumed under a broader Observability category. However, it fabricates supporting evidence (revenue growth, Splunk impact), undermining the reasoning. (4) The correctness score is 6 due to correct structural and strategic narrative but major factual overreach. Quantitative accuracy is low (4) due to unsupported percentage and misattributed causality. Qualitative accuracy is 7 because entity identification and timeline logic are mostly correct. Contextual relevance is high (9) as the answer directly addresses the strategic evolution question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 437,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The effective interest rate for the 4.663% 2051 Notes remained at 5.6% in both 2023 and 2022, as there is no indication of a change in the hedging or terms of these notes during this period. The notional amount associated with these notes was consistently $1,500 million in both years.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that in 2022, the 4.663% 2051 Notes were part of a $5.2 billion hedged portfolio, with swaps terminated and replaced at current rates—this context is entirely missing from the LLM response. Instead, the LLM claims the effective interest rate was 5.6% in both years, which contradicts the ground truth that the effective rate in 2023 was SOFR + 4.3%. There is no mention of SOFR or updated hedging terms in the LLM answer. Additionally, while the LLM correctly identifies the 2023 notional amount as $1.5 billion (or $1,500 million), it incorrectly asserts this amount was the same in 2022, whereas the original answer implies a reduction from a larger $5.2 billion pool, suggesting the $1.5 billion figure may be a subset or post-adjustment amount. (2) Quantitatively, the $1.5 billion notional in 2023 is accurate, but the 5.6% effective rate is unsupported and incorrect. The ground truth does not state an effective rate for 2022, but describes a restructuring of hedges, not a static rate. (3) The multi-hop reasoning fails: the LLM did not synthesize the evolution of the hedging strategy, the termination of swaps, or the change in rate benchmark (to SOFR). It incorrectly assumes stability where there was change. (4) Scores are low due to major factual inaccuracies in rates and notional evolution, though the answer is contextually relevant in addressing the right financial instrument and time frame.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 421,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods has evolved in terms of segmentation criteria and lines of business. In 2023, AIG has further refined its segmentation, particularly in U.S. Workers' Compensation, where it groups guaranteed cost and excess of deductible business separately and further segments by state and industry subset when meaningful differences exist. Additionally, unique subsets like U.S. government subcontractor accounts and construction wrap-up business are analyzed separately. For U.S. Excess Casualty, the segmentation includes attachment points and layers within an insured's program, reflecting a strategy toward higher attachment points. These changes indicate a more granular and nuanced approach to reserving, aiming to better capture the unique characteristics and risk profiles of different business segments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of AIG's use of expected loss ratio methods from 2022 to 2023. It accurately identifies the increased granularity in segmentation criteria and specifically highlights U.S. Workers' Compensation as a key line of business where more detailed segmentation was applied in 2023, which matches the original answer. The mention of segmentation by state, industry subset, and unique business types (e.g., government subcontractors, construction wrap-up) reflects the more structured approach described in the ground truth. However, the LLM answer introduces additional detail about U.S. Excess Casualty segmentation by attachment points and layers, which is not mentioned in the original answer and cannot be verified from the provided ground truth. While this may be factually accurate, it introduces information beyond what is confirmed, slightly reducing qualitative accuracy. The absence of explicit comparison to 2022’s more general use of the method (e.g., in sensitivity analysis without detailed segmentation) makes the evolution less clearly contrasted than in the original answer, though the implication of refinement in 2023 is present. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is highly relevant to the question. Semantic equivalence is mostly preserved, with only minor over-enrichment of unverified details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 401,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "PepsiCo's engagement with the 2.850% Senior Notes due 2026 remained consistent between 2023 and 2024, as the notes were authorized and issued in 2023 and continued to be referenced in 2024. In terms of its broader debt issuance strategy, PepsiCo expanded its debt offerings in 2024 by introducing new senior notes, such as the 4.500% Senior Notes due 2029 and the 4.800% Senior Notes due 2034, reflecting a continuation of its approach to diversify maturities and manage its capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PepsiCo maintained engagement with the 2.850% Senior Notes due 2026 from 2023 into 2024, which aligns with the ground truth. However, it introduces incorrect quantitative details about the new senior notes issued in 2024. The ground truth specifies the introduction of a 7.00% Senior Note due 2029 and a 5.50% Senior Note due 2035, while the LLM incorrectly states 4.500% Senior Notes due 2029 and 4.800% Senior Notes due 2034. These discrepancies in interest rates and maturity dates are significant and factually inaccurate. (2) The numbers and dates do not match the original answer—specifically, the percentages (4.500% vs 7.00%, 4.800% vs 5.50%) and maturities (2034 vs 2035) are wrong. There are no calculation errors per se, but the financial instruments described are different, leading to a misrepresentation of PepsiCo’s actual debt strategy. (3) The multi-hop reasoning is partially sound: the model correctly infers continuity in the use of the 2.850% notes and recognizes a broader trend toward diversification in debt issuance. However, because the supporting evidence (the specific new notes) is factually incorrect, the synthesis fails on key details. (4) The contextual relevance is high—the answer addresses both parts of the question (evolution of engagement with the 2026 notes and broader debt strategy) and attempts to draw a strategic conclusion. Due to major factual inaccuracies in the quantitative elements, the correctness score is moderate at 5, with lower quantitative accuracy (4), acceptable qualitative reasoning (6), and strong contextual relevance (8).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 449,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco's exposure to channel partner financing guarantees increased from fiscal 2022 to 2024. In fiscal 2022, the maximum potential future payments under these guarantees were $188 million, while in fiscal 2024, this amount was $127 million. However, when accounting for deferred revenue, the net exposure in 2022 was $179 million and in 2024 was $114 million (after subtracting $13 million in deferred revenue). This indicates a reduction in net exposure, suggesting that Cisco has refined its risk management strategy by either reducing the volume of guarantees or improving the terms of these guarantees to better align with revenue recognition. The company's continued monitoring and adjustment of these guarantees reflect a proactive approach to managing financial risks associated with channel partner financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in fiscal 2022, the volume of channel partner financing was $27.9 billion, with $1.4 billion subject to guarantees. The LLM incorrectly states that the maximum potential future payments were $188 million in 2022 and $127 million in 2024—these figures do not appear in the ground truth and are therefore factually wrong. Additionally, the LLM introduces 'deferred revenue' adjustments ($13 million) and net exposure calculations that are not supported by the original answer. (2) The quantitative values in the LLM response are entirely inconsistent with the ground truth: $188M and $127M vs. $1.4B disclosed exposure in 2022, and no data for 2024. Even allowing for format variations, the magnitude is off by nearly an order of magnitude. There is no mention of deferred revenue or net exposure in the original answer, so these calculations are fabricated. (3) The multi-hop reasoning is flawed. The original answer emphasizes that Cisco stopped disclosing specific figures after 2022, making year-over-year comparisons impossible. The LLM falsely claims precise figures for 2024 and draws conclusions about trends, which contradicts the ground truth's caution about lack of data. The reasoning about risk management strategy is speculative and based on incorrect data. (4) The contextual relevance is moderate—the question is about evolution of exposure and risk management, which the LLM attempts to address—but the factual foundation is so weak that the analysis is invalid. The conclusion about 'refined risk management' is unsupported given the actual lack of transparency post-2022. Thus, the correctness score is low due to major factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 482,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "The 2.45% 2030 Notes had a notional amount of $1,000 million in both 2022 and 2023. In 2022, an interest rate swap was in place for a notional amount of $1,000 million, converting the fixed rate to LIBOR + 1.0%. By 2023, the swap structure was updated to SOFR + 1.3%, reflecting the transition from LIBOR to SOFR as the reference rate. The effective interest rate increased slightly from 2022 to 2023 due to this change in the benchmark rate.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 2.45% 2030 Notes had a $1.0 billion ($1,000 million) notional amount in both 2022 and 2023 and that interest rate swaps were used to convert the fixed rate to a floating rate. It accurately notes the transition from LIBOR to SOFR between the years. However, there is a critical error in the spread: the original answer states that the swap converted the fixed rate to a 'floating LIBOR-based coupon' in 2022 but does not specify the spread as 'LIBOR + 1.0%'. The LLM incorrectly adds a '+1.0%' spread not present in the ground truth, which undermines quantitative accuracy. In 2023, the ground truth confirms the rate became 'SOFR + 1.3%', which the LLM correctly reports. (2) The claim that the 'effective interest rate increased slightly' is speculative and not supported in the original answer; while SOFR + 1.3% may differ from the prior LIBOR-based rate, no comparison of actual effective rates is provided in the ground truth, making this an unsupported inference. (3) The multi-hop reasoning is sound—correctly linking the note's status across years and recognizing the benchmark transition from LIBOR to SOFR—but the addition of an incorrect spread in 2022 and the unsupported conclusion about rate increase reduce factual precision. (4) Despite these issues, the core facts—note outstanding status, notional amount, use of swaps, and benchmark transition—are correct, warranting a score of 7 for overall correctness. Quantitative accuracy is penalized more heavily (6) due to the incorrect spread. Qualitative accuracy is higher (8) due to correct entity identification and logical flow. Contextual relevance is perfect (10) as all information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 473,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "Between 2022 and 2023, FedEx's relationship with Pass-Through Certificates remained consistent in terms of financial guarantees and obligations. In both years, FedEx Express issued $970 million of Pass-Through Certificates, Series 2020-1AA, with a fixed interest rate of 1.875% due in February 2034. These Certificates are secured by 19 Boeing aircraft, with a net book value of $1.8 billion in 2022 and $1.7 billion in 2023. FedEx fully and unconditionally guaranteed the payment obligations of FedEx Express in both years. No new Pass-Through Certificates were issued during this period, and the terms and guarantees remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its core claim. The ground truth states that in 2023, FedEx clarified that pass-through certificates were *not* direct obligations nor guaranteed by FedEx or FedEx Express, marking a significant shift from 2022 when they *were* fully and unconditionally guaranteed. The LLM incorrectly asserts that guarantees remained unchanged and were still in place in 2023, which directly contradicts the ground truth. (2) Quantitatively, the LLM provides some accurate figures: $970 million in certificates, 19 Boeing aircraft, and a net book value of $1.8 billion in 2022 align with the original answer. However, the claim of $1.7 billion in 2023 is unsupported in the ground truth, which does not mention a 2023 value. The interest rate (1.875%) and maturity date (February 2034) are not mentioned in the ground truth and thus appear fabricated. (3) The multi-hop reasoning is flawed: the question asks about the *evolution* of the relationship, implying a comparison and identification of change. The LLM fails this synthesis, asserting consistency where there was a clear policy shift. It does not recognize the critical distinction between 2022 (with guarantees) and 2023 (no guarantees). (4) Scores reflect major factual inaccuracies in both qualitative reasoning and quantitative claims, though some contextual elements (e.g., aircraft count, initial issuance amount) are correct, preventing a score of 0.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 402,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "Mastercard's use of risk mitigation arrangements to manage gross settlement exposure increased from $12,167 million in 2023 to $13,466 million in 2024, as shown in the provided data. This increase indicates that the company is proactively enhancing its risk management strategy by applying more extensive mitigation measures, such as cash collateral and credit enhancements, to reduce potential settlement risks. The evolution reflects Mastercard's commitment to strengthening its risk management framework and ensuring financial stability in the face of settlement uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the risk mitigation amounts for both years ($12,167 million in 2023 and $13,466 million in 2024), matching the ground truth exactly. It also correctly notes the increase in mitigation usage, which aligns with the factual evolution. However, the LLM does not explicitly mention the increase in gross settlement exposure from $75,023 million to $78,385 million, which is a key part of the original answer and the multi-hop nature of the question. While the implication of growing exposure is indirectly supported by increased mitigation, the omission of the actual gross exposure figures reduces completeness. (2) All numeric values cited (mitigation amounts) are accurate and properly formatted; no calculation errors. (3) The reasoning is sound: the model correctly infers that increased use of mitigation reflects a more robust risk management strategy. It appropriately synthesizes the trend across two years and draws a logical conclusion about strategic enhancement. However, full multi-hop synthesis would require referencing both the change in total exposure and the change in mitigated amount, which the LLM partially misses. (4) The answer is contextually excellent—directly relevant, well-articulated, and adds reasonable detail (e.g., mentioning cash collateral and credit enhancements) without overreaching. The qualitative accuracy is high but not perfect due to the missing gross exposure data. Overall, the answer is factually correct on the numbers it includes and provides valid interpretation, warranting a 9 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 436,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments decreased from $426 million as of May 31, 2022, to $146 million as of May 31, 2024. This reduction suggests that the company either reduced its hedging exposure or that some of its hedging contracts matured or were reclassified. The decline indicates a potential decrease in the company's foreign currency risk exposure or a shift in its hedging strategy during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, Nike's total liabilities for foreign exchange forwards and options designated as hedging instruments increased from $48 million in 2022 to $115 million in 2024. However, the LLM claims a decrease from $426 million to $146 million, which is factually wrong on both the direction and magnitude. None of the numbers match: the 2022 figure in the LLM answer ($426M) is nearly 9 times higher than the correct total ($48M), and the 2024 figure ($146M) is 27% higher than the correct $115M. (2) Calculations are also incorrect—there is no mention in the ground truth of a $426M liability in 2022 or $146M in 2024. The LLM appears to have either hallucinated data or misread sources. (3) The multi-hop reasoning is flawed: the question requires comparing liabilities across two years, broken down by balance sheet categories, and interpreting the change. The LLM fails to mention the split between accrued liabilities and deferred income taxes, omits the increase in accrued liabilities from $37M to $110M, and misses the drop in deferred liabilities from $11M to $5M. (4) The conclusion about decreasing exposure contradicts the ground truth, which shows a significant increase in total hedging liabilities, suggesting greater foreign exchange risk or more aggressive hedging. The only partially correct aspect is that the answer addresses the question’s intent—discussing change in liabilities and strategic implications—hence minimal contextual relevance. However, due to severe factual and quantitative errors, the overall correctness is extremely low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 455,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "Between 2022 and 2023, the representation of Bounty within P&G's Baby, Feminine & Family Care segment remained consistent in terms of its inclusion as a major brand under the Family Care sub-category. However, in the 2023 10-K filing, the segment description provided more specific detail about the North American market shares for Bounty and Charmin, stating that market shares were \"over 40% for Bounty and over 25% for Charmin.\" This suggests that Bounty maintains strong brand visibility and market dominance in the paper towel category within North America, reinforcing its position as a key brand in P&G's portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. According to the ground truth, Bounty was not explicitly listed as a key brand in the 2022 10-K, but was explicitly named in the 2023 filing—indicating an increase in visibility. The LLM incorrectly states that Bounty's representation 'remained consistent' as a major brand, which contradicts the ground truth. (2) The LLM introduces specific market share figures—'over 40% for Bounty and over 25% for Charmin'—which are not present in the original answer or supported by the evidence provided. These numbers are entirely fabricated in this context, failing the quantitative accuracy test. (3) The multi-hop reasoning is flawed: the question asks about the evolution of Bounty's representation across two filings and its implication for brand visibility. The LLM fails to identify the key change (from unlisted to explicitly listed) and instead invents new data about market shares to support a conclusion about visibility. This shows a failure to synthesize the actual information across filings. (4) While the LLM attempts to address brand visibility, it does so using incorrect facts and fabricated metrics, undermining the qualitative and quantitative accuracy. The contextual relevance is moderate because it discusses the right segment and brand, but the substance is factually wrong. Correctness score is low due to major factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 401,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Between fiscal 2022 and fiscal 2023, Oracle's hardware business, including Oracle Engineered Systems, remained a smaller portion of total revenues (6% in both years), with revenue recognition continuing to occur at the point of delivery for hardware and related software. However, the strategic emphasis appears to have shifted toward Oracle's cloud services, as cloud services revenues increased from 32% of total revenues in fiscal 2023 to 37% in fiscal 2024. Oracle's hardware business is positioned to support diverse IT environments but is expected to have lower operating margins compared to the cloud and license business due to higher production and support costs. The company continues to invest in hardware R&D but faces challenges from customer demand for cloud infrastructure over traditional hardware.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly notes that hardware revenue recognition occurs at the point of delivery, it fails to mention the key 2023 change in accounting treatment—specifically, the treatment of hardware and related software as a combined performance obligation, which is a central point in the original answer. Additionally, the LLM introduces revenue percentages for cloud services in fiscal 2023 (32%) and 2024 (37%), which are not present in the original answer and are irrelevant to the question about hardware business evolution between fiscal 2022 and 2023. The claim that hardware was 6% of revenue in both years is unsupported in the ground truth, which does not provide revenue percentages. (2) The quantitative inaccuracies include the unsupported 6% hardware revenue figure and the introduction of fiscal 2024 cloud revenue data, which was not part of the original comparison. There are no calculations in the original answer, so no calculation errors are present, but the LLM fabricates metrics. (3) The multi-hop reasoning is flawed: the original answer requires synthesis of changes in revenue recognition policy and strategic emphasis (e.g., R&D investment) between 2022 and 2023. The LLM acknowledges R&D investment but frames it as a continuation rather than a new emphasis in 2023. It also shifts focus to cloud strategy, which distracts from the hardware-specific evolution. (4) The contextual relevance is moderate—the answer discusses Oracle's hardware business and touches on revenue recognition and R&D, but introduces irrelevant cloud revenue projections and omits the key accounting policy shift. The qualitative accuracy is limited by incorrect emphasis and missing core details, leading to a partial but significantly flawed response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 503,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "ERLEADA (apalutamide) sales increased by 26.9% in 2023 compared to 2022, reflecting operational growth of 27.5% and a minor negative currency impact of 0.6%. This significant growth indicates a strong market trajectory, driven by continued share gains and market expansion in Metastatic Castration-Resistant Prostate Cancer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the 26.9% sales growth for ERLEADA from 2022 to 2023, which matches the ground truth calculation based on $1,881 million (2022) and $2,387 million (2023). The exact dollar amounts are not mentioned in the LLM answer, but the percentage growth is accurate and properly reflects the increase. The additional details about operational growth (27.5%) and currency impact (-0.6%) are plausible contextual additions that do not contradict the ground truth and may come from more granular reporting in the 10-K, so they do not reduce accuracy. (2) Quantitative accuracy is perfect: the 26.9% growth is correctly calculated as (2387 - 1881) / 1881 ≈ 0.269 or 26.9%. No numeric errors are present. (3) The multi-hop reasoning is sound—sales performance across two years is compared, and a conclusion about market trajectory is drawn. While the LLM does not explicitly cite the dollar figures, it correctly infers the key trend and supports it with relevant commercial context (market expansion, share gains in mCRPC), which aligns with and enriches the ground truth. (4) The answer is semantically equivalent in conveying the upward trajectory and strong market performance. The omission of exact sales figures slightly reduces completeness but does not impair the core factual correctness. Hence, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 397,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "From 2023 to 2024, CMCSA's relationship with local broadcast television stations has shifted toward greater negotiation and financial dependency, as the company moves away from \"must-carry\" obligations to seeking \"retransmission consent.\" This shift reflects a more competitive environment where local stations can demand payment or concessions for carriage rights, increasing programming costs for CMCSA. Additionally, as traditional multichannel video providers decline, CMCSA faces challenges in maintaining distribution agreements, heightening dependency on securing favorable terms with local stations to ensure nationwide broadcast reach.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the shift in CMCSA's relationship with local broadcast television stations from 2023 to 2024, emphasizing increased dependency due to retransmission consent, which aligns with the ground truth. It accurately captures the move from a competitive to a more interdependent/dependent relationship, particularly in the context of content distribution and carriage rights. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because while the LLM mentions negotiation and financial dependency, it frames the relationship as more competitive in 2024 (e.g., 'more competitive environment'), which contradicts the ground truth's emphasis on reduced competition and increased operational interdependence. The original answer highlights a shift from competition to dependency, whereas the LLM implies ongoing or heightened competition, which misrepresents the nature of the evolution. However, the core multi-hop reasoning—linking retransmission consent, programming distribution, and strategic dependency—is sound and well-synthesized. Contextual relevance is high, as all parts of the question (competitive positioning, dependency, content distribution, time frame) are addressed directly and appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 370,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "Between 2023 and 2024, the value of Held-to-Maturity (HTM) securities held by Mastercard (MA) decreased significantly from $306 million in 2023 to $38 million in 2024. This decline indicates a strategic shift in the company's investment approach, likely moving away from holding longer-term, fixed-income securities toward more liquid or short-term investment options. The reduction in HTM securities suggests a potential reallocation of capital to support other priorities, such as growth initiatives or to adapt to changing market conditions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual information is accurate: the value of HTM securities decreased from $306 million in 2023 to $38 million in 2024, which matches the original answer exactly. (2) Quantitative accuracy is precise—both dollar amounts and years are correctly reported, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly identifies the significant drop and infers a strategic shift in investment policy, including a likely move toward more liquid or short-term investments, which is consistent with the original interpretation. (4) The answer is contextually relevant, addressing both parts of the question—evolution of HTM value and its implication for investment strategy—and provides appropriate, logically supported insights without introducing inaccuracies or irrelevant details. Minor wording differences (e.g., 'strategic shift' vs. 'major shift') do not affect semantic equivalence and are acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 290,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the Always brand remained within the Baby, Feminine & Family Care segment, maintaining its position in the Feminine Care sub-category, which includes both menstrual care and adult incontinence. In 2022, Always was listed as part of the Feminine Care sub-category alongside Tampax and Always Discreet. In 2023, the categorization remained consistent, with Always still positioned under Feminine Care for menstrual products. There is no indication of a repositioning or shift in its product categorization during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in that it correctly identifies Always as remaining within the Baby, Feminine & Family Care segment and associated with Feminine Care in both 2022 and 2023. However, it fails to capture the key evolution noted in the ground truth: the strategic repositioning of Always under a more specific 'Menstrual Care' sub-category within Feminine Care in 2023, reflecting a refined categorization. The LLM incorrectly states there was 'no indication of repositioning,' which contradicts the ground truth. While entities (Always, Tampax, Always Discreet, segment name) and years are accurate, and no numerical data is present to challenge quantitative accuracy, the qualitative reasoning is flawed due to the failure to recognize and report the nuanced but intentional shift in product categorization. This omission significantly undermines the completeness and correctness of the answer, especially for a question specifically asking about evolution in positioning. The answer is contextually relevant and well-structured but misses the core insight of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 311,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023 with a continued strategic emphasis on cloud-based solutions, as reflected in the increased proportion of cloud services revenues (37% in 2024 vs. 32% in 2023 and 25% in 2022). Revenue recognition for Oracle Engineered Systems remains tied to the delivery of hardware products and related software, with revenues recognized at the point of delivery and transfer of ownership. While the hardware business represented 6% of total revenues in both fiscal 2024 and 2023, Oracle continues to invest in research and development to enhance and expand its hardware offerings, aligning with customer demand for integrated cloud and on-premise solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Oracle's hardware business, including Engineered Systems, represented 6% of total revenue in fiscal 2023 and 2024, which aligns with the ground truth. It also accurately notes that revenue recognition occurs at the point of delivery, consistent with both years. However, the LLM introduces cloud services revenue percentages (37% in 2024, 32% in 2023, 25% in 2022) that are not mentioned in the original answer and are irrelevant to the specific question about Engineered Systems, potentially distracting from the core focus. While not factually incorrect per se, this information is extraneous and not supported by the ground truth provided. (2) The key quantitative claim—6% of total revenue in 2023 and 2024—is accurate and matches the ground truth. No calculations are required, but the LLM correctly reports the percentage and time frame. The mention of cloud revenue proportions lacks sourcing from the original answer and may reflect hallucination or external knowledge not in the ground truth. (3) The multi-hop reasoning is partially sound: the LLM correctly synthesizes the financial contribution (6%) and revenue recognition policy across years. However, it fails to mention the key evolution noted in the ground truth—that 2022 did not disclose a specific percentage, while 2023 introduced one, marking a shift in transparency. This omission weakens the qualitative assessment of evolution. Also missing is the strategic emphasis on R&D and new risk factors like manufacturing partner performance and competition with cloud infrastructure, which are explicitly cited in the original answer as part of Oracle’s evolving strategic communication. (4) The correctness score is 7 because the core financial figure and revenue recognition are accurate, but important nuances about increased disclosure clarity and expanded strategic context in 2023 are omitted. Quantitative accuracy is 8 due to correct percentages and no numerical errors, though extraneous data slightly undermines precision. Qualitative accuracy is 7 due to partial reasoning and missing strategic details. Contextual relevance is 9 because the answer stays focused on Oracle and Engineered Systems, despite the irrelevant cloud revenue digression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 607,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Comcast's relationship with representation firms in advertising sales has evolved between 2023 and 2024 by expanding the use of representation agreements to sell advertising units on behalf of third parties, particularly in domestic and international markets. In 2023, the company noted that it works with representation firms as an extension of its sales force to sell a portion of advertising units, recording revenue net of agency commissions. By 2024, this strategy appears to have been further integrated, with a continued emphasis on leveraging representation firms to enhance advertising sales across owned networks and digital platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the 2023 model where Comcast worked with representation firms as an extension of its sales force, selling a portion of advertising units and recording revenue net of agency commissions. It also accurately reflects the 2024 evolution: the shift to more formalized representation agreements to sell advertising on behalf of third parties. The mention of 'domestic and international markets' and 'owned networks and digital platforms' adds contextual detail not contradicted by the original, though slightly more expansive in scope. The core evolution—from a co-selling model to a formal representation structure—is correctly captured. There are no numeric inaccuracies (dates: 2023, 2024 are correct; no financial figures to verify). The reasoning is sound and demonstrates proper multi-hop synthesis across years and strategic models. The only minor shortcoming is that the LLM does not explicitly use the phrase 'deeper strategic alignment' or directly state the shift 'from co-selling to formalized representation' as clearly as the original, but the meaning is semantically equivalent. Thus, the answer is highly accurate with only slight room for improved precision in framing the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 361,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle's approach to its industry-specific hardware offerings between fiscal 2022 and fiscal 2023 remained relatively consistent in terms of revenue recognition, with hardware revenues generally recognized at the point of delivery when ownership transfers to the customer. However, there was a slight strategic shift as Oracle emphasized its Oracle Cloud Services, leading to a relative decline in the proportion of hardware revenues (6% of total revenues in both fiscal 2024 and 2023) compared to the growing share of cloud services. This reflects Oracle's broader strategy to pivot customers toward cloud-based solutions while continuing to invest in hardware research and development to enhance existing offerings and support hybrid deployment models.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly notes that hardware revenue is recognized at the point of delivery, it fails to mention the key evolution in fiscal 2023: the more detailed explanation of combined performance obligations (hardware plus related software) and the clarification around revenue recognition timing. Instead, the LLM implies continuity, missing a core aspect of the evolution. Additionally, the LLM introduces a statistic—'6% of total revenues in both fiscal 2024 and 2023'—that is not present in the original answer and refers to fiscal 2024, which is outside the scope of the question (2022–2023). This undermines quantitative accuracy. (2) The percentage figures (6%) and reference to fiscal 2024 are unsupported by the ground truth and introduce incorrect data. The original answer does not provide any revenue percentages or figures, so including them constitutes a factual overreach. (3) The reasoning partially captures a strategic shift toward cloud services, which aligns with Oracle’s broader direction, but mischaracterizes the strategic emphasis evolution. The original answer highlights that Oracle increased its R&D investment focus and provided a more strategic innovation narrative in 2023, whereas the LLM frames the shift as a decline in hardware due to cloud growth—downplaying the enhanced strategic focus on hardware innovation mentioned in 2023. This reflects incomplete multi-hop synthesis: the model conflates hardware revenue trends with strategic emphasis without grounding in the provided truth. (4) Despite these issues, the answer is contextually relevant and captures a general trend of cloud transition. It retains some qualitative accuracy by noting continued R&D investment and hybrid deployment support, which loosely aligns with the original’s mention of ongoing R&D. However, the introduction of unverified quantitative data and failure to capture the nuanced evolution in revenue recognition and strategic framing reduce correctness and quantitative accuracy significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 566,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "IMBRUVICA (ibrutinib) experienced a significant decline in sales between 2022 and 2023, with sales dropping by 13.7% (from $3.784 billion in 2022 to $3.264 billion in 2023). This decline was primarily attributed to global competitive pressures from novel oral agents entering the market, which impacted its market share and sales performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the sales figures for IMBRUVICA in 2022 ($3.784 billion) and 2023 ($3.264 billion), and accurately calculates the 13.7% decline. These numbers match the ground truth exactly, and the calculation is correct: (3.784 - 3.264) / 3.784 ≈ 0.137. (2) The primary reason cited—competitive pressures from novel oral agents—is present in both the LLM and original answers. However, the LLM answer omits additional context from the ground truth, such as pandemic-related delays in new patient starts in 2022 and the potential factors in 2023 like market saturation or treatment shifts in oncology. While the core contributing factor (competition) is correctly identified, the explanation is slightly less complete. (3) The multi-hop reasoning is sound: the model correctly synthesizes sales data across two years and attributes the change to external market dynamics. It links the performance drop to competitive pressures, which is a key element in the original answer. (4) The quantitative accuracy is perfect. Qualitative accuracy is high but not full due to the missing nuance around pandemic impacts and possible treatment shifts. Contextual relevance is excellent—the answer directly addresses both parts of the question (sales evolution and contributing factors) with accurate, focused information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 374,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "Comcast's involvement with Universal Beijing Resort from 2023 to 2024 shows a slight decrease in debt levels, from $3.5 billion to $3.4 billion, with the debt secured by the resort's assets and equity interests. Comcast maintains a 30% ownership stake, and the resort remains consolidated under Comcast due to its power to direct economic activities. Financial risk exposure is limited to Comcast's equity interest, with no guarantees or liquidity arrangements in place, indicating stable but ongoing exposure tied to the resort's performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the debt levels for Universal Beijing Resort decreasing from $3.5 billion in 2023 to $3.4 billion in 2024, matching the ground truth. It also accurately notes Comcast's 30% ownership stake and the continued consolidation of the resort as a VIE (variable interest entity), with financial risk exposure limited to its equity interest. All key facts—debt amounts, ownership percentage, consolidation status, and risk limitation—are factually correct. (2) Quantitatively, the numbers are precise: $3.5 billion and $3.4 billion debt levels are correctly stated. While the ground truth specifies a $3.1 billion term loan reducing to $3.0 billion, this detail is omitted in the LLM answer but does not contradict it; the overall debt figures are accurate, and the slight reduction is properly reflected. No calculations are required, but comparisons over time are valid. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2023 to 2024), entities (Comcast and Universal Beijing Resort), and financial dimensions (debt, ownership, risk). It correctly infers that consolidation implies Comcast has power over economic activities, consistent with VIE accounting. The absence of guarantees or liquidity support aligns with the limited risk exposure described in the ground truth. (4) The only minor shortcoming is the lack of explicit mention of the term loan breakdown ($3.1B → $3.0B), which adds granularity to the debt reduction. However, this omission does not affect the overall correctness, as the total debt figures are accurate and the trend is properly characterized. Wording differs slightly (e.g., 'secured by the resort’s assets' is additional context not in the original but not incorrect), but semantic equivalence is maintained. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 541,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "From 2022 to 2023, the financial commitment related to future lease payments for build-to-suit facilities and equipment increased significantly, from approximately $3.4 billion to $0.9 billion. However, the $0.9 billion in 2023 is expected to commence from 2025 to 2027, while the $3.4 billion in 2022 was set to commence from 2023 to 2024. This indicates a strategic shift in FedEx's leasing approach, with a focus on deferring new build-to-suit commitments to later years, potentially to align with long-term operational needs and optimize capital allocation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of change: it states that the financial commitment 'increased' from $3.4 billion to $0.9 billion, when in fact it decreased significantly. This misrepresents the core quantitative trend. The correct evolution is a reduction from $3.4 billion in 2022 to $0.9 billion in 2023. (2) While the dollar amounts ($3.4 billion and $0.9 billion) and commencement periods (2023–2024 for 2022, 2025–2027 for 2023) are correctly cited, the comparison is inverted, making the quantitative analysis incorrect despite accurate individual values. The calculation of change (a ~73.5% decrease) is implied but misrepresented as an increase. (3) The multi-hop reasoning is partially sound in linking the timing shift to a strategic deferral of commitments, which aligns with the ground truth's interpretation of a shift toward fewer long-term build-to-suit leases and extended timelines. However, the flawed premise (increase vs. decrease) undermines the logic. (4) Contextual relevance is moderate because the answer addresses the right topic and draws a plausible strategic conclusion, but the incorrect directional claim severely compromises factual correctness. The conclusion about deferring commitments is somewhat supported by the delayed commencement dates, but the reduced dollar amount suggests a contraction in leasing activity, not just deferral. Thus, the overall correctness score is low due to the major quantitative misstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 415,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Between 2023 and 2024, Mastercard's relationship with Dynamic Yield LTD evolved from an acquisition in 2022 to being fully integrated into the company's operations. In 2022, Mastercard acquired Dynamic Yield for $325 million, and by 2023, the purchase accounting for this acquisition was finalized. In 2024, there were no further material changes to the acquisition or its integration. This acquisition and integration indicate that Mastercard is strategically focused on expanding its capabilities in data-driven solutions and enhancing its value-added services, aligning with its broader goals of growth, diversification, and innovation in the payments ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Mastercard acquired Dynamic Yield in 2022 for $325 million and that the integration was complete by 2023, with no material changes in 2024. These facts align with the ground truth. However, the LLM omits the key detail that $200 million of goodwill was attributed to synergies, which is a specific financial disclosure mentioned in the original answer. While not central, this omission reduces completeness. More importantly, the LLM mischaracterizes Mastercard's strategic focus as being on 'data-driven solutions' without referencing the pivot to cybersecurity via the Recorded Future acquisition in 2024, which is a critical inference in the ground truth. This weakens the qualitative reasoning. (2) Quantitatively, all numbers and dates are accurate: acquisition year (2022), amount ($325 million), and timeline (finalized by 2023, no changes in 2024). Format is consistent and correct. (3) The multi-hop reasoning is partially sound—LLM correctly links acquisition to integration and infers strategic focus on innovation. However, it fails to synthesize the contrast between Dynamic Yield (completed integration) and new 2024 acquisitions like Recorded Future, missing the strategic shift indicated in the ground truth. This is a key multi-hop element. (4) Correctness is scored 7 because core facts are right but strategic interpretation is incomplete. Quantitative accuracy is 10 due to correct numbers. Qualitative accuracy is 7 due to missing synthesis of strategic pivot. Contextual relevance is 9—answer is highly relevant but misses a nuanced strategic implication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 446,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers at Lowe's was amended and restated on May 26, 2022, as indicated in the 2024 filing under Exhibit 10.28, which references a filing date of November 27, 2024. There is no indication of further amendments to the plan between 2022 and 2024 based on the provided documents.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all quantitative aspects: it accurately identifies the most recent amendment date of the Severance Plan for Senior Officers as May 26, 2022, and correctly references the 2024 filing date of November 27, 2024, under Exhibit 10.28. These details match the ground truth exactly. The answer also correctly notes that no further amendments are indicated between 2022 and 2024, which aligns with the original answer's implication that the May 2022 amendment was the latest change. However, the LLM omits the 2022 reference to the prior version of the plan (amended May 29, 2020, filed August 26, 2020, Exhibit 10.29), which was part of the original answer and relevant to showing the evolution of the plan. While the core evolution is captured—namely that the plan was updated in 2022 and filed in 2024—the absence of the earlier version's details reduces completeness slightly, particularly in fully addressing the 'evolution' aspect across both years. The reasoning is sound and contextually appropriate, with accurate entity and document identification. The omission is minor but prevents a perfect score on qualitative accuracy. Overall, the answer is semantically very close and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 344,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This increase in fair value suggests that market perceptions of the company's debt improved over this period, likely reflecting greater confidence in Netflix's financial stability and creditworthiness.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in interpreting the direction of change in fair value. While it correctly states the fair value was $999 million on December 31, 2021, and $872 million on December 31, 2023, it incorrectly describes this as an 'increase' when it is actually a decrease. This misstatement undermines the entire conclusion. (2) Quantitatively, the dollar amounts and dates are accurate and match the ground truth, so numerical precision is acceptable. However, the comparison (increase vs decrease) is factually wrong. (3) The reasoning is fundamentally flawed: a drop in fair value from $999M to $872M indicates deteriorating market confidence or rising yield demands, not improved perceptions. The LLM incorrectly infers improved financial stability and creditworthiness, which contradicts the implication of declining fair value. This shows a failure in multi-hop reasoning—while the model retrieves correct numbers, it fails to synthesize them with financial logic. (4) Contextual relevance is high because the answer addresses both parts of the question (change in fair value and market perception) and focuses on the correct instrument and time period. However, due to the reversal of the key financial interpretation, the qualitative accuracy is very low, dragging down the overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 376,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA (ibrutinib) sales declined by 13.7%, from $3.784 billion to $3.264 billion. This decline indicates increasing competitive pressures in the oncology segment, which impacted its market position despite continued leadership in its therapeutic area.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, IMBRUVICA sales were $4,369 million in 2022, not $3.784 billion as stated in the LLM answer. The 2023 sales figure of $3.264 billion is correct. The calculated decline is therefore from $4,369M to $3,264M, which is a 25.2% drop, not 13.7% as claimed. The LLM underreports both the starting value and the percentage decline. (2) The calculation verification: ($3.784B to $3.264B) implies a decline of ($3.784 - $3.264)/$3.784 ≈ 13.7%, which is mathematically correct based on the numbers provided, but those numbers are factually wrong. The correct calculation is ($4,369 - $3,264)/$4,369 ≈ 25.2%, confirming the ground truth. (3) The qualitative reasoning is partially sound: the conclusion about competitive pressures and weakening market position is consistent with the context, especially given the mention of growing competitors like DARZALEX and ERLEADA in the original answer. However, the LLM fails to incorporate this comparative growth, weakening the multi-hop synthesis. It correctly identifies the decline as indicative of market challenges, but lacks supporting evidence from peer product performance. (4) Contextual relevance is strong—the answer addresses both parts of the question (sales evolution and market position implication) and stays focused on oncology segment dynamics. However, due to major factual errors in key financial figures and the resulting incorrect percentage change, the correctness and quantitative accuracy scores are low. The answer is not sufficiently accurate to reflect the true extent of IMBRUVICA's decline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 454,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve decreased from $168 million to $222 million. The increase in the shrink reserve had a larger impact on net earnings, with a 10% change in shrinkage rate affecting net earnings by approximately $32 million in 2024, compared to a $17 million impact from a 10% change in LCNRV reserve. These reserves reflect management's estimates of inventory losses and markdowns, influenced by historical trends and operational performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that the LCNRV reserve 'decreased from $168 million to $222 million', which is incorrect—the reserve actually increased from $168M to $222M. This misstatement undermines the quantitative accuracy. All other numbers are correct: the shrink reserve increase from $414M to $427M is accurate, and the sensitivity impacts on net earnings—$32M for a 10% change in shrinkage rate and $17M for a 10% change in LCNRV assumptions—are correctly reported. (2) The calculation implications for net earnings are accurately conveyed, but the direction of the LCNRV change is wrong, which affects interpretation. The original answer emphasizes growing reserve needs, especially for shrinkage; the LLM answer incorrectly implies a decline in LCNRV reserve, which contradicts the trend. (3) The multi-hop reasoning is partially sound—the model correctly identifies the two reserve types, their values in 2022 and 2024, and links them to earnings sensitivity. However, the erroneous direction of the LCNRV change indicates a failure in synthesizing the correct trend, likely due to a data misread. (4) Contextual relevance is high as the answer addresses both reserves, their evolution, and earnings implications. Qualitative reasoning is mostly logical but based on flawed input. Quantitative accuracy is reduced due to the incorrect directional claim despite correct endpoint values. Correctness score is 6 due to significant but not total factual error—core data points are present but one key trend is inverted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 431,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "Qulipta's status and financial contribution evolved significantly from 2022 to 2023. In 2023, Qulipta received regulatory approvals from the FDA in April and the European Commission in August for the preventive treatment of chronic migraine in adults. Financially, its net revenues increased by more than 100% in 2023, driven by strong market share uptake and market growth following these approvals.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it claims Qulipta received FDA approval in April 2023 and European Commission approval in August 2023, but in reality, Qulipta was approved by the FDA in 2021 for chronic migraine, so the 2023 approvals are factually incorrect. The European Commission approval in August 2023 is not supported by the ground truth and is likely confused with another product or company. (2) Quantitatively, the LLM states that net revenues increased by 'more than 100%' in 2023, but the ground truth reports actual figures: $405 million in the U.S. and $3 million internationally in 2023. Without 2022 revenue numbers, the 'more than 100%' claim cannot be verified and is misleading. The ground truth does not mention revenue growth percentage, so this is an unsupported inference. (3) The qualitative reasoning is partially sound in identifying a shift from development to commercialization, and the mention of regulatory approvals aligns thematically with the asset reclassification in 2022. However, the LLM fails to mention the key 2022 event: the $1.0 billion reclassification of R&D intangible assets upon approval, which is central to Qulipta’s status change. This missing multi-hop link between regulatory approval and accounting reclassification significantly weakens the reasoning. (4) Contextual relevance is fair—the answer addresses evolution in status and financial contribution—but omits critical financial details and introduces false dates and metrics. While the direction of evolution (development to commercialization) is correct, the factual foundation is flawed, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 456,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Between 2022 and 2023, Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities increased, as evidenced by the rise in the receivable amount from Resideo—from $157 million in 2022 to $187 million in 2023. This indicates that Honeywell incurred higher environmental costs during 2023, which were partially offset by Resideo under their indemnification and reimbursement agreement. While this arrangement reduces immediate financial exposure, the continued reliance on Resideo suggests ongoing environmental risks tied to legacy sites, which could impact Honeywell's cash flows and financial stability if Resideo's ability to reimburse is compromised.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Honeywell's financial dependency on Resideo increased between 2022 and 2023. The ground truth indicates that the dependency remained consistent, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters up to $140 million per year. The LLM incorrectly introduces receivable amounts of $157 million in 2022 and $187 million in 2023, which are not present in the ground truth and contradict the stated cap of $140 million per year. These numbers appear fabricated or misattributed. (2) Quantitative accuracy is severely compromised: the cited receivables exceed the contractual maximum of $140 million, and no such increase is supported by the original answer. There is no mention in the ground truth of receivables rising from $157M to $187M, nor is there any indication of a year-over-year increase in dependency. (3) The multi-hop reasoning is flawed. While the LLM correctly identifies the existence of an indemnification agreement, it draws an incorrect conclusion about evolving dependency based on unsupported numerical trends. The original answer emphasizes stability in the arrangement, whereas the LLM asserts an increase in dependency, which is not substantiated. (4) Contextual relevance is moderate—the response addresses environmental liabilities and risk exposure, and correctly references the indemnification framework. However, the core factual claim about changing dependency is false, undermining the validity of the conclusion about risk exposure. The reasoning about potential risks if Resideo cannot reimburse is plausible but built on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 463,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of 'original maturity' for cash equivalents has remained consistent between 2022 and 2024, with both years defining cash equivalents as highly liquid investments with an original maturity of three months or less from the time of purchase. However, the composition of short-term investments increased significantly, rising from $2,897 million in 2024 to $3,893 million in 2025, indicating a potential shift toward a more aggressive or diversified approach to managing short-term liquidity and possibly capitalizing on higher-yield short-term instruments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Target's definition of 'original maturity' for cash equivalents remained at three months or less from 2022 to 2024, which aligns with the ground truth. However, it introduces financial data about short-term investments increasing from $2,897 million in 2024 to $3,893 million in 2025, which is not present in the original answer and cannot be verified from the provided context. These figures and the reference to 2025 (outside the 2022–2024 scope) are factually unsupported and incorrect. (2) The quantitative inaccuracies are significant: the original answer contains no numerical data about investment amounts or changes over time, so the inclusion of specific dollar figures and a forward-looking year (2025) constitutes fabrication or hallucination. There is no mention of composition changes in the ground truth, making this a major deviation. (3) The reasoning partially captures the consistency in definition but fails on multi-hop synthesis—while the core definition is correctly identified across years, the LLM incorrectly infers a strategic shift based on fabricated data rather than the actual evolution noted in the original answer: enhanced discussion of fair value measurements. The model misses the key qualitative shift in disclosure practices around short-term instruments and instead invents a narrative based on non-existent numbers. (4) The correctness score is low due to major factual errors in numbers and timeline, though the core definition is right. Quantitative accuracy is poor due to hallucinated figures. Qualitative accuracy is moderate because the definition is correct but reasoning is flawed. Contextual relevance is acceptable as the topic and timeframe are generally appropriate, but the answer diverges into unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 491,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "The valuation and classification of NVDA's 3.50% Notes Due 2040 remained stable between 2023 and 2024, with a face value of $1,000 million in both years and an effective interest rate of 3.54%. The notes are classified as long-term debt, with a remaining term of 15.2 years as of January 26, 2025. This consistency in valuation and classification indicates that NVDA is maintaining a stable long-term debt structure, without significant refinancing or restructuring of this particular bond issue. It suggests a strategy of preserving long-term financing at favorable rates, supporting the company's capital needs without immediate pressure for repayment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative details. According to the ground truth, in 2023 the carrying value of NVDA's 3.50% Notes Due 2040 was $851 million as of January 28, 2024, and increased to $1,000 million by January 26, 2025. However, the LLM claims the face value was $1,000 million in both years, which misrepresents the evolution of valuation. The ground truth notes a change from $851M to $1,000M, indicating a material increase in carrying value, but the LLM incorrectly frames this as stable. While the effective interest rate (3.54%) and remaining term (15.2 years) are correctly reported as of 2025, the absence of the 2023 carrying value and mischaracterization of stability undermine accuracy. (2) The LLM also omits the Level 2 classification in the pricing hierarchy from 2023, which is part of the classification evolution. (3) The reasoning is partially sound—drawing a conclusion about stable long-term financing strategy is consistent with the ground truth—but it is based on incorrect premises about valuation stability. The correct interpretation should note that the increase in carrying value (from $851M to $1,000M) may reflect market valuation changes or accounting adjustments, not face value stability. (4) Despite these errors, the answer is contextually relevant and addresses both parts of the question—evolution of valuation/classification and strategic implication—with reasonable logic and correct entity identification (NVDA, 3.50% Notes Due 2040, correct dates). However, the quantitative inaccuracies significantly reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 447,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Between 2022 and 2023, Venclexta's total global revenue increased by 13.9%, from $2.009 billion in 2022 to $2.288 billion in 2023. This growth was driven by an 8% increase in U.S. net revenues and a 20.1% increase in international net revenues, reflecting continued market growth and market share uptake across all indications.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the total global revenue for Venclexta in 2022 ($2.009 billion = $2,009 million) and 2023 ($2.288 billion = $2,288 million), which matches the ground truth. However, it incorrectly states the growth rate between 2022 and 2023 as 13.9%, which is actually the 2023 growth rate according to the original answer, not the year-over-year increase from 2022 to 2023. The actual year-over-year growth rate from $2,009M to $2,288M is (2,288 - 2,009) / 2,009 = 13.89% ≈ 13.9%, so this is numerically accurate, but the original answer specifies that 13.9% was the reported growth rate in 2023 (likely vs. 2022), so the LLM’s usage is contextually acceptable. However, the LLM omits the 2022 growth rate of 10.4%, which is a key part of the question asking about evolution in both revenue and growth rate. (2) Quantitative accuracy is high: $2,009M and $2,288M are correct, and the implied 13.9% growth is accurate. But the answer fails to mention the 10.4% growth rate in 2022, making the comparison incomplete. (3) The multi-hop reasoning is partially sound—revenue figures are correctly synthesized across years, but the model does not fully address the evolution of the growth rate itself (i.e., increase from 10.4% to 13.9%). The inclusion of U.S. and international revenue growth adds detail not in the original answer, which may be factually correct but is not part of the ground truth and distracts from the core question. (4) Correctness is scored 7 because key revenue numbers are accurate and the overall trend is correctly implied, but the omission of the 2022 growth rate and lack of explicit comparison of growth rates reduces completeness. Quantitative accuracy is 8 due to correct dollar amounts and correct implied growth rate. Qualitative accuracy is 7 due to missing comparative growth context and introduction of unverified breakdowns. Contextual relevance is 10 as the response directly addresses the financial performance evolution of Venclexta.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 538,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Between 2022 and 2023, Netflix amended its Executive Severance and Retention Incentive Plan, with the Amended and Restated version effective as of January 1, 2024, as disclosed in the 2023 filing. This update reflects a formal plan revision, indicating a continued focus on structured executive compensation and retention strategies. No specific details about the changes in terms or conditions of the plan are provided in the filings, but the effective date marks a key evolution in the company's approach to executive incentives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates and plan names are correct: the 'Amended and Restated Executive Severance and Retention Incentive Plan effective January 1, 2024' is accurately cited with its December 8, 2023 filing date, and the 2022 reference to the prior version (filed September 10, 2021) is correctly implied as the baseline. The effective date of January 1, 2024, is correctly reported. (2) The answer correctly identifies the evolution between the two filings, noting the forward-looking amendment disclosed in the 2023 filing. (3) The multi-hop reasoning is sound—comparing the 2022 and 2023 filings to identify plan amendments and their effective dates—but slightly omits explicit mention of the 2022 plan’s September 10, 2021 filing date, which is part of the full evolution. However, this detail is contextually secondary to the main development (the 2024 amendment), so the omission does not undermine the core accuracy. (4) The LLM correctly conveys that no specific details about changes in terms are provided, maintaining semantic equivalence. The answer is fully relevant, focused, and factually correct, warranting a high score with only minor room for completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 349,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "From 2022 to 2024, Lowe's Benefit Restoration Plan was amended and restated as of January 1, 2025, indicating a deliberate revision to the structure of the plan. This evolution suggests that the company is actively reviewing and adjusting its retirement benefits to continue supporting employees whose benefits are limited by IRS provisions, thereby maintaining a competitive and comprehensive retirement offering for its workforce.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies the key evolution: the amendment and restatement of the Benefit Restoration Plan effective January 1, 2025, which is correctly tied to the 2024 10-K filing (exhibit 10.3), indicating proper documentation updates. The date (January 1, 2025) is correctly cited, and the context of IRS limitations is appropriately referenced. However, the LLM omits specific structural details present in the original answer, such as the inclusion of both employee salary deferrals and employer Company Match contributions in the plan design, which adds depth to the understanding of the plan’s mechanics. While the conclusion about Lowe’s strategic approach is reasonably inferred, the LLM’s phrasing ('amended and restated as of January 1, 2025') slightly conflates timing—it was introduced in 2024 for future effect, not amended in 2025. This is a minor issue in temporal framing but does not undermine factual correctness. The reasoning is sound and the answer addresses both parts of the question—evolution and implications—though with less specificity on the structural components. All entities (Lowe's, Benefit Restoration Plan, IRS limitations) are accurate, and the multi-hop synthesis between years and filings is logically handled. Wording differences are acceptable under semantic equivalence, but minor omissions prevent a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 392,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA's financial obligations related to the 0.584% Notes Due 2024 were fully repaid in fiscal year 2025. As of January 26, 2025, the balance for these notes was $0, compared to $1,250 million as of January 28, 2024. The repayment marked the conclusion of these obligations, which had an effective interest rate of 0.66%.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NVDA's liability for the 0.584% Notes Due 2024 was $1,185 million in fiscal year 2023 and was fully repaid by fiscal year 2024. However, the LLM claims the repayment occurred in fiscal year 2025, which is incorrect. The balance as of January 28, 2024 ($1,250 million) is also inaccurate—this contradicts the ground truth value of $1,185 million in FY2023. Additionally, the LLM references an effective interest rate of 0.66%, which is not mentioned in the original answer and cannot be verified from the provided truth. (2) Quantitative accuracy is low: the dollar amounts ($1,250M vs $1,185M), repayment date (FY2025 vs FY2024), and interest rate (0.66% vs 0.584%) are all incorrect. The final balance of $0 is correct in direction but tied to the wrong fiscal year. (3) The reasoning shows partial multi-hop understanding—repayment of debt obligations over time is correctly conceptualized, and the comparison between two fiscal years is attempted. However, the synthesis is based on incorrect data and timeline, undermining the logic. (4) Contextual relevance is high because the answer addresses the evolution of the debt obligation and attempts to compare balances across years, aligning with the question’s intent. Despite this, factual errors severely reduce correctness. The core claim—that the obligation was fully repaid—is directionally correct but temporally wrong, leading to a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 417,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Mavyret's global revenue decreased by 7.2% in 2023 compared to 2022, with a 12.7% decline in the United States and a 1.9% decrease in international markets. The U.S. decline was primarily due to competitive pressures, while international markets saw a slight decrease, partially offset by favorable pricing and market dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 7.2% global revenue decline, calculated from the drop from $1,541 million in 2022 to $1,430 million in 2023. The U.S. decline of 12.7% (from $755M to $659M) and international decline of 1.9% (from $786M to $771M) are both accurately stated. All numeric values and percentages match the ground truth, with acceptable format variations. (2) Quantitative accuracy is perfect: the percentage changes are correctly computed, and the directional trends (declines in both regions, larger U.S. drop) are accurate. (3) The multi-hop reasoning is sound—information from both years and both regions is synthesized correctly to describe global performance. The only minor shortcoming is the addition of causal explanations (e.g., 'competitive pressures', 'favorable pricing') not present in the original ground truth, which, while plausible, are not supported by the provided data. This slightly affects qualitative accuracy but does not introduce factual errors. (4) The answer is fully contextually relevant, addressing all parts of the question: global performance, U.S. and international trends, and year-over-year changes. Overall, the answer is factually correct and complete, with only minor speculative additions, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 360,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Between 2022 and 2024, Netflix remained in compliance with the covenant limitations related to its Senior Notes, including repayment obligations and restrictions. The Notes included limitations on activities such as creating liens, entering into sale and lease-back transactions, and merging or transferring substantial assets. As of both December 31, 2024 and December 31, 2023, the Company confirmed it was in compliance with all related covenants. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, demonstrating continued adherence to repayment obligations. The scope of restrictions remained consistent with standard covenants for senior unsecured debt instruments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Netflix remained in compliance with covenant limitations in both 2022 and 2024 and accurately reports the $400 million repayment of the 5.750% Senior Notes in 2024. These quantitative details—amount, interest rate, and timing—are factually correct and match the ground truth. (2) Quantitative accuracy is perfect: the $400 million repayment, 5.750% rate, and reference to compliance as of year-end 2023 and 2024 are all accurate. No calculation errors. (3) However, the LLM fails to capture a key qualitative evolution in the covenant scope: while the original answer notes that by 2024, certain Senior Notes no longer included restrictions on sale and lease-back transactions—indicating a narrowing of covenant scope—the LLM incorrectly asserts that 'the scope of restrictions remained consistent.' This misrepresents an important change in the covenant limitations and reflects a failure in multi-hop reasoning to compare covenant language across years. (4) Despite this, the answer is contextually relevant and covers compliance, repayment, and general restrictions. The core facts are correct, but the omission of the narrowed covenant scope reduces qualitative accuracy. Hence, correctness is scored 7 for missing a key detail, though numbers and overall relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 373,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Between 2022 and 2023, Honeywell restructured its Safety and Productivity Solutions segment by merging the Safety and Retail business unit with the Advanced Sensing Technologies unit to form the Sensing and Safety Technologies business unit. This structural change reflects a strategic evolution to integrate and streamline safety-related offerings, including gas detection and advanced sensing technologies, under a unified business unit.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core structural change—merging Safety and Retail with Advanced Sensing Technologies to form Sensing and Safety Technologies—and links it to a strategic integration of safety and sensing technologies. However, it omits key quantitative details from the ground truth: the $2,387 million revenue for the Safety and Retail unit in 2022. This omission affects completeness and quantitative accuracy. Additionally, while the ground truth specifies the change was introduced in July 2022 but reported in the 2023 filing, the LLM answer does not mention the July 2022 timing, instead framing the change as occurring between 2022 and 2023, which slightly misrepresents the timeline. (2) No incorrect numbers are stated, but the absence of the $2,387 million figure and the imprecise timing reduce quantitative accuracy. The format variation allowance does not apply since no numbers are wrong—just missing. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about organizational realignment and infers the strategic rationale. It accurately identifies the involved business units and the parent segment (implied via context). (4) Despite missing financial data and precise timing, the answer captures the essential evolution and structural change, making it largely correct and highly relevant. The qualitative accuracy is high due to correct entity identification and logical reasoning. Contextual relevance is perfect as it directly addresses the question's focus on evolution and structural change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 433,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "The Class B-2 Common Stock was not outstanding prior to 2024, as it emerged from the Class B-1 Common Stock exchange offer. In 2024, it became convertible into Class A Common Stock, similar to Class B-1, under the terms of the U.S. and Europe Retrospective Responsibility Plans. This conversion is staged based on litigation developments and will be fully convertible by 2028. The introduction of Class B-2 Common Stock impacts corporate governance by increasing the potential dilution of Class A Common Stock voting power and influencing decisions on significant transactions such as mergers or consolidations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that deviate from the ground truth. (1) It incorrectly states that Class B-2 Common Stock 'became convertible into Class A Common Stock' in 2024, whereas the original answer clarifies that no shares of Class B-2 were outstanding by 2024, meaning it no longer played an active role. The LLM reverses the timeline: in 2023, Class B-2 was convertible and had governance influence; by 2024, it was no longer outstanding. (2) The LLM introduces specific details not present in the ground truth, such as convertibility 'by 2028' and linkage to 'U.S. and Europe Retrospective Responsibility Plans' and 'litigation developments', which are unsupported and appear fabricated. (3) The claim that Class B-2 'emerged from the Class B-1 Common Stock exchange offer' contradicts the original answer, which states that Class B-2 was no longer outstanding prior to the Class B-1 exchange offer. (4) While the LLM correctly identifies potential dilutive effects on voting power and influence on corporate decisions, this is generic and not specific to the correct timeline or structural changes. (5) Multi-hop reasoning fails: the model does not correctly synthesize the evolution from active (2023) to non-outstanding (2024), instead inventing a new future conversion path. Quantitative accuracy is very low due to incorrect dates and invented timeframes. Qualitative accuracy is poor due to incorrect entity relationships and reasoning. Contextual relevance is moderate as it addresses corporate governance and convertibility, but with wrong facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 433,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "Between 2023 and 2024, The Home Depot enhanced the ease of shopping experience by expanding digital and in-store capabilities. In 2023, the company focused on improving digital properties, including mobile app features like store-specific maps and enhanced product landing pages, while investing in store experiences with self-checkout options, curbside pickup, and wayfinding signage. In 2024, these efforts evolved with further investments in digital platforms to improve navigation and personalization, as well as the rollout of Computer Vision in U.S. stores to improve product availability. Additionally, the company expanded its store network, opening 12 new stores in 2024, and continued leveraging its stores as fulfillment hubs for online orders, with 50% of U.S. online orders fulfilled through stores in 2024. These initiatives aimed to create a seamless, interconnected shopping experience across digital and physical channels.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several correct elements about The Home Depot's focus on digital and in-store enhancements between 2023 and 2024, such as mobile app features, self-checkout, and digital navigation. However, it introduces specific details not present in the ground truth, such as 'Computer Vision in U.S. stores,' '12 new stores opened in 2024,' and '50% of U.S. online orders fulfilled through stores in 2024.' These quantitative claims are not supported by the original answer and appear to be hallucinated or inferred beyond the provided data. While the general direction of investment in digital and in-store experience aligns with the ground truth, the specific initiatives differ. For example, the original answer highlights electronic shelf labels, reconfigured service desks, and personalized digital experiences like customer review summaries—none of which are mentioned in the LLM response. Instead, the LLM emphasizes curbside pickup and wayfinding signage, which were not cited in the ground truth. (2) The quantitative accuracy is partially correct: no explicit numbers are contradicted (e.g., no incorrect percentages or dollar amounts), but the LLM adds unsupported figures (e.g., 12 stores, 50% fulfillment), which reduces factual reliability. (3) The multi-hop reasoning is partially sound—the model correctly infers a progression from 2023 to 2024 with increasing digital integration—but fails to accurately synthesize the specific capabilities mentioned in the ground truth. The shift toward data-driven personalization and enhanced product content in 2024 is underrepresented, while unverified technical implementations (Computer Vision) are introduced. (4) The contextual relevance is high because the answer addresses the evolution of shopping experience across digital and in-store channels. However, the correctness score is reduced due to factual inaccuracies and omission of key details from the ground truth, despite plausible-sounding additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 537,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "The Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024 by introducing more specific forms of equity awards. In 2022, the plan included awards such as Restricted Stock Units (RSUs), Performance-Based RSUs, and Performance Share Units. By 2024, the plan expanded to include additional award structures, such as Cliff-Vested RSUs and Performance Award Performance Share Units, reflecting a more diversified approach to long-term equity compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Target Corporation's Long-Term Incentive Plan from 2022 to 2024. (1) It correctly identifies the core equity award types present in 2022—Restricted Stock Units (RSUs), Performance-Based RSUs, and Performance Share Units—though it omits some specific forms mentioned in the ground truth: Non-Qualified Stock Options, Price-Vested Stock Options, and Non-Employee Director awards (both options and RSUs). However, these omissions do not distort the overall structure or misrepresent the plan. (2) The introduction of Cliff-Vested RSUs and Performance Award Performance Share Units in 2024 is accurately reported, matching the ground truth. There are no numerical values requiring calculation, but dates (2022 and 2024) are correct. (3) The multi-hop reasoning—comparing the plan structure across years to identify expansion—is sound and logically presented. The conclusion that the plan diversified its equity compensation vehicles is well-supported. (4) While the LLM simplifies the list of 2022 awards, it captures the key evolution: expansion into more structured, time- and performance-based vesting mechanisms. The semantic meaning aligns closely with the original answer, with only minor completeness gaps. Hence, a correctness score of 9 is warranted—very close to full accuracy with only slight omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 382,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Qulipta was FDA approved in September 2021 for the preventive treatment of episodic migraine in adults. By 2023, its net revenues increased by more than 100%, driven by strong market share uptake and market growth, as well as the regulatory approval for the preventive treatment of chronic migraine in adults in April 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qulipta's FDA approval in September 2021 and mentions its indication for episodic migraine, which aligns with the ground truth. It also notes strong growth and market adoption, which is consistent with the commercial trajectory. However, it fails to provide specific revenue figures for 2023 ($408 million total, $405M U.S., $3M international) or 2022 ($158M U.S.), which are critical to assessing commercial performance evolution. Instead, it states 'net revenues increased by more than 100%'—a claim not directly supported by the ground truth data (from $158M to $405M U.S. is ~156% growth, so directionally correct but unverified in the answer without citing base numbers). The mention of approval for chronic migraine in April 2023 is accurate and adds context not in the original answer but may be extraneous. (2) Quantitative accuracy is low because no actual revenue numbers are provided, and the 'more than 100%' increase is vague and not tied to disclosed figures. The ground truth requires precise financial disclosures from AbbVie, which the LLM omits. (3) The reasoning is partially sound—it infers strong growth, which is valid, but lacks multi-hop synthesis of year-over-year financial data across 2021–2023. The absence of revenue in 2021 and growth to $158M in 2022 and $405M in 2023 are key hops missing. (4) Contextual relevance is high as the answer addresses the core topic—Qulipta’s commercial evolution—and includes relevant regulatory and market factors. However, the lack of specific financial data from AbbVie’s disclosures significantly undermines factual completeness and correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 454,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Between 2022 and 2024, Netflix's treatment and disclosure of the 2020 Stock Plan show a shift in equity compensation activities. In 2022, the Company granted stock options and reported significant stock-based compensation expenses ($575 million), while no stock options were granted in 2024, and compensation expenses dropped to $273 million. Additionally, in 2024, the focus shifted to RSUs and PSUs, with $15 million in RSU vesting value reported, compared to no RSUs or PSUs granted in 2022. The 2024 filing also highlights market-based performance targets for PSUs, reflecting a more performance-driven approach to equity compensation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that in 2022, the 2020 Stock Plan was only referenced in the exhibit list with no detailed description or activity disclosure, while in 2024 it was explicitly described with details on incentive stock options, nonstatutory stock options, and RSUs with vesting and performance criteria. The LLM instead fabricates specific financial figures—$575 million and $273 million in stock-based compensation expenses, $15 million in RSU vesting value—which are not present in the ground truth and cannot be verified from the provided context. There is no mention of PSUs or market-based performance targets in the original answer, nor any data about grants by year. (2) Quantitative accuracy is very low: all numbers introduced by the LLM ($575M, $273M, $15M) are unsupported and likely hallucinated. The ground truth does not provide any dollar amounts related to compensation expenses or vesting values for either year. (3) The multi-hop reasoning is flawed—the question asks about the evolution in *treatment and disclosure* of the plan (i.e., how it was described and reported), but the LLM shifts focus to fabricated equity grant activities and expense trends, missing the core distinction between mere documentation (2022) and substantive disclosure (2024). It fails to note that the 2022 filing only listed the plan as an exhibit without elaboration, while the 2024 filing integrated it into narrative disclosures with operational detail. (4) Contextual relevance is moderate because the answer addresses Netflix, the 2020 Stock Plan, and compares 2022 and 2024 filings in the domain of equity compensation, but it misinterprets the nature of the evolution (from structural disclosure to operational detail) and invents data to support a narrative not present in the ground truth. Thus, despite topical alignment, factual and qualitative inaccuracies severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 537,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "Between 2022 and 2023, the company maintained its use of derivative instruments for aluminum purchase agreements as part of its strategic sourcing and risk management approach. These agreements, classified as derivative instruments for accounting purposes, were not designated for hedge accounting treatment and were priced at prevailing market rates. In 2023, the notional amounts of commodity contracts related to these agreements decreased from $412 million in 2022 to $115 million, indicating a reduction in the volume of aluminum contracts not receiving hedge accounting treatment. The company continued to use such contracts to address long-term sourcing objectives and non-U.S. business needs, though their impact on the financial statements diminished in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—$412 million in 2022 and $115 million in 2023—that are not present in the original answer (ground truth) and cannot be verified from the provided context. These numbers appear fabricated or misattributed, severely undermining factual accuracy. The ground truth does not mention notional amounts, changes in contract volume, or any financial metrics related to the size of the derivative contracts. (2) Quantitative accuracy is low because the dollar amounts and implied reduction in contract value are not supported by the ground truth. There is no mention of $412M or $115M in the original answer, nor any data about changes in notional amounts. The LLM invents precise figures without basis, which constitutes a major factual error. (3) Qualitatively, the LLM captures part of the correct conceptual framework: aluminum purchase agreements are derivative instruments used for strategic sourcing and non-U.S. business needs, and they are not designated for hedge accounting. However, it misses the key evolution highlighted in the ground truth: that in 2023, the company clarified that the quantities in these contracts offset each other and are priced at prevailing market prices—this point about offsetting positions and pricing alignment is central to the strategic evolution but is absent in the LLM response. Instead, the LLM incorrectly attributes the evolution to a reduction in notional value, which is unsupported. (4) Contextual relevance is high because the answer stays focused on the topic—classification and strategic use of derivative instruments in aluminum procurement—and attempts to describe a shift between years. However, the introduction of unverified numerical data and the omission of the actual stated evolution (offsetting quantities and market pricing) result in a partially correct but significantly misleading response. The core reasoning fails the multi-hop synthesis requirement because it substitutes unsupported metrics for the actual disclosed qualitative refinement in strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 560,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "Between 2023 and 2024, the Directors' Code of Conduct remained accessible on the company's website, with the 2024 filing explicitly reiterating the URL for the document. However, the 2024 filing introduced a slight enhancement in clarity by specifying the exact web address as \"https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf,\" whereas the 2023 version had a slightly less precise URL. There was no indication of substantive changes to the scope or content of the Directors' Code of Conduct between the two years. The scope continued to apply to all directors of BNY Mellon, with the company committing to disclose amendments or waivers on its website.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. It claims the 2024 filing reiterates the same URL as 2023, but in reality, the URL changed significantly in 2024 to reflect a new domain (bny.com instead of bnymellon.com) and updated path structure. The LLM incorrectly states that the 2024 URL is the same as 2023 with only 'slightly less precise' wording, when in fact the original 2023 URL used 'bnymellon.com' and the 2024 URL uses 'bny.com', indicating a domain rebranding. (2) The LLM fails to mention the key factual change: the introduction of a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES' in 2024, which was not present in 2023. This omission directly contradicts the ground truth and represents a major failure in capturing the expanded scope. (3) The multi-hop reasoning is flawed—the question asks about evolution in accessibility and scope, but the LLM incorrectly concludes there were no substantive changes, missing both the URL/domain shift and the new compliance section. (4) While the answer is relevant to the topic and addresses the general idea of accessibility and scope, its factual inaccuracies—especially regarding the URL and the absence of new content—severely undermine correctness. The answer fabricates a narrative of continuity where there was meaningful change, resulting in a low score despite appropriate structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 393,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "Between 2023 and 2024, the structure and value of HD's 4.95% Senior Notes evolved significantly. In 2023, HD issued $750 million of 4.95% Senior Notes due September 30, 2026, while in 2024, HD issued $1.75 billion of 4.95% Senior Notes due June 25, 2034. This shift indicates a strategic move to extend the maturity of the company's long-term debt, likely to manage interest rate risk and stabilize future cash flows by locking in rates for a longer period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023 HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million, and by 2024, the carrying amount of these notes was $747 million as of February 2, 2025. Additionally, HD reported $980 million in 4.95% senior notes due September 2052. However, the LLM incorrectly states that in 2024 HD issued $1.75 billion of 4.95% senior notes due June 25, 2034 — a maturity date and issuance amount not present in the ground truth. This misrepresents both the amount and the maturity structure. (2) Quantitative accuracy is severely compromised: the $1.75 billion figure is incorrect (should be $980 million for the 2052 notes), the 2034 maturity date is fabricated, and the absence of the $747 million carrying value for the 2026 notes omits a key data point. The correct evolution involves a long-term extension to 2052, not 2034. (3) The multi-hop reasoning is flawed: while the LLM correctly infers a strategy of extending debt maturities, it does so based on incorrect data. The actual strategy — issuing long-dated debt (2052) at the same coupon rate — suggests a deliberate move to lock in fixed rates over a very long horizon, which the LLM misses due to incorrect synthesis. (4) Contextual relevance is moderate because the answer addresses the general theme of debt strategy and maturity extension, but the factual foundation is wrong, undermining the conclusion. The reasoning is plausible but built on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 429,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Between 2021 and 2023, Intel recognized $471 million in observable price adjustments on its investment in Beijing Unisoc Technology Ltd. in 2021. As of December 30, 2023, the net book value of the investment remained stable at $1.1 billion, the same as of December 31, 2022, indicating no significant changes in valuation during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $471 million observable price adjustment in 2021 and the $1.1 billion net book value as of December 30, 2023, matching the ground truth. It also accurately notes that the value was unchanged from December 31, 2022. All key facts are present and factually correct. (2) Quantitative accuracy is perfect: both dollar amounts ($471 million and $1.1 billion) and dates (2021, December 30, 2023, and reference to December 31, 2022) are correct. Format variations are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—linking the 2021 price adjustment to the stable valuation in 2023 shows understanding of the evolution over time. The LLM correctly infers stability in valuation despite the earlier adjustment. However, it omits the specific detail that Intel was accounting for the investment as a non-marketable equity security by end-2023, which is a minor but relevant aspect of the financial treatment. This omission prevents a perfect qualitative score. (4) The answer is highly relevant, directly addressing the evolution of financial treatment and valuation. The omission of 'non-marketable equity security' is a small gap in completeness but does not undermine the core correctness. Hence, correctness is scored 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 381,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "In 2022, Qulipta was newly launched and generated minimal net revenues, with $158 million in the U.S. and $158 million internationally. By 2023, Qulipta's commercial performance showed significant growth, with $405 million in U.S. net revenues and $408 million internationally, representing over 100% growth year-over-year. Additionally, in April 2023, AbbVie secured FDA approval for Qulipta for the preventive treatment of chronic migraine in adults, and in August 2023, the EC approved Aquipta (Qulipta) for the preventive treatment of migraine in adults with four or more migraine days per month. These approvals and strong revenue growth indicate a substantial advancement in Qulipta's regulatory and commercial development from 2022 to 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Qulipta's 2022 status. The ground truth states that in 2022, Qulipta was part of a group of products leading to the reclassification of $1.0 billion in intangible assets — not that it was 'newly launched' with $158M in U.S. and international revenues. These revenue figures are not present in the ground truth and contradict the narrative of 2022 being a regulatory/asset reclassification year rather than a commercial one. The 2023 revenue numbers ($405M U.S., $408M international) and >100% growth claim are unsupported by the provided ground truth, which focuses on regulatory milestones, not sales performance. (2) The dates of FDA approval (April 2023) and EC approval (August 2023) are correctly stated and align with the original answer, which is a key quantitative and temporal accuracy. However, the mention of 'Aquipta' instead of 'Qulipta' in the EC approval is a minor entity error. (3) The multi-hop reasoning is partially sound — the model correctly identifies the progression from earlier status to regulatory approvals in 2023, but incorrectly frames 2022 as a commercial launch year rather than an asset reclassification event. This undermines the correct synthesis of regulatory evolution. (4) While the answer is contextually relevant and captures the forward momentum of Qulipta’s development, the inclusion of fabricated revenue data severely impacts factual correctness. The qualitative reasoning about advancement is directionally correct but built on incorrect premises. Thus, the correctness and quantitative accuracy scores are moderate due to major factual deviations, though key regulatory dates are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 468,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Between 2022 and 2023, Boeing's framing of 'upgrades and conversions' within the Global Services segment remained consistent in its description as part of the full spectrum of services offered. However, in 2023, there was a subtle shift in strategic emphasis, with a stronger focus on leveraging these services to span the life cycle of defense and commercial aircraft programs to grow market share and enhance customer satisfaction and productivity. This reflects a more proactive stance on using upgrades and conversions as a competitive differentiator in a highly competitive market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct and captures a key aspect of the evolution in Boeing's strategic emphasis on 'upgrades and conversions' between 2022 and 2023. It correctly identifies a subtle shift in tone and strategic framing in 2023, noting a more proactive positioning of the service as a competitive differentiator. However, it diverges from the ground truth in key qualitative aspects: the original answer emphasizes that in 2022, 'upgrades and conversions' were listed among a broader, undifferentiated set of services (e.g., supply chain, training, spare parts), with no strategic framing, whereas in 2023, the service was embedded in a more structured narrative around sustaining aerospace platforms—indicating integration into core capabilities. The LLM answer introduces the idea of 'growing market share' and 'enhancing customer satisfaction and productivity' as stated strategic goals linked to upgrades and conversions in 2023, which is not present in the ground truth and represents an inference beyond the source text. While semantically plausible, this addition reflects interpretive language not supported by the actual 10-K filings as summarized in the knowledge graph. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and the answer is contextually relevant, addressing the evolution in language and strategic emphasis. However, the qualitative reasoning is partially flawed due to unsupported elaboration, missing the precise nature of the shift from 'general service' to 'integrated capability within platform sustainment.' Thus, while the direction of the assessment is correct, the specific evidence and framing do not fully align with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 464,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel's investment in Beijing Unisoc Technology Ltd. remained relatively stable in valuation between 2021 and 2023. As of December 30, 2023, the net book value of the investment was $1.1 billion, unchanged from December 31, 2022 ($1.1 billion). During 2021, Intel recognized $471 million in observable price adjustments for the investment. No significant impairments or gains/losses were reported for Unisoc in 2022 or 2023, indicating a consistent valuation over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.1 billion net book value for Intel's investment in Beijing Unisoc Technology Ltd. as of both 2021 and 2023, matching the ground truth. It accurately states the $471 million in observable price adjustments recognized in 2021. The claim that no significant impairments or gains/losses were reported in 2022 or 2023 aligns with the absence of such mentions in the 2023 filing, supporting the conclusion of valuation stability. (2) All numeric values—$1.1 billion (net book value), $471 million (adjustment in 2021)—are correct and properly attributed to the right years. The date December 31, 2022, is used as a proxy for the 2022 filing (which reports data as of December 25, 2021), but this is a minor discrepancy in presentation rather than a factual error, as filings typically reference year-end values. The core timeline and valuation points are preserved. (3) The multi-hop reasoning is sound: the model synthesizes data across years and filings to infer valuation consistency and absence of revaluation events post-2021. It correctly infers that lack of reported adjustments implies stability, which is consistent with the ground truth interpretation. (4) The answer is contextually complete and relevant, addressing both the valuation trend and recognition aspects of the question. The only minor shortcoming is the slightly imprecise date reference (December 31, 2022 vs. December 25, 2021 in the filing), and the omission of the explicit note that the 2021 adjustment was tied to an observable price change (though 'observable price adjustments' is correctly used). These do not detract significantly from factual accuracy, hence the 9/10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 470,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, the role of Self-Service Lockers at Home Depot has evolved to become a more integral part of the interconnected shopping experience. In 2023, the company mentioned self-service lockers at the front entrance of many stores as a convenient pickup option for online orders. By 2024, these lockers were highlighted as part of a broader strategy to enhance customer convenience, complementing curbside pickup and forming a key component of the interconnected retail programs (BOSS, BOPIS, BODFS, and BORIS). This evolution reflects Home Depot's focus on optimizing order fulfillment and delivery options to meet customer needs efficiently.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Self-Service Lockers at Home Depot from 2023 to 2024. (1) It correctly identifies that in 2023, lockers were a convenient pickup option for online orders, and by 2024, they were integrated into broader interconnected retail programs like BOSS, BOPIS, BODFS, and BORIS. The strategic shift toward enhanced fulfillment and customer convenience is accurately conveyed. (2) There are no numeric inaccuracies—while the LLM does not mention the specific statistic that 'approximately 50% of U.S. online orders were fulfilled through a store' in 2024, this is a notable omission affecting completeness. However, since no incorrect numbers are presented, quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and programs, showing an understanding of the expanding role of lockers within omnichannel fulfillment. (4) The answer is contextually relevant and directly addresses the question about the evolving role of lockers. The main shortcoming is the omission of the 50% fulfillment statistic, which weakens the support for the claim of increased operational significance. Despite this, the overall reasoning and factual content are strong, warranting a high correctness score with minor deduction for incompleteness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 375,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities in both 2023 and 2024 notes that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. However, the 2024 disclosure provides slightly more specificity by mentioning that these liabilities are not discounted and are included in accrued salaries and benefits and other current liabilities in the consolidated balance sheets, classified based on their nature. The 2023 disclosure does not explicitly clarify the classification in the balance sheet. Overall, the level of detail remains consistent, but 2024 adds a minor enhancement in specificity regarding presentation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Costco disclosed the use of 'historical claims experience, demographic factors, severity factors, and other actuarial assumptions' in both 2023 and 2024. According to the ground truth, these specific estimation factors were only introduced in the 2024 disclosure and were not present in 2023. The LLM incorrectly asserts consistency in disclosure content when there was a significant change. Additionally, the LLM claims that 2024 added information about non-discounting and balance sheet classification, which is not mentioned in the ground truth and appears to be fabricated or misattributed. (2) There are no numeric values to verify, but the temporal facts (what was disclosed in which year) are incorrect, constituting a major qualitative and factual error. (3) The multi-hop reasoning failed: the question required comparing disclosures across two years, and the model misunderstood the evolution—claiming minor enhancement when the ground truth describes a 'meaningful increase in transparency and specificity' with entirely new disclosures in 2024. The LLM missed the key point that 2023 lacked any detail on estimation factors and risk unpredictability, which were newly added in 2024. (4) The correctness score is low (2) because the core factual claim about disclosure evolution is wrong. Quantitative accuracy is low due to incorrect temporal attribution of disclosures. Qualitative accuracy is poor due to flawed reasoning and synthesis. Contextual relevance is moderate because the answer addresses the general topic and structure of disclosures, but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 453,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory-related costs evolved from 2021 to 2022, as the acquisition led to fair value adjustments to inventory, which increased cost of sales by $59 million in 2021. By 2022, these acquisition-related inventory charges had decreased, as noted by the partial offset of the 2022 cost of sales increase due to lower incremental charges from fair value adjustments to inventory related to the Aldevron acquisition. This indicates a reduction in the financial impact of inventory-related costs from the Aldevron acquisition in 2022 compared to 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of facts and timeline. It incorrectly states that the $59 million fair value adjustment occurred in 2021, while the ground truth specifies it occurred in 2022. Furthermore, the LLM claims the impact decreased by 2022, but the original answer states that the $59 million charge was present in 2022 and then disappeared in 2023. The LLM also discusses 2021–2022 evolution, but the question explicitly asks about 2022 to 2023, making the time frame mismatch a critical error. (2) Quantitatively, the $59 million figure is correct but misattributed to the wrong year. The $87 million charge in 2023 from excess inventory is completely missing in the LLM response, representing a major omission. There are no calculations in this question, but the temporal misalignment invalidates any valid numbers. (3) The multi-hop reasoning is flawed: the model fails to connect the Aldevron acquisition’s inventory impact in 2022 to its absence in 2023 and the emergence of a new, unrelated inventory charge. Instead, it fabricates a narrative about decreasing charges from 2021 to 2022, which is not supported by the ground truth. The required synthesis across years and causes (acquisition-related vs. operational) is missing. (4) Contextual relevance is moderate because the answer discusses inventory costs and the Aldevron acquisition, which are relevant topics, but it addresses the wrong time period and misses the key evolution from 2022 to 2023. The conclusion about reduced impact is unsupported and misdirected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 430,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Between 2023 and 2024, Costco's treatment and recognition of shop card liabilities remained consistent, with liabilities accounted for as a \"shop card liability, net of estimated breakage\" and included in other current liabilities in the consolidated balance sheets. The recognition of breakage is based on historical redemption data, indicating that Costco continues to estimate and account for unclaimed balances systematically. This approach suggests a conservative and data-driven method for handling unclaimed shop card balances, ensuring liabilities are appropriately recognized while accounting for the likelihood of unredeemed balances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Costco treated shop card liabilities as a liability net of estimated breakage in both 2023 and 2024, recognizing revenue upon redemption, with breakage estimated using historical redemption data. The LLM correctly identifies the accounting treatment and classification in the balance sheet. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or financial metrics. (3) The multi-hop reasoning is sound: the model synthesizes information across years and infers Costco’s systematic, data-driven approach to unclaimed balances. However, it slightly underemphasizes the evolution noted in the ground truth—the increased emphasis on 'estimated breakage' and methodology refinement in 2024—though the core consistency and data-driven nature are correctly conveyed. (4) The answer is contextually fully relevant, addressing both the treatment over time and what it indicates about Costco’s approach. The only minor shortcoming is the lack of explicit mention of the *evolution* or *increased emphasis* in 2024, which slightly reduces qualitative accuracy, but the overall meaning remains semantically equivalent. Hence, a score of 9 is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 373,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services (IFS) evolved significantly in strategic partnerships and customer engagement. In 2022, the IFS Accelerator Ecosystem Alliance program was launched, aiming to strengthen design and manufacturing ecosystems. By 2023, the program had doubled in size to over 40 strategic agreements, including multigenerational partnerships with ARM and Synopsys to enable optimized chip designs on Intel’s advanced nodes. Additionally, IFS expanded its RAMP-C program partnerships, securing customers like Nvidia and Microsoft, and announced a commercial agreement with Tower to provide foundry services in New Mexico. These developments reflect a strategic shift toward ecosystem collaboration and customer-centric manufacturing solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Intel's Foundry Services from 2022 to 2023 and correctly notes the expansion of the IFS Accelerator Ecosystem to over 40 strategic agreements and multigenerational deals with ARM and Synopsys. However, it introduces inaccuracies by claiming the program was 'launched' in 2022, while the ground truth states it was introduced as part of the broader IDM 2.0 strategy but does not specify the launch of the Alliance program in that year. More critically, the LLM mentions 'RAMP-C program partnerships' with Nvidia and Microsoft and a 'commercial agreement with Tower'—none of which appear in the ground truth and are unverified in this context. These are significant factual overreach. (2) The number 'over 40 strategic agreements' is correct and matches the ground truth. However, there are no numbers related to design wins on Intel 18A (four) or advanced packaging (five new wins), which are key quantitative metrics in the original answer. Their omission reduces completeness and accuracy. (3) The multi-hop reasoning is partially sound—linking ecosystem growth and partnerships to customer engagement—but fails to correctly synthesize the specific initiatives mentioned (design wins, AI-related packaging) and instead substitutes unverified programs and customers. The logical flow is plausible but based on incorrect or unsupported entities. (4) The contextual relevance is high as the answer addresses strategic partnerships and customer engagement over the two years. However, the correctness score is reduced due to fabrication of specific partnerships (Nvidia, Microsoft, Tower) and omission of key verified developments (design wins, AI packaging focus), leading to a partially correct but misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 484,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "Between 2022 and 2023, DHR's relationship with Aldevron, in terms of goodwill and net cash consideration, remained consistent, with no new acquisitions or changes to the goodwill recorded for Aldevron. In 2022, the goodwill related to the Aldevron acquisition was $6.1 billion, and the net cash consideration was $9.6 billion. In 2023, the goodwill remained at $6.1 billion, and the net cash consideration was still reported as $9.6 billion, indicating no material changes to the financial impact of the Aldevron acquisition during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that the financial impact remained consistent between 2022 and 2023. The ground truth states that while $6.1 billion of goodwill was recorded in 2022, the net cash consideration increased to $9.561 billion in 2023, indicating a revised or more detailed financial assessment. The LLM incorrectly claims that net cash consideration was $9.6 billion in both years and that there were no changes, which contradicts the evolution described in the original answer. (2) Quantitatively, the goodwill amount ($6.1 billion) is correct for 2022, but the net cash consideration is inaccurately reported as $9.6 billion in both years. The correct 2023 figure is $9.561 billion, which is more precise and indicates a development from the initial estimate. The LLM rounds and treats it as unchanged, missing the significance of the update. (3) The multi-hop reasoning fails because the model does not recognize that the increase in net cash consideration from the initial estimate (implied in 2022) to the finalized $9.561 billion in 203 reflects a material change in financial commitment. Instead, it asserts no material changes occurred, which is contrary to the ground truth’s emphasis on a 'significant increase in financial commitment.' (4) Scores are low because the answer misrepresents the key financial evolution. While entities (DHR, Aldevron, goodwill, net cash consideration) and years are correctly identified, the conclusion drawn is factually wrong, undermining correctness and qualitative reasoning. Contextual relevance is moderate because the answer addresses the right metrics and companies, but with incorrect substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 462,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The maturity date of the AT&T Inc. 1.800% Global Notes remained unchanged between the 2022 and 2024 SEC filings, with both documents listing the maturity date as September 5, 2026. This consistency indicates stability in AT&T's debt structure for this particular issuance, suggesting no refinancing or restructuring activity for these notes during this period. However, the broader evolution of AT&T's debt structure is reflected in the continued presence of long-term maturities, which supports long-term financial planning and liquidity management.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the maturity date remained unchanged. According to the ground truth, the maturity date changed from September 5, 2026 (2022 filing) to September 14, 2039 (2024 filing), a shift of over 13 years. The LLM incorrectly claims no change, which contradicts the verified data. (2) The quantitative accuracy is extremely low: the key dates are wrong in the LLM response. It reports September 5, 2026 for both years, but the 2024 filing clearly shows a new maturity of September 14, 2039. This error invalidates any subsequent analysis. (3) The multi-hop reasoning is flawed because the model failed to detect and synthesize the change across the two filings. Instead of identifying a significant extension in maturity, it concludes there was stability, leading to an incorrect interpretation of AT&T's debt structure evolution. The reasoning about 'no refinancing' is unsupported and opposite to what the data indicates. (4) Contextual relevance is low but not zero because the answer addresses the right topic (debt structure evolution) and mentions relevant concepts like refinancing and long-term planning, albeit based on false premises. However, due to complete factual inaccuracy in dates and misinterpretation of the core event, the overall correctness score is near minimum.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 374,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target remained in compliance with its debt leverage covenant in both 2023 and 2024, as stated in both filings. However, the structure of its credit facilities changed in October 2023, when Target obtained a new $1.0 billion 364-day unsecured revolving credit facility set to expire in October 2024, replacing the prior 364-day facility. Additionally, the company extended its existing $3.0 billion five-year unsecured revolving credit facility to October 2028. These changes likely provided greater flexibility and extended maturity terms, supporting continued compliance with the debt leverage covenant.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Target remained in compliance with its debt leverage covenant in both 2023 and 2024, and accurately reports the $1.0 billion 364-day facility and $3.0 billion five-year facility. However, it incorrectly states that the new 364-day facility was set to expire in October 2024, when in fact the renewal extended it to October 2025 (not 2024), which is a material date error. This misrepresents the timing of the renewal and undermines the accuracy of the credit facility update. (2) The dollar amounts ($1.0 billion, $3.0 billion) and the existence of both facilities are correct. The extension of the five-year facility to October 2028 is accurately noted. The error lies solely in the expiration date of the renewed 364-day facility. (3) The reasoning is generally sound—linking facility renewals and extensions to covenant compliance—but the incorrect expiration date weakens the multi-hop synthesis. The model implies the facility was renewed in October 2023 for expiration in October 2024, which suggests a same-term replacement, whereas the ground truth indicates a forward extension (to 2025), showing improved flexibility. This nuance is lost due to the date inaccuracy. (4) Despite the date error, the answer addresses both parts of the question—compliance evolution and credit structure changes—and draws a reasonable conclusion about flexibility supporting compliance. Hence, correctness is reduced to 7 due to a significant but not fundamental factual error in timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 420,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "Intel's approach to expanding digital readiness for global populations under its RISE strategy evolved from 2022 to 2023 by deepening external collaboration and expanding its initiatives. In 2022, Intel focused on scaling its Digital Readiness Programs, such as AI for Youth and AI for Workforce, in partnership with governments and institutions to equip individuals with digital and AI skills. By 2023, the company expanded its efforts through the RISE Technology Initiative, which provided a broader platform for collaboration with customers and partners to address global challenges. This included funding projects aimed at improving health and safety, making technology more inclusive, and expanding digital readiness for millions globally. Additionally, Intel contributed to the Alliance for Global Inclusion, advancing industry-wide diversity and inclusion practices, and launched the Global Inclusion Index to benchmark progress across sectors. These steps reflect a more strategic and collaborative approach to achieving digital readiness and inclusive growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and fabrications not present in the ground truth. While it correctly identifies Intel's RISE strategy and mentions external collaboration, it invents specific programs like 'AI for Youth' and 'AI for Workforce' in 2022 and claims the 'RISE Technology Initiative' was used to expand efforts in 2023—none of which are mentioned in the original answer. The most significant error is the claim that Intel 'launched the Global Inclusion Index' in 2023, whereas the ground truth states that the third iteration of the index was published and that organizations scoring 50% or higher were recognized, with Intel being one of 18 recognized out of 27 respondents. The LLM omits these critical quantitative benchmarks and recognition outcomes entirely. (2) Quantitative accuracy is low: the original answer includes specific numbers (18 recognized organizations, 27 respondents, 50% threshold), none of which appear in the LLM response. Instead, vague claims like 'expanding digital readiness for millions globally' are unsubstantiated and not in the source. (3) Multi-hop reasoning is partially correct—the model connects Intel, RISE, digital readiness, and the Alliance for Global Inclusion—but fails to synthesize the evolution from framework-building in 2022 to performance measurement and recognition in 2023. The progression from creating unified goals to benchmarking and recognition is missed. (4) Contextual relevance is high because the answer addresses the right topic, timeframe, strategy, and collaboration themes. However, factual correctness and completeness on the specific evolution—especially the maturation into a scored index system—are lacking, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 477,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson's relationship with Micromine evolved from an intended acquisition to a terminated agreement. In July 2022, AspenTech (a subsidiary of Emerson) entered into an agreement to acquire Micromine for approximately $623 million. However, on August 1, 2023, AspenTech announced the termination of the agreement due to regulatory uncertainties in Russia, a condition for closing the transaction. No termination fee was paid. The termination had no direct financial impact on Emerson, as no cash or material commitments had been incurred by the time the agreement was terminated.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core event—Emerson's subsidiary AspenTech terminated its agreement to acquire Micromine due to Russian regulatory uncertainty—but contains key factual inaccuracies. The deal was announced in 2023, not July 2022 (incorrect date). The acquisition value was AU$900 million (approx. $623 million USD), not $623 million outright, which misrepresents the currency and amount. The LLM claims 'no direct financial impact' on Emerson, which contradicts the ground truth: there was a $24 million mark-to-market gain in 2023 from foreign currency forward contracts, and in 2024, AspenTech terminated those contracts—both material financial events omitted. (2) Quantitative accuracy is partially correct: $623 million is approximately accurate (conversion from AU$900M), but the date (2022 vs 2023) is wrong, and the $24M gain is missing. The absence of this gain—a key financial implication—reduces quantitative accuracy. (3) Reasoning is logically structured but incomplete: it correctly identifies the shift from acquisition to termination, but fails to synthesize the multi-hop financial implications across 2023 and 2024 (gain in 2023, contract termination in 2024). The conclusion that there was 'no financial impact' contradicts documented gains and hedging activity. (4) Contextual relevance is high—the answer addresses the evolution and financial aspects of the relationship—but due to missing financial data and incorrect dates, the correctness score is moderate. The qualitative accuracy is slightly higher because the narrative flow and entity identification (AspenTech, Micromine, Emerson) are correct, and the regulatory rationale is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 461,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) decreased from approximately 17 million shares in 2022 to approximately 15 million shares in 2023. The average purchase price of shares under the ESPP also decreased from $305.14 in 2022 to $277.19 in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the share availability decreased from 17 million in 2022 to 15 million in 2023, and the average purchase price decreased from $305.14 to $277.19. These values exactly match the original answer. (2) The answer is complete, addressing both parts of the question—changes in share availability and average purchase price—across the two fiscal years. (3) Entity accuracy is correct: The Home Depot, U.S. ESPP, and the fiscal years 2022 and 2023 are properly identified. (4) The reasoning is sound and correctly synthesizes multi-hop information across years, accurately reflecting the trend of reduced share availability and lower average purchase price. While the LLM omits the detail that approximately one million shares were purchased in both years, this information is not directly asked in the question, which focuses on availability and average price. Thus, the omission does not affect correctness. The answer is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 308,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "Between 2022 and 2023, DHR experienced a notable shift in impairment triggers and associated charges across its business segments. In 2022, there were no impairment charges recorded, indicating a relatively stable environment for its intangible assets. However, in 2023, the company identified impairment triggers in the Biotechnology and Diagnostics segments, resulting in impairment charges totaling $77 million. This shift suggests an increased risk exposure in the Biotechnology segment's intangible asset portfolio, particularly technology-based assets, likely due to market or operational challenges. The emergence of impairment triggers in 2023 highlights a growing vulnerability in certain high-value segments, reflecting a more cautious outlook on the recoverability of intangible assets in these areas.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the 2022 filing. It claims 'no impairment charges recorded' in 2022, which contradicts the ground truth stating a $10 million impairment in the Diagnostics segment in Q1 2021 (disclosed in the 2022 filing). This is a critical error in both entity timing and quantitative reporting. The $77 million charge in 2023 is correctly reported. (2) Quantitative accuracy is partially correct: $77 million in 2023 is accurate, but the omission and mischaracterization of the 2022 filing's $10 million charge (from 2021) leads to an incorrect comparison. The answer fails to note that the 2022 filing did report an impairment, just from a prior year. (3) Multi-hop reasoning is partially sound—the model correctly identifies increased impairment activity in 2023 and links it to rising risk in Biotechnology. However, it misses the evolution from 2022 to 2023 because it incorrectly assumes no prior impairments, undermining the comparative analysis. The ground truth emphasizes that 2023 saw broader segment impact (Biotechnology newly affected) and increased magnitude, which the LLM captures in spirit but not fully in detail. (4) Contextual relevance is strong—the answer addresses the question's focus on evolving patterns and shifting risks, and correctly infers increased vulnerability in Biotechnology. However, due to the foundational error about 2022, the overall correctness is significantly reduced. Minor phrasing like 'technology-based assets' is interpretive but acceptable. Final scores reflect partial credit for correct 2023 data and directional insight, but major deductions for factual inaccuracy in the 2022 baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 469,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This increase suggests a higher level of involvement in business transactions tied to trade contracts, potentially indicating expanded trade activities or more extensive contractual obligations in 2023 compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023, matching the ground truth exactly. All numeric values and years are accurate. (2) The quantitative change is correctly represented with no calculation errors; the format ($362 million, $598 million) is consistent with the original and acceptable variations are not needed as the figures are identical. (3) The reasoning is sound: the increase is correctly interpreted as indicating greater involvement in trade-related business transactions, which aligns with the ground truth's interpretation of 'growing involvement or expansion.' The LLM adds reasonable context—'expanded trade activities or more extensive contractual obligations'—which is semantically equivalent and inferentially valid. (4) All parts of the question are addressed: the change in value between 2022 and 2023 is reported, and the implication about the company's involvement in trade contracts is accurately interpreted. The answer demonstrates correct multi-hop synthesis of financial data and business implications. All scores are maximized due to full factual accuracy, correct reasoning, and contextual completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 358,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The 0.300% Notes due 2028 were issued in 2020 and listed on the New York Stock Exchange, as noted in the 2024 SEC filing (page 1). In the 2023 filing, these notes were similarly referenced as part of IBM's financial instruments disclosures. The consistent inclusion of these notes in both filings indicates that IBM maintains transparency in its debt obligations and continues to disclose the terms and status of its outstanding notes, reflecting a stable and ongoing financial instrument disclosure practice.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 0.300% Notes due 2028 and their issuance in 2020, referencing the 2024 filing and NYSE listing, which aligns with the ground truth. However, it fails to capture the key evolution between the 2023 and 2024 filings — in 2023, the notes were only disclosed via Exhibit 4.1 as defining holder rights, while in 2024 they are explicitly listed as actively traded under ticker IBM28B. The LLM incorrectly implies the NYSE listing was noted in the 2024 filing alone but does not contrast the shift in disclosure status, which is central to the question. (2) Quantitatively, the percentage (0.300%), maturity year (2028), and issuance year (2020) are accurate. No calculations are required, so numerical precision is adequate. (3) The multi-hop reasoning is partially sound — the model recognizes both filings mention the notes, but it misses the qualitative shift from passive disclosure to active recognition as a traded instrument. This undermines the synthesis required to answer how the 'status evolved.' Instead, it concludes there is 'consistent inclusion' and 'stable disclosure practice,' which contradicts the ground truth indicating a meaningful change in disclosure depth and market recognition. (4) Contextual relevance is fair — the answer stays on topic and discusses IBM's financial instrument disclosures, but it misinterprets the significance of the change between years. The conclusion about 'transparency' and 'stable practice' is plausible but incorrect in emphasis, as the evolution suggests increased market engagement, not just continuity. Thus, while some facts are correct, the core analytical insight is missing, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 465,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "Between 2023 and 2024, IBM's 1.750% Notes due 2031 were consistently listed on the New York Stock Exchange (NYSE) under the trading symbol \"IBM31.\" In the 2023 filing, the notes were referenced as part of the incorporated exhibits detailing instruments defining holders' rights, filed in prior Form 8-K filings. In 2024, the notes remained registered on the NYSE, with no new registration or material changes in disclosure noted, indicating consistent treatment and ongoing exchange listing.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 1.750% Notes due 2031, the NYSE listing, and the trading symbol 'IBM31', which aligns with the ground truth. It also accurately references the incorporation by reference of the instrument defining holders' rights from prior filings. However, it incorrectly states that the notes were 'consistently listed' and 'remained registered' on the NYSE in both years, which contradicts the ground truth that in 2023 there was only disclosure (via incorporation by reference) and no formal exchange listing—registration occurred in 2024. This is a significant qualitative error in reasoning and timeline interpretation. (2) Quantitatively, all percentages, years (2023, 2024, 2031), and filing types (10-K, 8-K) are accurate. The trading symbol 'IBM31' is correctly stated. No calculation errors. (3) The multi-hop reasoning is flawed: the model fails to recognize the evolution from disclosure-only (2023) to formal registration (2024), instead asserting continuity. This misrepresents the core development the question asks about. The ground truth emphasizes a shift in status; the LLM denies such a shift occurred. (4) Contextual relevance is high—the answer addresses disclosure, registration, and exchange listing as asked. However, due to the critical mischaracterization of the timeline and status change, the overall correctness is reduced to a 6, as the central claim (evolution in treatment) is inaccurately assessed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 406,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Eli Lilly's financial relationship with Zyprexa evolved significantly between 2023 and 2024, primarily through the sale of the rights for the olanzapine portfolio, which includes Zyprexa. In 2023, Zyprexa contributed $1,694.8 million in revenue, with $1,615.4 million generated outside the U.S., largely driven by the sale of the rights for the olanzapine portfolio. By 2024, Zyprexa was no longer a revenue-generating product for Lilly, as the rights had been sold, shifting the business model from product sales to a one-time transaction. This change reflects a strategic move to monetize legacy assets and focus on newer, higher-growth products.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that Eli Lilly generated $1.45 billion from the sale of the olanzapine portfolio (including Zyprexa) outside the U.S. in 2023. However, the LLM claims Zyprexa contributed $1,694.8 million in total revenue in 2023, with $1,615.4 million outside the U.S., which contradicts the ground truth and introduces precise numbers not supported by the original answer. These figures are not only incorrect but also imply ongoing product sales revenue rather than a one-time rights sale. (2) The calculation and sourcing of $1,694.8 million and $1,615.4 million are unverified and inconsistent with the ground truth, which specifies $1.45 billion as the proceeds from the sale of rights—not annual product sales. The LLM misrepresents the nature and magnitude of the revenue. (3) While the LLM correctly identifies the shift in business model—from direct product sales to a transactional, post-sale arrangement—it misses the key nuance that in 2024, revenue from the prior sale was recognized under 'collaboration and other arrangements,' indicating ongoing accounting for the deal (e.g., deferred revenue, milestones, or royalties), not just a one-time transaction. This reflects a failure in multi-hop reasoning: the model does not connect the 2023 sale to continued revenue recognition in 2024 under a different category. (4) Despite incorrect numbers and incomplete reasoning, the answer is contextually relevant and captures the high-level strategic shift. It correctly notes the sale of rights and the exit from direct Zyprexa sales, aligning with the question’s focus on revenue recognition and business model evolution. However, due to major quantitative errors and incomplete qualitative synthesis, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 504,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "The Mobility Preferred Interests were fully repurchased by April 2023, leaving no amounts outstanding at December 31, 2023. In 2024, these interests no longer appear in the diluted earnings per share (EPS) calculation, as reflected in the absence of \"Mobility preferred interests\" in the 2024 diluted EPS table. In contrast, for 2023, the Mobility Preferred Interests contributed 72 shares to the diluted EPS denominator. Their repurchase in 2023 eliminated their ongoing impact on EPS calculations, removing a potential dilutive effect on earnings per share.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Mobility Preferred Interests were fully repurchased by April 2023 and no longer appear in the 2024 diluted EPS calculation, which aligns with the ground truth. It accurately notes the inclusion of 72 shares in the 2023 diluted EPS denominator, a detail consistent with the impact prior to repurchase. However, it omits key financial details from the original answer, particularly the reclassification of $2,670 million to current and noncurrent liabilities in 2023 and the total repurchase cost of $5,414 million, which are central to the 'financial impact' aspect of the question. (2) The number '72 shares' is correct and specific, but the dollar amounts—$2,670 million (twice) and $5,414 million—are missing entirely, representing a significant quantitative gap. These figures are critical for assessing the scale of the liability and redemption. (3) The reasoning around EPS treatment is sound: the model correctly infers that because the interests were retired, they no longer affect diluted EPS in 2024. However, it fails to mention the retrospective application of ASU 2020-06 for prior periods, which is a key nuance in the accounting treatment evolution. The multi-hop synthesis is partial—correct on EPS impact but incomplete on liability reclassification and settlement accounting. (4) The contextual relevance is high because the answer directly addresses the evolution of treatment and EPS impact. However, due to missing major financial figures and incomplete discussion of accounting standards, the overall correctness and qualitative accuracy are reduced to moderate levels.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 451,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "Between 2023 and 2024, IBM's 0.875% Notes due 2030 remained listed on the New York Stock Exchange under trading symbol IBM30A in both filings. In 2024, the notes were explicitly included in the list of securities registered under Section 12(b) of the Exchange Act on page 1, with no changes noted in their registration status compared to 2023. The 2024 filing also incorporated the relevant indenture and instruments by reference, consistent with prior disclosures. Thus, there was no material change in the listing or registration status of the 0.875% Notes due 2030 between the two periods.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim, directly contradicting the ground truth. (1) According to the original answer, in 2023 the 0.875% Notes due 2030 were only incorporated by reference from a prior 8-K filing (Feb 8, 2022), meaning they were not explicitly listed or registered with a trading symbol at that time. However, the LLM claims they were 'listed on the New York Stock Exchange under trading symbol IBM30A in both filings,' which is false for 2023. This misrepresents the evolution entirely. (2) The quantitative elements like the interest rate (0.875%) and maturity (2030) are correct, as is the trading symbol IBM30A and the reference to Exhibit 4.1 and the 8-K filing date (Feb 8, 2022), so some data points are accurate. However, the key change — the shift from referenced disclosure to explicit listing — is missed. (3) The multi-hop reasoning fails: the model should have compared the 2023 disclosure mechanism (incorporation by reference) with the 2024 status (explicit registration and listing) and concluded a material change occurred. Instead, it asserts 'no changes noted,' which is factually wrong. (4) Contextual relevance is moderate because the answer discusses the right instrument, time frame, and registration context, but draws the opposite conclusion of the ground truth. Thus, while some entities and references are correct, the overall factual correctness is low due to the central inaccuracy about listing status in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 404,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "The structure and distribution terms of the Telco Preferred Interests evolved from 2023 to 2024 by introducing a new class (Telco Class A-4) with an initial preferred distribution rate of 5.94% annually, subject to reset every four years, and callable starting in 2028. This indicates that AT&T is diversifying its preferred equity instruments to manage its capital structure, potentially accessing more favorable financing terms and offering investors varied return profiles.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. It claims the introduction of a 'Telco Class A-4' with a 5.94% distribution rate in 2024, callable starting in 2028 and resetting every four years—none of which appears in the ground truth. The original answer states no new classes were added in 2024; instead, the existing structure from 2023 (Class A-1: $2,000 at 4.25%; Class A-2/A-3: $5,250 at 6.85%) remained unchanged, with total preferred interests growing to $7,250. There is no mention of a Class A-4 or any new issuance in 2024. (2) Quantitatively, all numbers are wrong: the LLM invents a 5.94% rate, a four-year reset, and a 2028 call date—none of which are supported. The actual figures—$2,000, $5,250, 4.25%, 6.85%, seven-year reset—are completely absent or misrepresented. (3) The multi-hop reasoning fails: the LLM does not synthesize the correct evolution (no structural change, only clarification on distribution restrictions) and instead fabricates a new instrument. The actual reasoning should have noted the continuity of terms and the clarification in 2024 that missed distributions do not restrict dividends or share buybacks, indicating a strategic comfort with preferred equity. (4) The contextual relevance is low because the answer discusses a non-existent instrument, though it attempts to interpret AT&T’s financing strategy, which aligns with the question’s intent. However, the conclusion about 'diversifying' is unsupported by the actual data, which shows consistency, not diversification. Scores reflect near-total factual inaccuracy with only minimal relevance to the strategic theme.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 449,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One's involvement in multifamily commercial real estate loans under loss sharing agreements with government-sponsored enterprises (GSEs) increased between 2022 and 2023 in terms of risk exposure. As of December 31, 2023, the liability recognized on the consolidated balance sheets for these loss sharing agreements was $137 million, compared to $82 million as of December 31, 2022. This indicates a rise in the estimated potential credit losses associated with these agreements, reflecting an increase in risk exposure during the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Capital One's risk exposure in multifamily commercial real estate loans through loss sharing agreements with GSEs increased from $82 million in 2022 to $137 million in 2023. (2) Quantitative accuracy is perfect—both dollar amounts and years match the original answer exactly, with correct comparison indicating an increase. There are no calculation errors, and the figures are presented with precise dates (December 31, 2022 and 2023), which aligns with standard reporting periods. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and connects the increase in liability to greater risk exposure, accurately interpreting the financial implication of the rising liability. (4) The answer addresses all parts of the question—evolution over time, risk exposure, and involvement in GSE loss sharing agreements—without omissions or inaccuracies. Wording differs slightly but meaning is preserved, demonstrating strong qualitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 316,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "Amazon's co-branded credit card programs faced increased regulatory scrutiny and compliance obligations from 2022 to 2023, as highlighted in the 2023 10-K. The company noted that these programs could adversely affect operating results if renewed on less favorable terms or terminated. Additionally, compliance with evolving payment card association rules, data security requirements, and other regulations imposed higher costs and operational complexity, potentially impacting profitability. The 2023 filing emphasized the growing regulatory environment, including enhanced authentication processes and potential penalties for non-compliance, underscoring a shift toward more stringent oversight and associated financial risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increased regulatory scrutiny and compliance obligations for Amazon's co-branded credit card programs from 2022 to 2023, noting the risk of adverse impact on operating results due to less favorable renewals or termination. It accurately reflects the heightened regulatory environment and potential financial implications. However, it omits a key factual development from the ground truth: the introduction of data localization rules in 2023, which were not present in 2022 and represent a significant expansion in regulatory scope, especially for international operations. This omission reduces completeness and qualitative accuracy. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in this dimension. (3) The multi-hop reasoning is partially sound: the model correctly infers increased regulatory burden and its potential impact on operations and profitability by comparing disclosures across years. However, it fails to synthesize the specific new compliance obligation (data localization) that marks the strategic shift in 2023, weakening the depth of the analysis. (4) The answer remains contextually relevant and conveys a plausible narrative based on the 10-K trends, but the absence of data localization—a critical new risk—means the answer does not fully capture the evolution in regulatory risks. Hence, correctness and qualitative accuracy are reduced to 7, while quantitative accuracy remains high due to absence of numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 438,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "Between 2022 and 2024, PM's financial relationship with RBH evolved significantly. In 2022, RBH was deconsolidated from PM's consolidated financial statements following its filing under the Companies' Creditors Arrangement Act (CCAA) in 2019. This deconsolidation removed RBH's financial results from PM's consolidated statements. By 2024, PM continued to hold an equity investment in RBH, which was accounted for without a readily determinable fair value. Due to developments in the CCAA proceedings, including RBH's objection to a proposed settlement plan, PM evaluated its investment for impairment and recorded a $2,316 million non-cash impairment charge. The valuation of the remaining investment in RBH was based on a discounted cash flow analysis, reflecting the impact of litigation and settlement uncertainties.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the deconsolidation of RBH in 2022 due to CCAA proceedings initiated in 2019 and acknowledges PM's ongoing equity investment in RBH by 2024, which aligns with the ground truth. It also correctly notes the need for impairment analysis and the use of discounted cash flow in valuation. However, a critical factual error exists: the LLM states PM recorded a $2,316 million impairment charge, which is not present in the original answer and contradicts the ground truth that does not mention any specific impairment charge amount. This number appears fabricated or misattributed. (2) Quantitative accuracy is low because the $2,316 million figure is unsupported by the ground truth. The original answer references a CAD 3.1 billion allocation of damages to RBH, not an impairment charge by PM, and no USD-equivalent charge is mentioned. There is no indication PM recorded a non-cash impairment of that size in the provided truth. (3) The multi-hop reasoning is partially sound—correctly linking CCAA proceedings to deconsolidation and later to valuation challenges—but fails in accurately synthesizing the financial impact. The model introduces a specific charge not present in the source, indicating a breakdown in factual synthesis. (4) Contextual relevance is high as the response addresses consolidation status, evolution over time, and valuation considerations. Qualitative accuracy is moderate due to correct conceptual framework but undermined by the inclusion of an unsupported quantitative claim. Correctness score is 6 due to mostly accurate structure and entities but significant error in key financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 455,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Between 2023 and 2024, Baqsimi's financial performance and strategic positioning within LLY's product portfolio evolved significantly. In 2023, Baqsimi contributed $677.6 million in total revenue, a substantial increase from $139.3 million in 2022. This growth was primarily driven by the sale of rights for Baqsimi in 2023, which contributed $579.0 million in the U.S. By 2024, the revenue from Baqsimi was included in the broader category of \"collaboration and other revenue,\" which totaled $4,294.8 million. This suggests that the strategic positioning of Baqsimi shifted from being a direct product revenue contributor to a more integrated part of LLY's collaborations and intellectual property management strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly states Baqsimi's 2023 total revenue as $677.6 million, it introduces a false figure of $139.3 million for 2022, which is not present in the ground truth and irrelevant to the question. More critically, it claims that the $579.0 million from U.S. rights sale was part of 2023 revenue, which contradicts the ground truth stating that the sale of rights led to Baqsimi no longer being reported as a direct product revenue item in 2024. The LLM incorrectly frames the 2023 revenue as being 'driven by the sale of rights,' when in fact the $677.6 million appears to be product sales revenue prior to the divestiture. (2) The LLM references 'collaboration and other revenue' of $4,294.8 million in 2024, a specific number not found in the ground truth and unsupported by the original answer, which only states Baqsimi was included in collaboration and other arrangements without providing a total. This introduces a fabricated data point. (3) The reasoning partially captures the strategic shift—Baqsimi moving from direct product revenue to being part of collaboration arrangements—but misattributes the timing and financial cause. The ground truth emphasizes that after the 2023 sale of rights, Baqsimi was no longer a direct revenue contributor in 2024, whereas the LLM implies the rights sale drove 2023 revenue, which distorts the cause-effect relationship. (4) Despite these errors, the answer is contextually relevant and attempts to address the evolution in financial performance and strategic role. It correctly identifies the shift in reporting category, which shows some level of multi-hop understanding. However, due to major quantitative inaccuracies and flawed reasoning about the nature of the revenue shift, the correctness score is low. Quantitative accuracy is severely compromised; qualitative accuracy is moderate due to correct directional insight but incorrect supporting logic; contextual relevance is high as the response stays focused on the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 567,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, the composition of Union Pacific's Total Highway Revenue Equipment shifted significantly toward owned containers and chassis. In 2022, Union Pacific owned 48,962 containers (96.2% of total containers) and 29,875 chassis (68.1% of total chassis). By 2024, the company owned 46,375 containers (99.4% of total containers) and 4,356 chassis (78.4% of total chassis). This indicates a substantial increase in the proportion of owned chassis and a slight decrease in the proportion of owned containers during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Union Pacific owned 29,875 chassis in 2022 and 4,356 in 2024, it fabricates container ownership numbers (48,962 in 2022 and 46,375 in 2024), which do not match the ground truth. According to the original answer, total owned equipment was 78,837 in 2022 and 50,731 in 2024 — these totals include both containers and chassis — but the LLM incorrectly breaks these down into specific container counts that are not supported by the data. Additionally, the LLM claims that the proportion of owned containers increased to 99.4% in 2024, which cannot be verified from the provided ground truth and misrepresents the trend. (2) The ground truth emphasizes a major reduction in both owned and leased equipment, especially leased containers (down from 1,856 to 288) and leased units overall (from 16,004 to 1,485). The LLM answer completely omits any discussion of leased equipment changes, a critical component of the question. Furthermore, the percentages cited (e.g., 96.2%, 68.1%) are not present in the original data and appear to be invented. (3) The multi-hop reasoning is flawed: the model fails to synthesize the full picture of owned vs. leased equipment across years and instead focuses narrowly on ownership proportions without supporting data. It misses the strategic shift toward reducing total asset dependency — a key conclusion in the original answer. (4) Despite addressing the general topic (composition change in highway equipment), the answer is largely incorrect in numbers, omits key leased equipment data, and draws unsupported conclusions about increasing ownership proportions. The contextual relevance is moderate because it discusses the right company and time frame and touches on ownership trends, but the factual foundation is weak, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 512,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations increased from $16.973 billion as of December 31, 2022, to $18.043 billion as of December 31, 2023, representing an increase of $1.07 billion. This growth indicates a slight expansion in the role of securitized debt within the company's overall funding structure, though it remained a smaller component compared to deposits, which accounted for the majority of funding in both years.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the carrying value of securitized debt obligations as $18.043 billion in 2023, matching the ground truth. However, it introduces a figure of $16.973 billion for 2022 that is not present in the original answer, and no such number appears in the ground truth. While the increase of $1.07 billion is close to the actual difference ($18.043B - $16.973B = $1.07B), the 2022 figure is unverified and not supported by the provided truth, making the quantitative claim partially fabricated. (2) The original answer does not provide a specific 2022 dollar amount for securitized debt, only a qualitative description of its role as a key funding source. Thus, introducing a precise number constitutes a factual overreach. (3) The LLM correctly identifies that securitized debt remained a smaller component relative to deposits and that it was part of the funding structure in both years, showing adequate synthesis. However, it completely omits the key qualitative evolution noted in the ground truth: the reclassification to Level 2 in the fair value hierarchy in 2023, which signifies a shift toward standardized valuation methods and a more structured role. This omission misses a central aspect of the 'evolution' asked in the question. (4) While the answer is contextually relevant and addresses the funding role, the inclusion of unsupported numerical data and the failure to capture the methodological shift in valuation hierarchy reduce its qualitative and overall correctness. The answer leans on plausible but unverified numbers and misses a critical dimension of the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 451,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "The revenue from Zyprexa for LLY evolved significantly between 2023 and 2024 in terms of its source and recognition method. In 2023, Zyprexa revenue was primarily derived from product sales, with $79.4 million recognized in the U.S. and $1,615.4 million outside the U.S. However, in 2024, the source of Zyprexa revenue shifted as the company recognized revenue from the sale of rights for the olanzapine portfolio, including Zyprexa, which was disclosed as part of collaboration and other revenue. This change reflects a transition from product sales to revenue recognition based on the transfer of control of intellectual property rights, consistent with the company's accounting treatment for sales of product rights.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in revenue recognition for Zyprexa from product sales in 2023 to collaboration and other arrangements in 2024 due to the sale of rights for the olanzapine portfolio, which aligns with the ground truth. This reflects accurate qualitative understanding and correct multi-hop reasoning regarding the change in source and recognition method. (2) However, the quantitative accuracy is severely flawed. The LLM provides specific revenue figures—$79.4 million in the U.S. and $1,615.4 million outside the U.S. in 2023—which are not present in the original answer and cannot be verified from the ground truth. These numbers appear fabricated or misattributed, as the original answer makes no mention of any dollar amounts related to Zyprexa product sales. This introduces significant factual inaccuracies. (3) The reasoning is otherwise sound: the model correctly infers that the 2024 revenue stems from the 2023 sale of rights and is now classified under collaboration revenue, indicating proper synthesis across time and accounting categories. (4) The contextual relevance is perfect—the answer directly addresses the evolution of revenue source and recognition method. Due to the inclusion of unsupported numerical data, the correctness score is reduced to 7 (core facts correct but major quantitative error), quantitative accuracy is low at 4, qualitative accuracy is high at 8, and contextual relevance remains 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 407,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "The valuation methodology for Federal Government Securities in the pension plan remained consistent from 2022 to 2024, as they were classified as Level 2 investments and valued using a bid evaluation process with bid data from independent pricing sources. However, the classification of these assets in terms of fair value measurements changed slightly in presentation. In 2022, Federal Government Securities were categorized under \"Significant Other Observable Inputs (Level 2)\" with values of $742 million and $150 million for 2021 and 2022, respectively. By 2024, the values increased to $1,448 million and $1,508 million for 2023 and 2024, respectively, with the methodology remaining unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative data. According to the ground truth, Federal Government Securities were valued at $742 million in 2022. However, the LLM incorrectly states that the 2022 value was $150 million and introduces values for 2023 ($1,448 million) and 2024 ($1,508 million), which are not present in the original answer and contradict the provided truth. Additionally, the LLM falsely claims data for 2021 ($742 million) was included in the 2022 reporting, which is unsupported. (2) The quantitative inaccuracies are severe: the dollar amounts are completely wrong, and the trend of increasing values from $150M to over $1.4B is fabricated. No such figures appear in the ground truth, and no multi-year values were provided beyond 2022’s $742M. (3) On qualitative reasoning, the LLM correctly identifies that the classification remained Level 2 and that valuation uses bid evaluation with independent pricing sources—this aligns with the 2024 methodology clarification in the original answer. It also correctly notes consistency in classification over time, which reflects sound multi-hop reasoning between 2022 and 2024. However, it invents a 'slight change in presentation' not mentioned in the original and misrepresents the evolution as one of numerical trend rather than methodological clarification. (4) Contextual relevance is high because the response addresses the core question about valuation methodology and classification evolution. The reasoning structure is logical and focused, but the severe numerical errors undermine factual correctness, warranting a low correctness and quantitative accuracy score despite partially accurate qualitative insights.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 471,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "Capital One's credit score data utilization for product segmentation decisions remained relatively stable from 2022 to 2023, with the percentage of domestic credit card portfolios with FICO scores above 660 decreasing slightly from 69% to 68%, and the auto loan portfolios showing consistent distribution across credit score categories. This suggests that their credit risk modeling strategy prioritizes maintaining a balanced risk profile, with a focus on higher credit quality borrowers, and does not indicate a significant shift in segmentation approach during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that Capital One updated the time period of credit score data used for product segmentation—from 2020–2021 data in 2022 to 2022–2023 data in 2023—indicating a shift toward more current data in their risk modeling. In contrast, the LLM answer incorrectly claims the company's utilization 'remained relatively stable' and introduces specific portfolio percentages (69% to 68%) and references to FICO score thresholds and auto loan portfolios that are not present in the ground truth and cannot be verified from the provided information. These numbers appear fabricated or misattributed. (2) Quantitatively, the percentages cited (69%, 68%) do not appear in the original answer and are not supported by the knowledge graph. There is no mention of FICO >660, domestic credit card portfolios, or auto loan distributions in the ground truth, so these metrics fail verification. (3) The multi-hop reasoning is flawed: the question asks about the evolution in data utilization for segmentation decisions, specifically the recency of data used in modeling. The correct inference requires recognizing that using newer data (2022–2023 vs. 2020–2021) reflects a more dynamic and proactive risk strategy. The LLM instead focuses on static portfolio composition metrics not mentioned in the original, failing to address the core evolution in data sourcing. (4) The contextual relevance is moderate because the answer discusses credit score usage in segmentation and risk strategy, which are relevant themes, but it misses the key point about data recency and temporal updating. Due to major factual inaccuracies and incorrect reasoning, the correctness score is low at 2, with similarly low scores for quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 499,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "From 2022 to 2023, AWS's strategic positioning at Amazon evolved to become more central to the company's overall growth and investment priorities. In 2022, AWS was highlighted as a key area for technology and content investment, supporting product and service offerings through geographic expansion and infrastructure improvements. By 2023, AWS was explicitly identified as one of Amazon's three core business segments (alongside North America and International), reflecting its critical role in the company's financial performance and long-term strategy. Additionally, AWS continued to be a major focus for capital expenditures and innovation, particularly in cloud-based infrastructure, analytics, and machine learning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AWS evolved from a key investment area in 2022 to one of Amazon's three core business segments by 2023, alongside North America and International. The description of AWS's role in offering cloud services like compute, storage, analytics, and machine learning is consistent with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers that conflict—both correctly reference 2022 and 2023 as the relevant years. (3) The multi-hop reasoning is sound: the model correctly synthesizes AWS’s changing role across two years and segments it within Amazon’s broader organizational structure. (4) The only minor omission is that the LLM answer does not explicitly mention AWS’s role in 'internal operational efficiencies' or 'innovative software and electronic devices' from the 2022 context, which slightly reduces completeness in qualitative detail. However, this does not detract from the core accuracy. Overall, the answer is semantically equivalent and contextually precise, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 328,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved significantly due to ongoing litigation and restructuring. In 2022, RBH was deconsolidated from PMI's financial statements following its entry into CCAA proceedings in 2019 to address tobacco-related litigation in Canada. By 2024, PMI recorded a substantial non-cash impairment charge of $2.3 billion (equivalent to a $1.49 diluted EPS charge) related to its equity investment in RBH, reflecting the potential allocation of a CAD 32.5 billion proposed settlement among RBH and its co-defendants. This charge indicates a material financial exposure for PMI, driven by the unresolved allocation of the settlement amount and the ongoing CCAA process.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in PMI's financial relationship with RBH between 2022 and 2024. (1) It correctly states that RBH was deconsolidated in 2022 due to CCAA proceedings, aligning with the ground truth. The 2024 impairment charge is reported as $2.3 billion, which is a rounded version of the exact $2,316 million in the original answer—this is acceptable under format variation rules. The mention of a $1.49 diluted EPS charge adds detail not in the ground truth but does not contradict it. (2) The CAD 32.5 billion proposed settlement is correctly cited, and the connection to the impairment is logically explained. The only minor quantitative deviation is the rounding of $2,316 million to $2.3 billion without specifying it's an approximation, but this is not a material error. (3) The reasoning is sound: the shift from deconsolidation to equity method accounting and the resulting impairment due to litigation exposure is correctly synthesized across time and entities. The answer reflects multi-hop understanding—linking CCAA, deconsolidation, litigation, settlement proposal, and impairment. (4) The answer is fully relevant, directly addressing the evolution in accounting treatment and financial exposure. The only small omission is not explicitly stating that no loss accruals were made in 2022 due to estimation uncertainty, but the focus on 2024 impairment as the key development still makes the response comprehensive. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 427,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, Biktarvy has remained a cornerstone product for Gilead, with its revenue contribution showing a consistent upward trend. In 2022, Biktarvy generated $7,259 million in revenue, increasing to $8,624 million in 2023. However, associated product risks include growing competition in the HIV treatment market and potential pricing pressures from government programs like the U.S. Inflation Reduction Act of 2022, which could limit future pricing flexibility. Additionally, the product faces challenges related to reimbursement and rebates, which may impact profitability.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in revenue figures. The ground truth states that Biktarvy generated $8,624 million in 2022, but the LLM incorrectly reports $7,259 million for 2022 and $8,624 million for 2023—this reverses and distorts the actual data. No 2023 revenue is provided in the ground truth, so the claim of an increase to $8,624 million in 2023 is unsupported. (2) The quantitative inaccuracies are critical because they misrepresent the revenue trend, which is central to assessing commercial significance. The correct figure of $8,624 million in 2022 is mentioned, but misplaced in time. (3) Qualitatively, the LLM correctly identifies Biktarvy as a key product and notes relevant risks such as competition, pricing pressures from the Inflation Reduction Act, and reimbursement challenges. These align with the general risk environment described in the original answer, including regulatory and market-based threats. However, it misses the specific risk highlighted in the ground truth about reliance on TAF-based therapies and potential shifts in treatment paradigms, which is a key technical vulnerability. (4) Contextually, the answer addresses both revenue and risks as required by the question and maintains focus on GILD and Biktarvy’s commercial evolution. While the reasoning structure is sound and attempts multi-hop synthesis (linking revenue trends to external risks), the incorrect financial data undermines the overall correctness. The answer fabricates a year-on-year increase not present in the source, leading to a misleading narrative of growth rather than the more nuanced 'continued importance amid rising risks' conveyed in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 467,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "Union Pacific Railroad's (UPRR) financial stake in TTX increased from $1.6 billion in 2021 to $1.9 billion in 2024, reflecting a growing investment in the rail car pooling company. Operationally, UPRR's car hire expenses with TTX rose from $375 million in 2021 to $432 million in 2024, indicating increased utilization of TTX's rail car services. UPRR accounts for its investment in TTX using the equity method, and TTX remains a critical operational partner in supporting rail car needs across North America.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and years are accurate: UPRR's financial stake in TTX increased from $1.6 billion in 2021 to $1.9 billion in 2024, and car hire expenses rose from $375 million to $432 million over the same period. These values match the original answer exactly, with acceptable format consistency. (2) The answer addresses both parts of the multi-hop question—financial stake (investment value) and operational relationship (car hire expenses)—and correctly references the relevant time frame (2021 to 2024), even though the question asks about 2022–2024; however, the 2022 filing references 2021 data, which is consistent with the knowledge graph's grounding. (3) Entity accuracy is correct: Union Pacific Railroad (UPRR), TTX, equity method accounting, and the nature of TTX as a rail car pooling entity are all accurately identified. (4) The reasoning is sound: the LLM correctly infers that increasing investment and rising car hire expenses indicate deeper financial and operational involvement. It also adds contextually accurate details—such as the use of the equity method and TTX’s North American operational role—that enhance the answer without introducing error. The semantic meaning fully aligns with the original answer, with no factual discrepancies. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 389,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "Tesla shifted its approach to scaling Solar Roof production from 2022 to 2023 by enhancing installer training initiatives and collaborating with real estate developers and builders to reduce installation time and costs. In 2023, the company emphasized onboarding and training new installers more intensively, which reflects a more structured and scalable approach compared to 2022. Regarding supply chain risk management, Tesla acknowledged the sensitivity of production to global component constraints and supplier reliability, highlighting efforts to diversify sources and manage localized procurement to mitigate disruptions.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy in its portrayal of Tesla's shift in approach. According to the ground truth, Tesla moved *away* from an installer-focused strategy in 2023 toward greater emphasis on supply chain risk management. However, the LLM incorrectly states that in 2023, Tesla 'emphasized onboarding and training new installers more intensively,' which contradicts the original answer that the focus had shifted from installer expansion to supply chain resilience. This misrepresents the core evolution of strategy. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations are present, warranting a full score. (3) The multi-hop reasoning is partially sound: the model correctly identifies both installer training and supply chain elements as key themes across years, but fails the synthesis by reversing the directional shift—claiming increased focus on installers in 2023 when the truth indicates a pivot away from that focus. The mention of supply chain risks like global component constraints and supplier reliability is accurate and aligns with the 2023 emphasis, but the parallel claim of intensified installer training is not supported by the ground truth. (4) Contextual relevance is high because the answer addresses both parts of the question—installer training and supply chain risk—and uses appropriate terminology. However, due to the critical error in characterizing the strategic shift, the qualitative and overall correctness scores are significantly reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 442,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company's relationship with fountain retailers in the United States remained consistent, with the Company continuing to manufacture and sell fountain syrups directly to fountain retailers and authorized fountain wholesalers. There were no significant changes in this arrangement during the period, as the Company retained control over the production and distribution of fountain syrups in the U.S. market.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in stating that The Coca-Cola Company manufactures and sells fountain syrups in the U.S., but it incorrectly claims there were 'no significant changes' between 2022 and 2023. The ground truth shows a meaningful evolution: in 2022, the Company sold syrups directly to authorized wholesalers and certain retailers, with bottlers generally not authorized to manufacture. By 2023, the Company explicitly included bottling partners in the distribution chain, selling syrups to them for onward distribution to fountain retailers—indicating a more formalized or expanded tiered distribution model. The LLM answer fails to capture this shift, instead asserting continuity. While all entities (The Coca-Cola Company, fountain retailers, U.S. market) and years (2022, 2023) are correctly identified, and no numeric data is misstated (so quantitative accuracy is high), the qualitative reasoning is flawed. The model misses the multi-hop nuance of evolving distribution roles and relationships, particularly the expanded or clarified role of bottling partners in 2023. This omission significantly undermines the correctness of the response, especially given the question’s focus on how the relationship evolved. Contextual relevance is strong as the answer addresses the core topic, but the lack of recognition of change results in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 382,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "IBM's 0.950% Notes due 2025 are consistently classified as registered debt securities under IBM's 2024 10-K filing (page 1), listed as \"Securities registered pursuant to Section 12(b) of the Act\" with the trading symbol IBM25B on the New York Stock Exchange. In 2022, the Notes were similarly referenced in the context of financial instruments in the 10-K's exhibits section (page 31), though specific details on their classification were not explicitly provided. The 2024 filing provides more direct and updated registration details, confirming the Notes' ongoing status as publicly traded securities. There is no indication of a change in classification from 2022 to 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all details are accurate: the 0.950% Notes due 2025 are correctly identified, the trading symbol 'IBM25B' is accurate, and the reference to NYSE listing in 2024 is correct. The mention of Form 10-K pages (1 and 31) adds specificity, though page numbers are not part of the ground truth and cannot be verified independently — however, they do not contradict it. (2) The answer correctly identifies that in 2022 the notes were referenced in exhibits (consistent with the ground truth's reference to 8-K and Exhibit 4.1 from 2017), though it does not explicitly mention the 2017 filing date or Form 8-K, which is a minor omission. (3) The reasoning is sound: the LLM correctly infers that the instrument was already in existence in 2022 and became more formally registered and listed by 2024. However, the ground truth emphasizes an evolution from disclosure in filings to active listing, while the LLM concludes there was 'no indication of a change in classification,' which slightly underrepresents the shift in treatment. This is a key nuance — the evolution is not necessarily in accounting classification but in registration and trading status, which the LLM acknowledges via the symbol and exchange listing but downplays. (4) Despite this, the answer is contextually relevant, complete in key aspects, and factually accurate on all numeric and entity-related points. Minor deduction from 9 to 8 due to underemphasizing the evolution in disclosure and registration status as highlighted in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 437,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "From 2022 to 2024, Gilead's strategic positioning of Biktarvy in the HIV treatment market has evolved with increased focus on maintaining competitive differentiation amid growing market pressures and regulatory challenges. Biktarvy remains a key revenue driver, but Gilead faces heightened financial risk exposure due to factors such as reimbursement pressures, the threat of generic competition, and legislative actions like the Inflation Reduction Act (IRA), which could impact pricing and profitability. To sustain differentiation, Gilead continues to emphasize Biktarvy's efficacy and tolerability profile while investing in R&D for new HIV therapies to address evolving treatment paradigms and maintain market leadership.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in spirit but introduces elements not present in the original knowledge graph while omitting key specifics. (1) Correct aspects: The answer correctly identifies Biktarvy as a key product for GILD and acknowledges increasing financial risk exposure from 2022 to 2024, including threats from generic competition and evolving treatment paradigms. It appropriately frames Biktarvy’s strategic importance and Gilead’s efforts to maintain differentiation through efficacy and R&D. (2) Quantitative accuracy: There are no numeric values in either the original or LLM answer, so this dimension is neutral; no errors present. (3) Multi-hop reasoning: The LLM correctly synthesizes Biktarvy’s role in GILD’s portfolio and evolving risk, but adds unverified details—specifically mentioning the Inflation Reduction Act (IRA) and 'reimbursement pressures'—which are not in the original knowledge base and cannot be confirmed as part of the documented strategic shift. The original emphasizes a *paradigm shift away from TAF-based therapies* as the core scientific/competitive risk, which the LLM answer omits entirely. Instead, it focuses on pricing and regulatory risks, shifting emphasis from therapeutic obsolescence to external policy. (4) The omission of the TAF-based regimen vulnerability—a central element of the 2024 risk assessment—and the introduction of unsupported factors like IRA reduce qualitative accuracy. However, the overall direction of increased risk and reliance on Biktarvy is preserved, warranting a score of 7 for correctness and qualitative accuracy. Contextual relevance remains high as the response directly addresses strategic positioning, financial risk, and competitive differentiation over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 480,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued to reduce its defined benefit pension obligations by transferring them to insurance companies through group annuity contracts. In 2022, the company transferred $4.3 billion of gross defined benefit pension obligations and related plan assets to an insurance company for approximately 13,600 U.S. retirees and beneficiaries, recognizing a $1.5 billion noncash pension settlement charge. In 2023, Lockheed Martin made a voluntary offering to certain former employees, resulting in $414 million in lump-sum settlement payments for approximately 6,500 participants, which reduced the pension obligation without impacting 2023 financial statement pension income. These actions reflect the company's ongoing strategy to mitigate the financial impact of its defined benefit pension plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations via group annuity contracts and recognized a $1.5 billion noncash settlement charge; in 2023, the company made $414 million in lump-sum payments to about 6,500 former employees. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—dollar amounts, participant counts, and years are all correct. (3) The reasoning is sound: the LLM correctly identifies a strategic shift from large-scale annuity transfers in 2022 to direct individual settlements in 2023. It accurately notes that the 2023 payments did not impact pension income, which is consistent with the financial impact described in the ground truth. (4) The only minor shortcoming is that the LLM slightly softens the contrast between 2022 and 2023 by saying the company 'continued to reduce' obligations via annuities, when in fact 2023 did not involve an annuity purchase—this could imply continuity in method rather than evolution. However, it correctly describes the 2023 action as lump-sum payments and contextualizes it appropriately. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 376,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "The 2.875% Notes due 2025 (IBM25A) were issued and publicly traded as of 2022, as listed in the 2022 10-K under securities registered with the SEC. By 2024, these notes remained part of IBM's debt instruments maturing in 2025, with no new issuance or material changes indicated in the 2024 10-K. Thus, the composition of IBM's 2025-maturing debt, including the 2.875% Notes, remained consistent between 2022 and 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its qualitative reasoning. (1) Quantitatively, all dates and percentages are accurate: the 2.875% Notes due 2025 (IBM25A) are correctly identified as present in both 2022 and 2024, and no incorrect numbers are cited. There are no calculation errors. (2) However, the key multi-hop insight from the ground truth is missed: while the 2.875% Notes remained, the composition of IBM's 2025 debt did change—specifically, the 0.875% Notes due 2025 (IBM 25C) were present in 2022 but no longer listed in 2024. The LLM incorrectly states that the composition 'remained consistent,' which contradicts the ground truth showing a shift in debt structure. (3) The reasoning is flawed in that it fails to synthesize across the two years' filings to detect the removal of IBM 25C, which is central to the question about evolution in composition. The model correctly identifies the continuity of IBM25A but misses the discontinuity of another instrument, leading to an incomplete and misleading conclusion. (4) Therefore, while factually accurate on the notes it discusses, the answer lacks critical comparative analysis required by the question, warranting a mid-range score of 5 for correctness. Quantitative accuracy is high (9), qualitative accuracy is moderate due to flawed synthesis (5), and contextual relevance is strong as it addresses the core topic (8).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 394,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "Biktarvy's strategic importance within Gilead's HIV portfolio has grown significantly from 2022 to 2024, as it has increasingly offset revenue declines from Truvada and Atripla due to generic competition. In 2022, Biktarvy's sales growth was highlighted as a key driver of recovery in the HIV business post-pandemic. By 2024, Biktarvy's risk profile has evolved with heightened competitive pressures and regulatory challenges, including FDA-mandated labeling changes for CAR T-cell therapies and potential pricing constraints under the Inflation Reduction Act. Additionally, the introduction of a pediatric formulation in 2021 expanded its market reach, but ongoing risks include market share erosion from emerging competitors and potential Medicare price negotiations starting in 2026.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces information not present in the ground truth. While it correctly identifies Biktarvy as a key product in Gilead's HIV portfolio, it misrepresents the evolution of its strategic importance. The ground truth states that Biktarvy's position became more precarious by 2024 due to risks from treatment paradigm shifts, whereas the LLM claims its strategic importance has 'grown significantly,' which contradicts the source. (2) Quantitatively, the LLM mentions no specific revenue figures, percentages, or dates beyond a pediatric formulation launch in 2021 (not mentioned in the ground truth), and references to the Inflation Reduction Act, CAR T-cell labeling changes, and Medicare negotiations in 2026 are unsupported by the provided truth. The 11% revenue increase cited in the original answer for 2022 is omitted. (3) The multi-hop reasoning is flawed: the LLM fails to connect the increased risk in 2024 to the reliance on TAF-based therapies and the potential shift away from nucleoside analogs, a key insight in the ground truth. Instead, it cites external factors like FDA labeling changes for CAR T-cell therapies—irrelevant to Biktarvy—and pricing policies with no direct support. (4) Contextual relevance is moderate: the answer addresses competitive pressures and changes in the treatment landscape, but misattributes risks and overemphasizes unsupported regulatory and pricing issues. The core shift from growth driver (2022) to vulnerable asset (2024) is misrepresented, leading to a low correctness score despite some relevant thematic elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 446,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The balance of the U.S. litigation escrow account increased from $1,449 million at the end of fiscal year 2022 to $1,764 million at the end of fiscal year 2023. During fiscal year 2023, the Company deposited $1,000 million into the U.S. litigation escrow account.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The ending balance for fiscal year 2023 is incorrect: it states $1,764 million instead of the correct $3,089 million. Additionally, the deposit amount for fiscal year 2023 is wrong: it reports $1,000 million, but the correct amount is $1,500 million. The starting balance ($1,449 million at end of FY2022) is accurate. (2) Quantitative accuracy is low because two of the three key figures (ending balance and deposit) are incorrect. The increase from $1,449M to $1,764M implies only a $315M increase, whereas the actual increase was $1,640M ($3,089M - $1,449M), and the reported deposit of $1,000M does not match the actual $1,500M deposit in FY2023. (3) The reasoning is partially sound in that the model recognizes the need to report balance evolution and deposit contributions, but it fails to correctly synthesize the multi-hop data across fiscal years. It omits the correct deposit for FY2023 and misrepresents the final balance, undermining the multi-period comparison. (4) Contextual relevance is high because the answer addresses the right account, time periods, and types of information requested (balances and deposits), but the incorrect figures severely limit factual correctness. Minor wording differences would be acceptable under semantic equivalence, but the numerical discrepancies here are material and alter the interpretation of the account's evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 404,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Between 2022 and 2023, fountain syrups in Coca-Cola's North America operating segment remained a key part of the company's finished product operations. In the United States, Coca-Cola continued to manufacture fountain syrups and sell them to fountain retailers or authorized wholesalers, who distribute them for use in producing beverages for immediate consumption. The role of fountain syrups in the North America segment remained consistent, as these sales were included in the North America operating segment in both years. However, the overall percentage of net operating revenues attributed to finished product operations slightly decreased from 44% in 2022 to 42% in 2023, while concentrate operations increased from 56% to 58%, indicating a relative shift in revenue emphasis.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Coca-Cola continued to manufacture fountain syrups in the U.S. and sell them to retailers or wholesalers in both 2022 and 2023, which aligns with the ground truth. It also accurately reports the shift in revenue mix—finished product operations decreasing from 44% to 42% and concentrate operations increasing from 56% to 58%—which is factually correct and adds relevant context. However, the LLM fails to capture the key evolution highlighted in the original answer: the 2023 shift in language regarding bottling partners being authorized to manufacture fountain syrups *outside the U.S.* using company concentrates. This represents a significant qualitative change in the operating model that the LLM omits entirely. (2) Quantitatively, the percentages (44%, 42%, 56%, 58%) are accurate and consistent with the source data; no calculation errors are present. (3) The multi-hop reasoning is partially sound—linking fountain syrups to the North America segment and noting revenue trends—but it misses the critical synthesis between U.S. vs. non-U.S. manufacturing responsibilities and the strategic shift toward a decentralized, authorization-based model outside the U.S. This omission undermines the completeness of the response. (4) While the answer is contextually relevant and includes accurate financial data, it does not fully address the evolution in *manufacturing and distribution responsibilities*, which is the core of the question. The focus on revenue percentages, while useful, distracts from the operational model change described in the ground truth. Hence, the correctness score is moderate due to significant qualitative omissions despite numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 470,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "Between 2022 and 2024, IBM's debt instruments maturing in 2025 remained consistent in terms of the 0.950% Notes due 2025, as both the 2022 and 2024 10-K filings list these notes under the registered securities. There is no indication of changes in the composition or issuance of the 0.950% Notes due 2025 during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in noting that the 0.950% Notes due 2025 were present in both 2022 and 2024, which aligns with the ground truth. However, it fails to mention the key evolution in composition — specifically, that in 2022 there were three tranches of notes maturing in 2025 (including the 0.875% Notes), but by 2024, the 0.875% Notes were no longer listed. This omission represents a significant gap in completeness and accuracy regarding the evolution of the debt composition. (2) Quantitatively, the LLM does not provide any incorrect numbers — it correctly identifies the 0.950% Notes as existing in both years — but it omits the other two instruments (2.875% and 0.875%) and thus fails to reflect the full quantitative landscape. There are no calculation errors because no calculations were attempted. (3) The multi-hop reasoning is flawed: the question asks about the evolution of the composition of debt instruments maturing in 2025, which requires comparing the set of instruments across years. The LLM only confirms the continuity of one instrument rather than analyzing changes in the full portfolio, missing the reduction in diversity. (4) While the response is contextually relevant and addresses the 0.950% Notes correctly, it lacks the comparative analysis required for full accuracy. Hence, correctness is scored at 4 due to major omissions in synthesis, quantitative accuracy at 6 because no numbers are wrong but key ones are missing, qualitative accuracy at 4 due to incomplete reasoning, and contextual relevance at 8 because the response is on-topic and factually consistent where it speaks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 449,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Between 2022 and 2024, Disney's strategic approach to cruise ships evolved to include expansion plans and new destinations. In 2022, the company highlighted its cruise operations and related investments, while in 2024, it specifically noted plans for additional fleet expansion and the opening of a new Disney Cruise Line destination at Lighthouse Point on the island of Eleuthera in 2024. This reflects a shift from maintaining existing operations to actively expanding the cruise segment as part of its broader Experiences and Products strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but omits key elements from the ground truth. (1) It correctly identifies the evolution in Disney's strategy from 2022 to 2024, noting a shift toward active expansion of the cruise fleet and mentioning the Lighthouse Point destination, which aligns with the 2024 filing. However, the original answer emphasizes a strategic shift from passive dependence on consumer demand (2022) to active investment and growth (2024), including explicit mention of increased costs and uncertain returns due to capital intensity—this nuance is missing in the LLM response. (2) Quantitatively, there are no errors: the 2024 opening of Lighthouse Point is factually accurate and consistent with disclosures; no specific dollar amounts or numerical metrics are misstated. (3) The reasoning is sound in identifying a strategic shift, but it fails to fully synthesize the multi-hop insight that Disney’s framing evolved from demand-dependent performance to proactive capital investment with associated risks—this is a key qualitative difference. (4) Contextual relevance is high, as the answer directly addresses the evolution in cruise strategy and ties it to broader corporate direction. However, the omission of risk disclosures and the more strategic, capital-intensive framing in 2024 reduces completeness and qualitative accuracy, preventing a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 379,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "From 2022 to 2023, Lockheed Martin's approach to pension risk transfer transactions remained focused on mitigating the volatility of pension obligations and reducing future liabilities. In 2022, the company continued to evaluate such transactions, with a strategic intent to transfer pension obligations through group annuity contracts (GACs) using pension trust assets. While no specific 2023 transactions are detailed, the company expressed ongoing intent to explore similar opportunities. Financially, these transactions could result in noncash settlement charges, as seen in prior years, but also aim to reduce future funding requirements and PBGC premiums, thereby improving long-term financial stability.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic intent of Lockheed Martin to reduce pension volatility and continue evaluating risk transfer transactions, which aligns with the ground truth. However, it fails to include key quantitative details from the original answer: the 2022 filing specifically referenced a transaction on August 3, 2021, transferring $4.9 billion in pension obligations and resulting in a $1.7 billion noncash settlement charge—this level of specificity is missing. Additionally, the cumulative transfer of $11.6 billion since December 2018 and the impact on 95,000 retirees are omitted, significantly reducing quantitative accuracy. The LLM correctly notes that no 2023 transactions were detailed but misses the critical evolution in strategic framing: in 2023, Lockheed introduced a new risk—residual liability if insurers default on GACs—which reflects a more cautious tone not present in 2022. This shift in risk communication is a key qualitative development that the LLM fails to mention, weakening the qualitative accuracy. While the answer correctly identifies the financial implications (noncash charges, reduced funding needs, lower PBGC premiums), it does not reflect the nuanced change in risk disclosure or the backward-looking nature of the 2022 transaction. The reasoning is logically sound but incomplete, as it synthesizes only part of the multi-hop information (intent and financial impact) while missing the evolution in risk framing. Contextually, the answer remains relevant and addresses the core themes of financial impact and strategic intent, but lacks depth in showing how the approach evolved. Thus, the correctness score is moderate due to significant omissions in both quantitative and qualitative evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 475,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Between 2022 and 2023, Tesla's relationship with its financing partners has evolved in terms of accounts receivable management and leasing program risks. In 2022, Tesla highlighted that accounts receivable balances can fluctuate significantly due to factors such as government rebate processing timelines and customer payment clearing cycles, which can take up to two weeks. By 2023, Tesla emphasized the risks associated with managing its leasing programs, including the potential for residual value fluctuations, credit risk from customers, and the need to secure adequate financing or partners to support program growth. The company also noted that if actual resale values of returned vehicles are lower than pre-determined guarantees, it could harm its financial condition and operating results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Tesla noted accounts receivable could take up to two weeks to settle due to payment clearing cycles, which matches the original answer's 'up to approximately two weeks' timeline. The mention of government rebate processing is additional context not in the ground truth but does not contradict it. (2) In 2023, the LLM correctly identifies increased risks in leasing programs, including residual value risk (specifically noting lower resale values than guarantees could harm results), credit risk, and the need to secure financing partners—this matches the original answer's emphasis on residual value, credit, compliance, and partner dependency. (3) The multi-hop reasoning is sound: the answer synthesizes information across two years and correctly contrasts the shift from cash flow timing concerns in 2022 to broader financial and operational risks in 2023. (4) Minor deduction in qualitative accuracy because the original answer emphasizes a 'shift in focus' narrative more explicitly (from liquidity timing to broader risk), which the LLM implies but doesn't state as clearly. However, all factual content is correct, and semantic equivalence is strong. No numerical errors; dates and financial risks are accurately represented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 373,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola shifted its fountain syrup distribution strategy by increasing the role of its consolidated operations in the United States, where the Company directly manufactures and sells fountain syrups to fountain retailers and authorized wholesalers. Previously, outside the U.S., bottlers were typically authorized to manufacture and distribute fountain syrups. In 2023, the document emphasizes that in the U.S., bottlers are generally not authorized to manufacture fountain syrups, and this responsibility has been centralized under Coca-Cola’s North America operating segment. Meanwhile, outside the U.S., bottlers continue to play a key role in manufacturing and distributing fountain syrups, often through authorized fountain wholesalers. This evolution reflects a more centralized approach in the U.S. while maintaining a decentralized model in international markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the direction of change in Coca-Cola's fountain syrup distribution strategy. The ground truth states that in 2022, Coca-Cola directly sold syrups to wholesalers (including some bottlers), with bottlers generally not authorized to manufacture fountain syrups in the U.S. By 2023, outside the U.S., bottlers were typically authorized to manufacture syrups using concentrates—a shift toward greater bottler involvement internationally. However, the LLM incorrectly frames the evolution as a move toward centralization in the U.S. and claims that previously (in 2022) bottlers outside the U.S. were already authorized, which contradicts the original answer’s implication that this was a new development in 2023. The LLM reverses the timeline and misrepresents the nature of the change. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift from a centralized model in 2022 to a more integrated, bottler-involved model in 2023, especially outside the U.S. Instead, it incorrectly suggests the U.S. model became more centralized as a new development, when in fact that was the existing state in 2022. It also misattributes continuity to international markets when the ground truth indicates an evolution. (4) Contextual relevance is high because the answer addresses fountain syrup distribution, bottlers, wholesalers, and geographic distinctions. However, due to the reversal of the strategic shift and incorrect characterization of the evolution, the qualitative and overall correctness scores are low. Semantic equivalence is not achieved due to the inversion of the core factual progression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 503,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV showed notable changes in receivables and new investment activities. Receivables from the ATMP JV increased slightly, from $9 million as of December 30, 2023, to $12 million as of December 28, 2024. Additionally, AMD made a new equity contribution of $17 million to the ATMP JV on August 8, 2024, aligning with its existing 15% ownership stake. This brought the carrying value of AMD's investment in the ATMP JV to approximately $149 million by December 28, 2024, up from $99 million as of December 30, 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that receivables from the ATMP JV increased from $9 million in 2023 to $12 million in 2024, it incorrectly claims AMD made a $17 million equity contribution to the JV in 2024. The ground truth states there was no direct investment or loan by AMD in 2023, and in 2024, AMD entered into a $100 million one-year term loan — not an equity contribution. The LLM invents a $17M equity investment and falsely reports AMD’s carrying value increasing from $99M to $149M, which is not supported by the original answer. (2) Quantitative accuracy is low: the $17M equity contribution, $99M and $149M investment carrying values are entirely fabricated. Only the receivables figures ($9M and $12M) are correct. The date formatting (December 30, 2023, and December 28, 2024) is plausible but not confirmed in the ground truth, which only specifies years. (3) The multi-hop reasoning is flawed: the LLM misidentifies the nature of the financial activity (equity vs. loan), conflating a creditor relationship with ownership investment. It fails to recognize that the new financial activity is a loan, not an equity injection, which changes the interpretation of AMD’s role from strategic creditor to supposed co-owner expansion — a major mischaracterization. (4) Contextual relevance is moderate: the answer addresses receivables and new financial activities as asked, and the structure is relevant, but the core financial facts are incorrect, undermining the response. Correctness is severely compromised due to false numerical and qualitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 447,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolved through strategic settlements aimed at reducing pension obligations and associated financial impacts. In 2022, the company executed a significant transaction by purchasing group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and related plan assets to an insurance company, which resulted in a noncash, non-operating pension settlement charge of $1.5 billion. In 2023, the company made voluntary lump-sum settlement payments of $414 million to approximately 6,500 former employees who had not yet commenced receiving their vested benefits, reducing the pension obligation without incurring a settlement charge. These actions reflect a continued effort to mitigate the financial volatility and size of pension obligations by transferring risk to third parties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations via group annuity contracts and recognized a $1.5 billion noncash settlement charge; in 2023, it made $414 million in voluntary lump-sum payments to ~6,500 former employees. All numbers, years, and entities are accurate. (2) Quantitative accuracy is perfect: $4.3 billion, $1.5 billion, $414 million, and 6,500 employees are all correctly reported with no calculation errors. Format variations (e.g., 'billion' vs 'million') are consistent and correct. (3) The multi-hop reasoning is sound—LLM correctly contrasts the 2022 large-scale annuity transfer with the 2023 targeted lump-sum approach, noting the shift in strategy. It accurately adds that no settlement charge was incurred in 2023, which aligns with accounting rules when settlements are below the 'corridor threshold'—a nuance not in the original answer but factually correct and contextually appropriate. (4) The only reason for not scoring a 10 in qualitative accuracy is that the original answer emphasizes the 'shift from large-scale to targeted' approach slightly more explicitly, though the LLM conveys the same meaning. The LLM adds value by explaining the financial rationale (reducing volatility, risk transfer), enhancing contextual relevance without introducing error. All components of the question—evolution of approach, pension settlements, financial impacts—are fully addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 417,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved as follows: its investment in the ATMP JV increased from approximately $99 million as of December 30, 2023, to $149 million as of December 28, 2024, following an additional $17 million equity contribution in August 2024. Additionally, AMD's equity income from the ATMP JV rose from a gain of $16 million in 2023 to $33 million in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 2023 carrying value ($99M), 2024 carrying value ($149M), additional contribution ($17M), 2023 equity income ($16M), and 2024 equity income ($33M) are all correctly reported. The implied calculation—$99M + $17M = $116M vs. reported $149M—does not need to match exactly because the carrying value includes more than just contributions (e.g., equity income, adjustments); the final carrying value is taken directly from the source and correctly stated. (2) The answer is complete, addressing both parts of the question: AMD's investment evolution (via contribution and carrying value) and equity income change. (3) Entities are accurate: AMD, ATMP JV, correct fiscal years (2023 and 2024), and financial metrics (equity income, investment carrying value) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects AMD’s contribution in 2024 to the increase in carrying value and separately tracks the rise in equity income, correctly interpreting the financial relationship evolution. (5) Semantic equivalence is strong—wording differs slightly (e.g., 'gain of $16 million' vs. 'equity income'), but the meaning is identical. Minor date variations (Dec 30 vs. Dec 28) are within normal fiscal reporting ranges and do not affect accuracy. Overall, the answer is factually precise, comprehensive, and logically coherent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 410,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson significantly reduced its ownership stake in Kenvue. In May 2023, Kenvue completed its IPO, after which Johnson & Johnson retained approximately 89.6% ownership. In August 2023, Johnson & Johnson further disposed of an additional 80.1% of Kenvue shares through an exchange offer, reducing its ownership to 9.5% of the total outstanding shares, valued at $4.3 billion. By May 2024, Johnson & Johnson completed a Debt-for-Equity Exchange, effectively eliminating its remaining ownership stake in Kenvue. This process resulted in a one-time gain of $21.0 billion in 2023 from the exchange offer, which included a $2.8 billion gain on the retained shares, and a $0.4 billion loss in 2024 from the Debt-for-Equity Exchange.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the early ownership percentages. It incorrectly states that Johnson & Johnson retained 89.6% ownership after Kenvue's IPO in May 2023 and then disposed of an additional 80.1% in August 2023. This is logically and quantitatively flawed—selling 80.1% of the total shares would not result in a 9.5% retained stake from an 89.6% base. The ground truth indicates that after the exchange offer in 2023, J&J retained a 9.5% stake valued at $4.3B, with a $21.0B non-cash gain (including $2.8B on retained shares), which the LLM correctly reports. However, the path to that 9.5% is misrepresented. (2) The $21.0B gain in 2023 and $0.4B loss in 2024 are correctly cited, as is the full exit via Debt-for-Equity Exchange by May 2024 (though the original answer specifies the end of 2024, not May). The number of shares (182,329,550) is omitted in the LLM answer, but the outcome—complete exit—is correct. (3) The multi-hop reasoning is partially sound: the model connects the 2023 exchange offer, retained stake, valuation, gains, and 2024 exit. However, the incorrect narrative of ownership reduction (89.6% → minus 80.1% → 9.5%) shows flawed synthesis and undermines quantitative accuracy. (4) Despite the incorrect intermediate ownership figures, the final 9.5% stake, its valuation, the gains/losses, and the full exit are all correctly reported, warranting a moderate correctness score. Contextual relevance is high as all key events are addressed, but qualitative and quantitative accuracy are reduced due to the erroneous ownership percentages and timeline details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 450,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "Based on the provided document pages, AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. was included in historical guarantee agreements referenced in the 2022 filing (T_10k_2022.pdf, page 133). However, in the 2023 filing (T_10k_2023.pdf, pages 101-105), there is no specific mention of Southwestern Bell Telephone Co. in active guarantee agreements. This suggests that between 2022 and 2023, Southwestern Bell Telephone Co. was no longer explicitly included in current guarantee agreements, indicating a possible reduction or restructuring of AT&T's financial guarantee obligations related to this entity.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. (1) According to the original answer, AT&T's guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the entity explicitly included in Exhibit 4-c in both years. The LLM claims there is no mention in 2023, which is factually wrong. (2) There are no numeric values to verify, but the core factual assertion about the presence or absence of Southwestern Bell Telephone Co. in the 2023 guarantees is incorrect. (3) The multi-hop reasoning fails: the model incorrectly infers a change or removal based on absence in cited pages, while the ground truth confirms continued inclusion. This reflects a failure in synthesizing accurate information across the two years. (4) The answer is contextually relevant to the question topic but draws the opposite conclusion of the ground truth, making it highly misleading. Thus, the correctness score is very low due to major factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 287,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2023 has evolved with a strategic focus on expanding its capabilities and positioning itself as a leader in this emerging domain. In 2022, the company was already engaged in hypersonics programs with the U.S. Air Force and Army under its Missiles and Fire Control (MFC) and Space segments. By 2023, the company emphasized that multiple hypersonics programs were expected to enter early production phases through 2026, following successful testing and evaluation. This indicates a shift from development to production readiness, reflecting a stronger strategic positioning and increased responsibility in delivering hypersonic strike weapons for U.S. defense needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of Lockheed Martin's evolving role in hypersonics programs from 2022 to 2023, with accurate contextual framing around strategic positioning and program maturity. It correctly identifies continued involvement in hypersonics and a progression toward production, which aligns with the ground truth's implication of increased activity. However, there are key discrepancies in entity accuracy and reasoning synthesis: (1) The original answer notes that in 2022, hypersonics were described as a potential 'growth area' contingent on government funding and not yet a major active program, whereas the LLM claims Lockheed was already 'engaged' in programs with the Air Force and Army—this overstates the 2022 involvement based on the source. (2) The LLM introduces new information—'early production phases through 2026'—that is not present in the ground truth and cannot be verified from the provided knowledge graph, introducing speculative detail. (3) The shift in the original answer is from 'potential growth area' to 'major program under Space segment,' which reflects formal organizational prioritization; the LLM reframes this as a development-to-production shift, which, while plausible, is not explicitly supported in the ground truth. Quantitatively, there are no numbers, dates, or financial figures in either answer, so no inaccuracies exist in that domain (hence a score of 10). Contextual relevance is high as the response directly addresses strategic positioning and program responsibilities. Qualitative accuracy is reduced due to incorrect characterization of 2022 involvement and unsupported forward-looking claims. Correctness is scored at 7 because the core idea of increased strategic commitment is accurate, but key details misrepresent the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 494,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The balance of the U.S. litigation escrow account increased from $1,449 million as of September 30, 2022, to $1,764 million as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while $1,000 million was deposited during fiscal year 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported account balances, while correctly identifying the deposit amounts. According to the ground truth, the balance was $1.4 billion (i.e., $1,400 million) as of September 30, 2022, and increased to $3.089 billion ($3,089 million) by September 30, 2023. However, the LLM reports the 2022 balance as $1,449 million and the 2023 balance as $1,764 million—both of which are incorrect. The deposits, however, are accurate: $850 million in FY2022 and $1,000 million ($1.0 billion) in FY2023. (2) The quantitative inaccuracies are substantial: the final balance is off by over $1.3 billion, which represents a ~43% error relative to the correct value. This severely undermines the correctness of the response. While the deposit figures match the ground truth and are correctly attributed to the respective fiscal years, the balance evolution is completely misrepresented. (3) The multi-hop reasoning appears partially sound—linking deposits to account balance changes—but fails in execution because the balance figures do not align with the deposits or the prior year's balance. If only $1 billion was deposited in FY2023 and the starting balance was $1.4 billion, the resulting balance should be around $2.4 billion at most without withdrawals, yet the LLM claims $1.764 billion, which still doesn't reconcile. The correct trajectory (from $1.4B to $3.089B) reflects a net increase of $1.689B, consistent with cumulative deposits exceeding $1.85B over two years, but the LLM fails to reflect this. (4) The contextual relevance is high because the answer addresses both parts of the question—balance evolution and annual deposits—and uses appropriate fiscal years and entities. The qualitative accuracy is moderate because the reasoning structure is present but based on incorrect data. The correctness and quantitative accuracy scores are low due to the critical errors in the core financial figures, which are central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 540,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "From 2022 to 2024, Outdoor Garden has remained a subcategory within the \"Hardlines\" major product line, but its performance metrics have shown a slight decline in relative sales contribution. In 2022, Outdoor Garden accounted for 6.8% of total net sales, which decreased to 6.4% in 2023 and stabilized at 6.5% in 2024. While the absolute sales figures for Outdoor Garden remained relatively consistent, its positioning within the broader product strategy appears to have maintained a stable but non-expanding role, as the company has reallocated focus to other product lines such as Power and Plumbing, which saw higher percentage contributions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Outdoor Garden was a distinct product line with $10,317 million in net sales (6.8% of total). However, the LLM claims it was a subcategory within 'Hardlines' in 2022, which contradicts the ground truth that it was only grouped under 'Hardlines' by 2024. This misrepresents the core evolution of the product line's classification. Additionally, the LLM fabricates performance metrics for 2023 (6.4%) and 2024 (6.5%), which are not present in the original answer and contradict the strategic repositioning narrative. (2) Quantitative accuracy is low: while the 6.8% figure for 2022 is correct, the 6.4% and 6.5% figures for 2023 and 2024 are unsupported and incorrect based on the ground truth, which does not provide those percentages. The LLM also fails to mention the $10,317 million sales figure, reducing completeness. (3) The multi-hop reasoning is flawed: the original answer emphasizes a structural shift from standalone category to inclusion in Hardlines as a strategic repositioning. The LLM instead focuses on minor percentage fluctuations and invents a narrative of 'stable but non-expanding role' and reallocation to other lines like Power and Plumbing—information not present in the ground truth. This reflects incorrect synthesis. (4) Contextual relevance is moderate because the answer addresses the general topic of Outdoor Garden’s role and performance over time, but the incorrect classification timeline and fabricated metrics severely undermine factual correctness. The conclusion about strategic focus shifts is speculative and unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 457,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD has maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024 by reinforcing its culture of innovation, inclusivity, and respect, supported by employee engagement surveys, diversity and inclusion initiatives, and flexible work arrangements. This approach, combined with strong leadership development and competitive total rewards, suggests a proactive talent retention strategy aimed at sustaining high employee engagement and attracting top talent in the competitive semiconductor industry.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key aspects. The original answer states that AMD maintained the same cultural messaging verbatim from 2023 to 2024 despite workforce growth from 26,000 to 28,000 employees (a 7.7% increase), emphasizing consistency in language as evidence of cultural preservation. The LLM answer fabricates specific initiatives—employee engagement surveys, diversity programs, flexible work arrangements, leadership development, and total rewards—that are not mentioned or supported in the original answer. These additions are not grounded in the provided ground truth. (2) Quantitative accuracy is very low: the LLM fails to include any of the correct workforce numbers (26,000 in 2023, 28,000 in 2024), omits the 7.7% growth figure, and does not reference the verbatim repetition of cultural language, which is central to the original answer. (3) The multi-hop reasoning is flawed. The original answer draws a conclusion about talent retention strategy based on consistent messaging amid workforce expansion. The LLM invents mechanisms (e.g., surveys, flexible work) not present in the source, failing to correctly synthesize the actual evidence. (4) Contextual relevance is moderate—the LLM addresses the general theme of culture and talent retention in the semiconductor industry, and the overall direction (linking culture to retention) aligns with the original. However, the lack of factual grounding and invented details severely undermines correctness. While the intent to explain retention strategy is relevant, the answer does not reflect the actual data provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 442,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "The provided documents do not contain specific information regarding AT&T's relationship with The Ohio Bell Telephone Company or any changes in guarantee obligations between 2022 and 2023. Therefore, no direct answer can be provided based on the given pages.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is incorrect and fails to reflect the ground truth. (1) The original answer states that AT&T maintained a guarantee obligation for The Ohio Bell Telephone Company in both 2022 and 2023, with only a documentation update changing the exhibit reference. The LLM incorrectly claims no information is available, which contradicts the provided ground truth. (2) There are no numbers or calculations in this question, so quantitative accuracy is not applicable, but the LLM fails to report the factual timeline (2022 vs 2023) and key document references (Exhibit 4-c, updated in 2023), which are central to the answer. (3) The multi-hop reasoning required—linking AT&T’s ongoing guarantee across years and recognizing the continuity despite updated exhibit labeling—was not performed; instead, the model defaulted to an information denial despite having the necessary data in the context. (4) The response lacks contextual relevance to the extent that it denies the existence of information that is clearly present in the ground truth, suggesting a failure in retrieval or synthesis. While the question involves nuanced regulatory documentation, the LLM should have reflected the continuity of the guarantee relationship as described. The low contextual relevance score reflects that the answer is technically relevant in structure (acknowledging the topic) but factually disconnected from the actual content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 390,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "Between 2023 and 2024, GE experienced a significant shift in the financial impact of its relationship with AerCap, particularly in terms of gains on retained and sold ownership interests. In 2023, GE reported $5.7 billion in gains on retained and sold ownership interests, primarily related to its AerCap and GE HealthCare investments. However, in 2024, these gains decreased by $5.2 billion, contributing to a $2.5 billion decline in continuing earnings compared to 2023. This decline reflects a reduction in gains from AerCap-related transactions and other investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.7 billion gains in 2023 and the $5.2 billion year-over-year decrease in gains in 2024, both of which match the ground truth. The entities (GE, AerCap, GE HealthCare) and years (2023, 2024) are accurate. (2) Quantitatively, all numbers are correct: $5.7B gain in 2023 and a $5.2B decrease in 2024 are explicitly stated and align with the original answer. The LLM adds that this contributed to a $2.5B decline in continuing earnings, which is a plausible inference but not present in the ground truth; however, it does not contradict it and may reflect additional context from filings. (3) The multi-hop reasoning is sound: the model correctly synthesizes the change in gains between two years and attributes them primarily to AerCap and GE HealthCare, showing understanding of the evolving financial impact. (4) The only minor deviation is the introduction of the $2.5B decline in continuing earnings, which, while reasonable, is not in the original answer and slightly extends beyond the provided facts. This does not reduce correctness significantly but prevents a perfect 10. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 343,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Home Depot has strategically evolved its use of HD Supply between 2022 and 2024 by expanding its focus on professional customers and MRO (Maintenance, Repair, and Operations) services. In 2024, the company acquired SRS, a residential specialty trade distribution company, to accelerate growth with Pros, enhancing its ecosystem for complex purchase needs. HD Supply continues to serve as a key channel for MRO products and value-added services to multifamily, hospitality, healthcare, and government facilities, reflecting Home Depot's ongoing commitment to strengthening its offerings for professional customers.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of HD Supply in supporting Home Depot's professional customer focus and MRO services, which aligns with the ground truth. It correctly identifies HD Supply’s role in serving multifamily, hospitality, healthcare, and government facilities by 2024, reflecting accurate entity and contextual understanding. However, a critical factual error undermines the answer: the claim that Home Depot acquired SRS in 2024 is not supported by the original answer or the implied knowledge graph, and this acquisition is not mentioned in the ground truth. This introduces a significant inaccuracy in both entity and temporal reasoning. Additionally, while the original answer emphasizes a shift from integration risks in 2022 to strategic maturity in 2024, the LLM fails to mention the earlier challenges post-acquisition, thus omitting a key part of the multi-hop comparison across years. This lack of contrast between 2022 concerns and 2024 strategic integration weakens the qualitative accuracy. Quantitatively, there are no explicit numbers, so accuracy is high by default. Contextually, the answer remains relevant to the question’s focus on Pro customers and MRO evolution. Overall, partial correctness with major omissions and one significant factual error justifies a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 368,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "Between 2023 and 2024, AMD's patent portfolio grew from approximately 18,500 patent matters (12,800 issued patents and 5,600 pending) in 2023 to approximately 18,800 patent matters (13,200 issued patents and 5,600 pending) in 2024. This indicates a modest increase in the size of AMD's patent portfolio, particularly in issued patents. AMD continues to rely on cross-licensing and technology exchange agreements with other companies, which facilitate the transfer and receipt of technology and intellectual property rights. This evolution supports AMD's ongoing ability to innovate and compete in the semiconductor industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numeric values from the ground truth: patent matters increased from 18,500 to 18,800, issued patents from 12,800 to 13,200, and pending applications remained constant at 5,600 in both years. These figures are factually accurate and match the original answer exactly. (2) Quantitative accuracy is perfect—no calculation errors, and the numbers are presented clearly with consistent formatting. The slight growth in the patent portfolio is accurately characterized as a 'modest increase.' (3) The reasoning is sound: the LLM correctly infers that the growing patent portfolio strengthens AMD's position, and it accurately reflects AMD's continued reliance on cross-licensing for technology exchange. However, the original answer adds a slightly stronger strategic interpretation—that the expanded portfolio makes cross-licensing more 'strategically advantageous'—which the LLM omits, representing a minor gap in qualitative depth. (4) Contextual relevance is excellent; the response directly addresses the evolution of AMD's reliance on cross-licensing, ties in patent portfolio changes, and discusses implications for technology exchange. Overall, the answer is factually complete and semantically equivalent to the ground truth, with only a slight reduction in strategic nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 371,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "From 2023 to 2024, Johnson & Johnson's financial stake and strategic relationship with Kenvue evolved significantly. In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue following the exchange offer, which was recorded at a fair market value of $4.3 billion. By 2024, the Company completed a Debt-for-Equity Exchange on May 17, 2024, using its remaining 182.3 million shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This transaction resulted in Johnson & Johnson no longer owning any shares of Kenvue and recording a loss of approximately $0.4 billion in Other (income) expense. Thus, Johnson & Johnson fully disposed of its stake in Kenvue by mid-2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion in 2023, used 182.3 million shares (rounded from 182,329,550) in a debt-for-equity exchange in May 2024 to satisfy $3.6 billion in commercial paper, and recorded a $0.4 billion loss. The date of May 17, 2024, is a minor addition not in the original but does not contradict it. (2) Quantitative accuracy is excellent: all dollar amounts, percentages, and share counts are correct or appropriately rounded (182.3 million vs 182,329,550). The $0.4 billion loss and expense align with the original. (3) Multi-hop reasoning is sound—correctly synthesizing the transition from partial ownership in 2023 to full exit in 2024, including accounting treatment. (4) The only minor omission is that the 2023 $0.4 billion was an 'expense' due to changes in the stake, while in 2024 it was a 'loss' from the exchange; the LLM combines these as a loss, slightly conflating the two events. However, the overall meaning and financial impact are preserved. Semantic equivalence is maintained, and the answer fully addresses the evolution of the stake and strategic relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 345,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "AT&T's relationship with Indiana Bell Telephone Co. Inc. in terms of guarantee disclosures remained unchanged between 2022 and 2023. Both years include Indiana Bell Telephone Co. Inc. as one of the entities whose obligations are guaranteed by AT&T, as detailed in the guaranty disclosures in Notes 4-c of the 10-K filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that AT&T's guarantee relationship with Indiana Bell Telephone Co. Inc. remained unchanged between 2022 and 2023, which aligns with the ground truth. The key factual elements—continued inclusion of Indiana Bell in AT&T's guarantee disclosures and the stability of the relationship—are accurate. However, there is a minor discrepancy in the exhibit reference: the ground truth specifies Exhibit 4-d, while the LLM incorrectly cites Notes 4-c. This is a factual error in entity/document identification but does not affect the overall correctness of the conclusion. All other aspects, including the years (2022–2023), entities (AT&T and Indiana Bell Telephone Co. Inc.), and the nature of the disclosure (guarantee of obligations), are correctly identified and synthesized. The reasoning is sound, and the answer is contextually fully relevant. The semantic meaning matches the original answer despite the exhibit number inaccuracy, warranting a high correctness score with a slight deduction for the document reference error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 300,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE's financial relationship with AerCap evolved with a focus on cash outflows and investment gains. In 2023, GE paid net cash of $203 million to AerCap for ongoing activities, and the value of its equity and note investment in AerCap was recorded at $944 million. By 2024, GE had sold its remaining equity shares in AerCap, and the gains on retained and sold ownership interests related to AerCap contributed to a $5.2 billion decrease in continuing earnings compared to 2023. This suggests a reduction in direct financial involvement, with a shift from holding investments to realizing gains through sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the $203 million net cash payment to AerCap in 2023, aligning with the ground truth. However, it introduces a new figure—$944 million for the value of GE's equity and note investment in AerCap in 2023—which is not present in the original answer and cannot be verified from the provided ground truth, making it potentially inaccurate or hallucinated. The $5.2 billion decrease in gains is correctly cited, but the LLM misattributes it as a 'decrease in continuing earnings' rather than a 'decrease in gains on retained and sold ownership interests,' which is a significant shift in meaning. Furthermore, the original answer states that GE *held* an investment stake in AerCap in 2024, while the LLM claims GE *sold its remaining equity shares*, which directly contradicts the ground truth. (2) Quantitative accuracy is partially correct: $203M and $5.2B figures are accurate in magnitude and context, but the $944M figure is unsupported and likely incorrect. The calculation of the $5.2B decrease is mentioned but misinterpreted in financial context. (3) Multi-hop reasoning is partially sound—there is an attempt to show evolution from operational to investment-based involvement—but the conclusion that GE sold its stake is factually wrong, breaking the logical chain. The original describes a shift from operational involvement to holding an investment, not liquidation of that investment. (4) Scores reflect that core financial figures are correct and the general direction of strategic shift is recognized, but key factual errors—especially the claim of selling shares and the unsupported $944M valuation—undermine the answer's reliability. Contextual relevance is high as the response stays focused on the financial evolution between GE and AerCap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 503,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "From 2022 to 2024, The Home Depot has evolved its approach to store appearance and competition by integrating digital advancements to enhance the customer experience. In 2022, the company focused on store investments such as wayfinding signage, self-service lockers, and curbside pickup to improve convenience and speed of checkout. By 2024, these efforts expanded with further investments in store navigation tools, electronic shelf labels, and redesigned front-end areas to increase customer satisfaction. The company also emphasized a seamless, interconnected shopping experience by leveraging mobile apps and digital tools, enabling customers to research, compare, and purchase products both online and in-store. These enhancements reflect a strategic shift toward combining physical store appeal with digital integration to remain competitive in a rapidly evolving retail landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of The Home Depot's strategy from 2022 to 2024. It accurately captures the shift from focusing on physical store appearance and convenience features (e.g., wayfinding, curbside pickup) in 2022 to a more integrated, digitally-enhanced shopping experience by 2024. The mention of electronic shelf labels, mobile apps, and interconnected experiences reflects the correct strategic trajectory. However, the LLM introduces specific store enhancements like 'self-service lockers' and 'redesigned front-end areas' that are not present in the original answer, which may be plausible but are not supported by the provided ground truth. While these details do not contradict the source, they add granularity not present in the verified data, slightly reducing qualitative accuracy. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The answer fully addresses the question about evolution in store appearance, customer experience, and digital integration, making it contextually complete and relevant. The reasoning is sound and reflects appropriate multi-hop synthesis across years and strategic themes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 349,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved with increased resales and a new financial arrangement. In 2024, AMD's resales to the ATMP JV rose to $121 million from $14 million in 2023. Additionally, AMD provided a $100 million one-year term loan to one of the ATMP JVs in October 2024, secured by the ATMP JV's receivable balance due from AMD and bearing interest at SOFR plus 50 basis points. The carrying value of AMD's investment in the ATMP JV also increased to $149 million as of December 28, 2024, from $99 million as of December 30, 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in resales from $14 million in 2023 to $121 million in 2024, which matches the ground truth. It also correctly states the $100 million one-year term loan initiated in October 2024. However, it introduces two pieces of information not present in the original answer: (a) that the loan was 'secured by the ATMP JV's receivable balance due from AMD' and (b) that it bears interest 'at SOFR plus 50 basis points.' These specific terms are not mentioned in the ground truth and thus represent unverified additions. Additionally, the LLM mentions that AMD's investment carrying value increased from $99 million to $149 million, which is absent from the original answer and cannot be verified against the provided truth. (2) The resale figures and loan amount are quantitatively accurate, but the added financial terms and investment carrying values introduce unsupported numbers, reducing quantitative accuracy. (3) The reasoning is logically sound in identifying a deepening financial relationship and synthesizing resale and loan data across years. However, the inclusion of unverified details suggests potential hallucination or over-extrapolation, weakening the multi-hop synthesis reliability. (4) Despite the extra details, the core of the answer addresses the evolution in resales and new financial arrangements accurately and is highly relevant to the question. The correctness score is 7 because the key facts are correct, but the answer includes significant unverified additions that affect factual precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 431,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson enhanced its privacy compliance programs by strengthening its response to evolving privacy laws and international data flow regulations. In 2023, the company acknowledged the growing risks of unauthorized data access and cross-border data transfers due to new privacy laws and increased enforcement. By 2024, the company expanded its structured approach, emphasizing formal training programs for employees on data privacy, increased third-party risk assessments, and quarterly updates to the Regulatory Compliance & Sustainability Committee on cybersecurity and privacy matters. These measures reflect a more proactive and structured response to global privacy regulations and data localization requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces details not present in the original answer, while missing key aspects of the evolution described in the ground truth. (1) Correct elements: The general direction of enhanced privacy compliance in response to new laws and international data flows between 2023 and 2024 is accurate. The emphasis on increased enforcement, cross-border data transfers, and third-party risk aligns thematically with the original. (2) Quantitative accuracy: There are no specific numbers, dates, or financial figures in either answer, so no discrepancies exist—this aspect is accurate by default. (3) Multi-hop reasoning issues: The LLM answer incorrectly adds specific initiatives—such as 'formal training programs for employees,' 'quarterly updates to the Regulatory Compliance & Sustainability Committee,' and 'third-party risk assessments'—that are not mentioned in the original answer. These details, while plausible, are not supported by the ground truth and represent a fabrication or over-inference. Conversely, the LLM fails to mention the key evolution in scope from 'other territories' in 2023 to 'globally' in 2024, and the shift toward addressing data-driven initiatives and vendor ecosystems due to evolving technology—central points in the original. (4) The answer is contextually relevant and addresses the question’s intent, but the substitution of actual disclosed changes with unverified procedural enhancements reduces factual accuracy. While the overall trend of strengthening compliance is correct, the specific basis for that conclusion in the ground truth is misrepresented. Hence, the correctness and qualitative accuracy scores are moderate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 460,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE's financial exposure to Bank BPH decreased slightly in terms of estimated borrower litigation losses, which reduced from $2,669 million to $2,461 million. Additionally, the related valuation allowances also decreased from $1,712 million to $1,517 million. This indicates a modest improvement in the estimated losses and a corresponding reduction in the valuation allowances required to offset the financing receivables balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: estimated borrower litigation losses decreased from $2,669 million in 2023 to $2,461 million in 2024, and valuation allowances decreased from $1,712 million to $1,517 million. These figures match the original answer exactly, with acceptable formatting variations (e.g., 'million' vs 'M'). (2) Quantitative accuracy is perfect—both the primary figures and implied differences (e.g., a $208 million reduction in total losses and $195 million reduction in valuation allowances) are consistent with the data. (3) The reasoning is sound and captures the trend of decreasing exposure; however, the LLM omits a key qualitative insight present in the original answer: that by the end of 2024, the valuation allowance fully offset the financing receivables balance, indicating a strategic shift tied to a settlement program. This missing detail slightly weakens the qualitative depth and multi-hop synthesis, though the core trend is accurately interpreted. (4) Despite this omission, the answer remains highly relevant, factually correct, and responsive to the question about evolution in exposure. The scores reflect near-perfect accuracy with minor loss in qualitative completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 357,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024 by maintaining a consistent merchandising department categorization under the \"Hardlines\" major product line, as seen in both 2022 and 2024 disclosures. However, its financial performance showed a decline in net sales, dropping from $15,546 million in 2022 to $10,519 million in 2024, indicating a strategic or market shift or reduced consumer demand during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The ground truth states that in 2022, Indoor Garden was a standalone category with $15,546 million in net sales (10.3% of total revenue), but in 2024 it was reclassified under 'Hardlines'. The LLM incorrectly claims that Indoor Garden was categorized under 'Hardlines' in both 2022 and 2024, which contradicts the ground truth. Additionally, the LLM introduces a net sales figure for 2024 ($10,519 million) that is not present in the original answer and unsupported by the provided data. (2) Quantitative accuracy is partially correct for the 2022 net sales figure ($15,546 million), but the 2024 sales number is fabricated, and no percentage of total revenue is mentioned for 2024 in the ground truth. There is no basis for claiming a decline in sales. (3) The multi-hop reasoning is flawed: the key evolution is the reclassification from a standalone line to being grouped under Hardlines, indicating a strategic shift. The LLM misses this entirely and instead invents a narrative around declining sales and consistent categorization, which is the opposite of the truth. (4) Contextual relevance is moderate because the answer addresses HD and the Indoor Garden product line over the 2022–2024 period, but the core facts about categorization and strategic positioning are incorrect, undermining the response's validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 385,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive has maintained a consistent approach to managing cost volatility from commodity price fluctuations, emphasizing sourcing strategies, cost containment, and productivity initiatives. In 2022, the company noted using sourcing strategies alongside price increases and limited commodity hedging contracts to mitigate raw material exposure. By 2024, the company reiterated similar tactics, including sourcing strategies, selling price adjustments, and ongoing productivity efforts, while also highlighting the limited use of commodity hedging contracts, primarily in the Hill's Pet Nutrition segment. This evolution reflects a continued focus on proactive cost management amid ongoing commodity volatility.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Colgate-Palmolive and the relevant time frame (2022 to 2024), and accurately notes the use of sourcing strategies, cost containment, and productivity initiatives. It also correctly mentions the limited use of commodity hedging, particularly in the Hill's Pet Nutrition segment. However, it omits key details from the ground truth: in 2022, the company used derivative instruments and local currency borrowings as part of a broader risk management framework—not just limited hedging—and these instruments were applied to foreign exchange and interest rates as well as commodities. By 2024, the company increased focus on specific commodities (resins, essential oils, soybeans) and emphasized greater exposure to geopolitical and climatic disruptions, prompting more defensive sourcing tactics. The LLM answer fails to mention these specific commodities and the shift toward defensive strategies due to external pressures. (2) There are no numerical values in the question or answers, so quantitative accuracy is not applicable—no errors in dates or formats. (3) The multi-hop reasoning is partially sound: the model connects sourcing strategies across years and recognizes continuity, but it does not fully synthesize the evolution in strategy—particularly the broadening of risk factors and the strategic shift toward proactive, defensive measures in 2024. The answer downplays the evolution by framing it as a 'consistent approach' rather than acknowledging the increased emphasis and expanded scope noted in the ground truth. (4) The correctness score is 6 due to significant omissions in strategic evolution and specific risk factors; qualitative accuracy is 6 due to incomplete entity and contextual synthesis; quantitative accuracy is 10 as no numbers are involved and no factual inaccuracies in dates; contextual relevance is 8 because the answer stays on topic and addresses the core question, albeit with incomplete depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 534,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "Between 2023 and 2024, TREMFYA (guselkumab) sales increased by 16.6%, from $3.15 billion in 2023 to $3.67 billion in 2024. This growth was driven by market expansion and share gains. Additionally, TREMFYA received new regulatory approvals in 2024 for the treatment of ulcerative colitis, Crohn's disease, and pediatric psoriasis, which contributed to its sales performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the sales figures for TREMFYA in 2023 ($3.15 billion) and 2024 ($3.67 billion), which align with the ground truth values of $3,147 million and $3,670 million (rounded appropriately). The 16.6% growth rate is accurate and matches the ground truth calculation: (3,670 - 3,147) / 3,147 ≈ 16.6%. Thus, quantitative accuracy is perfect. (2) However, the LLM introduces new regulatory approvals in 2024 for ulcerative colitis, Crohn’s disease, and pediatric psoriasis as growth drivers—information not present in the original answer and unsupported by the provided ground truth. The actual stated drivers were market expansion, continued strength in PsO/PsA, favorable patient mix, and an 18.1% positive impact from operations offset by a 1.5% negative currency impact. These key qualitative factors are omitted or replaced. (3) While the LLM performs correct multi-hop reasoning by comparing two years’ sales and identifying growth drivers, it fabricates specific regulatory events instead of accurately synthesizing the operational and market-based factors from the source. This undermines the qualitative accuracy despite correct numbers. (4) The answer remains contextually relevant and addresses both parts of the question—sales evolution and contributing factors—but substitutes incorrect reasoning for correct data. Hence, correctness is reduced due to factual inaccuracies in the explanatory content, even though the numerical core is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 410,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E from 2022 to 2023, as reflected in the documents, does not indicate a change in Disney's 50% equity stake in A+E. However, the reporting of subscriber numbers for A+E channels like A&E, HISTORY, and Lifetime remained consistent, with domestic subscriber counts reported at 58 million for each channel in 2024 (from 2023 document). There is no indication that the partnership structure change directly impacted Disney's financial stake or the way subscriber numbers were reported during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect and contradicts the ground truth. It claims there was no change in Disney's 50% equity stake, but the original answer states that the relationship evolved *into* a 50% equity stake in 2023, implying it was not previously structured that way. This misrepresents the core structural change. Additionally, the LLM cites '2024' subscriber data from the 2023 document, which is factually unsupported and temporally inconsistent. The ground truth reports 58 million domestic subscribers in 2023 (down from 69 million in 2022), but the LLM incorrectly frames this as unchanged and consistent across channels without evidence. (2) Quantitative inaccuracies include the fabricated reference to '2024' data and the failure to report the correct 2022 figure of 69 million subscribers. The 58 million figure for 2023 is mentioned but misattributed in context and timing. No calculation errors per se, but incorrect data selection invalidates any numerical accuracy. (3) The multi-hop reasoning is flawed: the model fails to recognize the shift from a partnership to a joint ownership model, which changes both reporting of subscriber numbers and financial integration (via 'Equity in the income of investees'). Instead, it asserts no change occurred, missing the central transformation in reporting methodology. (4) Scores are low because the answer contradicts key facts about the structural change, misrepresents the timeline, and omits the shift in financial reporting. Contextual relevance is moderate because it discusses subscriber numbers and equity, but with incorrect conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 445,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "In 2023, GE reported a realized and unrealized gain of $129 million related to its investment in and note with AerCap. By 2024, GE had fully monetized its position in AerCap, as it received total proceeds of $6,587 million from the sale of its remaining AerCap shares, leaving only an AerCap senior note as its remaining position. This indicates a significant financial resolution of the relationship with AerCap between 2023 and 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects. The $129 million gain in 2023 is correctly mentioned, though the original answer specifies it as an 'unrealized gain,' while the LLM incorrectly labels it as both 'realized and unrealized,' which is factually inaccurate. The LLM introduces a new figure—$6,587 million in proceeds from the sale of AerCap shares in 2024—which does not appear in the ground truth and contradicts the original narrative. The ground truth states that GE experienced a $5.2 billion *decrease* in gains on retained and sold ownership interests in 2024 compared to 2023, with AerCap being a major contributor, implying a negative financial impact. In contrast, the LLM portrays the 2024 outcome positively, suggesting full monetization and resolution, which misrepresents the financial deterioration described in the original answer. (2) Quantitatively, the $129 million figure is accurate, but the $6,587 million proceeds figure has no support in the ground truth and appears fabricated or misattributed. The critical $5.2 billion decline in gains—a central point in the original answer—is entirely missing from the LLM response, representing a major omission. (3) The multi-hop reasoning is flawed: the LLM fails to connect the decline in financial performance from 2023 to 2024 and instead implies a successful exit, which contradicts the negative shift indicated in the ground truth. It also fails to explain that the relationship deteriorated financially despite any monetization activity. (4) While the LLM addresses the evolution of the GE-AerCap relationship and mentions relevant financial figures and timeframes, it misses the core analytical point—the negative financial shift—and substitutes it with unsupported claims of monetization. Thus, while contextually relevant and partially accurate, the answer is significantly incorrect in both quantitative details and qualitative interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 542,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Between 2022 and 2024, Mastercard has enhanced its multi-layered security approach by expanding its focus on addressing risks associated with third-party service providers. In 2022, the company emphasized its existing security measures, including network protection, fraud scoring, and collaboration with industry stakeholders to establish technical standards. By 2024, Mastercard explicitly highlighted efforts to monitor and respond to threats linked to third-party providers, indicating a more proactive stance in securing the broader payments ecosystem. This evolution reflects Mastercard's strategic response to emerging cybersecurity threats by integrating stronger safeguards and expanding its security framework to cover external partners, ensuring the integrity of its global payments network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in Mastercard's security approach between 2022 and 2024, accurately noting that while 2022 emphasized network protection and industry collaboration, 2024 included explicit focus on third-party provider risks. The absence of third-party risk mention in 2022 and its emergence in 2024 aligns with the ground truth. The strategic interpretation—that this reflects a broader ecosystem resilience effort—is semantically equivalent and well-reasoned. (2) There are no numeric values, percentages, or financial figures in the question or answers, so quantitative accuracy is not applicable in terms of calculations; however, the years 2022 and 2024 are correctly used throughout, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two time points and identifies a strategic shift based on the addition of third-party risk management. It infers the implication—that Mastercard is responding to increasing complexity in the payments ecosystem—consistent with the original answer. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'public-private partnerships' or 'experts across the organization' as mechanisms for monitoring third-party threats in 2024, which slightly reduces completeness in qualitative detail. However, the core facts, timeline, entities, and strategic interpretation are correct, warranting a high score. Contextual relevance is perfect as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 429,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Target Corporation remained in compliance with its debt leverage covenant in both 2022 and 2023. In 2022, it maintained a $3.0 billion unsecured revolving credit facility set to expire in 2026, and in 2023, it extended this facility to 2028 while obtaining a new $1.0 billion 364-day facility. The company explicitly stated in both years that it expects to remain in compliance with its covenants, indicating no material changes in covenant status despite adjustments to credit facilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Target was in compliance with its debt leverage covenant in both 2022 and 2023; the $3.0 billion unsecured revolving credit facility was extended from 2026 to 2028; and a new $1.0 billion 364-day facility was obtained in 2023, expiring in 2024. (2) Quantitative accuracy is perfect: all dollar amounts ($3.0 billion, $1.0 billion), timeframes (364-day, 2026, 2028), and facility types (unsecured revolving) match the original. (3) The multi-hop reasoning is sound—correctly synthesizing covenant compliance across two years and linking it to changes in credit facilities. (4) The only minor shortcoming is that the LLM omits the explicit mention that the new $1.0 billion facility expires in October 2024 (though '364-day' implies this), and the original specifies the prior facility was set to expire in October 2026 before extension. These are minor contextual details that do not affect the overall correctness. The LLM correctly captures the evolution and consistent compliance, making the answer semantically equivalent with high completeness and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 333,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "The risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, have evolved from 2023 to 2024 to include increased regulatory scrutiny, ethical concerns, and operational complexities. In 2023, the focus was on emerging ethical issues, potential reputational harm, and the need for additional resources to ensure ethical AI implementation. By 2024, the risks expanded to include more specific regulatory challenges, such as compliance with evolving AI laws like the EU AI Act and DORA, as well as heightened concerns around accuracy, bias, toxicity, and data provenance in generative AI. Additionally, the shift from AI content classification to content generation introduced new responsibilities and potential liabilities, requiring increased investment in compliance, governance, and proprietary datasets to manage these risks effectively.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of risks from 2023 to 2024. It accurately captures the expansion of risk from general third-party integration and ethical concerns in 2023 to more specific AI-related risks in 2024, including regulatory scrutiny (e.g., EU AI Act, DORA), ethical issues (bias, toxicity), and operational challenges like data provenance and governance. The mention of increased investment in compliance, governance, and proprietary datasets reflects the ground truth's emphasis on higher costs for AI governance and testing. However, the LLM answer does not explicitly mention that in 2023 the primary risk was tied to third-party integrations and warranty expectations—instead framing 2023 risks around 'emerging ethical issues'—which slightly misrepresents the initial risk focus. While ethical concerns were present, the ground truth emphasizes legal liability from third-party apps as the core 2023 risk, not internal AI ethics. This is a minor but notable omission in the multi-hop synthesis. All entities (Agentforce, generative AI, EU AI Act, DORA) and years (2023, 2024) are correctly identified. There are no numerical inaccuracies (quantitative accuracy is perfect by default, as no numbers are misstated). The reasoning is sound and contextually relevant, effectively contrasting the two years and explaining the evolving risk landscape. Thus, the answer earns a high score but not perfect due to the slight mischaracterization of 2023 risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 419,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal years 2023 and 2024, Lowe's delivery capability for parcel-eligible items improved significantly. In fiscal 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal 2024, this was enhanced to allow delivery within two business days or less for most parcel-eligible items. Additionally, in 2024, Lowe's finalized the rollout of its market-based delivery model and expanded its gig provider network, enabling same-day delivery for certain products and next-day delivery for major appliances in almost every U.S. zip code.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: delivery within two business days in 2023, improvement to 'two business days or less' in 2024, and expansion to next-day delivery for major appliances in nearly every U.S. zip code in 2024. These match the original answer exactly. (2) The only minor addition not present in the ground truth is the mention of 'finalized the rollout of its market-based delivery model' and 'expanded its gig provider network, enabling same-day delivery for certain products.' While these details are plausible and contextually consistent, they are not included in the verified knowledge graph and thus introduce slight over-specificity. However, they do not contradict the ground truth and are reasonable inferences. (3) The multi-hop reasoning is sound—LLM correctly compares delivery timelines across fiscal years and synthesizes improvements in speed and coverage. (4) The answer fully addresses both parts of the question: evolution between 2023 and 2024, and specific improvements made. Wording differs slightly but maintains semantic equivalence. The correctness score is 9 due to the minor addition of unverified operational details; otherwise, the answer is factually and contextually excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 363,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The financial impact of the Dermstore LLC sale on Target's consolidated revenues and operating income was minimal in both 2022 and 2023. Dermstore represented less than 1 percent of Target's consolidated revenues and operating income in 2022, and there is no specific mention of its impact in 2023, indicating that its contribution remained negligible in both years.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Dermstore's impact on Target's consolidated revenues and operating income was minimal in both 2022 and 2023, and accurately states that it represented less than 1 percent of revenues and operating income in 2022. However, it fails to mention that the same <1% threshold applied in 2023 as well, instead noting 'no specific mention,' which understates the certainty of the ground truth. The LLM omits key facts: the sale occurred in February 2021 (not during or after 2022), and the $335 million pretax gain was already recognized in Net Other (Income)/Expense at the time of sale, meaning no ongoing financial impact was expected or observed in 2022 or 2023. (2) Quantitatively, the LLM does not include the $335 million pretax gain, a critical financial figure directly tied to the sale’s impact. While it correctly references the <1% contribution, it misses the explicit confirmation that this low level of significance held in both years. (3) The reasoning is partially sound—correctly inferring minimal impact from small contribution—but fails the full multi-hop synthesis: it doesn’t connect the 2021 sale event to the absence of financial effects in 2022 and 2023, nor does it explain that post-sale, Dermstore no longer contributed to Target’s financials at all. (4) Scores reflect high contextual relevance and mostly accurate qualitative assessment, but deductions are made for missing key quantitative data and incomplete reasoning about the temporal and financial implications of the sale.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 426,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "Between 2023 and 2024, the strategic positioning of Data Cloud within Salesforce has evolved to become a more integral component of the broader Customer 360 platform, emphasizing its role in unifying and federating customer data across multiple service offerings. In 2023, Data Cloud was described as a trusted data engine that delivers a comprehensive view of customers by bringing disconnected enterprise data into Salesforce. By 2024, its role was further enhanced with the Einstein 1 Platform, which allows customers to connect data to build AI-powered apps and deliver new CRM experiences. This evolution reflects Salesforce's focus on leveraging Data Cloud to power automation, analytics, and AI-driven insights, thereby strengthening its competitive position in the enterprise data and AI landscape.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Data Cloud's role within Salesforce between 2023 and 2024, noting its function as a unifying data engine and its integration into broader platforms. It accurately reflects the 2023 description of Data Cloud as a trusted engine for delivering a 360-degree customer view. However, it misses key strategic shifts highlighted in the ground truth, particularly around competitive landscape and monetization risks. The 2024 filing emphasized that Salesforce faces increasing competition in relatively new and uncertain markets for offerings like Data Cloud and acknowledged limited experience in pricing consumption-based models—critical aspects of strategic positioning that the LLM answer omits. Instead, the LLM focuses on technological enhancements (e.g., Einstein 1 Platform, AI-powered apps), which, while relevant, are not mentioned in the original answer and may reflect inference beyond the source material. There are no numerical inaccuracies (quantitative accuracy is high), but the qualitative reasoning is partially flawed due to omission of risk and competitive context, resulting in an incomplete multi-hop synthesis. The answer remains contextually relevant and well-structured but fails to capture the full strategic nuance, especially the shift from product-centric to risk-aware messaging.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 375,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, LOW's treatment and accounting of forward interest rate swap contracts evolved in terms of hedge designation and financial impact as follows: In 2023, the company had forward interest rate swap agreements designated as cash flow hedges with a notional amount of $1,290 million, but by 2024, these contracts were no longer outstanding. In 2024, the company only maintained fixed-to-floating interest rate swap agreements designated as fair value hedges with a notional amount of $850 million, consistent with 2023. Financially, the settlement of forward interest rate swaps in 2023 and prior years resulted in gains, such as $247 million received in 2023, with related gains/losses recorded in other comprehensive income. In 2024, no new forward interest rate swaps were designated as cash flow hedges, indicating a shift in hedging strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in key quantitative details. The ground truth states that LOW had forward interest rate swap contracts with a notional amount of $2.0 billion in 2023, but the LLM incorrectly reports $1,290 million, which is factually wrong. Additionally, the LLM claims that fixed-to-floating swaps in 2024 had a notional amount of $850 million 'consistent with 2023'—but the ground truth does not mention this amount in 2023 or confirm consistency, making this a fabrication or misattribution. (2) While the $247 million settlement gain in 2023 is correctly cited, the LLM incorrectly implies that the $1,290 million notional relates to the same transaction as the $247 million gain, which undermines accuracy. The ground truth links the $247 million gain directly to the $2.0 billion notional swap related to the March 2023 Notes, which the LLM fails to accurately represent. (3) The qualitative reasoning partially captures the shift in hedge designation—from cash flow hedges in 2023 to fair value hedges in 2024—but misrepresents the nature of the transition. The ground truth emphasizes a change in accounting treatment (shortcut method, no earnings impact due to assumed perfect effectiveness), while the LLM incorrectly frames it as a simple termination of old contracts and introduction of new ones, missing the accounting methodology shift. It also falsely claims that forward swaps were 'no longer outstanding' in 2024 without evidence. (4) Contextually, the answer addresses the evolution of hedge designation and financial impact, so relevance is high. However, due to major errors in numbers, misrepresentation of the continuity of swap agreements, and incomplete or incorrect explanation of accounting treatment (e.g., omission of the shortcut method and its implications), the overall correctness is significantly compromised. Minor credit is given for correctly identifying the $247 million gain and the general shift from cash flow to fair value hedges.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 549,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "From 2022 to 2023, Target's strategy around its owned brands has evolved to emphasize strengthening its owned brands portfolio while curating leading national brands and expanding signature partnerships. In 2022, the focus was on differentiating through owned and exclusive brands to provide value and a unique shopping experience. By 2023, the strategy expanded to include delighting guests with newness, style, and value, with a stronger emphasis on elevating the owned brands portfolio and leveraging partnerships to enhance relevance and drive traffic and sales growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values to verify (e.g., sales figures, number of brands), but the years (2022 and 2023) are correctly referenced, satisfying quantitative accuracy. (2) The answer addresses both parts of the question: evolution in portfolio emphasis and strategic objectives. It correctly notes that in 2022, Target focused on differentiation through owned and exclusive brands for value and uniqueness, which matches the ground truth's 'descriptive presence' and 'over 40 brands' context. In 2023, the LLM correctly identifies the shift toward 'delighting guests with newness, style, and value' and using owned brands as a strategic lever for traffic and sales growth—directly reflecting the ground truth's emphasis on strategic elevation. (3) The multi-hop reasoning is sound: it synthesizes a strategic evolution across two years, correctly identifying the shift from showcasing to actively leveraging owned brands. The only minor shortcoming is that the LLM mentions 'curating leading national brands' and 'expanding signature partnerships,' which, while likely true, are not emphasized in the original answer and slightly dilute the core focus on owned brands as the primary strategic differentiator. However, this does not introduce inaccuracy, just a small expansion beyond the provided truth. (4) The semantic meaning is equivalent: the key strategic shift is correctly captured, with accurate reasoning and entity identification (Target, owned brands, 2022–2023 timeline). Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 461,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM's approach to software-enabled services has evolved with a stronger focus on expanding its end-to-end software platform and scaling digital solutions. In 2023, the company emphasized the rollout of its software-defined vehicle platform across most products, enabling over-the-air updates for features, performance, and driver assistance systems like Super Cruise. Additionally, GM expanded its OnStar ecosystem to offer a broader set of digital technology options for both retail and fleet customers. This indicates a significant investment in scalable digital solutions to enhance customer experience and support its transition to an all-electric and software-driven future.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in GM's approach to software-enabled services from 2022 to 2023. It accurately reflects the shift toward a more mature, scalable software platform with over-the-air update capabilities for features like Super Cruise and driver assistance systems, which aligns with the ground truth. The mention of expanding the OnStar ecosystem adds relevant context about digital service expansion, though this specific detail is not in the original answer. Quantitatively, there are no numbers, dates, or financial figures in either response that conflict—both correctly reference 2022 and 2023 as comparative years, and the LLM correctly identifies that platform deployment was underway by 2023 for future models (implied by 'select 2024 models' in the ground truth). However, the LLM slightly overgeneralizes by stating the platform is being rolled out across 'most products,' whereas the ground truth specifies only 'select 2024 models' like the Cadillac LYRIQ and Chevrolet Silverado EV—this is a minor overstatement but does not invalidate the overall trend. The reasoning is sound: it infers increased investment in scalable digital solutions based on platform deployment, matching the original conclusion. The answer is contextually relevant and addresses all parts of the question—evolution in service offerings, platform deployment, and implications for investment in scalability. While it omits explicit mention of the integration with AV and financing in 2022, it still conveys the progression from general to concrete software strategy. Thus, the answer is semantically equivalent in intent and factual core, warranting a high score with minor deductions for slight overgeneralization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 473,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category increased from fiscal 2022 to fiscal 2023. In fiscal 2022, revenue in this category increased by 11%, driven by growth in ThousandEyes and Intersight offerings. In fiscal 2023, revenue in the Observability product category increased by 14%, with growth in ThousandEyes and monitoring and analytics offerings. This indicates a continued positive contribution from ThousandEyes between the two fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key evolution in ThousandEyes' revenue contribution between fiscal years 2022 and 2023. (1) It correctly states that in fiscal 2022, the category grew by 11%, driven by ThousandEyes and Intersight, and in fiscal 2023, the Observability category grew by 14%, attributed to ThousandEyes and monitoring and analytics—both percentages match the ground truth. (2) However, the LLM omits the absolute dollar increases ($75 million in 2022 and $80 million in 2023), which are part of the original answer and important for assessing the scale of growth. While the percentage trends are correctly reported, the absence of dollar figures reduces quantitative completeness. (3) The reasoning is sound: the model correctly infers a continued positive contribution from ThousandEyes, aligning with the multi-hop synthesis of growth trends across two years and product category evolution (from Optimized Application Experiences to Observability). (4) Contextually, the answer is fully relevant, clearly addressing the evolution of revenue contribution. The omission of exact dollar amounts prevents a perfect score, but all other elements—entities, years, metrics, and logic—are correct. Hence, a 9 is justified for correctness, with high scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 362,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "Amendment No. 4 to the Lockheed Martin Executive Severance Plan was included in the 2023 10-K filing as Exhibit 10.34, referencing its incorporation by September 25, 2022. In the 2024 10-K, it retained its position as Exhibit 10.34, indicating continuity in its disclosure. This consistency suggests that the amendment remains a material component of the company's executive compensation framework and is systematically maintained in its annual disclosures, reflecting a deliberate and transparent strategy in reporting executive severance terms.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. According to the ground truth, Amendment No. 4 was *not* retained as a standalone Exhibit 10.34 in the 2024 10-K; instead, it was no longer listed as a separate exhibit and was incorporated into a consolidated sequence of amendments (Nos. 2, 3, 4, and 5). The LLM incorrectly asserts continuity in exhibit numbering and treatment, which contradicts the actual evolution described in the original answer. (2) The date 'September 25, 2022' is approximately correct (aligns with the September 2022 10-Q reference), so quantitative accuracy is partially satisfied, but the exhibit number and disclosure treatment are wrong. There are no calculations in this question, so numerical precision is limited to dates and exhibit numbers. (3) The multi-hop reasoning fails: the question requires comparing the treatment of a specific amendment across two years’ filings and inferring a shift in disclosure strategy. The LLM instead reports no change, missing the key shift from highlighted standalone disclosure to integrated historical inclusion. This reflects a failure in synthesizing the evolution across filings. (4) While the LLM addresses the general topic and attempts to interpret disclosure strategy, its conclusion about 'consistency' and 'systematic maintenance' is based on incorrect facts, undermining qualitative and overall correctness. Contextual relevance is moderate because it engages with the right document types and topic but draws incorrect inferences from flawed premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 428,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "From 2023 to 2024, JPMorgan's Tier 1 leverage ratio remained stable at 7.2% for both years, as shown in the leverage-based capital metrics. The Standardized CET1 capital ratio increased slightly from 15.0% in 2023 to 15.7% in 2024, indicating an improvement in the Firm's capital position relative to its risk-weighted assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states JPMorgan's 2023 Standardized CET1 capital ratio as 15.0%, it incorrectly claims it increased to 15.7% in 2024—this figure is not supported by the ground truth, which does not provide the 2024 CET1 ratio. More critically, the LLM asserts that the Tier 1 leverage ratio was 7.2% in both 2023 and 2024, but the ground truth only confirms 7.2% for 2024 and provides no data for 2023. Thus, claiming stability across both years is unsupported. (2) The quantitative accuracy is low because the model fabricates or assumes data not present in the ground truth—specifically the 2024 CET1 ratio and the 2023 Tier 1 leverage ratio. These are not minor discrepancies but unsupported additions. (3) The reasoning is partially sound in that it attempts to track evolution across years and focuses on the correct metrics, but it fails the multi-hop requirement by not grounding each data point in evidence. The conclusion about improving capital position is speculative and not in the original answer. (4) Contextual relevance is high because the response addresses the right company, time frame, and regulatory ratios, and interprets them in the context of capital strength. However, correctness and quantitative accuracy are severely compromised by hallucinated data points, warranting a mid-low score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 386,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial remained a distinct reportable segment within General Motors' consolidated financial statements, evaluated by the chief operating decision-maker using EBT-adjusted to assess its performance. The financial presentation of GM Financial continued to reflect its role as an operating segment, with interest income and interest expense included in its operating results. There is no indication of a significant change in its integration or financial reporting structure during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in stating that GM Financial remained a reportable segment and that its performance was assessed using EBT-adjusted, with interest income and expense included. However, it fails to capture the key evolution highlighted in the ground truth: the increased emphasis in 2023 on the financial adjustments related to deferred tax positions and the provision for income taxes due to inclusion in the consolidated tax return. Instead, the LLM claims there was 'no indication of a significant change,' which directly contradicts the ground truth that describes a more detailed and explicit focus on integration in 2023. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the question asks for an analysis of evolution between 2022 and 2023 in terms of integration and financial presentation, requiring comparison across two years’ disclosures. The LLM fails to identify the shift in disclosure detail regarding tax adjustments and stand-alone vs. consolidated reporting, missing the core qualitative change. (4) While the answer is relevant and correctly identifies GM Financial as a segment, it lacks the critical insight about enhanced disclosure of tax integration, resulting in a low correctness and qualitative accuracy score despite good contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 399,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "Between 2022 and 2024, Costco's treatment and disclosure of step-rent provisions and periodic rent increases in lease accounting remained consistent. The company recognizes step-rent provisions on a straight-line basis over the original lease term and any extension options it is reasonably certain to exercise. For leases with periodic rent increases tied to price indices or sales volume, these are classified as variable lease payments and accounted for accordingly. No material changes in accounting treatment or additional disclosures related to these provisions were noted in the 2024 filing compared to 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim. The ground truth states that there was a clear shift in accounting treatment between 2022 and 2024: in 2022, step-rent provisions based on price indices or sales volume were straight-lined, but by 2024, these increases were reclassified as variable lease payments and no longer straight-lined. The LLM incorrectly asserts that there was 'no material change' and that the treatment 'remained consistent,' which directly contradicts the documented evolution. While the LLM correctly identifies the concepts of straight-line recognition and variable lease payments, it misrepresents the timeline and change in policy. The mention of 'Costco' introduces a specific entity not present in the original answer, which does not name a company—this is an unwarranted assumption. The contextual relevance is moderate because the answer addresses lease accounting and step-rent provisions, but the failure to detect and report the key change in treatment severely undermines factual accuracy. No numerical data is present to assess quantitative accuracy beyond the correct use of general terms like 'straight-line' and 'variable lease payments,' but since the central claim about consistency is false, the qualitative and overall correctness scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 361,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "From 2023 to 2024, the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show a slight increase in the amount expected to be paid out in 2025, rising from $1,860 million to $1,800 million. Over the long-term period from 2029 to 2033 (or 2030 to 2034 in 2024), the total expected payments decreased slightly from $10,020 million to $9,990 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2025 projected payment: it states that the amount increased from $1,860 million to $1,800 million, which is factually incorrect because $1,800 million is less than $1,860 million, and the ground truth indicates the 2025 projection remained unchanged at $1,860 million. This misrepresents both the direction and magnitude of change. The long-term projection correctly notes a decrease from $10,020 million to $9,990 million, though the time period shifts from 2029–2033 (2023 filing) to 2030–2034 (2024 filing), which the model acknowledges but does not fully clarify as a shifted window rather than a direct comparison of identical periods. (2) Quantitative accuracy is low due to the incorrect $1,800 million figure for 2025, which contradicts the ground truth of $1,860 million in both years. The long-term numbers are accurate. (3) The multi-hop reasoning is partially sound—comparing projections across two years and identifying changes in near-term and long-term obligations—but fails in correctly retrieving and comparing the 2025 figures. The model incorrectly implies an increase while reporting a lower number, indicating flawed logic. (4) Contextual relevance is high as the answer addresses both the 2025 and long-term payout projections and attempts to synthesize changes between 2023 and 2024 filings. However, the factual error in a key number severely undermines correctness, warranting a moderate score of 4/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 413,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Between 2023 and 2024, JPMorgan Chase expanded its disclosures on resolution plan obligations, particularly emphasizing liquidity risk management strategies and funding cost considerations. In 2023, the disclosures highlighted the impact of market stress on liquidity, the need to maintain sufficient liquidity coverage ratios and net stable funding ratios, and the potential for higher funding costs due to resolution plan requirements. By 2024, the disclosures added more specific details about the potential effects of regulatory changes, such as amendments to Basel III and the GSIB surcharge, on capital and liquidity management. Additionally, JPMorgan Chase emphasized the importance of pre-positioning liquidity in foreign subsidiaries and the potential for increased funding costs from alternative sources if traditional funding channels were constrained.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original (ground truth) answer. (1) All factual elements are correct: JPMorgan Chase's 2023 disclosures correctly reference liquidity coverage ratio (LCR), net stable funding ratio (NSFR), higher funding costs, and constraints from resolution plan obligations, including reliance on alternative funding sources. In 2024, the expansion to include regulatory changes—specifically mentioned as Basel III and GSIB surcharge amendments—fits within the broader theme in the ground truth of evolving regulatory expectations and systemic event responses. While the original answer does not name Basel III or GSIB explicitly, it does state that changes in laws and regulations in response to systemic events could impact liquidity and capital, so the LLM's inclusion of these specific regulations is a reasonable elaboration consistent with the source. (2) There are no numbers, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in terms of calculations, but all time periods (2023, 2024) and contextual financial terms are used correctly—thus scored as 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how disclosures evolved across two years, identifying both continuity (liquidity ratios, funding costs) and progression (increased focus on regulatory dynamics). The only minor gap is that the original answer emphasizes the interaction of resolution plans with 'macroeconomic uncertainty' and 'systemic events' more explicitly, while the LLM focuses on regulatory changes without fully connecting them to broader macroeconomic shifts. This slight omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the evolution of disclosures on resolution plans, liquidity risk, and funding costs. Overall, the LLM captures the core evolution accurately and in appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 527,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Between 2022 and 2023, the financial structure of Optum Rx's pharmacy care services showed a notable increase in accounts receivable, rising from $7.1 billion to $8.6 billion. Revenue recognition for Optum Rx remains consistent, with product revenues recognized when prescriptions are dispensed and services revenue recognized as services are performed or made available to customers. There were no material bad-debt expenses or significant changes in contract assets or liabilities during this period, indicating stable credit quality and revenue recognition practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in accounts receivable from $7.1 billion in 2022 to $8.6 billion in 2023, matching the ground truth exactly. It also accurately describes the revenue recognition model—revenue recognized at the point of prescription dispensing for products and as services are performed or made available—which aligns with the gross revenue reporting model due to Optum Rx's primary obligation to pay providers. The statement about no material bad-debt expenses or significant changes in contract assets/liabilities, while not in the original answer, does not contradict it and may reflect additional context consistent with stable revenue practices. (2) All numeric values are correct and properly attributed to the right years; no calculation errors. (3) The multi-hop reasoning is sound: the model synthesizes information about revenue recognition and accounts receivable trends across two years for Optum Rx, correctly identifying continuity in accounting policy and change in receivables. (4) The only minor shortcoming is that the LLM does not explicitly mention the rationale for gross revenue reporting (i.e., the Company's primary obligation to pay network pharmacies regardless of collection), which is a key qualitative aspect in the ground truth. However, the implication of consistent revenue recognition practices covers much of this. Thus, the answer is highly accurate with near-complete alignment, warranting a 9/10 on correctness and qualitative accuracy, full marks on quantitative and contextual dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 432,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps remained relatively stable between 2022 and 2024. In 2022, UPS reported a reclassification of a $5 million loss from accumulated other comprehensive income (AOCI) to interest expense related to interest rate contracts, while in 2024, a $5 million loss was similarly reclassified. Additionally, in 2024, UPS had $146 million of pre-tax gains related to cash flow hedges deferred in AOCI, with no significant gains or losses reported for interest rate contracts in 2024 compared to a $1 million loss in 2023. This suggests a consistent use of interest rate swaps to hedge against forecasted interest rate payments, with minimal material changes in exposure or strategy during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative exposure and strategic evolution. The ground truth states that in 2022, UPS had a $28 million notional amount for Floating to Fixed Interest Rate Swaps, but the LLM incorrectly cites a $5 million loss reclassified from AOCI to interest expense—this is a different metric (income statement impact of hedges) and not the notional exposure. The LLM also introduces a $146 million pre-tax gain in 2024, which is unrelated to notional amount and not mentioned in the original answer. There is no mention of the $28 million figure or any notional swap amount in the LLM response, indicating a failure to report the key quantitative metric. (2) The numbers cited (e.g., $5 million loss in 2022 and 2024) may be factually present in filings but are misrepresented as indicators of exposure rather than income statement impacts. The $146 million gain is irrelevant to the question about notional exposure. The LLM fails to mention the 2022 $28 million notional amount and incorrectly implies stability, when the ground truth shows a strategic expansion. (3) The multi-hop reasoning is flawed: the question asks for evolution in both quantitative exposure and strategic approach, requiring synthesis of notional amounts and management commentary across years. The LLM focuses on P&L impacts of hedges rather than notional exposure or strategic intent. It misses the key shift from limited use in 2022 to a broader strategy in 2024 focused on managing the fixed-floating debt mix. Instead, it concludes 'relatively stable' use, which contradicts the ground truth. (4) The contextual relevance is moderate because it discusses interest rate swaps and risk management, but it answers a different question—about hedge accounting impacts rather than notional exposure or strategic evolution. Due to major factual inaccuracies, incorrect metrics, and flawed reasoning, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 528,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "Between 2022 and 2023, GM's financial relationship with LG Energy Solution (LGES) evolved in two key ways. First, the joint venture activities, specifically the Ultium Cells LLC battery cell production, continued to expand, with plans for mass production in multiple U.S. locations. Second, regarding recall-related costs, GM and LGES resolved commercial matters tied to the Chevrolet Bolt recall. By December 31, 2023, GM had accrued a total of $2.6 billion for recall costs and recognized $1.6 billion in receivables from LGES, with a remaining accrual of $0.6 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the continuation of Ultium Cells LLC joint venture activities in 2022–2023, the $2.6 billion accrued by GM for Bolt recall costs, and the $1.6 billion in receivables from LG Energy Solution are all factually accurate. The remaining $1.0 billion liability (implied as $2.6B - $1.6B = $1.0B) is slightly misstated as $0.6 billion in the LLM answer—this is a material error, though minor in context. (2) Quantitative accuracy is otherwise perfect: $2.6B and $1.6B match the original, and the time frame (by end of 2023) is correctly cited. The $0.6B discrepancy may stem from a typo or misstatement, as $2.6B - $1.6B = $1.0B, not $0.6B. (3) Multi-hop reasoning is sound—LLM correctly synthesizes joint venture developments and recall cost allocations across years and entities (GM and LGES). (4) The answer captures the shift from strategic collaboration to cost-driven dynamics, though it does not explicitly characterize the relationship shift as 'transactional' or 'due to product defects,' slightly weakening qualitative depth. However, the core evolution is accurately conveyed. Contextual relevance is excellent, addressing both joint ventures and recall costs as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 356,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Observability product category increased from fiscal 2022 to fiscal 2023. Specifically, revenue in the Observability category grew by 14% ($80 million) in fiscal 2023 compared to fiscal 2022, driven by growth in ThousandEyes and monitoring and analytics offerings. In fiscal 2024, this growth continued, with Observability revenue increasing by 27% ($176 million) compared to fiscal 2023, again driven by ThousandEyes and the contribution from the Observability Suite.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both timing and magnitude of revenue growth. It incorrectly states that Observability revenue grew by 14% ($80 million) in fiscal 2023 compared to fiscal 2022, but the ground truth states that the $80 million increase occurred in fiscal 2022. The 27% ($176 million) increase occurred in fiscal 2023, not fiscal 2024 as the LLM claims. This misalignment of fiscal years and associated figures severely undermines factual correctness. (2) Quantitatively, the LLM reverses the timeline: it assigns the $80 million growth to fiscal 2023 and the $176 million to fiscal 2024, which is incorrect. The original answer clearly states the $80 million increase was in fiscal 2022 and $176 million (27%) in fiscal 2023. Additionally, the 14% figure is not mentioned in the ground truth—fiscal 2023 growth was 27%, and organic growth (excluding Splunk) was 15%. (3) The multi-hop reasoning is flawed: the LLM fails to correctly track the evolution from fiscal 2022 to 2023 and instead projects the data into 2023–2024, missing the core comparison asked. It also fails to mention the key point that even excluding Splunk, Observability grew 15%, underscoring ThousandEyes' organic contribution. (4) Contextual relevance is moderate—the answer addresses ThousandEyes' role in Observability growth and mentions correct product names (e.g., Observability Suite), but due to incorrect fiscal year mappings and invented percentages, the overall correctness score is low. The qualitative reasoning is partially sound in attributing growth to ThousandEyes, but the incorrect timeline and numbers lead to a misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 457,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS's relationship with the 7.620% Debentures from 2022 to 2024 has remained consistent in terms of redemption terms and interest payment structure. The debentures, with a maturity of April 1, 2030, are redeemable at UPS's option at any time, with the redemption price being the greater of the principal amount plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Interest remains payable semi-annually in April and October, with no changes to the 7.620% rate or redemption terms during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct quantitative details: the maturity date (April 1, 2030), the interest rate (7.620%), the semi-annual interest payment schedule (April and October), and the redemption formula are all factually accurate and match the ground truth. The principal amount ($276 million) and carrying value ($280 million) from 2022 are omitted, but not incorrectly stated. (2) Quantitative accuracy is high because all provided numbers and dates are correct, though the omission of the 2022 carrying and principal values reduces completeness. The redemption price formula is accurately described. (3) The key qualitative error lies in reasoning and interpretation: the LLM claims the terms 'remained consistent' between 2022 and 2024, which contradicts the ground truth that in 2022, only basic details (maturity, principal, carrying value) were reported, while in 2024, UPS provided a more detailed and explicit description of redemption flexibility and interest payments. The evolution was not in the terms themselves changing, but in the level of disclosure and clarity—this nuance is missed by the LLM, which incorrectly frames the relationship as static. This reflects a failure in multi-hop reasoning: the model should have recognized that the evolution is in disclosure depth, not term changes. (4) Correctness is scored at 4 because while numbers are accurate, the core of the question—how the relationship evolved—is fundamentally misunderstood. The answer asserts no change, while the truth is an evolution in transparency and detail. Quantitative accuracy is high (8) due to correct figures. Qualitative accuracy is moderate (5) due to flawed reasoning. Contextual relevance is high (9) as the answer addresses the right instruments and time frame with relevant details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 492,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the total fair value of Fixed Maturity Securities AFS held by MET slightly decreased from $6.8 billion to $6.7 billion. In terms of composition, U.S. government bonds decreased in fair value from $1.5 billion in 2022 to $1.6 billion in 2023, while corporate securities remained relatively stable at around $3.1 billion. The fair value of foreign bonds and federal agencies also slightly decreased. Overall, the composition of Fixed Maturity Securities AFS remained largely consistent between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the total fair value of Fixed Maturity Securities AFS increased dramatically from $2,164 million (as of Dec 31, 2021, reported in 2022) to $6,714 million (in 2023), representing a large growth, not a slight decrease from $6.8B to $6.7B as claimed. The LLM incorrectly states a decrease when the actual trend is a substantial increase. (2) The numbers for U.S. government bonds and corporate securities are partially in the right range but misaligned in timing and direction. Ground truth shows U.S. government bonds at $1,575 million in 2023 (with $1,537M Level 1), and corporate securities at $3,083 million ($3,029M Level 2) — but the LLM incorrectly claims U.S. government bonds increased from $1.5B to $1.6B, which contradicts the direction and magnitude. Corporate securities are said to be 'stable at $3.1B', which is close to the 2023 figure but ignores the significant growth from 2022 levels. The LLM also introduces 'foreign bonds and federal agencies' which are not mentioned in the original answer, adding irrelevant and unsupported details. (3) The multi-hop reasoning is flawed: the model fails to correctly track the evolution from 2022 (reporting 2021 data) to 2023, misrepresents the trend, and misses the transformation emphasized in the ground truth. It does not reflect the 'substantial transformation' in size and composition. (4) Contextual relevance is moderate — the answer addresses the right topic (composition and value changes in AFS securities) and mentions the correct entities (MET, U.S. government bonds, corporate securities), but the incorrect quantitative trends and missing emphasis on growth undermine accuracy. The qualitative reasoning is weak due to incorrect synthesis across years. Minor formatting variations like $6.7B vs $6,714 million are acceptable, but directional and magnitude errors are critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 526,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "From 2022 to 2023, General Motors' relationship with Ultium Cells LLC evolved with increased financial involvement and regulatory implications. In 2022, GM made an investment of $0.5 billion in Ultium Cells LLC, as noted in GM's 2022 10-K. By 2023, the company faced regulatory consequences related to Ultium Cells LLC, as it self-disclosed potential violations of the Toxic Substances Control Act (TSCA) to the EPA. These violations were settled in November 2023 via a consent agreement with the EPA, which included civil penalties estimated at approximately $5.1 million, assessed jointly and severally to GM and Ultium Cells LLC. This indicates a shift from financial investment in 2022 to regulatory scrutiny and financial penalties in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: GM's $0.5 billion investment in Ultium Cells LLC in 2022, the self-disclosure of TSCA violations to the EPA in February 2023, and the November 2023 settlement with joint civil penalties of approximately $5.1 million. All numeric values—$0.5 billion, $5.1 million, and the years 2022 and 2023—are factually accurate and match the ground truth. (2) Quantitative accuracy is perfect: dollar amounts and dates are correct, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—linking GM’s initial financial investment in 2022 to its later regulatory entanglement in 2023 demonstrates synthesis across time and domains (financial and regulatory). The LLM correctly infers a shift in the nature of the relationship, though it phrases it as 'increased financial involvement' and 'regulatory scrutiny' rather than explicitly stating the shift from passive investment to operational integration. This is a minor omission in nuance but does not affect factual correctness. (4) Contextual relevance is excellent—the answer directly addresses both financial involvement and regulatory implications as asked. The only reason for not scoring a 10 in correctness and qualitative accuracy is that the LLM slightly underemphasizes the operational integration aspect highlighted in the ground truth, instead focusing on penalties rather than the broader implication of shared operational responsibility. However, the core facts, synthesis, and implications are accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 432,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "The company's use of variable-priced contracts for natural gas and fuel purchases has remained consistent between 2022 and 2024. In both periods, the company enters into variable-priced contracts for some purchases of natural gas and fuel for its gas stations, typically on an index basis. These contracts meet the criteria for derivative instruments but generally qualify for the \"normal purchases and normal sales\" exception, requiring no mark-to-market adjustments. There is no indication of a significant change in the company's strategy or volume related to these contracts during this period.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entities, years, and the nature of variable-priced contracts, and correctly identifies that these contracts qualify for the 'normal purchases and normal sales' exception with no mark-to-market adjustments. Quantitative accuracy is perfect—no numerical discrepancies, and dates (2022 and 2024) are correctly referenced. However, the core reasoning and conclusion diverge significantly from the original answer. The ground truth emphasizes an evolution in the company's approach—specifically, a more formalized or strategic use of variable-priced contracts by 2024, with explicit alignment to derivative accounting frameworks, suggesting a shift in management or accounting treatment. In contrast, the LLM claims there is 'no indication of a significant change,' which contradicts the original answer's assertion of a meaningful development in how these contracts are handled. This misrepresents the multi-hop synthesis required: the model fails to infer the implication of the increased accounting specificity as a sign of strategic evolution. Thus, while the surface-level facts are accurate, the qualitative interpretation and reasoning are flawed, leading to an incorrect overall conclusion about the stability of the company's strategy. Contextual relevance is high because the answer addresses the right topic and timeframe, but the failure to capture the nuanced evolution reduces correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 404,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco's financial reporting approach for the APJC segment did not show any changes between fiscal 2022 and fiscal 2023 in terms of the expense categories excluded from segment performance measurement. In both years, the company excluded research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements and other contingencies, charges related to asset impairments and restructurings, and certain other charges from the gross margin for each segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Cisco's financial reporting approach for the APJC segment remained unchanged between fiscal 2022 and 2023, with consistent exclusions from segment performance measurement. (2) All expense categories listed—research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation, significant litigation settlements, asset impairments, restructurings, and certain other charges—are accurately reported and match the original answer in scope and specificity. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the same set of expenses were excluded in both years, leading to the conclusion of no change in reporting approach. (4) The answer fully addresses the question about evolution (or lack thereof) in reporting, with complete and precise qualitative detail. Minor phrasing differences (e.g., 'other contingencies' and 'certain other charges') do not affect factual accuracy and are within acceptable variation. All entities—Cisco, APJC segment, fiscal years 2022 and 2023—are correct. No numerical inaccuracies; the focus is on categorical exclusions, which are correctly reported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 369,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "UNH's approach to managing medical cost trends in 2023, compared to 2022, shows a heightened focus on addressing rising outpatient procedure costs for seniors. In 2023, UNH observed increased care patterns, particularly related to outpatient procedures for seniors, which it expects to persist through 2024. To mitigate these increases, UNH emphasizes engaging physicians and consumers with information to help them make clinically sound, cost-effective choices. Additionally, the company is accelerating the transition from fee-for-service to value-based care models, which aim to improve quality and affordability while fostering collaboration between health plans and care providers. These strategies reflect a more proactive and integrated approach compared to 2022, where the focus was more on general cost management and pricing adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: UNH's 2022 focus on general cost management due to deferred care and risk-based arrangements is accurately summarized, and the 2023 shift toward targeted strategies for rising outpatient costs in seniors is correctly identified. The expectation that this trend will persist into 2024 is present in both answers. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes UNH's evolving strategy across two years, identifying the shift from general concern to proactive intervention. The mention of value-based care models and engagement of physicians/consumers with data-driven insights matches the core of the original answer, even if phrased slightly differently. (4) The only minor gap is that the LLM answer does not explicitly mention 'data-driven insights' or 'accurate cost prediction' from 2022 as emphasized in the original, instead summarizing it as 'general cost management and pricing adjustments'—a slight simplification but not factually incorrect. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 409,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "Between 2022 and 2024, UPS expanded its time-definite delivery services by enhancing network integration and service scope. The company invested in RFID-enabled Smart Package Smart Facilities and facility automation to improve efficiency and visibility across its global air and ground network. Additionally, UPS insourced the UPS SurePost service in 2025 to maintain greater control over delivery reliability. Internationally, UPS expanded cold-chain logistics capabilities, particularly in healthcare, and improved transit times through infrastructure investments in Europe and direct flights to key regions like ISMEA. These developments reflect a strategic focus on leveraging technology and optimizing the integrated network to meet growing customer demand for speed and reliability.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, such as the insourcing of UPS SurePost and network integration improvements, but introduces a critical factual error by stating the insourcing occurred in 2025 instead of 2024, which misaligns with the 2022–2024 timeframe in the question. Additionally, the original answer emphasizes the expansion of same-day pickup to seven days a week and returns in ~150 countries by 2024—details missing in the LLM response. The LLM adds plausible but unsupported details like RFID-enabled Smart Package Facilities and cold-chain logistics in healthcare, which are not present in the ground truth and cannot be verified from the provided context. (2) The date error (2025 vs. 2024) is a significant quantitative inaccuracy, especially since the question focuses on evolution between 2022 and 2024. No financial figures or percentages are present, so scoring focuses on temporal accuracy. (3) The reasoning partially reflects multi-hop synthesis—linking network integration with service expansion—but fails to accurately align the timeline and omits key developments (same-day pickup, returns expansion). The mention of infrastructure investments in Europe and ISMEA flights, while contextually relevant, are not supported by the ground truth. (4) Correctness is reduced due to the incorrect year and unsupported additions; however, the core idea of insourcing SurePost and enhancing integration is accurate, warranting a mid-range score. Contextual relevance is high as the response stays focused on UPS’s delivery evolution, but qualitative accuracy is limited by unverified details and timeline errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 453,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "In 2022, the 2.50% Notes maturing in April 2026 were first disclosed in the Thirteenth Supplemental Indenture dated April 20, 2016, included in the 2022 filing. In 2023, these notes were not newly issued but were referenced in the context of broader debt disclosures. Notably, in 2023, a new issuance of 4.800% Notes due April 1, 2026, was disclosed in the Twenty-Second Supplemental Indenture dated March 30, 2023, suggesting a refinancing or replacement of the original 2.50% Notes maturing in the same year.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 2.50% Notes were 'first disclosed' in the 2022 filing via the Thirteenth Supplemental Indenture dated April 20, 2016, which is contradictory—how could a 2016 indenture be first disclosed in 2022? The ground truth clarifies that in 2022, the notes were referenced in historical context, not introduced as new. More critically, the LLM falsely claims that in 2023, a new issuance of 4.800% Notes due April 1, 2026, was disclosed under a Twenty-Second Supplemental Indenture, suggesting a refinancing or replacement. This is not supported by the ground truth, which makes no mention of such a refinancing or new issuance. The core evolution described in the original answer—a shift in disclosure treatment from historical to active recognition—is entirely missed. (2) Quantitatively, the interest rate (2.50%), maturity (April 2026), and indenture date (April 20, 2016) are correct, but the introduction of a fictional 4.800% Note with a March 30, 2023 indenture is a major error. The date April 1, 2026, also does not match the original April 2026 maturity, introducing a discrepancy. (3) The multi-hop reasoning is flawed: instead of analyzing the change in disclosure treatment of the same instrument across two filings, the model invents a refinancing event based on a non-existent new note, failing to synthesize the actual evolution in reporting. (4) The contextual relevance is moderate because the answer discusses debt disclosures and indentures related to Lowe's, but the invented refinancing narrative misrepresents the actual procedural transition in disclosure, leading to a very low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 474,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "The impact of sovereign debt crises on Costco's merchandise sourcing and cost structure from 2022 to 2024 remained relatively consistent as a risk factor, with no significant evolution noted. Both filings highlight that sovereign debt crises, along with other economic factors, could affect demand for products, require changes in product mix, and impact the cost or ability to purchase inventory. However, Costco's filings for both years do not indicate specific material effects from sovereign debt crises on sourcing or costs during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that there was 'no significant evolution' in the impact of sovereign debt crises on Costco from 2022 to 2024, which directly contradicts the ground truth. The original answer clearly states a shift in tone and severity: in 2022, sovereign debt crises were mentioned as a potential macroeconomic risk among others, with possible effects on demand, inventory costs, and product mix. By 2024, the language had escalated to explicitly state that such crises would 'negatively impact' Costco's business, financial condition, and results of operations, indicating a heightened level of concern. The LLM incorrectly asserts consistency and lack of evolution, missing this critical progression. Additionally, the LLM claims that 'no material effects' were indicated in either year, but the 2024 filing's stronger language implies an increased perceived risk and potential materiality. While the entities (Costco, sovereign debt crises, sourcing, cost structure) and years (2022–2024) are correctly identified, and there are no numerical inaccuracies (as no numbers are involved), the qualitative reasoning and synthesis across years are flawed. The model fails the multi-hop requirement to compare and contrast the evolving risk assessment over time. Thus, while contextually relevant and free of quantitative errors, the answer is substantially incorrect in its interpretation and conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 396,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "The number of shares available for future grants under the 2020 Stock Incentive Plan decreased from 64 million in 2021 to 53 million in 2023. This reduction indicates that UnitedHealth Group has issued new share-based awards over this period, but the company still maintains a substantial capacity to grant additional awards under the plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the number of shares available for future grants in 2021 (64 million) and 2023 (53 million), matching the ground truth exactly. The decrease of 11 million shares is accurately implied. (2) All numeric values and years are correct, with no calculation errors. Format is consistent and clear. (3) The reasoning is sound: the reduction indicates share-based awards were issued, which aligns with the expected interpretation. The LLM adds that the company 'still maintains a substantial capacity,' which is a reasonable qualitative inference not contradicted by the ground truth, though not explicitly stated. This does not introduce inaccuracy but adds mild interpretive context. (4) The answer fully addresses both parts of the question: the change in shares and its implication for future award capacity. It synthesizes information across years correctly. The slight difference from the original answer is in tone (adding 'substantial capacity'), but the core facts and implications remain aligned. Thus, the answer is factually correct and contextually appropriate, warranting a high score with only minor deduction for slight interpretive addition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 338,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "Between 2022 and 2024, the expiration date of the collective bargaining agreement for the IAM National Pension Fund / National Pension Plan was extended from July 31, 2024, to July 31, 2029, following the ratification of a new National Master Agreement in July 2024. Additionally, UPS's contribution significance remained substantial, as it contributed more than 5% of the total plan contributions for 2022, 2023, and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expiration date change from July 31, 2024, to July 31, 2029, and accurately states that UPS contributed more than 5% of total plan contributions for 2022, 2023, and 2024. These facts align with the ground truth, which confirms the extension and sustained contribution significance. The only minor omission is that the original answer notes UPS's >5% contribution for 2019–2021 in the 2022 context, which the LLM does not mention. However, since the question focuses on the evolution between 2022 and 2024, this prior period is context rather than core to the change. (2) All dates and percentages are factually correct: July 31, 2024 (old expiration), July 31, 2029 (new expiration), and >5% contributions for 2022–2024 are all accurate. No calculations are required, but the temporal comparisons are sound. (3) The multi-hop reasoning is strong: the LLM synthesizes information about both the contractual expiration date and contribution significance across time, correctly linking UPS to the IAM National Pension Fund and reflecting changes over the period. The mention of the new National Master Agreement in July 2024 adds contextual detail not in the original but is plausible and does not contradict. (4) The answer is semantically equivalent to the ground truth in all key aspects, with only slight reduction in completeness regarding the pre-2022 contribution history. Scores reflect high accuracy, with a minor deduction in qualitative accuracy due to the omitted background context, though it does not undermine the core response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 438,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "The terms and availability under LOW's 2020 Credit Agreement evolved between fiscal years 2022 and 2023 as follows: In 2022, the agreement was amended to increase availability to $2.0 billion and extend the maturity to March 2025. By 2023, the 2020 Credit Agreement was further amended and restated as the 2023 Credit Agreement, extending its term to September 2028. The combined availability under the Credit Agreements remained at $4.0 billion in both 2022 and 2023, with no outstanding borrowings under the commercial paper program or credit agreements as of February 2, 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor inaccuracy regarding the 2022 amendment. The original answer states that in fiscal year 2022, the 2020 Credit Agreement already had a maturity date of March 2025 and $2.0 billion availability, implying these terms were set prior to 2022. However, the LLM incorrectly suggests that the agreement was 'amended in 2022' to set these terms, which is not supported by the ground truth. The rest of the quantitative details are accurate: the 2023 restatement extended maturity to September 2028, maintained $2.0 billion availability under the 2023 Credit Agreement, and total combined availability remained $4.0 billion in both years. (2) All dollar amounts ($2.0 billion, $4.0 billion) and dates (March 2025, September 2028) are correct and match the ground truth. The statement about no outstanding borrowings as of February 2, 2024, is additional but plausible context not contradicted by the original answer. (3) The multi-hop reasoning is sound—LLM correctly synthesized the evolution of the credit agreement across fiscal years 2022 and 2023, recognized the restatement into the 2023 Credit Agreement, and maintained accurate understanding of total availability. However, the misattribution of the 2022 amendment weakens the factual precision. (4) Scores reflect high accuracy in numbers and reasoning, with a moderate deduction in quantitative accuracy due to the incorrect implication about when the $2.0 billion availability and March 2025 maturity were established. Contextual relevance is perfect as all information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 444,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "MDLZ's notional amount for Net Investment Hedge (NIH) derivative contracts increased from $7,456 million in 2023 to $8,647 million in 2024, reflecting a growth of $1,191 million. This increase indicates an expanded use of NIH derivative contracts in 2024 to hedge against exchange rate movements for investments in non-U.S. operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the notional amounts for 2023 ($7,456 million) and 2024 ($8,647 million), and the increase of $1,191 million is accurate. However, it fails to mention the earlier time points from 2022, 2021, and 2020 that were included in the ground truth (specifically $3,915 million as of Dec 31, 2021 and $4,551 million as of Dec 31, 2020), which are critical to fully addressing the evolution between 2022 and 2024. (2) The numbers cited for 2023 and 2024 are factually correct and match the ground truth, so quantitative accuracy is high. (3) The reasoning is sound for the years it covers, but it omits the multi-hop synthesis required to show the full trend from 2020 through 2024, particularly skipping the 2022 reporting of prior years' data. This limits the qualitative accuracy as the evolution over the full period is not captured. (4) The answer is contextually relevant and correctly interprets the purpose of the contracts (hedging exchange rate risk), but the incompleteness in temporal coverage reduces correctness. While the 2023–2024 increase is valid, the question asks about evolution between 2022 and 2024, which requires including the earlier figures reported in the 2022 filing. Thus, the answer is partially correct but lacks completeness in multi-hop data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 369,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Between 2022 and 2024, Microsoft 365's integration with AI technologies has evolved significantly, with a focus on enhancing productivity and collaboration. In 2024, specific new capabilities introduced include **Copilot for Microsoft 365**, which combines AI with business data in the Microsoft Graph to streamline workflows, and **role-based AI assistants** such as Copilot for Sales, Copilot for Service, and Copilot for Finance, which provide tailored insights and automation. Additionally, **Copilot Pro**, a consumer subscription service, was launched to deliver faster and more powerful AI assistance across Microsoft 365 apps and the web. These advancements reflect Microsoft's commitment to embedding AI deeply into its productivity tools to drive efficiency and innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the evolution from AI-backed tools in 2022 to an 'AI-first platform' in 2024, the introduction of Copilot for Microsoft 365, and the role-specific extensions (Copilot for Sales, Service, and Finance) are all accurately reported. (2) There are no numeric values requiring verification (e.g., dates like 2022 and 2024 are correct and consistent with the original answer), so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound—correctly synthesizing the progression over time and the integration of AI with Microsoft Graph and business applications. The only minor addition not present in the ground truth is 'Copilot Pro,' which, while a real product, is more consumer-focused and not explicitly tied to Microsoft 365's enterprise productivity enhancements in the original answer. This does not make it incorrect but adds a detail outside the scope of the provided truth. (4) The answer is contextually excellent, addressing both parts of the question: the evolution between 2022 and 2024 and the specific 2024 capabilities. Semantic equivalence is strong, with slightly enhanced wording but no factual deviation. Hence, a correctness score of 9 is warranted due to the slight overreach with Copilot Pro, though the core answer is factually solid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 379,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "Between 2022 and 2024, 3M's approach to PFAS discharge characterization in its wastewater permits at the Decatur, Alabama facility evolved from acknowledging incomplete characterization and submitting permit modification applications to entering into an interim Consent Order with ADEM. In 2022, 3M disclosed that its NPDES permit did not include all PFAS in discharge and submitted an application to add them. By 2024, the company had entered into a 2020 interim Consent Order with ADEM, which required additional analytical studies, capital improvements, and ongoing compliance measures. The NPDES permit modification request remained pending, and 3M continued to optimize wastewater treatment systems to address PFAS.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in 3M's approach to PFAS discharge characterization at the Decatur facility, correctly noting the 2022 disclosure of incomplete characterization and the submission of a permit modification application to ADEM. It also accurately states that by 2024, the NPDES permit modification remained pending and that 3M was optimizing wastewater treatment systems. However, a critical factual error undermines the quantitative and qualitative accuracy: the LLM incorrectly claims that 3M entered into a '2020 interim Consent Order' with ADEM. The ground truth does not mention a 2020 Consent Order, and citing a 2020 agreement in the context of 2022–2024 evolution is factually incorrect and chronologically inconsistent. This error suggests a misrepresentation of the regulatory timeline and corrective actions. While the general direction of progress—from identification to implementation—is correctly conveyed, the inclusion of an unverified and likely false regulatory instrument (the 2020 Consent Order) introduces significant inaccuracy. The answer is semantically similar in structure and intent but fails on a key factual element, particularly regarding dates and regulatory actions. Thus, while the answer is contextually relevant and partially accurate in reasoning, the incorrect date and unverified agreement reduce its overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 382,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Lowe's Companies, Inc. issued the 4.550% Notes as part of the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. Between 2022 and 2023, there is no indication that the terms or status of these specific 4.550% Notes changed; they remained outstanding as disclosed in the 2023 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All key facts are accurate: the 4.550% Notes were issued under the Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. The answer correctly states that there was no change in the terms or status of the notes between 2022 and 2023. (2) Quantitative accuracy is perfect: dates and percentages match the original answer exactly. (3) The reasoning is sound—though the LLM does not explicitly mention that the note was 'first introduced' in 2019 as part of the 2022 context, it correctly implies continuity by stating the notes remained outstanding in 2023 with no changes. The multi-hop synthesis across years is accurate, even if slightly less detailed than the original. (4) The answer is semantically equivalent to the ground truth, with only minor omission of the explicit 'no new issuance or modification in 2023' phrasing. Wording differences do not affect factual correctness. Hence, a high score of 9 is justified, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 313,
        "total_tokens": 1492
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's financial relationship with KDP evolved significantly. In 2022, MDLZ held a significant equity stake in KDP and accounted for it under the equity method. However, in 2023, MDLZ's ownership in KDP fell below 5%, triggering a change in accounting from the equity method to marketable securities. As a result, MDLZ recognized a pre-tax gain of $493 million in 2023 on equity method transactions related to KDP prior to this change. Additionally, MDLZ sold the remainder of its KDP shares in 2023, receiving $2.4 billion in proceeds and recognizing a pre-tax gain of $593 million on the sale of marketable securities. Thus, the transition from equity method to marketable securities accounting led to significant gains in 2023, with no further financial relationship with KDP in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the timing and magnitude of gains. The ground truth states that MDLZ recognized a $71 million pre-tax gain in 2022 (Q1) from the sale of KDP shares, and a $493 million pre-tax gain in 2024 due to a change in accounting. However, the LLM incorrectly places the $493 million gain in 2023 and adds a completely unsupported $593 million gain from the sale of marketable securities, which is not mentioned in the original answer. Additionally, the $2.4 billion in proceeds from share sales is absent from the ground truth and thus unverified. (2) The quantitative inaccuracies are severe: the $593 million gain and $2.4 billion proceeds are fabricated. The $493 million gain is correctly stated but misattributed to 2023 instead of 2024. The 2022 gain of $71 million is entirely omitted. (3) The reasoning about the accounting change (from equity method to marketable securities due to ownership falling below 5%) is plausible and aligns with typical accounting treatment, but the multi-hop synthesis is flawed because it invents events not present in the source. The original answer does not mention full divestment or sale of remaining shares, nor does it state that the $493 million gain was split or preceded by another gain. (4) Contextual relevance is high because the answer addresses the evolution of the financial relationship and focuses on gains from accounting changes. However, the correctness score is low due to major factual and numerical errors, especially the incorrect year and additional fabricated gains, which distort the actual financial narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 452,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Between 2022 and 2024, the scale and positioning of Xbox Game Pass evolved significantly. In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party console and PC titles. By 2024, this number had grown to over 400 titles, reflecting Microsoft's strategic emphasis on expanding its gaming ecosystem and enhancing its position as a leading gaming platform. Microsoft's focus on cloud gaming and cross-device accessibility further reinforced Xbox Game Pass as a central pillar of its gaming strategy, aiming to engage a broader audience and solidify its leadership in the gaming industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Xbox Game Pass had over 100 titles in 2022 and over 400 by 2024, matching the ground truth exactly. These numbers are critical and accurately reported. (2) All quantitative elements are correct—no calculations were required, but the reported figures (100+ and 400+ titles) align precisely with the original answer. Format variations are not needed here as numbers are presented clearly. (3) The reasoning is sound: the LLM correctly infers a significant expansion in scale and strategic importance, noting Microsoft's focus on cloud gaming, cross-device access, and ecosystem growth. While the original answer uses the term 'cornerstone,' the LLM conveys equivalent strategic emphasis through phrases like 'central pillar' and 'leading gaming platform,' which are semantically aligned. (4) The answer is fully contextually relevant, addressing both the quantitative evolution (number of titles) and strategic positioning. The only minor difference is that the LLM does not explicitly mention 'content, community, and cloud services' from 2022 or use the exact phrase 'cornerstone,' but it captures the essence of strategic elevation. Thus, the answer is factually complete and accurate with only slight variation in emphasis, warranting a high score but not perfect due to slightly less precise terminology in describing strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 388,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "Based on the provided documents, the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan has not shown any specific changes from 2022 to 2024. The 2022 filing references the \"Form of Deferred Stock Unit Award Agreement for deferred stock units granted on or after January 1, 2019 to Non-Employee Directors under the 3M Company 2016 Long-Term Incentive Plan,\" and the 2024 filing does not indicate any amendments or new forms for these agreements. Therefore, the agreement structure and disclosure remain consistent as previously established.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that the structure and disclosure of the Deferred Stock Unit Award Agreement for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan remained unchanged from 2022 to 2024, with both filings referencing grants on or after January 1, 2019. The date (January 1, 2019) is correctly cited, and there is no indication of amendments to the agreement form during this period, which matches the original answer. The LLM correctly infers consistency in structure and disclosure. However, it omits a specific detail mentioned in the ground truth: the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing ongoing plan maintenance through amendments as of May 8, 2023. This is a minor but relevant nuance regarding disclosure evolution (i.e., updated referencing despite no change in agreement terms), which slightly affects completeness and qualitative accuracy. All entities (3M Company, 2016 Long-Term Incentive Plan, non-employee directors, Deferred Stock Unit Award Agreement) and years (2022–2024) are correctly identified. The reasoning is sound and synthesizes information across years appropriately. Quantitative accuracy is perfect—no calculations or numbers are misstated. Contextual relevance is excellent, directly addressing the question's focus on structural or disclosure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 396,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Between 2023 and 2024, the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio showed a slight decline in origination costs, with direct origination costs decreasing from $100 million in 2023 to $112 million in 2024. Additionally, the geographic concentration in California decreased from 43% in 2023 to 42% in 2024, though the loans in this region continued to perform consistently with the overall portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the description of origination costs. It states that 'direct origination costs decreasing from $100 million in 2023 to $112 million in 2024', which is logically incorrect—$112 million is an increase, not a decrease. The ground truth correctly identifies that unamortized premiums, discounts, and direct origination costs increased from $100M to $112M. The LLM misrepresents the direction of change, which is a significant quantitative and qualitative error. (2) The geographic concentration numbers (43% in 2023 to 42% in 2024) are correctly reported, which supports partial credit. However, the key financial trend—increasing costs—is inaccurately described as a decrease, undermining the core of the answer. (3) The multi-hop reasoning is partially sound: the model connects two data points (costs and concentration) across years and addresses both parts of the question. However, the synthesis fails due to the incorrect interpretation of the cost trend. (4) Contextual relevance is high—the answer addresses both origination costs and California concentration as asked. Despite correct percentages and entities (Charles Schwab Bank, First Mortgages and HELOCs, correct years), the major error in interpreting the cost change severely impacts correctness. Quantitative accuracy is low due to the misstatement of direction in financial change. Qualitative accuracy is moderate because reasoning structure is present but flawed. Correctness score is 4 due to one major error offset by correct geographic data and proper scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 437,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Based on the language in the product research and development sections of Nike's 10-K filings for fiscal 2023 and 2024, Nike's strategic emphasis on Dri-FIT technology has remained consistent as part of its broader innovation and product development efforts. Both years highlight the proliferation of Dri-FIT as one of the key technologies used in designing innovative products, particularly in apparel, to meet consumer preferences for performance and comfort. There is no explicit indication of a shift or increased emphasis on Dri-FIT in fiscal 2024 compared to fiscal 2023, suggesting that it continues to be a foundational technology within Nike's portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that Nike's strategic emphasis on Dri-FIT technology remained consistent between fiscal 2023 and 2024, which aligns with the ground truth. It accurately reflects that Dri-FIT was presented as a key technology in both years, with no shift in emphasis. The answer correctly notes the absence of any explicit change in focus or description, indicating stable strategic importance. While the ground truth specifies that the *exact same language* was used in both 10-K filings, the LLM answer does not mention this verbatim repetition, which is a minor omission affecting completeness but not the overall factual correctness. There are no numerical values to verify, so quantitative accuracy is scored as 10. The reasoning is sound, demonstrating proper synthesis across the two fiscal years, and the entities (Nike, Dri-FIT, fiscal 2023 and 2024, 10-K R&D sections) are correctly identified. The response is highly contextually relevant and semantically equivalent to the original answer, with only slight loss in precision regarding the verbatim repetition of text.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 310,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has enhanced its investment in backup and disaster recovery from 2022 to 2024 in response to increasing cybersecurity threats. In 2022, the company emphasized strengthening its cybersecurity posture through measures like network security, backup and disaster recovery, and workforce training. By 2024, the focus had expanded to include more sophisticated protections such as enhanced identity and access management, multi-factor authentication, privileged access management, and 24/7 security operations to monitor and detect threats. These efforts reflect a strategic evolution to address the growing complexity and frequency of cyber threats.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall evolution of Mondelez International's investment in backup and disaster recovery from 2022 to 2024, and correctly frames it as a response to increasing cybersecurity threats. The dates (2022 and 2024) are accurate, and the general progression from foundational measures to more advanced capabilities is logically presented. While the original answer emphasizes heightened alert status in 2022 due to global threats (especially during the pandemic) and explicitly mentions state-sponsored actors and AI threats in 2024, the LLM captures the strategic evolution but omits these specific threat vectors. The LLM adds details not in the original—such as identity and access management, multi-factor authentication, and 24/7 security operations—which, while plausible components of a mature cybersecurity program, are not mentioned in the ground truth and represent a slight over-extension beyond the provided knowledge. However, these additions do not contradict the source and are contextually relevant. There are no numerical values to verify, so quantitative accuracy is scored as 10. The reasoning is sound and multi-hop synthesis is adequate, though slightly less precise in threat specificity. The answer remains contextually highly relevant and conveys a semantically aligned, if slightly augmented, version of the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 389,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "From fiscal year 2022 to fiscal year 2024, Microsoft significantly increased its financial commitment and engagement with Black and African American-owned suppliers. In fiscal year 2022, Microsoft reported reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft achieved its full goal, spending $500 million with double the number of Black and African American-owned suppliers. Additionally, in 2024, Microsoft provided 162 low- or no-interest loans to small to medium-sized partners through its Partner Capital Fund, further demonstrating its expanded support for Black and African American-owned businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core financial commitment evolution: in FY2022, Microsoft reached over 90% of its $500M goal with double the number of Black and African American-owned suppliers, and by FY2024, it achieved the full $500M goal. This quantitative information is accurate and matches the ground truth. However, the LLM introduces new information not present in the original answer—specifically, that Microsoft provided '162 low- or no-interest loans' through its Partner Capital Fund in 2024. While this may be factually true in broader context, it is not part of the ground truth provided and replaces a key detail from the original: the $150M allocation to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This omission and substitution affect completeness and factual alignment. (2) All numbers mentioned in the LLM answer ($500M, 90%, 162 loans) are plausible and internally consistent, but the 162 loans detail is unsupported by the ground truth and distracts from the actual expansion of financial commitment described (the $150M allocation). The $500M goal and progress toward it are correctly reported. (3) The multi-hop reasoning is partially sound—Microsoft’s increased engagement is correctly inferred from progress toward the $500M goal. However, the synthesis is incomplete because it fails to incorporate the new $150M commitment, which represents a deeper strategic expansion beyond supplier spending. Instead, it adds a different form of support (loans) not referenced in the original, weakening the logical connection to the documented evolution. (4) The contextual relevance is high—the answer directly addresses Microsoft’s evolving financial commitment. The qualitative accuracy is reduced due to the omission of the $150M allocation and insertion of unverified loan data. Quantitative accuracy is mostly correct but penalized slightly for introducing unsupported specifics. Correctness score is 7 because the core facts about the $500M goal are accurate, but significant strategic expansion details are missing and replaced with extraneous information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 579,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "The availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees decreased from 10,638,639 shares as of December 31, 2021, to 8,565,087 shares as of December 31, 2023. This reduction indicates that Abbott has utilized a portion of the available shares for employee purchases under the plan during this period. The continued availability of shares suggests that Abbott remains committed to offering stock-based incentives to non-U.S. employees, supporting its global talent retention and motivation strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the two key figures—10,638,639 shares available as of December 31, 2021, and 8,565,087 as of December 31, 2023—which match the ground truth exactly. The time periods are accurately referenced, and the reduction in available shares is correctly described. (2) All numeric values are accurate, and the implied decrease of 2,073,552 shares is factually correct, though not explicitly calculated. The dates are properly aligned with the 2022 and 2023 reporting years as per the original answer. (3) The multi-hop reasoning is partially sound: the model correctly identifies the trend (decrease in available shares) and infers utilization of shares, which is reasonable. However, the qualitative interpretation diverges from the ground truth: while the original answer suggests a 'tightening or adjustment' in Abbott's strategy, the LLM interprets the continued availability as evidence of sustained commitment, which is plausible but less precise given the reduction. This reflects a difference in analytical emphasis rather than a factual error. (4) The correctness score is 7 because core facts and numbers are accurate (justifying high quantitative accuracy), but the qualitative interpretation slightly misaligns with the original inference of strategic tightening. Contextual relevance is high as the answer directly addresses both parts of the question—evolution of share availability and strategic implication—though the latter could better reflect the cautious tone of the original conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 425,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike has continued to integrate Nike Air technology into its product development strategy, emphasizing innovation and performance. In fiscal 2024, Nike Air-Sole and other cushioning components were supplied through its wholly-owned subsidiary, Air Manufacturing Innovation, as well as contract manufacturers in China and Vietnam. This reflects Nike's ongoing commitment to leveraging Nike Air technology across its footwear offerings, maintaining its focus on enhancing athletic performance and comfort while managing supply chain operations globally.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities and operations mentioned (e.g., Air Manufacturing Innovation, contract manufacturing in China and Vietnam), and there are no numeric inaccuracies since no numbers are presented. However, it fails to address the core of the question: the *strategic evolution* of Nike Air technology in product development between fiscal 2023 and 2024. The original answer identifies a key shift—from Nike Air being positioned as an innovative, growth-focused technology in 2023 to becoming a mature, integrated component alongside Zoom, Free, and React in 2024. The LLM answer does not mention this strategic repositioning or provide any comparative analysis between the two fiscal years. Instead, it focuses on supply chain and manufacturing details, which, while relevant to operations, do not reflect the strategic narrative shift evident in the filings. This represents a failure in multi-hop reasoning and qualitative synthesis. While the information provided is contextually relevant to Nike Air’s use, it misses the evolution in strategic framing, resulting in a partially correct but incomplete response. Hence, the correctness and qualitative accuracy scores are moderate to low, despite high contextual relevance and perfect quantitative accuracy (no incorrect numbers).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 366,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Between 2022 and 2023, Abbott has maintained Osmolite as a key product within its Nutritional Products segment, specifically as part of its enteral feeding portfolio. The product line strategy for enteral feeding has remained focused on providing a comprehensive range of solutions for healthcare institutions, with Osmolite continuing to be highlighted as one of the core offerings alongside products like Jevity, Glucerna, and Oxepa. There is no indication of a strategic shift in positioning for Osmolite during this period, suggesting that Abbott continues to emphasize its role in meeting diverse nutritional needs in clinical settings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly states that Osmolite remained a part of Abbott's enteral feeding portfolio in both 2022 and 2023, with no significant repositioning or strategic shift. The mention of other products like Jevity, Glucerna, and Oxepa is consistent with the original answer, though the LLM omits a few named products (Nepro®, Vital®, Freego™, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal), which slightly reduces completeness but does not affect the core conclusion. There are no numerical inaccuracies (quantitative accuracy is perfect as no calculations are involved and all years are correct). The reasoning is sound—correctly inferring stable positioning from consistent product listing—and the answer addresses all key aspects of the question: Osmolite’s role in the enteral feeding portfolio and product line strategy over the two years. Semantic equivalence is strong; the LLM conveys the same essential information as the ground truth, just with slightly less granular detail in the product list. Contextual relevance is excellent, directly addressing Abbott's strategy and Osmolite's positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 328,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M's regulatory engagement and remediation obligations related to PFAS discharge in Minnesota and Alabama have evolved significantly. In Minnesota, 3M continues to comply with the 2007 Settlement Agreement and Consent Order, addressing PFAS contamination at the Cottage Grove facility and former disposal sites in Oakdale and Woodbury. By 2024, 3M had implemented remedial actions, including wastewater treatment systems and stormwater management, and was navigating stricter Health Based Values (HBVs) and Health Risk Limits (HRLs) for PFOA and PFOS set by the Minnesota Department of Health. In Alabama, 3M entered into a voluntary remedial action agreement with ADEM for the Decatur facility, including capping former sludge incorporation areas. The company also faced regulatory scrutiny under the 2009 TSCA consent order and ongoing investigations into PFAS discharges, culminating in an interim Consent Order in 2020 that imposed additional operational and remediation obligations. These developments reflect increased regulatory pressure and evolving compliance requirements in both states.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of 3M's PFAS-related regulatory engagement and remediation obligations in Minnesota and Alabama between 2022 and 2024, with generally accurate facts and good contextual relevance. However, there are notable discrepancies in entity accuracy and completeness compared to the ground truth. Quantitatively, the LLM correctly references key dates such as the 2007 Settlement Agreement and the 2020 Interim Consent Order with ADEM, and correctly notes evolving standards in 2024 (e.g., HBVs and HRLs). These dates and regulatory frameworks are accurate, earning a high quantitative accuracy score. The LLM also correctly identifies MPCA and ADEM as key regulatory bodies and the Cottage Grove and Decatur facilities as focal sites. However, the LLM incorrectly states that 3M entered into a 'voluntary remedial action agreement' in Alabama, which is not mentioned in the ground truth; instead, the 2020 Interim Consent Order was the key instrument, and it was not described as voluntary. Additionally, the LLM references a '2009 TSCA consent order,' which does not appear in the ground truth and appears to be fabricated or misattributed, representing a significant factual error. Regarding qualitative accuracy, the LLM correctly describes ongoing remediation efforts and increased regulatory scrutiny but misses critical 2024 developments: the draft Clean Water Act permit issued by MPCA with stringent effluent limits and its revision in December 2024 after public comment. These are central to the evolution of regulatory pressure in Minnesota and were explicitly detailed in the original answer. The LLM also omits 3M's August 2024 public comments on the draft permit, a key engagement milestone. In Alabama, the LLM fails to mention that the 2020 Interim Consent Order remained in effect and that future remediation was expected to incur multi-year capital and operating costs—important forward-looking obligations. While the LLM conveys the general trend of increasing regulatory burden, it lacks the specific multi-hop synthesis of evolving permits, stakeholder engagement, and compliance challenges detailed in the ground truth. The answer is semantically aligned in broad strokes but falls short on precise regulatory mechanisms and timelines. Contextual relevance is high, as the response stays focused on PFAS discharge, regulatory bodies, and site-specific actions in both states. Overall, the answer is partially correct with accurate framing and some key facts, but significant omissions and one erroneous entity (2009 TSCA order) prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1655,
        "completion_tokens": 687,
        "total_tokens": 2343
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "Between 2022 and 2024, The Coca-Cola Company's financial relationship with Coca-Cola HBC AG remained classified as an equity method investment. As of December 31, 2024, The Coca-Cola Company owned a 22% stake in Coca-Cola HBC AG, with a carrying value of $1,147 million in its consolidated balance sheet. The fair value of Coca-Cola HBC AG's shares, based on quoted market prices, was $2,675 million as of the same date, indicating a significant difference of $1,528 million between fair value and carrying value. The stake percentage and equity method classification remained consistent during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Coca-Cola HBC AG remained an equity method investee from 2022 to 2024 and accurately states the 22% ownership stake as of December 31, 2024, which aligns with the ground truth. However, the ground truth does not mention the carrying value ($1,147 million), fair value ($2,675 million), or the difference ($1,528 million) — these figures are absent in the original evidence and thus introduce unsupported quantitative details. (2) While the 22% stake is correct, the additional financial figures (carrying value, fair value, and their difference) cannot be verified against the provided ground truth and appear to be hallucinated or sourced beyond the evidence. This significantly impacts quantitative accuracy. (3) The reasoning is sound in noting the continuity of equity method accounting and the new specificity of the 22% stake in 2024 versus non-disclosure in 2022, demonstrating correct multi-hop synthesis across years. However, the inclusion of unverified financial metrics weakens the overall factual integrity. (4) Despite the extraneous numbers, the core qualitative point — formalization and explicit disclosure of the 22% stake in 2024 versus absence of percentage in 2022 — is correct and relevant. The answer addresses the evolution in classification and stake percentage as asked, but adds unsupported data, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 392,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024 by increasing investment in product development for cloud integration and expanding deployment model flexibility. In fiscal 2022, Oracle highlighted its focus on enabling customer choice through hybrid models like Oracle Cloud@Customer and emphasized innovation in cloud and on-premise interoperability. By fiscal 2024, Oracle further integrated hybrid deployment capabilities, particularly through Oracle Cloud Infrastructure (OCI) and Oracle SaaS offerings, enabling seamless migration and workload portability between on-premise and cloud environments. This evolution reflects Oracle's commitment to supporting flexible deployment options while advancing its cloud migration strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Oracle's strategic evolution from a development-focused approach in fiscal 2022 to a more integrated deployment model by fiscal 2024, emphasizing hybrid capabilities like Oracle Cloud@Customer and interoperability. It accurately reflects the company's focus on customer choice, cloud migration, and seamless workload portability. However, it omits the specific $7.2 billion R&D investment figure from fiscal 2022, which is a key quantitative detail in the ground truth. This missing data point affects quantitative accuracy despite the qualitative reasoning being sound. (2) No incorrect numbers are stated, but the absence of the $7.2 billion R&D expenditure—which directly addresses the 'product development investment' part of the question—represents a significant omission. The LLM mentions increased investment generally but fails to provide the exact amount, reducing quantitative precision. (3) The multi-hop reasoning is strong: the model synthesizes Oracle’s hybrid deployment strategy across time, connects product development (e.g., Cloud@Customer) with deployment integration (e.g., OCI and SaaS), and infers strategic maturation from innovation to standardization. This demonstrates accurate understanding of the evolution in deployment model integration. (4) The correctness score is 8 because the core strategic narrative is accurate and complete in qualitative terms, but the missing R&D dollar amount prevents a higher score. Quantitative accuracy is 6 due to the omission of a critical financial figure. Qualitative accuracy is 9 due to excellent reasoning and entity recognition (Oracle, Cloud@Customer, OCI, SaaS, hybrid deployment). Contextual relevance is 10 as every part of the response directly addresses the question’s focus on evolution in product investment and deployment integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 504,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The filing status of the Wells Fargo & Company Mandatory Clawback Policy remained consistent between the 2023 and 2024 SEC 10-K disclosures. In both filings, the policy was listed as effective as of October 2, 2023, and was included as Exhibit 97. In the 2023 filing, it was \"Filed herewith,\" and in the 2024 filing, it was \"Incorporated by reference\" to the 2023 10-K. This indicates no substantive change to the policy's filing status between the two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in both factual content and reasoning. It accurately identifies that the Mandatory Clawback Policy was included as Exhibit 97 in both the 2023 and 2024 10-K filings, with the 2023 version 'Filed herewith' and the 2024 version 'Incorporated by reference' to the prior year—this matches the ground truth. The date of effectiveness (October 2, 2023) is correctly stated, and the conclusion that there was no substantive change is reasonable. However, the LLM states the 'filing status... remained consistent,' which slightly mischaracterizes the situation: while the policy itself did not change, the *filing method* did change—from direct filing to incorporation by reference—indicating a procedural shift. The ground truth emphasizes this procedural change, whereas the LLM downplays it by asserting consistency. This is a minor but important nuance in regulatory disclosure practices. Thus, while all entities, dates, and filing mechanics are correct (perfect quantitative and contextual accuracy), the qualitative interpretation slightly misses the emphasis on procedural evolution, warranting a strong but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 326,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher Scientific acquired CorEvitas, LLC on August 14, 2023, as part of its Laboratory Products and Biopharma Services segment, paying $910 million in cash and debt. This acquisition added real-world evidence solutions to enhance drug development and decision-making. The financial implications included a $627 million allocation to goodwill (non-tax deductible) and $260 million to customer relationships, with a weighted-average amortization period of 18 years for intangible assets. The acquisition was funded through cash and debt, contributing to increased net interest expense in 2023 due to higher debt levels.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $910 million acquisition cost matches the $0.91 billion in the original answer. The $627 million goodwill and $260 million customer relationships are plausible allocations consistent with the total purchase price, though these specific breakdowns are not in the ground truth; however, such details may come from more granular data and do not contradict the original. The 18-year weighted-average amortization period is correctly reported. The date 'August 14, 2023' is more specific than the original but not implausible. (2) The funding via cash and debt, and resulting increase in net interest expense, is a reasonable inference from the ground truth's mention of $5.94 billion in senior notes issued in 2023, supporting the debt context. (3) The qualitative reasoning is sound: the evolution from investment to full acquisition is correctly framed, and integration into the Laboratory Products and Biopharma Services segment is accurately stated. The strategic rationale (real-world evidence for drug development) is consistent. (4) Minor deduction in quantitative accuracy because the original answer does not specify the $627M/$260M allocation, so including them as facts introduces unverified detail, though not necessarily incorrect. Overall, the answer captures the evolution and financial implications accurately, with excellent multi-hop synthesis of acquisition, integration, amortization, and financing impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 416,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "Between 2022 and 2023, RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce remained contingent on the hours flown by V2500-powered aircraft in service as of the acquisition date, with payments due through June 2027. These payments are categorized under \"Other commercial aerospace commitments\" and are capitalized as collaboration intangible assets as they are made. In 2022, the expected payments were spread across the years through 2028, while in 2023, the expected maturity schedule was updated, showing a shift in timing, with a larger portion of the commitments scheduled for 2024 and 2025 compared to the prior year. The capitalization treatment remained consistent, with payments being amortized over the term of the underlying economic benefit.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timing and evolution of RTX's payment obligations. The ground truth states there was 'no indication of a change in the magnitude or timing' between 2022 and 2023, but the LLM claims there was a shift in the maturity schedule with more payments moved to 2024 and 2025, and even extends the original payment period to 2028—neither of which is supported by the original answer. These are major quantitative and factual errors. (2) The dates mentioned (June 2027) and categorization ('Other commercial aerospace commitments') are correct, and the capitalization treatment as collaboration intangible assets is accurately reported in both years. However, the claim about a changed maturity schedule and the mention of payments through 2028 directly contradict the ground truth, which emphasizes stability in the commitment structure. There are no numbers or dollar amounts in either answer, but the temporal scope (2027 vs 2028) and implied payment timing are incorrect. (3) The multi-hop reasoning is partially sound—the model correctly identifies the ongoing nature of the agreement, the contingent structure based on flight hours, and the accounting treatment. However, it incorrectly infers a change in timing where none was indicated, suggesting flawed synthesis or potential hallucination. (4) The contextual relevance is high because the answer addresses the right agreement, companies, and accounting treatment, and focuses on the requested years. However, the core claim about evolving timing undermines correctness. The qualitative accuracy is moderate due to correct entity identification and conceptual understanding, but penalized for the unsupported assertion of change. Quantitative accuracy is low due to incorrect timeframes and implied schedule shifts not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 509,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "The Coca-Cola Company's contingent payments tied to performance milestones for fairlife have evolved as follows from 2022 to 2024: \n\nIn 2022, the contingent consideration liability related to the acquisition of fairlife was $3,017 million, based on fairlife achieving certain financial targets through 2024, with a final payment due in 2025. By 2024, this liability had increased to $6,126 million, reflecting updated valuations based on revised financial projections and performance expectations. The fair value of the liability was determined using a Monte Carlo valuation model in 2023 and a discounted cash flow analysis in 2024. Additionally, The Coca-Cola Company made a milestone payment of $275 million in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 there was no mention of ongoing contingent payments related to fairlife, but the LLM claims a contingent liability of $3,017 million, which is not supported. By 2024, the ground truth confirms a remaining milestone payment is expected in 2025 based on performance through 2024, but the LLM fabricates specific dollar figures ($6,126 million liability, $275 million payment in 2023) and valuation methodologies (Monte Carlo in 2023, DCF in 2024) that are not present in the original answer. (2) All numeric values in the LLM response—$3,017 million, $6,126 million, $275 million—are incorrect and unsupported by the ground truth. There are no quantitative figures in the original answer, so any specific numbers represent hallucination. (3) The multi-hop reasoning is flawed: the LLM incorrectly implies an evolving liability with increasing values over time, whereas the original answer indicates that the contingent payment was not discussed in 2022 and only reappeared in 2024 disclosures as a single remaining obligation. The model fails to accurately represent the timeline and nature of the financial relationship. (4) While the LLM attempts to address the evolution of contingent payments and ties performance to milestones, it does so with fabricated data and incorrect reasoning, severely undermining factual correctness. The contextual relevance is moderate because it discusses the right topic (contingent payments for fairlife), but the details are largely invented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 436,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Between 2022 and 2024, Oracle has further advanced the integration of Oracle Cloud Services with enterprise applications and infrastructure technologies by positioning its Oracle Fusion Cloud applications—such as ERP, HCM, and EPM—as foundational components of a unified business innovation platform. This evolution emphasizes a common data model across core applications, enhancing interoperability and enabling seamless workflows between front- and back-office functions. Additionally, Oracle has reinforced the role of its Next-Generation Cloud Infrastructure (OCI) in powering these SaaS offerings, ensuring compatibility, scalability, and performance. The company has also expanded its industry-specific cloud solutions and focused on enabling customers to migrate and modernize their on-premise and cloud-based workloads, reflecting a strategic shift toward a more cohesive, cloud-first ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, addressing Oracle's strategic evolution in cloud services between 2022 and 2024 with a focus on integration with enterprise applications and infrastructure. It correctly identifies key elements such as Oracle Fusion Cloud applications (ERP, HCM, EPM), the role of OCI, and the push toward unified platforms and industry-specific solutions. However, it diverges from the ground truth in emphasis: the original answer highlights a shift from promoting individual innovations like the Autonomous Database in 2022 to a holistic, integrated platform narrative by 2024, with explicit mention of customer choice and deployment flexibility. The LLM answer omits the 2022 focus on Autonomous Database and the specific evolution in messaging around 'flexibility, interoperability, and customer choice' across deployment models. Instead, it introduces 'Next-Generation Cloud Infrastructure' and 'common data model' concepts not explicitly present in the ground truth. While these are reasonable inferences, they shift the emphasis from the documented strategic narrative to a more technical integration story. There are no numerical inaccuracies (quantitative accuracy is 10), and the reasoning is logical and relevant, but the qualitative accuracy is reduced due to incomplete alignment with the source evolution narrative. The answer is well-structured and relevant to the question, hence high contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 404,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "The Key/Specified Employee Policy was incorporated by reference in the 2023 SEC filing (WFC_10k_2023.pdf) under Exhibit 10(r), referencing its inclusion in the 2018 Annual Report. In the 2024 SEC filing (WFC_10k_2024.pdf), there is no direct mention or update to this policy, indicating no changes or new documentation related to the Key/Specified Employee Policy between the two filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea that the Key/Specified Employee Policy remained unchanged between the 2023 and 2024 filings and was incorporated by reference from the 2018 filing, which aligns with the ground truth. However, there is a critical discrepancy in the exhibit number: the LLM states Exhibit 10(r) in the 2023 filing, while the ground truth specifies Exhibit 10(v). This is a factual error that affects entity accuracy and undermines confidence in the sourcing. Additionally, the LLM claims there is 'no direct mention' of the policy in the 2024 filing, whereas the ground truth clarifies it was explicitly referenced as a continuing policy—indicating it *was* mentioned, just not updated. This omission misrepresents the extent of disclosure in the 2024 filing. While the conclusion about no changes is directionally correct, the reasoning is flawed due to incorrect exhibit citation and mischaracterization of 2024 documentation. The dates and years (2018, 2023, 2024) are accurate, and the overall context of incorporation by reference is correctly understood, supporting partial credit. Multi-hop synthesis is partially sound but weakened by incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 331,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of the 6.700% notes due 2028 remained unchanged at $285 million between 2022 and 2023, as noted in the long-term debt tables from both RTX_10k_2022.pdf and RTX_10k_2023.pdf. This stability suggests that RTX did not refinance or retire this specific debt issue during the period, indicating a strategy of maintaining existing long-term debt obligations without immediate restructuring.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both quantitative and qualitative aspects. According to the ground truth, the aggregate principal balance of the 6.700% notes due 2028 increased from $115 million in 2022 to $285 million in 2023. However, the LLM claims the balance 'remained unchanged at $285 million' in both years, which directly contradicts the ground truth. This error misrepresents the evolution of the debt and leads to an incorrect conclusion about RTX's debt management strategy. (2) The quantitative inaccuracy is severe: the 2022 value is wrong ($285M reported vs. $115M actual), and the change over time (an increase of $170M) is entirely missed. The calculation of no change is incorrect. (3) The multi-hop reasoning failed: the model should have compared the same debt instrument (6.700% notes due 2028) across two fiscal years from the respective 10-K filings, but either accessed the wrong data or misread the 2022 value. The synthesis across years is flawed. (4) The contextual relevance is partially met because the answer addresses the right metric and company, and attempts to interpret strategy, but due to factual errors, the conclusion is invalid. Hence, very low scores on correctness, quantitative, and qualitative accuracy; slightly higher for relevance due to correct framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 370,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "The carrying value of TMO's 1.95% 12-Year Senior Notes decreased from $773 million in 2023 to $725 million in 2024, while the effective interest rate increased slightly from 2.08% in 2023 to 2.07% in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the carrying values for both years ($773 million in 2023 and $725 million in 2024), which matches the ground truth. However, it incorrectly states that the effective interest rate 'increased' from 2.08% to 2.07%, when in fact it decreased slightly. This is a critical error in directional logic despite the numbers themselves being accurate. (2) Numeric values for carrying value and interest rates are factually correct in magnitude and year, but the qualitative interpretation of the rate change is wrong. The model says the rate increased when 2.07% is less than 2.08%, so it actually decreased. (3) The multi-hop reasoning is partially sound—information is correctly pulled for two consecutive years and synthesized across time—but the conclusion about the direction of the interest rate change fails basic numerical comparison, undermining the reasoning. (4) Scores reflect that core data is accurate (hence not a low score), but a significant factual error in interpreting the trend of the effective interest rate reduces correctness. Contextual relevance is high as all relevant metrics and time periods are addressed appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 334,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings reflects a shift in transparency and accessibility. In 2022, the Directors' Code of Conduct was mentioned but not directly linked, while in 2024, it was explicitly posted on the company’s website with direct URLs, signaling a stronger commitment to corporate governance and stakeholder accountability. This change implies improved governance practices by ensuring that the code is publicly accessible, reinforcing ethical standards and compliance expectations for directors.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. According to the ground truth, in 2022 BNY Mellon *did* provide a direct URL to the Directors' Code of Conduct, while in 2024 it *removed* the direct link and only listed the Code among other governance documents without specific mention or hyperlink. The LLM answer reverses this: it claims the Code was *not* linked in 2022 and *was* linked in 2024, which is the opposite of the truth. This fundamental error undermines the entire analysis. (2) There are no numeric values, percentages, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is flawed because the LLM misrepresents the direction of change between the two years. Instead of identifying a potential reduction in visibility or transparency (as the ground truth suggests), it asserts an improvement in governance transparency, based on incorrect data synthesis. This failure to accurately compare the two filings invalidates the conclusion. (4) Contextual relevance is moderate—the response addresses corporate governance implications and discusses transparency and accountability, which are relevant themes. However, because the underlying facts are inverted, the analysis is misleading. Correctness and qualitative accuracy are low due to the critical factual reversal.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 394,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon's Short-Term Credit Agreement evolved between 2023 and 2024 in the following ways:\n\n1. **Facility Size**: In 2023, Amazon had a $5.0 billion unsecured 364-day revolving credit facility established in November 2023. In 2024, the facility size remained at $5.0 billion, but the agreement was renewed in October 2024.\n\n2. **Maturity Date**: The 2023 agreement matured in October 2024, while the 2024 agreement matures in October 2025, with the possibility of a 364-day extension if approved by the lenders.\n\n3. **Timing of Establishment**: The 2023 agreement was established in November 2023, and the 2024 agreement was established in October 2024, replacing the prior 364-day agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: facility size ($5.0 billion in both years), maturity dates (October 2024 for 2023 agreement, October 2025 for 2024 agreement), and timing of establishment (November 2023 vs October 2024). These match the ground truth exactly. (2) Quantitative accuracy is perfect: all dollar amounts, dates, and durations (364-day) are correct. The mention of a possible extension is additional but not contradictory. (3) The multi-hop reasoning is sound—information is synthesized across two years and two agreements. The only minor omission is that the 2023 agreement replaced the November 2022 agreement, which adds context about renewal patterns, but this does not affect the core answer. Also, the LLM does not explicitly state that the change represents a 'procedural renewal rather than a substantive change,' which is a qualitative insight from the original answer, but the factual evolution is accurately conveyed. (4) Scores reflect near-perfect factual alignment, with full quantitative accuracy and high qualitative accuracy due to minor omission of contextual interpretation. Contextual relevance is complete as all parts of the question are addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 342,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "AMD's APU strategy evolved from 2022 to 2024 by integrating dedicated AI processing capabilities, such as neural processing units (NPUs), into its APUs, particularly with the launch of the Ryzen AI 300 Series in 2024. This shift targets the AI PC segment by combining high-performance computing with on-device AI acceleration, enhancing productivity and immersive user experiences. The integration of AI capabilities into APUs positions AMD to capture a larger share of the growing AI PC market, thereby boosting its revenue potential in this emerging segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately captures AMD's strategic shift from 2022 to 2024: moving from external GPU-based AI solutions to integrating NPUs directly into APUs, particularly with the 2024 launch of the Ryzen AI 300 Series. The answer correctly identifies the target market (AI PC segment) and the implications for revenue potential. All dates and product names (e.g., Ryzen AI 300 Series in 2024) are accurate. While the LLM omits specific mention of the 2022 focus on Instinct MI200 and Radeon PRO V620 GPUs and the 'first-to-market' differentiation, these are contextual details rather than core factual errors. The reasoning is sound, showing a logical evolution from product integration to market targeting and revenue implications. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is highly relevant to the question. The minor omission of AMD's prior external GPU focus slightly affects completeness in multi-hop synthesis, hence a 9 instead of 10 on qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 309,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "The treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic remained consistent between 2023 and 2024. In both years, dividends paid to U.S. residents were generally exempt from Irish dividend withholding tax (25% rate) if proper documentation (e.g., Form 6166 or Form V2) was provided. Additionally, if a U.S. shareholder was subject to withholding tax, the payment satisfied any potential Irish income tax liability, provided a statement of the withholding tax was submitted to Irish Revenue authorities. No material changes in this treatment were noted in the 2023 and 2024 filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same essential information as the ground truth. (1) All key facts are correct: the 25% Irish dividend withholding tax rate, the availability of exemptions for U.S. residents via Form 6166 or Form V2, the condition that withholding tax payment discharges Irish income tax liability upon submission of a statement to Irish Revenue, and the absence of changes between 2023 and 2024. (2) Quantitative accuracy is perfect: the 25% rate is correctly stated, and no incorrect numbers or dates are present. (3) The multi-hop reasoning is sound—information is correctly synthesized across years and tax jurisdictions, and the conclusion of no material change is logically supported. (4) The only minor shortcoming is that the LLM slightly rephrases 'no Irish income tax liability' as 'exempt from Irish dividend withholding tax', which is mostly accurate but slightly less precise—exemption from withholding does not always equate to no tax liability, though in this context (with proper documentation and non-Irish branch ownership), it is correct. However, the nuance about not holding shares through an Irish branch, present in the original, is omitted, which slightly reduces completeness. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 374,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "Between 2022 and 2024, the risk disclosure around new products and services, particularly regarding the platforms operating model initiative, has become more specific and prominent. In 2022, the risk was mentioned as a general concern that the company \"may not realize some or all of the expected benefits of our transition to a platforms operating model.\" By 2024, the disclosure was expanded and rephrased to highlight the broader transformational nature of the initiative, stating that \"new lines of business, new products and services or transformational or strategic project initiatives subject us to new or additional risks, and the failure to implement these initiatives could affect our results of operations.\" This evolution reflects increased emphasis on the potential operational and strategic risks associated with the platforms operating model as the initiative progressed.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reverses the timeline and misattributes the risk disclosures between 2022 and 2024, which is a critical factual error. According to the ground truth, in 2022, BNY Mellon discussed general risks related to new products, services, and strategic initiatives. By 2024, the disclosure evolved to specifically call out the 'transition to a platforms operating model' as a new source of risk, including the statement that 'we may not realize some or all of the expected benefits' of this transition. However, the LLM incorrectly states that the 2022 filing already mentioned the platforms operating model risk, and that the 2024 filing generalized it — the opposite of what actually occurred. (2) There are no numeric values, percentages, or dollar amounts in the question or answers, so quantitative accuracy is not applicable beyond correct year references (2022 and 2024), which are correctly used in terms of formatting. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the evolution of risk language over time. Instead of showing a progression from general to specific risk disclosure, it describes the reverse, indicating a failure in logical and factual synthesis across years. (4) While the answer is relevant to the topic and discusses risk disclosures around strategic initiatives and the platforms operating model, the core factual inversion undermines the correctness. The contextual relevance is moderate because it addresses the right company and initiative but with incorrect temporal logic and attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 434,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Amazon's 3.600% Note due 2032 was disclosed in both the 2023 and 2024 10-K filings under the Supplemental Indenture dated April 13, 2022 (Exhibit 4.2). In both years, the note terms remained consistent, with no new amendments or additional disclosures specific to the 3.600% Note due 2032 in 2024. The instrument details, including coupon rate and maturity, were unchanged between the two filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 3.600% Note due 2032 was disclosed under the same Supplemental Indenture (April 13, 2022) in both 2023 and 2024, with unchanged terms, coupon rate, and maturity—this aligns with the ground truth. The exhibit reference (4.2) adds precision. However, it omits a key factual evolution highlighted in the original answer: the trustee transition from Wells Fargo Bank, National Association (prior trustee) to solely Computershare Trust Company, National Association as successor trustee in 2024. This procedural change in administration is a central part of the relationship evolution and was explicitly noted in the ground truth. (2) Quantitatively, all dates, percentages, and exhibit numbers are accurate. There are no numerical or date inaccuracies. (3) The reasoning is sound in noting consistency of terms, but fails the multi-hop synthesis by not recognizing and reporting the trustee shift, which requires comparing trustee disclosures across the two years’ filings. This omission weakens the qualitative accuracy despite correct identification of the indenture and note terms. (4) The answer is contextually relevant and well-structured, but the missing trustee detail—a core aspect of the 'relationship evolution'—prevents a higher correctness score. While not a financial term change, the trustee transition is a material administrative update that the question specifically asks about in terms of 'debt instrument disclosures.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 412,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "From 2023 to 2024, MDLZ's treatment and disclosure of net investment hedge (NIH) derivative contracts showed notable changes in financial impact and presentation. In 2023, NIH contracts had a total fair value of a net liability of $219 million, whereas in 2024, this shifted to a net asset of $255 million. This change reflects a reversal in the fair value position of these contracts, indicating a more favorable financial position in 2024. Additionally, the presentation in the financial statements showed an increase in asset derivatives related to NIH contracts from $163 million in 2023 to $305 million in 2024, while liability derivatives decreased from $382 million to $50 million. This suggests an improvement in the effectiveness and valuation of MDLZ's hedging strategies during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2023, MDLZ disclosed fair values of derivative assets and liabilities as $1,347 million and $377 million in other current assets, and $250 million and $413 million in other assets as of December 31, 2023 and 2022 respectively. The LLM incorrectly reports a net liability of $219 million in 2023 and a net asset of $255 million in 2024, which are not supported by the original data. Additionally, the LLM claims asset derivatives increased from $163M to $305M and liabilities decreased from $382M to $50M, none of which appear in the ground truth. These numbers are entirely fabricated or misattributed. (2) There is no quantitative alignment with the original answer—no mention of $1,347M, $377M, $250M, or $413M in the correct categories or years. The LLM invents a 'net liability' and 'net asset' calculation not present in the source, and performs incorrect aggregations. (3) The multi-hop reasoning is flawed. The original answer emphasizes a shift in disclosure focus—from balance sheet valuation in 2023 to income statement impact in 2024 (specifically, 'Other income, net' including amounts excluded from hedge effectiveness). The LLM completely misses this qualitative shift and instead fabricates a narrative about improving fair values and hedging effectiveness, which is not stated or implied in the ground truth. (4) While the LLM attempts to address the evolution of treatment and disclosure, it fails on factual content and reasoning. It remains contextually relevant in topic (discussing NIH hedges over time) but is mostly incorrect in substance, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 464,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "From 2023 to 2024, the Abrams Main Battle Tank's modernization strategy has evolved with a focus on enhancing technological capabilities and addressing international demand. In 2023, the Army announced plans to develop the M1E3 Abrams, which includes updated systems architecture for easier technology integration and improved mobility and sustainment. By 2024, the emphasis remained on maximizing the Abrams' lethality and survivability, with strong international demand from NATO and allied nations reflected in a growing global installed base. Additionally, continued upgrades and support for non-U.S. partners highlight the program's global reach and adaptability to evolving threats.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of the Abrams modernization strategy from 2023 to 2024, identifying the development of the M1E3 Abrams in 2023 with updated systems architecture, improved mobility, and sustainment—consistent with the ground truth. It also accurately reflects the increased international demand in 2024, particularly among NATO and allied nations, and the growing global installed base across key regions. However, the LLM omits specific mention of the System Enhancement Package version 3 (SEPv3), which was a central component of the 2023 strategy and included upgrades in communications, power generation, fuel efficiency, optics, and armor. This omission slightly weakens completeness. (2) There are no numeric values, dates, or calculations in either the original or LLM answer that conflict; all temporal references (2023, 2024) are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes technological development (M1E3) and shifts in strategic focus (from technical roadmap to global procurement momentum). The connection between enhanced capabilities and international demand is logically presented. (4) The contextual relevance is high—the answer directly addresses both technological development and international demand as asked. The qualitative accuracy is slightly reduced due to the missing SEPv3 detail, but the core facts and strategic trajectory are correct. Wording differs but meaning is semantically equivalent on key points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 418,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD's role in the development and positioning of APUs has evolved to emphasize their integration across multiple segments, particularly in the Client and Embedded markets. In 2022, APUs were highlighted for their role in notebook and desktop platforms, offering balanced performance and efficiency. By 2024, APUs were strategically emphasized in the Embedded segment, supporting high-performance and low-power applications in enterprise and industrial settings, reflecting a broader market segmentation and a stronger strategic emphasis on tailored solutions for specialized computing needs.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it is scored as 10. The qualitative accuracy is low because the LLM misrepresents AMD's segmentation evolution. According to the ground truth, in 2022 APUs were part of a broad Enterprise, Embedded and Semi-Custom portfolio without specific segmentation, and by 2024 they were explicitly included in two reportable segments: Data Center and Client. The LLM incorrectly states that in 2022 APUs were highlighted for notebook and desktop platforms (overemphasizing Client focus prematurely) and claims a strategic shift toward the Embedded segment by 2024, which contradicts the ground truth—Embedded was part of the earlier, less segmented reporting, not the new 2024 structure. In reality, the 2024 shift placed APUs in Data Center and Client segments, signaling expansion into data center applications (e.g., AI, accelerators), not Embedded. The reasoning is flawed as it fails to capture the correct multi-hop evolution: from general inclusion in a hybrid segment (2022) to explicit placement in Data Center and Client (2024). The LLM instead invents a narrative around Embedded and tailored solutions that is not supported by the source. Contextual relevance is moderate—the answer addresses market segmentation and strategic emphasis over time, but with incorrect entity mapping and segment evolution, leading to a misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 404,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries remained consistent from 2023 to 2024. In both years, the company noted that the Irish Minister for Finance has the authority to restrict financial transfers between Ireland and third countries, with the list of restricted countries subject to ongoing change. Additionally, transfers involving countries under United Nations or EU sanctions may also be restricted under Irish law. There were no material changes in the nature or scope of these disclosures between the two periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that Medtronic's disclosures remained consistent between 2023 and 2024. The ground truth states that while the core regulatory framework was still disclosed in 2024, the company no longer emphasized the dynamic nature of the list of restricted countries—a meaningful change in emphasis that the LLM overlooks. Instead, the LLM claims there were 'no material changes,' which contradicts the original answer’s assertion of a 'potential shift in focus or stabilization.' This misrepresents the evolution of the disclosure. (2) There are no numeric values, dates, or calculations in this question, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly referenced, supporting a score of 10 for quantitative accuracy. (3) The multi-hop reasoning is flawed: the question asks for an analysis of how the disclosure *evolved*, requiring comparison across years and synthesis of changes in tone or emphasis. The LLM fails this by asserting consistency rather than identifying the nuanced shift noted in the ground truth. Entity accuracy (Medtronic, Financial Transfers Act 1992, Ireland, third countries) is correct, but reasoning about change over time is inaccurate. (4) Correctness and qualitative accuracy are low due to the failure to capture the evolving nature of the disclosure, despite correct entities and context. Contextual relevance is high because the answer addresses the right topic and legal framework, just with incorrect comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 427,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "The G700 aircraft was expected to enter service following certification in early 2024, as disclosed in the 2023 10-K. In 2024, production ramped up, with deliveries beginning in the second quarter of 2024, indicating successful certification and initial market deployment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of the G700 aircraft from 2023 to 2024. In 2023, it was expected to enter service after FAA certification in early 2024, which matches the ground truth. By 2024, deliveries began in Q2, indicating successful certification and transition to production—this is accurately reflected. (2) All dates and timeframes are correct: 'early 2024' for certification and 'second quarter of 2024' for deliveries align with the original answer. No numerical inaccuracies present. (3) The multi-hop reasoning is sound—information is synthesized across two years and filings, correctly showing progression from expected certification to actual delivery. The only minor omission is not explicitly stating that the aircraft 'entered service' or that it moved from 'development to active production,' but 'deliveries beginning' and 'production ramped up' convey a similar outcome. (4) The answer is semantically equivalent to the ground truth, with slightly less emphasis on the conceptual shift from future model to delivered product, but all key facts and timeline are preserved. Hence, high scores across all categories with a 9 on correctness due to slight lack of contextual depth in framing the transition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 353,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "In 2023, PMI renewed and extended its arrangement with KT&G for the exclusive commercialization of KT&G's smoke-free products outside of South Korea. By 2024, this collaboration had evolved into a long-term, fifteen-year agreement through January 29, 2038, providing PMI with exclusive, worldwide access (excluding South Korea) to KT&G's smoke-free brands and product-innovation pipeline. The 2024 agreement includes performance-review cycles and volume-based commitments for each three-year period, offering flexibility to adapt to changing market conditions. This reflects a stronger and more strategic dependency on KT&G for PMI's smoke-free product portfolio expansion, particularly in low- and middle-income markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 15-year agreement through January 29, 2038, and the exclusive worldwide commercialization rights (excluding South Korea), which aligns with the ground truth. It also accurately notes the focus on low- and middle-income markets. However, it incorrectly states that the 15-year agreement was established in 2024, while the original answer clarifies the agreement was announced in 2023. The LLM reverses the timeline: the long-term agreement was formed in 2023, not 2024. Additionally, the LLM introduces new details—'performance-review cycles' and 'volume-based commitments'—that are not present in the ground truth and cannot be verified, potentially misrepresenting the nature of the agreement. (2) Quantitatively, the date January 29, 2038, and the 15-year duration are accurate and consistent with the original. No calculations are involved, but temporal facts are mostly correct except for the misplacement of when the agreement was finalized. (3) The multi-hop reasoning is partially sound—PMI's strategic dependency and product integration are addressed, but the evolution from 2023 to 2024 is misrepresented. The ground truth emphasizes that by 2024, KT&G's products were integrated into PMI's heat-not-burn portfolio, signaling deeper operational integration. The LLM instead focuses on contractual mechanics not in the original and misses this key shift from distribution to strategic inclusion. (4) The contextual relevance is high as the answer addresses strategic dependency and commercialization. However, due to the timeline inversion and introduction of unverified terms, the qualitative accuracy is reduced. The core facts about exclusivity and market focus are correct, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 483,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "From 2022 to 2024, AMD's approach to semi-custom SoC products has evolved to become more integrated with broader product ecosystems and strategically aligned with AI and high-performance computing trends. In 2022, AMD emphasized the importance of securing customers for its semi-custom design pipeline and the success of third-party products incorporating its SoCs. By 2024, AMD expanded its strategic focus to include AI-driven solutions, leveraging its semi-custom SoCs in gaming consoles and cloud platforms while integrating dedicated neural processing units (NPUs) for AI PCs. Additionally, AMD's acquisition of Silo AI and its plans to acquire ZT Systems highlight its commitment to deepening ecosystem partnerships and enhancing software capabilities to support AI deployment at scale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution in AMD's strategy from 2022 to 2024: in 2022, AMD's semi-custom SoC business was dependent on third-party product success, and by 2024, it became more strategically integrated into broader ecosystems, particularly with AI. The mention of NPUs in AI PCs, use in gaming consoles and cloud platforms, and integration with CPUs/GPUs matches the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the answer synthesizes AMD's strategic shift across years and product lines. However, the mention of the 'acquisition of Silo AI' and 'plans to acquire ZT Systems' is not present in the original ground truth and may reflect external knowledge not confirmed in the provided filings. While these acquisitions are publicly known, they were not part of the knowledge graph source, so including them introduces unverified detail, slightly reducing qualitative accuracy. (4) The answer is contextually excellent—directly addresses strategic positioning and ecosystem integration over time. Overall, the core facts, timeline, and strategic evolution are correct, with only minor addition of unconfirmed details, warranting a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 378,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax on dividends paid to U.S. residents remained largely consistent, with dividends generally exempt from Irish dividend withholding tax if the beneficial owner is a U.S. resident and meets specific conditions. These include holding shares through the Depository Trust Company (DTC) with a U.S. address recorded or submitting valid tax certification forms. Additionally, U.S. residents who qualify for these exemptions typically do not face Irish income tax liability on the dividends, provided they do not hold shares through an Irish trade connection. No significant changes in exemptions or withholding tax obligations were noted in the 2024 disclosures compared to 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key developments in the evolution of Irish tax treatment between 2023 and 2024 as described in the ground truth. (1) What was correct: The answer correctly identifies that U.S. residents may be exempt from Irish dividend withholding tax and generally not subject to Irish income tax if they meet conditions (e.g., no Irish trade connection). It also correctly notes the continuity of the exemption framework and references valid mechanisms like tax certification and DTC holding, which align with typical procedures. The 25% withholding tax rate is not mentioned in the LLM answer, but no incorrect rate is stated, so no penalty on quantitative accuracy. (2) Quantitative accuracy: There are no numerical inaccuracies because the LLM does not state any numbers (e.g., the 25% rate), but it doesn't contradict them either. Since it avoids incorrect figures, quantitative accuracy is scored highly. (3) Multi-hop reasoning assessment: The major flaw is in qualitative accuracy. The ground truth emphasizes that in 2024, Medtronic *clarified* post-withholding procedures—specifically, that individuals subject to withholding can discharge further tax liability by furnishing a statement to Irish Revenue. This is a significant procedural clarification not mentioned in the LLM response. Additionally, the LLM incorrectly states that 'no significant changes' occurred, while the ground truth explicitly notes more structured exemption conditions and clarified procedures in 2024. This misrepresents the evolution of the tax treatment. (4) Justification for scores: Correctness is 6 because core concepts (exemptions, no tax liability without Irish connection) are accurate, but the failure to identify the 2024 clarifications—especially the post-withholding mechanism—constitutes a significant omission. Qualitative accuracy is low due to flawed reasoning about the evolution. Contextual relevance is high because the answer stays on topic and addresses the right entities and timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 543,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "General Dynamics experienced cost pressures in 2023 from supply chain impacts on the Virginia-class submarine schedule and cost growth on the DDG-51 program, which reduced the Marine Systems segment's operating margin by 110 basis points. In 2024, while these challenges persisted, the company's revenue outlook for the Columbia-class submarine initiative remained strong, with ship construction revenue increasing due to higher volume on the program. The Marine Systems segment's 2024 revenue was projected to rise to approximately $12.8–12.9 billion, with an operating margin of around 7.6%.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: the 110 basis point decline in operating margin in 2023 due to supply chain disruptions on the Virginia-class and cost overruns on the DDG-51 program; the projected 2024 Marine Systems revenue of $12.8–12.9 billion; and the expected operating margin of approximately 7.6%. The strong revenue outlook for the Columbia-class submarine program is accurately noted as a driver of increased ship construction revenue. (2) All numeric values are correct and match the original answer exactly: 110 basis points, $12.8–12.9 billion, and 7.6% margin. No calculation errors are present. (3) The multi-hop reasoning is sound—information is synthesized across time (2023 vs 2024), programs (Virginia-class, DDG-51, Columbia-class), and financial metrics (revenue, margin). The LLM correctly infers that despite ongoing cost pressures in 2024, the revenue growth and margin stabilization reflect improved program execution and strategic focus, which aligns with the original answer’s implication. (4) The only minor shortcoming is that the LLM answer does not explicitly state the shift in strategic focus from cost-driven margin pressure in 2023 to a more optimistic 2024 outlook, though this is implied through the data presented. This slight omission in framing prevents a perfect 10 on qualitative accuracy, but the factual and quantitative completeness remains excellent. Contextual relevance is full, as all parts of the question are addressed with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 429,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Based on the provided information, BKNG's financial dependency on Booking.com, as measured by the proportion of revenue derived from accommodation reservations, remained relatively stable between 2022 and 2023. In both years, approximately 89% of the company's total revenue was attributed to online accommodation reservation services, with the majority of these revenues stemming from Booking.com's accommodation reservations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that 89% of BKNG's revenue came from accommodation reservations in both 2022 and 2023, which matches the ground truth. The quantitative accuracy is perfect—percentages and years are correct. (2) All numbers are accurate: 89% in both years is correctly reported. There are no calculation errors. (3) However, the reasoning and qualitative analysis are weaker. The original answer notes that dependency 'slightly increased' and 'remained unchanged', which is contradictory, but the LLM interprets this as 'relatively stable', which is reasonable. However, the LLM fails to explicitly state that the proportion was identical in both years (89% in 2022 and 89% in 2023), missing the nuance that the dependency did not just remain stable but was numerically unchanged. Additionally, the original answer emphasizes 'sustained and concentrated dependency', which the LLM downplays by saying 'relatively stable'—a less precise characterization of high, unchanging reliance. (4) The correctness score is 7 because core facts and numbers are correct, but there is a minor omission in not explicitly confirming the percentage was unchanged, and the qualitative interpretation is slightly less precise than the ground truth. Quantitative accuracy is 10 due to correct percentages and years. Qualitative accuracy is 7 due to less precise reasoning and synthesis. Contextual relevance is 10 as the answer directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 406,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "Between 2023 and 2024, the company's Swiss Franc note decreased from $299 million to $0, indicating that the obligation was fully repaid by the end of 2024. This reduction suggests that the company successfully managed and settled its foreign currency obligations related to the Swiss Franc note within the one-year period, reflecting effective foreign currency risk management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key fact that the Swiss Franc note obligation decreased from $299 million in 2023 to $0 in 2024, which matches the ground truth. The conclusion that the obligation was fully repaid or eliminated by 2024 is accurate and consistent with the original answer. (2) Quantitatively, the numbers are correct: $299 million in 2023 and $0 in 2024 are accurately reported, with no calculation errors. Format is consistent and acceptable. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model infers from the elimination of the obligation that the company managed its foreign currency exposure, which aligns with the original answer’s interpretation. The only minor difference is that the original answer allows for either repayment or restructuring, while the LLM specifies 'repaid,' which is a slightly narrower interpretation but still plausible and not factually incorrect. (4) The answer is fully contextually relevant, addressing both parts of the question: the evolution of the Swiss Franc note and its implication for foreign currency obligations. The qualitative accuracy is slightly reduced due to the narrower interpretation of 'repaid' versus the more general 'repaid or restructured,' but this does not undermine the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 368,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "Goldman Sachs introduced new forms of Non-Employee Director RSU Award Agreements in the 2024 10-K filing, including a Cash-Settled variant (10.32 and 10.33), which were not explicitly listed in the 2023 10-K. Additionally, the 2024 filing includes updated agreements such as the One-Time/Year-End RSU Award Agreements (10.35 and 10.36), indicating a refinement or expansion of the structure and vesting terms for non-employee director compensation compared to the 2023 disclosure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces significant factual inaccuracies not present in the ground truth. (1) It claims Goldman Sachs introduced 'Cash-Settled variant (10.32 and 10.33)' and 'One-Time/Year-End RSU Award Agreements (10.35 and 10.36)' in the 2024 10-K, but the ground truth states that the key change was the addition of 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, with no mention of exhibits 10.32, 10.33, 10.35, or 10.36. These exhibit numbers and agreement types are fabricated or misattributed. (2) Quantitatively, the exhibit numbers and agreement forms cited do not match the original answer, making the quantitative accuracy very low. There are no correct numbers or exhibit references. (3) The reasoning is flawed: the LLM fails to identify the actual evolution — retention of the pre-2015 agreement and introduction of amendments — and instead invents new agreement types and exhibit numbers, indicating a failure in multi-hop synthesis or data retrieval. (4) While the answer is contextually relevant in that it discusses changes in RSU agreements for non-employee directors at Goldman Sachs between 2023 and 2024, the specific details are factually wrong. The core claim of 'new forms' and 'cash-settled variants' is unsupported by the ground truth, which emphasizes amendments to existing agreements, not new structural variants. Thus, despite addressing the general topic, the answer misrepresents the actual disclosure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 413,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Between 2023 and 2024, PM's long-term debt obligations related to the acquisition of Swedish Match AB evolved as follows: In 2023, the Euro credit facility borrowings associated with the acquisition amounted to $6,121 million, but by 2024, this had significantly decreased to $2,610 million. This reduction was primarily due to PMI prepaying approximately €3 billion (about $3.2 billion) under the 3-year tranche of the senior unsecured term loan facility on November 21, 2024, leaving only the €2.5 billion (approximately $2.6 billion) 5-year tranche outstanding as of December 31, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the long-term debt obligations for both 2023 ($6,121 million) and 2024 ($2,610 million), matching the ground truth exactly. These figures are critical and accurately presented. (2) The explanation of the reduction includes a specific prepayment event on November 21, 2024, where PMI prepaid approximately €3 billion (~$3.2 billion) under the 3-year tranche, which aligns with plausible repayment activity leading to the reduced balance. The remaining €2.5 billion (~$2.6 billion) 5-year tranche outstanding as of December 31, 2024, is consistent with the reported $2,610 million, allowing for minor exchange rate fluctuations. (3) The multi-hop reasoning is sound: the model connects the acquisition-related debt in 2023 to the repayment action in 2024 and explains the structural change in debt tranches, demonstrating synthesis across time and financial instruments. (4) The only minor shortcoming is that the original answer emphasizes the broader implication of reduced financial dependency, while the LLM focuses more on mechanics than strategic interpretation—however, this does not detract from factual accuracy. All entities (PM/PMI, Swedish Match AB, Euro credit facility, term loan tranches), years (2023, 2024), and metrics (long-term debt obligations) are correct. Wording differs but semantic meaning and factual content are equivalent or superior. Thus, quantitative accuracy is perfect, qualitative reasoning is strong, and relevance is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 416,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "BMY's strategic positioning around KRAS inhibition evolved significantly from 2023 to 2024 with the acquisition of Mirati, which added Krazati (adagrasib), a best-in-class KRAS G12C inhibitor, to its portfolio. In 2023, Krazati was already approved for second-line NSCLC and in development for first-line use in combination with a PD-1 inhibitor. By 2024, following the acquisition, BMY further integrated Mirati's pipeline, including additional KRAS inhibitors and enabling programs, strengthening its position in KRAS-targeted therapies. This acquisition marked a pivotal expansion in BMY's oncology portfolio, enhancing its ability to address KRAS-driven cancers across multiple indications.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core evolution in BMY's strategic positioning around KRAS inhibition via the Mirati acquisition and inclusion of Krazati in its portfolio. It accurately notes Krazati's approval in second-line NSCLC and development in first-line NSCLC with a PD-1 inhibitor. However, it incorrectly implies that Krazati was already approved and in BMY's portfolio in 2023, which contradicts the ground truth—BMY did not acquire Mirati until 2024, so Krazati was not part of its assets in 2023. Additionally, the LLM omits the key 2024 FDA approval for KRAS-mutated colorectal cancer with cetuximab, a significant expansion of Krazati’s indications. The $4.8 billion acquisition amount is not mentioned, a missing quantitative detail. (2) No explicit dollar amount is provided in the LLM answer, so the $4.8 billion figure is omitted—this affects quantitative accuracy. Dates (2023 vs 2024) are misattributed regarding Krazati’s approval timeline in relation to BMY’s ownership. (3) The multi-hop reasoning is partially sound—linking acquisition to pipeline enhancement—but incorrectly assumes BMY had exposure to Krazati pre-acquisition. The synthesis across time, company, and drug development stages is flawed in temporal attribution. (4) Despite these issues, the answer captures the strategic significance of the Mirati acquisition and BMY’s strengthened position in KRAS inhibition, maintaining high contextual relevance. The core message aligns with the ground truth but contains key factual inaccuracies in timeline and completeness of approvals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 436,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Goldman Sachs updated its disclosure and positioning of the Restricted Partner Compensation Plan in 2024 by incorporating it into the broader context of its compensation governance policies, particularly emphasizing alignment with regulatory and internal governance standards. The 2024 10-K reaffirms the existence of the Amended and Restated Restricted Partner Compensation Plan, originally disclosed in 2006, while also highlighting the introduction of the Amended and Restated The Goldman Sachs Group, Inc. Clawback Policy effective December 1, 2023, which complements and reinforces the governance framework around executive and partner compensation. This evolution reflects a more integrated approach to compensation governance, ensuring transparency and accountability in light of evolving regulatory expectations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the introduction of the Clawback Policy effective December 1, 2023, and its placement as a new governance element in the 2024 filing, which aligns with the ground truth. It also accurately notes that the Restricted Partner Compensation Plan was reaffirmed and originally established in 2006 (consistent with prior disclosures). However, the LLM omits key structural details about the exhibit numbering and positioning shift—specifically, that the plan moved from Exhibit 10.3 in 2023 to Exhibit 10.4 in 2024 and was pushed later in the exhibit list, a detail central to the 'positioning' aspect of the question. Instead, the LLM generalizes about 'broader context' and 'integrated approach' without referencing the actual exhibit reordering. (2) Quantitatively, all dates (December 1, 2023) and exhibit references (though only one is mentioned) are accurate. The LLM correctly identifies the Clawback Policy as 'Amended and Restated' and effective in late 2023, matching the timeline. However, it fails to mention the specific exhibit numbers for the Restricted Partner Compensation Plan in both years, which are factual data points in the ground truth. (3) The reasoning is partially sound: the LLM correctly infers that the introduction of the Clawback Policy reflects a shift toward stronger compensation governance and regulatory alignment. This is a valid interpretation. However, it does not fully synthesize the multi-hop insight that the *relative prioritization* of disclosures—evidenced by exhibit order—changed, with Clawback now appearing earlier (Exhibit 10.1) and thus signaling strategic repositioning. This omission weakens the qualitative accuracy. (4) The answer is contextually relevant and well-articulated, addressing the evolution in disclosure and governance. It captures the spirit of increased accountability but misses the concrete evidence (exhibit sequence) used in the ground truth to support that claim. Hence, while factually reasonable, it lacks completeness on structural disclosure changes, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 567,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) evolved its approach to heat-not-burn products by reclassifying them under the broader \"smoke-free products\" category, which also includes vapor and oral nicotine products. In 2023, PMI further integrated heat-not-burn products into its business segments, reporting them alongside other smoke-free offerings, excluding wellness and healthcare, and highlighting their growth in shipment volumes and net revenues. This shift reflects a strategic move to emphasize the company's transition toward smoke-free alternatives and aligns with its long-term goal of ending cigarette sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core evolution in PMI's approach to heat-not-burn products from 2022 to 2023, particularly the reclassification under 'smoke-free products' and the strategic emphasis on transitioning away from cigarettes. It accurately reflects the shift in product categorization and business integration, noting the inclusion of heat-not-burn products alongside vapor and oral nicotine offerings. However, it omits a key detail from the ground truth: in 2023, PMI explicitly included licensed KT&G heat-not-burn products in its portfolio, indicating broader integration beyond internally developed products. This is a significant point about business expansion and product line diversification that the LLM answer misses. Additionally, while the LLM mentions 'wellness and healthcare offerings' in passing, it incorrectly states they are excluded from the smoke-free category, whereas the original answer clarifies they are included in the broader grouping. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the reasoning is logically sound, though slightly incomplete. The answer remains contextually relevant and conveys most of the key information with appropriate synthesis across years and categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 360,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb reinforced its compliance with the SEC Consent Order by enhancing the role and responsibilities of its business risk and disclosure group. The group was established as part of the Consent Order measures to ensure robust governance and transparency. In 2024, the company emphasized continued adherence to the Consent Order by maintaining procedures to monitor and limit sales to direct customers, as well as by escalating and resolving compliance concerns through its governance process. The business risk and disclosure group played a central role in these efforts, ensuring that financial reporting and risk management practices aligned with the Consent Order requirements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and overall narrative. It correctly identifies that the business risk and disclosure group was established in response to the SEC Consent Order and played a central role in compliance governance. The answer accurately reflects that in 2024, the group remained active and integral to ongoing compliance, with continued procedures for escalating and resolving compliance issues. However, the LLM omits specific details mentioned in the original answer, such as the formal review and certification process for SEC filings, the retention of an outside consultant to re-engineer accounting processes, and the explicit integration of the group into the ongoing compliance framework. While the LLM captures the continuity and reinforcement of the group’s role, it does not fully convey the structural enhancements implemented in 2023 or confirm the absence of modifications in 2024. There are no numerical inaccuracies (quantitative accuracy is perfect, as no numbers are misstated), and all entities (Bristol-Myers Squibb, SEC Consent Order, business risk and disclosure group) are correctly identified. The reasoning is sound and contextually appropriate, but the answer falls slightly short in completeness regarding the multi-hop synthesis of governance evolution across the two years. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 416,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix remained consistent between 2023 and 2024, with the expected long-term rate of return on plan assets maintained at 5.25%. The asset allocation strategy also remained stable, with equity securities allocated between 20% to 30% and debt securities between 70% to 80%. The company continued to use its asset allocation mix and historical returns, adjusted for current and expected market conditions, to determine the expected return.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The original answer states that UNP changed its disclosure language and approach between 2023 and 2024—specifically, moving from a more comprehensive explanation of expected return (including asset allocation, historical returns, and market conditions) with a disclosed actual return of 6% in 2023, to a narrower statement in 2024 that the expected return 'depends on' asset allocation alone, with no mention of other factors or the actual return. The LLM incorrectly asserts that the treatment 'remained consistent,' which directly contradicts the ground truth. (2) Quantitatively, the LLM introduces a specific expected long-term return of 5.25%, which is not mentioned in the original answer, nor is it supported by the provided ground truth. Similarly, the allocation ranges (20%-30% equity, 70%-80% debt) are fabricated and not present in the original. The actual return of 6% in 2023 is omitted entirely. (3) The multi-hop reasoning is flawed: the question asks for an evolution in treatment, requiring comparison across years and analysis of changes in disclosure language and content. The LLM fails to detect or report the shift in language and scope of factors, instead asserting stability without evidence. (4) The answer is contextually relevant in that it discusses pension plan expected returns and asset allocation, but it fabricates details and misses the central point of change over time, resulting in a largely incorrect response. Minor credit is given for addressing the general topic correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 435,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon enhanced the accessibility and integration of its Directors' Code of Conduct by explicitly listing it among the corporate governance materials made available on its website. In the 2023 10-K (page 2), the Directors' Code of Conduct is directly referenced as one of the key governance documents accessible to the public, alongside other materials like the Corporate Governance Guidelines and Committee Charters. This reflects a more centralized and transparent approach to corporate governance reporting compared to the 2022 10-K, where the disclosure was less prominently featured and required cross-referencing to external sources.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies the evolution in BNY Mellon's disclosure approach between 2022 and 2023: in 2022, the Directors' Code of Conduct was mentioned with applicability to directors and website posting, while in 2023 it was more prominently listed among key governance documents like Corporate Governance Guidelines and committee charters. The LLM correctly notes the enhanced accessibility and integration into a centralized governance framework. The mention of 'page 2' in the 2023 10-K is a minor addition not in the original answer, but does not contradict it and plausibly supports the claim. There are no errors in entities (BNY Mellon, Directors' Code of Conduct, Corporate Governance Guidelines, Committee Charters), years (2022, 2023), or reasoning. The answer captures the multi-hop synthesis—comparing two years’ disclosures and inferring improved transparency and structure. Wording differs slightly (e.g., 'less prominently featured' vs. 'referenced in the context of broader corporate governance disclosures'), but the semantic meaning is equivalent. No calculations or numeric data are involved, so quantitative accuracy is scored as 10 by default. One point was deducted from qualitative accuracy only because the LLM implies the 2022 disclosure 'required cross-referencing to external sources,' which is not stated or implied in the original and slightly overreaches; otherwise, reasoning is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 410,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with engineered systems. The company has expanded deployment options for Oracle Database to include on-premise, Oracle Cloud Infrastructure (OCI), and hybrid environments such as Oracle Exadata Cloud@Customer and OCI Dedicated Region. This evolution reflects Oracle's commitment to supporting cloud migration and hybrid IT environments by offering consumption-based pricing, automated scaling, and seamless integration with Oracle's AI and middleware services. The focus on engineered systems like Oracle Exadata Database Machine further underscores Oracle's strategy to deliver optimized, secure, and high-performance solutions tailored for both cloud and on-premise needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and strategic interpretation. (1) It accurately captures Oracle's emphasis on deployment flexibility in both 2023 and 2024, correctly naming key offerings such as Oracle Exadata Cloud@Customer and referencing hybrid and on-premise deployments. The mention of engineered systems like Oracle Exadata Database Machine is accurate and relevant. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors in this regard, scoring a 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes Oracle's evolution from flexible deployment models to integrated engineered systems and correctly infers that this reflects a strategic focus on optimized, secure, high-performance solutions for hybrid and cloud environments. However, it omits specific mention of the 'Roving Edge Infrastructure' from 2023 and does not explicitly contrast the 2023 'flexibility-first' approach with the 2024 'integration-first' shift as clearly as the original answer. Also, while OCI Dedicated Region is mentioned, it was not in the ground truth, which focused on Cloud@Customer—this is a minor factual overreach but not a major error. (4) The answer remains highly contextually relevant, addressing all core aspects of the question: deployment flexibility, integration with engineered systems, cloud migration, and hybrid IT strategy. The omission of nuanced evolution language and one or two specific product names prevents a perfect score, but the overall qualitative accuracy is strong. Thus, correctness is rated 8 for minor completeness gaps despite strong factual and reasoning alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 478,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb (BMY) enhanced its formal review and certification process for annual and quarterly SEC reports by reinforcing compliance monitoring and governance procedures. The company maintained its established measures, including a formal certification process, a business risk and disclosure group, and external consultant oversight. In 2024, BMY further emphasized compliance by maintaining regular monitoring of its sales practices and inventory management procedures to ensure adherence to the SEC Consent Order. These efforts reflect a continued commitment to transparency and regulatory compliance.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces a company (Bristol-Myers Squibb, BMY) not mentioned in the original answer, which does not specify the company name. This is a critical entity error, as the ground truth does not identify the firm, making the LLM's attribution to BMY unsupported and factually questionable. While the description of the evolution—continued emphasis on compliance monitoring, governance procedures, and integration with sales and inventory controls—aligns generally with the original answer's narrative of sustained enforcement and integration by 2024, the LLM fabricates specific structures like the 'business risk and disclosure group' and 'external consultant oversight' that are not present in the ground truth. The timeline (2023 implementation under a Consent agreement, ongoing monitoring in 2024) is accurately reflected, and there are no numerical inaccuracies (quantitative accuracy is high due to absence of incorrect figures). However, the reasoning is compromised by unsupported entity-specific claims, weakening the multi-hop synthesis. The answer is contextually relevant and addresses the evolution of compliance monitoring and governance, but lacks fidelity to the source data. Thus, while semantically similar in structure and intent, it fails on entity accuracy and introduces unverified details, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 383,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) has increasingly positioned heat-not-burn (HNB) products as a core component of its smoke-free product portfolio, with a notable rise in shipments and market presence. In 2023, PMI reported a 14.7% increase in heated tobacco unit (HTU) shipments compared to 2022, driven by growth across all regions, particularly in Europe and Japan. The company categorizes HNB products under its \"smoke-free products\" segment, which includes heat-not-burn, e-vapor, and oral nicotine products, and reported total smoke-free product net revenues of $12.84 billion in 2023, up from $10.19 billion in 2022. This reflects PMI's strategic shift toward expanding its reduced-risk product offerings and reinforcing its market positioning in the evolving tobacco and nicotine landscape.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of PMI's positioning of heat-not-burn (HNB) products from 2022 to 2023, noting the inclusion of HNB within the broader 'smoke-free products' segment alongside e-vapor and oral nicotine products, which aligns with the ground truth. It also captures the strategic shift toward commercialization and expansion. However, it introduces specific quantitative claims not present in the original answer or supported by the provided ground truth: namely, the 14.7% increase in heated tobacco unit (HTU) shipments and the exact net revenue figures of $12.84 billion in 2023 and $10.19 billion in 2022. These numbers, while plausible, are not part of the ground truth and thus represent unsupported additions. (2) The quantitative accuracy is reduced because these figures and percentage changes cannot be verified against the original answer, which contains no numerical data. The model fabricates precise financial metrics and growth rates, which constitutes a significant deviation despite the thematic plausibility. (3) The qualitative reasoning is strong: the model correctly synthesizes the shift in product categorization and market positioning, understands the multi-hop nature of the question (evolution over time, changes in categorization and strategy), and draws a reasonable conclusion about PMI’s strategic direction. It correctly identifies the integration of HNB into a broader smoke-free category, which matches the ground truth. However, it omits the key detail about PMI including licensed KT&G heat-not-burn products in its portfolio—a specific indicator of expanded partnerships mentioned in the original answer. This is a meaningful omission in completeness. (4) Contextual relevance is high because the response directly addresses the question’s focus on market positioning and product categorization over the 2022–2023 period. The structure and flow are appropriate, and the core message aligns with the ground truth, even if augmented with unverified numbers. Overall, the answer gets the strategic narrative right but undermines its correctness with unsupported quantitative claims and a missing key detail about KT&G licensing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 593,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with other Oracle technologies. The 2024 filing highlights Oracle Database's availability across diverse IT environments, including Oracle Cloud, Oracle Exadata Cloud@Customer, OCI Dedicated Region, and other public cloud services. Additionally, Oracle has strengthened integration with Oracle Cloud Infrastructure (OCI), Oracle Autonomous Database, and Oracle Middleware, enabling seamless hybrid and multicloud deployment models. These advancements reflect Oracle's commitment to providing customers with adaptable solutions that align with evolving enterprise IT needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2023 to 2024) and correctly identifies Oracle Database's deployment flexibility across environments, including Oracle Cloud, Exadata Cloud@Customer, and OCI Dedicated Region. It also accurately notes deeper integration with Oracle Cloud Infrastructure (OCI), Autonomous Database, and Middleware, which aligns with the evolution toward integration with Oracle technologies. However, the LLM answer omits a key element from the ground truth: the strategic shift positioning Oracle Database as a foundational component of Oracle Engineered Systems like Oracle Exadata Database Machine, which integrates hardware, storage, and software for optimized performance. While the LLM mentions Exadata Cloud@Customer, it does not emphasize the broader engineered systems strategy or the transition from a standalone product to a core integrated component, which is central to the 2024 evolution. The answer is semantically close and contextually relevant, with no numerical inaccuracies (quantitative accuracy is perfect as no incorrect figures are presented), but the qualitative reasoning is slightly incomplete due to missing this strategic nuance. Thus, the correctness and qualitative accuracy scores are reduced slightly, but not severely, due to strong overall alignment with the core facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 371,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "BMY's strategic relationship with Krazati evolved significantly from 2023 to 2024 through the acquisition of Mirati in January 2024, which provided BMY with the rights to Krazati, a KRAS inhibitor approved for second-line NSCLC and in development for first-line NSCLC in combination with a PD-1 inhibitor. This acquisition reflects BMY's commitment to expanding its oncology portfolio and accelerating innovation in lung cancer treatments. In 2024, BMY made a financial commitment of $4.8 billion (or $4.1 billion net of cash acquired) for the acquisition of Mirati, which included contingent value rights (CVRs) potentially worth up to $1.0 billion tied to the FDA acceptance of an NDA for the PRMT5 Inhibitor within seven years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $4.8 billion acquisition cost (with $4.1 billion net of cash acquired) and the $1.0 billion in contingent value rights (CVRs) tied to the PRMT5 inhibitor NDA acceptance are correctly reported. The date of the acquisition in January 2024 aligns with the timeline. (2) The answer is complete, addressing both the evolution of BMY's relationship with Krazati—from a portfolio mention in 2023 to full ownership via the Mirati acquisition in 2024—and the specific 2024 financial commitments. (3) Entity accuracy is perfect: BMY, Mirati, Krazati, KRAS inhibitor, NSCLC (second-line and first-line), PD-1 inhibitor, PRMT5 Inhibitor, FDA, and EMA are all correctly identified and contextualized. (4) The multi-hop reasoning is sound: the model correctly infers that BMY’s acquisition of Mirati was the mechanism for obtaining Krazati, links the strategic evolution to regulatory approvals (FDA/EMA), and connects the $1.0 billion CVR to a specific milestone (FDA NDA acceptance within seven years). The answer conveys the same information as the ground truth with equivalent detail and precision, demonstrating full semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 351,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "The 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV are listed in both the 2022 and 2023 10-K filings under the Company's securities registered pursuant to Section 12(b) of the Exchange Act, with the trading symbol BK/P. There is no explicit indication of a change in the status or treatment of these securities between 2022 and 2023 in the provided pages. Both filings confirm the securities are fully and unconditionally guaranteed by The Bank of New York Mellon Corporation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the securities are registered under Section 12(b), listed on the NYSE with symbol BK/P, and fully guaranteed by The Bank of New York Mellon Corporation in both 2022 and 2023. (2) There are no numeric values requiring calculation, but the percentage '6.244%' is correctly stated, and years (2022, 2023) are accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across two years of filings to conclude no change in status or treatment, which aligns with the ground truth. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of the securities’ status. Minor wording differences (e.g., 'no explicit indication of a change' vs 'there was no change') do not affect factual accuracy. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 264,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "From 2022 to 2023, PMI's short-term credit arrangements increased from approximately $1.9 billion to $2.7 billion, while borrowings under these arrangements slightly decreased from $295 million to $283 million. This suggests that PMI has expanded its liquidity buffer by increasing available credit, even as it reduced actual borrowing. The increase in available credit arrangements indicates a stronger near-term liquidity posture, providing PMI with greater flexibility to manage working capital needs or unexpected cash flow requirements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: capacity increased from $1.9 billion in 2022 to $2.7 billion in 2023, and utilization decreased from $295 million to $283 million. These values match the original answer exactly, with acceptable formatting (e.g., 'approximately $1.9 billion' is reasonable given typical reporting conventions). (2) The answer is complete, addressing both the change in capacity and utilization, and drawing the correct implication about PMI's near-term liquidity posture. (3) Entity accuracy is correct—PMI is the focus, and the years 2022 and 2023 are properly referenced. (4) The reasoning is sound: the model correctly synthesizes that increased capacity with decreased utilization indicates a stronger liquidity buffer and more conservative financial management, which aligns with the original conclusion. The LLM conveys the same semantic meaning as the ground truth, with slightly rephrased but equivalent logic and implications. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 312,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Between 2023 and 2024, Oracle's positioning of the Autonomous Database has evolved to emphasize deeper integration with other Oracle Cloud services and enhanced automation capabilities. In 2023, the focus was on the database's self-driving features, such as automated maintenance, tuning, and scaling, along with integration with Java Cloud and Oracle APEX for application development. By 2024, Oracle expanded its emphasis on seamless integration with emerging technologies like generative AI, IoT, and blockchain through OCI, while also enhancing automation with machine learning-driven diagnostics and threat detection. Additionally, Oracle highlighted the deployment flexibility of Autonomous Database, including on-premise and hybrid options like Exadata Cloud@Customer and OCI Dedicated Region, to support diverse customer environments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Oracle's positioning of the Autonomous Database from 2023 to 2024 with respect to integration and automation. It accurately notes the 2023 focus on self-driving features like automated maintenance, tuning, and scaling, which aligns with the ground truth emphasis on automated operations and reduced IT overhead. The mention of integration with Java Cloud and Oracle APEX in 2023 is consistent with the original answer. In 2024, the LLM correctly identifies enhanced automation via machine learning, including diagnostics and threat detection. However, it introduces 'generative AI, IoT, and blockchain' as new integration points in 2024, which are not mentioned in the ground truth; instead, the original answer emphasizes open interfaces, native machine learning, data lake houses, and real-time analytics. These additions represent a factual overreach or misattribution not supported by the source. Additionally, while deployment flexibility (on-premise, hybrid) was part of the 2023 positioning per the ground truth, the LLM implies this was a 2024 enhancement, which misrepresents the timeline. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—scored 10 by default as no errors exist. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes changes over time and identifies key services, but incorrectly infers new integrations (e.g., blockchain, generative AI) not present in the source, weakening the qualitative accuracy. (4) Despite some inaccuracies in specifics, the overall trajectory of increased integration and automation is correct, and the answer remains highly relevant to the question, warranting a 7 for correctness and qualitative accuracy, 9 for contextual relevance, and full marks for quantitative accuracy due to absence of numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 519,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "Between 2023 and 2024, GM's financial relationship with Ultium Cells Holdings LLC remained stable in terms of capital involvement, with committed capital contributions of $0.8 billion at both December 31, 2023, and 2024. However, the maximum exposure to loss slightly decreased from $3.5 billion in 2023 to $3.3 billion in 2024. Strategically, GM continued to position Ultium Cells as a key partner in its battery cell production efforts, maintaining its noncontrolling interest while lacking the power to directly influence the entity's activities that most impact its economic performance. This reflects GM's ongoing investment in battery technology to support its electrification goals without full consolidation or control of Ultium Cells.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that GM's involvement shifted from a contingent commitment of $0.8 billion in 2023 to a realized investment of $0.7 billion in 2024, indicating a strategic evolution. In contrast, the LLM claims GM maintained a stable $0.8 billion commitment in both years, which directly contradicts the ground truth. Additionally, the LLM introduces a 'maximum exposure to loss' of $3.5B and $3.3B, which is not mentioned in the original answer and appears to be fabricated or misattributed information. (2) Quantitatively, the $0.8B figure for 2023 matches, but the claim that it remained $0.8B in 2024 is false—the actual capital involvement changed to a $0.7B direct investment. The $3.5B and $3.3B figures have no support in the ground truth and introduce significant inaccuracies. (3) The multi-hop reasoning fails: the LLM does not recognize the shift from contingent commitment to direct investment, mischaracterizes the nature of GM's involvement, and incorrectly concludes there was stability rather than strategic realignment. It also fails to note the change in strategic positioning implied by moving from a VIE without control to a more direct stake. (4) Contextual relevance is moderate because the answer discusses GM and Ultium Cells in the correct timeframe and touches on strategic positioning, but the core financial evolution is misrepresented. Due to major factual and quantitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 425,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the financial impact of the Litigation Management Deed evolved as follows: in 2022, during the Sixth Anniversary Release, $3.5 billion of as-converted value was released, and 176,655 series A preferred shares were issued. In 2024, during the Eighth Anniversary Release, $2.7 billion of as-converted value was released, and 99,264 series A preferred shares were issued.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: $3.5 billion and 176,655 shares in 2022, and $2.7 billion and 99,264 shares in 2024, matching the ground truth exactly. All numeric values, years, and events (sixth and eighth anniversary releases) are accurate. (2) Quantitative accuracy is perfect—dollar amounts and share counts are correct, and no calculations were required beyond what was provided. Format consistency is appropriate and clear. (3) The multi-hop reasoning is sound, as the model correctly associates the 2022 and 2024 events with their respective releases under the Litigation Management Deed and synthesizes the correct financial metrics across years. However, the LLM omits the interpretive conclusion present in the original answer—specifically, that the decrease in both value and shares suggests a reduction in financial burden over time. While not strictly necessary for correctness, this minor omission slightly affects qualitative completeness. (4) Despite this, the answer is factually complete, contextually precise, and directly addresses both parts of the question (evolution of as-converted value and shares issued). The omission of the interpretive summary does not detract from core accuracy, hence a high score of 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 369,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial and strategic relationship between 3M and the Aearo Entities evolved significantly due to litigation and business adjustments. In 2023, the Aearo Entities voluntarily initiated Chapter 11 bankruptcy proceedings in July 2022, which were dismissed in June 2023, leading to 3M reconsolidating Aearo. This period involved a $1.2 billion pre-tax charge in 2022 for the Combat Arms Earplugs litigation and a $4.2 billion pre-tax charge in 2023 for the CAE Settlement. In 2024, the CAE Settlement was amended to pay $6.0 billion in cash, with payments beginning in September 2023, and 3M recorded a $4.2 billion pre-tax charge. The Aearo Entities remained part of 3M's consolidated operations, with litigation costs related to Aearo impacting the Safety and Industrial segment and Corporate special items.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that the Aearo Entities 'voluntarily initiated Chapter 11 bankruptcy proceedings in July 2022' — while this date may be contextually plausible, the original answer does not mention the initiation date, only the dismissal in 2023, so this detail is unsupported. More critically, the LLM claims a $1.2 billion pre-tax charge in 2022 and a $4.2 billion charge in 2023 for the CAE Settlement, but the ground truth does not specify these exact figures or their timing with such precision. The $6.0 billion amended settlement in 2024 and payments starting in September 2023 are not mentioned in the original answer and appear to be fabricated or misattributed. (2) Quantitative accuracy is low: none of the dollar amounts or charges cited in the LLM answer are present in the ground truth, and the original answer emphasizes that the reconsolidation had an 'immaterial income statement impact,' contradicting the large charges described. (3) The reasoning is partially sound in recognizing the reconsolidation in 2023 and ongoing litigation context, but it fails to capture the key strategic shift in 2024 toward financial treatment in the Transportation and Electronics segment. Instead, it misattributes Aearo-related costs to the Safety and Industrial segment and Corporate special items, which is not supported. The multi-hop synthesis between litigation resolution and segment-level financial reporting is missing. (4) Contextual relevance is moderate because the answer addresses litigation and business adjustments, but it introduces incorrect financial figures and misrepresents the strategic evolution. The core transformation from litigation resolution (2023) to strategic financial reporting (2024) is not accurately conveyed, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 505,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, the financial treatment of Class C Common Stock evolved in terms of its earnings per share (EPS) performance, showing a significant increase. In 2022, the basic EPS for Class C Common Stock was $28.03, which rose to $38.97 in 2024. This increase reflects improved profitability or a reduction in the share count on an as-converted basis. Additionally, the relationship between Class C and other stock classes was influenced by conversion rate adjustments and the release of value tied to litigation settlements, which reduced the as-converted share count and potentially enhanced EPS for Class C holders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the numerical values for earnings per share (EPS). According to the ground truth, in 2024, Class C Common Stock had a basic EPS of $33.17 and diluted EPS of $33.13, not $38.97 as stated by the LLM. Additionally, the LLM claims a 2022 basic EPS of $28.03 for Class C, but the original answer does not provide any EPS figures for Class C in 2022—only a qualitative description of its governance role. Thus, both the 2022 and 2024 EPS numbers in the LLM answer are incorrect and unsupported by the ground truth. (2) The calculation or trend implied (increase from $28.03 to $38.97) is therefore also invalid. The ground truth highlights a comparative performance in 2024 between Class C and Class A EPS, which the LLM fails to mention—Class A had $8.29 basic EPS in 2024, a key point for contextualizing Class C's outperformance. (3) The qualitative reasoning about conversion adjustments and litigation settlements influencing share count and EPS is not present in the original answer and appears to be fabricated or inferred beyond available data. While the question requires multi-hop reasoning across years and stock classes, the LLM invents mechanisms (e.g., litigation settlements) not referenced in the ground truth, undermining the validity of its explanation. (4) Despite these issues, the LLM correctly identifies that Class C’s financial treatment evolved primarily through improved EPS performance and attempts to relate it to structural factors like conversion rates, showing some contextual understanding. However, due to major quantitative errors and unsupported causal claims, the overall correctness is low. The answer is partially relevant but factually unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 480,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "Qualcomm's involvement in the development and commercialization of ADAS/AD technology has evolved significantly from fiscal 2022 to fiscal 2024. In fiscal 2022, Qualcomm's focus on ADAS/AD was primarily through its QCT segment, with investments in R&D for technologies beyond mobile handsets, including ADAS/AD. By fiscal 2024, Qualcomm's engagement in ADAS/AD had expanded, as evidenced by the acquisition of Veoneer's Arriver business in fiscal 2022, which brought autonomous driving software capabilities into Qualcomm's portfolio. This acquisition, combined with continued R&D investments, led to a notable increase in QCT's automotive revenue, which rose from $1,509 million in fiscal 2022 to $2,910 million in fiscal 2024, reflecting stronger commercialization efforts in automotive applications such as connectivity, digital cockpit, and ADAS/AD.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth does not mention any specific revenue figures for QCT's automotive segment in fiscal 2022 ($1,509 million) or fiscal 2024 ($2,910 million), nor does it attribute the evolution of ADAS/AD commercialization to an acquisition of Veoneer's Arriver business. While Qualcomm did acquire Arriver from Veoneer, the knowledge graph does not confirm this occurred in fiscal 2022 or that it directly caused the stated revenue increase. These specific numbers and causal claims are unsupported by the ground truth and appear to be hallucinated or inferred beyond available data. (2) The quantitative accuracy is low because the cited revenues and their implied growth are not present in the original answer, and no calculations or figures were provided in the ground truth to validate them. Even allowing for format flexibility, introducing precise dollar amounts absent from the source constitutes a significant error. (3) Qualitatively, the reasoning is partially sound: the LLM correctly identifies a shift from development to commercialization and ties ADAS/AD to broader automotive revenue growth. It also correctly references strategic activities like R&D and acquisitions as drivers. However, the multi-hop synthesis is flawed—while Arriver may be contextually relevant, its inclusion here goes beyond the provided knowledge graph. The core evolution—ADAS/AD moving from investment phase (2022) to revenue-generating product line (2024)—is accurately captured, which supports a moderate qualitative score. (4) Contextual relevance is high because the answer addresses the question’s focus on strategic evolution and revenue categorization, using appropriate segments (QCT) and timelines. Despite factual inaccuracies, the structure and intent align well with the query. Overall, the answer captures the directional truth but fails on key facts and numbers, warranting a correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 541,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's U.S. Retrospective Responsibility Plan evolved by increasing the U.S. litigation escrow account balance from $1.4 billion to $3.089 billion, primarily through deposits of $1.5 billion in 2024 and $1.0 billion in 2023. The plan's mechanisms, such as the escrow account, loss sharing agreements, and makewhole agreements, remain in place to distribute liability among members and mitigate the financial impact of litigation. This evolution suggests that Visa is proactively managing litigation risk by bolstering financial safeguards and maintaining structured risk-sharing frameworks to address potential future liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth does not mention specific escrow account balances of $1.4 billion or $3.089 billion, nor does it reference $1.5 billion and $1.0 billion deposits in 2024 and 2023. These numbers are entirely fabricated and not supported by the original answer, which only states that in 2022 the plan used a U.S. litigation escrow account without specifying the amount, and that by 2024 the structure had become more complex with additional mechanisms. (2) The quantitative inaccuracies are severe because they introduce precise figures that do not appear in the ground truth, leading to a false sense of specificity. There is no mention of account balances or annual deposits in the original answer, so these values cannot be verified and are incorrect. (3) The qualitative reasoning partially captures the evolution of the plan by noting increased structure and risk-sharing mechanisms like loss sharing and makewhole agreements, which are mentioned in the ground truth. However, it omits key elements such as the U.S. litigation escrow agreement, conversion feature for Class B stock, indemnification obligations, interchange judgment sharing agreement, and omnibus agreement—critical components that demonstrate the plan’s increased complexity. The conclusion about proactive risk management aligns with the original answer’s interpretation, but the reasoning is based on incorrect data. (4) The correctness score is low due to major factual and quantitative errors, despite some correct conceptual framing. Quantitative accuracy is severely compromised. Qualitative accuracy is moderate because the general direction of evolution (more structured, risk-sharing) is correct, but missing key mechanisms limits completeness. Contextual relevance is high as the answer stays focused on the question and attempts to address both the evolution and implications for litigation risk.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 537,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck's financial stake in Lynparza, as reflected in alliance revenue, increased by 9% in 2024 compared to 2023, indicating sustained growth in the product's performance. This growth was primarily driven by higher demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for a new indication, further suggesting its growing strategic importance in key markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the 9% growth in alliance revenue for Lynparza in 2024 compared to 2023, which matches the ground truth. It also accurately notes the January 2025 China approval for an adjuvant early breast cancer indication, confirming regulatory expansion. However, it omits the specific $1.5 billion net intangible asset Merck reported in 2023, which was a key part of the financial stake description in the original answer. This omission slightly reduces completeness but does not affect the core correctness of performance indicators. (2) All numbers and dates are accurate: 9% growth and January 2025 approval are correctly cited. No calculations were required, but the comparison across years is valid. (3) The multi-hop reasoning is sound—linking revenue growth to international demand and connecting the China approval to strategic importance shows proper synthesis across financial and regulatory domains. The only missing link is the initial asset value in 2023, which would have strengthened the evolution narrative. (4) Despite the minor omission, the answer conveys the essential evolution—growth in value via performance and expanded strategic relevance—making it semantically close to the ground truth. Hence, high scores across all dimensions with a small deduction in qualitative accuracy for incomplete financial stake context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 383,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Between 2022 and 2024, Skoal's market position within Altria's oral tobacco products segment declined, as its retail share dropped from 9.3% in 2023 to 7.6% in 2024. This decline was driven by retail share losses in the moist smokeless tobacco (MST) category, while on! oral nicotine pouches gained share, increasing from 6.8% in 2023 to 8.3% in 2024. The overall oral tobacco products segment retail share also decreased from 42.5% in 2023 to 37.5% in 2024, reflecting competitive pressures and a shift in consumer preferences toward nicotine pouches.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Skoal's retail share decline from 9.3% to 7.6% and the rise of on! from 6.8% to 8.3%, as well as the overall segment decline from 42.5% to 37.5%. However, it incorrectly states Skoal's 9.3% share was in 2023, while the ground truth specifies 2022. This misalignment in timing affects the accuracy of the trend interpretation. (2) All numerical values are correct except for the attribution of Skoal's 9.3% share to 2023 instead of 2022. The 2024 figures are accurate. The calculation of share changes is implied and consistent, but the off-by-one year error impacts multi-hop reasoning. (3) The reasoning correctly infers that Skoal lost share amid a shift toward nicotine pouches and overall segment contraction, and it appropriately references competitive dynamics with on!. However, it omits a direct comparison with Copenhagen, which declined from 23.5% to 19.1%, a key point in the original answer that contextualizes Skoal's relative underperformance. (4) Despite the timing error and missing Copenhagen comparison, the answer captures the core trend and competitive shift. Quantitative accuracy is slightly reduced due to the year misattribution, but qualitative reasoning and contextual relevance remain strong as the answer addresses the evolution of Skoal's position and competitive dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 377,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "The revenue contribution from Dynamics 365 within Microsoft Cloud increased from fiscal year 2022 to 2023. In fiscal year 2022, Dynamics products and cloud services revenue grew by 25%, driven by Dynamics 365 growth of 39%. In fiscal year 2023, Dynamics products and cloud services revenue was $6.481 billion, compared to $5.437 billion in 2022, indicating continued strong growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts for Dynamics 365 revenue in 2022 ($5.437 billion) and 2023 ($6.481 billion), which are not present in the original ground truth and cannot be verified from the provided information. These figures represent a significant factual addition not supported by the source. While the 25% growth in Dynamics products and cloud services and the 39% increase in Dynamics 365 in fiscal year 2022 are correctly stated, the exact revenue figures for Dynamics 365 in 2023 are not disclosed in the original answer, making the LLM's precise numbers speculative. (2) The calculation of growth from $5.437B to $6.481B implies an 19.2% increase, which is not confirmed in the ground truth. The original answer only confirms that Dynamics 365 continued to grow but does not provide exact figures or percentages for 2023. (3) The reasoning partially follows the multi-hop structure by connecting Dynamics 365 to Microsoft Cloud revenue across two fiscal years, but it overreaches by asserting specific revenue values not present in the source, undermining the factual integrity. (4) The contextual relevance is high because the answer addresses the evolution of Dynamics 365 revenue contribution as asked. However, the quantitative accuracy is low due to unsupported numerical claims, and the overall correctness score is reduced significantly because the core addition (exact revenue figures) is unverified and likely incorrect, despite some correct qualitative elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 417,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "Merck's Balance Sheet Risk Management Program has expanded in scope and complexity from 2023 to 2024. In 2023, the program primarily used forward exchange contracts to hedge monetary assets and liabilities denominated in currencies like the euro, Japanese yen, and Chinese renminbi, with these contracts not designated as hedges and marked to market through Other (income) expense, net. By 2024, Merck expanded its hedging activities to include additional currencies such as the Swiss franc and increased the use of interest rate swap contracts, which were designated as fair value hedges for fixed-rate debt. Additionally, Merck incorporated more comprehensive net investment hedging strategies, using forward contracts and euro-denominated debt to hedge against foreign exchange rate movements in foreign operations, with unrealized gains and losses recorded in foreign currency translation adjustment within OCI.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of Merck's Balance Sheet Risk Management Program evolution from 2023 to 2024. (1) While it correctly identifies the use of forward exchange contracts in 2023 and their accounting treatment (not designated as hedges, marked to market through Other (income) expense, net), it incorrectly states that the Swiss franc was added in 2024—Swiss franc was already part of the 2023 hedging scope per the original answer. (2) The introduction of 'interest rate swap contracts' and their designation as fair value hedges for fixed-rate debt is entirely fabricated and not mentioned in the ground truth; the original answer specifies no such instruments. (3) The claim about 'net investment hedging strategies using euro-denominated debt' and recording in OCI is incorrect—this type of hedging is not referenced in the original answer, which focuses solely on balance sheet exposure via forwards, put options, and collars. (4) The original answer states that in 2024, Merck introduced purchased local currency put options and collar options, which the LLM fails to mention entirely. Instead, it invents new instruments and strategies. (5) The strategic layering of hedges over time based on cost-benefit assessments—a key qualitative evolution—is omitted. (6) The LLM incorrectly expands the scope to include new instruments (swaps), new accounting treatments (OCI), and new strategies (net investment hedging), none of which are supported by the ground truth. While the answer is structured logically and addresses the general theme of program expansion, the core factual content—especially regarding instruments used and hedging scope evolution—is largely incorrect. Quantitative accuracy is low due to absence of specific numbers (though none were in the original), but the main issue is qualitative: wrong entities, instruments, and reasoning. Contextual relevance is moderate because it attempts to answer the right question about program evolution, but with fabricated details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 550,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "PayPal's involvement with merchant receivables from 2022 to 2024 shows a decline in credit loss provisions and an increase in direct investment in merchant financing products. The allowance for credit losses on merchant receivables decreased from $160 million in 2023 to $113 million in 2024, reflecting improved credit quality in the PayPal Business Loan (PPBL) portfolio. Additionally, PayPal increased its investment in merchant receivables, with the outstanding balance rising from $1.2 billion in 2023 to $1.5 billion in 2024, driven by growth in its merchant finance offerings such as PayPal Working Capital (PPWC) and PPBL.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of increased direct investment in merchant receivables and mentions correct programs (PPWC and PPBL), which aligns with the ground truth. However, it introduces specific figures for credit loss allowances ($160M in 2023 and $113M in 2024) that are not present in the original answer and cannot be verified against the provided ground truth. The original answer discusses a principal and interest coverage ratio of 9% as of December 31, 2021 (down from 23% in 2020), but the LLM does not mention this key metric at all, instead focusing on allowance amounts not referenced in the ground truth. (2) The only verified correct quantitative data is the increase in outstanding receivables from $1.2 billion in 2023 to $1.5 billion in 2024, and the $1.8 billion in receivables purchased in 2024 (though the latter is omitted in the LLM answer). The LLM incorrectly implies that the $1.2B to $1.5B growth occurred from 2023 to 2024 without mentioning the 2022 baseline or the broader shift in strategy over that period. (3) The multi-hop reasoning is partially sound—linking reduced provisions to improved credit quality and tying growth in receivables to product expansion shows logical synthesis—but it fails to capture the full evolution from 2022 to 2024, particularly PayPal’s shift from risk disclosure to active investment. The omission of the 2021 coverage ratio context weakens the longitudinal analysis. (4) The contextual relevance is high because the answer addresses both credit loss provisions and direct investment, but the introduction of unverified numerical claims reduces quantitative accuracy significantly. While the directionality of trends is correct, the absence of key data points and inclusion of unsupported figures limits factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 493,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, the financial significance of smokeable products to MO has shown a mixed trend. Goodwill allocated to smokeable products remained stable at $99 million in 2022 and 2024, indicating no impairment or changes in valuation during this period. However, operating income performance for smokeable products declined slightly, from $10,670 million in 2022 to $10,821 million in 2024, representing a marginal increase despite a decrease in net revenues from $21,756 million in 2023 to $21,204 million in 2024. This suggests that while smokeable products remain a core contributor to operating income, their revenue has faced some pressure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both numbers and trends. It incorrectly states that operating income for smokeable products declined from $10,670 million in 2022 to $10,821 million in 2024, which is logically inconsistent — $10,821M is higher than $10,670M, so this is an increase, not a decline. More critically, the original answer states that operating income was $10,670M in 2023, not 2022, and $10,821M in 2024 — the LLM misattributes the 2023 operating income figure to 2022, creating a false timeline. Additionally, the LLM claims goodwill remained at $99 million in 2024, but the original answer explicitly states that no updated goodwill figure is disclosed for 2024 — thus, asserting it remained at $99 million is unsupported and incorrect. The LLM also introduces net revenues ($21,756M in 2023, $21,204M in 2024) that are not present in the original answer, adding unverified data. (2) Quantitative accuracy is low: operating income years are misassigned, 2024 goodwill is falsely reported as unchanged, and unverified revenue figures are introduced. The only correct numbers are the 2022 goodwill ($99M) and the 2024 operating income ($10,821M), though the latter is misused in context. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution over time due to incorrect year-to-value mappings and introduces unsupported conclusions about revenue pressure and stable goodwill. It misses the original answer’s key insight about shifting reporting focus away from goodwill toward performance metrics. (4) Despite factual inaccuracies, the answer is contextually relevant — it addresses both goodwill and operating income trends and attempts to interpret financial significance. However, due to major quantitative and reasoning errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 499,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "The revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud increased from $13,816 million in fiscal year 2022 to $14,989 million in fiscal year 2023, representing a growth of $1,173 million or approximately 8.5%.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The numbers provided—$13,816 million ($13.816 billion) and $14,989 million ($14.989 billion) for LinkedIn's commercial portion—are not supported by the ground truth. The original answer states that Microsoft Cloud revenue (which includes LinkedIn's commercial portion) was $91.2 billion in FY2022 and $111.6 billion in FY2023. The LLM incorrectly isolates LinkedIn's commercial revenue as if it were separately reported at those amounts, which is not stated or implied in the ground truth. (2) The calculation of $1,173 million growth and 8.5% increase may be mathematically correct based on the numbers given, but it is based on fabricated inputs. (3) The multi-hop reasoning fails: the ground truth does not break out LinkedIn’s standalone commercial revenue within Microsoft Cloud; it only reports the total Microsoft Cloud revenue including LinkedIn. Therefore, the LLM invents granular data that is not present in the source. (4) While the direction of change (growth) aligns with the overall trend in Microsoft Cloud, the LLM misrepresents the scope and magnitude by attributing specific revenue figures to LinkedIn’s commercial segment that are not disclosed. This constitutes a hallucination of precise figures, leading to a very low correctness score. Contextual relevance is moderate because the answer addresses revenue evolution in the right timeframe and general direction, but factual accuracy is severely lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 416,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Between 2023 and 2024, Lynparza's commercialization and market expansion progressed with geographic approvals and revenue growth. In 2023, Lynparza received FDA and Japan's MHLW approvals for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC). By 2024, alliance revenue for Lynparza grew 9%, driven by higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval as adjuvant treatment for germline BRCA-mutated, HER2-negative high-risk early breast cancer, further expanding its global reach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts from the ground truth: 2023 FDA and Japan MHLW approvals for BRCA-mutated mCRPC, 9% alliance revenue growth in 2024, and January 2025 China NMPA approval for adjuvant treatment in high-risk early breast cancer. All entities (Lynparza, FDA, MHLW, NMPA), indications, and timeframes are accurate. (2) Quantitative accuracy is perfect: the 9% revenue growth and correct years (2023, 2024, January 2025) match the original answer exactly. No calculations were required, but the numeric and temporal data are precise. (3) The multi-hop reasoning is sound—information is synthesized across regulatory approvals and revenue performance across years and geographies. The only minor omission is that the 2023 approval was specifically in combination with abiraterone and prednisone/prednisolone based on the PROpel trial, and the 2025 approval was based on the OlympiA trial; these trial names and combination therapy details are missing but do not alter the core factual accuracy. (4) The answer is contextually fully relevant, directly addressing geographic approvals and revenue growth as asked. The omission of trial names and combination therapy details slightly affects qualitative completeness but not overall correctness, justifying a 9/10 on qualitative accuracy and 9/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 375,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "RTX's financial treatment of the Powder Metal Matter resulted in a decrease in the future income tax benefits related to this matter between 2023 and 2024. In 2023, the Powder Metal Matter contributed $644 million to future income tax benefits, while in 2024, this amount was reduced to $455 million. This reduction indicates a decline in the anticipated tax benefits associated with the Powder Metal Matter in the subsequent year.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in financial treatment of the Powder Metal Matter from 2023 to 2024 in terms of future income tax benefits, with accurate dollar amounts: $644 million in 2023 and $455 million in 2024. The direction and magnitude of the change (a decrease) are correctly stated. However, the original answer notes a key qualitative shift in treatment—from being a reduction in sales in 2023 to being classified under future income tax benefits in 2024—which the LLM answer omits. This is a significant conceptual point that changes the interpretation of the financial impact and represents a multi-hop synthesis failure. (2) Quantitatively, the numbers are accurate and consistent with the ground truth. The decrease of $189 million and the 29.3% reduction are implied by the figures but not explicitly calculated in the LLM answer; however, the omission of the percentage is not a factual error, just a lack of completeness. (3) The reasoning is partially sound: the LLM correctly interprets the tax benefit amounts across years but fails to recognize and communicate the shift in accounting treatment (from sales reduction to tax benefit), which is central to how the financial treatment evolved. This undermines the qualitative accuracy despite numerical correctness. (4) Contextual relevance is high because the answer addresses the core question about changes in financial treatment related to future tax benefits, but the missing conceptual shift limits completeness and reasoning depth. Thus, correctness is reduced to 7 due to the omission of a key multi-hop insight, even though the quantitative core is solid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 454,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "The borrowing capacity of the Paidy Credit Agreement increased from ¥50.0 billion (approximately $355 million) in 2022 to ¥90.0 billion (approximately $574 million) by 2024, following a modification in September 2022. As of December 31, 2024, the full ¥90.0 billion was drawn down, leaving no available borrowing capacity. The terms of the agreement, including interest rates based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60%, remained consistent, with the agreement set to terminate in February 2027.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the 2022 borrowing capacity. The ground truth states the 2022 secured revolving credit facility was approximately $198 million (not ¥50.0 billion or $355 million as claimed). The $198 million figure is materially different from $355 million, making this a significant quantitative error. Additionally, the LLM claims the full ¥90.0 billion was drawn down as of December 31, 2024, leaving no available capacity—this detail is not present in the original answer and is unsupported. (2) The 2024 borrowing capacity of ¥90.0 billion (~$574 million) and the interest rate (TIBOR + 0.40%–0.60%) are correctly reported, as is the February 2027 maturity. However, the claim that terms 'remained consistent' is incorrect—the original answer states the facility was restructured from secured to unsecured and added a financial covenant (maximum consolidated leverage ratio), both major changes. The LLM incorrectly implies continuity in terms when there was significant evolution. (3) The multi-hop reasoning is partially sound—information is synthesized across years and terms—but fails in key areas: it misrepresents the 2022 capacity and omits critical structural changes (secured to unsecured, new covenant). The September 2022 modification is not mentioned in the ground truth, introducing an unsupported event. (4) Despite these issues, the answer addresses the core question about evolution in capacity and terms, correctly identifying the 2024 figures and maturity, hence a moderate score. Quantitative accuracy is low due to incorrect dollar amounts and unsupported drawdown claim. Qualitative accuracy is moderate due to correct identification of some terms but failure to capture key changes. Contextual relevance is high as the response stays focused on the evolution of the credit agreement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 508,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Between 2022 and 2024, Altria reduced its total long-term debt while continuing to utilize long-term senior unsecured notes as part of its capital structure. In 2022, Altria had $28.0 billion in total debt, and by 2024, this had decreased to $24.9 billion. During this period, Altria issued new long-term senior unsecured notes, such as the $1.0 billion issuance in February 2025, to refinance maturing debt and manage its debt profile. The weighted-average coupon interest rate on total long-term debt slightly increased to 4.3% in 2024 from 4.0% in 2022, reflecting changes in market conditions and refinancing activities. Overall, Altria maintained a strategic approach to its debt management, leveraging long-term senior unsecured notes to optimize its capital structure and liquidity.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and omits key information from the ground truth. While it correctly identifies that Altria used long-term senior unsecured notes in both 2022 and 2024, it introduces incorrect quantitative data not present in the original answer. For example, the claim that total debt decreased from $28.0 billion in 2022 to $24.9 billion in 2024 is not supported by the ground truth, which does not provide total debt figures. Similarly, the mention of a $1.0 billion note issuance in February 2025 is factually problematic because it refers to a future event beyond the 2024 timeframe and is not mentioned in the original answer. The weighted-average coupon increase from 4.0% to 4.3% is also absent from the ground truth and thus cannot be verified as correct. (2) The only numbers in the original answer are cash and cash equivalents ($4.5B in 2022, $3.1B in 2024) and the $3.0B Credit Agreement—none of which are mentioned in the LLM response. The absence of these key figures significantly undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound in that the model attempts to assess evolution in capital structure, but it fails to synthesize the correct inference: the reduction in cash reserves implies potentially increased reliance on external financing like unsecured notes. Instead, the LLM focuses on unsubstantiated debt reduction and refinancing activity, missing the core analytical point. (4) Contextual relevance is high because the answer addresses Altria’s use of long-term senior unsecured notes over time and ties it to capital structure strategy. However, due to significant factual inaccuracies, omissions of key data (cash levels), and introduction of unsupported figures, the overall correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 497,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "RTX's financial treatment of the Powder Metal Matter shifted from a $644 million deferred tax asset in 2023 to $455 million in 2024, indicating a reduction in its associated tax benefits. This decline suggests that the company's expected future tax benefits from this matter have diminished, likely due to adjustments in the valuation or resolution of related uncertainties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key financial figures—$644 million in 2023 and $455 million in 2024—for RTX's tax benefits related to the Powder Metal Matter, matching the ground truth exactly. These numbers are presented accurately with correct years and dollar amounts, satisfying quantitative accuracy. (2) The calculation of a decline from $644M to $455M is implied and correct, though no explicit arithmetic is performed. The direction and magnitude of change are properly conveyed. (3) The reasoning is sound: the LLM correctly infers that the reduction indicates diminished future tax benefits, which aligns with the ground truth's interpretation. It adds a plausible explanation—'adjustments in the valuation or resolution of related uncertainties'—that is reasonable and consistent with financial reporting practices, though this specific rationale is not in the original answer. This addition does not contradict but slightly extends the ground truth, which is acceptable under semantic equivalence. (4) All entities—RTX, Powder Metal Matter, years 2023 and 2024, and the concept of future income tax benefits—are correctly identified and synthesized. The answer fully addresses both parts of the question: the evolution between years and the implication for future tax benefits. The only reason for not scoring a 10 is that the original answer emphasizes the 'reduced financial benefit over time' without speculating on causes, while the LLM introduces a minor interpretive element. However, this does not detract from factual correctness. Thus, the answer is factually complete, quantitatively precise, contextually relevant, and logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 457,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "PayPal's utilization of the Paidy Credit Agreement evolved significantly between 2022 and 2024. In 2022, the agreement had a borrowing capacity of approximately $198 million, with $98 million drawn down as of December 31, 2021. By 2024, the Paidy Credit Agreement was modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and the full amount was drawn down during the year, leaving no available borrowing capacity as of December 31, 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key numbers are correct: $198 million borrowing capacity in 2022, $98 million drawn down as of December 31, 2021 (correctly contextualized for 2022 usage), and by 2024, increased capacity of ¥90.0 billion (~$574 million) with full drawdown. The conversion from yen to dollars is appropriately noted and matches the time-specific exchange rate implied in the ground truth. (2) Quantitative accuracy is perfect: the 2022 available capacity (~$100 million) is correctly implied by the difference between $198M and $98M, and the 2024 full drawdown leaving zero available is accurately stated. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across years and entities (PayPal, Paidy Credit Agreement), tracks changes in borrowing capacity and utilization over time, and infers increased reliance. (4) The answer addresses all parts of the question: evolution of borrowing capacity, actual drawdown, and implications over the 2022–2024 period. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or logical errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 325,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "From 2023 to 2024, Accenture plc maintained its ownership structure where Accenture Canada Holdings Inc. exchangeable shares remained redeemable or exchangeable on a one-for-one basis for Accenture plc Class A ordinary shares. Noncontrolling interests in Accenture Canada Holdings Inc. held by current and former Accenture Leadership members were less than 1% as of August 31, 2024. In fiscal 2024, Accenture plc repurchased a small number (47,752) of Accenture Canada Holdings Inc. exchangeable shares for $15,254, indicating minimal changes in the equity relationship between the entities during the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly states that noncontrolling interests were less than 1% as of August 31, 2024, aligning with the ground truth. It also accurately describes the one-for-one exchangeability of Accenture Canada Holdings Inc. exchangeable shares for Accenture plc Class A ordinary shares. However, it introduces a specific repurchase of 47,752 exchangeable shares for $15,254 in fiscal 2024, which is not mentioned in the original answer and cannot be verified from the provided ground truth. This addition of unverified quantitative data undermines factual accuracy. (2) The dollar amount of $15,254 for 47,752 shares implies an average price of about $0.32 per share, which is unrealistically low for a company like Accenture and suggests a potential data error or misinterpretation. No such transaction appears in the ground truth, making this a significant quantitative inaccuracy. (3) The reasoning partially captures the evolution in equity structure but fails to mention the key qualitative development in 2024: the formal linkage between exchangeable shares and Accenture plc Class X ordinary shares, including the restriction that Class X shares must not fall below the number of exchangeable shares. This is a critical multi-hop element showing structural evolution, which the LLM omits. (4) While the answer is contextually relevant and addresses ownership and exchange mechanisms, the inclusion of unsupported numerical data and omission of key structural details (Class X shares) reduces correctness. The core idea of minimal change is partially valid, but the explanation lacks the depth of structural formalization emphasized in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 472,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Between 2022 and 2024, Merck's approach to managing balance sheet risk through forward exchange contracts has evolved in terms of currencies and cost-benefit considerations. In 2022, the company primarily focused on developed country currencies like the euro, Japanese yen, British pound, Canadian dollar, and Swiss franc, while entering into forward contracts for developing country currencies such as the Chinese renminbi only when a cost-benefit analysis deemed it economical. By 2024, the list of currencies remained similar, but the company refined its cost-benefit analysis to include more granular assessments of exposure magnitude, exchange rate volatility, and hedging instrument costs, particularly for the euro, Swiss franc, Japanese yen, and Chinese renminbi. Additionally, Merck continued to use euro-denominated notes as economic hedges of net investment in foreign operations, though the pretax losses from these contracts decreased from $296 million in 2022 to $192 million in 2024, indicating a potential improvement in alignment with exchange rate movements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, Merck hedged both developed and developing country currencies, with specific mention of the Chinese renminbi, and used a cost-benefit analysis for developing markets. By 2024, the detailed discussion of cost-benefit analysis and specific mention of the renminbi were omitted, suggesting a simplification or shift in focus. In contrast, the LLM claims that in 2024, Merck *refined* its cost-benefit analysis to include more granular assessments—this is the opposite of the ground truth, which indicates a reduction in detail. Additionally, the LLM introduces specific pretax loss figures ($296M in 2022, $192M in 2024) and claims about euro-denominated notes and their losses decreasing, which are not present in the original answer and cannot be verified from the provided ground truth. These numbers and claims are entirely fabricated or misattributed. (2) Quantitative accuracy is very low because the dollar amounts and their trends are incorrect and unsupported. There is no mention in the ground truth of pretax losses from forward contracts or their change over time, so these figures fail verification. (3) The multi-hop reasoning is flawed: instead of recognizing the *omission* of cost-benefit details in 2024 as a sign of potential simplification, the LLM incorrectly infers increased granularity. This misrepresents the evolution of Merck's approach. The synthesis across years is therefore invalid. (4) Contextual relevance is moderate because the answer addresses balance sheet risk, forward contracts, currencies like the renminbi and euro, and cost-benefit considerations—but the factual core is wrong, undermining overall correctness. The inclusion of plausible-sounding but incorrect details reduces trustworthiness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 500,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggests a reduction in its financial impact on future income tax benefits. In 2023, the Powder Metal Matter contributed a $644 million future income tax benefit, while in 2024, this benefit decreased to $455 million. This decline indicates that the anticipated tax benefits associated with the matter have diminished, likely due to ongoing legal or regulatory developments affecting the resolution of the issue.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the timeline and nature of the Powder Metal Matter's financial impact. It incorrectly states that in 2023, the Powder Metal Matter contributed a $644 million future income tax benefit. However, according to the ground truth, in 2023 the matter was disclosed as a $5.3 billion net sales charge (operational loss), not a tax benefit. The $644 million figure was the 2023 value of the future income tax benefit, which decreased to $455 million in 2024 — this part is correctly reported. However, the LLM misrepresents the 2023 context by omitting the $5.3 billion operational impact and incorrectly framing the $644 million as an existing tax benefit in 2023, rather than part of a deferred tax asset carryforward. (2) Quantitatively, the $644 million (2023) and $455 million (2024) figures are accurate and correctly compared as decreasing, but the absence of the $5.3 billion charge — a key financial figure — severely undermines completeness and accuracy. The LLM fails to mention the shift from an operational loss to a tax asset, which is central to the reasoning. (3) The multi-hop reasoning is flawed: the model does not synthesize the change in disclosure from an operational impact (sales charge) in 2023 to a tax asset in 2024. Instead, it assumes the tax benefit existed in 2023 as such, missing the evolution in accounting treatment. This undermines the qualitative accuracy of the interpretation. (4) Despite the reasoning flaws, the answer is contextually relevant — it addresses the question about the change in financial impact on future income tax benefits and correctly notes the decrease in the tax benefit value. Hence, partial credit is given for correctly identifying the reduction in tax benefit from $644M to $455M, but major deductions apply for misrepresenting the 2023 financial reality and omitting the shift from operational loss to tax asset treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 526,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "PayPal's involvement in the merchant receivables space between 2022 and 2024 has grown significantly, both in terms of scale and partnership structure. In 2022, PayPal's merchant finance offerings included products like PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL), with $1.7 billion in merchant receivables purchased during the year, and an outstanding balance of $1.2 billion as of December 31, 2023. By 2024, PayPal expanded its offerings, purchasing $1.8 billion in merchant receivables and increasing the outstanding balance to $1.5 billion as of December 31, 2024. PayPal continues to partner with institutions such as WebBank in the U.S., purchasing receivables from them and servicing the portfolios. The company also enhanced its credit risk management practices, with an improved credit quality of the merchant receivables portfolio reflected in a reduced allowance for credit losses from $160 million in 2023 to $113 million in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that PayPal purchased $1.7 billion in merchant receivables in 2022, but the ground truth does not specify the amount purchased in 2022—only that $1.7 billion was purchased in 2023. Similarly, the LLM claims the outstanding balance was $1.2 billion as of December 31, 2023, which is correct, but incorrectly attributes this figure to 2022 in the narrative flow, creating a misleading timeline. The $1.8 billion purchase in 2024 and $1.5 billion outstanding balance as of December 31, 2024, are accurate. However, the LLM introduces new information not present in the ground truth: a reduction in allowance for credit losses from $160 million in 2023 to $113 million in 2024. This data point is unsupported by the original answer and represents a significant factual addition. (2) The participation interest sold to the partner institution—$53 million in 2024 vs $44 million in 2023—is completely omitted, which is a key indicator of evolving institutional collaboration. This omission undermines the completeness of the response regarding PayPal's relationship with partner institutions. (3) The qualitative reasoning is partially sound: the LLM correctly identifies the ongoing partnership with WebBank and the structure of receivables purchases and servicing. It also captures the growth trend in scale. However, it fails to explain the accounting treatment (derecognition of participation interests) mentioned in 2022, which is a critical aspect of the evolution in PayPal’s relationship with partner institutions. The multi-hop synthesis is incomplete—while scale is addressed, the structural evolution in partnerships is underdeveloped. (4) Contextual relevance is high, as the answer focuses on the right domain, products, and trends. However, due to significant quantitative errors and omission of key partnership metrics, the correctness score is reduced to 6. Quantitative accuracy is scored low (5) due to incorrect attribution of figures to years and introduction of unsupported data. Qualitative accuracy is moderate (7) because core concepts are understood but not fully or accurately detailed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 598,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck's alliance revenue from Lynparza increased by 9% in 2024 compared to 2023, and by 17% overall from 2022 to 2024. This growth was primarily driven by higher demand in most international markets. Additionally, in January 2025, Lynparza received approval in China as an adjuvant treatment for a specific type of early breast cancer, which is expected to further support its sales growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces significant inaccuracies. The ground truth states that Merck's alliance revenue from Lynparza was $989 million in 2022 and grew by 9% by 2024. The LLM incorrectly claims a 9% increase from 2023 to 2024 and a 17% total increase from 2022 to 2024. There is no mention in the original answer of a 17% cumulative increase or a year-over-year 9% increase in 2024 versus 2023 — the 9% is explicitly from 2022 to 2024. This represents a critical quantitative error. (2) The approval in China in January 2025 is correctly mentioned and aligns with the ground truth, as is the indication (adjuvant treatment in early breast cancer based on OlympiA). However, the LLM frames this as 'expected to further support sales growth,' which is a reasonable inference but not explicitly stated in the original. (3) The reasoning partially captures the multi-hop nature: it connects international demand to revenue growth and references a future approval as a contributing factor. However, it fabricates a two-step growth breakdown (9% from 2023–2024 and 17% total) not present in the source, undermining the quantitative reasoning. (4) The contextual relevance is high — all information pertains directly to the question. Qualitative accuracy is moderate because entities (Lynparza, Merck, China approval, international demand) are correct, but the synthesis includes unsupported calculations. Quantitative accuracy is low due to incorrect percentages and lack of base-year clarity. Correctness score is 6 because core drivers (international demand, China approval) are right, but the financial evolution is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 459,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal's involvement in merchant receivables from 2022 to 2024 shows a significant improvement in financial exposure and operational performance. By 2024, the allowance for credit losses on merchant receivables decreased to $113 million from $160 million in 2023, reflecting improved credit quality in the portfolio. Additionally, the percentage of current merchant receivables increased to 90.4% in 2024 compared to 87.0% in 2023, while delinquency rates and net charge-off rates declined, indicating better risk management and operational performance. These improvements suggest PayPal has effectively mitigated risks and enhanced the stability of its merchant finance offerings during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and focus. The original answer emphasizes PayPal's evolving operational and financial role in merchant receivables through direct purchases and servicing, with specific figures: $1.8B purchased in 2024 (up from $1.7B in 2023) and a growing outstanding balance of $1.5B (up from $1.2B). In contrast, the LLM answer discusses credit loss allowance decreasing from $160M to $113M and delinquency metrics improving, which are not mentioned in the ground truth and contradict the narrative of expanding exposure. These numbers appear fabricated or misattributed. (2) Quantitative accuracy is very low: none of the LLM's numbers (e.g., $113M allowance, 90.4% current receivables) appear in the ground truth. The ground truth does not provide any data for 2022 on allowances or delinquency rates, nor does it mention improvements in credit quality. The LLM invents metrics rather than reporting the actual shift in business model. (3) The multi-hop reasoning is flawed. The question asks about evolution in financial exposure and operational role. The ground truth identifies a strategic shift: from passive risk accounting (CECL) in 2022 to active purchasing and servicing by 2024. The LLM instead assumes the evolution is about improving credit performance, missing the core transformation in business model and operational engagement. It fails to mention PPWC, PPBL, servicing responsibilities, or receivables purchases—key elements in the original. (4) Contextual relevance is moderate because the answer discusses merchant receivables and risk trends, which are related, but it misses the central theme of PayPal becoming a direct purchaser and servicer. The answer is plausible-sounding but factually misaligned. Correctness score is low due to major factual and conceptual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 502,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "Merck's involvement in the development and commercialization of Lynparza from 2022 to 2024 has shown steady regulatory and commercial progress. In 2022, Lynparza was under regulatory review for adjuvant treatment of BRCA-mutated, HER2-negative early-stage breast cancer, with a PDUFA date set for Q1 2022. By 2024, alliance revenue from Lynparza had grown 9%, driven by higher demand in international markets. Additionally, in January 2025, China's NMPA approved Lynparza as adjuvant treatment for germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, marking a significant regulatory expansion. This reflects both ongoing collaboration with AstraZeneca and continued global market expansion for Lynparza.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key facts from the ground truth. It accurately states that in 2022, Lynparza was under FDA review for adjuvant treatment of BRCA-mutated, HER2-negative high-risk early breast cancer with a PDUFA date in Q1 2022. It correctly reports the 9% growth in alliance revenue in 2024 due to international demand. It also accurately notes the January 2025 approval by China's NMPA (referred to as NMPA, which is correct) for the same indication based on the OlympiA trial. (2) Quantitatively, all numbers and dates are correct: 9% revenue growth in 2024, PDUFA in Q1 2022, and approval in January 2025. The mention of January 2025 is consistent with the original answer’s forward-looking regulatory momentum, even though the question period ends in 2024—this is acceptable as it reflects the outcome of ongoing efforts through 2024. (3) The reasoning is sound and reflects multi-hop synthesis: the answer connects regulatory developments (FDA review in 2022 → China approval in 2025) with commercial performance (9% revenue growth), demonstrating evolution over time. It also correctly implies the AstraZeneca collaboration through 'alliance revenue,' which is contextually accurate. (4) The only minor shortcoming is that the original answer emphasizes 'continued global regulatory momentum' as a trend through 2024, while the LLM answer presents the China approval as a discrete event slightly beyond the timeframe (January 2025). However, since regulatory approvals are often the result of submissions made in prior years, and the original answer itself references the 2025 approval as evidence of 2024 momentum, this does not constitute a factual error. Wording differences are semantically equivalent and do not affect accuracy. Scores reflect high correctness with near-perfect quantitative and contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 505,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Between 2022 and 2024, Boeing extended the risk management horizon for its commodity purchase contracts, with hedging now covering forecasted transactions through 2028, up from previous periods. Additionally, the financial exposure related to commodity contracts decreased, as evidenced by lower unrealized losses (e.g., a 10% market price change would have resulted in $46 million in unrealized losses in 2021, but the 2024 notional amounts and fair values suggest reduced exposure). Boeing continues to use commodity swaps and purchase contracts to hedge against price volatility, maintaining a strategy to offset potential unfavorable market price changes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly notes Boeing's use of commodity swaps and purchase contracts for hedging, it incorrectly states the hedging horizon extends through 2028, whereas the original answer specifies 2031—a significant discrepancy in time frame. Additionally, the LLM references '2021' for the $46 million unrealized loss impact, but the ground truth states this figure was disclosed in 2022, not 2021, introducing a factual error in year attribution. (2) The $46 million figure itself is accurate, but its misattribution to 2021 undermines quantitative accuracy. The claim of 'reduced exposure' in 2024 based on 'notional amounts and fair values' is unsupported by the original answer, which does not mention a decrease in financial exposure—only an extension of hedging horizon. Thus, the inference of lower exposure lacks grounding. (3) The reasoning partially captures the evolution in Boeing’s strategy—extending the hedging horizon—but fails to fully synthesize the multi-hop insight that this shift aligns with extended production planning cycles and represents a strategic move toward multi-decade cost predictability. The conclusion about reduced financial exposure is speculative and contradicts the original answer’s emphasis on broader, not necessarily smaller, exposure management. (4) Despite these issues, the answer remains contextually relevant, addressing both risk management horizon and financial exposure as asked. It correctly identifies Boeing’s continued use of derivatives and purchase contracts. However, due to incorrect dates, overstated conclusions about reduced exposure, and underreporting of the true 2031 horizon, the correctness score is limited to 6—partially correct but with significant factual and interpretive flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 502,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Between 2021 and 2024, Schwab's exposure to PALs (Pledged Asset Lines) increased significantly, with the total PALs balance rising from $12,709 million in 2021 to $17,024 million in 2024. In terms of collateralization, all PALs were fully collateralized by securities with fair values in excess of borrowings in 2021, and this remained the case in 2024 as no allowance for credit losses for PALs was required. Regarding the allowance for credit losses, Schwab's total allowance for credit losses increased from $18 million in 2021 to an implied higher level in 2024, reflecting broader credit risk management practices and macroeconomic conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the allowance for credit losses and the reasoning behind collateralization. While it correctly states that PALs were fully collateralized in 2021 with fair values exceeding borrowings, it incorrectly claims this remained the case in 2024 with 'no allowance for credit losses required,' which contradicts the ground truth stating there *was* an allowance in 2024, albeit decreased due to improved credit quality. The ground truth emphasizes a shift from reliance on collateralization to credit quality assessment, which the LLM answer misses entirely. (2) The quantitative figures cited—$12,709 million in 2021 and $17,024 million in 2024—are plausible but not present in the original answer or knowledge graph; the ground truth does not provide specific dollar amounts for PAL balances, only qualitative trends (slight growth). Similarly, the $18 million allowance in 2021 is fabricated; the original answer states no allowance was required in 2021 because of full collateralization. The implied increase in allowance by 2024 is also incorrect—the ground truth says the allowance *decreased*. (3) The multi-hop reasoning is flawed: the model fails to connect the evolution from collateral-based risk mitigation (2021) to forward-looking credit loss modeling (2024), which is the core of the question. It incorrectly assumes increasing PAL balances necessitate higher allowances, showing poor synthesis of risk management logic. (4) Scores reflect partial credit for mentioning full collateralization in 2021 and addressing both collateral and allowance components, but major deductions for incorrect numbers, misrepresentation of trends, and failure to capture the key conceptual shift in risk assessment approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 491,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024, Boeing's financial treatment and strategic positioning of the 777X program evolved as cost impacts and research & development (R&D) investments increased. In 2022, R&D expenses for the 777X were part of a broader decline in total R&D spending, which decreased by $227 million compared to 2021, reflecting reduced spending on the 777X and enterprise product development. By 2024, however, R&D expenses for the 777X program had risen significantly, contributing to a $435 million increase in total R&D expenses compared to 2023, as Boeing ramped up investments in product development for the 777X and other enterprise initiatives. Additionally, the 777X program contributed to higher cost of sales in 2024 due to reach-forward losses, reflecting ongoing challenges in managing program costs and delays.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding R&D trends in 2022. The ground truth states that R&D spending increased by $525 million in 2023 over 2022, implying rising investment in 2022 as a base year, but the LLM claims that total R&D spending declined in 2022 by $227 million due to reduced 777X spending—this contradicts the original answer and misrepresents the financial trajectory. Additionally, the LLM incorrectly implies that the $435M R&D increase in 2024 was solely due to the 777X, while the original answer notes it was part of a two-year trend ($525M increase in 2023, then $435M in 2024), which the LLM fails to acknowledge. (2) Quantitative accuracy is low: the $227M decrease in R&D in 2022 is not supported by the ground truth, which instead highlights a $525M increase in R&D in 2023 vs 2022—indicating the opposite trend. The LLM invents a comparison to 2021 not present in the original answer, introducing unsupported data. While the $435M increase in 2024 is correctly cited, it is miscontextualized without the prior $525M increase. (3) The multi-hop reasoning is flawed: the model fails to correctly trace the evolution from 2022 (cost burden) to 2024 (strategic investment) by misrepresenting 2022 as a period of reduced investment rather than the beginning of escalating costs that later transitioned into strategic prioritization. It also incorrectly suggests that ongoing reach-forward losses in 2024 reflect continued problems, whereas the original answer frames the program's financial impact in 2022 as negative but evolving into a strategic focus by 2024 despite those earlier losses. (4) Contextual relevance is high because the answer addresses the question’s core about financial treatment and strategic positioning over time, and uses appropriate financial terminology. However, due to major factual and quantitative errors in the R&D narrative and misrepresentation of the program's 2022 status, the correctness score is limited to 4—partially correct on direction (increased R&D by 2024) but significantly flawed in execution and detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 570,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Between 2022 and 2024, Schwab's exposure to and risk management of Portfolio Against Loans (PALs) remained relatively stable in terms of methodology but showed notable portfolio growth. The credit loss allowance for PALs continued to rely on the practical expedient based on collateral maintenance provisions, as these loans are collateralized by marketable securities with liquid markets, and collateral is monitored daily. This methodology limits inherent credit risk. However, the PALs portfolio grew significantly, with total pledged asset lines increasing from $17,024 million in 2024 to a larger portion of Schwab's overall loan portfolio compared to 2022, reflecting increased client demand for such products.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claim that 'total pledged asset lines increased from $17,024 million in 2024' — this number is presented as a 2024 figure but is framed as a starting point, implying growth from that value, which misrepresents the data. More critically, the ground truth does not provide any specific dollar amount for the PALs portfolio in 2022 or 2024, so introducing $17,024 million as a factual figure is unsupported and likely incorrect. This severely undermines quantitative accuracy. (2) The original answer notes a slight decrease in the PALs portfolio in 2023 before growth in 2024, but the LLM implies continuous growth without acknowledging the 2023 dip, missing a key dynamic. Additionally, the original highlights that the allowance for credit losses decreased as a ratio to year-end loans in 2024 due to improved credit quality and lower projected loss rates — a critical point about risk profile improvement despite portfolio growth — which the LLM omits entirely. (3) The LLM correctly identifies the continued use of the practical expedient for credit loss allowance and daily collateral monitoring, showing accurate understanding of risk management continuity. It also correctly links collateralization with marketable securities to reduced credit risk, reflecting sound qualitative reasoning on methodology. However, it fails to synthesize the multi-hop insight that even as the portfolio grew, the risk profile declined due to improved metrics — a core element of the original answer. (4) The contextual relevance is high because the response addresses both exposure (portfolio growth) and risk management (methodology, collateral monitoring). However, due to the fabricated number and omission of key trends (2023 decrease, allowance ratio decline), the correctness score is limited to 5 — partially correct but with major factual and completeness gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 529,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ's value of British pound sterling notes decreased from $356 million in 2022 to $386 million in 2023. This shift indicates that the company is actively managing its foreign exchange risk by adjusting its hedging positions in response to market conditions and operational needs, as part of its broader strategy to hedge net investments in international operations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, MDLZ's value of British pound sterling notes increased from $3 million in 2022 to $45 million in 2023. However, the LLM incorrectly states the values as $356 million in 2022 and $386 million in 2023, which are not only wrong but also imply a much larger scale and opposite direction of change (increase of $30 million vs. actual increase of $42 million from a much smaller base). (2) The quantitative accuracy is severely lacking: both the 2022 and 2023 figures are incorrect, and the implied change ($30 million increase) does not match the actual $42 million increase. There is no indication that the model accessed or interpreted the correct data points. (3) The reasoning and qualitative analysis are partially plausible in context—discussing foreign exchange risk management and hedging strategies—but it is based on false premises. The conclusion about active risk management is generic and does not reflect the specific strategic implication suggested by the ground truth: a substantial shift indicating increased exposure or hedging in GBP due to UK market activities. The model fails the multi-hop reasoning requirement as it does not correctly identify or synthesize the actual financial values across years. (4) Contextual relevance is moderate because the answer addresses the general topic of FX risk management and attempts to interpret the financial shift, but due to completely incorrect numbers and lack of alignment with the true magnitude and direction of change, the overall correctness score is very low. Minor credit is given for addressing both parts of the question structure (change in value and strategic implication), but factual grounding is almost entirely absent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 486,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In the 2022 filing, the 3.125% 2025 Notes had an effective interest rate of LIBOR + 1.8%, while in the 2024 filing, the effective rate was updated to SOFR + 2.1%. This shift from LIBOR to SOFR reflects Amgen's adaptation to the transition away from LIBOR to SOFR as the benchmark interest rate. The consistent notional amount of $1,000 million and the use of interest rate swaps to hedge these notes indicate a stable approach to managing interest rate risk, ensuring a mix of fixed and floating rate debt. This strategy helps Amgen mitigate exposure to interest rate fluctuations and maintain financial flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in the 2022 filing, the 3.125% 2025 Notes had a fixed interest rate of 3.125% with no mention of a variable rate or LIBOR. However, the LLM incorrectly states that the 2022 effective rate was 'LIBOR + 1.8%,' which contradicts the original answer. Additionally, the LLM claims the use of interest rate swaps and a notional amount of $1,000 million, which are not mentioned in the ground truth and cannot be verified. (2) The only correct quantitative element is the 2024 rate being SOFR + 2.1%, which matches the ground truth. However, the claim about LIBOR + 1.8% in 2022 is false, and no dollar amounts or other numbers were present in the original answer to support the $1,000 million figure. (3) The reasoning is flawed because it assumes a transition from LIBOR to SOFR for the same instrument, but the ground truth indicates a shift from a fixed rate to a floating rate tied to SOFR, not a benchmark transition on an already floating rate. The multi-hop synthesis fails because the model misrepresents the 2022 disclosure entirely. (4) The contextual relevance is moderate because the answer addresses the general topic of interest rate changes and financing strategy, but the incorrect facts and invented details (swaps, notional amount) severely undermine the accuracy. The conclusion about financial flexibility is speculative and not supported by the ground truth comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 410,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab's reliance on its Commercial Paper Issuance Program increased between 2022 and 2024 in response to market disruptions and rising interest rates. In 2022 and 2023, rapid interest rate hikes led to significant client reallocation of cash away from sweep accounts into higher-yielding alternatives, creating liquidity pressures. To address these outflows, Schwab utilized higher-cost supplemental funding sources, including its commercial paper program, as noted in the 2024 filing. The 2024 document also highlights that CSC maintains a commercial paper issuance program as part of its diversified funding strategy, which became more critical during periods of market volatility and constrained liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Schwab's reliance on its Commercial Paper Issuance Program from 2022 to 2024. (1) It correctly identifies that Schwab introduced the program in 2022 as part of its external financing tools and increased reliance by 2024 due to rising interest rates and client cash outflows. The key drivers—market disruptions, rising short-term rates in 2022 and 2023, and client reallocation from sweep accounts—are accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022, 2023, 2024) are correct and contextually appropriate. (3) The multi-hop reasoning is sound: the LLM correctly links rising rates → client outflows → liquidity pressure → increased use of commercial paper, and references the 2024 filing as confirmation of its ongoing role. It also correctly identifies the program as part of a diversified funding strategy alongside other mechanisms, though it omits specific mention of FHLB advances and repurchase agreements, which slightly reduces completeness. (4) The answer is semantically equivalent to the ground truth, with only minor omissions (e.g., no mention of credit rating downgrade risks or universal shelf registration), but the central narrative on increased reliance due to market conditions is fully supported. Hence, a score of 9 is justified—excellent accuracy with very minor contextual gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 413,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625% Notes due 2024 were fully repaid by December 31, 2024, as indicated by the absence of any remaining notional amount in the 2024 report, compared to $1.4 billion outstanding in 2023. These notes were hedged using interest rate swaps with a rate of SOFR + 3.4% in 2023. The repayment reflects the company's active debt management strategy, which includes refinancing and reducing higher-cost debt, as evidenced by the termination of related interest rate swaps in 2024. This approach helps optimize interest expenses and manage financial risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 3.625% Notes due 2024 were fully repaid by 2024 and had a $1.4 billion outstanding balance in the prior year, aligning with the ground truth carrying value of $1,400 million in 2022. However, the LLM states the amount was outstanding in 2023, while the ground truth specifies 2022, introducing a one-year discrepancy. Additionally, the LLM mentions interest rate swaps hedging the notes at SOFR + 3.4% in 2023 and their termination in 2024, which is not present in the original answer and may be extraneous or unverified information. The key shift from fixed to floating rate debt is implied through the mention of SOFR but not explicitly stated as a replacement structure. (2) The dollar amount ($1.4 billion = $1,400 million) is accurate in value but attributed to 2023 instead of 2022, affecting temporal accuracy. The absence of notional amount in 2024 is correctly noted. However, the introduction of SOFR + 3.4% and swap terminations lacks corroboration in the ground truth and may reflect overinference. (3) The multi-hop reasoning is partially sound: the model connects repayment of fixed-rate debt with active debt management and refinancing strategy. It infers a strategic intent to reduce higher-cost debt, which aligns with the ground truth’s interpretation. However, it does not clearly state that the fixed-rate notes were *replaced* with floating-rate debt, a key point in the original answer. Instead, it references hedging instruments and their termination, shifting focus away from direct debt structure evolution. (4) The correctness score is 7 because core facts (repayment, original amount) are correct, but there are notable issues in timing and unsupported details about hedges. Quantitative accuracy is 6 due to the misattribution of the $1.4 billion to 2023 instead of 2022 and the introduction of unverified rates. Qualitative accuracy is 8 because the reasoning about debt optimization is logical and relevant, though slightly misaligned. Contextual relevance is 9 as the answer directly addresses the question’s focus on debt strategy evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 572,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Between 2022 and 2024, Schwab's approach to providing financial support to variable interest entities (VIEs) remained consistent in that it did not provide or intend to provide financial or other support to VIEs beyond what was contractually required. In 2022, Schwab noted that its funding commitments for VIEs were contingent on specific conditions and expected to fulfill these commitments between 2022 and 2025. By 2024, Schwab reiterated its policy of not providing support beyond contractual obligations, with no indication of a shift in intent or conditions for funding commitments.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Schwab's approach remained consistent between 2022 and 2024. According to the ground truth, there was a clear evolution: in 2022, Schwab stated it did not provide and did not intend to provide support beyond contractual obligations; by 2024, it acknowledged it may choose to provide credit, liquidity, or other support to its proprietary funds under stress conditions like significant valuation declines or redemptions, even without contractual obligation. This represents a meaningful shift toward a more proactive stance, which the LLM answer completely misses. The LLM incorrectly asserts there was 'no indication of a shift,' directly contradicting the ground truth. While the answer correctly references years (2022, 2024) and the general topic of funding commitments, it fails on the essential qualitative and multi-hop reasoning required to detect a change in intent and conditions. The mention of funding commitments expected between 2022 and 2025 is not supported in the ground truth and introduces irrelevant information. Quantitative accuracy is acceptable because there are no numerical errors per se (no numbers were misstated), but the answer fabricates a narrative of consistency. Contextual relevance is moderate as it addresses the right topic and timeframe but draws the wrong conclusion. The failure to identify a key change in policy results in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 398,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "MDLZ's financial relationship with JDE Peet's between 2022 and 2023 remained a source of flexibility for MDLZ's liquidity and capital structure. In 2023, proceeds from the sale of JDEP shares contributed to improved cash flow from investing activities, as noted in the net cash provided by investing activities of $2,812 million, partially driven by higher proceeds from the current year's JDEP share sales. Additionally, the investment in JDE Peet's is highlighted as providing MDLZ with additional financial flexibility in its liquidity and capital resource planning. There is no indication of a material change in the nature of this investment's impact on MDLZ's liquidity or capital structure during the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but introduces significant inaccuracies. While it correctly notes that the investment in JDE Peet's contributes to MDLZ's financial flexibility in 2023, it incorrectly claims that proceeds from the sale of JDEP shares contributed to cash flow in 2023. The ground truth does not mention any sale of shares or proceeds; instead, it emphasizes a reclassification of the relationship from 'Has_Stake_In' in 2022 to 'Invests_In' in 2023, indicating a strategic shift, not a divestment. This mischaracterization fundamentally undermines the accuracy of the response. (2) The quantitative claim of $2,812 million in net cash from investing activities due to JDEP share sales is not supported by the original answer and introduces a specific figure absent from the ground truth. There is no verification that this number is accurate or correctly attributed, leading to a moderate quantitative accuracy score due to the presence of an unsupported but plausible-looking figure. (3) The multi-hop reasoning is flawed: the model fails to recognize the qualitative evolution in the nature of the relationship (reclassification of investment type), which is central to the question. Instead, it assumes continuity and cites a financial impact (proceeds from sale) that was not present in the source. This reflects a failure to synthesize the correct change in investment posture over time. (4) Contextual relevance is fair because the answer addresses liquidity and capital structure impacts and focuses on the right companies and timeframe, but it misses the core conceptual shift (from stake to strategic investment) and replaces it with an incorrect transactional narrative. Thus, while relevant, it is factually and conceptually misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 488,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "The interest rate applied under the swap agreements for the 3.125% 2025 Notes evolved from LIBOR-based rates in 2022 to SOFR-based rates by 2024. Specifically, in 2022, the effective interest rate was LIBOR + 1.8%, while by 2024, it was SOFR + 2.1%. This reflects a transition from LIBOR to SOFR as the reference rate for the interest rate hedging strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the shift from LIBOR to SOFR and the 2024 rate of SOFR+2.1%, it incorrectly states that in 2022 the rate was LIBOR+1.8%. The original answer explicitly states that the exact rate for the 3.125% 2025 Notes swap in 2022 was not disclosed, making the LLM's specific claim of LIBOR+1.8% unsupported and incorrect. Additionally, the transition from LIBOR to SOFR may be contextually plausible, but the original answer does not confirm this shift occurred specifically for these notes in 2022—only that swaps were terminated and reentered at then-current rates. (2) The quantitative accuracy is low because the LLM fabricates a specific rate (LIBOR+1.8%) not present in the ground truth. The $1,000 million notional amount is not mentioned in the LLM answer, missing a key quantitative anchor. (3) The reasoning partially captures the evolution of the hedging strategy but fails on multi-hop synthesis: it assumes a LIBOR-based structure in 2022 without evidence, and does not reflect that the 2022 rate was undisclosed. The model adds information not present in the source. (4) Contextual relevance is high because the answer addresses the evolution of the swap strategy and focuses on the correct financial instrument and time frame. However, the incorrect specificity undermines correctness. The core development—shift to SOFR+2.1% by 2024—is accurate and relevant, but the unsupported 2022 figure reduces overall reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 420,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "From fiscal year 2022 to fiscal year 2023, the fair value of Walmart's equity investments measured using Level 2 inputs decreased from $5,819 million to $4,414 million. The magnitude of this change was a reduction of $1,405 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported numbers. While it correctly states that Walmart's fair value of equity investments measured using Level 2 inputs decreased, it incorrectly reports the fiscal year 2023 value as $4,414 million instead of the correct $5,570 million. This leads to an incorrect change magnitude of $1,405 million instead of the correct $249 million. (2) The calculation of the change is mathematically correct based on the numbers provided ($5,819M - $4,414M = $1,405M), but the underlying data is wrong, making the result factually inaccurate. The ground truth shows a decrease of only $249 million ($5,819M to $5,570M), which the model fails to capture. (3) The reasoning structure is sound—recognizing a decrease and calculating the difference—but the multi-hop synthesis fails because the model uses incorrect input data from the SEC filings, suggesting either retrieval or interpretation errors. (4) Contextual relevance is high because the answer addresses the right company, metric, time frame, and type of change. However, due to major quantitative inaccuracies, the correctness and accuracy scores are low. Minor entity and metric identification is correct, but numerical fidelity is critically flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 357,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Apple's characterization of its reliance on marketing abilities remained consistent between its 2023 and 2024 10-K filings. In both documents, Apple emphasized that while it holds a broad portfolio of intellectual property, its success is primarily attributed to the innovative skills, technical competence, and marketing abilities of its personnel. There was no notable evolution in how the company described its reliance on marketing abilities during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Apple's characterization of its reliance on marketing abilities 'remained consistent' between the 2023 and 2024 10-K filings. The ground truth shows a clear evolution in language: from 'relies primarily' on innovative skills, technical competence, and marketing abilities in 2023, to 'depends heavily' on the same factors in 2024, with added strategic context about ensuring a 'continual and timely flow' of competitive offerings. This shift indicates a stronger, more strategic emphasis on these capabilities, including marketing, in response to competitive pressures. The LLM incorrectly asserts no change, missing this key evolution entirely. There are no numeric values in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default. Qualitative accuracy is very low because the model failed to detect the nuanced but important shift in wording and strategic framing, which undermines the multi-hop reasoning required to compare the two filings. Contextual relevance is moderate because the answer addresses the right documents and general topic, but fails to capture the actual evolution in characterization. The answer is semantically different from the ground truth and conveys a misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 361,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "The notional amount for the interest rate swap contracts related to the 3.625% 2024 Notes was $1,400 million in both 2022 and 2024, indicating no change in the notional amount. However, the interest rate structure changed from LIBOR + 3.2% in 2022 to SOFR + 3.4% in 2024, reflecting the transition from LIBOR to SOFR as the reference rate. This indicates that Amgen adjusted its hedging strategy to align with the market shift from LIBOR to SOFR, maintaining the same notional exposure but updating the benchmark rate to ensure continued effective hedging of interest rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the notional amount was $1,400 million in both 2022 and 2024, but the ground truth states that in 2022, Amgen terminated $5.2 billion in swaps (not $1.4 billion) across multiple notes including the 3.625% 2024 Notes, and by 2024 the notional amount for this specific note dropped to $0 as of December 31, 2024, down from $1,400 million in December 2023. The LLM incorrectly implies the notional amount remained constant, which contradicts the unwinding of the hedge. (2) The interest rate structure is partially correct—SOFR+3.4% in 2023 is accurate—but the LLM fabricates a 'LIBOR + 3.2%' rate in 2022, which is not mentioned in the ground truth. The original answer does not specify the 2022 rate, so this is an unsupported inference. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that the drop to $0 notional by end-2024 indicates full termination of the hedge as maturity approached, a key point in the original answer. Instead, it incorrectly assumes continuity in hedging. (4) While the mention of LIBOR-to-SOFR transition provides contextually relevant background, the core facts about notional amounts, timing, and strategic implications are incorrect, leading to a low correctness score. The answer is semantically dissimilar to the ground truth despite addressing the general topic of hedging strategy evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 395,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "Schwab's integration of the iRebal portfolio rebalancing solution from TD Ameritrade Institutional into its offerings for independent advisor clients reflects its strategic focus on enhancing its Advisor Services segment. By retaining and leveraging iRebal, Schwab expanded its capabilities to provide customizable portfolio management tools, strengthening its competitive positioning in the RIA market by offering a more comprehensive and technologically advanced suite of services tailored to advisor needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but lacks key details from the original answer, particularly regarding the evolution of iRebal's integration from 2022 to 2023. While it correctly identifies that Schwab retained and leveraged iRebal from TD Ameritrade Institutional for independent advisors, it omits the critical progression: in 2022, Schwab was merely retaining iRebal without full integration, whereas by 2023, it had incorporated iRebal as a core offering, signaling deeper platform integration. This evolution is central to answering how the integration 'evolved' over time, which the LLM answer fails to address explicitly. Additionally, the answer misses the broader context of Schwab’s integration progress—specifically the transition of over $1.6 trillion in assets and 15 million client accounts by 2023—which strengthens the competitive positioning narrative. There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and the entities mentioned (Schwab, TD Ameritrade Institutional, iRebal, RIA market) are correct. The reasoning is sound but incomplete; it draws a logical conclusion about competitive positioning but skips the multi-hop synthesis between the timeline of integration and Schwab’s broader platform consolidation. The answer remains contextually relevant and captures the general strategic intent, warranting a high relevance score. However, due to missing key temporal developments and supporting metrics, the overall correctness and qualitative accuracy are reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 416,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Between 2023 and 2024, Apple reintroduced the iMac as part of its product lineup, as disclosed in its 2024 10-K filing. While the 2023 10-K did not specifically mention the iMac in its product announcements, the 2024 filing listed the iMac as a new product launched in the first quarter of 2024. This suggests a renewed focus on the desktop segment, complementing the growth in Mac sales driven primarily by laptops during 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces a significant factual inaccuracy: it claims Apple 'reintroduced' the iMac and labeled it a 'new product launched in Q1 2024' in the 2024 10-K. The ground truth does not support this—there is no indication in the original answer that the iMac was discontinued and then reintroduced, nor is there specific mention of a Q1 2024 launch. Instead, the evolution described is one of increased strategic emphasis, with the iMac being elevated to a key product announcement alongside major launches like the MacBook Pro and iPad Pro in the MD&A section. This suggests a refresh or redesign, not a reintroduction. The LLM correctly identifies that the iMac was not highlighted in the 2023 10-K but was in the 2024 filing, which aligns with the shift in disclosure tone. However, the inference of 'reintroduction' and specific timing (Q1 2024) goes beyond the source material and misrepresents the nature of the change. While the general idea of renewed focus is consistent, the reasoning is flawed due to unsupported specifics. Quantitative accuracy is high because there are no explicit numbers or dates that are incorrect (the Q1 2024 mention is unsupported but not contradicted by the ground truth), and contextual relevance is strong as the response addresses the evolution in disclosure strategy. Qualitative accuracy is moderate due to incorrect characterization of the product's status despite capturing a shift in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 406,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX's 2.820% Notes Due 2051 were issued in 2021 with a principal balance of $1,000 million and remained outstanding as of December 31, 2022, but were repaid by December 31, 2024. This repayment indicates a shift in the company's long-term debt structure, as it reduced its exposure to ultra-long-term obligations, potentially to optimize interest costs or refinance at more favorable terms. The repayment also reflects active debt management to adjust the maturity profile and align with strategic financial goals.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 2.820% Notes Due 2051 were repaid by December 31, 2024, while the ground truth confirms the notes remained outstanding with the same $1,000 million principal balance in both 2022 and 2024. Additionally, the LLM claims the notes were issued in 2021, but the original answer states they were introduced in 2022. These errors directly contradict the ground truth. (2) Quantitatively, the $1,000 million principal amount is correct, but the repayment claim is false, and no supporting numbers are provided for the alleged repayment or refinancing. The broader debt increase from $40,078 million to $41,146 million is entirely omitted, undermining the context of overall debt growth. (3) The reasoning is flawed: the LLM infers active debt management and refinancing, but the ground truth shows no change in the 2051 notes, indicating stability rather than reduction in ultra-long-term debt. The multi-hop synthesis fails—while the question requires comparing the specific note's status over time and relating it to overall debt trends, the LLM incorrectly asserts repayment and misses the key insight that the note remained stable within a growing debt portfolio. (4) Scores reflect major factual errors in timing and status of the debt instrument, leading to a low correctness and quantitative accuracy score. Qualitative accuracy is slightly higher because the answer attempts logical financial reasoning (e.g., refinancing motivation), though based on false premises. Contextual relevance is moderate as it addresses the general theme of debt structure evolution but misrepresents the core facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 463,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "Between 2022 and 2023, Schwab's IDA agreement evolved by reducing the service fee on client cash deposits held at the TD Depository Institutions from 25 basis points in 2022 to 15 basis points in 2023. Additionally, Schwab transitioned the IDA agreement and related intercompany lending agreements from referencing LIBOR to alternative benchmark indices, completing this shift by June 30, 2023, as part of the broader phase-out of LIBOR.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in service fee from 25 to 15 basis points between 2022 and 2023, aligning with the ground truth. It also accurately captures the transition from LIBOR to alternative benchmarks as part of the IDA agreement evolution. The only minor discrepancy is that the original answer does not specify a 'June 30, 2023' deadline for the LIBOR transition, which the LLM includes—this detail is plausible but not verifiable from the ground truth provided, slightly affecting qualitative accuracy. (2) All numeric values—25 and 15 basis points—are correct and properly attributed to the respective years. No calculations are required, and the dates mentioned (2022, 2023) match the scope of the question. (3) The multi-hop reasoning is sound: the model synthesizes changes in fee structure and reference rate adjustments across two years, correctly linking them to Schwab's IDA agreement. The addition of 'intercompany lending agreements' is a minor expansion beyond the original but contextually reasonable. (4) The answer is semantically equivalent to the ground truth, with high factual accuracy, completeness, and relevance. The slight over-specification of the June 30 date prevents a perfect score, but overall correctness remains very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 363,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The change in Filorga's financial treatment from being a standalone reporting unit with $221 million in goodwill in 2023 to being listed among other trademarks within broader segments in 2024 suggests a shift in its strategic importance and valuation approach. This likely reflects a reevaluation of Filorga's role within the company's portfolio, potentially indicating a reduced standalone strategic value or a decision to integrate its performance with broader brand segments. The company may also be simplifying its reporting structure or adjusting how it assesses the value of acquired intangible assets, aligning Filorga with other trademarks under a more aggregated valuation framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in Filorga's financial treatment from 2023 to 2024, accurately stating that it was a standalone reporting unit with $221 million in goodwill in 2023 and was aggregated into broader segments in 2024 without separate disclosure. All factual elements—goodwill amount, years, and change in reporting—are correct. (2) Quantitative accuracy is perfect: the $221 million goodwill figure and the years 2023 and 2024 are correctly cited with no calculation errors. Format is consistent with ground truth. (3) The reasoning is sound and captures the multi-hop implication: the shift from standalone to aggregated reporting suggests a strategic reevaluation, integration into broader segments, and a change in valuation approach. The LLM infers plausible strategic motivations (integration, simplification, aggregated assessment) that align with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention the impact on impairment analysis or how reduced visibility might affect future decisions like divestiture or investment—details present in the original answer. However, the core meaning and strategic implications are semantically equivalent. Hence, high scores across all dimensions with a 9 on correctness due to slight incompleteness in downstream implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 378,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "Apple's 2024 10-K filing reflects a more detailed and forward-looking disclosure about the iPhone 16 Pro compared to the 2023 filing, indicating a shift toward emphasizing product innovation and strategic positioning. In the 2024 filing, the iPhone 16 Pro is explicitly listed among the key product launches in the fourth quarter, highlighting its role in the product lineup. This contrasts with the 2023 filing, which focused more on performance metrics and less on specific product introductions. The evolution in disclosure suggests Apple is aligning its reporting strategy to underscore technological advancements and competitive differentiation, particularly as it introduces new features like Apple Intelligence™ and other innovations tied to its product roadmap.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both factual content and reasoning. (1) It inaccurately claims that the 2024 10-K contains a 'forward-looking disclosure' about the iPhone 16 Pro and that it is 'explicitly listed among key product launches in the fourth quarter'—this contradicts the ground truth, which states that in the 2024 filing, the iPhone 16 Pro is treated as an existing product, not a future launch. In reality, the 2023 filing refers to the iPhone 16 Pro as part of the 'Fourth Quarter 2024 product lineup' (i.e., forward-looking), while the 2024 filing retrospectively includes it as part of the current product portfolio. The LLM reverses the timeline and misrepresents the nature of the disclosures. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in terms of calculations, but the temporal references (2023 vs 2024 filings and their content) are factually wrong, which counts toward factual inaccuracy. (3) The multi-hop reasoning fails: the model does not correctly synthesize the shift from forward-looking (2023) to retrospective (2024) disclosure, which is the core of the evolution in reporting strategy. Instead, it invents a narrative about increased detail and emphasis on innovation, Apple Intelligence™, and competitive differentiation that is not supported by the ground truth. (4) While the answer is relevant to Apple's reporting and product strategy, it misrepresents the actual evolution in disclosure, leading to a low correctness score. Contextual relevance is moderate because it addresses disclosure evolution, but the substance is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 444,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "Between 2022 and 2023, the company enhanced its Economic Value of Equity (EVE) simulations by updating deposit beta assumptions in a declining market interest rate environment, which improved the accuracy of interest rate risk assessments. Additionally, the company incorporated the impact of client cash allocation changes on the balance sheet and actively managed interest rate exposure through adjustments in asset and liability structures. In 2023, the company also began utilizing interest rate swap derivative instruments to assist with managing interest rate risk, which were integrated into both net interest revenue and EVE analyses. These changes reflect a more dynamic and comprehensive approach to modeling interest rate risk, particularly in response to evolving market conditions and balance sheet dynamics.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in modeling assumptions between 2022 and 2023, such as updating deposit beta assumptions in a declining rate environment and incorporating client cash allocation changes into the balance sheet dynamics—both of which are accurate and supported by the ground truth. However, the LLM introduces new information not present in the original answer: the use of interest rate swap derivatives integrated into net interest revenue and EVE analyses in 2023. This detail is absent from the ground truth and cannot be verified, representing a significant factual overreach or hallucination. (2) There are no numeric values, percentages, or dollar amounts in either the question or answers, so quantitative accuracy is not compromised—score reflects full alignment on available data points. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the shift in EVE simulation use from 2022 to 2023, particularly around deposit betas and client cash flows. However, the addition of derivative instruments breaks the chain of verified reasoning and undermines the qualitative accuracy. (4) Contextual relevance is high because the response directly addresses the evolution of EVE modeling with appropriate focus on assumptions and balance sheet dynamics. The correctness score is reduced due to the introduction of unverified content, even though core accurate elements are present. A score of 6 reflects partial correctness with significant but not fundamental errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 424,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 enhanced its competitive positioning by expanding its product portfolio into edge networking, including mobile broadband and wireless access points. This move allowed Qualcomm to leverage its foundational technologies (such as 5G, Wi-Fi 6/6E, and RF solutions) across a broader range of applications, strengthening its presence in the networking market and differentiating itself from competitors. By integrating its Snapdragon platforms with RF front-end components and wireless access point solutions, Qualcomm improved its ability to offer end-to-end, optimized connectivity solutions, thereby increasing its market reach and reinforcing its leadership in the connected intelligent edge ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Qualcomm transitioned from enabling wireless access point technologies in 2022 (via chipsets and foundational innovations like 5G and Wi-Fi 6) to directly producing access points in 2023 as part of a broader networking portfolio. The years (2022 and 2023) are correctly referenced, and no numeric values (e.g., financials, percentages) are present that could introduce inaccuracies—so quantitative accuracy is perfect. (2) The answer addresses all parts of the question: it explains the strategic shift, its impact on competitive positioning (stronger, direct competition with Broadcom/Intel implied via full-system solutions), and product portfolio breadth (explicitly mentions expansion into wireless access points, routers, and end-to-end solutions). (3) Multi-hop reasoning is sound: the model correctly synthesizes Qualcomm’s evolution from component supplier to system-level player by integrating its existing technologies (Snapdragon, RF front-end) into new product offerings. (4) While the LLM does not explicitly name competitors like Broadcom and Intel (mentioned in the original), it conveys the same competitive implication—enhanced positioning through end-to-end solutions. The omission is minor and does not detract from the core accuracy. Wording differs but semantic meaning matches. Thus, correctness is 9/10—very close to perfect, with only slight room for more specific competitive benchmarking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 417,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "The interest-only payment structure of Schwab's HELOC product evolved slightly from 2022 to 2023. In 2022, approximately 28% of adjustable-rate mortgages had interest-only terms, with 89% of these not scheduled to reset for three or more years. By 2023, the percentage of adjustable-rate mortgages with interest-only terms decreased to 27%, and the portion not scheduled to reset for three or more years dropped to 86%.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all quantitative aspects: (1) The percentages for 2022 (28% interest-only, 89% not resetting for 3+ years) and 2023 (27%, 86%) are exactly correct. (2) All entities—adjustable-rate mortgages, interest-only terms, reset periods, and the implied link to Schwab's HELOC product—are correctly identified and contextualized. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years and two metrics (percentage of interest-only loans and those not resetting), capturing the slight decrease in both. (4) The answer conveys the same information as the original, with only minor omission of the interpretive phrase 'suggesting a slight tightening or evolution in the interest-only structure,' which slightly reduces qualitative completeness but does not affect factual correctness. Wording differences are acceptable under semantic equivalence. No calculation errors; all numbers match exactly. Contextual relevance is full—directly addresses the evolution over time as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 303,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "Qualcomm's involvement in the XR (Extended Reality) market evolved from 2022 to 2023, as reflected in both strategic investments and product revenue disclosures. In 2022, XR was included under the IoT (Internet of Things) category in QCT's revenue streams, with IoT revenues amounting to $7,353 million. By 2023, while IoT revenues slightly decreased to $5,940 million, the QSI (Qualcomm Strategic Investments) segment explicitly highlighted investments in XR as part of its focus areas, including early-stage companies in industries such as 5G, AI, automotive, and XR. This indicates an increased strategic emphasis on XR through investments, even as product revenue for broader IoT applications saw a decline.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies Qualcomm's strategic investments in XR via QSI in 2023, it incorrectly states that XR was part of the IoT category in QCT's revenue streams in 2022 with specific dollar amounts ($7,353 million and $5,940 million). The ground truth does not support these figures or the claim that XR was broken out as part of IoT revenue in 2022. Moreover, the original answer emphasizes a shift from investment (2022) to direct revenue generation (2023), whereas the LLM answer incorrectly suggests that XR was already generating product revenue in 2022 under IoT and that QSI only highlighted XR in 2023 — reversing the evolution. (2) The quantitative figures cited (e.g., $7,353M and $5,940M IoT revenues) are not present in the ground truth and cannot be verified; thus, they are likely hallucinated. There is no mention in the original answer of using IoT revenue to infer XR performance. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the progression from indirect involvement via investments (2022) to direct commercialization and revenue recognition (2023). Instead, it implies XR was already monetized in 2022 and emphasizes investment only in 2023, which contradicts the ground truth. (4) Scores reflect major factual and directional errors in both quantitative and qualitative dimensions, though the mention of QSI focusing on XR in 2023 provides some contextual relevance, preventing a score of 0.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 420,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 has remained unchanged at $1,100 million between 2022 and 2024, as noted in the long-term debt sections of both RTX_10k_2022.pdf and RTX_10k_2024.pdf. This stability indicates that RTX has not refinanced or repaid this specific long-term debt issue during this period, reflecting a consistent component of its long-term debt structure with a maturity date in 2052.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at $1,100 million between 2022 and 2024, which matches the ground truth exactly. All numeric values—$1,100 million, 3.030%, 2052 maturity—are accurate and properly attributed to RTX. (2) There are no calculations required beyond comparison across years, and the model correctly identifies stability in the balance, confirming no repayments or issuances. Format consistency is acceptable ($1,100 million is standard and matches the original). (3) The multi-hop reasoning is sound: the model references both the 2022 and 2024 10-K filings (RTX_10k_2022.pdf and RTX_10k_2024.pdf), indicating cross-document synthesis to confirm consistency over time. This demonstrates proper handling of a multi-period comparison. (4) The qualitative interpretation is largely aligned with the ground truth—stability reflects consistency in long-term debt management. The only minor gap is that the LLM does not explicitly mention 'strategic consistency in managing this portion of its capital structure,' a nuance present in the original answer, but the core implication (consistent component of long-term debt) is preserved. Thus, while highly accurate, it misses slight depth in strategic interpretation, warranting a 9 instead of 10 on qualitative accuracy. All other dimensions are fully correct and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 396,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "AXP's focus on Corporate Card solutions evolved between 2023 and 2024 by emphasizing differentiation and innovation in its commercial payments offerings. In 2023, the company highlighted evolving card value propositions and enhancing expense management solutions. By 2024, the strategy expanded to include designing innovative products and features such as financing, banking, and payment solutions tailored for business customers. This shift suggests a broader commercial payments strategy aimed at deepening engagement with businesses through tailored, integrated financial solutions, reinforcing AXP's position in the B2B payments market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: AXP's 2023 focus on evolving card value propositions and differentiating corporate card and expense management solutions is accurately reflected, as is the 2024 shift toward innovative, integrated solutions including financing, banking, and payments. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the years 2023 and 2024 are correctly attributed to the respective strategic focuses, earning full marks. (3) The multi-hop reasoning—comparing AXP’s strategic emphasis across two years and inferring a broader commercial payments strategy—is sound and well-synthesized. The LLM correctly identifies the evolution from product differentiation to integrated financial services. (4) The only minor shortcoming is a slight reduction in specificity regarding 'accounts payable expense management' (mentioned in ground truth but summarized as 'expense management' in the LLM answer), and the LLM does not explicitly state that the Corporate Card is being embedded into a wider suite, though the idea is implied through 'integrated financial solutions'. This small omission prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is contextually complete, relevant, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 393,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "Between 2023 and 2024, PCA SKIN's strategic positioning within Colgate-Palmolive's Oral, Personal, and Home Care segment appears to have remained consistent in terms of distribution channels. The 2023 and 2024 filings both indicate that products in this segment, including PCA SKIN, are primarily sold to traditional and e-commerce retailers, wholesalers, distributors, and, in some cases, skin health professionals. There is no indication of a significant shift in distribution strategy for PCA SKIN during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in that it identifies the continuity of PCA SKIN's presence in Colgate-Palmolive's portfolio and mentions consistent distribution channels such as traditional and e-commerce retailers, wholesalers, and distributors. However, it fails to accurately reflect a key evolution noted in the ground truth: in 2024, the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies, indicating a strategic refinement in positioning toward more specialized skincare channels. The LLM answer acknowledges skin health professionals but frames them as part of the existing 2023 structure ('in some cases'), which contradicts the ground truth that this was a new addition in 2024. This omission or misrepresentation of a critical change in distribution strategy significantly undermines the qualitative accuracy. There are no numerical figures to assess, so quantitative accuracy is not applicable but assumed correct by default. Contextually, the response is relevant and addresses the question's focus on distribution channels, but the failure to identify the strategic shift results in a moderate correctness score. The multi-hop reasoning is weak because the model did not correctly synthesize the temporal change between 2023 and 2024 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 368,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Between 2022 and 2023, Opdivo's strategic focus and commercial positioning evolved by expanding into new tumor indications and advancing combination therapies. In 2023, Opdivo received FDA and EC approvals for adjuvant treatment of melanoma, neoadjuvant treatment of NSCLC, and additional approvals in Japan for NSCLC. These approvals, along with ongoing registrational studies, reflect a broader commercial positioning across earlier lines of therapy and new tumor types. The expansion into new indications and combinations, including with Yervoy and other agents, is expected to drive Opdivo's revenue growth trajectory, as noted in the 2023 10-K, which highlights that increased demand for Opdivo partially offset revenue declines in other areas.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of strategic evolution, new indications, and implications for revenue. It accurately captures the expansion into earlier lines of therapy (neoadjuvant NSCLC, adjuvant melanoma) and new approvals in key markets including the U.S. (FDA), EU (EC), and Japan, which reflects a valid synthesis across geographies and indications. The mention of combination therapies with Yervoy and other agents is consistent with the original answer. The revenue growth trajectory is correctly tied to increased demand for Opdivo, particularly as a partial offset to declines elsewhere, as stated in the 2023 10-K—this shows accurate qualitative reasoning and contextual understanding. However, the LLM omits specific reference to the full breadth of 2022 indications (e.g., bladder, blood, CRC, HCC, MPM, stomach cancers) and does not mention the subcutaneous formulation, which is a key strategic element highlighted in the ground truth for sustaining long-term adoption. While the LLM correctly infers growth drivers, it lacks explicit mention of the monotherapy expansion and delivery mechanism innovation, resulting in minor incompleteness. There are no numerical inaccuracies—dates (2022–2023), regulatory bodies (FDA, EC), and therapeutic areas are correctly identified. The reasoning is sound and multi-hop, connecting approvals to strategic focus and then to revenue implications. Overall, the answer is factually strong and contextually precise but misses a few key details from the ground truth, warranting a score of 8 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 438,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express's investment in foreign government bonds and obligations remained relatively stable between 2023 and 2024 in terms of fair value, with $770 million in 2024 compared to $770 million in 2023. In terms of maturity distribution, all of these investments were due within one year in both years, indicating a short-term focus.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It claims American Express's investment in foreign government bonds was $770 million in both 2023 and 2024, which directly contradicts the ground truth stating $549 million in 2023 and $765 million in 2024. Additionally, the LLM states that all investments matured within one year in both years, while the truth shows that in 2023, all $549 million matured in 12 months or more, and in 2024, $764 million matured within one year and only $1 million after one year. (2) Quantitative accuracy is extremely low: the dollar amounts are wrong for both years, and the maturity distribution is completely misrepresented. There is no indication of the significant shift from long-term to short-term maturities, nor the gross unrealized loss of $1 million in 2023. (3) The multi-hop reasoning is flawed—the question requires comparing fair value and maturity distribution across two years, but the LLM fails to detect any change and fabricates equal values. It also fails to synthesize the shift in strategy from long-term to predominantly short-term holdings. (4) Contextual relevance is low but not zero because the answer addresses the right topic (foreign government bonds, fair value, maturity distribution), but with entirely incorrect data and conclusions. The answer suggests stability when there was a major strategic shift, leading to a correctness score of 1 due to near-total factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 410,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Between 2022 and 2024, Walmart's use of intercompany financing arrangements remained consistent in purpose, aiming to ensure cash is available where needed at minimal cost. As of January 31, 2025, $3.3 billion of cash held outside the U.S. was not freely transferable due to local laws or other restrictions, compared to $4.3 billion as of January 31, 2022. Transfers of such cash to the U.S. typically require approval from noncontrolling interest shareholders, particularly in entities like Flipkart.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and dates are correct: $4.3 billion in 2022 and $3.3 billion in 2024 (reported as of January 31, 2025, which corresponds to fiscal year 2024, consistent with Walmart's fiscal calendar). These match the original answer exactly. (2) The answer correctly identifies the decrease in restricted cash and the general requirement for approval from noncontrolling interest shareholders. (3) The multi-hop reasoning is sound—comparing two fiscal years, tracking changes in intercompany financing restrictions, and identifying shareholder approval conditions. (4) The only minor shortcoming is that the LLM answer still references Flipkart specifically as a key example of where approvals are needed, whereas the ground truth notes a broader shift away from Flipkart-specific language to a more general reference to noncontrolling interests. This slightly underrepresents the evolution in framing described in the original answer. However, since Flipkart remains a material noncontrolling interest, this is not factually incorrect, just less precise in capturing the nuance of structural change. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 355,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Between 2023 and 2024, the composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained consistent in terms of fixed income securities and equity securities allocation. In both years, the allocation was 80% for fixed income securities and cash equivalents and 20% for equity securities. This alignment reflects the plan's target allocation range of 75% to 85% for fixed income and 15% to 25% for equity securities.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the asset allocation remained unchanged between 2023 and 2024, and accurately captures the intended target allocation range (75%-85% fixed income, 15%-25% equity), which aligns with the plan's strategy. However, it rounds the exact percentages to 80% and 20%, while the ground truth specifies 79.5% and 20.5%, respectively. Though close, this introduces a minor quantitative inaccuracy. Additionally, the LLM omits the actual dollar amounts ($210M in fixed income, $54M in equity, $264M total), which are key quantitative details present in the original answer. (2) The percentages are approximated rather than precisely reported; while 80/20 is a reasonable simplification, the exact figures (79.5%/20.5%) should have been included for full quantitative accuracy. The absence of dollar values reduces completeness and precision. (3) The multi-hop reasoning is sound—the model correctly infers no change in allocation between years and connects this to the stated target ranges, demonstrating good synthesis. (4) The answer is contextually relevant and conveys the core conclusion (no evolution in allocation), but loses points on quantitative accuracy due to rounding without qualification and omission of exact figures. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 367,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Between 2022 and 2024, Honeywell's 2006 Stock Plan for Non-Employee Directors evolved by introducing more specific and updated forms of award agreements, such as the \"Form of Stock Option Award Agreement\" and \"Form of Restricted Stock Unit Agreement\" under the 2016 Stock Plan for Non-Employee Directors. This shift suggests a move toward modernizing and diversifying the non-employee director compensation structure, emphasizing equity-based incentives like restricted stock units (RSUs) alongside traditional stock options, potentially aligning director compensation more closely with long-term shareholder value.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the evolution of Honeywell's 2006 Stock Plan for Non-Employee Directors. (1) It incorrectly references the '2016 Stock Plan' and introduces award agreements under that plan, which is factually wrong—the original answer and filings pertain only to the 2006 plan. There is no mention of a 2016 plan in the context of non-employee directors in the relevant filings. (2) Quantitatively, the answer fabricates information: it claims new forms were 'introduced' under a different plan, but the ground truth shows that in 2022, both Option and Restricted Unit Agreements were present (Exhibits 10.30 and 10.32), and by 2024, only the Option Agreement remained (Exhibit 10.29), with the Restricted Unit Agreement no longer listed. The LLM incorrectly implies continuity and expansion of RSUs when the evidence suggests a reduction or discontinuation. (3) The reasoning is flawed: instead of identifying a potential shift away from restricted units toward options, the LLM suggests increased emphasis on RSUs, which contradicts the evidence. This fails the multi-hop synthesis—comparing exhibit lists across years to infer changes in compensation strategy. (4) While the answer addresses director compensation and equity forms, which is contextually relevant, its factual inaccuracies and incorrect interpretation of the direction of change severely undermine its validity. The conclusion about 'modernizing and diversifying' is unsupported and opposite to the trend indicated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 421,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Between 2022 and 2024, Walmart's strategic position regarding its ownership stake in Flipkart evolved as it faced potential regulatory risks in India. In 2022, Walmart's ownership in Flipkart was reduced from approximately 83% to 75% following a new equity funding round. By 2024, Flipkart became subject to investigations by the Directorate of Enforcement in India under the Foreign Direct Investment rules, which alleged potential violations prior to Walmart's acquisition of a majority stake. These proceedings could result in monetary penalties or share ownership restrictions, exposing Walmart to regulatory risks. Additionally, Flipkart faced an antitrust investigation by the Competition Commission of India, further increasing potential financial and operational exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the reduction in Walmart's ownership stake in Flipkart from approximately 83% to 75% in 2022, which aligns with the ground truth. It also accurately notes the $3.2 billion equity funding event (implied by 'new equity funding round') though it omits the explicit dollar amount, which is a minor omission. The mention of regulatory scrutiny by the Directorate of Enforcement under FDI rules is correct, including the pre-2018 timeline (prior to acquisition). However, the LLM incorrectly implies that the investigation was active in 2024, while the original answer clarifies that the show cause notice was issued in July 2021 and followed by information requests—no new 2024 initiation is stated. Additionally, the LLM introduces an antitrust investigation by the Competition Commission of India, which is not mentioned in the ground truth and thus constitutes an unsupported addition. (2) Quantitatively, the percentages (83% to 75%) are accurate, and the context of equity funding is correct. The missing $3.2 billion figure is a partial quantitative gap, but the core numeric facts are preserved. (3) The multi-hop reasoning is mostly sound—linking reduced ownership to ongoing regulatory exposure despite partial exit—but overreaches by introducing an unverified antitrust probe. The synthesis between ownership change and continued risk exposure is valid and reflects understanding. (4) Scores reflect high factual accuracy and relevance, with deductions for the unsupported claim about antitrust investigation and slight omission of the exact funding amount and precise timeline of regulatory actions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 451,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, HON's U.S. cash balances increased from $11.5 billion in 2022 to $8.0 billion in 2024 being held in non-U.S. subsidiaries, with total cash holdings rising from $11.5 billion in 2022 to $11.0 billion in 2024. The strategic emphasis shifted toward funding acquisitions and managing liquidity through debt issuance, with a notable increase in borrowings from $19.6 billion in 2022 to $31.1 billion in 2024, reflecting a focus on strategic acquisitions and capital expenditures.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that U.S. cash balances increased from $11.5 billion in 2022 to $8.0 billion in 2024 being held in non-U.S. subsidiaries—this misrepresents both the direction and location of the funds. According to the ground truth, total cash decreased slightly from $11.5 billion (as of Dec 31, 2021, reported in 2022) to $11.0 billion (as of Dec 31, 2023, reported in 2024), with $8.0 billion of that latter amount held in non-U.S. subsidiaries. The LLM incorrectly frames $8.0 billion as U.S. cash, when it is explicitly non-U.S. cash. Additionally, the LLM claims total cash holdings rose from $11.5B to $11.0B, which is a decrease, not an increase. (2) The LLM introduces unrelated financial data—debt increasing from $19.6B to $31.1B—information not present in the original answer and irrelevant to the question about cash composition and geographic distribution. These numbers are unverified and distract from the core topic. (3) The multi-hop reasoning is flawed: the question asks about evolution in composition and strategic emphasis of U.S. cash balances, but the LLM misidentifies where the cash is held and incorrectly infers a strategic shift toward acquisitions funded by debt, which is not supported in the ground truth. The original answer states the strategic emphasis remained on safety and diversification, unchanged. (4) Due to major factual errors in numbers, misattribution of geographic distribution, and introduction of unsupported strategic shifts, the correctness score is low at 3. Quantitative accuracy is poor (3) due to incorrect values and directional claims. Qualitative accuracy is also low (3) because of faulty reasoning and entity/metric confusion. Contextual relevance is moderate (5) as the answer addresses cash balances and strategy, but with significant distortions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 511,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "From 2023 to 2024, the financial treatment and liability estimation methodology for the Membership Rewards program evolved primarily through refinements in the assumptions used for the Ultimate Redemption Rate (URR) and the Weighted Average Cost (WAC) per point. In 2023, the URR and WAC per point were estimated using statistical and actuarial models based on redemption trends, card product types, and historical data. By 2024, the methodology incorporated more detailed sensitivity analyses, explicitly quantifying the impact of changes in these assumptions. For instance, a 25 basis point increase in URR would raise the liability by approximately $197 million, and a 1 basis point increase in WAC per point would increase it by about $220 million. Additionally, the liability modeling in 2024 emphasized the influence of macroeconomic scenarios and redemption pattern changes due to product updates and partner contract adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the shift from deferred fees in 2023 to a more detailed liability modeling approach in 2024 is accurately described. The quantitative sensitivity figures—$197 million for a 25 basis point increase in URR and $220 million for a 1 basis point increase in WAC per point—are exactly as stated in the original answer. (2) Quantitative accuracy is perfect: all dollar amounts and basis point changes match the ground truth, with acceptable phrasing like 'approximately' and 'about' not detracting from precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of methodology across years, identifying the introduction of sensitivity analysis and more granular assumptions. The only minor gap is that the LLM emphasizes 'refinements in assumptions' and 'macroeconomic scenarios' and 'partner contract adjustments' in 2024, which are not explicitly mentioned in the ground truth. While plausible elaborations, they slightly extend beyond the provided information. (4) Contextual relevance is excellent—the response directly addresses the evolution in financial treatment and liability modeling, focusing on deferred fees and modeling assumptions as required. Overall, the answer is factually correct, well-structured, and only slightly overreaches in adding contextual details not present in the original, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 407,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe's strategic positioning and integration of Frame.io evolved significantly between 2022 and 2024 by embedding it more deeply into Adobe's broader product ecosystem. Initially acquired in late 2020 for $1.18 billion and integrated into the Digital Media segment, Frame.io was positioned to enhance video collaboration capabilities. By 2024, Frame.io had become a core part of Adobe's creative workflow, with direct integrations into Adobe Premiere Pro, After Effects, Photoshop, and Workfront, enabling seamless real-time collaboration and feedback. Additionally, Frame.io was included in Adobe GenStudio, aligning it with AI-powered tools like Adobe Firefly and Adobe Express to support large-scale content production, demonstrating a stronger alignment with Adobe's vision of an interconnected, AI-enhanced creative ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Frame.io's integration from 2022 to 2024 with accurate qualitative details. All key points from the ground truth are present: Frame.io's acquisition cost ($1.18 billion), its initial positioning in the Digital Media segment, and its deeper integration by 2024 into Premiere Pro, After Effects, Photoshop, and Workfront. The inclusion in Adobe GenStudio is accurately mentioned. (2) Quantitative accuracy is perfect: the $1.18 billion acquisition price is correct, and no other numerical errors are present. The mention of late 2020 acquisition is factually accurate (outside the ground truth but not contradicted), though the ground truth focuses on 2022 onward. This does not detract from correctness. (3) Multi-hop reasoning is sound: the LLM synthesizes Frame.io’s strategic evolution across time and product lines, correctly linking it to Adobe’s broader ecosystem and AI strategy via GenStudio and Firefly/Express. The progression from standalone collaboration tool to core ecosystem component is logically and accurately portrayed. (4) The only minor gap is that the ground truth emphasizes the shift 'from initial integration to full ecosystem incorporation' as a conceptual evolution, which the LLM implies but doesn’t explicitly frame in those terms. However, the semantic meaning and factual content are equivalent. Wording differences are acceptable under semantic equivalence. Scores reflect high accuracy with a minor deduction in qualitative accuracy for slightly less precise framing of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 436,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "Between 2022 and 2023, the fair value measurements of equity-like funds under private alternative investments using significant unobservable inputs (Level 3) remained relatively stable. In 2022, equity-like funds had a Level 3 fair value measurement of $25.4 million, and in 2023, this amount slightly decreased to $25.1 million. Thus, there was minimal change in the composition of these investments in terms of Level 3 valuations during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key aspects. According to the ground truth, the Level 3 fair value for equity-like funds was $5.5 million in 2022 and increased to $25.4 million in 2023, representing a fivefold increase. The LLM incorrectly states that the 2022 value was $25.4 million and 2023 was $25.1 million, implying stability or a slight decrease, which contradicts the actual significant growth. (2) Quantitative accuracy is extremely low: both years' values are wrong. The LLM swaps the correct 2022 and 2023 figures and introduces a false narrative of stability. No correct calculation or trend is presented. (3) The multi-hop reasoning is fundamentally flawed. The question asks about the evolution in composition of Level 3 valuations, which requires comparing two time points and interpreting the change. The LLM fails to detect the actual large increase and instead fabricates a minimal change, leading to an incorrect conclusion about valuation methodology trends. (4) Contextual relevance is partially met as the answer discusses the correct topic (Level 3 fair value of equity-like private alternative investments) and time frame (2022–2023), but the factual errors render the response misleading. Due to complete failure in numerical accuracy and resulting incorrect interpretation, the correctness score is 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 377,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Adobe acquired Frame.io in October 2021 for $1.18 billion and began integrating it into the Digital Media segment. By 2024, Frame.io is positioned as a cloud-native creative collaboration platform, directly integrated with key Adobe apps like Premiere Pro, After Effects, and Photoshop, streamlining workflows for video production, reviews, and approvals. It is also part of Adobe GenStudio, enabling content production at scale, highlighting its deeper integration and strategic role in enhancing Adobe's creative ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe acquired Frame.io in October 2021 (not 2022, but the answer correctly references the 2021 acquisition), and integration into the Digital Media segment began shortly after. By 2024, Frame.io is deeply integrated with Premiere Pro, After Effects, Photoshop, and is part of Adobe GenStudio—matching the original answer. The $1.18 billion acquisition price is accurate and adds useful detail not in the ground truth, but does not contradict it. (2) Quantitative accuracy is perfect: the date (October 2021) and dollar amount ($1.18 billion) are correct. No calculations required. (3) Reasoning is sound: the answer captures the evolution from post-acquisition integration in the early 2020s to a core component of Adobe’s creative ecosystem by 2024. It correctly identifies the multi-hop progression from acquisition to functional and strategic integration. (4) Minor deduction in qualitative accuracy because the original answer also mentions integration with Lightroom and Workfront, which the LLM omits. However, the inclusion of 'key Adobe apps' and the named major integrations preserves semantic equivalence. Contextual relevance is full—directly addresses the evolution between 2022 and 2024 as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 365,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "Between 2022 and 2024, CVS expanded its approach to Medication Management by enhancing clinical programs and digital tools to improve medication adherence and cost efficiency. In 2022, the company emphasized programs like Pharmacy Advisor and Drug Savings Review, which provided counseling and outreach to help members with chronic diseases adhere to prescriptions and identify cost-saving alternatives. By 2024, CVS had further integrated digital tools such as the Health Engagement Engine and AI-driven analytics to deliver real-time insights and automate interventions across retail, mail, and specialty pharmacies. Additionally, the launch of Cordavis and the expansion of value-based care initiatives, including in-home health evaluations and ACO participation, underscored CVS's commitment to leveraging data and technology for better health outcomes and cost management.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general direction of CVS's evolution in Medication Management from 2022 to 2024, focusing on enhanced digital tools and clinical programs, which aligns with the question's intent. However, it introduces several factually incorrect or unverifiable program names and tools not present in the ground truth. In 2022, the LLM mentions 'Pharmacy Advisor' and 'Drug Savings Review,' which are not referenced in the original answer; instead, the ground truth highlights formulary management via the National Pharmacy and Therapeutics Committee, real-time benefit tools, mail/specialty pharmacy, and opioid prescription limits. By 2024, the LLM cites 'Health Engagement Engine,' 'Cordavis,' and 'AI-driven analytics,' none of which appear in the ground truth; instead, the correct tools are the NovoLogix preauthorization platform and enhanced analytics for lower-cost alternatives. The LLM also references 'in-home health evaluations' and 'ACO participation,' which are not mentioned in the original. While the general theme of digital integration and value-based care is correct, the specific clinical programs are misidentified. The expansion through Oak Street Health, operating 239 centers in 27 states, is a key factual point entirely missing from the LLM response. The launch of the CVS Weight Management program with GLP-1 optimization and lifestyle coaching is also omitted. Quantitatively, no incorrect numbers are stated (e.g., no false counts of clinics or financials), so the score for quantitative accuracy is high. Contextually, the answer stays on topic and addresses adherence and cost efficiency. However, due to significant factual inaccuracies in entity identification and missing key programs, the qualitative and overall correctness scores are low. The reasoning shows an understanding of a shift toward digital and integrated care but fails to correctly synthesize the actual multi-hop evidence from the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 526,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved significantly from 2022 to 2024 by deepening its collaboration features and expanding its integration with key Creative Cloud applications. In 2022, Adobe acquired Frame.io and began integrating it into Creative Cloud, focusing on enhancing Frame.io's review and approval capabilities in Premiere Pro and After Effects to deliver a native collaborative platform for video editing. By 2024, Frame.io had evolved into a robust cloud-native creative collaboration platform, streamlining the production of creative assets by enabling real-time upload, review, and approval, frame-accurate commenting, and annotations. Specific enhancements included support for video workflows beyond post-production, such as casting and location scouting, as well as integrations for still image cameras and marketing campaign management. Frame.io was also integrated with Adobe Workfront and made available in Adobe GenStudio, enabling content production at scale.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of timeline, acquisition, and strategic evolution of Frame.io within Adobe's Creative Cloud ecosystem. It accurately notes the 2022 acquisition and initial integration focus on Premiere Pro and After Effects, as well as the 2024 evolution into a broader cloud-native collaboration platform. The mention of real-time upload, review, approval, and frame-accurate commenting is consistent with the enhanced collaboration features. Integration with Adobe Workfront is correctly identified. However, the LLM introduces two inaccuracies: (1) it claims Frame.io was made available in 'Adobe GenStudio,' which is not mentioned in the ground truth and appears to be fabricated or confused with another product; (2) it mentions 'support for casting and location scouting' and 'integrations for still image cameras and marketing campaign management'—while these may be plausible extensions, they are not specified in the original answer, which instead highlights integration with Photoshop, Lightroom, and the Camera to Cloud functionality enabling direct uploads from on-set cameras. The latter is a specific, factual enhancement that the LLM omits. The answer captures the strategic shift but substitutes some correct details with plausible but unverified enhancements. Quantitative accuracy is perfect—no numbers or dates are incorrect. Contextual relevance is high as it directly addresses the evolution and feature enhancements. Qualitative accuracy is slightly reduced due to the substitution of specific, verified features with unconfirmed ones, though the overall reasoning and synthesis remain sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 456,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "The use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024 by becoming a more prominent factor in fair value determination, particularly for loans and lending commitments. In 2023, fair value was primarily based on recently executed transactions, market price quotations, and valuation models incorporating market observable inputs. By 2024, the role of recently executed transactions was emphasized further, with a stronger focus on benchmarking to prices and rates observed in the primary market for similar loan types and borrower profiles. Additionally, the valuation process increasingly relied on recently executed transactions for comparable loans, market price quotations, and valuation models that incorporated observable inputs such as comparable loan or debt prices and CDS spread levels. This evolution reflects a shift toward greater reliance on observable market data to enhance transparency and accuracy in fair value assessments.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of the use of recently executed transactions from 2023 to 2024. (1) Correct elements: The answer correctly identifies that recently executed transactions were used in 2023 alongside market price quotations and valuation models, and that observable market inputs remained important in 2024. The contextual framing around transparency and accuracy is reasonable. (2) Quantitative accuracy: There are no numeric values in the question or ground truth, so this aspect is not applicable; the LLM does not introduce any incorrect numbers, so it scores highly here by default. (3) Multi-hop reasoning assessment: The LLM fails to capture the key shift in the *scope and targeting* of transaction data use. The ground truth specifies that in 2024, the use became more focused on *held-for-sale* loans and *extended to other investments*, using methods like discounted cash flow and comparable company multiples. The LLM instead claims a general 'increased emphasis' and 'greater reliance', which misrepresents the evolution as broader rather than more targeted. It also introduces 'CDS spread levels' and 'primary market benchmarking' not present in the original, adding unsupported detail. (4) The answer is contextually relevant and well-structured but misses the core nuance of a more *targeted application* in 2024, instead suggesting a blanket increase in reliance. This fundamental mischaracterization of the directional change reduces the correctness and qualitative accuracy scores despite accurate general context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 440,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Between 2022 and 2024, Adobe has positioned Substance 3D Stager more cohesively within the broader Substance 3D ecosystem, emphasizing its role in enabling users to build and assemble 3D scenes as part of a comprehensive 3D content creation workflow. In 2022, the product was described as part of the Substance 3D Collection, highlighting its individual capabilities for scene building. By 2024, Substance 3D Stager is more explicitly integrated into a unified ecosystem that includes tools like Substance 3D Painter, Sampler, Designer, and Modeler, with a focus on seamless interoperability and a holistic approach to 3D asset creation and management. This evolution reflects Adobe's strategy to enhance cross-product collaboration and streamline the 3D creative process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of Substance 3D Stager's positioning from 2022 to 2024 is accurately described, with correct emphasis on its role in building and assembling 3D scenes. The integration into the broader Substance 3D ecosystem, including Painter, Sampler, Designer, and Modeler, is correctly identified. (2) There are no numeric values requiring verification (e.g., financials, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022 and 2024), which are accurate. (3) The multi-hop reasoning is sound—LLM synthesizes information across time points (2022 vs 2024) and product ecosystem context, correctly inferring a strategic shift toward integration and workflow cohesion. (4) The only minor deviation from the original answer is that the LLM mentions Stager being part of the 'Substance 3D Collection' in 2022, which is slightly more specific than the ground truth's reference to it being a trademark; however, this does not contradict known facts and is contextually reasonable. Overall, the answer captures the core strategic evolution accurately and with strong contextual and semantic fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 347,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE's strategic positioning regarding grid-scale batteries evolved as part of its broader energy transition strategy. In 2022, GE acknowledged that technologies like grid-scale batteries were still in early stages of deployment and would play a critical role in enabling deep decarbonization in the power sector. However, the company highlighted the uncertainty and challenges associated with developing and commercializing such technologies. By 2023, GE emphasized the importance of grid-scale batteries as part of the energy transition, noting that their adoption would depend on factors like technological advancements, cost considerations, and supportive policy frameworks. GE's strategic reliance on grid-scale batteries increased as part of its efforts to position itself in the evolving energy landscape, particularly through its Renewable Energy and Power businesses, which are integral to its GE Vernova portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in spirit but lacks precise alignment with the specific evolution described in the original answer. (1) Correct elements: The answer correctly identifies the general trend of GE increasing strategic emphasis on grid-scale batteries from 2022 to 2023, acknowledges uncertainty in early stages, and ties the technology to decarbonization and GE’s Renewable Energy and GE Vernova businesses. The years (2022, 2023) and entities (GE, grid-scale batteries, energy transition) are accurate. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this criterion is satisfied by default—no errors in dates or figures. (3) Multi-hop reasoning: The LLM captures the directional shift but misses the specific linguistic and strategic nuance in the original answer—namely, the shift from 'may become more important over time' (2022) to being a dependency 'in part' for achieving decarbonization goals (2023). This subtle but important shift—from speculative interest to strategic reliance—is underemphasized. The LLM mentions increased reliance but does not anchor it in the exact framing from the filings. (4) The answer is contextually relevant and well-structured, but the qualitative accuracy is reduced because it paraphrases the strategic evolution without capturing the precise escalation in strategic positioning as reflected in the original language of the filings. Hence, correctness and qualitative accuracy are scored at 7—core facts are right, but key nuances are missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 428,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "CVS's disclosure regarding broker-quoted debt securities in its fair value measurements indicates that the company did not have any broker-quoted debt securities for the years ended December 31, 2024, 2023, or 2022. This suggests that the use of broker quotes has remained absent in its fair value measurements during this period. Additionally, the absence of broker-quoted debt securities implies that their presence has not had a material impact on CVS's financial reporting or valuation methodologies for these years.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that CVS did not have any broker-quoted debt securities for 2024, 2023, and 2022, which aligns with the ground truth. However, the original answer specifies that in 2022, CVS disclosed no broker quoted securities for 2021 and 2020, and by 2024, the disclosure covered 2024 and 2023. The LLM incorrectly extends the absence to 2022 as part of the 2024 disclosure, when the original answer does not confirm whether the 2022 year was explicitly mentioned in the 2024 filing. This is a minor factual overreach. (2) All dates and years mentioned are factually consistent with the ground truth in terms of the absence of broker-quoted securities, so quantitative accuracy is perfect. (3) The multi-hop reasoning is partially sound: the model correctly infers consistent absence of such securities, but misses the nuanced evolution in disclosure tone — specifically, that the 2024 filing no longer mentions impact or review processes related to broker quoted securities, indicating reduced emphasis. This qualitative shift is a key part of the original answer and is omitted. (4) The answer is contextually relevant and addresses the core question about presence and impact, but lacks the comparative evolution in disclosure language over time, which limits completeness and qualitative accuracy. Hence, correctness is reduced to 7 for missing a key analytical point despite strong factual grounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 397,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, the composition of BlackRock's Equity Securities at FVTNI changed as follows: \n\n- **Equity securities/mutual funds** increased from $1,585 million in 2023 to $1,950 million in 2024, reflecting a $365 million growth. \n- **Equity method investments**, particularly in equity, fixed income, and multi-asset mutual funds, rose from $246 million in 2023 to $347 million in 2024, an increase of $101 million. Other equity method categories, such as hedge funds and private equity funds, remained relatively stable. \n\nOverall, there was a notable increase in both equity securities/mutual funds and equity method investments in 2024 compared to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, in 2023, BlackRock reported $1,211 million in equity securities/mutual funds, but the LLM incorrectly states $1,585 million. Similarly, equity method investments were $1,895 million in 2023 per the original answer, but the LLM reports only $246 million—this is a major discrepancy. The 2024 figures for equity securities/mutual funds ($1,950 million) are correct in the LLM answer, but the equity method investments are wrong: LLM reports $347 million vs. the correct $2,783 million. (2) Calculations are therefore also incorrect: the LLM reports a $365 million increase in equity securities/mutual funds, but the correct increase is $739 million ($1,950M - $1,211M). The LLM’s reported $101 million increase in equity method investments is vastly understated compared to the actual $888 million increase. (3) The multi-hop reasoning is partially sound in structure—comparing two years and two categories—but fails due to reliance on incorrect source data. The mention of 'fixed income, multi-asset mutual funds' and 'hedge funds and private equity funds' introduces granular detail not present in the ground truth and appears fabricated or misattributed. (4) Despite correct framing and relevance to the question’s intent, the severe numerical inaccuracies—especially in magnitude—warrant a low correctness score. Contextual relevance is high as the answer addresses the right categories and time frame, but quantitative accuracy is critically flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 436,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "From 2022 to 2024, UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities remained consistent in terms of unrealized losses and the allowance for credit losses. In 2022, the Company reported $274 million in gross unrealized losses for available-for-sale debt securities as of December 31, 2021, and the allowance for credit losses on these securities was not material. Similarly, in 2024, the Company noted that the allowance for credit losses on available-for-sale debt securities as of December 31, 2024, remained not material. The Company consistently evaluated impairments based on expected cash flows, issuer credit quality, and its intent to hold the securities, concluding that the unrealized losses were temporary and primarily due to interest rate changes rather than credit deterioration.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but misses the key evolution described in the ground truth. It incorrectly states that UnitedHealth Group's evaluation and treatment 'remained consistent' from 2022 to 2024, which contradicts the ground truth that identifies a meaningful shift toward a more formalized impairment accounting framework by 2024. The LLM fails to mention the structural change in how credit-related impairments are now recorded—through a separate allowance account and impacting investment income—which is central to the evolution. (2) Quantitatively, the LLM introduces a specific figure of $274 million in gross unrealized losses as of December 31, 2021, which is not present in the original answer and cannot be verified against the ground truth; this number may be fabricated or misattributed. The original answer does not provide any dollar amount for unrealized losses, only a qualitative explanation. The statement that the allowance was 'not material' in both years aligns with the ground truth for 2021 (referenced in 2022 report), but the 2024 assessment in the original answer emphasizes process evolution, not just materiality. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies factors like expected cash flows and issuer credit, it fails to synthesize the change in accounting treatment over time. The original answer highlights a progression from a qualitative, low-risk stance to a more structured recognition framework—this evolution is entirely missing in the LLM response, which instead asserts consistency. (4) Contextual relevance is high because the answer addresses the right topic, company, and time frame, and discusses relevant concepts like unrealized losses and credit deterioration. However, the failure to capture the core conceptual shift significantly undermines factual accuracy and qualitative reasoning, warranting moderate scores in quantitative (due to unsupported number) and low in qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 541,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Between 2022 and 2023, AMD's financial relationship with the ATMP Joint Venture (JV) showed an increase in both investment value and equity income. The carrying value of AMD's investment in the ATMP JV rose from approximately $69 million in 2022 to $99 million in 2023. Additionally, equity income from the ATMP JV increased, with gains recorded at $14 million in 2022 and $16 million in 2023. Purchases from the ATMP JV remained consistent at $1.7 billion in both years, while payables to the JV decreased from $463 million in 2022 to $363 million in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in carrying value and equity income from 2022 to 2023, and accurately reports the 2023 carrying value ($99 million) and both years' equity income ($14M in 2022, $16M in 2023). However, it incorrectly states the 2022 carrying value as $69 million, whereas the ground truth is $83 million—a significant factual error. This undermines the quantitative accuracy. (2) The additional details about purchases ($1.7B) and payables (decrease from $463M to $363M) are contextually relevant but not requested in the question, which focused only on investment value and equity income. While not incorrect, they do not add to the core correctness. (3) The multi-hop reasoning is partially sound—AMD’s increasing stake and income are correctly inferred—but the incorrect baseline value in 2022 affects the validity of the trend analysis. (4) The qualitative reasoning and structure are strong, and the answer is highly relevant, but the key numerical inaccuracy in the 2022 carrying value reduces the correctness score. A correct trend with wrong numbers cannot score highly on quantitative accuracy or overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 332,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth Group's exposure to tort claims, particularly those related to the delivery of health care services, has remained a consistent risk between 2022 and 2024. In both periods, the company faced claims such as medical malpractice by affiliated physicians or health care practitioners, including those who are employed by or contract with the company or serve in managed care networks. The nature of these claims has not changed significantly, but the potential financial impact has increased due to the rising number of legal actions and the complexity of new theories of liability that may not be subject to damage caps. Additionally, in 2024, the company highlighted a cyberattack on its Change Healthcare business, which, while not a tort claim, underscores the broader risk environment and potential for increased legal and financial exposure. The company remains largely self-insured for litigation risks, and the potential for actual losses to exceed recorded liabilities remains a concern.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that UnitedHealth Group faces tort claims related to medical malpractice and professional liability, and that the company is largely self-insured—consistent with the 2022 ground truth. It also correctly notes the increasing number of legal actions and the emergence of new liability theories not subject to damage caps, which aligns with the original answer. However, the LLM incorrectly implies that the nature of the claims has not changed significantly, whereas the ground truth states a clear shift in 2024 toward broader legal risks involving clinical quality, patient safety, and reputational harm—indicating an evolution in both nature and scope. The LLM mentions the 2024 cyberattack on Change Healthcare, which is factually accurate and relevant to overall risk, but it is not a tort claim and distracts from the specific evolution in tort exposure. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model synthesizes self-insurance and malpractice risks across time, but fails to fully capture the qualitative shift in risk profile from 2022 to 2024 as emphasized in the ground truth. The evolution from narrowly defined malpractice exposure to broader systemic risks (including reputational and relationship impacts) is underdeveloped. (4) The answer is contextually relevant and well-structured, but misses a key nuance in the evolution of tort claims. While it captures continuity, it underrepresents the change in focus and expansion of risk in 2024, which is central to the question. Hence, correctness and qualitative accuracy are reduced to 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 475,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Between 2023 and 2024, Boeing's three-year revolving credit agreement, originally expiring in August 2025, remained in place with a $3.0 billion total commitment. In 2024, Boeing entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029, while terminating older, smaller facilities. This evolution reflects a shift toward securing longer-term liquidity and consolidating borrowing capacity, indicating a strategy to enhance financial flexibility and ensure robust backup liquidity for corporate needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.0 billion three-year revolving credit agreement from 2023 expiring in August 2025, and the new $4.0 billion five-year facility expiring in May 2029 established in 2024. It accurately notes the continuation of the original agreement and the termination of older facilities. All key facts from the ground truth are present except the explicit mention that two other credit facilities were terminated, though the phrase 'older, smaller facilities' reasonably implies this. (2) Quantitative accuracy is perfect: dollar amounts ($3.0 billion, $4.0 billion), expiration dates (August 2025, May 2029), and agreement durations (three-year, five-year) all match the original answer exactly. No calculation errors. (3) The multi-hop reasoning is sound—correctly synthesizing changes across years and facilities to infer Boeing’s strategic intent around liquidity and financial flexibility. The conclusion about enhancing financial flexibility and securing longer-term liquidity aligns with the ground truth. (4) The answer is semantically equivalent to the original, with only minor wording differences (e.g., 'consolidating borrowing capacity' vs 'reinforcing financial flexibility'). The omission of specifying 'two' terminated facilities is a minor detail that does not undermine the overall correctness. Thus, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 404,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "The financial impact of the 2017 Performance-based Options evolved between 2023 and 2024 as follows: the total fair value of options vested decreased from $56 million in 2023 to $52 million in 2024, while the aggregate intrinsic value of options exercised increased significantly from $44 million in 2023 to $373 million in 2024. This reflects the vesting of the final tranche in 2024 and a higher stock price, leading to greater intrinsic value upon exercise.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information from the ground truth. The fair value of options vested decreased from $56 million in 2023 to $52 million in 2024, and the intrinsic value of options exercised increased from $44 million to $373 million—both figures match the original answer exactly. (2) All numeric values are accurate and properly attributed to the correct years and financial metrics. Format variations (e.g., 'aggregate' vs. 'total') do not affect meaning and are semantically equivalent. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes data across two years and two financial metrics (fair value of vesting and intrinsic value of exercises), and even adds a reasonable qualitative insight about the final tranche vesting and higher stock price, which aligns with the implied context without contradicting it. (4) The answer is fully complete, addressing both parts of the question (evolution of fair value and intrinsic value), with correct entities (2017 Performance-based Options, 2023, 2024), and conveys the same conclusion as the ground truth. All scores are maximized due to full factual accuracy, correct synthesis, and appropriate contextual interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 347,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Between 2022 and 2023, AMD's approach to estimating adjustments for product return rights remained largely consistent, with no specific changes in methodology explicitly mentioned in the provided pages. The methodology continued to rely on historical data, including actual historical returns, rebates, and credits issued to OEM and distributor customers, adjusted for known events or current economic conditions. Additionally, estimates for distributor price incentives and price protection were based on historical incentives and known future price movements derived from internal and external market data analysis. The company emphasized that these estimates have historically been materially consistent with actual results, though they remain subject to management judgment.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in stating that AMD used historical data for estimating product return adjustments in both years, which aligns with the ground truth. However, it fails to identify the key qualitative evolution in AMD's methodology between 2022 and 2023. The original answer specifies that in 2023, AMD adopted a more structured approach by explicitly incorporating 'rights of return and rebates' as variable consideration under ASC 606-10-32-8 through 14 and shifted to using the 'most likely amount' method for estimating returns. This represents a significant methodological refinement toward greater alignment with accounting standards, which the LLM answer omits entirely. Instead, the LLM claims 'no specific changes in methodology were explicitly mentioned,' which contradicts the documented shift in approach. While the entities (AMD, years 2022–2023, product returns) and general context are accurate, and there are no numerical inaccuracies (hence full quantitative accuracy), the failure to capture the core change in accounting treatment and estimation logic results in a low qualitative accuracy score. The answer is contextually relevant and well-structured but misses the critical multi-hop insight about evolving compliance with ASC 606 guidance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 356,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The number of shares under option for the 2017 Performance-based Options decreased from 1,549,080 in 2023 to 625,825 in 2024, reflecting significant exercises and forfeitures during the year. Specifically, 905,219 shares were exercised, and 18,036 shares were forfeited. This indicates a high level of activity, with a substantial portion of the options being exercised by employees, likely due to the options reaching their vesting and exercise milestones, while a smaller number were forfeited, suggesting relatively stable employee retention for this cohort.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the starting number of shares (1,549,080 in 2023), ending number (625,825 in 2024), exercised shares (905,219), and forfeited shares (18,036) are identical to the ground truth. The implied calculation (1,549,080 - 625,825 = 923,255 total reduction; 905,219 + 18,036 = 923,255) is correct, confirming the numbers are consistent. (2) The answer is complete, addressing both parts of the question: the evolution of shares (decrease from 2023 to 2024) and the interpretation regarding exercise and forfeiture trends. (3) Entity accuracy is perfect: the option plan (2017 Performance-based Options), years (2023 and 2024), and financial terms (exercised, forfeited) are correctly identified. (4) The reasoning is sound and adds contextual insight—linking the high exercise volume to vesting milestones and interpreting low forfeitures as a sign of stable retention—without contradicting the ground truth. The LLM successfully performs multi-hop synthesis by connecting the numerical change to underlying employee behavior. (5) Semantic equivalence is achieved: while the LLM elaborates slightly more on implications, all core facts and conclusions align with the original answer. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 374,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx has expanded its role and strategic positioning within UnitedHealth Group by enhancing its pharmacy care services and integrating more deeply into the broader health care ecosystem. In 2024, Optum Rx managed $178 billion in pharmaceutical spending, up from $112 billion in 2022, reflecting significant growth in its pharmacy spend management. The service offerings have evolved to include more comprehensive clinical programs, digital tools, and a stronger focus on integrating medical, pharmacy, and behavioral care. Additionally, Optum Rx has embedded pharmacists into patient care teams to improve health outcomes and lower total cost of care, aligning with UnitedHealth Group's broader strategy of value-based care and holistic health management.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. It states that Optum Rx managed $178 billion in pharmaceutical spending in 2024, which is incorrect — the ground truth reports $112 billion in 2022 and explicitly notes that no spending figures were provided for 2024. This $178B figure is fabricated and represents a major factual error. Additionally, the claim of growth from $112B to $178B implies a specific increase not supported by the source. (2) Other service offerings mentioned — such as comprehensive clinical programs, digital tools, integration of medical/pharmacy/behavioral care, and embedding pharmacists into care teams — are plausible extensions of the 2022 description and align thematically with UnitedHealth’s value-based care strategy, so these qualitative elements are partially correct. However, these enhancements are not explicitly confirmed in the 2024 data provided in the ground truth. (3) The multi-hop reasoning is partially sound: the model attempts to show evolution over time and connects Optum Rx to broader UnitedHealth Group strategy, which is valid. But it invents data to support the narrative, undermining the reasoning. (4) While the answer addresses the question's focus on evolution in service offerings and strategic positioning, it does so with incorrect numerical foundations. The contextual relevance is high because it stays on topic and discusses integration, strategy, and care models appropriately. However, the quantitative inaccuracy severely undermines the correctness score, warranting a 4/10 — partially correct but with major factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 452,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "The composition and valuation of BlackRock's Equity Securities at FVTNI related to investments held for deferred cash compensation plans decreased from $241 million as of December 31, 2023, to $173 million as of December 31, 2024. This indicates a reduction in the value of these investments used to economically hedge the market valuation changes on certain deferred cash compensation plans during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. According to the ground truth, BlackRock reported $9 million in Equity Securities at FVTNI in 2023 related to deferred cash compensation plans, not $241 million. In 2024, this category was reclassified and no longer appeared under FVTNI but instead under 'Investments related to deferred cash compensation plans' in the Equity Method section with a value of $173 million. The LLM incorrectly states that the value decreased from $241M to $173M, implying a reduction in investment value, when in fact the change reflects a reclassification in reporting, not an economic decrease. (2) The numbers are significantly off: $241M vs. $9M in 2023 is a major discrepancy. The 2024 figure of $173M is correct but misattributed to the wrong category and interpreted as a decline rather than a reclassification. (3) The multi-hop reasoning failed: the model did not recognize that the change was due to a reclassification in financial statement presentation, not a change in market value. It missed the key qualitative shift in how the investments were categorized (from FVTNI to Equity Method), which is central to understanding the change in composition. (4) The contextual relevance is moderate because the answer addresses the right topic and time frame, but the factual and conceptual errors severely undermine correctness. Quantitative accuracy is very low due to wrong figures and misinterpretation of trends. Qualitative accuracy is poor because the reasoning misrepresents the nature of the change. Correctness score is low due to major factual and interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 452,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "The aggregate available authorization for Accenture's open-market share purchase program increased from $3,129,296 as of August 31, 2022, to $6,694,281 as of August 31, 2024. This significant increase indicates a more aggressive capital allocation strategy, with the company prioritizing share repurchases as a means to return value to shareholders and optimize capital structure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change in aggregate available authorization. The ground truth states a decrease from $3,129,296 in 2022 to $2,694,281 in 2024, but the LLM incorrectly claims an increase from $3,129,296 to $6,694,281—more than doubling the actual 2024 figure. This misrepresents the core quantitative fact. (2) The numbers are not accurate: the 2022 figure is correct, but the 2024 figure is wrong ($6,694,281 vs. correct $2,694,281), and the implied change is +$3.565 billion instead of the actual decrease of -$435,015. Calculations and comparisons are therefore fundamentally flawed. (3) The multi-hop reasoning fails because the model draws the opposite conclusion based on incorrect data: claiming an 'aggressive capital allocation strategy' when the truth indicates a more conservative approach due to reduced authorization. The synthesis across years is invalid due to incorrect data retrieval. (4) Despite the severe factual errors, the answer is contextually relevant—it addresses the right company, metric, time frame, and attempts to interpret capital allocation strategy—hence a moderate score for contextual relevance. However, correctness and quantitative accuracy are severely compromised, warranting a correctness score of 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 366,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved with increased specificity regarding share repurchase activity and shareholder rights. In 2022, the focus was on general repurchase activity, including open-market purchases and redemptions, with no specific figures for exchangeable shares. By 2024, the disclosures became more detailed, explicitly reporting 47,752 shares of Accenture Canada Holdings Inc. Exchangeable Shares repurchased for $15,254, and providing a clearer explanation of the relationship between these shares and Accenture plc Class A ordinary shares. Additionally, the 2024 filing emphasized the non-transferability and redemption terms of Class X ordinary shares, which are linked to the exchangeable shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It claims that in 2024, 47,752 exchangeable shares were repurchased for $15,254 — this specific transaction data is not present in the ground truth and contradicts it. The ground truth does not provide any exact number of exchangeable shares repurchased in 2024, only a remaining share repurchase authorization of $2,694,281 as of August 31, 2024. The LLM invents precise figures unsupported by the source. (2) The ground truth emphasizes the evolution from general intent in 2022 to more structured disclosure in 2024, especially regarding shareholder rights (e.g., one-for-one exchangeability, alignment of Class X shares with exchangeable shares). While the LLM captures the directional shift toward more detailed disclosure, it misrepresents the nature of the added detail — it incorrectly focuses on specific repurchase volumes rather than the clarified rights and structural alignment. (3) The multi-hop reasoning is partially sound: the model identifies the evolution in disclosure and attempts to contrast 2022 and 2024. However, it fails to correctly synthesize the key developments — particularly the one-for-one exchangeability and share alignment — and instead inserts false precision around repurchase activity. (4) Contextual relevance is high because the answer addresses the core themes: repurchase activity and shareholder rights over time. However, correctness is low due to fabricated numbers and omission of the most important 2024 disclosures. The qualitative accuracy is moderate because the conceptual framework is reasonable but based on incorrect data. Quantitative accuracy is poor due to the inclusion of unsupported figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 479,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The global revenue from Electrophysiology Devices increased by 14.4% between 2023 and 2024, excluding the impact of foreign exchange fluctuations. This growth was driven by higher procedure volumes and increased demand for catheters and cardiac mapping products across all regions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the percentage change excluding foreign exchange fluctuations (14.4%), which matches the ground truth. However, it omits the actual revenue figures for 2023 ($2,195 million) and 2024 ($2,467 million), which are key components of the question. The total percentage change (12.3%) is also missing. (2) While the 14.4% figure is accurate, the absence of the dollar amounts and the reported 12.3% overall change means the quantitative response is incomplete. The calculation of 14.4% as the FX-neutral growth is correct, but without showing or referencing the base figures, full verification is hindered. (3) The reasoning about growth drivers (procedure volumes, demand for catheters and mapping products) is plausible and adds context, but this information was not requested in the question and does not compensate for missing factual elements. The model fails to fully synthesize the multi-hop requirement of reporting both absolute revenues and both percentage changes. (4) Scores reflect that core percentage data is correct (hence partial credit), but the omission of revenue figures and one of the two percentages significantly reduces completeness and quantitative accuracy. Contextual relevance is high as the answer stays focused and adds reasonable qualitative context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 368,
        "total_tokens": 1511
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Accenture's investment in Duck Creek Technologies is accounted for using the equity method, reflecting its significant influence through a 16% ownership stake. As of August 31, 2022, the carrying amount of the investment was $138.9 million, with an estimated fair value of $223.2 million. In fiscal 2023, Accenture recorded a $253 million investment gain related to this investment, which positively impacted its adjusted effective tax rate and adjusted diluted earnings per share. No specific updates on the investment's valuation or performance are provided in the 2024 filing, but the 2023 gain indicates a notable positive impact on financial performance during that period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timing. The ground truth states that the fiscal 2022 investment value was $223,166 (approximately $223.2 thousand), not $223.2 million as stated by the LLM—this is a critical error of three orders of magnitude. Additionally, the LLM claims the carrying amount was $138.9 million as of August 31, 2022, which does not appear in the original answer and contradicts the ground truth. The $253 million gain is correctly cited but attributed to fiscal 2023 in the LLM answer, while the original answer specifies fiscal 2024—this misalignment in fiscal year reduces quantitative accuracy. (2) The calculation of the gain is not explicitly verified, but the $253 million figure itself matches; however, its attribution to the wrong fiscal year undermines confidence. The ownership percentage (16%) and accounting method (equity method) are correct. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the investment’s impact on financial performance (e.g., tax rate and EPS), which shows understanding of financial implications. However, it fails to reflect the evolution from 2022 to 2024 clearly, especially by omitting the 2024 update and incorrectly stating that no 2024 data is available. (4) Despite these issues, the answer remains contextually relevant, addressing investment valuation and financial impact. The qualitative reasoning about influence and financial effects is accurate, and the core narrative of value increase is preserved, albeit with flawed support. Hence, correctness is reduced primarily due to significant numerical and temporal inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 456,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Between 2022 and 2023, Union Pacific shifted its executive compensation strategy by increasing the scale and emphasis on retention share and unit awards while reducing reliance on stock options. In 2022, the 2021 Stock Incentive Plan included 389,207 retention shares, and by 2023, the number of retention units and shares available for issuance rose significantly to 31,979,909 under active equity compensation plans. This shift reflects a strategic focus on long-term retention and performance-based incentives, aligning executive interests with shareholder value through vesting periods and performance metrics like ROIC and operating income growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It states that '31,979,909' retention shares and units were available for issuance in 2023, which is incorrect and not supported by the ground truth. The original answer specifies 954,405 retention shares and 366,046 retention units as outstanding (not available for issuance), totaling about 1.32 million instruments, not over 31 million. This is a major numerical error that undermines the answer's credibility. Additionally, the LLM incorrectly frames the 2022 figure as being from the 2021 plan 'in 2022', while the ground truth states it was outstanding as of December 31, 2021, which is a subtle but important timing discrepancy. (2) The calculation and comparison of numbers are flawed. The LLM implies a massive increase to over 31 million, which is not accurate. The actual increase from ~389k to ~1.32 million is significant but not nearly as large. The introduction of retention units in 2023 is correctly inferred as a strategic shift, but the scale is misrepresented. (3) The multi-hop reasoning is partially sound—linking increased retention instruments to a shift in executive compensation strategy is valid and aligns with the ground truth. The mention of performance metrics like ROIC and operating income growth adds context not in the original answer, which may be plausible but is unsupported by the provided truth and thus speculative. (4) Despite the incorrect numbers, the answer captures the general strategic direction—increased use of retention-based compensation and a move away from stock options—so it retains some qualitative and contextual relevance. However, the severe quantitative inaccuracies limit its correctness score to 4, as the core data is wrong even if the directional interpretation is reasonable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 502,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "Between 2023 and 2024, MetLife's application of GAAP guidance for adjusted earnings remained consistent in excluding market volatility and asymmetrical accounting adjustments. Adjusted earnings continue to exclude net investment gains/losses, net derivative gains/losses, market risk benefit (MRB) remeasurement gains/losses, and asymmetrical accounting associated with in-force reinsurance. In 2024, the adjustments were applied similarly to 2023, with exclusions for market-driven distortions and non-economic accounting impacts across segments. The 2024 disclosures reflect ongoing adherence to these principles without significant changes in methodology.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in identifying that MetLife excludes market volatility and asymmetrical accounting adjustments from adjusted earnings, and correctly references exclusions such as MRB remeasurement gains/losses and in-force reinsurance asymmetrical accounting. However, it fails to capture the key evolution between 2023 and 2024 as described in the ground truth. Specifically, the LLM claims there were 'no significant changes in methodology,' which directly contradicts the ground truth stating that MetLife expanded exclusions in 2024—particularly around policyholder liability remeasurement gains (losses) and net investment income adjustments for joint ventures under the equity method. These are material updates that the LLM omits. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2023, 2024) are correct, hence a score of 8. (3) The multi-hop reasoning is flawed: the question asks how the application evolved, requiring comparison across years and synthesis of changes in GAAP guidance application. The LLM fails this by asserting consistency rather than evolution, missing the refinement and expansion of exclusions in 2024. (4) Contextual relevance is moderate—the response stays on topic and discusses adjusted earnings and exclusions, but misses the core of the question: the evolution and increased specificity in 2024. Thus, correctness is reduced to 4 due to significant factual omission of developments in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 431,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "From 2022 to 2024, Accenture's approach to achieving compressed transformations has evolved by expanding the scope of technologies leveraged and enhancing the breadth of transformation services offered. In 2022, the focus was on technologies like cloud, data, AI, and emerging innovations such as the metaverse and quantum computing. By 2024, the emphasis has shifted to include generative AI as a transformative force, alongside blockchain, robotics, 5G, edge computing, and advanced automation. Additionally, the scope of services has broadened to include deeper integration of AI and digital twins in operations, expanded offerings in intelligent operations via SynOps, and a stronger focus on sustainability and talent development to support enterprise-wide reinvention.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general evolution of Accenture's approach to compressed transformations from 2022 to 2024 and correctly identifies the expansion in both technology and service scope. However, there are notable discrepancies in the specific technologies mentioned. The original answer specifies digital twins, IoT, 5G, advanced robotics, and metaverse in 2022, while the LLM includes quantum computing and blockchain—technologies not mentioned in the ground truth. Quantum computing is not referenced in the original data for 2022, and blockchain is not part of the documented technological toolkit. In 2024, the LLM correctly highlights generative AI and robotics but misses the addition of artificial reality / virtual reality and Accenture’s own development of automation equipment and commercial hardware, which are key differentiators in the ground truth. Additionally, the LLM introduces 'SynOps' and 'sustainability and talent development' as expanded offerings, which are not mentioned in the original answer. While these may be plausible, they are not supported by the provided ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly infers an evolution in technological focus and service breadth over time. However, it fails to accurately synthesize the exact technologies and service expansions documented in the knowledge graph, particularly the shift toward digitally transforming capital projects (e.g., plant construction, power grids, data centers), which is a major point in the original answer and entirely missing in the LLM response. (4) The contextual relevance is high because the answer addresses the evolution of Accenture’s transformation approach, but the correctness score is reduced due to factual inaccuracies and omissions in key technologies and service scope. The answer is plausible but not factually aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 556,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Between 2023 and 2024, Abbott's use of interest rate hedge contracts remained consistent in managing exposure to changes in the fair value of fixed-rate debt. In both years, Abbott had interest rate hedge contracts with notional values totaling approximately $2.2 billion. These contracts were designated as fair value hedges, effectively converting fixed-rate debt obligations into variable-rate obligations for the hedged portions. The fair value of these contracts was recorded on the balance sheet, with offsetting adjustments to the carrying amount of the related fixed-rate debt. The 2024 disclosures indicate no significant changes in the strategy or scale of these hedging activities compared to 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Abbott maintained $2.2 billion in notional value of interest rate hedge contracts in both 2023 and 2024, accurately reflecting the quantitative consistency in hedge usage. It correctly identifies the contracts as fair value hedges that convert fixed-rate debt to variable-rate debt, which aligns with the ground truth. However, the LLM omits a key qualitative point from the original answer: the increase in the average interest rate on long-term debt from 3.6% in 2023 to 3.8% in 2024. This is a significant detail that provides context about underlying debt or market rate changes despite stable hedging notional amounts. (2) All numeric values—$2.2 billion notional amount and the correct years—are accurate and match the ground truth. There are no calculation errors. (3) The reasoning is sound in recognizing the continuity of Abbott’s hedging strategy across years and the mechanism of fair value hedges. However, the multi-hop synthesis is incomplete because it fails to integrate the evolution in the cost of debt (interest rate increase), which is central to understanding how exposure management evolved in context. (4) The answer is highly relevant and factually correct on the hedging program’s scale and designation, earning high marks for quantitative accuracy and contextual relevance. The omission of the interest rate shift reduces completeness and depth of qualitative analysis, justifying a slight deduction in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 421,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "MetLife's treatment and definition of Adjusted Earnings remained largely consistent between 2023 and 2024, with both years excluding market volatility, asymmetrical and non-economic accounting, and revenues/costs from divested businesses. However, in 2024, the adoption of LDTI simplified the measurement model for DAC and VOBA, leading to updated adjustments in the calculation of Adjusted Earnings, including the exclusion of changes in fair value associated with MRBs and certain guarantee remeasurements. Additionally, 2024 included enhanced segment expense disclosures under ASU 2023-07, aligning with GAAP guidance for segment reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements correctly but misses critical nuances and contains inaccuracies in the evolution of Adjusted Earnings between 2023 and 2024. (1) Correctly identifies that LDTI adoption in 2023 triggered changes in Adjusted Earnings, particularly around DAC/VOBA amortization and exclusion of MRB fair value changes and guarantee remeasurements—this aligns with the original answer. It also correctly notes consistency in excluding market volatility, asymmetrical accounting, and divested business impacts. However, it incorrectly states that LDTI adoption occurred in 2024, when the ground truth specifies the change was implemented in 2023. This is a significant factual error affecting the timeline of the evolution. (2) The LLM mentions 'enhanced segment expense disclosures under ASU 2023-07'—a detail not present in the original answer and not tied to the definition of Adjusted Earnings itself, potentially conflating segment reporting enhancements with the metric's calculation. This introduces extraneous information and distracts from the core evolution of exclusions. (3) The original answer emphasizes that 2024 refinements included more structured exclusions like inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts—these are entirely missing in the LLM response, representing a major omission in completeness. (4) While the LLM correctly identifies some exclusions (MRBs, guarantee remeasurements), it fails to mention the explicit 2024 expansion to exclude net investment gains/losses, derivative gains/losses, and goodwill impairments, which are central to the refinement. (5) The reasoning is partially sound in linking LDTI to changes in Adjusted Earnings, but the misattribution of timing and lack of specificity on 2024's expanded exclusions weakens the multi-hop synthesis. Overall, the answer is directionally correct but lacks precision and completeness on the key developments, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 539,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From 2022 to 2024, Accenture's available share repurchase authorization increased from $3,129,296 as of August 31, 2022, to $2,694,281 as of August 31, 2024, following additional authorizations of $4,000,000 in 2024 and $3,000,000 in 2022. Share acquisitions primarily occurred through open-market purchases, with 11,753,807 shares in 2024 compared to 9,635,751 in 2022, while other purchases, such as those for payroll tax obligations, slightly decreased. The company also continued utilizing its Employee Share Purchase Plan (ESPP), issuing 84,424,032 shares under the 2010 ESPP by August 31, 2024, with annual issuance rates fluctuating between 4.3 million and 5.7 million shares during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. Most critically, it incorrectly states that the available authorization increased from $3,129,296 in 2022 to $2,694,281 in 2024, which is a decrease, not an increase, and contradicts the claim of additional authorizations totaling $7 million. The ground truth does not mention any new authorizations in 2022 or 2024, nor does it report the 2024 authorization level—thus the LLM fabricated data. The share purchase numbers (11.7M in 2024 vs 9.6M in 2022) and ESPP issuance (84.4M shares) are not supported by the original answer and appear invented. (2) Quantitative accuracy is very low: the only correct number is the 2022 available authorization ($3,129,296), but all other figures (new authorizations, 2024 authorization, share volumes, ESPP data) are incorrect or unsupported. The claim of increased authorization despite a lower ending balance shows flawed calculation logic. (3) Qualitatively, the reasoning fails on multi-hop synthesis. The original answer emphasizes a shift in acquisition methods—from open-market purchases to share withholding for tax obligations—and a narrowing in scope to Accenture plc Class A shares. The LLM instead claims open-market purchases increased and other purchases slightly decreased, missing the key shift entirely. It also conflates share repurchase programs with the Employee Share Purchase Plan (ESPP), which is unrelated to repurchases and not mentioned in the context of the buyback program in the ground truth. (4) Contextual relevance is moderate because the answer addresses share purchase programs and time evolution, but it introduces irrelevant elements (ESPP issuance volumes) and misrepresents the core dynamics of funding and acquisition methods. The focus on incorrect metrics reduces overall relevance despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 505,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "From 2023 to 2024, MetLife's treatment and valuation methodology for Unit-linked Securities remained consistent in terms of cost basis, as these securities are primarily equity securities and fixed maturity securities valued at original cost adjusted for amortization, repayments, and impairments. However, there was an increase in the estimated fair value of Unit-linked Securities, rising from $10,331 million in 2023 to $11,900 million in 2024, indicating heightened sensitivity to market conditions and valuation inputs. The changes in fair value are influenced by factors such as equity returns, interest rates, and market volatility, as outlined in the fair value sensitivity disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly references Unit-linked Securities and MetLife, it incorrectly states that the cost basis methodology remained consistent from 2023 to 2024. The ground truth shows a clear shift from a cost-based approach (original cost for equities, amortized cost for fixed maturities) in 2023 to a Level 3 fair value methodology using significant unobservable inputs (e.g., mortality, lapse rates, equity volatility) in 2024. This evolution toward a more dynamic, assumption-driven model is entirely missed by the LLM. Instead, the LLM claims consistency in cost basis, which contradicts the ground truth. (2) The quantitative figures cited—$10,331 million in 2023 and $11,900 million in 2024—are not present in the original answer and cannot be verified against the provided ground truth. Since the ground truth does not include specific dollar amounts for fair value, these numbers appear to be hallucinated or sourced from outside the provided context. This severely undermines quantitative accuracy. (3) The multi-hop reasoning is flawed. The question asks about changes in treatment and valuation methodology, particularly cost basis and fair value sensitivity. The correct answer requires synthesizing disclosures across two years to identify a shift from static cost-based valuation to dynamic Level 3 fair value modeling with sensitivity analysis. The LLM fails this synthesis, instead asserting continuity and focusing on unverified fair value increases influenced by market factors like equity returns and interest rates—inputs not emphasized in the 2024 ground truth (which highlights unobservable actuarial assumptions, not market conditions). (4) Contextual relevance is moderate because the LLM addresses the general topic (valuation of Unit-linked Securities) and mentions fair value sensitivity, but misidentifies the nature of the change and introduces unsupported data. The emphasis on market conditions rather than unobservable inputs reduces qualitative accuracy. Overall, the answer is partially relevant but factually incorrect on the core evolution of methodology, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 588,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "Between fiscal years 2022 and 2023, the structure and vesting timeline of market-based RSUs evolved as follows: In fiscal year 2022, market-based RSUs generally vested over four years, subject to satisfaction of market conditions tied to total stockholder return (TSR) on an absolute basis and relative to an index group. In fiscal year 2023, in addition to the four-year vesting RSUs, Broadcom also granted market-based RSUs that vested over five years, subject to satisfaction of stock price performance milestones. This indicates a diversification in vesting timelines and performance metrics for market-based RSUs in 2023 compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: four-year vesting in 2022, introduction of five-year vesting in 2023, and performance conditions based on TSR and stock price milestones. There are no numerical inaccuracies. (2) The answer correctly identifies the evolution in structure and vesting timelines across the two fiscal years, capturing both the continuation of four-year RSUs and the addition of five-year RSUs tied to stock price performance. (3) The reasoning is sound and reflects proper multi-hop synthesis—comparing the structures between 2022 and 2023 and identifying the expansion in vesting designs. (4) The only minor difference from the original answer is that the LLM mentions TSR being measured on an 'absolute basis' in addition to relative to an index group, which was not specified in the ground truth; however, this does not contradict it and may reflect additional context. Also, the ground truth specifies the payout range (0% to 300%), which the LLM omits. This is a small completeness gap but does not undermine the core accuracy. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 343,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "Between 2023 and 2024, the phase-in treatment of the CECL standard's impact on regulatory capital continued under the CECL Transition Rule. In 2023, 50% of the cumulative \"day 2\" CECL impact was phased in, with the remaining 50% to be phased in over 2024 and 2025. By December 31, 2024, 75% of the impact had been phased in, with the final 25% to be added in January 2025. During the phase-in period, the Company added back an aggregate amount of $2.4 billion to regulatory capital in 2021, and phased in $600 million per year from 2022 to 2024, with the remaining $600 million phased in by January 1, 2025.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the CECL phase-in was 25% per year from January 1, 2022, through December 31, 2024 — meaning 75% would be phased in by end of 2024, not 75% by end of 2024 with 25% in 2025 as stated. The LLM incorrectly states that 50% was phased in by 2023 and implies a four-year phase-in ending in 2025, contradicting the three-year (2022–2024) framework. (2) The dollar amounts ($2.4 billion total, $600 million annually) are entirely fabricated and not present in the ground truth; the original answer contains no specific dollar figures. These numbers cannot be verified and appear invented. (3) The multi-hop reasoning is flawed: the LLM misidentifies the phase-in schedule and introduces entity-specific financial data (e.g., 'the Company added back...') not referenced in the question or ground truth, suggesting confusion between general regulatory treatment and a specific firm’s application. (4) While the answer correctly references the CECL Transition Rule and acknowledges a phase-in mechanism, it fails on core quantitative and qualitative accuracy. The contextual relevance is moderate because it addresses the right topic and timeframe but distorts key details. Correctness is severely penalized due to incorrect percentages, dates, and invented financials.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 379,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom's relationship with Wilmington Trust, National Association evolved with the issuance of new senior notes under additional indentures. In 2022, the company issued senior notes such as the 4.00% Senior Notes due 2029 and 4.15% Senior Notes due 2032 under indentures dated April 14 and April 18, 2022, respectively. In 2023, Broadcom expanded its senior notes offerings further, issuing the 5.050% Senior Notes due 2027, 2029, and 2031 under a July 12, 2024 indenture, as well as the 4.150%, 4.350%, 4.550%, and 4.800% Senior Notes due 2028, 2030, 2032, and 2034, respectively, under a subsequent October 2, 2024 indenture. These developments reflect an expansion in the types and terms of senior notes issued under their indentures with Wilmington Trust.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Broadcom issued senior notes under indentures from January 2021 (not April 2022), with interest rates ranging from 1.950% (due 2028) to 3.750% (due 2051). The LLM incorrectly claims that in 2022, notes were issued under indentures dated April 14 and April 18, 2022, including a 4.00% note due 2029 and 4.15% due 2032—these specific notes and dates do not appear in the ground truth. Furthermore, the LLM states that in 2023, Broadcom issued notes under a July 12, 2024 indenture and an October 2, 2024 indenture, including a 5.050% note due 2027 and others—this is chronologically impossible (issuing in 2023 under 2024 indentures) and factually incorrect. The ground truth confirms that the new indentures were dated April 18, 2022, and July 12, 2024, with notes issued later, including a 4.926% note due 2037 and October 2024 notes ranging from 4.150% to 4.800%. (2) Quantitative accuracy is very low: multiple incorrect interest rates (e.g., 5.050%, 4.350%, 4.550%), incorrect maturity years (e.g., due 2027, 2030, 2031), and incorrect indenture dates (April 14, 2022; October 2, 2024). The LLM fabricates details not present in the ground truth. (3) Multi-hop reasoning is flawed: the model fails to correctly track the evolution from 2022 to 2023, misrepresents the timeline, and invents future-dated indentures as active in 2023. It also misses the key insight that interest rates increased over time and maturities extended, instead listing a disjointed and incorrect set of notes. (4) Contextual relevance is moderate—the answer addresses the relationship with Wilmington Trust and senior notes, so the general topic is correct, but the specific details are largely fabricated. Due to major factual and chronological errors, the correctness score is low at 3, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 522,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One's regulatory capital add-back under the CECL Transition Rule evolved from 2023 to 2024 by following a phased-in approach. As of December 31, 2021, Capital One added back $2.4 billion to its regulatory capital under the CECL Transition Rule. By January 1, 2024, 75% of this amount had been phased in, and the remaining $600 million was fully phased in by January 1, 2025. This progression reflects the 25% annual phase-in of the cumulative impact from 2022 through 2024, as outlined in the CECL Transition Rule.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2.4 billion add-back amount and the 75% phase-in by January 1, 2024, which aligns with the ground truth. However, it incorrectly states that the add-back was effective as of December 31, 2021, whereas the ground truth specifies that the 50% phase-in was effective January 1, 2023. This misrepresents the timeline of the phase-in progression. Additionally, the mention of full phase-in by January 1, 2025, while logically consistent with a 25% annual increase, goes beyond the scope of the question, which only asks about the evolution from 2023 to 2024. (2) The $2.4 billion figure is correct, and 75% of that equating to $1.8 billion phased in (with $600 million remaining) is mathematically accurate. However, the ground truth emphasizes a 25 percentage point increase from 50% to 75% over the year, which the LLM fails to explicitly mention, weakening the quantitative narrative. (3) The reasoning correctly reflects the 25% annual phase-in under the CECL Transition Rule and synthesizes the concept of multi-year phase-in properly, showing sound understanding of the rule’s structure. However, it does not clearly articulate the 2023 (50%) to 2024 (75%) transition, which is central to the question. (4) The answer remains highly relevant and addresses the core topic of CECL phase-in progression, but minor factual inaccuracies in timing and over-extension into 2025 reduce its correctness. Overall, the answer is mostly accurate but contains key omissions and timeline errors that prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 430,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "Following the Broadcom acquisition, the treatment of VMware stock options for non-employee directors evolved as follows: in 2022, all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors were accelerated and converted into the right to receive cash and shares of Broadcom common stock in equal parts. By 2023, after the completion of the VMware Merger, these awards had already been settled under the terms of the merger agreement, with no further changes mentioned in the 2023 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly states that in 2022, outstanding in-the-money VMware stock options and RSUs for non-employee directors were accelerated and converted into equal parts cash and Broadcom shares upon acquisition. By 2023, it confirms the settlement occurred under the merger agreement. This matches the original answer's core claim: a transition from planned conversion (2022) to actualization (2023). (2) There are no numeric values requiring calculation, but the dates (2022 and 2023) and the description of the conversion terms (cash and Broadcom shares in equal parts) are correct. (3) The multi-hop reasoning is sound—synthesizing information across two years and reflecting the evolution from plan to execution. The only minor shortcoming is that the LLM says in 2022 the awards 'were accelerated and converted', while the original answer clarifies this was a *planned* action contingent on acquisition completion. The LLM slightly conflates timing by stating it happened in 2022, whereas the actual conversion occurred in 2023 upon completion. However, this is partially mitigated by the clarification that settlement occurred 'after the completion of the VMware Merger'. (4) Despite this nuance, the answer remains semantically equivalent in intent and outcome, with high contextual relevance and entity accuracy (VMware, Broadcom, non-employee directors, RSUs, stock options, merger timeline).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 406,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "From 2022 to 2024, the therapeutic positioning of Vraylar evolved by expanding its role in treating major depressive disorder (MDD) as an adjunctive therapy, with Phase 3 clinical trial results showing statistically significant improvement in depressive symptoms in one trial and numerical improvement in another. By 2024, Vraylar was positioned as a treatment for acute and maintenance treatment of schizophrenia in adults, acute treatment of manic or mixed episodes in bipolar disorder, acute treatment of depressive episodes in bipolar I disorder, and as an adjunctive treatment in MDD, reflecting a broader and more established therapeutic role in psychiatric care.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: in 2022, Vraylar was in Phase 3 trials for MDD with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement—this is accurately reflected. By 2024, the drug's indications expanded to include schizophrenia, bipolar disorder (manic/mixed and depressive episodes), and adjunctive MDD treatment, which the LLM correctly identifies. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts), but the qualitative descriptions of trial outcomes ('statistically significant' vs 'numerical improvement') match the original answer. (3) The multi-hop reasoning—synthesizing disclosures across 2022 and 2024 to show evolution in therapeutic positioning—is sound and well-articulated. The LLM correctly infers a broader and more established role over time. (4) The only minor shortcoming is that the LLM slightly softens the 2022 characterization by saying 'statistically significant improvement in depressive symptoms in one trial' without explicitly noting that the other trial did not achieve statistical significance—though it does say 'numerical improvement,' the emphasis on lack of significance is slightly weaker than in the original. This does not rise to an error but represents a small loss in precision. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 420,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "From 2022 to 2024, GE's accounting policy for long-term services agreements has remained consistent in using the percentage of completion method for revenue recognition, based on costs incurred relative to total expected costs. However, there is a notable evolution in the emphasis on estimating customer asset utilization and contract billing adjustments. In 2024, GE explicitly highlights the use of historical utilization trends and forward-looking information (e.g., market conditions and asset retirements) to refine revenue estimates, acknowledging that revisions to utilization or cost estimates can significantly impact contract profitability. Additionally, the 2024 disclosure provides more granular detail on the net liability balance and the sensitivity of contract profitability adjustments, reflecting a more transparent and dynamic approach to managing billing estimates and contract performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that GE used the percentage of completion method in both 2022 and 2024. According to the ground truth, GE used the straight-line method in 2022 and only shifted to the percentage of completion method in 2024, primarily in the CES segment. This misrepresents a key evolution in accounting policy. The LLM incorrectly claims consistency in method, when in fact there was a significant change. (2) Quantitatively, the LLM fails to include any of the specific numbers from the ground truth: the $6.6 billion net liability, the $162 billion total estimated life of contract billings, or the 4.1% ratio. These are central to the 2024 policy evolution and were explicitly mentioned in the original answer. Their absence indicates a failure to report critical quantitative disclosures. (3) The multi-hop reasoning is flawed because the model did not correctly synthesize the change in revenue recognition method over time. It also introduces details not present in the ground truth, such as 'historical utilization trends' and 'sensitivity of contract profitability adjustments,' which, while plausible, are not supported by the provided truth. The LLM invents a narrative of refinement and transparency without grounding in the actual data. (4) While the answer is contextually relevant—focusing on revenue recognition and billing estimates—it misses the core factual shift and omits key metrics, leading to a low correctness score. The qualitative reasoning appears sophisticated but is based on incorrect premises, reducing its accuracy despite coherent structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 444,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "In the 2022 10-K filing (page 30), IBM's disclosure of the 1.250% Notes due 2027 is not explicitly mentioned. However, in the 2023 10-K filing (page 1), IBM explicitly lists the 1.250% Notes due 2027 under the section detailing securities registered pursuant to Section 12(b) of the Exchange Act, with the trading symbol \"IBM 27B\" and noting they are traded on the New York Stock Exchange. This indicates an increased level of direct disclosure in 2023 compared to 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy by stating that the 1.250% Notes due 2027 were 'not explicitly mentioned' in the 2022 10-K, which contradicts the ground truth. According to the original answer, IBM did disclose the notes in the 2022 10-K by referencing Exhibit 4.3 to Form 8-K filed on January 30, 2019, as part of the instruments defining the rights of holders. This omission or misrepresentation undermines the correctness of the response. However, the 2023 disclosure details are accurate: the notes are correctly identified as being listed under Section 12(b), with trading symbol 'IBM 27B' on the NYSE. (2) Quantitatively, all referenced percentages (1.250% Notes due 2027) and symbols ('IBM 27B') are correct, and no numerical calculations are required, so quantitative accuracy is high. (3) The reasoning is partially sound in identifying a shift toward more direct disclosure in 2023, but the failure to acknowledge the 2022 reference to the notes via Exhibit 4.3 breaks the multi-hop synthesis required—this is a critical gap in reasoning. The conclusion about 'increased level of direct disclosure' could be valid if the 2022 omission were true, but since the 2022 disclosure did occur (albeit indirectly), the logic is flawed. (4) Contextual relevance is strong because the answer addresses the evolution of disclosure and focuses on the correct filings and sections. However, due to the major error in 2022 disclosure status, the overall correctness score is reduced to 5—partially correct but with a significant factual deficiency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 434,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "Between 2022 and 2024, the structure of AbbVie's performance-vested RSUs has remained consistent in terms of vesting increments, with the potential to vest in one-third increments over a three-year performance period. The performance metrics for these RSUs have also remained unchanged, as they are tied to AbbVie's return on invested capital (ROIC) performance relative to a defined peer group of pharmaceutical, biotech, and life sciences companies. No significant changes in the vesting structure or performance criteria were noted in the provided documents for this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the vesting structure and performance metric (ROIC relative to a peer group), correctly noting that the one-third annual vesting over a three-year period and the ROIC-based performance criterion remained consistent between 2022 and 2024. All entities (AbbVie, performance-vested RSUs, ROIC, peer group) and timeframes are correctly identified, and there are no numerical or date inaccuracies. However, the LLM answer misses a key qualitative evolution noted in the ground truth: the streamlining or simplification of the performance metric description by 2024, particularly the removal of references to specific years tied to tranches (e.g., awards from 2020 and 2021 mentioned in 2022 disclosures). While the core metrics are unchanged, the ground truth emphasizes a shift in presentation and standardization of criteria, indicating an evolution in how the performance conditions are communicated. The LLM incorrectly states 'no significant changes' were noted, which overlooks this nuance. This omission affects the depth of the multi-hop synthesis—comparing not just what metrics are used, but how their framing evolved—resulting in a partially complete answer. Despite this, the answer remains contextually relevant and quantitatively precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 363,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "From 2022 to 2024, GE's financial relationship with AerCap, as reflected in realized and unrealized gains or losses, evolved as follows: In 2022, GE reported a significant unrealized loss of $865 million related to its investment in and note with AerCap. By 2023, this improved to an unrealized gain of $129 million, indicating a recovery in the valuation of the investment. In 2024, GE recorded a smaller realized and unrealized gain of $38 million, suggesting a more stable and positive financial position in its relationship with AerCap.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a figure for 2023—$129 million unrealized gain—which is not present in the original ground truth. The ground truth only provides data for 2022 ($865M unrealized loss) and 2024 ($38M realized and unrealized gain). This 2023 number is unsupported and incorrect, significantly undermining quantitative accuracy. (2) The 2022 and 2024 figures are correctly stated: $865 million unrealized loss in 2022 and $38 million gain in 2024 match the ground truth. However, the addition of the 2023 data point introduces a false data point and implies a trajectory not confirmed by the source. (3) The reasoning about the evolution of GE's financial relationship with AerCap is generally sound—moving from loss to gain suggests improvement—and the conclusion about a more stable and positive position in 2024 aligns semantically with the original. However, the multi-hop synthesis is flawed because the model fabricates an intermediate step (2023) rather than acknowledging the gap between 2022 and 2024. (4) Correctness score is 6 due to partial factual accuracy: core numbers for 2022 and 2024 are correct, but the insertion of an incorrect 2023 value reduces overall reliability. Quantitative accuracy is low (4) due to the false $129M figure. Qualitative accuracy is moderate (7) as reasoning and entity identification (GE, AerCap, investment gains/losses) are correct, but the logic is based partly on false data. Contextual relevance is high (9) as the response directly addresses the evolution of financial relationship using the correct metrics and entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 437,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In the 2023 SEC filing (page 1), IBM's 0.300% Notes due 2026 are explicitly listed under \"Securities registered pursuant to Section 12(b) of the Act\" with the trading symbol IBM 26B, indicating clear disclosure and visibility as a registered financial instrument. In contrast, the 2022 filing does not directly reference the 0.300% Notes due 2026 in the provided pages, suggesting that its disclosure status was less prominent or possibly included in broader, incorporated documents not shown here. Thus, the 2023 filing provides more direct and transparent visibility for these notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all details are correct: the 0.300% Notes due 2026 are correctly associated with the 2023 filing and the trading symbol IBM 26B, with no incorrect numbers or dates. (2) The answer correctly identifies the shift in disclosure status between 2022 and 2023: in 2023, the notes are explicitly listed in Section 12(b) of the Act as registered securities, while in 2022, they are not directly referenced in the provided pages. (3) The reasoning is sound—though the LLM notes the 2022 absence 'in the provided pages' rather than citing the Exhibit 4 to Form 8-K from 2016 as in the ground truth, this reflects a minor omission rather than an error, likely due to limited access to full historical documents. The core multi-hop insight—that the 2023 filing shows increased visibility and formal recognition compared to 2022—is correctly inferred. (4) The answer is contextually relevant and addresses both disclosure status and visibility. The only reason for not scoring a 10 is the lack of specific mention of the 2016 Form 8-K exhibit reference in 2022, which slightly reduces completeness in entity provenance, though the overall qualitative and factual accuracy remains very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 354,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "Between 2022 and 2024, GE's approach to the RISE Program has evolved from initial development and announcement to a more mature phase of testing and integration of sustainable technologies. In 2022, the RISE Program was introduced as a joint initiative with Safran, targeting a 20% reduction in fuel consumption and CO2 emissions through innovations like Open Fan, compact core, and hybrid electric systems. By 2024, GE had progressed to completing over 250 tests on a full-scale Open Fan engine and emphasized the program as a core part of its strategy for sustainable flight, aligning with broader investments in next-generation propulsion technologies. This reflects a shift from conceptual development to active testing and positioning RISE as a key component of GE's long-term vision for decarbonizing aviation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of GE's RISE Program from 2022 to 2024, accurately stating the 20% reduction target in fuel consumption and CO2 emissions, the collaboration with Safran, and the focus on technologies like Open Fan and hybrid electric systems. The mention of 'over 250 tests on a full-scale Open Fan engine' by 2024 aligns with public disclosures and represents a factual advancement from conceptual design to testing, which is consistent with the ground truth's emphasis on increased investment and active R&D. (2) All quantitative elements are accurate: the 20% reduction figure is correctly cited, and while the original answer does not specify the number of tests, the LLM's inclusion of 'over 250 tests' is factually supported in external SEC-adjacent disclosures and press releases from GE during 2024, making it a valid addition rather than an error. (3) The multi-hop reasoning is sound—LLM synthesizes information across time (2022 announcement vs. 2024 progress), entities (GE and Safran), and technological focus, correctly inferring a strategic shift from announcement to active development. The only minor deviation is that the original answer emphasizes 'significant investments' as the marker of 2024 evolution, while the LLM emphasizes testing milestones. However, both reflect the same underlying shift from concept to execution, making them semantically equivalent. (4) The answer is fully contextually relevant, directly addressing the strategic emphasis and investment focus evolution. The slightly higher emphasis on testing vs. funding does not contradict the ground truth but complements it, warranting a high score but not perfect due to the subtle difference in framing the 2024 shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 478,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, the role and emphasis on asset securitizations within American Express's funding strategy remained a key component but showed subtle shifts in context. In both years, securitizations were highlighted as part of a diverse funding mix that includes deposits, unsecured debt, and secured borrowings. However, in 2023, the discussion placed greater emphasis on the importance of securitizations as a cost-effective funding source amid evolving market conditions and regulatory developments, such as the proposed rulemaking on long-term debt requirements. Additionally, the 2023 filing provided more detailed descriptions of securitization activities and their role in funding Card Member loans and receivables, indicating a more strategic and transparent approach to leveraging this funding tool.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies when compared to the ground truth. While both years mention securitizations as part of the funding mix, the key evolution identified in the original answer is that in 2022, securitizations were only defined in a glossary as a financial term without strategic emphasis, whereas in 2023 they were explicitly elevated to a core funding source alongside deposits and unsecured debt. The LLM incorrectly states that securitizations were 'highlighted' as part of the funding mix in both years, which misrepresents the 2022 disclosure as more strategic than it was. Additionally, the LLM introduces claims not present in the ground truth, such as securitizations being emphasized as a 'cost-effective' funding source in 2023 and being discussed in the context of 'regulatory developments like the proposed rulemaking on long-term debt requirements'—these specifics are not supported by the original answer. (2) There are no numerical values, dates, or calculations in either answer, so quantitative accuracy is not applicable; however, the LLM does not fabricate any numbers, so this dimension is neutral. (3) The multi-hop reasoning is partially sound—the model correctly identifies a shift in emphasis from 2022 to 2023—but it fails to accurately characterize the nature of the 2022 disclosure (glossary definition vs. strategic discussion) and adds unsupported strategic rationale for 2023. The synthesis is therefore incomplete and somewhat misleading. (4) The contextual relevance is high because the answer addresses the evolution of securitizations in American Express’s funding strategy and attempts to compare disclosures across years. However, the qualitative inaccuracy in representing the extent and nature of the disclosures significantly undermines factual correctness, warranting a mid-range score of 5 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 510,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "From 2022 to 2023, Emerson's financial and strategic relationship with AspenTech evolved through increased investment returns and deeper operational integration. In 2023, Emerson recognized a mark-to-market gain of $56 on its equity investment in AspenTech, reflecting improved financial performance. Operationally, the 2022 acquisition of Heritage AspenTech led to the creation of a new AspenTech segment, which contributed $656 million in sales in 2022 and showed a shift from a $7 million loss in 2021 to a $12 million profit in 2022, indicating successful integration and performance improvements.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It incorrectly states that Emerson recognized a $56 mark-to-market gain in 2023, which is not present in the ground truth; the original answer mentions a $12 earnings gain in 2022, not a $56 gain in 2023. Additionally, the LLM claims the acquisition of Heritage AspenTech occurred in 2022, but the ground truth states the acquisition happened in 2023. The LLM also misattributes the $656 million in sales to 2022 as part of the new segment’s contribution, but the original answer does not specify the year of that revenue contribution in context of post-acquisition performance. The shift from a $7M loss in 2021 to $12M profit in 2022 is fabricated and not supported by the ground truth. (2) Quantitative accuracy is partially correct: $656 and $12 appear in the ground truth (as sales and earnings gain, both in 2022), but the LLM misrepresents them as part of integration results rather than pre-acquisition performance. The $56 gain and the 2021 loss figure are entirely incorrect. (3) The multi-hop reasoning is flawed: the LLM fails to correctly sequence the timeline and nature of the relationship evolution. It incorrectly frames the 2022 data as evidence of post-acquisition integration, when in fact the acquisition occurred in 2023. It misses the key point that Emerson gained a 55% controlling stake in 2023, marking a shift to operational control, and that this acquisition improved gross margins by 0.6 percentage points—a critical strategic impact omitted in the LLM answer. (4) Despite these errors, the answer is contextually relevant, addressing investment returns and operational integration, and includes some correct entities (Emerson, AspenTech, financial figures). However, due to significant factual and chronological errors, especially around the timing of the acquisition and misrepresentation of financial impacts, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 523,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly due to the business combination to create \"New AspenTech.\" In 2022, Emerson became the accounting acquirer of Heritage AspenTech, recording a noncontrolling interest of $5.9 billion for the 45% ownership retained by former Heritage AspenTech stockholders. This noncontrolling interest was valued using the closing market price of Heritage AspenTech shares. By 2023, Emerson increased its ownership in AspenTech, and the financial impact of the Heritage AspenTech acquisition continued to influence equity and expenses, including intangible amortization and acquisition-related costs. Additionally, in 2023, Emerson acquired National Instruments Corporation, further expanding its industrial software portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key inaccuracies. It correctly identifies the 2022 creation of New AspenTech and the $5.9 billion noncontrolling interest, which aligns with the ground truth. However, it incorrectly states that Emerson became the 'accounting acquirer of Heritage AspenTech'—in reality, Emerson contributed its software business and $6.0 billion cash to form a new entity (New AspenTech), in which it held a 55% stake. The answer omits the $6.0 billion cash contribution and the $550 million decrease to additional paid-in capital, both critical to the 2022 accounting impact. (2) The LLM claims Emerson 'increased its ownership in AspenTech' in 2023, which is not supported by the ground truth; no change in ownership stake is mentioned for 2023. It also introduces the acquisition of National Instruments Corporation in 2023, which is irrelevant to the AspenTech financial relationship and not mentioned in the original answer. The ground truth specifies a $572 million increase in SG&A expenses in 2023 due to AspenTech integration and higher stock compensation, but the LLM only vaguely references 'acquisition-related costs' and 'intangible amortization' without quantification. (3) The multi-hop reasoning is partially sound—linking 2022 noncontrolling interest accounting to 2023 expense and margin impacts—but fails to accurately synthesize the evolution: the shift from initial equity accounting (2022) to operational integration effects (2023) is underdeveloped. (4) The contextual relevance is high as it addresses the core topic of financial evolution, but quantitative accuracy is reduced by missing and incorrect figures. Qualitative accuracy is moderate due to correct identification of noncontrolling interest and transaction significance, but flawed entity and ownership dynamics. Correctness score reflects partial accuracy with significant omissions and one major factual error (ownership increase in 2023).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 534,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "Between the 2022 and 2023 SEC filings, IBM's treatment and disclosure of the 6.22% Debentures due 2027 remained consistent in terms of reference and classification. In both filings, the debentures are listed as securities registered under Section 12(b) of the Exchange Act and are specifically identified with the ticker symbol \"IBM 27\" on the New York Stock Exchange. The 2022 filing references the instrument defining the rights of the holders of the debentures as Exhibit 3 to Form 8-K filed on August 1, 1997, and the 2023 filing retains the same reference, indicating no material change in the disclosure or treatment of these debentures.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. The ground truth states that there was a clear evolution in disclosure—from a historical reference in 2022 (Exhibit 3 to Form 8-K on August 1, 1997) to a more structured, market-oriented presentation in 2023 that includes the trading symbol IBM 27. However, the LLM claims the treatment and disclosure 'remained consistent' and that the ticker symbol was present in both filings, which contradicts the ground truth. This misrepresents the key change. (2) Quantitatively, the dates (August 1, 1997) and the debenture details (6.22%, due 2027) are correctly referenced, and the ticker symbol 'IBM 27' is accurately mentioned. These individual data points are correct, hence a higher quantitative accuracy score. (3) The multi-hop reasoning is flawed: the model fails to compare the nature of disclosure across years. It incorrectly assumes that because the same exhibit reference and ticker exist, there is no change—ignoring that the 2023 filing introduced a new level of structured, visible disclosure not present in 2022. The synthesis across filings is therefore inaccurate. (4) Contextual relevance is moderate because the answer discusses the right entities and filings, but the conclusion is opposite to the ground truth. The answer would be appropriate if the question were about continuity, but it misjudges the evolution aspect central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 398,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers has increased from 2023 to 2024, as the company assumes more economic risk for funding healthcare costs in return for premiums. This shift has implications for cost estimation, as the company must more accurately predict and manage medical costs, which are influenced by factors such as medical inflation, utilization rates, and regulatory changes. Additionally, the company's service delivery responsibilities have expanded, requiring enhanced care management and integration of value-based care models to ensure quality outcomes and cost efficiency.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the increase in UnitedHealth Group's financial risk exposure from 2023 to 2024 through risk-based arrangements and notes the implications for cost estimation and service delivery. It accurately reflects that the company assumes economic risk for healthcare costs in exchange for premiums, which aligns with the ground truth. However, the LLM omits specific qualitative details present in the original answer that are critical to full completeness: (1) the expanded responsibility in 2024 for unpaid claims if providers face financial difficulties or fail to meet obligations, and (2) the increased operational risk tied to providers' solvency, cost management, and data reporting for cost estimation. These omissions represent a lack of full multi-hop synthesis across the 2023 and 2024 disclosures. While the general direction of increased risk and broader responsibilities is correct, the absence of these specific 2024 risk mechanisms reduces the qualitative accuracy. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. The answer remains contextually relevant and semantically aligned in broad strokes but lacks the precise evolution of risk described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 354,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly in terms of investment magnitude and strategic involvement. In 2022, Emerson acquired two of its industrial software businesses and contributed them to Heritage AspenTech, resulting in Emerson owning 55% of AspenTech's common stock. By 2023, Emerson's strategic involvement deepened further, as it acquired National Instruments Corporation (NI) for $8.2 billion and continued to hold a controlling stake in AspenTech. Financially, Emerson recognized a mark-to-market gain of $24 related to AspenTech's foreign currency forward contracts in 2023, compared to a loss of $50 in 2022, indicating improved financial alignment and risk mitigation in its relationship with AspenTech.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that in 2022, Emerson acquired two industrial software businesses and contributed them to Heritage AspenTech, resulting in 55% ownership. In reality, according to the ground truth, Emerson's $362 million investment in 2022 was a financial stake, not a contribution of businesses or a controlling interest. The 55% ownership occurred in 2023, not 2022, when Emerson contributed its Industrial Software Business and $6.0 billion in cash — not through an acquisition of software businesses as stated. The LLM also introduces an irrelevant acquisition of National Instruments (NI) for $8.2 billion, which is unrelated to the AspenTech transaction and not mentioned in the original answer. Additionally, the $24 mark-to-market gain and $50 loss related to foreign currency forward contracts are factually incorrect in context — these figures do not reflect the core investment magnitude or strategic evolution described in the ground truth. (2) Quantitative accuracy is severely compromised: the $362 million 2022 investment is omitted; the $6.0 billion cash contribution in 2023 is missing; the 55% ownership is misattributed to 2022 instead of 2023; and fabricated numbers like $8.2 billion (NI acquisition) and $24/$50 gains/losses are introduced without basis in the original. (3) Multi-hop reasoning is flawed: the model fails to correctly trace the evolution from a minority financial investment in 2022 to a controlling strategic stake in 2023. Instead, it reverses the timeline and invents events, indicating a failure to synthesize the correct sequence and nature of transactions. (4) Contextual relevance is moderate because the answer addresses Emerson and AspenTech and attempts to discuss financial and strategic evolution, but the core facts, timing, and transactions are incorrect, undermining overall correctness. The answer introduces unrelated events (NI acquisition) and misrepresents the nature of the relationship shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 545,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023 by becoming a more integral part of Adobe's AI-driven personalization strategy. In fiscal 2022, Adobe Target was described as a tool for testing, targeting, and optimizing content across channels, while in fiscal 2023, it is highlighted as an AI- and machine learning-driven personalization engine that enables customers to deliver omnichannel, personalized experiences at scale. This evolution indicates Adobe's strategic direction of leveraging AI and machine learning to enhance customer experience management, enabling businesses to create more accurate and personalized customer journeys.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Adobe Target evolved from being a content testing and targeting tool in fiscal 2022 to an AI- and machine learning-driven personalization engine in fiscal 2023. The description of its capabilities—omnichannel personalization, large-scale testing via AI—matches the original. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct use of fiscal years (2022 and 2023), which are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two fiscal years and infers Adobe's strategic direction in AI-driven personalization. The only minor omission is that the original answer explicitly names other components of Adobe’s customer journey solutions (Marketo Engage, Adobe Campaign, Journey Optimizer), which the LLM answer leaves out. While not critical to the core evolution of Adobe Target, this contextual detail slightly enriches the completeness. (4) The semantic meaning and strategic implication are correctly conveyed: Adobe is increasingly emphasizing AI-powered personalization as a core differentiator. Wording differs slightly but meaning is equivalent. Thus, the answer is factually complete and correct with only a minor reduction in qualitative richness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 388,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson's financial stake in AspenTech evolved significantly from 2022 to 2023, primarily due to the acquisition of Heritage AspenTech in the third quarter of 2022. This acquisition led to the conversion of Heritage AspenTech's stock-based compensation awards into AspenTech awards, with the fair value of these awards allocated between pre- and post-combination service periods. In 2023, Emerson continued to integrate AspenTech by maintaining and managing its stock-based compensation plans, including performance stock units and restricted stock units, which were subject to performance and service conditions. Post-acquisition integration activities focused on aligning these compensation structures with Emerson's broader financial and operational strategies.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 acquisition of Heritage AspenTech and describes the conversion of stock-based compensation awards, which aligns with the post-acquisition integration activities. It also accurately notes the continuation of stock-based compensation plans like performance stock units (PSUs) and restricted stock units (RSUs) in 2023. However, it omits the specific financial stake amount of $8,326 million reported by Emerson in 2022, a key quantitative detail from the ground truth. This omission significantly affects quantitative accuracy. (2) The ground truth explicitly states a balance of $8,326 million related to AspenTech in 2022, which the LLM fails to mention. While the LLM references the acquisition and its timing (Q3 2022), it does not provide any dollar figures or financial metrics to quantify Emerson's stake, making the response incomplete on a core factual element. (3) The multi-hop reasoning is sound—linking the 2022 acquisition to 2023 integration efforts involving compensation alignment—but misses the synthesis of financial magnitude. The LLM correctly infers operational integration through incentive structures, showing good qualitative understanding. (4) The contextual relevance is high as the response stays focused on the evolution of the relationship, stake, and integration. Qualitative accuracy is strong due to correct entity identification (Heritage AspenTech, PSUs, RSUs) and logical flow. However, the lack of the $8,326 million figure results in a lower quantitative score and pulls the overall correctness down to 7, as this is a major financial fact central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 453,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "From 2022 to 2023, Adobe Experience Platform's role within Adobe's customer journey solutions evolved significantly, particularly in AI integration and cross-channel campaign orchestration. In 2022, the platform was positioned as a foundational infrastructure for collecting, connecting, and activating customer data in real time, enabling robust customer profiles and AI-driven insights. By 2023, Adobe Experience Platform had further integrated AI-powered tools through Adobe Sensei and Adobe Sensei GenAI, enhancing capabilities in real-time personalization, customer journey management, and cross-channel campaign orchestration. Specifically, Adobe Journey Optimizer, built on the Experience Platform, was highlighted for its ability to deliver personalized, connected customer journeys across channels using real-time insights and AI-driven automation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Adobe Experience Platform from 2022 to 2023, particularly in its enhanced role in AI integration and cross-channel orchestration. (1) It correctly identifies that in 2022, the platform served as foundational infrastructure for data integration and AI-driven insights via Adobe Sensei. In 2023, it accurately notes the platform's deeper integration with AI tools and its role in powering Adobe Journey Optimizer for cross-channel orchestration. However, the LLM omits mention of Adobe Mix Modeler, a key 2023 addition that leveraged Adobe Experience Platform and Adobe Sensei for marketing investment optimization—a significant multi-hop detail from the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable; the years 2022 and 2023 are used correctly. (3) The reasoning is sound and reflects a correct synthesis of the platform’s evolving role, though the absence of Adobe Mix Modeler reduces completeness in the qualitative dimension. The mention of 'Adobe Sensei GenAI' is not in the original answer and may reflect overextension, but it does not contradict the core facts. (4) The answer remains highly contextually relevant, directly addressing the evolution in AI integration and campaign orchestration. The omission of one key component (Mix Modeler) prevents a perfect score, but the core narrative is accurate and well-aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 416,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In response to Medicare Advantage funding pressures from 2023 to 2024, UnitedHealth Group intensified medical and operating cost management, adjusted member benefits, and implemented or increased member premiums to offset reduced government benchmarks. Additionally, the company selectively ceased offering benefit plans in certain counties and focused on expanding into markets where they could maintain financial viability. The company also accelerated the transition to fully accountable value-based care delivery models to improve care quality and efficiency while managing costs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in UnitedHealth Group's care delivery model approach from 2023 to 2024 in response to Medicare Advantage funding pressures. It correctly identifies cost management, benefit adjustments, premium changes, and withdrawal from certain counties as responses to reduced government benchmarks—aligning with the ground truth's mention of operational adjustments due to funding pressures. The reference to accelerating value-based care models matches the original answer’s emphasis on transitioning to accountable models for efficiency. However, the LLM answer omits specific 2023 investments in clinical engagement, care coordination technology, and new delivery channels (e.g., in-home and virtual care), which were central to the initial growth-oriented strategy. While it mentions expansion into viable markets, it does not fully convey the strategic shift from expansion-focused investment to cost containment and retrenchment as clearly articulated in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (UnitedHealth Group, Medicare Advantage, value-based care) are correctly identified. The reasoning is sound but slightly less nuanced in portraying the strategic pivot. Semantic equivalence is mostly preserved, with only minor omissions affecting completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 381,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "The 1.950% Notes due 2029 were issued by TMO and listed on the New York Stock Exchange with the trading symbol \"TMO 29\" in both the 2022 and 2023 10-K filings, indicating no change in their issuance status between the two years. There is no specific information provided in the given pages to suggest any material change in the composition or terms of TMO's debt instruments, including the 1.950% Notes due 2029, between 2022 and 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.950% Notes due 2029 were present in both 2022 and 2023 with the trading symbol TMO 29, which matches the ground truth. All quantitative elements—interest rate (1.950%), maturity year (2029), and trading symbol—are accurate. (2) However, the LLM fails to mention the introduction of new debt instruments in 2023—specifically the 3.200% Notes due 2026 and the 3.650% Notes due 2034—which is a key part of the evolution in TMO's debt composition. This omission significantly weakens the completeness and qualitative accuracy of the answer. (3) The reasoning is partially sound in confirming continuity of the 1.950% Notes, but the model does not synthesize the broader shift in financing strategy indicated by the addition of new notes, which requires multi-hop reasoning across the 2023 debt portfolio changes. The claim that 'no specific information' suggests a change contradicts the ground truth, which confirms new instruments were added. (4) While the answer is factually correct on the specific point about the 1.950% Notes, it lacks critical context about portfolio expansion, leading to a correctness score of 6. Quantitative accuracy is perfect (10), but qualitative accuracy is reduced due to incomplete synthesis (5). Contextual relevance remains high (8) as the response addresses the core instrument, albeit incompletely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 385,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, TMO's debt instruments remained largely consistent in terms of the 0.500% Notes due 2028, as both filings list these notes under the same trading symbol (TMO 28A) on the New York Stock Exchange. However, in 2023, there was an introduction of the \"3.200% Notes due 2026\" (TMO 26B) and the \"1.375% Notes due 2028\" (TMO 28), which were not explicitly listed in the 2022 filing. This suggests a diversification of TMO's debt structure in 2023, with the addition of new note categories to manage maturity profiles and interest rate exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continued presence of the 0.500% Notes due 2028 and the introduction of the 3.200% Notes due 2026 in 2023, which aligns with the ground truth. However, it incorrectly states that the '1.375% Notes due 2028' were introduced in 2023 as a new category, when in fact they were already present in 2022 according to the original answer. This is a significant factual error affecting both quantitative and qualitative accuracy. Additionally, the LLM implies the 1.375% Notes due 2028 were not in the 2022 filing, which contradicts the ground truth. (2) The percentages and maturities for the 0.500% Notes due 2028 and 3.200% Notes due 2026 are correct, but the misattribution of the 1.375% Notes due 2028 as a new 2023 issuance is a critical numerical/entity error. The trading symbols (TMO 28A, TMO 26B, TMO 28) are not part of the ground truth and appear to be fabricated or assumed without evidence, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—recognizing continuity in existing notes and identifying new issuances—but fails in synthesizing the correct timeline for the 1.375% Notes due 2028. The conclusion about diversification is reasonable but based on flawed premises. (4) Contextual relevance is high because the answer addresses debt composition changes and strategic implications. However, due to key factual inaccuracies in entity presence across years, the correctness score is reduced to 6—partially correct but with significant errors in entity and temporal attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 430,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The range of excess fair value over carrying value for DHR's reporting units decreased between the 2023 and 2024 annual goodwill impairment analyses. In 2023, the range was from approximately 140% to 495%, while in 2024, it narrowed to approximately 70% to 450%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for both years are accurate: 140% to 495% in 2023 and 70% to 450% in 2024. These values are reported correctly with appropriate qualifiers like 'approximately'. (2) The answer addresses the change in range over time, noting the decrease and narrowing of the range, which aligns with the ground truth observation of a reduced cushion, especially at the lower end. (3) The reasoning is sound: the comparison between the two years correctly implies a decline in the excess fair value, particularly for the most at-risk reporting unit (lowest percentage). (4) All entities—DHR, reporting units, goodwill impairment analyses, and the correct years (2023 vs. 2024)—are accurately referenced. The answer is semantically equivalent to the original, conveying the same core insight with slightly more concise wording. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 280,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "The treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolved from 2022 to 2023 by increasing the available share pool more significantly in 2023. In both years, canceled RSUs and shares withheld for tax purposes increased the available share pool by a factor of two times the number of affected shares. However, in 2022, 14.7 million RSUs were canceled and 41 million shares were withheld, while in 2023, 8.1 million RSUs were canceled and 37 million shares were withheld. Despite fewer cancellations in 2023, the share pool replenishment was still substantial due to the tax-withheld shares.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the treatment of canceled RSUs and tax-withheld shares. According to the ground truth, in 2022, canceled RSUs and tax-withheld shares replenished the share pool at a 2x factor, but in 2023, the language specifying this 2x factor was omitted, indicating a change in treatment. The LLM incorrectly states that the 2x factor applied in both years, which contradicts the ground truth. This is a critical factual error in both reasoning and content. Additionally, the LLM introduces specific numerical values (14.7M, 41M, 8.1M, 37M) that are not present in the original answer and cannot be verified from the provided context, making them potentially fabricated or misattributed. These numbers undermine quantitative accuracy. While the answer addresses the general topic and attempts to compare 2022 and 2023, it fails the multi-hop reasoning requirement by not recognizing the policy change (removal of the 2x factor), which is the central point of the question. The contextual relevance is moderate because it discusses the right plan and topic, but the incorrect mechanism and unsupported numbers severely limit usefulness. Semantic equivalence is not achieved due to the reversal of the key factual evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 354,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Between 2023 and 2024, Aldevron remained integrated within Danaher's Life Sciences segment, as highlighted in the 2024 10-K. Aldevron, acquired in 2021 for approximately $9.6 billion, is a key contributor to Danaher's genomic medicines business, manufacturing high-quality plasmid DNA, mRNA, and proteins for research, clinical, and commercial applications. There is no indication of a change in Danaher's financial stake in Aldevron during this period, as it continues to be a wholly owned subsidiary.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but misses key aspects of the evolution in Danaher's relationship with Aldevron between 2023 and 2024 as described in the ground truth. (1) Quantitatively, the $9.6 billion acquisition figure is reasonably close to the ground truth's $9,561 million (i.e., $9.561 billion), so the dollar amount is acceptable with rounding. However, the LLM states the acquisition was in 2021, which contradicts the implication in the original answer that the financial stake was still being accounted for separately in 2023—suggesting either a more recent transaction or delayed integration. The original answer emphasizes a change in accounting treatment between 2023 and 2024, which the LLM fails to acknowledge. (2) Completeness: The question asks about the evolution of the relationship, particularly regarding financial stake and integration. The LLM asserts Aldevron 'remained integrated' in 2024 but does not address the key shift from a separately accounted stake in 2023 to full integration by 2024. This evolution is central to the ground truth but missing in the LLM response. (3) Entity accuracy is correct—Aldevron, Danaher, Life Sciences segment, and genomic medicines are all accurately referenced. (4) Reasoning: The LLM fails the multi-hop synthesis. It does not connect the 2023 financial stake (with specific cash allocation) to the 2024 absence of separate accounting, which indicates a strategic shift. Instead, it assumes continuity, contradicting the ground truth's narrative of integration progression. (5) Semantic equivalence is partially met—while the description of Aldevron’s business is accurate, the dynamic change in ownership structure and segment integration over time is omitted, leading to a materially incomplete answer. Thus, the correctness score is moderate due to accurate background details but significant omission of the temporal evolution and financial accounting changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 524,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Between 2023 and 2024, Microsoft 365's strategic positioning evolved significantly with deeper integration of AI technologies. In 2024, Microsoft 365 became an \"AI-first platform,\" incorporating Copilot for Microsoft 365, which combines AI with business data to enhance productivity and streamline workflows. Role-specific AI tools like Copilot for Sales, Service, and Finance were introduced to deliver tailored insights. Commercial business metrics reflect strong performance, with Office Commercial products and cloud services revenue growing by 14% in 2024, driven by a 16% increase in Office 365 Commercial. Additionally, Microsoft 365 Consumer subscribers reached 82.5 million, showing the product's expanding reach and AI-driven value proposition.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and introduces unsupported data. While it correctly identifies the increased AI integration in Microsoft 365, particularly through Copilot for Microsoft 365, it incorrectly states that Microsoft 365 'became' an 'AI-first platform' in 2024. According to the ground truth, this positioning was already established in 2023. Additionally, the LLM claims that 'Office Commercial products and cloud services revenue grew by 14% in 2024, driven by a 16% increase in Office 365 Commercial' — this specific revenue growth data is not present in the original answer and cannot be verified from the provided ground truth. The figure of 82.5 million Microsoft 365 Consumer subscribers is also not mentioned in the original and appears to be fabricated or misattributed. (2) Quantitative accuracy is low because the LLM introduces specific percentages (14%, 16%) and a subscriber count (82.5 million) that are not in the ground truth and cannot be confirmed. These numbers may be plausible but are not supported by the provided information, making them factually unreliable. (3) The multi-hop reasoning is partially sound — the model correctly links AI integration (Copilot) with productivity and commercial impact, and it recognizes the importance of consumer and commercial metrics. However, it fails to accurately reflect the key 2024 change noted in the ground truth: the expansion of the Microsoft 365 Consumer subscribers metric to include Basic subscribers for internal alignment. This is a critical strategic shift that the LLM overlooks. (4) Contextual relevance is high because the answer addresses AI integration and commercial performance, which are central to the question. Qualitative accuracy is moderate due to correct identification of AI tools and strategic themes, but the inclusion of unsupported metrics reduces reliability. Correctness score is 6 due to partially accurate reasoning and thematic alignment, but significant factual and quantitative errors prevent a higher rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 550,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Between 2023 and 2024, Microsoft has elevated Copilot Pro's role as a consumer subscription service, emphasizing its integration within Microsoft 365 apps and web-based AI assistance. In 2023, Copilot was positioned as part of the broader Copilot stack, enhancing productivity across Microsoft 365 applications. By 2024, Copilot Pro was highlighted as a standalone offering, providing faster and more powerful AI assistance, underscoring its importance in both productivity and consumer-facing AI experiences.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts: Copilot Pro was introduced as a consumer subscription in 2023 offering faster and more powerful AI assistance in Microsoft 365 apps and on the web, and by 2024, its positioning emphasized differentiation and integration within Microsoft's broader AI strategy. The answer correctly identifies the evolution from being part of the broader Copilot stack in 2023 to being highlighted as a standalone offering in 2024. However, it omits the nuance present in the original answer regarding the 'broader narrative of AI-driven transformation across Microsoft's ecosystem,' which is a key qualitative shift in emphasis. While the LLM captures the core trajectory, it does not fully convey the strategic integration of Copilot Pro into Microsoft's AI-first positioning, slightly weakening the multi-hop synthesis. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Microsoft, Copilot Pro, Microsoft 365, 2023, 2024) are correctly identified. The response is highly relevant to the question and conveys semantically similar information, warranting a high correctness score with minor deductions for incomplete contextual depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 349,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan had approximately 50 million shares available for issuance as of December 31, 2023, and this decreased to approximately 47 million shares available for issuance as of December 31, 2024. This indicates a reduction of 3 million shares in the remaining shares available for issuance between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that approximately 50 million shares were available as of December 31, 2023, which contradicts the ground truth. The original answer explicitly states that no specific figure was provided for remaining shares in 2023. This is a major factual error. The 47 million shares figure for December 31, 2024, is correct and matches the ground truth. (2) The calculation of a 3 million share reduction is based on fabricated data (50M to 47M), making the quantitative analysis invalid. There is no support in the original answer for any numerical change between years due to absence of 2023 data. (3) The reasoning fails on a critical multi-hop aspect: the model assumes continuity and comparability between two years' data, but the ground truth indicates that only 2024 had a disclosed number. The evolution described should focus on increased transparency, not numerical depletion. The LLM misrepresents the nature of the change by emphasizing quantity change over disclosure practice change. (4) While the answer addresses the question's focus on evolution and availability, it does so with incorrect numbers and flawed logic, warranting a low correctness score. Contextual relevance is moderate because it discusses the right plan and timeframe, and correctly identifies a trend in share availability, albeit with wrong specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 382,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Microsoft maintained its updated accounting policy for the estimated useful lives of server and network equipment, which was changed in July 2022. The useful lives were extended from four years to six years due to investments in software that improved operational efficiency and advances in technology. This change became effective at the start of fiscal year 2023 and remained in place for fiscal year 2024, with no further modifications indicated in the 2024 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in Microsoft's accounting policy—extending the estimated useful lives of server and network equipment from four to six years, effective at the start of fiscal year 2023, and maintaining it in fiscal year 2024. The factors influencing the change—investments in software improving operational efficiency and advances in technology—are accurately reported and match the ground truth. (2) Quantitatively, all details are correct: the change from 4 to 6 years is accurate, and the timing (effective beginning FY2023) aligns with the original answer. The mention of July 2022 as the announcement date is consistent with Microsoft's fiscal calendar (FY2023 begins July 1, 2022), so this is a valid inference and does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly links the policy change timing, its drivers, and its continuation into FY2024. The only minor shortcoming is that the original answer adds contextual depth by noting that sustained cloud and AI infrastructure investments supported the rationale, which the LLM answer omits. This is a small but relevant point that slightly reduces completeness. (4) The answer is semantically equivalent in factual content, highly relevant, and well-reasoned. The omission of the forward-looking context about cloud/AI investments in FY2024 prevents a perfect 10, but all core facts and logic are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 403,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "MDT's exposure to auction rate securities remained consistent in fair value at $33 million in both 2022 and 2023. In both years, these securities were classified within \"other assets\" in the consolidated balance sheet, indicating no material change in either fair value or classification during the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value of auction rate securities as $33 million in both 2022 and 2023, which matches the ground truth and earns full points for quantitative accuracy. However, it incorrectly states that the securities were classified under 'other assets' in both years. According to the original answer, in 2022 they were included under 'Total' in the investment portfolio without a separate classification, and only in 2023 were they explicitly reclassified into 'Other Assets'. This is a critical qualitative error in entity classification and balance sheet presentation. (2) All dollar amounts and years are accurate, with no calculation issues. (3) The multi-hop reasoning fails because the model does not recognize the change in classification between years—it incorrectly assumes consistency where there was a meaningful shift in reporting. The question specifically asks how the exposure evolved, and the answer misses the evolution in balance sheet treatment. (4) While the answer is contextually relevant and addresses the question's structure, the incorrect classification undermines the core of the response, warranting a moderate correctness score of 4 due to the significant factual error in financial statement classification despite correct numerical values.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 366,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "The net losses from Cisco's available-for-sale debt investments increased from a loss of $21 million in fiscal 2023 to a loss of $67 million in fiscal 2024. This indicates a deterioration in the performance of this investment category, likely due to factors such as interest rate fluctuations and market conditions affecting the fair value of these investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net losses for both fiscal years—$21 million in 2023 and $67 million in 2024—matching the ground truth exactly. The increase in losses is accurately portrayed. (2) All numeric values are correct and properly attributed to the right fiscal years. No calculation is required beyond the comparison, which is correctly interpreted as an increase in losses. Format variations are not an issue here as the numbers are presented clearly and consistently. (3) The multi-hop reasoning is sound: the model synthesizes data from two different fiscal years and correctly infers a negative trend in investment performance. The conclusion that performance deteriorated is logically consistent with the data. The addition of potential causes (interest rate fluctuations, market conditions) is reasonable context and does not contradict the ground truth; however, this explanatory detail is not present in the original answer, so while it doesn't reduce accuracy, it slightly extends beyond the provided facts. (4) The answer is fully contextually relevant, addressing both parts of the question: the change in net gains/losses and what it indicates about performance. The only minor deviation is the inclusion of speculative factors not in the original, but this does not impair factual correctness. Thus, the answer is highly accurate with excellent quantitative and qualitative performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 397,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Between 2023 and 2024, Cisco's approach to the APJC region evolved by maintaining a geographic operational structure while shifting financial investments toward strategic priorities such as AI integration, cybersecurity, and cloud-based solutions. This shift reflects a focus on enhancing value-added services and adapting to customer demands for modernized infrastructure and digital resilience. The implications for Cisco's revenue model in the APJC region suggest a move toward recurring revenue streams from subscriptions and services, as opposed to relying solely on hardware sales, aligning with broader industry trends toward flexible consumption models.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. While it correctly identifies Cisco and the APJC region and references a strategic shift, it fabricates the nature of the evolution. The ground truth states that in 2023, Cisco directly operated in APJC as a geographic segment, and in 2024 added financial investments via marketable/non-marketable equity and equity method investments. The LLM instead claims a shift toward AI, cybersecurity, and cloud solutions with a move to recurring revenue—information not supported by the provided ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, since no numbers are present or required beyond years (which are correct: 2023 and 2024), this dimension does not penalize the answer. (3) The multi-hop reasoning is flawed: the model fails to synthesize the actual shift from operational presence to include financial investment, instead inventing a narrative about service model evolution and subscription revenue. This misrepresents the core transformation described in the original answer. (4) Contextual relevance is moderate because the answer discusses Cisco’s strategy in APJC over the same time period and touches on revenue model implications, but it does so using incorrect drivers and mechanisms. The actual implication—potential dual revenue from operations and investment returns—is entirely missing. Thus, while the topic is relevant, the substance is factually inaccurate, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 428,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Between 2022 and 2024, Apple has adapted its App Store commission policies and regulatory compliance in response to legal and market pressures. In 2022, the company acknowledged potential changes to the App Store due to litigation, competition, and regulatory requirements, without specifying details. By 2024, Apple had implemented concrete changes, particularly in the U.S. and the EU. In the U.S., it modified how developers communicate with consumers about alternative purchasing mechanisms within iOS and iPadOS apps. In the EU, Apple adjusted its business terms to comply with the Digital Markets Act (DMA), introducing alternative fee structures, distribution methods for apps, and payment processing options. These changes reflect Apple's proactive response to regulatory scrutiny and legal challenges, aiming to balance compliance with maintaining its business model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Apple's 2022 acknowledgment of potential App Store changes due to legal and market pressures, and the 2024 implementation of concrete changes in the U.S. and EU are accurately described. The mention of the Digital Markets Act (DMA) compliance in the EU, alternative fee structures, distribution methods, and payment options is factually sound. The U.S.-specific change allowing developers to communicate about alternative purchasing mechanisms is also correct and adds useful detail not explicitly in the original but consistent with known regulatory developments. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only years (2022, 2024), which are correct. (3) The multi-hop reasoning is strong: the answer synthesizes Apple’s evolving stance across time and jurisdictions, connecting legal pressures (DMA) to specific business changes. It correctly infers a shift from general risk disclosure to actionable policy changes. (4) The only reason for not scoring a perfect 10 is minor: the original emphasizes the potential financial impact on App Store revenue and commissions more explicitly, particularly the risk to Apple’s financial condition, which the LLM answer implies but does not directly state. Otherwise, the answer is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 403,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "Between 2022 and 2024, Texas Instruments shifted the allocation strategy for its U.S. Retiree Health Care Plan toward a higher proportion of fixed income securities and cash equivalents and a lower proportion of equity securities. In 2022, the allocation was 64% fixed income and 36% equity, while in 2024, it increased to 80% fixed income and 20% equity. This shift reflects a more conservative approach, aligning with the plan's goal to better match the interest rate sensitivity of its liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift from a more balanced allocation in 2022 to a more conservative 80/20 fixed income to equity split in 2024, which aligns with the ground truth. However, the 2022 percentages (64% fixed income, 36% equity) are not explicitly stated in the original answer. The original provides dollar amounts: $248M in fixed income and cash equivalents and $137M in equity. Calculating the actual 2022 allocation: total assets = $248M + $137M = $385M. Fixed income portion = $248M / $385M ≈ 64.4%, equity = $137M / $385M ≈ 35.6%. Thus, the percentages are quantitatively accurate, but the LLM presents them as if directly reported, not derived. (2) The 2024 allocation (80% fixed income, 20% equity) matches the original answer exactly. The shift toward conservatism and capital preservation is correctly interpreted, though the LLM adds a rationale about liability matching not present in the original, which is plausible but not verifiable from the ground truth. (3) The multi-hop reasoning is sound—comparing 2022 and 2024 allocations and inferring a strategic shift. The synthesis across years and asset classes is accurate. (4) The correctness score is 8 because core facts and calculations are correct, but the presentation of derived percentages as explicit disclosures slightly overreaches. Quantitative accuracy is 7 because while the numbers are mathematically correct, they are inferred, not directly reported. Qualitative accuracy is 9 due to strong reasoning and correct interpretation. Contextual relevance is 10—fully addresses the question’s focus on allocation evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 449,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "Texas Instruments' strategic emphasis on Embedded Processing Products has seen a decline in both revenue and operating profit from 2022 to 2024. In 2022, Embedded Processing contributed $3.26 billion in revenue and $1.25 billion in operating profit, while in 2024, these figures dropped to $2.53 billion in revenue and $352 million in operating profit. This segment remains part of TI’s two reportable segments, Analog and Embedded Processing, but its contribution to overall performance has diminished compared to the Analog segment. The decline reflects shifting market dynamics and reduced demand for embedded processing products, though TI continues to focus on analog and embedded processing as core components of its competitive advantages.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the revenue and profit figures provided ($3.26B revenue and $1.25B operating profit in 2022; $2.53B and $352M in 2024) are false and not supported by the ground truth. The original answer contains no financial figures for Embedded Processing, so these numbers are hallucinated. (2) The claim of a decline in performance is unsupported and contradicts the actual strategic evolution described in the ground truth, which emphasizes increased importance and structural elevation of the segment. (3) Qualitatively, the LLM fails the multi-hop reasoning: instead of identifying the strategic shift in segment reporting and competitive emphasis from 2022 to 2024, it fabricates financial deterioration. The only correct element is the mention that Embedded Processing is a reportable segment alongside Analog in 2024, but even this is framed incorrectly as continuity rather than a strategic change. (4) Contextually, the answer addresses the right topic (strategic emphasis on Embedded Processing) and mentions the correct segments, but the core reasoning and data are entirely inaccurate. The ground truth describes a strategic elevation and increased focus, while the LLM describes a decline. This represents a complete inversion of the correct interpretation, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 387,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "TMO issued 2.00% 10-Year Senior Notes in 2022, with a carrying value of $728 million as of December 31, 2021, and by 2024, the carrying value increased to $663 million. The effective interest rate for these notes rose from 2.10% in 2022 to 2.07% in 2024. This reflects changes in valuation and amortization adjustments over the period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that TMO had $1,200 million in 2.00% 10-Year Senior Notes due October 15, 2031, with an effective interest rate of 2.23% in both 2022 and 2024. The LLM incorrectly reports a carrying value of $728 million as of December 31, 2021 (not 2022), and claims it increased to $663 million by 2024—this is quantitatively wrong and logically inconsistent (an increase from $728M to $663M is a decrease). Additionally, the effective interest rates cited (2.10% in 2022 rising to 2.07% in 2024) contradict themselves and do not match the ground truth of a stable 2.23%. (2) All key numbers are incorrect: principal amount ($1,200M vs reported $728M/$663M), timing (using 2021 data instead of 2022), and interest rates (2.23% vs 2.10%/2.07%). There are no valid calculations or consistent trends supported by the ground truth. (3) The multi-hop reasoning failed completely—the model did not correctly identify the consistent issuance and valuation over 2022–2024, misrepresented the trend, and used incorrect years and values. It also confused carrying value with principal amount without clarification. (4) The answer receives a low correctness score due to pervasive factual errors. Quantitative accuracy is near-zero because all numbers are wrong. Qualitative accuracy is low due to flawed logic and entity misrepresentation. Contextual relevance is slightly higher only because the answer addresses the general topic of TMO’s senior notes, but even the interpretation of valuation changes is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 440,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "Between 2022 and 2024, REMICADE's financial performance declined significantly, with sales dropping by 12.8% in 2024 compared to 2023, and a continued decline attributed to biosimilar competition. This indicates that REMICADE's role in Johnson & Johnson's Pharmaceutical segment has weakened, as it faces increasing market pressure from biosimilars, leading to reduced revenue and market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 12.8% sales decline in REMICADE from 2023 to 2024, aligning with the ground truth ($1,839 million to $1,605 million), and accurately reflects the weakening role of REMICADE in Johnson & Johnson's Pharmaceutical segment. The mention of biosimilar competition as a driver is consistent with the implied reasons in the original answer (e.g., increased competition, newer biologics). (2) Quantitatively, the 12.8% decrease is accurate: (1,839 - 1,605) / 1,839 ≈ 0.1278, which rounds to 12.8%. The years referenced (2022–2024) are contextually appropriate, and the sales figures, though not explicitly restated, are correctly used in deriving the percentage change. (3) The multi-hop reasoning is sound—linking REMICADE’s declining sales to its reduced strategic role in the Immunology portfolio demonstrates synthesis across time and business context. The LLM infers competitive pressure as a cause, which is a reasonable interpretation of the ground truth’s mention of competition and newer biologics, though it specifies 'biosimilars' not explicitly stated in the original. This is a plausible and industry-accurate inference but slightly extends beyond the provided evidence. (4) The answer is highly relevant, complete in addressing both financial evolution and strategic implications, and semantically equivalent to the ground truth despite more concise phrasing. The only minor limitation is the absence of explicit mention of REMICADE’s 2022 status as a key product, though the temporal framing implies it. Overall, factual accuracy and reasoning are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 443,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "From 2022 to 2024, REMICADE's sales declined from $3.19 billion to $1.605 billion, representing a significant reduction of 50.5%. This decline is primarily attributed to ongoing biosimilar competition in the United States and other markets. Within JNJ's Immunology portfolio, REMICADE's performance indicates a weakening market position, as newer products like STELARA and TREMFYA have driven growth, while REMICADE faces sustained pressure from biosimilars, leading to a continued erosion of its sales and market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports REMICADE's sales of $3.19 billion in 2022 and $1.605 billion in 2024, matching the ground truth values ($3,190 million and $1,605 million). The calculated decline of 50.5% from 2022 to 2024 is accurate: (3,190 - 1,605) / 3,190 ≈ 0.500, or 50.0% (the LLM's 50.5% is a minor rounding difference, likely from using $3.19B = $3,190M exactly, so still acceptable). The ground truth mentions a 12.8% drop from 2023 to 2024, which the LLM does not include, but it correctly captures the overall downward trend. (2) All numeric values are factually correct with acceptable formatting variations (e.g., $3.19 billion = $3,190 million). The calculation of the total decline is approximately correct and reasonably presented. (3) The LLM performs sound multi-hop reasoning by connecting REMICADE's declining sales to biosimilar competition and contextualizing its weakening position within JNJ's Immunology portfolio, referencing growth in newer products like STELARA and TREMFYA. This adds valuable context not explicitly in the ground truth but aligns with plausible market dynamics and enhances the answer without introducing inaccuracies. (4) The answer fully addresses both parts of the question: the sales evolution (quantitative trend) and the implication for market position. The only minor omission is the specific 2023-to-2024 decline percentage (12.8%), but the overall trajectory is correctly conveyed. Thus, the answer is highly accurate, complete, and contextually rich, warranting a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 449,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "Between 2021 and 2024, REMICADE's sales declined from $3.19 billion to $1.605 billion, representing a reduction of 50.2%. This significant decline was primarily driven by biosimilar competition in the United States and other international markets, with additional competitors continuing to enter the infliximab market. The ongoing biosimilar competition has consistently pressured REMICADE's sales, leading to a steady decrease over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. The original answer states that REMICADE's sales were $16.8 billion in 2021 as part of total Immunology sales, not $3.19 billion for REMICADE alone. The 2024 figure of $1,605 million ($1.605 billion) is correct. The claimed 50.2% decline is therefore based on incorrect starting data and is inaccurate. The original specifies a 12.8% decrease from 2023 to 2024, which the LLM does not mention. (2) The calculation of a 50.2% decline from $3.19B to $1.605B is mathematically correct, but the initial value is wrong. The ground truth does not support $3.19B as REMICADE's 2021 sales. (3) The qualitative reasoning about biosimilar competition in the U.S. and global markets is consistent with the original answer and correctly identifies the primary factor behind the decline. The mention of ongoing market entry by competitors adds context, though it's slightly more detailed than the original. However, the failure to accurately isolate REMICADE's sales from broader Immunology totals indicates a failure in multi-hop reasoning—likely misattributing segment-level data to the product level. (4) The contextual relevance is high because the answer addresses both parts of the question—sales evolution and contributing factors—and stays focused on REMICADE. However, the quantitative inaccuracy severely undermines the correctness score, warranting a 4. The qualitative accuracy is moderate due to correct reasoning but flawed data sourcing, and quantitative accuracy is low due to the incorrect baseline sales figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 442,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Between 2022 and 2024, STELARA (ustekinumab) experienced a decline in sales. In 2022, STELARA sales were $9.1 billion, representing an 18.5% increase compared to 2021. However, by 2024, STELARA sales had decreased to $10.4 billion, a 4.6% decline compared to 2023, primarily due to share loss from European biosimilar entrants. Additionally, the expiration of STELARA's U.S. patent in 2023 and the expected launch of biosimilars in 2025 further signaled potential future sales reductions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, STELARA generated $10,361 million ($10.36 billion) in sales in 2024, not $10.4 billion, and there is no mention of 2022 sales being $9.1 billion in the original answer—instead, the focus was on regulatory status (filing for pediatric use). The ground truth does not state 2022 sales or an 18.5% increase from 2021, making that data incorrect or unsupported. The 4.6% decline from 2023 to 2024 is correctly cited, and $10.4 billion is close to the actual $10.361 billion, so that part is approximately accurate. (2) The calculation of the 4.6% decline aligns with the ground truth (from $10,858M to $10,361M: a ~4.6% drop), which is correct. However, the claimed $9.1B in 2022 is inconsistent with the known $10,858M in 2023 and contradicts the trend. (3) The reasoning partially captures the commercial trajectory—acknowledging declining sales due to biosimilars and patent expiration—but fails to incorporate the key 2022 regulatory context (pediatric filing) that was central to the original answer. This missing element breaks the multi-hop synthesis between regulatory status and commercial performance. (4) The contextual relevance is high because the answer addresses the evolution of STELARA’s commercial performance and future outlook, but correctness is low due to incorrect sales figures for 2022 and lack of mention of the actual 2022 regulatory development. The qualitative accuracy is moderate because the explanation for decline is plausible and aligns with industry trends, but it omits and fabricates key data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 458,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The total net revenue from Restasis in the United States decreased from $621 million in 2023 to $382 million in 2024, representing a 38.5% decrease. In comparison, the decrease from 2022 to 2023 was 49.6%.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Restasis U.S. net revenue was $382 million in 2023 and decreased to $172 million in 2024. The LLM incorrectly states 2023 revenue as $621 million and 2024 as $382 million, reversing the correct 2023 figure and inventing a higher prior value. The percentage decrease of 38.5% in the LLM answer is attributed to the 2023–2024 period, but in the ground truth, 38.5% is the decrease from 2022 to 2023, not 2023 to 2024. The LLM also states a 49.6% decrease from 2022 to 2023, which does not match the ground truth (which does not provide the 2022 figure or that specific percentage). The correct 2023–2024 decrease is 55.2%, which the LLM omits entirely. (2) Number verification: Ground truth: 2023 = $382M, 2024 = $172M → decrease = (382-172)/382 ≈ 55.2%. LLM claims 2023 = $621M, 2024 = $382M → (621-382)/621 ≈ 38.5%, which matches its percentage but uses fabricated numbers. The 38.5% in ground truth refers to 2022→2023, not 2023→2024. (3) Multi-hop reasoning is flawed: the model fails to correctly retrieve and sequence revenue figures across years, misaligns percentages with time periods, and introduces incorrect data. It appears to confuse Restasis revenue with another product or year. (4) Correctness and quantitative accuracy are low due to wrong numbers and misattributed percentages. Qualitative accuracy is slightly higher because the model attempts the correct type of analysis (year-over-year change, percentage decrease). Contextual relevance is moderate as it addresses the right drug and metric but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1107,
        "completion_tokens": 447,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "The role and strategic importance of Master Lease Agreements (MLAs) for AMT evolved between 2022 and 2023 by enhancing long-term revenue stability and supporting international growth. MLAs provide consistent, long-term revenue and reduce non-contractual churn, which became increasingly important as AMT expanded its global portfolio of communications sites. In 2023, AMT emphasized that MLAs help build strong strategic partnerships with tenants, streamline colocation processes, and enable rapid deployment of equipment, particularly in emerging and evolving markets. This strategic use of MLAs supported AMT's international expansion by aligning with carrier investments in 4G/5G network deployments and facilitating organic growth across diverse markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic importance of Master Lease Agreements (MLAs) in supporting AMT's international growth and tenant relationships, highlighting long-term revenue stability, reduced churn, and operational efficiencies. However, it omits specific quantitative details from the ground truth: the exact size of AMT’s international portfolio in 2022 (~177,000 sites) and 2023 (~182,000 sites), which are key factual anchors in the original answer. While the LLM mentions portfolio expansion, it does not quantify it. (2) All numbers referenced in the LLM answer are consistent with the ground truth where mentioned, but the absence of specific site counts affects completeness. No incorrect numbers are presented, so quantitative accuracy is high. (3) The multi-hop reasoning is generally sound—linking MLAs to international growth, tenant partnerships, and operational benefits—but fails to fully synthesize the evolution between 2022 and 2023 with precise data points. The original answer shows a progression in emphasis (from deployment speed in 2022 to churn reduction and risk mitigation in 2023), which the LLM only partially reflects. (4) The answer is contextually relevant and well-structured, but the lack of specific metrics and slight misordering of emphasis (e.g., placing tenant partnerships more prominently in 2023 when they were already emphasized in 2022) reduces qualitative and overall correctness. Minor omissions prevent a higher score despite strong thematic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 421,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Between 2023 and 2024, the Google Marketing Platform continued to serve as a key channel for advertising revenue generation, with revenues primarily recognized on a gross basis for ads placed on Google Network properties. This means the full amount billed to customers is recorded as revenue, with payments to Google Network partners classified as cost of revenues. There is no indication of a material change in this revenue recognition model during the period. However, advertising revenue contributions from the Google Marketing Platform are part of broader advertising revenue streams that include Google Search, YouTube, and other Google Network properties, with no specific standalone growth metrics for the Google Marketing Platform provided in the documents.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that advertising revenues for Google Network properties are recognized on a gross basis, with the full amount billed recorded as revenue and payments to partners treated as cost of revenue—this aligns with the 2023 portion of the ground truth. However, it fails to capture the key evolution in 2024 described in the original answer: the shift toward a more nuanced evaluation of principal versus agent status and the emphasis on control over advertising inventory as a justification for gross reporting. This is a significant omission in the qualitative evolution of the platform’s role. Additionally, the LLM claims there is 'no indication of a material change,' which contradicts the ground truth’s explicit description of an evolved role and more detailed explanation in 2024. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the model correctly identifies the revenue recognition model and its application across Google Network properties, but fails to synthesize the change over time (2023 vs 2024) and the deeper accounting rationale introduced in 2024, which is central to the question. (4) Correctness is scored 5 due to partial factual accuracy but major omission of the 2024 evolution; qualitative accuracy is 5 because core concepts are right but reasoning lacks depth and contains a misleading claim of no change; contextual relevance is 8 because the answer addresses the general topic and revenue recognition but misses the specific evolution asked for.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 454,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "Based on the information provided in the document pages:\n\nIn 2023, the fair value of Federal Funds Sold and Securities Borrowed or Purchased Under Agreements to Resell was $291,669 million, and by 2024, it increased to $521,878 million. The volume of these transactions also increased from $291,669 million in 2023 to $521,878 million in 2024. This significant increase indicates that Bank of America (BAC) expanded its short-term funding strategies in 2024, likely to capitalize on higher interest rates and optimize its liquidity position. The rise in fair value suggests that the market value of these short-term instruments increased, reflecting favorable market conditions or improved creditworthiness.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2023, the volume of Federal Funds Purchased & Sec Loaned had a net change of $16,466 million, and in 2024, the fair value was $192,859 million. However, the LLM claims the fair value was $291,669 million in 2023 and $521,878 million in 2024—values that are not supported by the ground truth and represent a completely different magnitude. Additionally, the LLM confuses 'Federal Funds Sold' and 'Securities Borrowed' with 'Federal Funds Purchased & Sec Loaned', which are opposite positions (lending vs. borrowing). This misidentification of the financial instrument fundamentally undermines the answer. (2) The numbers cited by the LLM do not match the ground truth: $291,669M and $521,878M are over 150% higher than the correct 2024 fair value of $192,859M. The volume and fair value are incorrectly treated as identical figures in both years, suggesting no distinction between volume and fair value, which is conceptually flawed. (3) The multi-hop reasoning fails because the LLM uses the wrong financial line item—likely confusing assets (federal funds sold) with liabilities (federal funds purchased). This leads to an incorrect conclusion about BAC’s short-term funding strategies. The original answer correctly identifies an increase in short-term funding liabilities, while the LLM incorrectly infers expansion based on lending activity. (4) The contextual relevance is moderate because the answer discusses short-term funding strategies and attempts to interpret trends, but due to incorrect entities and numbers, the reasoning and conclusion are invalid. The qualitative accuracy is low due to entity confusion and flawed logic. Quantitative accuracy is very low due to grossly incorrect figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 492,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations became more detailed and specific. In 2022, the discussion was limited to general references in the context of market risks and critical accounting estimates. By 2024, the company provided more explicit information, including the impact of higher settlement charges due to lump sum distributions and the purchase of a group annuity contract, which directly linked market conditions to changes in pension and retiree medical expenses.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of PepsiCo's disclosures. (1) Correctly identifies that disclosures became more detailed between 2022 and 2024 and that 2022 references were tied to critical accounting estimates, aligning with the ground truth. However, the LLM introduces specific operational details—'higher settlement charges due to lump sum distributions' and 'purchase of a group annuity contract'—that are not mentioned in the original answer and are unsupported by the provided ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; the score of 10 reflects no errors in numbers or dates. (3) The multi-hop reasoning is flawed: while the model correctly infers increased disclosure detail, it fabricates specific financial events rather than accurately reporting the broadening of risk context to include inflationary, deflationary, and recessionary conditions as stated in the ground truth. This misrepresents the nature of the expanded disclosure. (4) Contextual relevance is high because the answer addresses the evolution of risk sensitivity disclosures and stays focused on pension and retiree medical plan liabilities. However, the introduction of unverified specifics reduces factual accuracy. The core progression from general to more explicit disclosure is correct, but the substance of the 2024 update is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 401,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Between 2023 and 2024, Adobe Scan has evolved from being a standalone scanning tool into a more integrated component of Adobe's broader document management ecosystem. In 2023, Adobe Scan was described as a free mobile app that converts paper documents into PDFs for sharing. By 2024, it is positioned as part of Adobe Document Cloud, with tighter integration with Adobe Acrobat, Acrobat Sign, and cloud-based workflows, emphasizing seamless document creation, editing, and collaboration across platforms. This shift reflects Adobe's strategy to unify its document management offerings under the Document Cloud umbrella, enhancing cross-product functionality and user experience.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth, earning a high correctness score. (1) It correctly identifies Adobe Scan's 2023 positioning as a free mobile scanning tool integrated with Adobe Document Cloud and its evolution by 2024 into a more tightly integrated component of Adobe's document ecosystem. The entities (Adobe Scan, Adobe Document Cloud, Acrobat, Acrobat Sign) and years (2023, 2024) are accurate. (2) There are no numeric values, financial figures, or calculations in the question or answers, so quantitative accuracy is not applicable—scored 10 by default as no numbers were misstated. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2023 vs 2024) and ecosystem components (mobile app → integration with Acrobat, Sign, cloud workflows). However, the LLM omits specific 2024 advancements mentioned in the ground truth—namely AI-driven features like Content Credentials and Firefly-powered generative AI workflows, which are key to Adobe’s shift toward digital trust and enterprise integration. This is a meaningful but not critical omission. (4) The answer remains contextually relevant and captures the strategic shift toward deeper integration and unified document management. While it conveys a slightly less technologically nuanced picture than the original, the semantic meaning and strategic trajectory are equivalent. Hence, qualitative accuracy is slightly reduced to 8 due to missing AI-specific enhancements, but contextual relevance remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 426,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini's role and integration across Google's products evolved significantly from its initial launch in 2023 to 2024. In 2023, Gemini was introduced as a multimodal AI model capable of understanding and combining text, code, audio, images, and video. By 2024, Gemini 2.0 was launched, enhancing its capabilities and expanding its integration to all seven of Google's two-billion-user products: Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. Specific advancements in multimodal capabilities included the ability to process and generate content across diverse formats, such as image generation, coding support, and app integration, as well as improved AI-driven features like AI Overviews and NotebookLM for enhanced user interaction and productivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini was introduced in 2023 as a multimodal model; by 2024, Gemini 2.0 launched and was integrated into all seven of Google's two-billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. The dates, product count, and product names are accurate. (2) Quantitative accuracy is perfect: 'two-billion-user products' matches the ground truth phrasing, and no numerical errors are present. (3) The multi-hop reasoning is sound—correctly linking Gemini’s evolution from 2023 to 2024, its expanded integration, and advancements in multimodal capabilities. (4) The LLM adds specific examples like 'AI Overviews' and 'NotebookLM' and mentions 'image generation, coding support, and app integration' as multimodal advancements, which are plausible extensions of Gemini’s capabilities and consistent with the ground truth, though not explicitly mentioned in the original. It omits mention of Project Astra and Project Mariner, which were highlighted in the ground truth as experimental research prototypes, representing a minor omission. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the answer fully addresses both parts of the question: evolution of integration and multimodal advancements. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 408,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Between 2022 and 2024, Linde's relationship with helium had a mixed impact on sales and operating profit. In 2024, sales in the \"Other\" segment, which includes global helium wholesale, decreased by 2% compared to 2023 due to lower helium volumes. However, operating profit in the \"Other\" segment increased by 44% in 2024, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher costs related to helium. This indicates that while helium-related sales declined, insurance recoveries helped boost profitability in the segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key developments in Linde's relationship with helium between 2022 and 2024. It accurately states that in 2024, lower helium volumes led to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale—this matches the ground truth. It also correctly notes the 44% increase in operating profit for the 'Other' segment and the role of insurance recovery in Linde Advanced Materials Technology (LAMT), partially offset by higher helium-related costs. However, the LLM omits the explicit shift in relationship from neutral/positive in 2022 (helium as a supply) to negative in 2024, which is a key qualitative evolution mentioned in the original answer. (2) Quantitatively, all numbers are accurate: the 2% sales decrease and 44% operating profit increase are correctly reported. The comparison to 2023 (implied in 'compared to 2023') is acceptable since 2024 results are typically compared to the prior year, though the original focuses on evolution from 2022. (3) The multi-hop reasoning is sound—linking helium volumes to sales impact and helium costs to profit constraints shows proper synthesis across segments and financial metrics. However, the answer does not fully trace the evolution from 2022, weakening the longitudinal analysis. (4) The scores reflect high factual accuracy and relevance, with a minor deduction in correctness and qualitative accuracy for missing the 2022 baseline characterization of helium as a supply, which is central to the 'evolution' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 431,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights decreased from $1,708 million in 2022 to $1,708 million in 2024, with no change in magnitude. This is based on the data provided in the document pages for PEP_10k_2022.pdf and PEP_10k_2024.pdf.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key aspects. The net value of acquired franchise rights is stated as $1,708 million in both 2022 and 2024, which contradicts the ground truth of $789 million in 2022 and $598 million in 2024. There is no mention of the actual decrease, and the claim of 'no change' is false. (2) Quantitatively, both the reported values and the implied change (zero) are wrong. The correct change is a decrease of $191 million ($789M - $598M), which the LLM fails to identify. The numbers cited ($1,708M) do not match the ground truth and appear to be fabricated or misextracted. (3) The reasoning is flawed: the model claims to base its answer on specific documents but fails to perform even basic comparison or synthesis. It does not recognize a change when one clearly exists in the data, indicating a failure in multi-hop reasoning. (4) Contextual relevance is moderate because the answer addresses the right metric (net value of acquired franchise rights) and time frame (2022 to 2024), but the incorrect data renders the response misleading. The mention of source documents adds superficial relevance but does not improve accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 333,
        "total_tokens": 1432
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil remained stable from 2023 to 2024. In both years, Tengizchevroil is mentioned as part of Chevron's affiliates contributing to natural gas production, with no significant changes in the production volumes or delivery commitments specifically attributed to Tengizchevroil in the provided data.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil remained stable from 2023 to 2024. The ground truth shows clear increases in both consumed and sold volumes: from 596 to 609 million cubic feet per day (consumed) and from 7,148 to 7,569 million cubic feet per day (sold). The LLM incorrectly claims no significant changes, which contradicts the data. (2) Quantitatively, the LLM fails to report any of the actual numbers from either year, missing the opportunity to compare them. There are no calculations or figures provided, resulting in a severe deficit in quantitative accuracy. (3) The reasoning is flawed: while Tengizchevroil is correctly identified as part of Chevron’s affiliates contributing to natural gas production, the model fails to perform the necessary multi-hop comparison across years and does not recognize the increase as indicative of growing dependency or delivery commitments. The conclusion of 'no significant changes' is unsupported. (4) Contextual relevance is moderate because the answer addresses the right entity (Tengizchevroil) and topic (natural gas production), but it fails to report actual changes, making it misleading despite being on-topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 361,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "The role of Google Network partners in Google's advertising revenue model appears to have shifted slightly between 2023 and 2024, as the description of how payments to these partners are treated has become more nuanced. In 2023, payments to Google Network partners were generally described as part of the cost of revenues, with the implication that Google typically reports advertising revenues on a gross basis for ads placed on these properties. By 2024, the description emphasizes the evaluation of whether Google acts as the principal or agent in these transactions, indicating a more detailed and conditional approach to determining revenue recognition. This suggests a potential shift toward a more granular assessment of the role Google plays in these transactions, which could affect how revenues and costs are reported.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that in 2023, payments to Google Network partners were described as part of operating cash outflows, and in 2024, they were re-categorized under Traffic Acquisition Costs (TAC), explicitly tied to ad revenue generation. However, the LLM answer incorrectly claims that in 2023, payments were part of 'cost of revenues' and that in 2024, the change involved a principal vs. agent evaluation affecting revenue recognition. This misrepresents the actual evolution described in the ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the LLM fails to correctly identify the shift from general operating expense to TAC, which is a key strategic reclassification linking payments directly to ad performance. Instead, it fabricates a narrative around revenue recognition models (principal vs. agent), which is not supported by the ground truth. (4) The contextual relevance is moderate because the answer discusses Google Network partners and payment descriptions, but it introduces irrelevant concepts (revenue gross vs. net, principal/agent) and misses the actual evolution in cost classification. Thus, while the topic is relevant, the substance is incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 398,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, Bank of America has noted an increasing global regulatory focus on climate change, with new or heightened regulatory requirements across various jurisdictions, including state, federal, and non-U.S. regions. The jurisdictional divergence in these requirements has led to greater legal, compliance, and public disclosure risks and costs for the company. In 2024, the firm emphasized the evolving nature of climate-related risks and the challenges in managing them due to the complexity of regulatory landscapes and stakeholder expectations. This indicates that the compliance risks have grown more pronounced as the regulatory environment becomes more fragmented and demanding.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately captures the increasing regulatory focus on climate change from 2023 to 2024, the role of jurisdictional divergence, and the resulting rise in legal, compliance, and disclosure risks and costs for Bank of America. The answer correctly identifies that these risks stem from state, federal, and non-U.S. jurisdictions and emphasizes the growing complexity due to fragmented regulatory landscapes. However, it slightly misses the key evolution highlighted in the original answer: the shift from *anticipated* risks in 2023 to *actual, experienced impacts* in 2024. The original answer notes a qualitative change—from expectation to tangible impact—which the LLM answer does not explicitly convey, instead describing a general intensification. This omission affects the depth of the multi-hop reasoning but does not invalidate the core facts. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and all entities (Bank of America, climate-related regulatory requirements, jurisdictional divergence) are correctly identified. The response is fully contextually relevant and well-structured. Thus, while factually sound and comprehensive, it falls short on fully capturing the nuanced progression in risk realization over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 377,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "General Motors has increased its strategic emphasis on full-size pickup trucks from 2022 to 2024, as evidenced by the significant contribution of these vehicles to GM North America's (GMNA) sales and profitability in 2024. In 2024, increased sales of full-size pickup trucks were a primary driver of the 11.4% year-over-year growth in GMNA's total net sales and revenue. Additionally, full-size pickup trucks contributed to a 18.1% increase in GMNA's EBIT-adjusted, highlighting their role in strengthening GM's performance and market positioning.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of GM's focus on full-size pickup trucks from 2022 to 2024 and links it to improved performance and market positioning, which aligns with the ground truth. However, the quantitative claims in the LLM answer are not supported by the original answer. Specifically, the LLM states that full-size pickup trucks drove an 11.4% year-over-year growth in GMNA's total net sales and revenue and contributed to an 18.1% increase in EBIT-adjusted. These specific percentages (11.4% and 18.1%) do not appear in the ground truth and cannot be verified from the provided information. The ground truth mentions a 'significant increase in net wholesale volumes' and a 'variable profit of approximately 160% for trucks on a weighted-average basis,' which the LLM fails to include. This omission of the key profitability metric (160% variable profit) represents a significant factual gap. (2) The numbers cited in the LLM answer (11.4%, 18.1%) are not present in the ground truth and appear to be fabricated or misattributed, leading to a major quantitative inaccuracy. The correct quantitative indicator from 2024 is the ~160% variable profit for trucks, which the LLM omits entirely. (3) The multi-hop reasoning is partially sound: the model correctly infers that increased truck sales improved performance and market positioning, connecting 2022 risk to 2024 strength. However, it fails to accurately report the specific financial evidence (variable profit of ~160%) that supports this shift, instead introducing unsupported metrics. (4) The contextual relevance is high because the answer addresses the strategic evolution and performance implications. Qualitative accuracy is moderate due to correct entity and year identification (GM, 2022–2024, full-size pickup trucks) and logical flow, but undermined by incorrect metrics. Quantitative accuracy is low due to incorrect percentages. Correctness score is 6 because the core idea is right but key factual support is wrong or missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 550,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "From 2022 to 2024, the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts increased significantly. In 2022, the allocation was $284 million (Southern Company level) and $21 million (Alabama Power), while in 2024, it rose to $369 million (Southern Company level) and $349 million (Georgia Power). This shift indicates a strategic move toward safer, more liquid, and lower-risk investments, likely reflecting the company's focus on preserving capital and ensuring reliable funding for future decommissioning obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numbers and misrepresents the data. According to the ground truth, in 2022, Alabama Power had $21M and Georgia Power had $293M in U.S. Treasury and agency securities; by 2024, Alabama Power decreased to $20M and Georgia Power increased to $349M. The LLM incorrectly aggregates or fabricates a 'Southern Company level' figure of $284M in 2022 and $369M in 2024, which is not supported by the original answer and cannot be derived by summing the two subsidiaries (21+293=314M in 2022, not 284M; 20+349=369M in 2024, which matches only by coincidence). The use of 'Southern Company level' introduces an entity-level aggregation not present in the ground truth and misattributes the data. (2) The calculation for 2024 total ($369M) happens to match the sum of the two subsidiaries in that year (20+349), but the 2022 total ($284M) does not match the actual sum ($314M), indicating an error in sourcing or arithmetic. The LLM also fails to mention Georgia Power’s 2022 allocation and Alabama Power’s 2024 allocation, omitting key data points. (3) The multi-hop reasoning is flawed: the ground truth emphasizes a shift in allocation focus toward Georgia Power, suggesting internal reallocation within the corporate structure. The LLM instead interprets the trend as a company-wide move toward safer assets, which misses the nuanced intra-company shift and mischaracterizes the strategic implication. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—it addresses the evolution of allocations and attempts to interpret investment strategy. However, due to major quantitative errors and flawed synthesis, the correctness score is low. The qualitative score reflects partial understanding of the concept but failure in execution. Contextual relevance is high because the structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 518,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "From 2022 to 2024, PepsiCo's relationship with independent bottlers has evolved in terms of financial incentives and strategic dependency by maintaining exclusive contracts while adjusting bottler funding programs to support trade and consumer initiatives. The 2024 document highlights that PepsiCo provides annual, negotiated financial incentives to independent bottlers for advertising, new product support, and equipment placement, emphasizing continued strategic dependency on bottlers for distribution and brand promotion. Additionally, PepsiCo's shift in its alcoholic beverage business to a trademark licensing and flavor sales model suggests a strategic move to reduce direct dependency on bottlers while maintaining collaborative financial support structures.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of financial incentives from 2022 to 2024, noting annual negotiated funding for advertising, new product support, and equipment placement, which aligns with the ground truth. However, it introduces the claim about 'exclusive contracts' and a strategic shift in the alcoholic beverage business to a trademark licensing model, which is not present in the original answer and may reflect incorrect or unsupported inference. This introduces factual inaccuracies in the reasoning chain. (2) Quantitatively, the LLM answer does not include the specific 14% revenue contribution from Walmart, a key data point in the ground truth that underscores strategic dependency. While no incorrect numbers are stated (so quantitative accuracy is not penalized heavily), the omission of this critical percentage reduces completeness and precision. (3) The multi-hop reasoning is partially sound—linking changes in incentive structures to strategic dependency is valid—but the model adds unverified strategic shifts (e.g., reducing dependency via licensing) that contradict the ground truth's emphasis on *increased* strategic dependency. This undermines qualitative accuracy. (4) Contextual relevance is high because the response addresses both financial incentives and strategic dependency over the specified time frame and uses appropriate terminology. However, the inclusion of unsupported strategic pivots and omission of key evidence (Walmart’s 14% contribution) prevents a higher correctness score. The answer captures the direction of evolution but misrepresents the nature and magnitude of strategic dependency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 455,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "Adobe Firefly's role within Adobe's product innovation strategy has evolved from being a newly introduced generative AI product in 2023 to a more central and integrated component of Adobe's AI-driven offerings in 2024. In 2023, Firefly was positioned as an example of Adobe's foray into generative AI, with the company emphasizing its potential to disrupt traditional creative workflows. By 2024, Firefly is highlighted as part of Adobe's broader strategy to incorporate AI across its product suite, with increased focus on responsible AI development, regulatory compliance, and market competitiveness. The 2024 risk disclosures reflect a more mature integration of Firefly into Adobe's innovation roadmap, acknowledging both its strategic importance and the associated challenges in AI governance and adoption.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its interpretation of Adobe Firefly's evolving strategic role from 2023 to 2024, with accurate dates and no numerical inaccuracies (quantitative accuracy is perfect as there are no numbers to verify and no incorrect figures). The answer correctly identifies Firefly as a generative AI product introduced in 2023 and becoming more central in 2024. However, it diverges from the ground truth in key factual details: the original answer states that in 2023, Firefly was listed in trademark filings (indicating established branding), not necessarily described as 'newly introduced' or emphasized for disrupting workflows—details not supported by the ground truth. Additionally, while the LLM mentions 'responsible AI development' and 'regulatory compliance' in 2024, the ground truth specifically notes that Firefly was highlighted in the *risk factors* section, signaling strategic importance and associated risks, not broader integration themes. The LLM infers plausible context but adds unsupported qualitative details. The core evolution—trademark to risk disclosure, indicating growing strategic weight—is implied but not explicitly captured. Thus, while reasoning is logical and contextually relevant, the qualitative accuracy is reduced due to unsupported inferences rather than direct evidence from the knowledge graph. Semantic equivalence is partially achieved, but key evidence sources (trademark listing in 2023, risk factor mention in 2024) are underemphasized or misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 417,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "The role of contractual rent escalations in driving tenant billing growth has been impacted by increased churn and lease cancellations in 2023. Specifically, contractual rent escalations on existing tenant leases have continued to contribute to tenant billing growth, but their effectiveness has been partially offset by higher churn rates. In 2023, churn accounted for approximately 3% of tenant billings, primarily driven by the U.S. & Canada property segment, where lease cancellations and non-renewals by T-Mobile and its legacy Sprint Corporation leases have caused elevated churn. This suggests that while contractual rent escalations remain a key driver of revenue, their impact has been dampened by the increased tenant turnover and lease cancellations observed in 2023 compared to 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: contractual rent escalations remained a driver of tenant billing growth in both 2022 and 2023, but their impact was partially offset in 2023 by increased churn of approximately 3%, primarily in the U.S. & Canada segment due to T-Mobile's lease cancellations (including legacy Sprint leases). These details match the original answer. (2) Quantitative accuracy is perfect: the 3% churn rate is correctly cited, and no other numbers are misstated. Format and context are consistent with the ground truth. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across time (2022 vs 2023), identifies the continued role of escalations, and contrasts it with the new headwind of elevated churn. It appropriately infers that escalations are still a driver but less effective due to churn, which reflects the nuanced shift described in the original. (4) The only minor shortcoming is that the original answer explicitly notes rent escalations were listed alongside new colocation and lease amendments in 2022 as growth drivers, which the LLM omits. While not critical to the core comparison, this contextual detail adds completeness. Otherwise, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 373,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Chevron's relationship with Tengizchevroil between 2023 and 2024 shows that the company remained a significant investor, with Affiliate Capital Expenditures (Capex) for 2023 amounting to $2.31 billion, primarily directed toward the Tengizchevroil FGP/WPMP Project in Kazakhstan. In 2024, approximately half of the projected $3 billion in Affiliate Capex is still allocated to Tengizchevroil, highlighting continued investment in the project. Production involvement remains strong, as Tengizchevroil is noted as a key contributor to Chevron's global production, particularly in Kazakhstan.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's ongoing capital expenditure commitments and production involvement with Tengizchevroil in both 2023 and 2024, aligning with the ground truth's emphasis on a shift from investment to operational focus. However, there is a key quantitative discrepancy: the LLM states that 2023 Affiliate Capex was $2.31 billion, while the original answer does not specify the actual 2023 amount but only mentions that nearly half of the *expected* 2024 Affiliate Capex ($3 billion) was allocated to Tengizchevroil. This $2.31 billion figure is not present in the ground truth and appears to be an unsupported addition, reducing quantitative accuracy. (2) The $3 billion projected Affiliate Capex for 2024 and the 'approximately half' allocated to Tengizchevroil matches the ground truth and is correctly reported. Production involvement is accurately described as ongoing and significant, particularly in Kazakhstan. (3) The multi-hop reasoning is sound—LLM synthesizes information across years and connects capital commitments to production outcomes. It correctly infers continued strategic importance, though it misses the explicit shift in emphasis from capital investment (2023) to production contribution (2024) as framed in the original answer. (4) Despite the incorrect $2.31 billion figure, the overall narrative is factually consistent and contextually relevant, with strong qualitative reasoning and entity accuracy (Chevron, Tengizchevroil, FGP/WPMP Project, Kazakhstan). The answer addresses both capital expenditure and production involvement across both years, satisfying the multi-part question. The score is reduced primarily due to the unsupported numerical claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 469,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "Between 2023 and 2024, the specificity of UPS's bond matching approach for determining the discount rate for U.S. pension and postretirement benefit plans remained consistent in methodology but showed changes in the resulting rates. In 2023, the U.S. pension discount rate was 5.42%, while in 2024, it increased slightly to 5.88%. For U.S. postretirement medical benefits, the discount rate decreased from 5.80% in 2023 to 6.18% in 2024. These adjustments reflect the updated bond matching approach applied to the projected benefit payments, aligning with the yield curve of high-quality fixed-income debt instruments available at each respective measurement date.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the question. The question asks about the evolution of the *specificity* and *methodological framing* of UPS's bond matching approach in determining the discount rate, not the resulting discount rates themselves. The original answer focuses on a shift in language from describing the method as directly selecting bonds to stating it 'guides' the selection—indicating a subtle operational framing change. The LLM instead provides discount rate numbers for 2023 and 2024, which are not present in the ground truth and appear fabricated. (2) Quantitative Accuracy: The percentages cited (5.42%, 5.88%, 5.80%, 6.18%) are not found in the ground truth and are factually unsupported. There is no mention of actual discount rate values in the original answer, so these numbers are incorrect. (3) Reasoning: The LLM fails the multi-hop reasoning task. It misinterprets the question as asking for changes in discount rates rather than changes in the description or application of the bond matching methodology. It does not reference any evolution in language or policy framing, which is the core of the ground truth. (4) Contextual Relevance: While the answer stays within the domain of pension discount rates and bond matching, it misses the conceptual focus on disclosure language and methodological specificity. The inclusion of non-existent numerical data significantly undermines accuracy. The answer would be more relevant if it discussed the shift from 'selecting specific bonds' to 'using the approach as a guide,' which reflects the actual evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 442,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "From 2022 to 2024, Linde's relationship with helium showed a mixed impact on its financial performance. In 2024, global helium volumes contributed to a 2% decrease in sales for the \"Other\" segment compared to 2023. However, operating profit for the \"Other\" segment increased by 44%, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher costs related to helium. This indicates that while helium-related sales declined, cost management and insurance recoveries helped improve profitability during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of helium's negative impact on sales and mentions the 2% decrease and $32 million figure indirectly via context, but fails to explicitly state the $32 million amount, which is a key quantitative detail from the ground truth. It correctly identifies the 44% increase in operating profit for the 'Other' segment, though this metric is not in the original answer and may be inferred incorrectly. The original answer does not state a 44% increase in operating profit; instead, it notes downward pressure on operating profit due to helium costs, partially offset by insurance recovery—this is a significant discrepancy. (2) The LLM claims a 44% operating profit increase, which is not supported by the ground truth and introduces a major quantitative inaccuracy. The $32 million sales decline is implied through the 2% decrease but not explicitly mentioned, reducing quantitative precision. (3) The reasoning partially reflects multi-hop synthesis: it connects helium volumes to sales decline and links insurance recovery to profit improvement. However, it misrepresents the evolution from 2022 to 2024 by omitting the shift from helium as a supply input (neutral/positive role) to a source of operational challenges. The answer focuses on 2024 vs 2023 rather than the full 2022–2024 evolution requested. (4) Correctness score is 6 due to partial factual alignment—core elements like declining helium sales and cost pressures are present, but key numbers are missing or incorrect, and the overall narrative diverges on profitability impact. Quantitative accuracy is low (5) due to missing $32M and unsupported 44% figure. Qualitative accuracy is moderate (7) as entities (LAMT, helium volumes, insurance) are correctly identified and logically connected, though reasoning has gaps. Contextual relevance is high (9) because the answer addresses the financial impact of helium and attempts the required comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 529,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Bank of America's unfunded capital contributions for renewable energy investments decreased from $6.2 billion at the end of 2023 to $4.6 billion at the end of 2024. The corresponding change in recognized tax credits related to these investments showed a slight decline, from $4.0 billion in 2023 to $3.9 billion in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All numbers are correct — unfunded capital contributions decreased from $6.2 billion in 2023 to $4.6 billion in 2024, and recognized tax credits declined from $4.0 billion to $3.9 billion. The time periods are accurately referenced as 2023 and 2024. (2) Completeness: The answer addresses both parts of the question — the evolution of unfunded capital contributions and the corresponding change in tax credits. (3) Entity accuracy: The company (Bank of America), financial metrics (unfunded capital contributions, recognized tax credits), and years (2023, 2024) are all correctly identified. (4) Reasoning: The LLM correctly infers a decrease in commitments and a slight decline in tax benefits, though it omits the interpretive sentence about 'reduction in near-term funding commitments' and 'tax benefits remaining stable.' However, this does not affect factual correctness, as the core data and trends are accurately reported. (5) Semantic equivalence: The answer conveys the same factual content as the original, with equivalent phrasing and no misleading statements. Minor omission of interpretive context does not detract from correctness. All scores are 10 due to full factual alignment and accurate multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 369,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "From 2022 to 2024, General Motors has shifted its approach to fleet sales involving commercial fleet customers by emphasizing a more strategic and profitable engagement. In 2022, fleet sales accounted for 11.3% of total vehicle sales, with a focus on managing less profitable fleet transactions, particularly with daily rental car companies. By 2024, GM has refined its sales channels by leveraging its dealer network and, in some cases, engaging directly with fleet customers to enhance profitability. The company has also prioritized fleet sales that align with its broader strategic goals, such as promoting electric vehicles (EVs) and hydrogen fuel cell technologies, which are expected to improve long-term profitability and sustainability.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific percentage (11.3% of total vehicle sales in 2022) that is not present in the original answer (ground truth) and cannot be verified from the provided context, making it factually unsupported. This is a significant quantitative inaccuracy. Additionally, the mention of electric vehicles (EVs) and hydrogen fuel cell technologies as part of GM's fleet strategy in 2024 is not mentioned in the ground truth and represents an unsupported addition. (2) There are no verifiable calculations in the response, but the inclusion of the 11.3% figure without sourcing or confirmation from the ground truth undermines quantitative accuracy. The years (2022 and 2024) are correctly referenced, but the associated metrics are not validated. (3) The qualitative reasoning is partially sound: the shift from less profitable fleet sales in 2022 to a more structured, profitability-focused approach in 2024 using both dealer and direct channels aligns with the ground truth. The synthesis of channel evolution (dealer network and direct engagement) is accurate and reflects multi-hop understanding. However, the addition of strategic goals around EVs and hydrogen technologies goes beyond the provided information and weakens the reasoning fidelity. (4) Contextual relevance is high because the answer addresses the core question about evolution in sales channels and profitability considerations. Despite factual overreach, the structure and intent of the response are aligned with the question. The correctness score is 6 due to correct channel evolution description but penalized for unsupported data points and strategic claims not in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 460,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "PepsiCo's relationship with Sabra evolved from a joint venture ownership to a licensing arrangement between 2022 and 2024. In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners but retained a 39% noncontrolling interest in the newly formed joint venture. Additionally, PepsiCo acted as the exclusive distributor for the joint venture's portfolio in the U.S. for small-format and foodservice customers. By 2024, PepsiCo had transitioned to licensing the use of the Sabra brand, indicating a shift from equity ownership to a brand licensing model. Financially, this change reduced PepsiCo's direct exposure to the juice business while allowing continued brand association and distribution rights.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both facts and reasoning. The original answer states that PepsiCo owned Sabra as part of a joint venture in 2022 and by 2024 held a 50% equity stake, recognizing a $122 million pre-tax gain from remeasuring the retained interest at fair value. The LLM answer incorrectly claims that PepsiCo transitioned to a licensing model and references the sale of Tropicana and Naked brands to PAI Partners, which is unrelated to Sabra. These brands were part of a separate transaction and not connected to Sabra’s ownership structure. (2) Quantitatively, the LLM fails to mention the correct equity stake (50%, not 39%), the correct financial gain ($122 million), and incorrectly associates the 39% noncontrolling interest with Sabra when it pertains to the PAI joint venture for juice brands. No correct numbers are provided related to Sabra. (3) The multi-hop reasoning is flawed: the model conflates two distinct transactions—PepsiCo’s divestiture of juice brands and its restructuring of Sabra ownership. There is no evidence in the LLM answer that it correctly synthesized information about Sabra’s ownership change; instead, it fabricates a licensing arrangement not mentioned in the ground truth. (4) The contextual relevance is low because the answer discusses a different business relationship (juice brands with PAI Partners) and misrepresents the nature of PepsiCo’s evolution with Sabra. While the general theme of strategic divestment is relevant, the specific entities, figures, and outcomes are incorrect, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 439,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Adobe Scan has been positioned as a complementary tool within Adobe's Document Cloud ecosystem in both 2023 and 2024. In 2023, Adobe Scan is highlighted as a free mobile scanning app that transforms paper documents into PDFs for instant sharing. By 2024, Adobe Scan is similarly described as a free mobile app but is more explicitly integrated into Adobe Document Cloud services, emphasizing its role in enabling seamless workflows with other Document Cloud offerings like Adobe Acrobat and Acrobat Sign. This suggests a continued focus on integration and utility within Adobe's broader digital document ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately reflects that in 2023, Adobe Scan was an established product (as a free mobile scanning app), and by 2024, it was more explicitly integrated into Adobe Document Cloud. The key entities—Adobe Scan, Document Cloud, Acrobat, Acrobat Sign—are correctly identified, and the years 2023 and 2024 are properly used. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of numbers does not affect correctness, and the model does not introduce any false numerical claims. (3) The multi-hop reasoning is sound: the model correctly infers a progression in positioning from being a standalone app to a more integrated component of Document Cloud, which matches the ground truth’s emphasis on evolving from trademark status to strategic integration. However, the LLM omits the specific detail from the original answer that Adobe Scan was formally listed as a trademark in 2023, which is a minor but notable omission in completeness. Instead, it describes functionality without referencing the trademark status, which slightly weakens the qualitative accuracy. (4) Despite this omission, the answer captures the core evolution in positioning and remains contextually relevant and semantically equivalent in intent and meaning. The conclusion about increased integration and strategic emphasis is valid and well-supported. Hence, a score of 8 is justified for both correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy due to no numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 447,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "General Motors' financial exposure and obligations to Stellantis from 2022 to 2024 regarding indemnifications and historical liabilities have remained largely consistent, with no material changes noted. Following the 2017 sale of the Opel/Vauxhall business to Stellantis, GM continues to indemnify Stellantis for certain losses arising from inaccuracies in representations, warranties, or breaches of covenants in the agreement, as well as for specific liabilities such as emissions claims, product liabilities, and recalls. In 2022, GM mentioned indemnifying Stellantis for an immaterial amount related to Takata inflator recalls in legacy Opel vehicles, and as of 2024, it believes any further indemnification for such matters is remote. Additionally, GM remains subject to potential indemnification claims related to consumer lawsuits in Europe over alleged emissions violations by pre-sale Opel/Vauxhall vehicles, though it is unable to estimate any reasonably possible material loss or range of loss. Overall, the nature of these obligations has not evolved significantly, and GM continues to assess these exposures as immaterial or not reasonably estimable.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely factually accurate and aligns with the ground truth in terms of key entities, timeframes, and types of liabilities (emissions, Takata recalls, indemnifications). It correctly identifies that GM continues to have indemnification obligations to Stellantis stemming from the 2017 Opel/Vauxhall sale, and notes the immateriality of accrued amounts as of 2024. Quantitatively, while no specific dollar figures are given in either answer, the use of 'immaterial' and 'remote' aligns with the original answer’s assertion of reduced exposure, so quantitative accuracy is high given the available information. However, the LLM answer underemphasizes the evolution in the *nature* of the relationship—shifting from supply-related transactions in 2022 to indemnification-focused exposure in 2024—which is a central point in the ground truth. The LLM states that 'no material changes' occurred and that the nature 'has not evolved significantly,' which contradicts the original answer’s emphasis on a transformation from operational to passive financial obligations. This misrepresents the multi-hop synthesis required: connecting the decline in supply activity (2022) with the rise in structured indemnities (2024) as evidence of meaningful evolution. Thus, while the individual facts are mostly correct, the reasoning and qualitative interpretation downplay a key shift, leading to a lower qualitative accuracy score. Contextual relevance is strong as all parts of the question are addressed, including timeline, nature of obligations, and financial exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 429,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's relationship with co-packers has remained consistent in terms of operational dependency, as the company continues to utilize a highly distributed network of plants, warehouses, and distribution centers owned or leased by co-packers, strategic alliances, or joint ventures. There is no indication of increased strategic involvement during this period; the company's reliance on co-packers is primarily operational to support its manufacturing and distribution needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The original answer states that PepsiCo's relationship with co-packers evolved from an operational dependency in 2022 to a more strategic, ownership-based involvement by 2024, citing a shift in language from 'highly distributed network' to 'strategic alliances or joint ventures in which we have an equity interest.' The LLM answer incorrectly asserts that there was no change in strategic involvement and that the relationship remained consistent, which directly contradicts the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify or calculate. The years 2022 and 2024 are correctly referenced, so no entity errors in timing. (3) The multi-hop reasoning is flawed: the task required comparing PepsiCo's descriptions across two years to identify a shift in strategic posture. The LLM failed to detect or report this evolution, instead asserting continuity, indicating a failure in synthesizing the change in language and strategic implication. (4) Correctness and qualitative accuracy are low due to the central factual inaccuracy. Contextual relevance is moderate because the answer addresses the right topic (co-packers, operational network) and timeframe, but misses the key evolution the question was designed to assess.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 384,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "Between 2023 and 2024, SPG's financial relationship with ABG evolved significantly. In 2023, SPG recognized a pre-tax gain of $157.1 million from the sale of a portion of its interest in ABG and a non-cash pre-tax gain of $10.3 million from a deemed disposal due to ABG's capital transaction, which diluted SPG's ownership to approximately 9.6%. By 2024, SPG fully divested its remaining interest in ABG, resulting in a pretax gain of $414.8 million. This marked a strategic shift, as SPG exited its investment in ABG entirely, capitalizing on the gains while reallocating resources to other ventures such as acquiring additional stakes in TRG.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. In 2023, the original answer states SPG recognized a $59.1 million gain from deemed disposals due to ABG's capital transactions, not $10.3 million as stated by the LLM. The $157.1 million gain from the sale of a portion of its ABG interests is correctly mentioned. However, the LLM incorrectly claims a $414.8 million gain in 2024 from full divestiture, which is not supported by the ground truth; instead, the original answer reports only an $18.8 million gain from the sale of a portion of its ABG interest (related to a December 2021 transaction). Additionally, the LLM invents a 'full divestiture' and 'strategic shift to other ventures like TRG,' which are not mentioned in the original. (2) The quantitative errors are severe: $59.1M vs $10.3M, and $18.8M vs $414.8M are massive discrepancies. The 9.6% ownership dilution is not in the original answer and appears fabricated. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers a complete exit from ABG and a strategic pivot to TRG, which contradicts the original answer's indication of ongoing collaboration via a new Reebok partnership. The original describes a shift toward operational collaboration, not divestment and reallocation. (4) While the answer addresses the evolution of the financial relationship and mentions gains, it misrepresents both the magnitude and nature of the transactions. The contextual relevance is moderate because it attempts to describe the relationship's evolution, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 442,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "From 2022 to 2024, Lockheed Martin's involvement in Sikorsky helicopter programs, managed under the Rotary and Mission Systems (RMS) segment, saw increased production volume. In 2022, RMS reported higher production volume on various Sikorsky helicopter programs, contributing to a $735 million increase in product sales. By 2024, Sikorsky programs remained a key focus for RMS, with continued production of helicopters such as the Black Hawk, Seahawk, and CH-53K King Stallion, as well as the completion of the VH-92A Presidential helicopter program. The scope of these programs expanded to include sustainment, training, and logistics solutions, reflecting a broader role in supporting both U.S. and international customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the general evolution of Lockheed Martin's involvement in Sikorsky helicopter programs from 2022 to 2024, including increased production volume and expanded program scope, which aligns with the ground truth. It correctly identifies key programs (Black Hawk, Seahawk, CH-53K King Stallion) and notes the strategic importance of these programs within the RMS segment. However, it introduces a significant factual error: it states that higher production volume contributed to a $735 million increase in product sales in 2022, whereas the ground truth reports a $560 million increase in *product costs*, not sales. This misrepresents both the magnitude and the nature of the financial impact.\n\n2) Quantitative inaccuracy is critical here: the LLM reports $735 million in increased *product sales*, while the original answer specifies a $560 million increase in *product costs*. These are different metrics (sales vs. costs) and different amounts. This error undermines the factual reliability of the response, especially since the question asks about production volume impacts, which are tied to cost and operational performance, not revenue. No other numbers are provided in the LLM answer for verification.\n\n3) The qualitative reasoning is sound in terms of multi-hop synthesis: the model connects Sikorsky programs to the RMS segment, tracks their evolution over time, and infers an expanded scope including sustainment and logistics. It also correctly identifies the completion of the VH-92A program as part of the 2024 scope, which adds value beyond the ground truth. However, the ground truth emphasizes a shift from being a 'cost driver' to a 'strategic product line,' a nuance not reflected in the LLM answer.\n\n4) Contextual relevance is high—the answer directly addresses production volume and program scope over the 2022–2024 period and includes relevant helicopter programs and customer focus. Despite the major quantitative error, the overall direction and intent of the answer are aligned with the question. The score is limited primarily by the incorrect financial figure and mischaracterization of costs as sales.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 575,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, increasing its ownership to 100%. However, the entity was subsequently sold and deconsolidated in fiscal 2025, meaning it was no longer part of Walmart's financial holdings by fiscal 2024. Therefore, between fiscal 2023 and fiscal 2024, Walmart's ownership stake and financial investment in Alert Innovation were fully divested.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion and increased ownership to 100%, which matches the ground truth. However, it introduces a new claim that the entity was 'sold and deconsolidated in fiscal 2025', which is not present in the original answer and contradicts the timeline—fiscal 2025 occurs after fiscal 2024, so this detail is factually inconsistent with the available information. The original answer only states that there was no mention of Walmart retaining ownership in fiscal 2024, implying a divestiture, but does not specify when or how it occurred. (2) The dollar amount ($0.4 billion) and ownership percentage (100%) are accurate and correctly formatted. There are no calculation errors. (3) The multi-hop reasoning is partially sound—Walmart’s full acquisition in 2023 and exit by 2024 is correctly inferred—but the addition of a 'fiscal 2025' deconsolidation introduces unsupported information, weakening the logical chain. The model overreaches by specifying a future event not in the source. (4) Scores reflect high quantitative accuracy and contextual relevance since the core facts are correct and directly address the question, but qualitative accuracy and overall correctness are reduced due to the introduction of an unverified timeline element that affects reasoning integrity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 381,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG's utilization of the Supplemental Facility showed a shift in borrowing activity and repayment strategy. In 2023, the Operating Partnership issued €750.0 million in senior unsecured bonds to repay €750.0 million outstanding under the Supplemental Facility, indicating a focus on refinancing and reducing variable-rate debt. By 2024, the Supplemental Facility had a borrowing capacity of $3.5 to $4.5 billion, with available capacity at $8.2 billion under the combined Credit Facilities. Although there was no outstanding balance under the Commercial Paper program by year-end 2024, the weighted average interest rate on the Credit Facilities had increased to 5.29%, reflecting broader market rate trends. SPG's repayment strategy emphasized refinancing high-cost debt and maintaining liquidity, as evidenced by the redemption of several notes and the repayment of mortgages related to property acquisitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth. It incorrectly states that SPG issued €750.0 million in senior unsecured bonds in 2023 to repay the Supplemental Facility, whereas the ground truth indicates that the €750.0 million was *borrowed* under the Supplemental Facility and then repaid *after* bond issuance—this reverses the causal sequence and misattributes the bond issuance currency and purpose. The ground truth specifies that the 2024 bond issuance was $1.0 billion (not €750M), which the LLM omits entirely. (2) Quantitative inaccuracies include: no mention of the November 17, 2023 repayment date; incorrect characterization of the Supplemental Facility’s capacity as $3.5–$4.5 billion and combined availability as $8.2 billion—these figures are not in the ground truth and appear fabricated; the 5.29% interest rate is mentioned without context or relevance to the Supplemental Facility specifically. (3) Multi-hop reasoning is partially present but flawed: the model attempts to discuss refinancing strategy but fails to correctly link the 2023 borrowing and repayment to the bond issuance, and does not acknowledge the complete cessation of Supplemental Facility usage in 2024. It also conflates the Commercial Paper program and Credit Facilities with the Supplemental Facility without clarifying their relationship. (4) Despite these issues, the answer captures the general trend of reduced reliance on the facility and refinancing via long-term debt, which provides some qualitative and contextual alignment, justifying moderate scores in those areas. However, the core financial facts and timeline are incorrect, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 478,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Between 2023 and 2024, Linde has maintained helium as a key process gas within its industrial gases business, but there is no indication of a strategic shift in positioning it as a primary product. Helium is consistently listed among process gases (e.g., hydrogen, carbon dioxide, specialty gases) sold through merchant distribution, which allows for longer-distance shipping and flexible, shorter-term contracts. Linde’s supply strategy for helium remains aligned with its broader industrial gases distribution methods, emphasizing merchant delivery and long-term supply agreements where applicable, without specific new initiatives highlighted in the 2024 filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about Linde's treatment of helium between 2023 and 2024. According to the ground truth, helium was explicitly listed as a primary product in 2023 but was no longer specifically named in 2024, indicating a strategic repositioning and reduced emphasis as a standalone offering. The LLM incorrectly states there is 'no indication of a strategic shift,' which directly contradicts the documented change in disclosure. While the answer correctly references merchant distribution and general supply strategies (hence perfect quantitative accuracy on non-numerical descriptors), it fails to identify the key qualitative shift: the removal of helium from explicit product listings in 2024. This omission reflects a failure in multi-hop reasoning—comparing disclosures across years to detect changes in strategic positioning. The answer is contextually relevant to the question and uses appropriate terminology, but misses the central evolution in helium's status. Thus, the correctness score is low due to major factual inaccuracy in the core insight, despite correct general descriptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 320,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the allocation of assets in the U.S. Retiree Health Care Plan remained within the target ranges but shifted slightly. Fixed income securities and cash equivalents increased from 65% in 2022 to 80% in 2023, while equity securities decreased from 35% in 2022 to 20% in 2023. This change reflects a more conservative allocation towards fixed income, aligning with the plan's strategy to match the interest rate sensitivity of liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. While it correctly identifies a shift toward fixed income and away from equity, the actual dollar amounts and percentages provided in the LLM answer do not match the ground truth. The original answer states that in 2022, fixed income and cash equivalents were $248 and equity was $137 (total $385), which corresponds to approximately 64.4% and 35.6% respectively—close but not exactly 65%/35%. In 2023, fixed income was $210 and equity was $54 (total $264), which is about 79.5% and 20.5%—again roughly matching the 80%/20% cited, but these percentages were not explicitly stated in the source data and appear to be inferred. However, the LLM introduces 'target ranges' and 'strategy to match interest rate sensitivity' which are not present in the original answer and constitute unsupported qualitative additions. (2) The quantitative inaccuracies are significant: the LLM reports percentages instead of the actual dollar values requested and does not mention the total asset decline from $385 to $264. The shift is portrayed as a proportional reallocation within a stable portfolio, whereas the ground truth shows a substantial reduction in total assets, especially in equities (from $137 to $54, a 60.6% drop). The LLM fails to note the absolute decreases, focusing only on proportions. (3) The multi-hop reasoning is flawed because the model appears to infer allocation percentages without grounding them in the actual reported dollar figures, and it assumes strategic intent not present in the data. It does recognize the directional change (more fixed income, less equity), showing partial synthesis. (4) The correctness score is low due to major factual and numerical inaccuracies. Quantitative accuracy is poor because the answer omits actual dollar amounts and fabricates precise percentages not in the source. Qualitative accuracy is slightly higher because the general trend is correctly identified. Contextual relevance is moderate since the answer addresses asset allocation changes but misrepresents the nature of those changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 569,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's financial performance showed significant growth, with product sales increasing by 56% to $1.1 billion in 2023 compared to $680 million in 2022, driven by higher demand in new and existing geographies. Strategically, Trodelvy received FDA approval for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. Additionally, the European Commission approved Trodelvy as monotherapy for a similar patient population, expanding its regulatory footprint and therapeutic positioning.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in financial figures. According to the ground truth, Trodelvy generated $380 million in product sales in 2022; the LLM incorrectly states $680 million. It further claims $1.1 billion in 2023 sales with a 56% increase, which is unsupported by the provided data—no 2023 revenue figures are available in the ground truth. These quantitative errors severely undermine the answer's correctness. (2) The calculation of a 56% increase from $680M to $1.1B is mathematically plausible (~61.8% increase), but both numbers are factually wrong, making the entire financial narrative invalid. The ground truth explicitly states that 2023 revenue figures are not provided, so asserting precise numbers is a critical error. (3) On qualitative aspects, the LLM correctly identifies key regulatory milestones: FDA and European Commission approvals for HR+/HER2- metastatic breast cancer in 2023, which aligns with the ground truth and shows accurate multi-hop reasoning regarding strategic positioning. The description of the approved indications is also semantically consistent. (4) Despite strong contextual relevance—addressing both financial performance and strategic positioning as asked—the answer fails on quantitative accuracy due to fabricated revenue data. The qualitative accuracy is moderate because the reasoning around regulatory developments is sound, but the financial claims are not. Contextual relevance is high as the structure and intent match the question well.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 421,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron's downstream-related earnings from GS Caltex declined from $874 million in 2022 to $58 million in 2024, indicating a significant reduction in profitability from this joint venture. Despite this decline, the continued inclusion of GS Caltex in Chevron's downstream investments and the substantial investment balance ($4,144 million in 2024) suggest that the joint venture remains strategically important for Chevron's downstream operations in South Korea.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The claim that Chevron's downstream-related earnings from GS Caltex declined from $874 million in 2022 to $58 million in 2024 is not supported by the ground truth. The original answer does not provide specific earnings figures for GS Caltex alone, only that Chevron reported higher downstream-related earnings from GS Caltex in 2022 and maintained a 50% ownership stake in 2024. The LLM invents precise numbers without basis. Additionally, the $4,144 million investment balance in 2024 is not mentioned in the ground truth. (2) The only correct quantitative point is the general trend of decreased revenue with affiliated companies, but even this is misrepresented: the original answer states that Chevron's total sales with affiliated companies (including GS Caltex) decreased from $16,286 million in 2022 to $13,850 million in 2024 — a fact the LLM fails to accurately cite or attribute. The LLM incorrectly frames this as a decline in GS Caltex-specific earnings rather than broader affiliated revenue. (3) The multi-hop reasoning is flawed. The LLM incorrectly isolates GS Caltex as the sole driver of a dramatic earnings drop, which is unsupported. It also fails to mention the continued strategic role of GS Caltex in downstream operations beyond fabricated numbers. While it correctly identifies the joint venture structure and its geographic importance, it does not reference the 50% ownership or the partnership with GS Energy as stated in the original. (4) The contextual relevance is moderate because the answer addresses the strategic importance and the joint venture’s role, but the severe quantitative inaccuracies and invented data undermine correctness. The qualitative reasoning is partially sound but built on false premises. Thus, the correctness score is low due to fabrication of key financial figures and misrepresentation of trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 519,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 to 2024, the CH-53K program, managed under Lockheed Martin's Rotary and Mission Systems (RMS) segment, showed positive production growth and risk retirements. In 2022, the CH-53K program contributed to a 5% increase in RMS net sales due to higher production volume. By 2024, production volume on the CH-53K program continued to rise, contributing $140 million to RMS' $1.0 billion net sales increase. Additionally, risk retirements positively impacted the program's performance in 2022, and while specific 2024 risk retirement details for CH-53K are not provided, the overall RMS segment experienced favorable contract mix and cost recoveries, indicating continued progress in managing program risks.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth states that the CH-53K contributed approximately $140 million in increased profit in 2022 due to risk retirements and production volume, not a 5% increase in RMS net sales as claimed. The LLM incorrectly states that CH-53K contributed $140 million to a $1.0 billion net sales increase in 2024—this is unsupported by the original answer, which does not mention any such sales contribution or net sales increase. Additionally, the original answer notes a 73% decline in RMS operating profit in 2024, which the LLM omits entirely, instead suggesting favorable conditions without acknowledging the broader profit deterioration. (2) The numbers are largely incorrect: no 5% sales increase is mentioned in the ground truth for 2022, and the $1.0 billion net sales increase in 2024 is fabricated. The $140 million figure is real but refers to profit improvement in 2022, not a 2024 sales contribution. (3) The multi-hop reasoning is flawed—the LLM fails to connect the 2022 profit gains from risk retirements to the 2024 context of declining RMS profitability, which is central to the original answer’s analysis. Instead, it implies continued positive momentum without addressing the 73% profit drop. (4) While the LLM correctly identifies CH-53K as part of RMS and mentions risk retirements and production volume, the core financial narrative is reversed: the original highlights a decline in profitability post-2022, while the LLM suggests ongoing improvement. This undermines factual correctness despite some contextual alignment. Hence, low quantitative and correctness scores, moderate qualitative, and high relevance due to topic focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 479,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "Between 2022 and 2023, PayPal's approach to seller protection programs evolved by enhancing its strategic emphasis on risk management and expanding its value proposition for merchants. In 2022, the focus was on providing risk management and seller protection programs as part of broader merchant support. By 2023, PayPal explicitly highlighted its proprietary, end-to-end payments platform and data-driven systems to improve the safety and security of transactions, reflecting a more integrated and proactive approach to mitigating risk exposure for both merchants and consumers.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a shift in PayPal's approach to seller protection between 2022 and 2023, noting increased strategic emphasis and integration with broader platform capabilities. However, it omits key quantitative details from the original answer—specifically, the 2022 risk exposure with historical transaction loss rates between 0.09% and 0.15% of TPV—which is a significant factual component of the ground truth. This omission reduces completeness and factual richness. (2) There are no numeric inaccuracies in the LLM response because it does not include any numbers; thus, quantitative accuracy is high by default, but the failure to include the specific loss rate range from the ground truth limits its factual completeness. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic evolution from risk management to a more integrated, value-added service. However, it fails to connect the 2022 risk exposure data to the 2023 strategic pivot, weakening the synthesis. The original answer explicitly contrasts 2022's risk-focused framing with 2023's growth-oriented positioning, which the LLM only implies. (4) Contextual relevance is strong—the response stays on topic and addresses the evolution in strategy and risk approach. However, the lack of specific metrics and weaker differentiation between the two years' strategic priorities results in a moderate correctness score. The answer captures the general direction of change but misses key evidence that defines the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 426,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Between 2023 and 2024, Starbucks' approach to ready-to-drink beverages remained largely consistent in terms of revenue recognition, with sales recognized upon shipment to customers or redemption for stored-value cards and loyalty rewards. However, the 2024 filing highlights continued expansion in the use of reusable packaging for such products, reflecting a greater emphasis on sustainability. Supplier dependency for ready-to-drink beverages, which are sourced from several specialty suppliers under long-term contracts, remains stable, with Starbucks expressing confidence in the reliability of its suppliers based on historical performance and established relationships. There is no indication of significant changes in supplier dependency or revenue recognition practices for these products between the two periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses the key evolution highlighted in the ground truth. While it correctly states that revenue recognition remained consistent—sales recognized upon shipment—it fails to capture the strategic shift in focus from revenue reporting in 2023 to supply chain resilience and supplier dependency in 2024. Instead, the LLM introduces a new detail about 'reusable packaging' and 'sustainability' not present in the original answer, which is unsupported by the ground truth. This misrepresents the nature of the evolution. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the absence of specific figures is consistent with the original answer’s note that no specific revenue numbers were disclosed. Thus, no factual error in this regard. (3) The multi-hop reasoning is flawed: the question asks for how the approach evolved, particularly in revenue recognition and supplier dependency. The LLM correctly notes stable supplier relationships but misses the critical point that 2024 emphasized long-term contracts as a risk mitigation strategy, signaling a strategic pivot. It incorrectly implies no significant change, whereas the ground truth clearly states a shift from revenue-centric disclosure to supply-chain risk management focus. (4) The contextual relevance is high because the answer addresses the right topic and timeframe, and correctly identifies supplier structures and revenue recognition mechanics. However, the qualitative inaccuracy in capturing the strategic evolution reduces correctness. The answer is factually plausible but does not reflect the documented shift in emphasis between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 468,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's geographic reach and regulatory approvals expanded significantly. In 2022, Trodelvy was approved in the U.S. for metastatic urothelial cancer (UC) and in Canada for metastatic triple-negative breast cancer (TNBC). By 2023, Trodelvy received European Commission (EC) approval as monotherapy for HR+/HER2- breast cancer and additional FDA approvals for the same indication, expanding its availability in key international markets. Sales increased by 56% in 2023 compared to 2022, reflecting higher demand in new and existing geographies.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the 2023 EC approval for HR+/HER2- breast cancer and additional FDA approvals for the same indication, which aligns with the ground truth about expanded regulatory approvals. However, it introduces unverified claims not present in the original answer, such as approval in Canada for metastatic triple-negative breast cancer (TNBC) and U.S. approval for metastatic urothelial cancer (UC) in 2022—neither of which are mentioned in the ground truth. The $370M U.S. and $10M Europe sales figures from 2022 are omitted, reducing completeness. (2) The claim of a '56% sales increase in 2023' is unsupported by the original answer, which provides no year-over-year sales growth data—this is a significant quantitative inaccuracy. No calculation can be verified because the original answer does not provide 2023 sales figures or growth rates. (3) The reasoning partially reflects multi-hop synthesis by connecting regulatory approvals to expanded market access, but it fabricates geographic approvals (Canada) and indications (UC) not present in the source. The link between approvals and increased sales is speculative and not grounded in the provided truth. (4) The contextual relevance is high because the answer addresses the evolution of geographic reach and regulatory approvals, but correctness is undermined by factual inaccuracies and unsupported metrics. The qualitative accuracy is moderate due to correct identification of some 2023 approvals but flawed entity and metric usage. Quantitative accuracy is low due to the invented 56% growth figure and missing actual sales data from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 466,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's ownership stake in ABG evolved through a series of transactions. In 2023, Simon sold a portion of its interest in ABG for $300.2 million, resulting in a pre-tax gain of $157.1 million and a dilution of its ownership to approximately 9.6%. In 2024, Simon fully exited its remaining interest in ABG by selling it for cash proceeds of $1.2 billion, which generated a pre-tax gain of $414.8 million. Thus, Simon's ownership stake in ABG was completely divested by the end of 2024, with significant financial gains realized in both years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both factual content and reasoning. The original answer states that Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG in 2023—specifically from 12.3% to 11.8%, then 11.7%, and finally to 9.6%—due to capital transactions involving ABG, not direct sales by SPG. These dilutions led to non-cash pre-tax gains of $36.4M, $12.4M, and $10.3M, respectively. In contrast, the LLM claims a single $300.2M sale with a $157.1M gain in 2023 and a $1.2B sale with a $414.8M gain in 2024, which are completely fabricated numbers not present in the ground truth. (2) Quantitatively, every number is wrong: the gains are misstated (e.g., $36.4M + $12.4M + $10.3M = $59.1M total in reality, not $157.1M), and the 2024 transaction involving $1.2B and $414.8M gain has no basis in the original answer. The original answer explicitly states that SPG did not report any new transactions in 2024, only referencing a prior 2021 transaction with an $18.8M gain and a $100M acquisition. (3) The multi-hop reasoning is fundamentally flawed: the LLM incorrectly infers a full divestiture in 2024, while the ground truth indicates no active stake changes were disclosed in 2024. It also mischaracterizes the nature of the 2023 events as direct sales rather than equity dilution, which is a critical distinction in financial reporting. (4) The contextual relevance is low but not zero because the answer does address SPG’s stake in ABG over 2023–2024, but the factual inaccuracies render it misleading. Correctness, quantitative, and qualitative scores are very low due to complete failure in factual alignment and reasoning. Contextual relevance receives minimal points for topic alignment only.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 480,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "Between 2023 and 2024, the 2012 Equity Incentive Plan was amended with the addition of a Fourth Amendment in 2024 (filed on August 1, 2024). Additionally, new forms of award agreements were disclosed in 2024, including \"Additional Forms\" filed on April 25, 2024, expanding the plan's structure and terms compared to the 2023 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Fourth Amendment is correctly dated August 1, 2024, and the new forms of award agreements are accurately noted as being filed in April 2024 (specifically April 25, 2024, per the LLM answer, which adds precision not contradicted by the original). The reference to the 2023 filing correctly implies that prior amendments (up to the Third) and earlier forms (2012 and 2017) were included, though this is slightly less explicit than the original answer. (2) Quantitative accuracy is perfect: dates (August 1, 2024; April 25, 2024) match the expected timeline and are consistent with the knowledge graph. No calculations are required, but temporal references are correct. (3) The multi-hop reasoning is sound—comparing the 2023 and 2024 filings to identify evolution in amendments and award forms is properly executed. The LLM correctly infers progression (Fourth Amendment, new forms) indicating plan expansion. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2012 and 2017 forms referenced in the 2023 filing, which the original answer includes for completeness. However, the focus of the question is on the evolution *between* years, and the LLM emphasizes the 2024 additions, which is contextually appropriate. Thus, while slightly less comprehensive, the answer remains factually correct and semantically equivalent in intent. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 435,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "The treatment and valuation of capitalized software licenses evolved between 2022 and 2023, as the value increased from $152 million in 2022 to $223 million in 2023, according to the balance sheet data. Additionally, the amortization expense for capitalized software rose from $54 million in 2022 to $63 million in 2023. This increase in both the capitalized value and the related amortization indicates a growing investment in software licensing by the company during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in capitalized software licenses from $152 million in 2022 to $223 million in 2023, which matches the ground truth and is factually accurate. However, it introduces an additional claim not present in the original answer or ground truth: that amortization expense increased from $54 million in 2022 to $63 million in 2023. This specific amortization data is not mentioned in the original answer and cannot be verified from the provided ground truth, making it a significant factual overreach. (2) While the core valuation numbers ($152M and $223M) are correct and properly attributed to the respective years, the inclusion of unverified amortization expenses undermines quantitative accuracy. There are no calculation errors in the numbers presented, but the addition of unsupported data reduces reliability. (3) The reasoning correctly infers that increasing capitalized value indicates growing investment in software licensing, which aligns with the original answer’s conclusion. However, the LLM fails to mention the evolution in disclosure quality—from a policy description in 2022 to a quantified asset in 2023—which is a key qualitative point in the ground truth about how treatment and valuation evolved. This omission weakens the multi-hop synthesis, as the shift in reporting transparency is as important as the numerical change. (4) The answer is contextually relevant and addresses the general trend of investment in software licensing, but lacks completeness in capturing the full scope of 'treatment and valuation' evolution. The score reflects partial correctness: core facts are right, but missing key qualitative insights and introducing unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 476,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "Between 2022 and 2023, PayPal increased its utilization of European customer balances for credit activities, with the approved amount rising from $3.8 billion in 2022 to $3.0 billion in 2023, representing 37% and 39% of European customer balances, respectively. This indicates a strategic shift to more efficiently leverage customer funds to support credit products, reducing reliance on external capital and optimizing liquidity. The increase suggests PayPal is actively expanding its credit offerings while adhering to regulatory frameworks, such as those set by the CSSF.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the approved amount of European customer balances increased from $3.8 billion in 2022 to $3.0 billion in 2023, when in fact it decreased from $3.8B to $3.0B. This misrepresents the direction of change. Additionally, while the percentages (37% and 39%) are correctly cited, the interpretation of this as an 'increase' in utilization is misleading—the dollar amount approved declined, even though the percentage of available balances used rose slightly. Crucially, the LLM omits the key strategic development in 2023: the new €40 billion agreement to sell consumer installment receivables, with $5.5 billion sold during the year, which signals a shift toward external funding mechanisms. This omission severely undermines the answer’s completeness and qualitative accuracy. (2) Quantitative inaccuracies include the reversal of the trend (claiming an increase instead of a decrease in approved balances), despite correct raw numbers ($3.8B and $3.0B) and percentages (37%, 39%). However, the misstatement of direction invalidates any correct individual values. (3) The multi-hop reasoning is flawed: the model fails to synthesize the full picture—declining internal funding approval alongside a new large-scale external funding program—leading to an incorrect conclusion about strategy (i.e., reducing reliance on external capital, when the opposite is true). (4) Contextual relevance is moderate because the answer addresses the general topic and timeframe, and attempts to interpret strategic intent, but due to major factual and inferential errors, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 459,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks' investment in Valor Siren Ventures I L.P. had a total carrying value of $211.9 million as of September 29, 2024. The financial impact of this investment is included in \"interest income and other, net\" on Starbucks' consolidated statements of earnings, though related financial statement activities were not material during the periods presented. No specific prior year carrying value for Valor Siren Ventures I L.P. is provided, but the overall carrying value of non-core equity investments increased from $439.9 million as of October 1, 2023, to $463.9 million as of September 29, 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the $211.9 million carrying value as of September 29, 2024, and correctly notes that the financial impact is included in 'interest income and other, net' and is non-material—this aligns with the ground truth. However, it incorrectly implies that the $211.9 million refers only to Valor Siren Ventures I L.P., while the original answer clarifies this is the combined value of both Valor Siren Ventures I L.P. and II L.P. This is a significant factual misrepresentation. Additionally, the LLM introduces data not present in the ground truth—namely, the total non-core equity investments of $439.9 million as of October 1, 2023, and $463.9 million as of September 29, 2024—which, while possibly accurate, is irrelevant to the specific question about Valor Siren Ventures I L.P. and distracts from the required multi-hop comparison. (2) The date (September 29, 2024) is correct. The $211.9 million figure is accurate but misattributed in scope (I L.P. vs. I + II L.P.). The prior-year breakdown for Valor Siren I L.P. alone is correctly noted as undisclosed, but the introduction of aggregate non-core investment values is extraneous and unsupported by the original answer. (3) The reasoning partially fails the multi-hop requirement: the model should have contrasted the lack of specific disclosure in 2023 with the quantified combined value in 2024, emphasizing the evolution in reporting clarity. Instead, it substitutes unrelated aggregate figures, weakening the synthesis. (4) Scores reflect mostly correct numbers and context, but with a critical error in entity specificity and inclusion of unsupported aggregate data, reducing qualitative and overall correctness despite strong relevance and partial accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 477,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, the strategic positioning of Analog Products at Texas Instruments (TI) experienced a decline in financial contribution, with a 15% decrease in revenue and a 30% drop in operating profit, primarily due to lower demand and higher manufacturing costs. Despite this, TI maintained its focus on strengthening its competitive advantages, particularly in manufacturing and technology, as outlined in its strategy to maximize free cash flow per share. The Analog segment continued to represent a core part of TI's business model, though its performance in 2023 reflected broader market challenges compared to the strong growth seen in 2021 and 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The original answer states that Analog Products remained a core strategic pillar in 2023 with continued strong gross margin (67.5%) driven by manufacturing efficiency, particularly 300mm wafer production. In contrast, the LLM claims a 15% revenue decline and 30% drop in operating profit due to lower demand and higher costs—information not present in the ground truth and factually incorrect based on the provided knowledge. There is no mention of declining financials in the original; instead, the emphasis is on sustained margins and strategic reinforcement. (2) The quantitative inaccuracies are severe: the LLM fabricates specific percentages (15% revenue decrease, 30% profit drop) with no basis in the ground truth, which reports no such declines. The original highlights gross margin of 67.5% in 2022 and continuity into 2023, but the LLM omits this key metric and replaces it with invented negative performance data. (3) The multi-hop reasoning fails: while the LLM correctly identifies Analog Products as a core part of TI’s business and mentions free cash flow per share as a metric, it misrepresents the evolution as a decline rather than a strategic repositioning around TI’s four sustainable advantages (cost, supply chain control, etc.). The synthesis between years is flawed—instead of showing continuity and reframing, it invents a downturn. (4) Contextual relevance is moderate because the answer discusses Analog Products, TI’s strategy, and financial metrics, but the factual foundation is wrong. The mention of manufacturing strategy and cash flow aligns with the original, but the overall narrative contradicts the ground truth. Thus, correctness is very low due to fabricated data and incorrect characterization of performance trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 502,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron's capital allocation strategy in the Lower 48 region from 2022 to 2023 shows an increase in depreciation, depletion, amortization, and impairments, rising from $4,854 million in 2022 to $5,729 million in 2023. This suggests a higher level of capital investment and asset utilization in the region during 2023, reflecting a more aggressive capital allocation strategy focused on development and production activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in depreciation, depletion, amortization, and impairments (DD&A) from $4,854 million in 2022 to $5,729 million in 2023, matching the ground truth exactly. These figures are presented accurately with correct dollar amounts and years. (2) All numeric values are correct and consistent with the original answer; the rise of $875 million is implied and mathematically accurate ($5,729M - $4,854M = $875M), though not explicitly stated, which does not detract from correctness. (3) The reasoning is sound: the LLM correctly infers that rising DD&A reflects increased capital investment and a more aggressive capital allocation strategy in the Lower 48, which aligns with the multi-hop logic in the ground truth. It appropriately links financial metrics to strategic intent. (4) While the LLM answer captures the core evolution in capital allocation and supports it with accurate data and logical interpretation, it omits the comparative context with other regions (e.g., Europe, Middle East and North Africa) mentioned in the original answer, which provides additional strategic contrast. This minor omission prevents a perfect 10 on qualitative accuracy, but the response remains highly accurate and relevant overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 358,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Between 2023 and 2024, Verizon has continued to position FWA broadband as a core component of both its Consumer and Business segments, leveraging its 5G and 4G LTE networks to provide an alternative to traditional landline internet access. In 2023, FWA was highlighted as part of the Consumer segment's residential fixed connectivity solutions and as a service within the Business segment for small and medium businesses. By 2024, FWA remained a key offering in both segments, with continued emphasis on its role in expanding broadband access for residential and business customers, particularly in areas where traditional wired infrastructure is limited. The target customer segments remained largely consistent, with FWA serving as a flexible, high-speed connectivity solution for both consumer and business markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Verizon offered FWA broadband in both 2023 and 2024 through 5G and LTE networks, targeting both Consumer and Business segments, which aligns with the ground truth. It accurately reflects the continuity in positioning and target customer segments. However, it omits the specific figure of 3.1 million FWA broadband connections reported in 2023, which is a key quantitative detail from the original answer. Additionally, the LLM answer does not mention the shift in language from 'provides' in 2023 to 'produces' in 2024, which the ground truth highlights as indicative of a more strategic, product-centric evolution in 2024. This nuance in strategic positioning is missing, weakening the qualitative accuracy. (2) There are no numerical inaccuracies—since the only number in the ground truth (3.1 million) was omitted rather than misstated, quantitative accuracy remains high. No incorrect calculations or dates are present. (3) The reasoning is sound in recognizing FWA’s role across segments and its function as an alternative to landline internet, but it fails to synthesize the subtle but important shift in strategic framing between the years, which is central to the question about evolution. This represents a partial multi-hop synthesis failure. (4) The answer is contextually relevant and well-structured, addressing both product portfolio positioning and customer segments. The omission of the 3.1 million figure and the strategic language shift prevents a higher score, but core facts about network use and segment targeting are correct, justifying a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 449,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2022 to 2024, transitioning from a 55% ownership stake in the newly formed \"New AspenTech\" (created through the combination of Emerson's industrial software businesses with Heritage AspenTech) to proposing a full acquisition of the remaining shares in 2024. This evolution positively impacted Emerson's gross margin, as the Heritage AspenTech acquisition in 2022 contributed 0.6 percentage points to the 2023 gross margin, and the Test & Measurement acquisition in 2023 further increased the 2024 gross margin by 1.8 percentage points. Additionally, Emerson's equity structure was affected through the recognition of gains on its equity investments and the eventual proposed full acquisition, which would consolidate AspenTech entirely under Emerson's ownership.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson did not hold a 55% stake in 2022; rather, the 55% ownership was acquired by 2024 as part of forming 'New AspenTech.' The LLM incorrectly states that the 55% stake existed at the start (2022) and then implies a full acquisition was proposed later, reversing the actual timeline. Additionally, the LLM introduces a 'Test & Measurement acquisition in 2023' contributing 1.8 percentage points to 2024 gross margin—this is entirely fabricated and not present in the original answer or implied by the context. The only correct quantitative point is the 0.6 percentage point contribution to 2023 gross margin from the AspenTech-related transaction. (2) The numbers mentioned—0.6 percentage points—is accurate and matches the ground truth. However, the additional claim of a 1.8 percentage point increase from a nonexistent acquisition severely undermines quantitative accuracy. Dates (2022, 2023, 2024) are used in correct sequence but attached to incorrect events. (3) The multi-hop reasoning is flawed: the model fails to correctly trace the evolution of ownership (from partnership to majority stake), instead inventing a reverse narrative and adding unrelated acquisitions. It also conflates equity impacts, attributing changes only to gains on investments, while the original answer specifies gains/losses from AspenTech stock plans and restructuring of software assets. (4) Contextual relevance is high—the answer addresses the relationship evolution, gross margin, and equity structure as asked. However, due to major factual and directional errors in the timeline and invented financial data, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because some terminology and structure align, but reasoning is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 506,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "From 2022 to 2023, the financial relationship between NextEra Energy (NEE) and FPL Group Capital Inc. remained closely intertwined, particularly through shared obligations under long-term debt and capital structure arrangements. In both years, NEE and FPL Group Capital Inc. were jointly involved in issuing various debt instruments, including floating rate notes and fixed-rate debentures, with multiple series maturing between 2024 and 2079. Notably, in 2023, additional amendments and terms were set for existing debentures (e.g., Series J, K, and L), indicating continued coordination in managing their capital structures. These obligations highlight a shared financial framework where NEE and FPL Group Capital Inc. maintain joint or overlapping responsibilities in their debt and capital management strategies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that in 2022, the relationship was defined by a 1998 guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc., but the LLM omits this entirely and instead claims joint debt issuance in both years, which contradicts the original answer. The LLM incorrectly states that NEE and FPL Group Capital Inc. were jointly issuing debt instruments like floating rate notes and fixed-rate debentures in both 2022 and 2023, which is not supported by the ground truth. Instead, the evolution was from a guarantee to NEE issuing junior subordinated debentures *to* FPL Group Capital Inc. in 2023—not joint issuance. (2) Quantitatively, the LLM invents maturity dates 'between 2024 and 2079' and references Series J, K, and L debentures with 'amendments in 2023', none of which appear in the ground truth. The correct series issued in 2023 were B, C, L, M, N, O, and P, with maturities from 2057 to 2082. These are significant factual deviations. (3) The multi-hop reasoning is flawed: the question asks for evolution in the *nature* of obligations and capital structure involvement, but the LLM fails to recognize the shift from a guarantee (2022) to a capital financing arrangement via debentures issued by NEE to FPL Group Capital Inc. (2023). Instead, it assumes continuity and joint obligations, missing the directional change in the financial relationship. (4) Contextual relevance is moderate because the answer discusses debt instruments and capital structure, which are relevant themes, but the specifics are factually wrong and misrepresent the entities' roles and the nature of their financial ties. The core transformation described in the ground truth—strategic shift from guarantee to long-term financing—is entirely absent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 501,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "Between 2022 and 2024, the InterStim II neurostimulator has seen continued market acceptance and growth as part of Medtronic's Pelvic Health therapies. In 2022, the Pelvic Health division experienced strong growth driven by the recently launched InterStim Micro and SureScan MRI leads, while InterStim II contributed to the broader Pelvic Health portfolio. By 2024, InterStim II remained a key offering, with continued acceptance alongside the newer InterStim X recharge-free neurostimulator and InterStim Micro rechargeable neurostimulator. This evolution reflects Medtronic's strategy to expand its Pelvic Health portfolio with diverse, patient-friendly neurostimulation solutions for conditions like overactive bladder and fecal incontinence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: InterStim II's continued market acceptance between 2022 and 2024, its role within Medtronic's Pelvic Health portfolio, and the introduction and positioning of InterStim Micro and InterStim X are accurately described. The conditions treated—overactive bladder, urinary retention, and bowel/fecal incontinence—are correctly noted. (2) There are no numeric values to verify (e.g., revenue figures, growth percentages), so quantitative accuracy is not compromised; all dates (2022, 2024) are used appropriately. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution of product positioning by noting the shift toward emphasizing recharge status (explicitly identifying InterStim X and Micro by their recharge characteristics), which reflects the broader strategic diversification mentioned in the ground truth. While the original answer emphasizes the 'recharge-free' attribute of InterStim II specifically in 2024, the LLM implies this by contrasting it with the rechargeable Micro and the recharge-free X, though it does not explicitly label InterStim II as recharge-free. This is a minor omission but does not distort the overall accuracy. (4) The answer is contextually relevant, directly addressing the evolution of market positioning and acceptance relative to other devices and broader Pelvic Health therapies. The slight lack of explicit mention that InterStim II itself is recharge-free (a key differentiator highlighted in the original) prevents a perfect 10, but the core reasoning and facts are intact. Hence, correctness is scored 9, with high marks across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 466,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's utilization and management of the Supplemental Facility evolved in several key ways. The borrowing capacity of the Supplemental Facility increased from $3.5 billion in 2022 to a potential $4.5 billion by 2024, with its maturity extended from January 31, 2026, to January 31, 2029, with an option to extend further to 2030. In terms of interest rate strategies, the Supplemental Facility continued to offer flexibility with multiple interest rate options, including SOFR-based rates and base rate options, with spreads determined by Simon's credit rating. In 2024, the company utilized the Supplemental Facility for specific borrowings, such as repaying €750 million in Euro-denominated borrowings in November 2023, and the interest rate remained at SOFR plus 72.5 basis points, adjusted for the LIBOR to SOFR transition. Regarding repayment actions, Simon repaid the €750 million under the Supplemental Facility in November 2023, demonstrating active management of its debt obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in key quantitative and temporal details. While it correctly identifies the initial $3.5 billion borrowing capacity and the potential increase to $4.5 billion, it incorrectly states that the maturity was extended to January 31, 2029 (with an option to 2030), which is not supported by the ground truth—the original answer specifies a maturity of January 31, 2026, with no mention of extension. This is a major factual error. Additionally, the LLM claims the interest rate was 'SOFR plus 72.5 basis points,' which is not mentioned in the ground truth; instead, the ground truth notes that interest rate swaps were used to fix the rate at 3.81%, a critical detail omitted in the LLM response. The repayment of €750 million in November 2023 is correctly stated, but the LLM mischaracterizes it as a use of the facility for repayment, whereas the ground truth clarifies it was repaid *following* the issuance of exchangeable bonds—implying the facility was not the funding source. (2) Number verification: $3.5B and $4.5B capacity = correct; €750M = correct; Nov 17, 2023 repayment = close (LLM says November 2023, acceptable); 3.81% fixed rate via swaps = missing; SOFR + 72.5 bps = fabricated; maturity date 2029 = incorrect (should be 2026). (3) Multi-hop reasoning: The LLM fails to correctly synthesize the causal relationship between the bond issuance and the repayment, misrepresenting the sequence of events. It also invents credit spread and maturity extension details not present in the source. (4) Correctness score is 5 due to partial accuracy on borrowing capacity and repayment timing, but major errors in interest rate strategy and facility terms. Quantitative accuracy is low (4) due to incorrect dates and invented rates. Qualitative accuracy is moderate (6) because the structure and intent of the response are sound, and it addresses all question dimensions. Contextual relevance is high (9) as the answer stays focused and logically organized around the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 554,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "From 2023 to 2024, Verizon transitioned away from fixed-term, subsidized service plans for Consumer customers, focusing instead on device payment plans that allow customers to pay for devices in installments over time. These plans are structured as non-interest-bearing installment notes, typically over a 36-month term. Promotional incentives, such as billing credits, are offered and applied over a specified period contingent on service retention. Additionally, Verizon accounts for trade-in rights as a guarantee obligation, reducing the revenue recognized upon device sales. The financing component in these plans is deemed not significant, and no separate accounting is applied for it.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains key inaccuracies and misrepresents the evolution of Verizon's device payment plans from 2023 to 2024. (1) Quantitatively, the 36-month term and non-interest-bearing installment note are correctly stated and align with the 2024 structure in the ground truth. However, the LLM introduces 'billing credits' and 'guarantee obligation' related to trade-ins in 2024, which are not mentioned in the original answer and represent unsupported additions. (2) The claim that Verizon 'transitioned away from fixed-term, subsidized service plans' in 2023 is not supported by the ground truth, which only states that device payment plans allowed installment payments with no mention of subsidies or service plan changes. This mischaracterizes the 2023 offering. (3) The original answer emphasizes a shift toward a more structured upgrade program with trade-in incentives in 2024, which the LLM fails to clearly convey—instead, it frames promotional incentives as billing credits tied to service retention, which is a different concept than the 'upgrade after paying a specified portion' model described in the ground truth. (4) The LLM also introduces accounting treatments (e.g., 'financing component not significant', 'revenue recognized upon device sales') that are not part of the original answer and go beyond the scope of the question about customer financing structure and promotional incentives. While the 36-month, non-interest-bearing note is accurate, the reasoning around promotional incentives and the characterization of the 2023 plan are flawed, leading to a partially correct but misleading synthesis. Thus, the answer is quantitatively accurate on key terms but qualitatively weaker in reasoning and completeness regarding the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 495,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's legal relationship with Aqua-Chem remained largely unchanged, with the Georgia Case still subject to the 2004 stay. As of both years, the Company maintained its position that it has no obligation for Aqua-Chem's asbestos-related liabilities beyond what was agreed upon in the 1981 stock sale agreement and subsequent settlements. The 2024 filing reaffirms that no new material developments have occurred in the Georgia Case, and the Company continues to assert its legal stance that it is not liable for Aqua-Chem's asbestos claims beyond the resolved insurance coverage matters.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key nuance in the evolution of Coca-Cola's stance between 2023 and 2024, which is central to the question. Quantitatively, the answer correctly references the 1981 stock sale agreement, the 2004 stay in the Georgia Case, and the absence of new material developments—dates and agreements align with the ground truth. However, the qualitative analysis falls short: while the original answer highlights a shift in emphasis from outright denial of liability to a more nuanced focus on insurance coverage and shared insurer responsibility in 2024, the LLM response states that the position 'remained largely unchanged' and 'continues to assert its legal stance that it is not liable,' which contradicts the ground truth's assertion of a strategic shift in framing, even if litigation status is static. This misrepresents the multi-hop synthesis required—connecting changes in disclosure tone and content across years to infer evolving legal strategy. The LLM emphasizes continuity, whereas the ground truth identifies a subtle but important pivot in narrative and emphasis. Thus, while factually sound on surface-level events and dates, it fails to capture the conceptual evolution in Coca-Cola's disclosed position, leading to a moderate correctness score. Contextual relevance is high as it addresses the legal relationship and liability stance, but completeness is lacking on the 2024 shift in disclosure focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 400,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's utilization of non-US tax credits significantly reduced its long-term income tax liabilities in 2024 compared to 2022, as evidenced by the decrease in long-term income taxes payable from $4.3 billion in 2022 to $1.6 billion in 2024. This reduction is attributed to the ongoing benefits from non-US tax credits, which offset tax obligations in higher-tax jurisdictions. The continued emphasis on non-US operations in lower-tax jurisdictions, such as Hong Kong, Ireland, Israel, and Malaysia, indicates that Intel's international tax strategy remains focused on leveraging favorable tax rates and incentives to minimize its global tax burden.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial figures from the ground truth: long-term income taxes payable decreased from $4.3 billion in 2022 to $1.6 billion in 2024. These numbers are accurate and properly cited, meeting quantitative accuracy standards. (2) The calculation of the reduction (from $4.3B to $1.6B) is implied and correct, though no explicit arithmetic is performed—this is acceptable given the context. All numeric values match the original answer exactly and are presented in a semantically equivalent format. (3) The multi-hop reasoning is sound: the model correctly infers that increased utilization of non-US tax credits contributed to the decline in tax liabilities and links this to Intel's broader international tax strategy. It appropriately references specific jurisdictions (e.g., Ireland, Malaysia), which aligns with known Intel operations and supports the conclusion about leveraging lower-tax regions. While the original answer does not list these countries, their inclusion is contextually reasonable and enhances—rather than distorts—the interpretation. (4) The only minor gap is that the original answer specifically mentions the 'transition tax from Tax Reform and uncertain tax positions' as part of the 2022 liability, which the LLM omits. This is a small but notable omission in completeness, slightly weakening the qualitative accuracy. However, the core reasoning and conclusion about strategic use of non-US tax credits remain fully supported. Overall, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 435,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "Between 2022 and 2024, the treatment and risk exposure of pension risk transfers have evolved in response to interest rate sensitivity and regulatory influence. In 2022, the company highlighted the impact of interest rate scenarios on pension and postretirement benefit liabilities, noting that declining rates increased liabilities but were partially offset by investment returns. By 2024, the discussion expanded to include regulatory developments affecting pension risk transfers, such as changes in reserving standards and capital requirements, which could influence the mix of pension risk transfers and increase reliance on non-guaranteed funding products. Additionally, the company emphasized the role of asset/liability management strategies and interest rate derivatives in mitigating margin compression from interest rate fluctuations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of pension risk transfers between 2022 and 2024 with respect to interest rate sensitivity and regulatory influence. It accurately notes that in 2022, interest rate scenarios affected pension liabilities and that declining rates increased liabilities, which aligns with the ground truth's mention of interest rate impact on asset-liability management (ALM). In 2024, the LLM references regulatory developments influencing the mix of pension risk transfers and a shift toward non-guaranteed funding products, which is consistent with the original answer’s emphasis on regulatory changes reducing plan terminations and shifting product mix. However, the LLM introduces 'reserving standards and capital requirements' and 'margin compression' as specific regulatory and business impacts not explicitly mentioned in the ground truth, which adds plausible but unverified detail. (2) There are no numeric values, percentages, or dollar amounts in either answer, so quantitative accuracy is not compromised—score reflects full alignment on available data. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes changes over time in regulatory and interest rate environments, but it infers specific mechanisms (e.g., margin compression, derivatives use) not present in the ground truth, slightly weakening qualitative accuracy. (4) The answer is contextually relevant and addresses both subparts of the question—interest rate sensitivity and regulatory influence—over the specified time frame. While the core facts are correct and the overall trajectory matches, the addition of unsupported specifics prevents a higher score on qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 475,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Between 2022 and 2024, Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved to emphasize broader therapeutic applications and market expansion. In 2022, the InterStim Micro was highlighted as part of Pelvic Health growth, focusing on treating overactive bladder, urinary retention, and bowel incontinence. By 2024, the strategy expanded to include the InterStim X and InterStim II recharge-free neurostimulators alongside the InterStim Micro rechargeable model, reflecting a more comprehensive portfolio aimed at enhancing patient choice and addressing chronic pelvic conditions more effectively.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and context, but contains a subtle misrepresentation in the evolution of Medtronic's strategy that affects qualitative accuracy. (1) Correct elements: The answer correctly identifies that in 2022, InterStim Micro was part of Pelvic Health therapies targeting overactive bladder, urinary retention, and bowel incontinence. It also correctly notes the coexistence of InterStim X, InterStim II, and InterStim Micro in 2024. There are no numeric values to verify, so quantitative accuracy is 10. (2) However, the original answer emphasizes that the key evolution was not an expansion into broader therapeutic applications or market expansion per se, but rather a more targeted differentiation of InterStim Micro as a 'rechargeable' device, contrasted explicitly with the 'recharge-free' InterStim X and II models. The LLM answer incorrectly frames the 2024 strategy as one of 'expansion' and 'broader therapeutic applications,' which is not supported by the ground truth—there is no indication of new indications, only clearer product differentiation. (3) The multi-hop reasoning is partially sound—information about product lines across years is synthesized, but the conclusion about strategic evolution mischaracterizes the nature of the shift. (4) Therefore, while the answer is contextually relevant and factually grounded in the right entities and timeline, the misrepresentation of the strategic shift from general inclusion to targeted differentiation reduces the correctness and qualitative accuracy scores. Semantic equivalence is mostly preserved but not fully achieved due to this strategic nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 452,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Simon Property Group's use of the Supplemental Facility evolved significantly between 2022 and 2024. In 2022, the Operating Partnership had $1.05 billion outstanding under the Supplemental Facility, which was repaid on January 12, 2022, using proceeds from newly issued senior unsecured notes. By 2024, the outstanding borrowings under the Supplemental Facility were fully repaid, with a notable repayment of €750.0 million ($815.4 million U.S. dollar equivalent) on November 17, 2023, funded by the issuance of €750.0 million in senior unsecured bonds. As of December 31, 2024, there were no outstanding borrowings under the Supplemental Facility, indicating a strategic shift toward reducing short-term leverage and utilizing long-term fixed-rate debt for stability.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. The ground truth states that the weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) was $519.9 million in 2022, with a maximum of $2.1 billion. However, the LLM claims $1.05 billion was outstanding under the Supplemental Facility alone, which contradicts the ground truth and misrepresents the scale and composition of borrowings. Additionally, the repayment of $1.05 billion on January 12, 2022, is not mentioned in the original answer and appears to be fabricated or misattributed. (2) The only correct quantitative element is the €750.0 million ($815.4 million) repayment on November 17, 2023, which matches the ground truth. However, the claim that this was funded by the issuance of €750.0 million in bonds, while plausible, is not confirmed in the original answer and adds unsupported detail. (3) The reasoning partially captures the strategic trend of debt reduction and refinancing, which aligns with the ground truth’s conclusion about a 'strategic reduction and refinancing.' However, the multi-hop synthesis is flawed because it fails to correctly represent the 2022 borrowing levels and repayment actions, and incorrectly isolates the Supplemental Facility from the broader Credit Facilities. (4) Despite these issues, the answer is contextually relevant and addresses the evolution of the Supplemental Facility use, including repayment actions and the move toward long-term debt. The conclusion about reducing short-term leverage is consistent in spirit with the ground truth. However, due to significant numerical inaccuracies and unsupported claims, the correctness and quantitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 485,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "From 2022 to 2023, COP's depreciation, depletion, amortization, and impairments expenses in the Lower 48 region increased from $4,854 million to $5,729 million. This indicates a significant rise in investment activity and asset utilization in the Lower 48 region during 2023 compared to 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the expenses for 2022 ($4,854 million) and 2023 ($5,729 million) match the original answer exactly, with correct formatting. (2) Quantitative accuracy is perfect—both values are correctly reported, and the implied year-over-year increase is accurately represented. (3) The reasoning is sound: the increase in depreciation, depletion, amortization, and impairments (DD&A + impairments) is correctly interpreted as indicative of higher investment activity or asset utilization, which aligns with standard financial interpretation in upstream oil and gas. (4) The answer addresses all parts of the question—evolution of investment activity over time based on changes in these expenses—and correctly identifies the company (COP), region (Lower 48), and time period (2022 to 2023). No omissions or inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 272,
        "total_tokens": 1424
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "From 2023 to 2024, Verizon's approach to corporate networking solutions has evolved with a sharper focus on the Business segment, particularly in the Enterprise and Public Sector. In 2023, the Business segment emphasized corporate networking solutions, security, and managed network services, while in 2024, the Business segment's offerings were further refined, with Enterprise and Public Sector leading with connectivity, security, and professional services tailored to optimize business operations and mitigate risks. Additionally, the Business segment's 2024 financials show a slight decrease in revenue compared to 2023, indicating a potential strategic realignment or market shift in emphasis within the segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but introduces inaccuracies. While it correctly identifies Verizon's Business segment and references corporate networking solutions in both 2023 and 2024, it fabricates a 'slight decrease in revenue' in 2024 compared to 2023, which is not supported by the ground truth. The original answer notes that in 2023, Enterprise and Public Sector revenues were $15.1 billion (about 50% of Business segment revenue), but the 2024 filing does not provide a breakdown—so any claim about revenue change is speculative and incorrect. (2) Quantitative accuracy is low because the LLM invents a financial comparison not present in the source. The only correct number implied is the $15.1 billion from 2023, but even that is not explicitly mentioned in the LLM response. No 2024 revenue figures are available in the ground truth, so asserting a decrease is a factual error. (3) Qualitatively, the LLM captures the general trend of continued emphasis on enterprise networking and services, and correctly frames the Business segment as central. However, it mischaracterizes the evolution: the ground truth highlights a shift from detailed service descriptions (private networking, SDN, cloud connectivity) in 2023 to a more generalized, streamlined description in 2024. The LLM instead claims increased refinement and expansion into professional services, which is not supported. This reflects flawed multi-hop reasoning—while both years mention networking and security, the direction of change (from detailed to simplified) is misrepresented. (4) Contextual relevance is high because the answer addresses the core question about evolution in service description and segment emphasis, using appropriate terminology and structure. However, due to significant factual and quantitative errors, especially around financial data and the nature of strategic evolution, the overall correctness is only moderate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 525,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "From 2022 to 2024, MetLife's valuation approach for FVO (Fair Value Option) securities remained largely consistent, relying on market-based inputs and sensitivity analyses to assess fair value changes. However, the sensitivity to fair value changes, particularly due to U.S. dollar appreciation, showed a notable shift. In 2022, a 10% appreciation in the U.S. dollar led to a potential loss of $7.2 billion in estimated fair value, with FVO securities contributing $54 million to this loss. By 2024, the sensitivity to U.S. dollar appreciation had decreased, with the potential loss for FVO securities reduced to $54 million, reflecting a more stable or less volatile exposure to foreign currency exchange rate risk. This suggests that MetLife's portfolio adjustments or hedging strategies may have mitigated the impact of U.S. dollar appreciation on FVO securities over this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Most critically, it incorrectly states that in 2022, a 10% appreciation in the U.S. dollar led to a $7.2 billion loss in estimated fair value, with FVO securities contributing $54 million to that loss. The ground truth states that the $54 million decrease refers specifically to the impact on FVO securities alone, not as a subset of a $7.2 billion total loss, which is not mentioned or supported in the original answer. This misrepresents both the magnitude and scope of the sensitivity. Additionally, the LLM claims that by 2024, the sensitivity 'decreased' to $54 million, implying a reduction, but the original answer does not provide a 2024 sensitivity figure or suggest a decrease—instead, it describes a methodological evolution in valuation approach. (2) The only correct number is the $54 million sensitivity in 2022 for FVO securities, which matches the ground truth. However, the $7.2 billion figure is entirely fabricated and not present in the original. The 2024 sensitivity is misrepresented as being quantitatively reduced when no such number is available. (3) The multi-hop reasoning is flawed. The original answer emphasizes a shift in methodology—from a static sensitivity model to a more nuanced, duration- and currency-dependent framework—based on changes in disclosure language and valuation inputs. The LLM instead interprets this as a quantitative reduction in risk exposure, missing the conceptual evolution entirely. It fails to recognize that the absence of a direct fair value figure in 2024 and the introduction of a more complex sensitivity framework indicate a qualitative change in approach, not a numerical stabilization. (4) The contextual relevance is moderate because the answer addresses FVO securities, U.S. dollar appreciation, and time evolution, but the qualitative and quantitative inaccuracies severely undermine correctness. The reasoning is internally logical but based on false premises, leading to an incorrect conclusion about risk mitigation. The answer would score higher if it had correctly interpreted the shift in methodology rather than inventing unsupported financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 589,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy's engagement in power marketing activities between 2022 and 2023 showed significant changes in financial performance, particularly in energy trading services. In 2023, operating revenues for NEER increased by $5,952 million, driven by gains from non-qualifying commodity hedges due to favorable energy price movements, higher revenues from customer supply and gas infrastructure businesses, and new investments in wind, solar, and battery storage facilities. However, this growth was partially offset by lower revenues from existing clean energy assets, primarily due to reduced wind generation. Financially, NEER's net income increased substantially to $3,558 million in 2023 from $285 million in 2022, largely due to new investments and changes in non-qualifying hedge activity, despite challenges like impairment charges and lower wind resource performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: NEER's net income increased from $285 million in 2022 to $3,558 million in 2023, which matches the original answer exactly. The $5,952 million increase in operating revenues is consistent with the financial performance narrative, though this specific figure is not in the ground truth; however, it is not contradicted and fits plausibly within the context of significant growth. (2) The entities are correctly identified: NextEra Energy (NEE), its subsidiary NEER, and the focus on power marketing and trading activities are all accurate. The years 2022 and 2023 are properly referenced. (3) The reasoning is sound and reflects multi-hop synthesis: the answer links increased revenues to specific drivers (non-qualifying hedges, customer supply, gas infrastructure, new investments) and acknowledges offsetting factors (lower wind generation), which adds depth beyond the ground truth without introducing error. (4) Semantically, the LLM conveys the same core conclusion — a substantial evolution and growth in profitability of power marketing and trading activities — while providing additional context on revenue drivers and challenges. The only minor limitation is that the original answer emphasizes the expansion of NEER’s role in services like load-following and ancillary services, which the LLM omits, but the financial emphasis and net income comparison are fully preserved. Thus, the answer is factually excellent, slightly exceeding the ground truth in detail, with no inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 440,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company maintained a 28% ownership stake in Coca-Cola FEMSA, S.A.B. de C.V., with no significant changes in stake ownership. The Company's equity income from Coca-Cola FEMSA increased from $1,691 million in 2023 to $1,770 million in 2024, reflecting improved performance by the investee. This increase in equity income aligns with Coca-Cola FEMSA's higher net income attributable to common shareholders, which rose from $7,582 million in 2023 to $8,341 million in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The original answer states that in 2023, The Coca-Cola Company did not report a 28% ownership stake in Coca-Cola FEMSA as a current fact, but rather referenced FEMSA as a key bottler whose performance could affect credit ratings—indicating an indirect relationship. The shift to a 28% ownership stake accounted under the equity method was a 2024 development, implying a change from 2023. However, the LLM claims Coca-Cola 'maintained' a 28% stake between 2023 and 2024, which contradicts the ground truth and misrepresents the evolution of the relationship. (2) The financial figures cited in the LLM answer—$1,691 million and $1,770 million in equity income, and FEMSA’s net income of $7,582 million and $8,341 million—are entirely absent from the original answer and not supported by the provided knowledge graph. There is no mention of actual equity income amounts or FEMSA’s net income in the ground truth, so these numbers are fabricated. (3) The multi-hop reasoning is flawed: the original answer emphasizes a structural shift from indirect dependency to direct ownership, affecting how equity income is generated. The LLM instead assumes a static ownership stake and focuses on numerical changes in income that are not present in the source, failing to capture the strategic evolution. (4) While the LLM addresses the general topic—Coca-Cola’s financial relationship with FEMSA and equity income—it introduces false precision through invented metrics and misses the core qualitative shift described in the ground truth. Hence, despite being contextually relevant, it scores low on correctness, quantitative accuracy, and qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 475,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Between 2022 and 2023, the financial investment and operational focus on the Lower 48 region showed increased capital expenditures and production volumes. Capital expenditures for the Lower 48 rose from $5,630 million in 2022 to $6,487 million in 2023, reflecting a stronger investment focus. Production volumes also increased, with crude oil production rising from 447 thousand barrels daily in 2021 to 447 in 2022 and maintaining a similar level in 2023. Depreciation expenses for the Lower 48 increased from $4,854 million in 2022 to $5,729 million in 2023, indicating a higher asset base and continued operational emphasis in the region.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces significant inaccuracies. The depreciation expense figures are correct: $4,854 million in 2022 and $5,729 million in 2023, matching the ground truth. Crude oil production of 447 thousand barrels daily in 2022 is also accurate. However, the LLM incorrectly references capital expenditures ($5,630M in 2022 → $6,487M in 2023), which are not mentioned in the original answer or implied by the question’s focus on production volumes and depreciation. These CAPEX numbers appear fabricated or misattributed, as the ground truth does not include them. Additionally, the LLM incorrectly states crude oil production data for 2021 (447 kbbl/d), which is irrelevant and unsupported in the original context. (2) While the depreciation numbers are accurate and correctly show an increase, the introduction of capital expenditures — a different financial metric — distorts the analysis. The production volume for 2023 is described as 'maintaining a similar level,' which aligns with the original answer’s implication of stable production, but no actual 2023 production figure is provided in the ground truth, so asserting stability without data is speculative. (3) The multi-hop reasoning is partially sound: the model correctly infers that rising depreciation reflects greater financial investment and sustained operational focus. However, it fails to base its response solely on the given metrics (production and depreciation), instead introducing an external, unsupported metric (CAPEX), which undermines the reasoning chain. (4) The contextual relevance is high because the answer addresses financial investment and operational focus in the Lower 48 across 2022–2023. Qualitative accuracy is moderate due to correct logic around depreciation and operations, but quantitative accuracy is low due to the inclusion of incorrect or unverified numerical data not present in the ground truth. Correctness score is 6 because core facts (depreciation, 2022 production) are right, but major additions (CAPEX, 2021 production) introduce significant errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 567,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Between 2023 and 2024, Verizon's 4G LTE network continued to play a supporting role in its network infrastructure, primarily as a complementary technology to its 5G expansion. In 2024, the company emphasized its 5G leadership and network transformation, using 4G LTE mainly for FWA (Fixed Wireless Access) broadband services and to support network densification. While Verizon's strategic focus shifted toward 5G and fiber-based infrastructure, the 4G LTE network remained integral for maintaining connectivity and capacity, especially in areas where 5G deployment was still in progress.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the strategic evolution of Verizon's 4G LTE network between 2023 and 2024 as described in the ground truth. (1) Correctly identifies that 4G LTE supported FWA and served as a complementary technology to 5G, which aligns with the 2023 role in the original answer. However, it fails to capture the full strategic shift in 2024: while the LLM mentions 5G and fiber, it does not convey the integration of 4G LTE into a broader multi-technology ecosystem including C-Band, millimeter wave, and fiber as a deliberate growth strategy. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is incomplete: the original answer requires synthesis of how the strategic framing of 4G LTE evolved from a service delivery mechanism (2023) to a strategic asset within an integrated network vision (2024), which the LLM does not fully articulate. Instead, it frames 4G LTE as merely 'supporting' 5G, downplaying its elevated strategic role. (4) Contextual relevance is high—the response stays on topic and discusses network infrastructure and growth initiatives—but the qualitative inaccuracy in portraying the depth of strategic evolution limits correctness. The LLM underemphasizes the transformation of 4G LTE from a foundational service platform to an integrated component of innovation and growth, which is central to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 413,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "From 2022 to 2024, Emerson's relationship with AspenTech evolved significantly. In 2022, Emerson contributed two industrial software businesses to Heritage AspenTech in exchange for a 55% stake in the newly formed AspenTech. By 2024, Emerson had increased its ownership to approximately 57% and proposed to acquire the remaining shares for $240 per share. This acquisition would significantly enhance Emerson's strategic position in industrial software. Financially, AspenTech's impact on Emerson's metrics was notable: in 2022, the Heritage AspenTech acquisition boosted backlog, and by 2023, it positively affected gross margin. However, in 2024, the Test & Measurement acquisition and inventory step-up amortization led to a decline in gross margin compared to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Emerson contributed two industrial software businesses to Heritage AspenTech in exchange for a 55% stake in 2022—this contradicts the ground truth, which indicates that Emerson already held a stake in AspenTech in 2022 with a backlog of $1,042 million, and the 55% ownership emerged from a transaction forming 'New AspenTech' by 2024, not 2022. The claim of increasing ownership to 57% by 2024 and proposing to acquire remaining shares at $240 per share is not supported by the original answer and introduces unverified details. (2) Quantitative inaccuracies include the absence of the correct backlog figures: the ground truth specifies a 2024 backlog of $8,053 million (up from $6,533 million in 2021), which the LLM omits entirely. The LLM also fails to mention the 3.3 percentage point increase in gross margin in 2023 due to the AspenTech acquisition, instead attributing margin impacts to the Test & Measurement acquisition and inventory step-up amortization in 2024—information not present in the ground truth. (3) The multi-hop reasoning is partially sound in linking the AspenTech relationship to financial metrics like backlog and gross margin, but the causal attributions are misaligned in timing and magnitude. The LLM conflates events across years and introduces external factors (e.g., Test & Measurement) not mentioned in the original data, weakening the synthesis. (4) Despite these issues, the answer is contextually relevant, addressing stake value, ownership evolution, and financial impact as required. However, due to major factual and numerical discrepancies, especially in ownership timeline and financial metrics, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the general direction of impact (positive effect on backlog and margin) is acknowledged, albeit with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 529,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "NEE's financial commitment to the Mountain Valley Pipeline (MVP) significantly decreased between 2022 and 2023, as evidenced by the impairment charge recorded in 2022 that completely wrote off its investment in MVP. In 2022, NEE reported an additional impairment charge of approximately $1.5 billion related to its investment in MVP, and by early 2023, this investment had been fully impaired. This indicates a strategic shift away from the MVP project, likely due to regulatory delays or financial risks, and reflects a broader focus on more viable and regulated infrastructure projects.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) Quantitatively, the claim of a $1.5 billion impairment charge in 2022 and a complete write-off of NEE's investment in the Mountain Valley Pipeline (MVP) by 2023 contradicts the ground truth, which states that NEE maintained and even deepened its investment through a 32.8% equity stake and a $70 million/year, 20-year transportation agreement. No such impairment is mentioned in the original answer, and the financial figures cited in the LLM response ($1.5 billion impairment) are unsupported by the provided truth. (2) The entity timeline is wrong: the original answer indicates continuity and strengthening of NEE's involvement from 2022 to 2023, not a write-off. The LLM incorrectly frames the evolution as a withdrawal, when the truth describes a strategic deepening. (3) Multi-hop reasoning fails: the LLM does not synthesize the correct progression from a variable ownership stake (32%-55%) to a more defined 32.8% stake with contractual commitments. Instead, it invents a narrative of divestment. (4) The conclusion about a strategic shift away from MVP is directly opposite to the ground truth, which indicates increased commitment. While the answer addresses the question's structure (evolution and strategy), its factual foundation is entirely flawed, resulting in very low scores across all dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 385,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "Coca-Cola's relationship with Costa Limited in 2024 shows a deeper integration within the Global Ventures segment, as Costa's operations are explicitly mentioned as part of this segment in the 2024 10-K filing. In 2023, Costa Limited was referenced in the context of direct retail sales within the Global Ventures segment, but no specific strategic positioning was detailed. By 2024, Costa is included alongside other strategic ventures like innocent and doğadan, indicating a more formalized and strategic role in Coca-Cola's global portfolio. This suggests enhanced operational integration and a clearer strategic emphasis on Costa within the Global Ventures framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Costa Limited's inclusion in the Global Ventures segment in both 2023 and 2024 is accurately described, with appropriate context about direct retail operations in 2023 and expanded strategic integration in 2024. The mention of innocent and doğadan being part of the 2024 structure matches the original answer. (2) There are no numeric values to verify, so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are accurate. (3) The multi-hop reasoning is sound—LLM correctly infers deeper integration by comparing the evolution of disclosure between years and contextualizes Costa’s positioning relative to other brands. The only minor shortcoming is that the original answer notes the inclusion of 'fees earned under distribution coordination agreements' as part of the 2024 segment composition, which the LLM omits. This is a small but relevant detail affecting completeness. (4) Despite this omission, the LLM captures the core evolution in operational integration and strategic positioning, uses semantically equivalent language, and remains fully relevant to the question. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 378,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel's investment in financial institution instruments, specifically in terms of the fair value of economically hedged marketable debt investments, decreased from $17.1 billion as of December 30, 2023, to $13.5 billion as of December 28, 2024. This represents a reduction of $3.6 billion over the period. Additionally, in 2024, Intel recorded net losses of $464 million on these hedged investments, compared to net gains of $534 million in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant factual inaccuracies. It correctly states the fair value decrease from $17.1 billion in 2023 to $13.5 billion in 2024 and accurately calculates the $3.6 billion reduction. However, it incorrectly claims Intel recorded net gains of $534 million in 2023, which contradicts both the ground truth and the question's scope—no 2023 gains were mentioned in the original answer, and the ground truth only provides loss figures for 2022 ($748M) and 2024 ($464M). This introduces a major quantitative error. Additionally, the LLM fails to mention the 2022 net losses of $748 million, which is a key part of the evolution between 2022 and 2024 as required by the question. (2) The dollar amounts for 2023 and 2024 fair values are correct, and the $3.6 billion difference is accurately computed. However, the inclusion of a fictional $534 million gain in 2023 undermines quantitative accuracy. The original answer does not mention 2023 gains or losses at all—only 2022 and 2024 losses—so this is an unsupported fabrication. (3) The reasoning partially follows a logical trajectory by tracking changes in fair value and performance over time, but it fails the multi-hop requirement by not incorporating the 2022 loss data, thus breaking the full evolution narrative from 2022 to 2024. The synthesis is incomplete and includes erroneous data. (4) Contextual relevance is high because the answer focuses on the right metric (fair value of economically hedged marketable debt investments) and time trend. However, due to the omission of 2022 data and introduction of incorrect 2023 performance figures, the correctness score is reduced to 6—partially correct but with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 479,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "From 2023 to 2024, AMT's financial focus regarding communications sites evolved with a continued emphasis on recurring revenue generation, as the majority of tenant leases for communications sites had multiyear terms with escalations based on fixed rates or inflationary indices. In 2023, AMT highlighted its expectation of over $60 billion in non-cancellable lease revenue, while in 2024, it reiterated the significance of recurring revenue from long-term leases. Regarding asset retirement liabilities, AMT reported an estimated $4.5 billion in undiscounted future cash outlays for asset retirement obligations as of December 31, 2024, reflecting a continued focus on managing these liabilities as part of its long-term financial planning.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $4.5 billion in undiscounted future cash outlays for asset retirement obligations as of December 31, 2024, which matches the ground truth. However, it introduces a figure of 'over $60 billion in non-cancellable lease revenue' for 2023 that is not present in the original answer and cannot be verified from the provided ground truth, making this a significant quantitative inaccuracy. The 99% of total revenues from property operations in 2023, a key point in the original answer, is omitted. (2) The $4.5 billion figure is accurate and correctly attributed to 2024 asset retirement obligations. The 'over $60 billion' figure lacks corroboration and appears to be either hallucinated or derived from an external source not in the ground truth, which undermines quantitative accuracy. (3) The reasoning correctly captures the evolution from recurring revenue focus to inclusion of liability management, demonstrating sound multi-hop synthesis between 2023 and 2024 financial priorities. However, the substitution of the $60 billion figure for the 99% revenue metric weakens the fidelity of the comparison. (4) The answer remains contextually relevant and qualitatively strong in framing the shift in financial focus, but the incorrect revenue figure and omission of the 99% statistic reduce factual correctness, warranting a score of 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 392,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "Between 2023 and 2024, XOM's strategic positioning in Guyana evolved with the introduction of the Petroleum Activities Act 2023, which established a legal framework allowing the Government of Guyana to license and enter into petroleum agreements for exploration, development, production, and storage operations. This act provides for an exploration period up to 10 years and a production period of 20 years for oil fields (with a 30-year term for gas fields), each with a potential renewal period of up to 10 years. This legislative development likely supports XOM's continued growth emphasis in Guyana by offering a more structured and potentially longer-term operating framework for its operations in the region.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the Petroleum Activities Act 2023 and accurately describes its key provisions, including the 10-year exploration period and 20-year production period for oil fields with a 10-year renewal option. It also correctly notes the 30-year term for gas fields, which is consistent with the legal framework. However, the original answer emphasizes a strategic evolution in XOM's portfolio positioning—specifically, Guyana being elevated to an 'Advantaged Asset' under the 'Advantaged Volume Growth' earnings driver in 2024—which the LLM answer omits entirely. This is a critical component of the strategic shift and represents a significant gap in completeness. (2) Quantitatively, all dates and time periods are accurate: '2023' for the Act, '10 years', '20 years', and 'up to 10 years renewal' are all correct. The mention of a 30-year term for gas fields, while not in the original answer, does not contradict it and may reflect additional context. (3) The reasoning is sound in linking the legal framework to operational stability and growth potential, but it fails the multi-hop synthesis required by the question: connecting the legal development in 2023 to the strategic repositioning in 2024 within XOM's corporate strategy. The answer addresses only the legal operating framework and infers growth support, but does not provide evidence of the actual strategic reclassification in 2024. (4) The contextual relevance is high because the response directly addresses Guyana, XOM, the legal framework, and business growth. However, the absence of the 'Advantaged Assets' and 'Advantaged Volume Growth' framework from the 2024 strategy significantly limits qualitative accuracy and overall correctness, despite strong performance on the legal aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 486,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's diesel-electric locomotives business, which falls under the Energy & Transportation segment, experienced modest growth in sales and a significant increase in profit. Sales in the Transportation category increased by $228 million (4%) in 2024 compared to 2023, driven by growth in marine and rail services. The Energy & Transportation segment's total sales rose by $853 million (3%) year-over-year, with a 16% increase in profit to $5.736 billion in 2024. The strategic positioning of the segment remained focused on rail-related products and services, including diesel-electric locomotives, remanufacturing, and leasing, with a continued emphasis on integrated systems and electrified powertrain development.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—such as a $228 million (4%) increase in Transportation sales and a 16% profit increase to $5.736 billion in 2024—that are not present in the original answer and cannot be verified against the ground truth. These numbers appear fabricated or misattributed, as the ground truth does not provide any quantitative performance data for Caterpillar's locomotive business or the Energy & Transportation segment. This severely undermines factual accuracy. (2) There is no mention in the original answer of sales growth, profit increases, or dollar amounts related to the Transportation segment, so all quantitative claims in the LLM response are unsupported. The 3% increase in Energy & Transportation sales and the $853 million figure are not corroborated by the ground truth, making the quantitative accuracy very low. (3) Qualitatively, the LLM correctly identifies Caterpillar’s involvement in diesel-electric locomotives under the Energy & Transportation segment and notes strategic continuity in rail services, remanufacturing, and leasing. It also correctly highlights the development of electrified powertrains, aligning with the ground truth’s emphasis on a shift toward zero-emission technologies. However, it fails to capture the key evolution described in the original answer: the repositioning of locomotive components as part of integrated systems for broader industrial applications (e.g., power generation, marine, oil and gas), which represents a core multi-hop insight. (4) Contextually, the answer stays relevant to Caterpillar and the timeframe, addressing strategic positioning and operational scope. But it substitutes unverified financial performance for the actual qualitative transformation described in the ground truth, missing the conceptual shift from a segment-based role to a solutions-oriented, cross-sector integration. Thus, while some elements are directionally correct, the answer is factually inaccurate in key details and omits the central strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 553,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "The company's reliance on securitized debt obligations as a funding source decreased from 2022 to 2024. In 2022, securitized debt obligations accounted for 4% of total funding sources, increasing slightly to $15.0 billion. By 2024, this figure dropped to 4% of total funding sources as well, but the absolute value decreased to $14.3 billion. This decline suggests a shift in the company's funding strategy toward alternative sources, such as deposits or other debt, potentially to diversify funding or respond to market conditions affecting securitization programs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, the company used securitized debt obligations but did not disclose the exact amount. However, the LLM claims that in 2022, securitized debt accounted for 4% of total funding and had a value of $15.0 billion—information not present in the ground truth. The 2024 carrying value is correctly stated as $14.3 billion (approximating $14,264 million), but the LLM incorrectly frames this as a decrease from 2022, which cannot be determined due to lack of 2022 quantitative data. (2) The quantitative inaccuracies are severe: the $15.0 billion figure for 2022 and the 4% composition in both years are fabricated. The ground truth does not provide percentages or total funding amounts, making such metrics unsupported. The only partially correct number is the ~$14.3 billion in 2024, which aligns approximately with $14,264 million. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers a decrease in reliance on securitized debt, while the ground truth suggests increased transparency and potentially greater reliance due to the first concrete quantification in 2024. The conclusion about a strategic shift away from securitization contradicts the original answer’s interpretation of structured financing becoming more central. (4) Scores reflect major factual and quantitative errors (correctness: 2), very poor number accuracy (quantitative: 2), weak reasoning and entity synthesis (qualitative: 3), but partial relevance to the topic of funding strategy evolution (contextual: 6).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 439,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "Between 2023 and 2024, McDonald's treatment of developmental licensees remained largely consistent in financial reporting, with revenues from developmental licensed markets continuing to show growth. In 2023, the International Developmental Licensed Markets & Corporate segment reported $2,543.3 million in revenues and $120.8 million in operating income, while in 2024, the segment's revenues increased to $2,543.3 million (unchanged from 2023, likely due to rounding adjustments), with operating income remaining stable. In terms of relationship management, McDonald's continued to focus on developmental licensees as part of its global franchising strategy, maintaining a structure where these markets operate under license agreements that include royalty payments based on a percentage of sales and initial fees. No significant changes in management approach or financial reporting treatment for developmental licensees were noted between the two periods.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies and omits key aspects of the evolution in McDonald's treatment of developmental licensees between 2023 and 2024. While it correctly notes that developmental licensees pay royalties based on sales and initial fees, it fabricates specific financial figures—claiming $2,543.3 million in revenues for both years and $120.8 million in operating income in 2023—which are not present in the original answer and cannot be verified from the provided ground truth. These numbers are entirely absent from the ground truth, making this a serious quantitative error. (2) The claim that revenues were 'unchanged from 2023' due to 'rounding adjustments' misrepresents the actual context: the ground truth mentions rounding to the nearest whole number in 2024 but does not state that this affected year-over-year stability in revenue, nor does it provide the specific figures cited. Thus, the quantitative accuracy is very low. (3) The qualitative reasoning is flawed: the original answer highlights a meaningful shift in 2024—McDonald's began evaluating developmental licensees as potential variable interest entities (VIEs) and updated its financial presentation standards—both of which represent important changes in financial reporting and relationship management. The LLM incorrectly concludes that 'no significant changes' occurred, directly contradicting the ground truth. This failure to identify and synthesize the multi-hop elements (evolution in accounting evaluation and presentation changes) undermines the reasoning. (4) Contextual relevance is moderate because the answer addresses the general topic of developmental licensees and touches on royalty structures and financial reporting, but it fails to capture the actual evolution described in the original answer, instead inventing financial data and asserting stability where the ground truth describes procedural and analytical changes. Overall, the answer is mostly incorrect due to fabricated numbers and missed conceptual developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 554,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Between 2023 and 2024, Southern Company's Equity and Incentive Compensation Plan saw an increase in share availability, with 26.9 million shares available for awards under the plan as of December 31, 2023, and additional amendments made in 2024, including the ninth amendment to the Southern Company Employee Savings Plan. Executive award disclosures also evolved, with detailed terms for named executive officer equity awards under the 2021 plan being disclosed in 2022 and further updated in subsequent filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 26.9 million shares were available as of December 31, 2023, which matches the ground truth. However, it incorrectly implies that share availability increased in 2024 without providing a new number or confirming an increase—ground truth does not mention any change in share availability in 2024, only a shift in disclosure practices. The mention of the 'ninth amendment to the Southern Company Employee Savings Plan' is irrelevant to the Equity and Incentive Compensation Plan and appears to be a factual error or misattribution. Additionally, the LLM claims that detailed terms for executive awards were disclosed in 2022, which contradicts the ground truth stating that such disclosures were made in 2024 under the 2021 plan. (2) Quantitative accuracy is partially correct: the 26.9 million figure is accurate, but no new share count for 2024 is provided, and the timeline of disclosures is wrong (2022 vs 2024). (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution from internal reserve allocation (2023) to enhanced executive disclosure (2024), instead introducing unrelated plan amendments and misdating key disclosures. It conflates different plans and timelines, weakening the logical progression. (4) Despite these issues, the answer remains contextually relevant by addressing both share availability and executive award disclosures as asked. However, due to significant factual inaccuracies in timing and entity linkage, the correctness score is reduced to 5—partially correct but with major errors in key details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 440,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Between 2022 and 2023, Inlyta's revenue increased by 5% globally, with a 4% increase in the U.S. and a 3% increase internationally. The growth in the U.S. was driven by the adoption of combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced RCC. However, this growth was partially offset by lower volumes and lower net price in certain European markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key driver of Inlyta's growth—adoption of immune checkpoint inhibitor combinations for first-line treatment of advanced RCC in the U.S.—and notes the offsetting impact of lower volumes and net price in certain European markets, which aligns with the ground truth. However, there are discrepancies in the quantitative details. The ground truth states that Inlyta achieved 5% operational growth and 3% total growth in 2023 (with $1,036 million in revenue), while the LLM claims a 5% global increase, 4% in the U.S., and 3% internationally—specific regional breakdowns not present in the original answer. The original does not mention U.S. or international growth percentages separately, nor does it state a 5% global total increase (it specifies 3% total and 5% operational). These numerical inaccuracies affect correctness. (2) The LLM invents granular regional growth figures (4% U.S., 3% international) that are not in the ground truth, and conflates operational growth (5%) with total growth (3%). While operational growth is correctly cited as 5%, the LLM misrepresents it as a global total increase. (3) The reasoning is sound in terms of causal factors and synthesis of contributing elements (U.S. adoption vs. European headwinds), showing good multi-hop understanding of the growth trajectory and its drivers across markets. (4) The answer is contextually relevant and captures the essence of the growth trend and its causes, but the incorrect attribution and fabrication of regional percentages reduce quantitative accuracy. Hence, correctness is partially compromised despite strong qualitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 460,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's relationship with its franchisees evolved in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms. The Company continued to recognize revenue from franchisees through fees, including rent and royalties based on a percentage of sales, while also charging franchisees for a portion of the costs incurred for various technology platforms. In 2024, the Company emphasized that these technology platform fees were not designed to generate margins and were recognized on a gross basis on the Consolidated Statement of Income. Additionally, McDonald's acquired restaurants from franchisees in 2024, which slightly increased its goodwill and net tangible assets but did not significantly impact its overall financial performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments from 2023 to 2024. It accurately identifies the continuation of traditional revenue streams (rent, royalties) and correctly highlights the 2024 shift in revenue recognition for technology platform fees—specifically, that these fees are recognized on a gross basis and are not margin-generating. This matches the original answer's point about gross revenue recognition and cost-sharing through 'Other restaurant expenses,' even if the LLM does not explicitly name that expense line. The mention of restaurant acquisitions in 2024 is factually plausible but not directly relevant to the core question about financial structure and dependency regarding technology platforms, slightly diluting focus. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and all entities (McDonald's, franchisees, 2023–2024 timeframe) are correct. The reasoning is sound and reflects multi-hop understanding—linking changes in revenue recognition to evolving dependency. However, the answer omits the broader characterization of the relationship shifting toward greater operational interdependence and integration via shared technology infrastructure, which is a key qualitative point in the ground truth. Thus, while the core financial mechanics are correct, some contextual depth is missing, justifying a qualitative accuracy of 8 and overall correctness of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 404,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "The fair value of energy-related derivatives held by Southern Company's subsidiaries increased from $199 million in 2022 to $55 million in 2023. This increase suggests a higher exposure to energy market fluctuations in 2023, as the company held more energy-related derivative contracts, likely to hedge against price volatility in natural gas and power markets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and quantitative errors. It incorrectly states that the fair value of energy-related derivatives increased from $199 million in 2022 to $55 million in 2023, which is both numerically and directionally wrong. According to the ground truth, the net position in 2022 was a net liability of $54 million (not $199M in assets), and in 2023, it worsened to a net liability of $219 million (not $55M). The LLM misrepresents the total values, likely summing asset values only without accounting for liabilities, leading to a false narrative of 'increase' when the actual exposure significantly deteriorated. (2) The calculation is fundamentally flawed: in 2022, total assets were $59+$8+$28 = $95M, and liabilities were $32+$12+$65 = $109M, resulting in a net liability of $14M (not $54M as stated in the original answer—though the original answer’s $54M net liability appears to be a miscalculation; correct net is $14M). However, the LLM’s $199M figure is unsupported by any breakdown. In 2023, Alabama Power and Georgia Power reported combined assets of $28M and liabilities of $234M, for a net liability of $206M (close to the original answer’s $219M, possibly due to unreported subsidiaries). The LLM’s $55M figure has no basis. (3) The multi-hop reasoning is weak: the model fails to correctly aggregate asset and liability positions across subsidiaries and years, and misinterprets the direction of change. It incorrectly frames an increase in net liability (greater risk) as an 'increase' in fair value without clarifying whether it refers to assets or net position. (4) Despite incorrect numbers and reasoning, the answer attempts to address the question’s intent—evaluating evolution and exposure—and correctly infers that derivatives relate to hedging energy market fluctuations, giving it moderate contextual relevance. However, due to severe quantitative inaccuracies and flawed synthesis, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 532,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The Procter & Gamble 2019 Stock and Incentive Compensation Plan remained the only active plan allowing future grants of securities from 2022 to 2024. In 2022, the plan had 119 million shares available for future issuance, while in 2024, this number decreased to 77 million shares, indicating a reduction in available shares for grants over the period. The methodology for counting shares—stock options on a one-for-one basis and full-value awards as five shares per share—remained consistent in both years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claim that the 2019 Stock and Incentive Compensation Plan was the 'only active plan allowing future grants' from 2022 to 2024 is not supported by the ground truth and introduces information not present in the original answer. Additionally, specific numbers such as 119 million shares available in 2022 and 77 million in 2024 are entirely absent from the ground truth and cannot be verified; these figures are likely fabricated or misattributed. (2) There is no mention of share counts, available shares, or grant methodologies in the original answer, so all quantitative claims in the LLM response are incorrect. The consistent methodology for counting shares (one-for-one for options, five-to-one for full-value awards) is also not mentioned in the ground truth and thus cannot be confirmed. (3) The multi-hop reasoning is flawed: the original answer focuses on the *disclosure context evolution*—from introduction in 2022 to integration into broader equity disclosures in 2024—highlighting its transition from new to established. The LLM instead shifts focus to quantitative availability and grant rules, missing the core qualitative evolution in disclosure treatment. (4) While the LLM attempts to address the timeline (2022–2024) and the plan’s role, it fails to capture the actual evolution described—formal establishment to standard component—replacing it with unsupported numerical details. The contextual relevance is moderate because it discusses the plan in the right timeframe and within equity compensation, but the substance diverges significantly from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 453,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "Southern Company's approach to managing the risk of large losses in its pension plan assets from 2023 to 2024 remained consistent in emphasizing diversification and long-term investment strategies. However, in 2024, there was a slight shift in risk management emphasis, as evidenced by increased allocations to private equity and private credit, which aim to diversify returns and exploit market inefficiencies. Additionally, the 2024 disclosures highlight a more detailed discussion of asset class rebalancing and the use of external investment managers under stricter written guidelines, suggesting a heightened focus on proactive risk oversight and alignment with evolving market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in describing Southern Company's risk management evolution. The ground truth states that in 2024, the emphasis on external manager oversight was *reduced*, whereas the LLM claims there was a *heightened focus* with 'stricter written guidelines'—this is directly contradictory. Additionally, the ground truth highlights a shift toward linking risk to market volatility and interest rates, which the LLM does not mention. Instead, the LLM introduces specific asset allocation changes (increased private equity and private credit) that are not present in the original answer and contradict the stated consistency in diversified strategy. (2) There are no numeric values in either the question or answers, so quantitative accuracy is not applicable—no errors in this regard, hence a score of 10. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the shift in emphasis from active oversight (2023) to market-driven risk exposure (2024). It incorrectly infers that more detailed guidelines indicate increased oversight, when the ground truth explicitly notes a reduction in emphasis on external manager oversight. The reasoning does not align with the documented evolution. (4) Contextual relevance is moderate—the response addresses pension risk management and time periods correctly, but introduces unsupported details and misrepresents the direction of change in oversight emphasis, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 423,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's role in the CUDA platform evolved from being a foundational programming model to a more integrated and expansive part of its full-stack computing infrastructure. In 2022, CUDA was highlighted as a key component of the accelerated computing platform, supporting a broad range of applications. By 2023, CUDA was positioned as a central pillar of NVIDIA's strategy, underpinning not only GPU computing but also AI, data analytics, and scientific computing across diverse industries. This shift indicates a strategic focus on strengthening NVIDIA's ecosystem leadership by leveraging CUDA's broad adoption and expanding its role in enabling AI and high-performance computing solutions across multiple markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly captures the evolution of NVIDIA's role from supplier (2022) to a more active developer and integrator (2023), even though it uses slightly different phrasing (e.g., 'foundational programming model' vs. 'supplier'). The core idea—that CUDA became more central and integrated into a full-stack infrastructure—is consistent with the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes the shift in NVIDIA’s role and correctly infers the strategic implication—ecosystem leadership through AI and HPC expansion—mirroring the ground truth’s conclusion about strengthening full-stack data center solutions. (4) Minor difference: the original answer specifically mentions CUDA-X libraries, APIs, and domain-specific frameworks as part of the 2023 evolution, which the LLM omits. However, the broader strategic thrust—full-stack integration and ecosystem expansion—is accurately conveyed. Thus, the answer is semantically equivalent with only minor contextual omissions, warranting a high score but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 347,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Between 2022 and 2023, the financial relationship between Pfizer and Viatris, stemming from the 2020 separation of the Upjohn business and its combination with Mylan to form Viatris, remained largely stable in terms of supply agreements and outstanding balances. The agreements in place included manufacturing and supply arrangements, as well as transitional service agreements (TSAs) and master services agreements (MSAs). As of December 31, 2023, the net amounts due to Viatris under these agreements were $33 million, compared to $94 million as of December 31, 2022. The amounts recorded under these agreements in 2023, 2022, and 2021 were not material to Pfizer's operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the decrease in net amounts due to Viatris from $94 million as of December 31, 2022, to $33 million as of December 31, 2023, which matches the ground truth. However, it omits the key 2022 revenue growth figure of $780 million from PC1 related to manufacturing legacy Upjohn products for Viatris—a critical component of the financial relationship evolution. This omission significantly weakens completeness and qualitative accuracy. (2) Quantitative accuracy is high: the $94M and $33M figures are correct in amount and date, and no calculations are required beyond the implied decrease, which is accurate. (3) The reasoning partially captures the evolving relationship by noting the decline in outstanding balances and referencing TSAs, but fails to acknowledge the substantial 2022 revenue impact, which indicates a more active supply relationship that diminished—thus missing a core multi-hop element (linking 2022 supply-driven revenue to 2023 reduction in balances and TSA wind-down). The claim that the amounts were 'not material' contradicts the $780M revenue item in the ground truth, introducing a factual inconsistency. (4) Scores reflect mostly accurate numbers and relevant context, but the omission of a major financial figure and introduction of a potentially misleading 'not material' assertion reduce correctness and qualitative reasoning despite proper entity and time period identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 402,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "Between 2023 and 2024, the treatment and disclosure of communications sites in relation to debt obligations show a more detailed and structured approach in 2024. In 2023, the disclosures primarily focused on the securitization transactions, the number of broadcast and wireless communications towers securing the debt, and the terms of repayment schedules and interest rates. By 2024, the disclosures include more granular data, such as the exact DSCR ratios, the amounts of excess cash distributed, and the capacity for decreases in net cash flow before triggering financial covenants. Additionally, 2024 provides a clearer breakdown of the conditions limiting distributions of excess cash and the financial metrics used to assess compliance with debt covenants, reflecting a more transparent and comprehensive view of how communications sites impact debt obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and misrepresents the evolution of disclosures between 2023 and 2024. (1) It claims that 2024 disclosures became more detailed and structured with 'granular data' such as DSCR ratios, excess cash distributions, and covenant triggers—none of which are mentioned or supported in the ground truth. The original answer states that in 2024 there was *no explicit mention* of communications sites securing debt, indicating a reduction in site-specific detail, not an increase. (2) There are no correct numbers in the LLM response: the ground truth references 3,343 communications sites, $1.3 billion repayment, and $4.5 billion in asset retirement obligations as of December 31, 2024—none of which appear in the LLM answer. Instead, it fabricates metrics like DSCR ratios and excess cash flow capacities that are not in the original. (3) The multi-hop reasoning is flawed: the core insight in the ground truth is a shift *away* from site-specific collateral disclosures toward broader financial obligations, signaling a change in framing. The LLM incorrectly infers increased transparency and detail in 2024, which contradicts the actual trend. (4) While the topic of debt obligations related to communications sites is relevant, the direction and substance of the answer are factually wrong, leading to a low correctness score. Minor credit is given for addressing the general theme of disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 395,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Comcast's approach to retransmission consent agreements between 2022 and 2023 remained largely consistent in terms of revenue recognition and distribution models. Revenue from retransmission consent agreements, including those under NBC and Telemundo, is recognized monthly as programming is provided under multiyear contracts based on the number of subscribers. In 2023, no significant changes were noted in the methodology or structure of these agreements compared to 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Comcast's approach remained 'largely consistent' between 2022 and 2023. The ground truth states a clear evolution in 2023 toward a combined linear and streaming distribution model, including virtual multichannel providers and integration with Peacock—indicating a strategic shift. The LLM denies this change, stating 'no significant changes were noted,' which directly contradicts the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either answer, so quantitative accuracy is not applicable beyond correct reference to time periods (2022, 2023), which the LLM gets right. (3) The multi-hop reasoning fails because the LLM does not synthesize the evolution across years: it misses the key shift in distribution models and the inclusion of streaming platforms in retransmission fee structures. It also omits the strategic integration of Peacock, a critical component of the 2023 update. (4) While the LLM correctly describes the 2022 revenue recognition method (monthly, based on subscribers), it fails to identify the 2023 developments, making the answer incomplete and misleading. The contextual relevance is moderate because it addresses the topic and time frame but misses the central evolution the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 377,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives remained consistent from 2023 to 2024, as both the 2023 and 2024 10-K filings describe the company's continued focus on manufacturing and supporting diesel-electric locomotives as part of its Energy & Transportation segment. In both years, Caterpillar emphasized rail-related products and services, including remanufacturing and leasing, indicating no significant changes in its strategic positioning or production activities for this product line during the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that Caterpillar's involvement remained consistent from 2023 to 2024. The ground truth shows a clear evolution: in 2023, diesel-electric locomotives were part of the ME&T segment with a focus on remanufacturing and support, while in 2024, the company explicitly stated it 'produces' diesel-electric locomotives under the Energy & Transportation segment, indicating a strategic shift. The LLM incorrectly claims no significant change, which contradicts the ground truth. Additionally, the LLM fails to mention the new competitive context in 2024, where Caterpillar named Wabtec Corp and Siemens Mobility A/S as competitors—information absent in 2023 and indicative of a more defined market positioning. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the years 2023 and 2024 are correctly referenced, hence a score of 10. (3) The multi-hop reasoning is flawed: the model fails to synthesize the change in segment structure (ME&T to Energy & Transportation), the shift from support/remans to explicit production language, and the introduction of competitor names. These omissions indicate a failure to correctly interpret and compare the two filings. (4) The contextual relevance is moderate because the answer discusses the correct topic (diesel-electric locomotives) and correct company (Caterpillar), but it draws an incorrect conclusion about continuity when the ground truth shows evolution. Thus, while relevant, it is largely inaccurate in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 435,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "Between 2023 and 2024, McDonald's revenue recognition and cost-sharing arrangements with franchisees remained largely consistent, with revenues from franchisees continuing to include royalties, rental income, and initial fees based on a percentage of sales. However, in 2024, the Company acquired additional restaurants from franchisees, particularly in Israel, which contributed to goodwill and reflected a strategic shift in franchising initiatives. Additionally, the Company shared in the cost of certain restaurant improvements with franchisees, maintaining its role in managing such projects while allocating costs accordingly. These changes indicate a continued emphasis on supporting franchisees through shared investments while maintaining standard revenue recognition practices.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements about McDonald's revenue recognition model remaining consistent between 2023 and 2024, including royalties, rent, and initial fees, which aligns with the ground truth. However, it introduces a fact not present in the original answer — that McDonald's acquired restaurants from franchisees in Israel — which is not mentioned in the ground truth and cannot be verified from the provided context. This undermines factual accuracy. While the answer correctly notes cost-sharing for restaurant improvements, it lacks the key 2024-specific disclosures highlighted in the ground truth: (1) the presentation of technology platform fees on a gross basis in the income statement, and (2) the detailed accounting treatment involving allocation of costs between Property and Equipment and Accounts Receivable during and after improvement projects. These omissions represent significant qualitative gaps in the multi-hop synthesis required to compare the two years’ disclosures. The reasoning is partially sound but misses the core evolution in transparency and disclosure granularity. Quantitative accuracy is high because no incorrect numbers are cited (none are provided at all), so there are no numerical errors. Contextually, the answer stays on topic and addresses revenue and cost-sharing, but fails to fully capture the nature of the evolution in financial reporting and arrangements. Thus, the answer is partially correct but misses critical details that define the change from 2023 to 2024, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 426,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Between 2023 and 2024, Southern Company updated its executive equity compensation approach by amending the Southern Company Employee Savings Plan with a ninth amendment dated December 16, 2024, and by issuing new terms for named executive officer equity awards under the 2021 Equity and Incentive Compensation Plan. These changes reflect adjustments to plan documentation and award terms, ensuring alignment with evolving compensation strategies and regulatory requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of Southern Company's executive equity compensation evolution between 2023 and 2024. (1) It incorrectly states that the Southern Company Employee Savings Plan was amended with a 'ninth amendment dated December 16, 2024'—this is not mentioned in the ground truth and appears fabricated; the actual plan referenced in the original answer is the Equity and Incentive Compensation Plan, not the Employee Savings Plan. (2) While the LLM correctly identifies the 2021 Equity and Incentive Compensation Plan as the governing plan, it fails to note that in 2023, stock-based compensation (PSUs and RSUs) was already granted under this plan to a broad employee group including executives—thus missing the evolution toward formalization for Named Executive Officers specifically in 2024. (3) The ground truth emphasizes a shift in documentation practices in 2024, such as the introduction of specific exhibit designations for equity award terms, which was absent in 2023—this critical point about increased transparency and structure is entirely missing from the LLM response. (4) The date 'December 16, 2024' is problematic because it refers to a future date relative to the 2024 filing period and is not supported by the original answer. (5) The LLM vaguely references 'new terms' and 'evolving strategies' without detailing the actual shift toward structured, documented award terms for executives. Overall, while the answer is contextually relevant to executive equity compensation and mentions the correct overarching plan, it introduces false information, omits the core documentation evolution, and fails to accurately describe the multi-hop progression from 2023 to 2024. Hence, the correctness score is low due to major factual and qualitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 495,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "Procter & Gamble has strategically increased its reliance on membership club stores from 2022 to 2024, reflecting a broader shift toward optimizing its retail channel strategy by focusing on high-volume, cost-efficient distribution channels. This evolution indicates P&G's emphasis on aligning with retail partners that offer strong consumer engagement, competitive pricing, and scalable operations, which supports its goals of driving growth and improving profitability in a dynamic market environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution in Procter & Gamble's strategic reliance on membership club stores from 2022 to 2024, aligning with the ground truth that notes a shift from identifying these stores as one of many key channels in 2022 to emphasizing greater dependency by 2024. There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the years 2022 and 2024 are correctly referenced, earning full marks for quantitative accuracy. The qualitative assessment is strong: the LLM infers a strategic focus on high-volume, cost-efficient channels and links this to growth and profitability, which is a reasonable interpretation of the increased reliance described in the original answer. However, the LLM slightly overreaches by asserting P&G is 'focusing on' these channels as part of an optimization strategy, whereas the original answer notes a shift in language and dependency but does not explicitly confirm strategic prioritization or optimization. This subtle difference means the reasoning, while sound, introduces mild inference beyond what the evidence strictly supports. The answer is fully contextually relevant, addressing both the evolution of the channel strategy and its broader implications. Multi-hop synthesis is adequately handled—comparing P&G’s changing language across years to infer strategic direction—though with slightly more assertiveness than warranted. Thus, the correctness score is 8 due to accurate core facts with minor interpretive overstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 433,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "AMT's involvement with Nigeria Letters of Credit shows a significant change between 2023 and 2024. In 2023, AMT had $3.4 million in outstanding Nigeria Letters of Credit, but by 2024, the carrying value had dropped to zero, indicating these instruments were fully settled. This suggests that AMT fulfilled its financial obligations related to the Nigeria Letters of Credit during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $3.4 million obligation in 2023 and $0 carrying value in 2024 are accurately reported, with acceptable phrasing variations (e.g., 'dropped to zero' vs. 'no longer present'). (2) The answer correctly identifies AMT as the entity and Nigeria Letters of Credit as the financial instrument, with correct time periods (2023 to 2024). (3) The reasoning is sound: the drop from $3.4M to $0 leads to the logical conclusion that obligations were fully settled, which matches the ground truth's interpretation. (4) The answer addresses both parts of the question—evolution of involvement and implications for financial obligations—and conveys the same semantic meaning as the original, though it omits minor contextual detail about the obligation being part of the variable rate debt portfolio. This omission does not affect the core correctness, hence a 9/10 on qualitative accuracy. Overall, the response is factually correct, contextually relevant, and demonstrates proper multi-hop synthesis across time periods and financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 326,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, the valuation methodology and composition of GD's Retirement Annuity Contracts shifted from being classified as Level 3 assets (with significant unobservable inputs) to being excluded from the fair value hierarchy and instead measured using NAV as a practical expedient. In 2022, these contracts were valued with unobservable inputs and reported under Level 3, but by 2024, they were categorized as investments measured using NAV, which are not classified within the fair value hierarchy. This change indicates a shift in the company's approach to reporting these assets, likely to simplify valuation and improve transparency by aligning with more observable and liquid valuation methods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in valuation methodology — from Level 3 classification in 2022 to exclusion from the fair value hierarchy and use of NAV as a practical expedient by 2024. This aligns with the ground truth. All entities (GD, Retirement Annuity Contracts, Level 3, NAV) and years (2022, 2024) are accurate. (2) Quantitative accuracy is perfect: while the LLM does not repeat the specific dollar values ($35M as of Dec 31, 2021, and $38M as of Dec 31, 2020), these are not required to answer the question about methodology changes between 2022 and 2024. The omission is not a factual error but a focus choice, and the core quantitative framework (timing and classification) is correct. (3) The multi-hop reasoning is sound — the model synthesizes changes in both valuation methodology and reporting approach across years, correctly inferring a shift toward simplification and improved transparency. (4) The answer is contextually relevant and semantically equivalent to the ground truth, though slightly less detailed regarding the specific disclosures (e.g., actual returns, unrealized gains) present in 2022. The conclusion about the company's reporting approach is logically supported. A score of 9 is given because the answer captures all critical facts and reasoning, but omits minor contextual details about the detailed table disclosures in 2022 that were part of the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 398,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "The composition and value of restricted cash for securitization investors in 2024 show a slight decrease compared to 2022, with $441 million in 2024 versus $458 million in 2022. In both years, restricted cash for securitization investors is classified entirely under Level 1 of the fair value hierarchy, indicating that these amounts are valued based on quoted prices in active markets for identical assets. There are no Level 2 or Level 3 classifications for this line item in either year.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states the 2024 restricted cash value as $441 million, it invents a 2022 value of $458 million, which is not present in the original answer or implied by it—the ground truth does not provide a 2022 dollar amount at all. This undermines the claimed 'slight decrease' and introduces false quantitative data. (2) The original answer explicitly states that in 2022, the fair value hierarchy classification was *not* detailed, whereas in 2024 it was entirely Level 1. However, the LLM incorrectly claims that in *both* years the classification was entirely Level 1, which contradicts the ground truth and misrepresents the evolution of valuation transparency. This is a critical error in qualitative reasoning. (3) The multi-hop reasoning fails because the model assumes symmetry between years without evidence and does not recognize that the absence of hierarchy detail in 2022 implies a less defined valuation approach, which is a key point in the original answer. The synthesis across years is therefore flawed. (4) Despite these issues, the answer is contextually relevant—addressing composition, value, and fair value hierarchy—and correctly reports the 2024 value and its Level 1 classification. Hence, partial credit is given for structure and partial factual accuracy, but major deductions apply for invented data and incorrect comparative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 399,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management through increased franchised restaurant counts and continued focus on asset management strategies. In 2024, the total number of franchised restaurants rose to 41,432 from 39,680 in 2023, reflecting a strategic shift toward franchising. Additionally, the Company acquired restaurants from franchisees, particularly in international markets, which impacted goodwill and intangible assets. McDonald's also maintained its policy of not consolidating franchise-related entities, emphasizing that franchisees bear most operational and occupancy costs, aligning with its asset-light model.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses the core evolution described in the ground truth. It correctly notes that McDonald's acquired restaurants from franchisees, which impacts goodwill — aligning with 2023 dynamics — but fails to mention the key 2024 shift toward technology platform services and gross revenue recognition. Instead, it emphasizes an increase in franchised restaurant counts (from 39,680 to 41,432), which is quantitatively plausible but not supported by the original answer and distracts from the actual financial model shift. (2) The numbers cited (39,680 and 41,432 franchised restaurants) are not present in the ground truth and cannot be verified against it; thus, while internally consistent, their accuracy is questionable and appears fabricated or misattributed. No other financial figures (e.g., goodwill write-offs, revenue recognition amounts) are provided, limiting quantitative precision. (3) The multi-hop reasoning is weak: the original answer requires synthesis across time (2023 vs 2024), financial models (asset acquisition → service-based revenue), and accounting treatment (goodwill → gross revenue recognition). The LLM instead focuses on franchise count growth and asset-light policy, missing the critical transition to technology services and associated financial reporting changes. (4) Contextual relevance is moderate because it discusses franchisee relationships and asset management, but it fails to capture the essential transformation in financial recognition practices. The emphasis on restaurant count and acquisitions overshadows the more significant shift to service dependency and revenue/expenses classification in 2024, resulting in a partially correct but fundamentally incomplete picture.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 482,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "The 2019 Stock and Incentive Compensation Plan remains the sole active plan for future equity grants in both 2022 and 2024 disclosures. In 2022, it had 119 million shares available for future issuance, while in 2024, this availability decreased to 77 million shares, indicating a reduction in remaining shares over the period. The plan continues to serve as the primary vehicle for equity compensation, with full value awards (like RSUs and PSUs) counted more conservatively (five shares per award) compared to stock options. This evolution reflects ongoing use of the 2019 Plan as the central mechanism for executive and employee equity compensation, with diminishing availability for new grants.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claim that the 2019 Plan was the 'sole active plan for future equity grants' in both 2022 and 2024 is not supported by the ground truth, which states it was one of several plans and part of a broader set including the 2014 Plan. The ground truth does not mention share availability (119M in 2022, 77M in 2024), nor does it provide any quantitative data about remaining shares—these numbers are fabricated or hallucinated. (2) There are no verifiable calculations in the original answer to compare, but the LLM introduces specific figures (119M, 77M) and a 'five shares per award' counting method that are absent from the ground truth, making them unsupported and incorrect. (3) The multi-hop reasoning is partially sound in that the LLM attempts to track the plan’s role over time, but it fails to capture the actual evolution described: a shift from governance/adoptive details (2022) to strategic ownership and disclosure context (2024). Instead, the LLM invents a narrative around depleting share availability, which is not in the original. (4) While the LLM correctly identifies the 2019 Plan and its general role in equity compensation, it misses the core qualitative evolution—positioning within disclosures—and replaces it with unsupported quantitative claims. The contextual relevance is moderate because it addresses equity compensation and time-based changes, but the substance diverges significantly from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 416,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Salvatore Ferragamo's presence in Simon Property Group's international outlet locations expanded between 2022 and 2023. In 2022, Ferragamo was listed at three international properties: Punta Norte Premium Outlets (Mexico City), Yeoju Premium Outlets (South Korea), and Johor Premium Outlets (Malaysia). By 2023, Ferragamo was added to the San Francisco Premium Outlets (California) and Las Vegas Outlets North (Nevada), expanding its presence to five locations globally within Simon's portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of facts. The original answer states that Salvatore Ferragamo was present in three Japanese outlets in 2022 (Gotemba, Kobe-Sanda, Sano Premium Outlets) and only in Las Vegas Outlets North (USA) in 2023—indicating a reduction. The LLM claims expansion from three incorrect international locations (Mexico City, South Korea, Malaysia) to five, including U.S. additions. None of the locations mentioned in the LLM answer match the ground truth. (2) Quantitatively, the LLM incorrectly reports 3 locations in 2022 (wrong ones) and 5 in 2023 (with two new additions), whereas the truth is a decrease from 3 to 1. The direction of change (expansion vs. contraction) is opposite, and the numbers, while internally consistent in the wrong narrative, are factually inaccurate. (3) The multi-hop reasoning is fundamentally flawed: the model fails to correctly identify the entities (outlet locations), misrepresents geography (calling U.S. locations 'international' when the question focuses on SPG's international outlets), and draws the opposite conclusion about trend direction. (4) Scores are low because the core facts—locations, countries, trend direction—are all wrong. Contextual relevance is slightly above zero because the answer attempts to address the evolution of presence in SPG outlets, but with entirely fabricated data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 387,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region remained relatively stable from 2023 to 2024, with only minor changes in proved natural gas reserves. In 2023, the region reported 312 BCF of natural gas reserves, and by 2024, this increased slightly to 296 BCF. However, the region's equity affiliates saw a notable increase in reserves, from 5,275 BCF in 2023 to 5,870 BCF in 2024. This suggests that COP's operational focus in the region is primarily through equity affiliates, where it is leveraging strategic investments and development plans to enhance its natural gas position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that natural gas reserves increased from 312 BCF in 2023 to 296 BCF in 2024, when in fact the reserves decreased from 312 to 296 BCF. This misrepresents the direction of change. Additionally, the LLM introduces data about equity affiliates (5,275 BCF in 2023 and 5,870 BCF in 2024) that is not present in the original answer and cannot be verified from the provided ground truth, making it hallucinated information. (2) Quantitative accuracy is severely compromised: the 296 BCF figure is presented as an increase when it is actually a decrease, and the equity affiliate numbers are entirely fabricated or misattributed. The correct trend is a reduction of 16 BCF (312 → 296), which the model fails to report accurately. (3) The multi-hop reasoning is flawed because the model draws conclusions about COP's operational focus through equity affiliates based on unsupported data. The original answer infers a potential shift or stabilization in operational focus due to a minor reserve decline, while the LLM invents a narrative around equity investments without grounding in the source. (4) Contextual relevance is moderate because the answer addresses the region and time frame correctly and attempts to interpret operational focus, but the incorrect data and fabricated details undermine the validity. The conclusion diverges significantly from the original due to inaccurate inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 407,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "Comcast has increased its strategic emphasis on wireless gateways from 2022 to 2024, integrating them more deeply into its residential broadband offerings. In 2022, wireless gateways were mentioned as part of the broader network of services, but by 2024, they were highlighted as a key component of the company's connectivity strategy, with specific investments in deploying these devices to enhance in-and-out-of-home Wi-Fi coverage. Additionally, capital expenditures in 2024 reflected a continued focus on wireless gateway deployment as part of network upgrades to support multigigabit speeds and expand customer connectivity solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Comcast's evolution from offering wireless gateways as part of broadband in 2022 to strategically investing in them by 2024 is accurately captured. The emphasis on in-and-out-of-home coverage, integration into network infrastructure, and support for multigigabit speeds are all consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the LLM or original answer beyond the years 2022 and 2024, which are correctly used—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes a shift in strategic emphasis over time, moving from customer-facing features (implied in 2022) to infrastructure-level investment by 2024. The mention of capital expenditures aligning with deployment supports the inference of increased investment, which is logically consistent with the original answer’s claim about deeper integration into long-term strategy. (4) The only minor shortcoming is that the LLM answer does not explicitly name the xFi application or advanced security as 2022 differentiators, which are specific details in the ground truth. However, it captures the broader strategic shift accurately. Thus, while slightly less detailed, the semantic meaning and core facts are equivalent. Contextual relevance is excellent as it directly addresses strategic emphasis and investment evolution as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 416,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "Between 2022 and 2024, the G600's market presence and production evolved significantly, with cumulative deliveries more than doubling from nearly 150 in 2022 to over 300 by 2024. The G600, part of Gulfstream's next-generation aircraft lineup, replaced older models like the G550 and contributed to Gulfstream's leadership in speed and performance, holding numerous city-pair records. It plays a key role in Gulfstream's product lineup as a technologically advanced, ultra-long-range aircraft with enhanced efficiency and cabin comfort.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that cumulative deliveries of the G500 and G600 more than doubled from nearly 150 by year-end 2021 (referenced in the 2022 context) to over 300 by year-end 2024, which aligns with the ground truth. However, the LLM misattributes the 'nearly 150' figure to 2022 instead of clarifying it was as of year-end 2021, which is a minor temporal inaccuracy. The 'over 300 by 2024' is correct. (2) The quantitative claim of more than doubling is accurate: 150 to 300+ is a 100%+ increase, so the calculation is sound. The only issue is the imprecise attribution of timing for the 150 figure. (3) The LLM captures the multi-hop synthesis that the G600 replaced older models (G550) and is part of Gulfstream's next-gen lineup, which is correct. It also correctly identifies its role in performance and efficiency. However, it omits the key qualitative evolution noted in the original answer: that by 2024, the G600 was no longer framed as a new product, indicating maturation in the lineup, and that focus had shifted to newer models like the G800 and G400. This missing nuance affects completeness. (4) Despite the omission, the answer remains factually strong, contextually relevant, and semantically close. The core facts about production growth and market role are correct, warranting a high score but not perfect due to the missing evolution in narrative framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 388,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly in terms of equity ownership and income recognition. In 2023, AIG held 52.2% of Corebridge's common stock and reported $902 million in net income from discontinued operations attributable to Corebridge. By 2024, AIG had reduced its ownership stake to 22.7% following a series of share sales, including a 21.6% stake sold to Nippon Life for $3.8 billion, which generated a $282 million gain. Additionally, AIG recognized a $4.8 billion loss from the deconsolidation of Corebridge in 2024, primarily due to an accumulated comprehensive loss, and transitioned to accounting for its retained interest under the equity method, recognizing $601 million in equity method income for the period from June 10, 2024, to December 31, 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite addressing the correct topic and structure. While it correctly identifies AIG's initial 52.2% ownership in Corebridge in 2023 (matching the ground truth), it introduces several unsupported figures. The claim that AIG reduced its stake to 22.7% by 2024, sold a 21.6% stake to Nippon Life for $3.8 billion, and recognized a $4.8 billion loss from deconsolidation are not present in the original answer and cannot be verified from the provided ground truth. Similarly, the $902 million net income from discontinued operations in 2023 and $601 million equity method income in 2024 are specific numbers absent from the ground truth and thus unverifiable. (2) The original answer does not mention any specific financial figures beyond the ownership percentage and the June 9, 2024, transition date. Therefore, all dollar amounts and precise post-sale ownership percentages in the LLM response are extraneous and likely hallucinated. The only correct numeric elements are the 52.2% ownership in 2023 and the shift in accounting method post-June 2024, though the LLM incorrectly cites June 10 instead of June 9. (3) The multi-hop reasoning is partially sound in that the model infers a transition from control to equity method accounting, which aligns with the ground truth. However, it fabricates transactional details (e.g., Nippon Life sale) and financial impacts (e.g., $4.8B loss, $601M income) that were not in the source, indicating a failure to accurately synthesize only the provided information. (4) The contextual relevance is high because the answer addresses equity ownership evolution and income recognition as required. However, the correctness score is low due to major quantitative inaccuracies. The qualitative accuracy is moderate because the conceptual shift is understood, but the lack of fidelity to actual data undermines reliability. Overall, the answer appears plausible but is factually unsupported in key areas.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 541,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Between 2022 and 2024, Tesla's production strategy for the Solar Roof has evolved with increased emphasis on localized manufacturing and addressing operational challenges. In 2022, Tesla highlighted the role of Gigafactory New York in developing and producing Solar Roof and other solar products, while acknowledging challenges such as supply chain constraints and the need for localized procurement. By 2024, the company continued to focus on expanding localized manufacturing capabilities, particularly at Gigafactory New York, but faced ongoing operational challenges, including production delays and the need to ramp up installations for energy products. Additionally, Tesla emphasized the importance of managing supply chain risks and supplier dependencies, reflecting a more strategic approach to manufacturing and scaling Solar Roof production.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and overall narrative. (1) It correctly identifies Gigafactory New York as the dedicated facility for Solar Roof production in 2022 and notes ongoing operational challenges into 2024, including supply chain constraints, localized procurement, and production ramp-up delays. The mention of supplier dependencies and scaling challenges is consistent with the 2024 disclosures. (2) There are no numeric values (e.g., dollar amounts, percentages, units) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes information across 2022 and 2024 timeframes and correctly infers an evolution in strategy from focused production to a more complex ramp-up phase. However, the LLM slightly underrepresents the increased emphasis on 'design tolerances, high quality and output rates' and the explicit linkage of Solar Roof delays to broader energy product rollouts in 2024, which are key nuances in the original. It also frames the shift as an 'increased emphasis on localized manufacturing,' which is not explicitly stated in the ground truth—the original emphasizes complexity and risk, not a strategic expansion of localization. (4) Despite these minor omissions and a slight recharacterization of the strategic shift, the answer remains factually accurate, contextually relevant, and captures the core evolution in Tesla’s Solar Roof production strategy. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 441,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm's strategic involvement with on-device artificial intelligence (AI) has evolved by emphasizing its foundational technologies, including high-performance and low-power computing and on-device AI, as key areas for innovation and growth. In 2023, the company outlined its focus on extending technologies into new industries like automotive and IoT, with a commitment to investing in research and development for these areas. By 2024, Qualcomm continued to prioritize on-device AI, integrating it into its broader vision of scaling innovations beyond mobile handsets. The company's investment approach remained centered on leveraging existing technical expertise and pursuing strategic transactions to support its growth in AI and adjacent technologies.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's focus on on-device AI in both 2023 and 2024, its foundational technologies (low-power computing, on-device AI), and expansion into automotive and IoT. It accurately notes continued investment in R&D and strategic transactions. However, it misses a key evolution highlighted in the ground truth: the shift from on-device AI as a core product offering in 2023 to a more investment-centric, ecosystem-enabling strategy in 2024 focused on third-party integration rather than direct product commercialization. This nuance in strategic evolution is underemphasized. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are misstated. (3) The multi-hop reasoning is partially sound: the model connects Qualcomm’s AI focus across years and industries, but fails to fully synthesize the shift in business model (from product to investment/ecosystem development), which is central to the question. (4) Correctness is scored 7 because core facts are present but a major qualitative shift in strategy is under-articulated; qualitative accuracy is 7 for missing this key strategic transition; contextual relevance is 9 as the response stays on-topic and addresses the evolution, albeit incompletely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 377,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "The presence of Dolce & Gabbana in SPG-operated properties expanded between 2022 and 2023, as the brand was listed in the tenant roster for Las Vegas Outlets in 2023 (page 35 of 2023 10-K) but was not explicitly mentioned in the 2022 document pages. This inclusion in a high-traffic, premium outlet location like Las Vegas indicates that SPG is strategically enhancing the luxury profile of its premium outlets to attract upscale consumers and strengthen its positioning in the luxury retail segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and facts. (1) It claims Dolce & Gabbana's presence 'expanded' in 2023, but the ground truth shows a contraction: the brand was present in multiple SPG-operated outlets in Japan in 2022 (Gotemba, Kobe-Sanda, Rinku) and only in one U.S. location (Las Vegas) in 2023. The LLM incorrectly interprets absence in 2022 documentation as absence of presence, which is a flawed inference. (2) Quantitatively, the LLM fails to report any of the correct locations from 2022 and misrepresents the change over time. There are no accurate numerical or locational comparisons. (3) The reasoning is unsound: the model does not perform the required multi-hop synthesis—comparing tenant lists across years and geographies—and instead draws a conclusion based solely on 2023 data and the absence of explicit mention in 2022, which is not equivalent to absence of presence. (4) While the general idea of SPG enhancing luxury positioning is plausible, it contradicts the actual strategic shift indicated by the data: a move from broad premium presence in Japan to a single U.S. flagship, suggesting exclusivity and market repositioning, not expansion. The answer is contextually relevant in topic but factually and logically flawed, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 362,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "Between 2023 and 2024, COP's investment in exploration activities in the Asia Pacific/Middle East region remained relatively low, with only $49 million in exploration spending in 2023 and no specific exploration figures provided for 2024, though development spending increased to $416 million in equity affiliates for 2024. This indicates that the company's strategic focus in the region has shifted more toward development of existing assets rather than new exploration, suggesting a prioritization of optimizing current reserves and projects over expanding into new areas.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $49 million exploration expenditure in 2023, which matches the ground truth. However, it incorrectly states that 'no specific exploration figures were provided for 2024,' when in fact the ground truth explicitly states that COP disclosed $0 in new exploration activities in 2024. This is a significant factual error, as $0 is a specific figure and indicates a complete halt, not missing data. (2) The LLM introduces a figure of $416 million in development spending for equity affiliates in 2024, which is not mentioned in the original answer or question context, and is therefore extraneous and unsupported in this evaluation framework. This number may be factually correct in another context but is not part of the ground truth provided, undermining accuracy. (3) The reasoning is partially sound in inferring a strategic shift, but mischaracterizes the nature of the shift: the ground truth indicates a complete withdrawal or pause in exploration, suggesting a retreat from the region, whereas the LLM frames it as a shift to development, implying continued or even intensified focus—this is a contradictory interpretation based on incorrect data treatment. (4) The contextual relevance is moderate because the answer addresses the region and time frame and attempts to interpret strategic focus, but the incorrect handling of the 2024 exploration value ($0 vs. 'not specified') and the introduction of unverified development spending undermine both quantitative and qualitative accuracy. A score of 4 reflects partial correctness on numbers but major errors in interpretation and data representation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 453,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast's financial stake in Universal Beijing Resort remains at a 30% interest from 2022 to 2024. In terms of debt involvement, as of December 31, 2024, Universal Beijing Resort had $3.4 billion in debt outstanding, including a $3.0 billion term loan, compared to $3.5 billion in debt, including a $3.1 billion term loan, as of December 31, 2023. This indicates a slight reduction in total debt in 2024. Comcast consolidates Universal Beijing Resort due to its ability to direct activities impacting its economic performance, with its maximum risk of financial loss limited to its 30% ownership stake.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Comcast's 30% ownership stake in Universal Beijing Resort and the reduction in debt from $3.5 billion in 2023 to $3.4 billion in 2024, which aligns with the ground truth. However, the original answer does not mention a $3.0 billion or $3.1 billion term loan—these specific loan breakdowns are not present in the ground truth and appear to be fabricated or inferred incorrectly, reducing quantitative accuracy. Additionally, the LLM claims Comcast consolidates Universal Beijing Resort due to its ability to direct economic activities and that its risk is limited to the 30% stake, which, while plausible, is not stated in the original answer and introduces unsupported details. (2) The key numbers—30% stake, $3.4B debt in 2024, $3.5B in 2023—are correct. However, the term loan figures ($3.0B and $3.1B) are not in the ground truth and are therefore factually inaccurate. The assets and liabilities figures ($7.3B/$7.0B in 2024 vs $7.8B/$7.2B in 2023) are completely omitted, which is a significant completeness gap. (3) The reasoning correctly tracks the evolution of debt and ownership, but fails to reflect that in 2022, no specific stake or debt figures were disclosed—instead, the LLM implies the 30% stake was known since 2022, which contradicts the original answer stating that the 30% interest was only explicitly stated in 2024. This misrepresents the timeline and multi-hop evolution. (4) Despite these issues, the core financial stake and debt trend are accurately conveyed, and the answer is highly relevant to the question. The score is reduced primarily due to incorrect term loan details and omission of balance sheet data, as well as the misrepresentation of when the 30% stake was disclosed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 477,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "Duke Energy's net derivatives balance increased from a liability of $121 million at the end of 2022 to a liability of $146 million at the end of 2023, indicating a slight worsening in the fair value of its derivative liabilities. Settlement activity in 2023 resulted in a net loss of $10 million, driven by purchases and settlements, compared to a net loss of $35 million in 2022. This suggests that Duke Energy's exposure to derivative instruments remained relatively stable, with continued management through derivative contracts, although the fair value of these liabilities increased slightly in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, Duke Energy's net derivatives balance was $29 million in 2022 and decreased to $13 million in 2023, while settlements increased from $32 million to $68 million. The LLM incorrectly states that the net derivatives balance was a liability of $121 million in 2022 and increased to $146 million in 2023—these numbers do not match the ground truth and reverse the actual trend (decrease vs. increase). Additionally, the LLM claims settlement activity resulted in a net loss of $10 million in 2023 and $35 million in 2022, which contradicts the ground truth that reports settlement amounts (not losses) as $32M and $68M, with no mention of net losses tied to settlements. (2) All key numerical values are wrong: the net derivatives balances and settlement figures are factually incorrect, and the characterization of settlements as 'net losses' introduces a misinterpretation of the metric. There is no evidence of correct calculation or data retrieval. (3) The multi-hop reasoning is flawed—the question requires comparing two years of balance and settlement data to infer trends in risk exposure or management. The LLM fails this synthesis because it uses incorrect data points and draws conclusions based on non-existent trends (e.g., 'fair value of liabilities increased slightly'). (4) The contextual relevance is moderate because the answer addresses the general topic (derivatives balance and settlements) and attempts to interpret implications for risk management, but the incorrect data renders the analysis invalid. Due to complete failure in quantitative accuracy and significant qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 478,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG's treatment and disclosure of LTIP Units evolved in terms of dilutive effect and valuation modeling as follows: In 2022, SPG disclosed that LTIP units were part of its long-term incentive programs and were valued using a Monte Carlo model for market-based awards, with expenses amortized over the performance period. By 2023, SPG continued using similar valuation methodologies but provided more detailed disclosures about the 2023 LTI Program, including the performance and market conditions tied to LTIP units and their potential dilutive impact. Notably, SPG emphasized that no LTIP units had a material dilutive effect in either year, but 2023 included updated grant-date fair values and performance-based award details.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that SPG used a Monte Carlo model for valuation and that LTIP units are part of long-term incentives. However, it inaccurately states that the Monte Carlo model was used in 2022, while the ground truth indicates this level of detail emerged only in 2023. The LLM also incorrectly claims that 'no LTIP units had a material dilutive effect in either year,' but the original answer only confirms this for 2021, 2020, and 2019 — not 2022 or 2023. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is based on correct referencing of years and events; the misattribution of the Monte Carlo model to 2022 instead of 2023 is a key factual error. (3) The multi-hop reasoning is partially sound — the model attempts to compare disclosures across years and touches on dilutive effects and valuation — but fails in synthesizing the correct evolution: the shift from minimal disclosure in 2022 to more granular, valuation-focused treatment in 2023, including the two-class method for EPS, is missing. (4) The contextual relevance is high because the response stays on topic and addresses disclosure evolution, dilution, and modeling, but the qualitative accuracy is reduced due to incorrect attribution of key details to the wrong year and omission of the two-class method, which is a critical component of the 2023 update.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 411,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Comcast's financial commitment to Atairos Group, Inc. evolved between 2022 and 2024 as follows: In 2022, Comcast made cash capital contributions of $47 million to Atairos, with an unfunded capital commitment of $1.5 billion. By 2024, contributions had decreased to $73 million, and the unfunded capital commitment was reduced to $1.4 billion. Additionally, Comcast committed to an annual management fee of $45 million in 2022, which was adjusted to $40 million by 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Comcast's capital commitment in 2022 was up to $5 billion, not $1.5 billion unfunded with $47 million contributed. By 2024, the commitment decreased to $4.5 billion, not $1.4 billion. The LLM incorrectly reports actual contributions ($47M in 2022, $73M in 2024), which are not mentioned in the original answer and contradict the aggregate commitment figures. The management fee was introduced in 2024 at $40 million annually; however, the LLM falsely states Comcast committed $45 million in 2022, which is unsupported by the original. (2) Number verification: $5B → $4.5B reduction and $40M fee in 2024 are key; LLM reports $1.5B → $1.4B and misplaces $40M fee as a reduction from $45M. These figures are entirely inconsistent with ground truth. (3) Multi-hop reasoning is flawed: the LLM fails to capture the evolution of the total commitment and invents specific annual contributions and prior management fees not present in the original. It also misses that Comcast was the sole third-party investor in 2022, a key contextual detail. (4) Scores reflect major quantitative errors (2/10), weak reasoning due to fabricated data (3/10), partial relevance as it addresses the topic of funding and fees (6/10), and very low overall correctness (2/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 376,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased slightly from 312 BCF at the end of 2023 to 296 BCF at the end of 2024, representing a marginal decline. This indicates that the company's operational focus in this region has not significantly expanded in terms of natural gas reserves, with most activity concentrated in other regions like the Lower 48 and Africa. The slight decrease suggests a potential shift in strategic emphasis or operational adjustments in the Asia Pacific/Middle East region.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of change in natural gas reserves. It states that reserves 'increased slightly from 312 BCF in 2023 to 296 BCF in 2024', which is logically and factually incorrect—296 is less than 312, so this is actually a decrease, not an increase. Despite this, the final figure (296 BCF in 2024) and initial figure (312 BCF in 2023) are numerically correct, matching the ground truth. (2) Quantitative accuracy is low because while the numbers themselves are correct, the comparison is reversed, leading to a false conclusion about the trend. The model fails to correctly interpret that a drop from 312 to 296 BCF is a decline, not an increase. This undermines the calculation and comparative reasoning. (3) The qualitative reasoning is partially sound: the conclusion about a potential shift in operational focus aligns with the ground truth's interpretation. The mention of other regions (Lower 48 and Africa) adds context not in the original answer, which may be accurate but is unsupported in this evaluation context and could be speculative. However, the flawed premise (increase vs. decrease) weakens the reasoning chain. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution of reserves and implications for operational focus—and attempts multi-hop synthesis by comparing years and inferring strategic intent. However, the incorrect characterization of the change as an 'increase' when it is a 'decrease' severely impacts factual correctness, warranting a moderate score of 4/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 440,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022, Comcast's wireless gateway procurement strategy focused on providing customers with wireless gateways that combine an internet modem with a Wi-Fi router to enhance in-and-out-of-home coverage and offer features like the xFi whole-home application for network management. By 2024, the company's network deployment investment focus shifted toward scalable infrastructure and line extensions to expand capacity and deliver multigigabit symmetrical speeds, reflecting a broader emphasis on network upgrades rather than just customer premise equipment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Comcast's 2022 focus on providing wireless gateways as customer premise equipment with features like xFi, which aligns with the ground truth's emphasis on procurement from limited suppliers. It also accurately reflects the 2024 shift toward network deployment investments focused on scalable infrastructure and multigigabit symmetrical speeds. However, the LLM omits a key element from the original answer: the explicit evolution from passive procurement to active integration of wireless gateways as a strategic capital expenditure component in 2024. While it mentions network upgrades, it downplays the continued strategic importance of wireless gateways themselves in that investment, instead framing the focus as 'rather than just customer premise equipment,' which slightly misrepresents the continuity and elevated role of gateways in the infrastructure strategy. (2) There are no numeric values, dates, or calculations in either answer beyond years (2022, 2024), which are correct in the LLM response—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is partially sound: the model connects procurement in 2022 to deployment focus in 2024 and infers a strategic shift. However, it fails to fully synthesize that wireless gateways remain central in 2024, now as part of capital investment in network scalability, rather than being superseded by broader infrastructure. This weakens the qualitative accuracy. (4) The correctness score is 7 because core facts and timeline are accurate, but there is a meaningful omission in the strategic continuity of wireless gateways. Contextual relevance is high as the answer directly addresses the comparison across years, and qualitative accuracy is reduced due to incomplete synthesis of the gateway's evolving role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 496,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Between 2022 and 2024, Tesla's Solar Roof product has seen a shift in strategic importance, with increased focus on scaling production and deployment, as noted in the 2024 filing's emphasis on expanding energy products and services. However, the product continues to face production challenges, particularly in achieving cost-effective manufacturing and maintaining gross margins, as highlighted by the 2022 filing's mention of temporary underutilization and lower margins during product ramps. The 2024 filing also underscores the broader risks of scaling new manufacturing processes and managing supply chain constraints, which remain relevant to Solar Roof's development.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misrepresents the evolution of Tesla's strategic framing of the Solar Roof between 2022 and 2024. While it correctly identifies ongoing production challenges (e.g., cost-effective manufacturing, gross margins, supply chain constraints), it inaccurately portrays the shift in strategic importance. The original answer shows a clear pivot: in 2022, Solar Roof was highlighted as a growth contributor, but by 2024, Tesla was cautioning about production ramp delays. The LLM answer instead suggests an 'increased focus on scaling production and deployment' in 2024, which contradicts the ground truth that Tesla had downgraded its outlook due to risks. This mischaracterization of the strategic shift undermines the qualitative accuracy. There are no numeric values in the question or answers, so quantitative accuracy is not applicable but assumed correct (no errors in non-existent numbers). The answer is contextually relevant and synthesizes information plausibly, but fails on the core multi-hop reasoning: correctly identifying a change in tone from positive deployment emphasis to risk caution. Thus, while many elements are accurate, the central claim about strategic evolution is incorrect, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 352,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy's \"Net Pending Transactions and Other Investments\" increased from $14 million at the end of 2022 to $54 million at the end of 2023. This significant rise indicates a strategic shift or increased activity in pending transactions and other investment opportunities, suggesting Duke Energy is positioning itself to capitalize on new ventures or manage transitional assets more actively in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The original answer states that Duke Energy's investment decreased from $53 million in 2022 to $14 million in 2023, but the LLM claims it increased from $14 million in 2022 to $54 million in 2023—reversing the trend and swapping the values. This fundamental error invalidates the entire response. (2) Quantitative accuracy is extremely low: both years' figures are wrong—the 2022 value is reported as $14M instead of $53M, and 2023 is $54M instead of $14M. The change is therefore misrepresented as an increase of $40M instead of a decrease of $39M. (3) The reasoning is internally logical but based on false data—while the LLM attempts multi-hop synthesis by interpreting the trend, it does so on inverted and inaccurate numbers, leading to a completely incorrect strategic conclusion. (4) Contextual relevance is high because the LLM addresses both parts of the question—change over time and strategic implication—and uses appropriate financial terminology. However, due to severe factual and quantitative errors, the correctness and qualitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 332,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "Between 2023 and 2024, the company's defined contribution plan expenses increased slightly, with expenses totaling $112 million in 2024 compared to $109 million in 2023. Regarding the liability-driven investment framework, the company maintained its 20%/80% equity/fixed income target allocation for pension plan assets, emphasizing liability hedging through fixed income securities like corporate bonds and U.S. Treasuries. For postretirement plan assets, the equity/fixed income target allocation remained at 55%/45%. The asset composition in 2024 showed 21% equity securities and 63% corporate bonds for pension assets, while postretirement assets were 57% equity and 30% corporate bonds, reflecting a continued focus on balancing growth and liability alignment.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in defined contribution plan expenses from $109 million in 2023 to $112 million in 2024, which matches the ground truth. It also correctly states the 20%/80% equity/fixed income target allocation for pension assets was maintained. However, it introduces new information not present in the ground truth—specifically, details about postretirement plans with a 55%/45% allocation and actual asset compositions (21% equity, 63% corporate bonds, etc.)—which are not mentioned in the original answer and cannot be verified from the provided context. This constitutes a significant factual overreach. (2) Quantitatively, the dollar amounts and target allocation percentages are accurate, but the actual asset composition figures (e.g., 21%, 63%) are not supported by the ground truth and appear fabricated or misattributed. There are no calculation errors, but the inclusion of unsupported numbers reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly compares expense changes and target allocation continuity. However, it fails to address the key qualitative evolution highlighted in the ground truth—the 2024 filing's new disclosure about characterizing the actual composition of plan assets as a transparency enhancement. Instead, it invents specific composition data, missing the conceptual point about improved disclosure practices. (4) The contextual relevance is high because the answer addresses the core topics: plan expenses and investment framework evolution. However, correctness is compromised by hallucinated data and omission of the true qualitative development (enhanced disclosure intent), leading to a moderate score of 5. The answer gives a false sense of precision with unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 492,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Qualcomm's strategic focus on On-Device AI evolved as the company emphasized integrating AI capabilities into its foundational technologies, particularly in wireless connectivity and high-performance, low-power computing. In fiscal 2024, Qualcomm highlighted continued investments in advancing On-Device AI to support growth in industries beyond mobile handsets, such as automotive and IoT. The company also noted the importance of developing leading AI technologies to sustain its long-term business growth, aligning with its vision for 5G and AI convergence. Specific investments included research and development expenditures of $8.9 billion in fiscal 2024, with a focus on enhancing AI capabilities across its Snapdragon platforms and expanding AI-driven solutions for automotive and IoT applications.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Qualcomm's strategic focus from a vision in fiscal 2023 to active investment in fiscal 2024, particularly in automotive and IoT, which aligns with the ground truth. However, it introduces a specific R&D expenditure figure of $8.9 billion in fiscal 2024, which is not present in the original answer and cannot be verified from the provided ground truth. This affects quantitative accuracy. (2) The ground truth does not include any numerical data (e.g., R&D spend), so the inclusion of $8.9 billion is an unsupported addition. While R&D investments are plausibly part of Qualcomm’s strategy, the specific number and its attribution to AI enhancements are not confirmed in the original answer, making this a significant factual overreach. (3) The multi-hop reasoning is sound: the model correctly identifies the shift from strategic positioning in 2023 to active investment in 2024, and synthesizes the expansion into automotive and IoT across years. It accurately reflects the qualitative evolution in strategy, even if it embellishes with unverified specifics. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of focus and specific investments. The qualitative accuracy is strong due to correct entity and timeline usage (Qualcomm, fiscal 2023–2024, On-Device AI, 5G, automotive, IoT), but the unsupported number reduces confidence in factual precision. Correctness is therefore rated 7 due to core accuracy with a notable factual overstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 430,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members is referenced in both the 2022 and 2023 10-K filings under Exhibits 9.1 and 9.2, indicating no substantive changes in its classification or presentation. This consistency suggests a stable governance structure, as the agreement remains a key component of corporate governance without any noted amendments or reclassifications between the two periods.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that the Voting Trust Agreement was referenced in both the 2022 and 2023 10-K filings and interprets this as a sign of governance stability, which aligns with the general conclusion in the ground truth. However, it misses the key nuance in the evolution of the classification and presentation: the removal of the 'Second Amended and Restated' modifier in the 2023 filing. The original answer highlights a specific change in terminology — from 'Second Amended and Restated Voting Trust Agreement' in 2022 to simply 'Voting Trust Agreement dated March 1, 2004' in 2023 — which indicates no amendments were made since the last restatement. The LLM incorrectly states there was 'no substantive changes in its classification or presentation,' when in fact, the presentation did change (by dropping the 'amended and restated' language), even if the substance remained the same. This mischaracterization reflects a failure in multi-hop reasoning: the model did not detect and interpret the significance of the altered descriptor across filings. While the conclusion about stability is directionally correct, it is based on incomplete and slightly inaccurate analysis of the presentation change. All entities (Melvin Simon & Associates, Simon family, 10-K filings, Exhibits 9.1 and 9.2) and years (2022, 2023) are correctly identified, and there are no numerical inaccuracies (quantitative accuracy is high due to absence of incorrect numbers). Contextually, the response is relevant and addresses the question’s focus on governance stability. However, the lack of precision in describing the evolution of the agreement's presentation reduces qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 463,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 312 BCF at the end of 2023 to 296 BCF at the end of 2024, indicating a slight decline. This modest reduction, despite upward revisions in equity affiliates due to technical improvements, suggests that the region's strategic importance to COP's global reserves portfolio has diminished slightly compared to other regions like the Lower 48, which saw significant growth in reserves.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM incorrectly states that reserves 'increased from 312 BCF to 296 BCF', which is factually wrong—the correct trend is a decrease from 312 to 296 BCF. This misstatement severely undermines the quantitative and qualitative accuracy. However, the numbers themselves (312 BCF in 2023 and 296 BCF in 2024) are correct, and the description of a 'slight decline' is accurate in intent, despite the contradictory verb 'increased'. The 5.1% reduction is not mentioned, but the general direction and magnitude of change are implied correctly after correcting the verb error. (2) The quantitative values (312 and 296 BCF) are accurate and match the ground truth. However, the LLM says 'increased' when it should say 'decreased', which is a critical error in interpretation. The calculation of a 16 BCF reduction (312 - 296) is implied but not stated, and the percentage drop (~5.1%) is missing. The mention of equity affiliates having upward revisions due to technical improvements is plausible but not explicitly supported in the ground truth, which only states that equity affiliates held 5,870 BCF in 2024—no reason for change is given. (3) The multi-hop reasoning is partially sound: the model attempts to compare regional strategic importance and references other regions (e.g., Lower 48), which shows an effort to contextualize. However, the conclusion that strategic importance 'diminished slightly' is based on flawed reasoning due to the incorrect direction of change stated. The ground truth allows for such an interpretation but grounds it in correct data. (4) The contextual relevance is high—the answer addresses both parts of the question (evolution of reserves and strategic importance) and attempts synthesis. However, the critical error in stating the direction of change reduces correctness significantly. The answer would score higher if the verb 'increased' were corrected to 'decreased'.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 518,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge underwent significant changes. In 2024, AIG deconsolidated Corebridge, resulting in a $4.8 billion loss due to the recognition of accumulated comprehensive loss. Post-deconsolidation, AIG adopted the fair value option for its retained interest in Corebridge, which was reflected as an equity method investment. This led to equity method income of $601 million for 2024, driven by dividends received and changes in Corebridge's stock price. AIG also sold portions of its Corebridge stake, including a 21.6% ownership stake to Nippon for $3.8 billion, generating a $282 million gain in the fourth quarter of 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces information not present in the ground truth. While it correctly identifies the shift from consolidation to equity method reporting in 2024, it fabricates key financial figures and events. The $4.8 billion loss from deconsolidation, $601 million equity method income, and the $282 million gain from a stake sale to Nippon are not mentioned in the original answer and cannot be verified against the provided ground truth. Additionally, the sale of a 21.6% stake to Nippon for $3.8 billion is absent from the original, making these details unsupported. (2) Quantitatively, the original answer specifies $9,368 million in total Corebridge debt in 2023, broken into $6,452 million in senior unsecured notes and $989 million in junior subordinated debt—none of which are referenced in the LLM response. The LLM fails to mention any debt structure details from 2023, a major omission given the question's focus. Instead, it invents new numbers (e.g., $601M income) that do not align with the ground truth. (3) The multi-hop reasoning is partially sound in recognizing the transition from consolidation to equity method accounting, which reflects a correct understanding of the structural change. However, it fails to connect the 2023 debt composition to the 2024 equity method shift as required, and instead introduces unrelated transactions (e.g., Nippon sale) that break the logical chain. (4) Contextual relevance is high because the answer addresses the evolution of the financial relationship and focuses on debt and equity method income as asked. However, due to significant factual errors, invented figures, and missing core data from the original, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the conceptual shift is understood, but not properly supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 513,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "NextEra Energy's investment strategy in Special Use Funds has shifted from 2022 to 2024, with a notable increase in equity securities and a decrease in fixed income securities. In 2022, the Special Use Funds included approximately $5,511 million in marketable equity securities and $2,505 million in fixed income securities for NEE. By 2024, equity securities in these funds had grown to $9,799 million, while fixed income securities had decreased to $1,342 million. This shift suggests a higher risk appetite, as equity investments typically carry more volatility and growth potential compared to fixed income. It also indicates a potential long-term liquidity strategy, as the increased allocation to equities may reflect confidence in long-term returns to support obligations such as nuclear decommissioning and storm reserves.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, NextEra Energy's (NEE) Special Use Funds were entirely composed of fixed income securities with a carrying amount of $2,505 million—there were no equity securities. However, the LLM claims $5,511 million in equity securities in 2022, which is completely incorrect. In 2024, the ground truth shows $6,164 million in equity securities, but the LLM reports $9,799 million, a major overstatement. The LLM also reports $1,342 million in fixed income securities in 2024, but the correct total for fixed income (sum of U.S. Government/municipal bonds, corporate debt, and asset-backed securities) is $722M + $685M + $873M = $2,280 million, not $1,342 million. (2) These numerical errors invalidate the quantitative analysis. The LLM incorrectly suggests a decrease in fixed income when in fact the total fixed income portion increased from $2,505M to $2,280M (though composition changed), and it vastly overstates equity holdings in both years. (3) The reasoning is partially sound in interpreting a shift toward equities as indicating higher risk appetite, which aligns with the actual strategic shift. However, because the underlying data is wrong, the multi-hop synthesis fails—this is not a decrease in fixed income but a repositioning into equities while maintaining substantial fixed income. (4) Contextual relevance is fair because the answer addresses the evolution of allocation, risk appetite, and liquidity strategy as asked. However, due to severe quantitative inaccuracies and incorrect entity values, the correctness score is low. The answer fabricates data rather than reflecting the true transformation from 100% fixed income to a diversified, equity-heavy portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 486,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The nature and magnitude of the risk associated with site infrastructure sharing have evolved between 2022 and 2024 due to the adoption of 5G technology, which has increased the likelihood of extensive sharing of site infrastructure through RAN sharing, roaming, or resale arrangements among wireless service providers. This trend has the potential to slow new lease activity as carriers may utilize shared equipment rather than deploy new infrastructure, or decommission equipment on existing sites where portions of their networks become redundant. Additionally, the increased use of advanced network technologies like 5G has introduced risks related to reduced demand for traditional tower-based services, potentially impacting lease rates and the need for additional infrastructure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of site infrastructure sharing risk between 2022 and 2024 in the context of 5G adoption and its impact on new lease activity, and accurately reflects that RAN sharing, roaming, and resale arrangements are key drivers. It correctly notes that such sharing can slow new lease activity or lead to decommissioning, aligning with the 2022 risk description. However, it omits a critical nuance present in the ground truth: the specific financial risk arising from AMT not being compensated when carriers use shared infrastructure. This compensation issue is a key evolution in the 2024 filing and represents a more mature articulation of the risk, which the LLM answer fails to mention. While the answer captures the general trend and technological drivers (5G, RAN sharing), it lacks the entity-specific detail (AMT's lack of compensation) that defines the heightened risk magnitude in 2024. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are cited), and the reasoning is logically sound but incomplete in synthesis. The contextual relevance is high as it directly addresses the question’s focus on risk evolution and 5G’s role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 341,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Chevron's investment in Angola LNG Limited, which processes and liquefies natural gas in Angola, has seen a reduction in its investment value between 2022 and 2023. Specifically, the investment balance decreased from $1,963 million in 2022 to $1,762 million in 2023. Additionally, Chevron's equity in earnings from Angola LNG Limited dropped significantly, from $1,857 million in 2022 to $513 million in 2023, indicating a decline in the affiliate's performance or Chevron's share of its profits during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core aspects of the question. (1) The original answer focuses on a structural evolution in Chevron's relationship with Angola LNG Limited—specifically a shift from 'Depends_On' to 'Invests_In' in terms of investment classification—while maintaining a constant 36.4% ownership. The LLM instead introduces financial figures (investment balance and equity earnings) that are not present in the ground truth and are factually unsupported by the provided knowledge. There is no mention in the ground truth of a decrease in investment value from $1,963M to $1,762M or a drop in equity earnings from $1,857M to $513M; these numbers appear fabricated or sourced from outside the knowledge graph. (2) Quantitative accuracy is low because all cited numbers are incorrect or unverifiable against the ground truth. The ground truth does not provide any dollar amounts related to investment balances or earnings, so the LLM invents data rather than reporting structural changes. (3) Qualitatively, the reasoning is flawed: the LLM interprets the question as asking about financial performance trends, whereas the actual evolution is in the classification of the investment relationship (from dependency-based to direct investment). It fails to mention the key terms 'Depends_On' and 'Invests_In', which are central to the correct answer. (4) Contextual relevance is moderate because the LLM stays within the domain of Chevron and Angola LNG Limited and discusses equity method accounting concepts like investment value and equity earnings, but it misses the actual point about structural and accounting relationship changes. The answer reflects a plausible but incorrect interpretation, likely due to hallucination of financial data and misalignment with the true multi-hop insight—change in relationship type, not financial magnitude.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 506,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 aircraft's role in Gulfstream's product lineup remained prominent, with performance metrics highlighting its status as a fast, fuel-efficient, and high-capacity business jet. By year-end 2023, cumulative deliveries of the G600 exceeded 250, up from nearly 150 in 2021, indicating growing adoption. The G600 continues to compete effectively within its class, holding over 90 city-pair speed records. Production and support for the G600 remain active as Gulfstream expands its global service network and invests in sustainability initiatives, including the use of sustainable aviation fuel (SAF), which aligns with the aircraft's advanced performance and environmental benefits.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct information but misses key aspects of the evolution in the G600's role as described in the ground truth. While it correctly notes that cumulative deliveries exceeded 250 by end of 2023, it does not mention that the G600 was no longer considered 'new' in 2023 or that it had replaced the G550 as a clean-sheet design. The answer fabricates or infers unsupported metrics such as 'nearly 150 in 2021' deliveries, which is not in the original answer and cannot be verified from the provided context. It also introduces extraneous details like 'over 90 city-pair speed records' and sustainability/SAF initiatives that are not part of the ground truth and were not asked about in the question. (2) Quantitative accuracy is partially correct: the 'over 250 deliveries by end of 2023' aligns with the original answer, but the claim about 150 deliveries in 2021 is unsupported and likely inaccurate based on the knowledge graph. No other numbers (e.g., fuel efficiency, speed records) are corroborated. (3) The multi-hop reasoning is weak: the question asks about evolution in role, performance metrics, and production status. The LLM fails to capture the strategic shift from 'recent addition' in 2022 to 'mature product' in 2023, and misses the critical point that the G600's technologies (e.g., Symmetry Flight Deck) became foundational for newer models like G700/G800/G400 — a key evolution in its role. This synthesis is absent, indicating a failure in multi-hop reasoning. (4) Scores reflect partial factual correctness on delivery numbers and ongoing production, but significant omissions and additions of irrelevant or unverified data reduce overall accuracy. Contextual relevance is higher because the answer stays focused on the G600 and Gulfstream, addressing performance and production, even if inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 504,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees evolved through increased strategic collaboration and financial co-investment to modernize and enhance restaurant performance. The Company co-invests with franchisees to fund improvements, aligning with consumer preferences and brand value. Financially, franchisees continue to pay rent, royalties, and initial fees, while McDonald's shares in the cost of certain restaurant improvements, particularly in the U.S. This collaboration reflects a stronger partnership model aimed at driving long-term value for both McDonald's and its franchisees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's relationship with franchisees between 2022 and 2024. It correctly identifies the shift from a traditional franchising model to one involving co-investment and strategic collaboration. The financial mechanisms—franchisee payments (rent, royalties, fees) and McDonald's cost-sharing in restaurant improvements—are accurately described. The emphasis on modernization, consumer preferences, and long-term value aligns with the ground truth. The only minor omission is the explicit mention that McDonald's previously did not invest in restaurant capital under developmental licenses in 2022, which would strengthen the contrast between the two time periods. However, the overall reasoning and synthesis across the two years are sound, and the answer correctly reflects the strategic shift. No numerical inaccuracies are present—there are no specific dollar amounts or percentages in the original, so the absence of numbers does not detract. The entities (McDonald's, franchisees), time frame (2022–2024), and financial terms are all correct. The answer is semantically equivalent to the ground truth with slightly less emphasis on the 'passive' nature of the pre-2024 model, but the key transformation is clearly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 360,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a slight decline in net revenues, which decreased by $720 million (from $22,476 million in 2022 to $21,756 million in 2023). Operating income for smokeable products remained relatively stable, decreasing marginally by $18 million (from $10,688 million in 2022 to $10,670 million in 2023).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: net revenues decreased from $22,476 million in 2022 to $21,756 million in 2023 (a $720 million decrease, correctly calculated), and operating income declined from $10,688 million to $10,670 million (a $18 million decrease, also correctly stated). (2) The answer is complete, addressing both net revenues and operating income across both years as required by the question. (3) Entity accuracy is perfect—'smokeable products' is the correct segment, and the years 2022 and 2023 are correctly referenced. (4) The reasoning is sound: the LLM correctly synthesized year-over-year performance, identified the direction and magnitude of changes, and characterized the trend as a 'slight decline' and 'relatively stable' with only a marginal drop in operating income, which aligns with the ground truth's description of 'small decrease in both revenue and profitability'. (5) Semantic equivalence is achieved—the LLM conveys the same information with slightly more detailed numerical analysis (explicitly stating the dollar differences), enhancing clarity without introducing error. All aspects of the multi-hop financial comparison are handled accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 354,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within BMY's product development and commercialization strategy has evolved through expanded therapeutic approvals and a continued emphasis on immunotherapy (IO) leadership. In 2024, Opdivo received multiple approvals, including FDA approval for Opdivo Qvantig (a subcutaneous formulation) across multiple indications, EC approval for urothelial carcinoma in combination with chemotherapy, and approvals in Japan for unresectable urothelial carcinoma. Collaboratively, BMY maintained joint development and commercialization efforts with Ono in Japan, South Korea, and Taiwan, while expanding Opdivo's use in combination therapies, such as with Yervoy and NKTR-214, reflecting a strategic focus on diversifying beyond IO and leveraging partnerships to drive innovation and market reach.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies and omissions compared to the ground truth. (1) Correct aspects include the mention of continued collaboration with Ono and the expansion of Opdivo in combination therapies. However, the key 2024 FDA approval for urothelial carcinoma in combination with cisplatin and gemcitabine—specifically highlighted in the original answer—is mischaracterized. The LLM incorrectly states that the EC (not FDA) approved urothelial carcinoma in combination with chemotherapy, while the ground truth specifies a March 2024 *FDA* approval for this indication. Additionally, the LLM introduces 'Opdivo Qvantig' and approvals in Japan without any mention in the original answer, which are unverified and likely incorrect or unsupported by the source. (2) Quantitative accuracy is low: the date (March 2024) is omitted, and the regulatory body (FDA vs EC) is wrong. The subcutaneous formulation (Qvantig) and approvals in Japan are not mentioned in the ground truth, suggesting fabrication or hallucination. (3) Multi-hop reasoning is partially sound—linking collaboration with Ono and therapeutic expansion—but fails to correctly synthesize the strategic shift from co-development to independent commercialization leadership by BMY, which is central to the original answer. The evolution in strategy is underemphasized and misrepresented. (4) Contextual relevance is high as the response stays focused on Opdivo’s role in BMY’s strategy, partnerships, and approvals. However, due to factual errors in key approvals, dates, and regulatory bodies, and the introduction of unsupported details, the overall correctness is reduced to a 6—partially correct but with significant flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 472,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in the referenced rates and associated covenants. In 2022, AMT's debt instruments referenced rates such as LIBOR and EURIBOR, with spreads based on debt ratings. For example, the 2021 EUR Three Year Delayed Draw Term Loan and USD Delayed Draw Term Loans bore interest at rates above LIBOR or EURIBOR, with margins ranging from 0.875% to 1.750% for LIBOR-based borrowings and 1.125% and 0.125% over EURIBOR. By 2024, AMT's referenced rates included SOFR, as seen in the Nigeria Letters of Credit, which bore interest at SOFR plus a spread. Additionally, covenants related to debt service coverage ratios (DSCR) remained consistent, with the Cash Trap DSCR at 1.30x and the Minimum DSCR at 1.15x, ensuring cash flow management and reserve account requirements to maintain compliance and avoid defaults.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in AMT's interest rate benchmark disclosures from LIBOR/EURIBOR in 2022 to SOFR in 2024, which aligns with the ground truth. It correctly identifies the shift in referenced rates, citing SOFR in the context of Nigeria Letters of Credit, and provides specific margin ranges for LIBOR and EURIBOR-based borrowings in 2022. However, there are quantitative inaccuracies: the ground truth does not specify margins of 0.875%–1.750% for LIBOR or 1.125% and 0.125% over EURIBOR; these exact figures are not present in the original answer and appear to be fabricated or misattributed. Additionally, while the LLM mentions consistent DSCR covenants (1.30x and 1.15x), the ground truth does not confirm that these specific ratios remained unchanged between 2022 and 2024—instead, it notes a shift in disclosure focus from detailed covenants and renewal terms in 2022 to consequences of non-compliance in 2024. Thus, the LLM incorrectly implies continuity in covenant metrics that the original answer does not support. The reasoning is logically structured and contextually relevant, showing understanding of the multi-hop nature (evolution over time, rate changes, covenant presentation), but the inclusion of unsupported numerical details reduces quantitative accuracy. The answer is semantically aligned in direction but not fully factually substantiated on specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 386,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with franchisees evolved to emphasize co-investment in real estate and restaurant improvements. The Company continues to own or secure long-term leases on land and buildings for conventional franchised restaurants, while franchisees invest in equipment and other site-specific elements. Additionally, McDonald's has increasingly co-invested with franchisees to fund modernization and operational upgrades, aiming to enhance restaurant performance and brand value. This strategy reflects a collaborative approach to drive long-term growth and align with evolving consumer expectations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the evolution in McDonald's relationship with franchisees between 2022 and 2024, noting a shift toward a more structured co-investment strategy. The core model—McDonald's owning or leasing land and buildings while franchisees invest in equipment and interior elements—is correctly described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; the score reflects absence of errors. (3) The multi-hop reasoning is sound: the LLM infers a strategic evolution from general collaboration in 2022 to a defined real estate and co-investment model in 2024, which is consistent with the original answer. However, the LLM slightly overstates the clarity of the 2022 positioning by not explicitly noting that real estate roles were not detailed then, which is a minor omission in completeness. (4) The answer is contextually relevant and conveys the key takeaway: a move toward structured co-investment. While the wording differs, the semantic meaning is equivalent. The qualitative score is reduced slightly due to this lack of contrast between the vague 2022 description and the explicit 2024 model in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 363,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective October 26, 2022, as noted in the 2023 filing. This update suggests that Altria is periodically reviewing and refining its director compensation structure to align with evolving governance standards or strategic priorities, reflecting a commitment to transparent and structured corporate governance practices.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key event—the amendment and restatement of the 2015 Stock Compensation Plan for Non-Employee Directors effective October 26, 2022, as disclosed in the 2023 filing. This aligns with the ground truth. However, the LLM omits the specific quantitative detail from 2022 that 703,256 shares were available for issuance under the plan, which was part of the original answer and directly relevant to the 'status and documentation' aspect of the question. (2) The date 'October 26, 2022' is accurate and correctly cited. No calculations are required, but the absence of the share number reduces quantitative completeness. The reference to the 2023 filing incorporating the amendment is correct and consistent with the ground truth’s mention of incorporation by reference from the September 30, 2022, Form 10-Q. (3) The reasoning is sound: the LLM correctly infers that the amendment reflects ongoing governance refinement and alignment with evolving standards, which is a valid interpretation of the plan update. It synthesizes the implication correctly, though it does not explicitly reference the mid-cycle nature of the change noted in the ground truth. (4) The answer is contextually fully relevant and well-articulated, but the missing share availability figure prevents a top score. The omission affects completeness on a multi-part question, particularly the 'status' component in 2022. Thus, while the core facts and implications are correct, the answer is partially incomplete on a key factual element.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 428,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "The impact of roaming and resale arrangements among wireless service providers on American Tower's (AMT) leasing activity has intensified from 2022 to 2024, as these arrangements have increasingly been used as alternatives to leasing AMT's communications infrastructure. In 2022, the filing noted that such arrangements could slow new lease activity or lead to decommissioning of equipment on existing sites. By 2024, the discussion expanded to include the impact of advanced technologies like 5G and radio access network (RAN) sharing, which further enable carriers to reduce their reliance on new infrastructure deployments. This evolution indicates growing competitive pressures, as carriers seek cost-efficient alternatives to traditional leasing, potentially limiting AMT's new lease growth and revenue opportunities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: the evolution from 2022 to 2024 is properly captured, with roaming and resale arrangements initially posing a risk to new lease activity and later expanding to include RAN sharing and potential decommissioning. The mention of 5G as a contributing factor is consistent with the original. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how the nature of competitive pressure evolved over time and links it to technological advances and carrier behavior. The only minor shortcoming is that the LLM slightly compresses the nuance that in 2022, the concern was primarily about slowing new leases, while decommissioning became a more prominent risk by 2024. The LLM implies both risks existed in 2022, which slightly misrepresents the progression. (4) Despite this small conflation, the overall reasoning, entity accuracy (AMT, 5G, RAN sharing, resale arrangements), and contextual relevance are excellent. The answer directly addresses the evolution and its implications for competitive pressures and lease growth, fulfilling the multi-part question with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 376,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize strategic investment and operational alignment to drive growth and brand consistency. The Company has increased collaboration with franchisees on capital investments, co-funding initiatives to modernize restaurants and enhance technology, reflecting a shared commitment to innovation and customer experience. Operational expectations have also intensified, with a stronger focus on adherence to Global Brand Standards, food safety, and digital transformation, ensuring franchisees align with McDonald's evolving strategic priorities and values.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in McDonald's relationship with franchisees from 2022 to 2024. It accurately reflects the shift toward strategic investment and increased operational expectations. While the original answer specifies that in 2022 the focus was on pandemic-related challenges (labor, supply chain) and the 'Accelerating the Arches' strategy, the LLM answer omits explicit mention of the pandemic context and the strategy by name, which is a minor but notable omission affecting completeness. However, it correctly identifies the 2024 shift to co-investment for restaurant modernization and technology, aligning with the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The LLM conveys the correct qualitative shift—toward co-investment and higher operational standards—and maintains contextual relevance throughout. The reasoning is sound and synthesizes the multi-hop elements (change over time, strategic and operational dimensions), though with slightly less specificity than the original. Thus, the answer is semantically close and factually aligned but lacks a few key contextual details from 2022, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 353,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "NextEra Energy's investment strategy in equity securities within its Special Use Funds evolved from 2022 to 2024 by showing a shift from unrealized losses to significant unrealized gains. In 2022, NEE reported unrealized losses of $1,028 million, while by 2024, this had turned into unrealized gains of $917 million. Additionally, the fair value of equity securities in the Special Use Funds increased from $5,290 million in 2023 to $6,164 million for NEE in 2024, indicating a more robust and positive performance in equity investments during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, NextEra Energy held $8,922 million in Special Use Funds with no breakdown of equity securities, but the LLM claims $5,290 million in equity securities in 2023—a figure not mentioned in the original answer and unsupported by the provided truth. Additionally, the LLM introduces unrealized losses of $1,028 million in 2022 and gains of $917 million in 2024, which are completely absent from the ground truth and represent fabricated data. The only correct number is the $6,164 million in equity securities in 2024, which matches the original answer. (2) Quantitative accuracy is very low: two major figures (unrealized losses/gains and 2023 equity value) are incorrect or hallucinated. The only accurate number is the 2024 equity allocation. There is no evidence in the ground truth of performance shifts from losses to gains or year-over-year fair value changes including 2023. (3) The multi-hop reasoning is flawed. The original answer infers a strategic shift based on increased disclosure and explicit allocation to equities in 2024 compared to no breakdown in 2022. The LLM instead constructs a narrative around performance metrics (unrealized gains/losses) and a 2023 data point that are not present in the ground truth, failing to correctly synthesize the actual evolution—transparency and disclosure—rather than performance or incremental investment growth. (4) Contextual relevance is moderate because the answer discusses equity securities in Special Use Funds and covers the 2022–2024 timeframe, but the focus on financial performance and missing 2022 equity breakdown misaligns with the actual strategic evolution described in the original answer. Due to major factual and quantitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 499,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a slight decline in net revenues, which decreased by $720 million (from $22,476 million in 2022 to $21,756 million in 2023). Operating income remained relatively stable, with a minor decrease of $18 million (from $10,688 million in 2022 to $10,670 million in 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: net revenues of $22,476 million in 2022 and $21,756 million in 2023, and operating income of $10,688 million in 2022 and $10,670 million in 2023. The calculated differences (a $720 million decrease in net revenues and an $18 million decrease in operating income) are accurate. (2) All numeric values match the original answer exactly, and the arithmetic for year-over-year changes is correct. Format variations (e.g., using 'million' instead of 'M') are acceptable and do not affect accuracy. (3) The reasoning is sound: the model correctly synthesizes performance across two years and two financial metrics, identifying both the revenue decline and the near-stability of operating income. The conclusion of 'slight decline' and 'relatively stable' aligns with the ground truth's characterization of 'marginal decrease'. (4) The only minor shortcoming is that the LLM answer does not explicitly state that both revenue and profitability declined year-over-year, though this is implied. The original answer emphasizes the decline in both metrics, while the LLM slightly softens the operating income change by calling it 'relatively stable'. However, this is a nuance in phrasing, not a factual error. All core facts, calculations, and entities are correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 383,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between 2022 and 2023, the utilization of Accenture plc Class A Ordinary Shares primarily involved share purchase programs aimed at repurchasing shares for treasury, with the intention of using them for employee benefits, including equity awards. In 2022, Accenture repurchased 12,180,917 shares under open-market and other share purchase programs for a total of $4,111,266. These shares were held as treasury shares and were intended for use in employee-related equity awards. In 2023, the company continued its share repurchase activities, with an increased total consideration of $6,456,648, reflecting a continued commitment to returning value to shareholders and supporting employee compensation programs.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that in 2022, Accenture had an aggregate available authorization of $3,129,296 for share purchase programs, not a repurchase of $4,111,266 as claimed by the LLM. Furthermore, the LLM invents a 2023 repurchase amount of $6,456,648, which is not present in the original answer and contradicts the disclosed authorization amount. There is no mention in the ground truth of 12,180,917 shares being repurchased in 2022, nor any total consideration amounts for either year. (2) The original answer emphasizes that by 2023, Accenture clarified the intended use of repurchased Class A Ordinary Shares as treasury shares for employee benefits, and in fiscal 2024, shares were withheld for payroll tax obligations—separate from the public buyback program. The LLM correctly identifies the intended use for employee benefits and equity awards, which aligns qualitatively with the original answer. However, it fails to mention the key distinction that share withholding for payroll taxes in fiscal 2024 was separate from the publicly announced authorization, a critical nuance in the evolution of utilization. (3) The multi-hop reasoning is partially sound—the LLM connects share repurchases to treasury use and employee compensation—but it fabricates numerical data rather than accurately reporting the authorization amount. This undermines the reasoning despite correct directional logic. (4) The contextual relevance is high because the answer addresses share purchase programs and their intended usage, directly responding to the question’s focus. However, due to major quantitative errors and omission of key distinctions (e.g., separation between buybacks and tax withholding), the overall correctness score is low. Minor positive credit is given for correctly identifying the general trend toward employee compensation usage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 528,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, AMT's operating covenants remained largely consistent in structure, with a focus on debt service coverage ratios (DSCR) and reserve account requirements to ensure sufficient cash flow for debt servicing. However, there were notable changes in the types of debt instruments and interest rate benchmarks. In 2022, debt instruments referenced LIBOR or EURIBOR as the base rate, with a fixed margin of 1.125%. By 2024, AMT transitioned to using SOFR (Secured Overnight Financing Rate) for certain debt instruments, such as the Nigeria Letters of Credit, which bore interest at SOFR plus a spread. Additionally, the 2023 Securitization introduced fixed-rate securities with interest rates of 5.490% and 5.735%, reflecting a shift toward longer-term fixed-rate financing. These changes indicate a strategic move toward diversifying interest rate benchmarks and securing more stable, long-term funding.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution in AMT's operating covenants from LIBOR/EURIBOR to SOFR-based benchmarks between 2022 and 2024, particularly highlighting the Nigeria Letters of Credit tied to SOFR. It correctly identifies the shift in interest rate benchmarks and contextualizes it as part of a broader strategic transition. However, the ground truth does not mention specific margin values (e.g., 'fixed margin of 1.125%') or the 2023 Securitization with interest rates of 5.490% and 5.735%—these figures are not supported by the original answer and appear to be fabricated or inferred beyond available data. This introduces a quantitative inaccuracy, as these precise percentages and the reference to a '2023 Securitization' are not present in the ground truth. While the qualitative reasoning about a shift toward fixed-rate and diversified financing is plausible, it goes beyond the scope of the original answer, which only confirms a benchmark shift from LIBOR to SOFR for specific instruments. The entity names (AMT, SOFR, LIBOR, EURIBOR), years (2022, 2024), and debt instruments (Letters of Credit in Nigeria) are accurate and contextually relevant. The multi-hop synthesis is sound in linking changes in benchmarks to debt instruments over time, but the addition of unsupported specifics reduces quantitative accuracy. Overall, the answer conveys the core correct evolution with minor overreach on details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 398,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Between the 2023 and 2024 SEC filings, Disney+ Hotstar's subscriber base remained relatively stable, with approximately 36 million paid subscribers as of September 28, 2024, compared to the prior year. The consolidation of Star+ into Disney+ in Latin America during June 2024 streamlined Disney's international streaming strategy by simplifying its product offerings and focusing on a unified Disney+ platform, enhancing operational efficiency and user experience in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Disney+ Hotstar had approximately 36 million paid subscribers as of September 28, 2024, matching the ground truth. It also accurately notes the consolidation of Star+ into Disney+ in Latin America by June 2024. However, the phrasing 'compared to the prior year' implies a year-over-year comparison, which is not explicitly supported in the original answer—no 2023 subscriber number is given, only a single data point as of September 28, 2024. This introduces a minor inaccuracy in interpretation. (2) All numbers and dates are correct: 36 million subscribers and June 2024 consolidation align with the original. No calculations were required. (3) The multi-hop reasoning is sound: the model correctly links the Star+ consolidation to a broader international strategy of streamlining services, referencing improved operational efficiency and user experience, which matches the strategic inference in the ground truth. (4) The answer is semantically very close to the original, with only slight overinterpretation regarding subscriber trend stability. All key facts are present and correctly synthesized, warranting a high correctness score with a minor deduction for implied data not in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 349,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "The number of employees covered under collective labor agreements remained relatively stable, with approximately one-fifth of the company's employees covered by such agreements in both 2022 and 2023. In 2022, 21 agreements covered approximately 3,000 employees, while in 2023, 20 agreements are expected to cover approximately 2,100 employees. This slight decrease suggests a potential reduction in the number of employees under collective agreements, but the company continues to prioritize maintaining labor agreements without material disruption, indicating a consistent strategy of managing labor relations proactively.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces inaccuracies. The ground truth states that in 2022, the company *expected to negotiate* agreements covering ~3,000 employees in the *following year* (i.e., 2023), and in 2023, it projected negotiations for ~2,100 employees in the *upcoming year* (i.e., 2024). The LLM misrepresents this as agreements covering 3,000 employees in 2022 and 2,100 in 2023, incorrectly assigning the timeframes. This is a critical error in temporal alignment and projection interpretation. (2) The numbers 3,000 and 2,100 are factually present in the ground truth, so quantitative values are partially correct, but their assignment to years is wrong. The claim of 'one-fifth of employees' and number of agreements (21 vs 20) are not in the original answer and appear to be hallucinated or inferred without basis. (3) The multi-hop reasoning is flawed because the LLM fails to recognize that the figures refer to *future negotiations expected*, not actual coverage in those years. This undermines the synthesis of labor strategy — while both answers note a decrease, the LLM incorrectly frames it as a realized change rather than a shift in projected negotiation scope. (4) The contextual relevance is high because the answer addresses employee counts, collective agreements, and strategy implications. However, due to incorrect year mappings, hallucinated details (number of agreements, proportion of workforce), and mischaracterization of projections as current coverage, the overall correctness is significantly compromised. The conclusion about proactive management is plausible but not directly supported by the ground truth, which emphasizes a reduction in renegotiation scale as indicative of fewer expiring agreements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 485,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "NextEra Energy's investment in U.S. Government and municipal bonds increased from 2022 to 2024. In 2022, the total value was $137 million, while in 2024, it rose to $722 million for NEE and $561 million for FPL, resulting in a combined total of $1,283 million. This represents a significant increase in value compared to 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. While it correctly states the 2022 investment value of $137 million, it incorrectly reports the 2024 value as $722 million for NEE and $561 million for FPL, with a combined total of $1,283 million. The ground truth states that in 2024, the investment was $161 million for NEE (NextEra Energy), with no mention of FPL (Florida Power & Light) in this context. The LLM introduces FPL, which is a subsidiary but not relevant to this specific investment figure as reported in the knowledge graph. (2) The calculation is therefore completely incorrect: the actual increase is $24 million (from $137M to $161M), or ~17.5%, whereas the LLM implies an increase of over $1.1 billion, which is factually wrong. (3) The multi-hop reasoning fails because the model incorrectly combines entities (NEE and FPL) that were not linked in the original data for this metric. It also misrepresents the evolution of a single company's investment by introducing unrelated figures. (4) Despite the severe quantitative and qualitative errors, the answer is contextually relevant in that it attempts to describe the evolution of bond investments over time and mentions the correct company and time frame, hence a moderate relevance score. However, the core facts and calculations are incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 381,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Between 2022 and 2024, Opdivo's role in Bristol-Myers Squibb's portfolio has expanded significantly in terms of therapeutic approvals and manufacturing strategy. In 2024, Opdivo received multiple new approvals, including for urothelial carcinoma, non-small cell lung cancer (NSCLC) neoadjuvant/adjuvant treatment, and combinations with Yervoy for colorectal cancer, reflecting its growing importance in oncology. Additionally, the FDA approved Opdivo Qvantig, a subcutaneous formulation, expanding its delivery options and convenience. Manufacturing strategy also evolved, with BMS leveraging both internal capabilities and third-party partnerships to meet demand, as highlighted in 2022, and continuing to invest in biologics manufacturing infrastructure to support Opdivo's expanding role.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continuation of Opdivo's manufacturing strategy involving both internal and third-party manufacturing, as stated in the 2022 context. It also accurately reflects the expansion of therapeutic approvals by 2024, including the new indication for urothelial carcinoma, which aligns with the ground truth. However, the LLM adds several unverified approvals—such as for NSCLC neoadjuvant/adjuvant treatment and colorectal cancer in combination with Yervoy—and mentions the FDA approval of Opdivo Qvantig (subcutaneous formulation), none of which are supported by the original answer or implied in the knowledge graph. These additions introduce factual inaccuracies, though they are plausible given Opdivo’s real-world development trajectory. (2) Quantitatively, the answer does not include incorrect dates or numbers—it correctly cites March 2024 for the urothelial carcinoma approval (implied in original) and references ongoing manufacturing strategies from 2022. The lack of specific dollar amounts or percentages makes quantitative accuracy less critical here, but the temporal references are mostly accurate. (3) The multi-hop reasoning is partially sound: the model connects manufacturing strategy across years and links new approvals to portfolio evolution. However, it overextends by introducing unmentioned approvals, failing to restrict synthesis to the documented evidence. (4) The contextual relevance is high because the response directly addresses both manufacturing strategy and therapeutic approvals, the two key dimensions of the question. The core evolution—expanded clinical use and sustained manufacturing investment—is correctly conveyed, but the inclusion of unsupported approvals reduces factual precision. Hence, a score of 7 is justified: the central thrust is accurate, but significant overstatement of approvals affects qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 521,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, National Geographic magazine remained part of Disney’s Entertainment segment, specifically under Content Sales/Licensing, with Disney owning 73% of the business. There is no indication of structural changes to its ownership or strategic positioning within the company during this period. National Geographic continued to be reported alongside other content licensing activities, including film and episodic content distribution, and was distinct from the National Geographic Channels and Expeditions, which are also part of Disney’s broader portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that National Geographic magazine was part of Disney's Entertainment segment under Content Sales/Licensing and accurately states the 73% ownership in 2023, which aligns with the ground truth. However, it fails to capture the key evolution between 2023 and 2024: in 2024, Disney no longer emphasized its 73% ownership and instead described the magazine as being 'published' by the company, indicating a shift from an ownership-focused to an operational relationship. This change in strategic positioning and business structure is central to the question but is entirely missed by the LLM, which claims 'no indication of structural changes'—directly contradicting the ground truth. While the entities (Disney, National Geographic magazine, Content Sales/Licensing) and the time frame (2023–2024) are correctly identified, the reasoning is flawed because it does not synthesize the change in disclosure and strategic framing across the two years. The quantitative accuracy is high because the 73% figure is correct and no erroneous calculations are made. Contextual relevance is moderate—while the answer discusses the right entities and segment, it overlooks the core evolution in business structure. The failure to detect and report the shift in ownership emphasis and strategic positioning results in a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 382,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "Between 2023 and 2024, PayPal's description of its transaction management databases' capabilities related to global payment processing in different currencies has shown a slight but notable evolution. In 2023, PayPal stated that consumers could send payments in approximately 150 currencies and withdraw funds in 56 currencies. By 2024, the company expanded these figures, noting that consumers can now send payments in approximately 140 currencies and withdraw funds in 57 currencies. This suggests a continued enhancement in PayPal's global payment processing capabilities, with a focus on increasing the number of supported currencies to better serve its international user base.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. While the ground truth confirms that PayPal supported withdrawal in 56 currencies in 2023 and 57 in 2024, the LLM incorrectly introduces 'sending payments in approximately 150 currencies' in 2023 and '140 currencies' in 2024—figures not present in the original answer or supported by the knowledge graph. These numbers are both incorrect and contradictory (a decrease from 150 to 140), undermining the claim of 'enhancement.' (2) The only correct numeric detail is the increase in withdrawal currencies from 56 to 57, which aligns with the ground truth. However, the addition of unsupported sending-currency figures constitutes a major quantitative error. (3) The reasoning is partially sound in identifying an evolution in PayPal's description and linking it to global payment capabilities, but it fails in multi-hop synthesis by introducing unverified data. The original answer emphasized a shift in language (consumer-centric framing, 'consumers' before 'merchants'), which the LLM omits entirely—missing a key qualitative nuance. (4) Contextual relevance is high as the response addresses the evolution of PayPal's transaction database descriptions in the context of global payments and currencies. However, due to major quantitative inaccuracies and omission of key qualitative details, the overall correctness score is reduced to 4, reflecting partial accuracy with significant errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 411,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The interest rate terms for the Series K Debentures increased significantly from 2023 to 2024, with the rate resetting from 6.051% in March 2023 to a higher rate in 2024, indicating NEE's strategy to refinance existing debt at more favorable terms amid shifting market conditions. This action reflects an effort to optimize financing costs and manage debt maturity schedules proactively.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error: it claims the interest rate increased to a 'higher rate in 2024', but the ground truth states that the rate was reset to 6.051% in March 2023 and that the terms effective March 1, 2023 (via a letter dated March 1, 2023) indicated a continuation of that rate into 2024. There is no indication of a further rate increase in 2024. This misrepresents the evolution of the interest rate. (2) Quantitatively, the 6.051% rate in March 2023 is correctly mentioned, but the claim of a subsequent increase in 2024 is unsupported and incorrect. No new rate is provided, making the comparison invalid. The date (March 1, 2023) for the letter setting the ongoing terms is omitted, and the timeline is misrepresented. (3) The multi-hop reasoning is partially sound in linking the rate reset to NEE's financing strategy, but the conclusion that NEE refinanced to secure 'more favorable terms' contradicts the ground truth, which indicates a higher rate was locked in—likely due to less favorable market conditions. The strategy interpretation is thus flawed. (4) Contextual relevance is strong as the answer addresses both parts of the question—rate evolution and strategic implication—and discusses financing strategy appropriately. However, due to the critical error in rate movement and strategic interpretation, the correctness and quantitative accuracy scores are low. Minor credit is given for identifying the correct initial rate and the general context of debt management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 422,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil's application of the Unit-of-Production Depreciation method remained consistent between 2022 and 2023, with the method continuing to rely on proved reserves as the basis for depreciation calculations. However, in 2023, there was a noted emphasis on adjusting depreciation rates for properties where proved reserves were substantially de-booked, using reserves determined at the most recent SEC price to ensure equitable cost allocation. This adjustment reflects a response to changes in proved reserves and asset life assumptions, particularly in light of evolving market conditions and regulatory environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: ExxonMobil maintained the core Unit-of-Production Depreciation method from 2022 to 2023, using proved reserves as the basis, with a refinement in 2023 to emphasize the use of the most recent SEC price when reserves were substantially de-booked. The answer correctly identifies the trigger (substantial de-booking of reserves) and the response (use of SEC price-based reserves for more equitable cost allocation). (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in terms of calculations, but all references to years (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information about methodological consistency, changes in application due to reserve changes, and the rationale tied to economic and regulatory conditions. The only minor omission is that the original answer notes the fallback to straight-line depreciation when asset life doesn’t correlate with reserves—a detail not explicitly mentioned in the LLM response. However, this does not undermine the core focus on the evolution related to SEC pricing and reserve de-bookings. (4) The LLM answer is contextually precise, directly addressing the evolution of the method in response to changes in proved reserves and asset life assumptions. Wording differs slightly but meaning is preserved. Thus, the correctness score is 9 due to high accuracy with a minor completeness gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 422,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Between 2023 and 2024, Netflix has increasingly focused on scaling its internal studio operations to produce original programming, as highlighted by its acquisitions such as Scanline and Animal Logic. This shift reflects a strategic move to reduce reliance on third-party production partners and instead build in-house capabilities to control content development, production quality, and costs. The 2024 filing emphasizes the expansion of original content, including games and live programming, alongside efforts to enhance brand differentiation and member engagement through internally produced, exclusive content.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies Netflix's strategic shift toward internal studio scaling through acquisitions like Scanline and Animal Logic, and notes the reduced reliance on third-party production partners. It accurately reflects the emphasis on building in-house capabilities to control content development and production. The 2024 focus on expanding original content, including games and live programming, and enhancing brand differentiation through internal production aligns with the ground truth's indication of a stronger internal focus. However, the LLM omits a key qualitative detail present in the original answer: the explicit mention in 2023 of risks associated with third-party partners (legal violations, insolvency, fraud) and the fact that this risk language was dropped in 2024—suggesting a strategic de-emphasis on external dependencies. This omission reduces completeness in capturing the evolution of risk disclosure and strategic framing. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Netflix, Scanline, Animal Logic, years 2023–2024) are correct. The reasoning is sound and contextually relevant, but the lack of direct comparison between 2023 risk disclosures and their absence in 2024 slightly weakens the multi-hop synthesis, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 369,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Mastercard's Cyber and Intelligence Solutions have evolved from primarily focusing on fraud prevention and transaction security to becoming a broader, more integrated component of the company's value-added services. In 2022, these solutions were highlighted as part of Mastercard's efforts to ensure secure and confident transactions. By 2023, the strategic positioning emphasized not only fraud prevention but also expanded capabilities such as digital identity verification (through the acquisition of Ekata) and open banking solutions, reflecting a more proactive and comprehensive approach to cybersecurity and intelligence across the global payments ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Mastercard's Cyber and Intelligence Solutions from 2022 to 2023, aligning with the ground truth in terms of strategic shift: from a fraud-focused component under 'Other revenues' to a more elevated, value-added service enhancing the broader payments ecosystem. The qualitative description of expanded capabilities (e.g., digital identity via Ekata, open banking) is plausible and contextually consistent with Mastercard's known acquisitions and strategy, though the original answer does not explicitly mention Ekata or open banking—these are reasonable inferences but not present in the ground truth. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed correct by default (scored 10). The reasoning is sound and reflects multi-hop understanding across years and strategic framing. The core facts—increased strategic importance, broader role in payments—are accurately conveyed, but the LLM adds specific details (Ekata, open banking) not confirmed in the original knowledge graph, slightly reducing qualitative accuracy. Contextual relevance is excellent, directly addressing the evolution in strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 343,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "From 2023 to 2024, Tesla's approach to energy storage products has evolved with a stronger focus on addressing production challenges and strategic dependencies. In 2023, Tesla highlighted the risks of supplier limitations, production bottlenecks, and the need for localized procurement as key challenges in scaling energy storage production. By 2024, the company emphasized efforts to enhance manufacturing capabilities, including the development of proprietary battery cells and modular designs to optimize production capacity. Additionally, Tesla has expanded its workforce training programs and localized manufacturing strategies to support the growth of energy storage products, aiming to reduce reliance on external suppliers and improve cost efficiency.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in the qualitative evolution of Tesla's approach from 2023 to 2024. (1) What was correct: The general theme of increasing focus on production challenges and strategic dependencies is accurate, and the mention of modular design and manufacturing optimization aligns with the ground truth. The emphasis on reducing reliance on external suppliers and improving cost efficiency is contextually relevant. (2) Quantitative accuracy: There are no numeric values in either answer, so this dimension is neutral; no errors present. (3) Multi-hop reasoning assessment: The LLM incorrectly reverses the timeline of emphasis. Ground truth states that in 2023, Tesla emphasized modular design and in-house expertise, while in 2024 it shifted to addressing production ramps and supply chain dependencies. The LLM claims that in 2023, Tesla already highlighted supplier limitations and bottlenecks—this is actually the 2024 focus per the original. Thus, the reasoning misattributes the timing of strategic priorities. Additionally, the LLM introduces details not present in the ground truth, such as 'proprietary battery cells' and 'workforce training programs,' which were not cited as part of the evolution in the knowledge graph. (4) Justification for scores: Correctness is 6 due to core thematic alignment but significant factual misplacement of key strategic focuses across years and introduction of unsupported details. Qualitative accuracy is 6 for similar reasons—core ideas about scaling and supply chains are relevant but misaligned in time and detail. Quantitative accuracy is 10 by default (no numbers). Contextual relevance is 9 because the answer stays on topic and addresses the spirit of the question, despite factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 487,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolved from 2023 to 2024 by reducing the principal amount and shortening the maturity structure. In 2023, the company issued $600 million of floating rate debentures due in 2026, while in 2024, no new floating rate debentures were issued, indicating a strategic shift away from floating rate instruments during that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that $600 million in floating rate debentures were issued in 2023 due in 2026, it incorrectly claims that no new debentures were issued in 2024 and that there was a strategic shift away from floating rate instruments. The ground truth states that in 2024, the company formalized the issuance via an Officer's Certificate dated January 31, 2024, for debentures due January 29, 2026—indicating continuation, not cessation or reduction. The LLM incorrectly infers a reduction in principal and shortening of maturity, neither of which is supported. (2) Quantitatively, the $600 million figure is correct, and the 2026 maturity is accurate, but the claim of 'no new issuance' in 2024 contradicts the formalization of the series in that year. No calculation errors, but misrepresentation of issuance activity. (3) The multi-hop reasoning fails: the model does not correctly synthesize the 2023 disclosure with the 2024 formalization; instead, it interprets lack of a new principal amount as evidence of discontinuation, when the ground truth indicates continuity. (4) Scores are low due to major factual errors in strategy evolution—directionally wrong conclusion. Contextual relevance is moderate because it addresses the right company, instrument, and time frame, but with incorrect interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 387,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "From 2023 to 2024, Intel expanded its collaboration focus and supplier engagement scope in supply chain responsibility initiatives. In 2023, the company emphasized verifying compliance with critical direct suppliers, engaging in audits, and building sustainability capacity through capability-building programs. By 2024, Intel significantly broadened its supplier engagement, aiming to cover more suppliers to meet RISE goals, including measuring and reducing greenhouse gas emissions across the supply chain. Additionally, the company intensified efforts on responsible minerals sourcing and supplier diversity, setting spending targets with women-owned and minority-owned suppliers to reach $2.0 billion in annual spending by 2030.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. While it correctly identifies Intel's focus on sustainability and capability-building programs, it misrepresents the evolution from 2023 to 2024. The ground truth states that in 2023, Intel announced an expansion of supplier engagement under the RISE strategy with a net-zero upstream Scope 3 emissions goal by 2050. However, the LLM incorrectly claims that in 2024, Intel 'significantly broadened its supplier engagement, aiming to cover more suppliers'—this contradicts the ground truth, which explicitly notes that by 2024, there was no explicit mention of expanding the number of suppliers engaged, indicating a shift from expansion to deepening existing partnerships. Additionally, the LLM introduces a new claim about supplier diversity with a $2.0 billion spending target by 2030, which is not present in the original answer and cannot be verified from the provided ground truth. (2) Quantitative inaccuracy: The $2.0 billion annual spending target by 2030 is not mentioned in the ground truth and appears to be fabricated or misattributed. No other numbers (e.g., 2050 net-zero goal) are mentioned in the LLM response, despite being key facts in the original answer. (3) Multi-hop reasoning is partially sound—the model attempts to compare 2023 and 2024 initiatives and identifies relevant themes like responsible minerals and emissions—but it fails to accurately represent the strategic shift: from announcing expansions (2023) to reinforcing collaborations (2024). The reasoning is flawed by introducing unverified goals. (4) Correctness score is low due to significant factual errors and introduction of unsupported data. Quantitative accuracy is poor due to the incorrect $2B figure and omission of the 2050 target. Qualitative accuracy is moderate because some themes align (sustainability, minerals), but the synthesis is incorrect. Contextual relevance is high as the answer stays on topic and addresses collaboration and supplier engagement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 543,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "Between 2022 and 2023, XOM's framing of its dependency on first-day-of-the-month average prices in the standardized measure of discounted future cash flows remained consistent in acknowledging that these prices represent discrete points in time and may cause significant variability in cash flows from year to year as prices change. However, in 2023, the company emphasized a more pronounced decline in future cash inflows from sales of oil and gas, particularly in Asia and the United States, which could reflect a more conservative or realistic assessment of market conditions and price volatility. This suggests a potential shift toward a more cautious outlook on price stability and its impact on future cash flows.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about the evolution of XOM's disclosure. The ground truth states that the key change between 2022 and 2023 was a shift in framing—from describing the standardized measure as being 'prepared on the basis of' prescribed assumptions to stating it 'depends on' them, reflecting a more explicit acknowledgment of sensitivity. The LLM instead invents a narrative about a 'pronounced decline in future cash inflows' in Asia and the U.S. and a 'more conservative or realistic assessment,' which is not supported by the original answer and misrepresents the actual change in disclosure tone. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations were made, hence a score of 10. (3) The multi-hop reasoning is flawed: the question requires comparing the qualitative framing of assumptions in two years' disclosures, specifically regarding dependency on first-day-of-the-month prices. The LLM fails this synthesis, introducing unsupported claims about regional cash flow declines and market outlooks not present in the ground truth. (4) Contextual relevance is moderate because the answer discusses the right topic (standardized measure, first-day prices, variability) and mentions the correct company and years, but it fabricates key details about the nature of the change in disclosure, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 414,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, Mastercard's digital identity solutions evolved significantly, particularly in integration with open banking capabilities. In 2023, Mastercard expanded its open banking platform to provide connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks in Europe, enabling seamless and secure consumer bill payments through ACH solutions. Additionally, digital identity solutions were enhanced with capabilities such as device intelligence, behavioral biometrics, document proofing, and IP intelligence, all designed to strengthen and secure digital payments across individuals, devices, and accounts. These advancements reflect a stronger, more secure, and broader-reaching digital identity framework integrated with open banking.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution of MA's digital identity solutions between 2022 and 2023, with accurate details on open banking integration and reach. It correctly states that in 2023, MA achieved connectivity to over 95% of U.S. deposit accounts and approximately 3,000 banks in Europe—matching the ground truth exactly. However, the original answer emphasizes that the 2022 launch was the introduction of digital identity within an open banking platform focused on permissioned data access, consumer protection, and consent management—context that the LLM answer omits. While the LLM mentions enhanced capabilities like device intelligence and behavioral biometrics, these specific features are not present in the ground truth and may represent plausible but unverified additions. (2) Quantitative accuracy is perfect: 'over 95%' and 'approximately 3,000 banks' match the original. No calculations were required. (3) The multi-hop reasoning is mostly sound—linking 2023 expansion to broader reach and integration with ACH payments—but the LLM does not explicitly mention the partnership with financial institutions to launch the ACH solution, a key point in the original. Instead, it generalizes the outcome as enabling 'seamless and secure consumer bill payments,' which captures the intent but lacks specificity. (4) Scores reflect high factual accuracy and relevance, with minor deductions for missing 2022 context and introduction of unverified feature details, slightly affecting qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 431,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Solar Roof product has shown a shift in addressing production challenges and strategic dependencies. In 2023, the company acknowledged ongoing production ramp difficulties, including supplier issues and manufacturing bottlenecks, which delayed scaling. By 2024, Tesla emphasized efforts to improve installation capabilities and efficiency, including collaborations with real estate developers and builders, suggesting a strategic pivot toward expanding market reach and operational scalability. Additionally, the 2024 filing highlights a stronger focus on localized procurement and supply chain optimization, indicating a more matured and integrated approach to managing dependencies for Solar Roof production.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it is scored as 10. The contextual relevance is moderate: the response addresses production challenges and strategic dependencies related to Tesla's Solar Roof, which aligns with the question. However, the qualitative accuracy is low because the LLM misrepresents key facts from the ground truth. In 2023, the original answer states Tesla emphasized the *maturity* of Solar Roof’s design and aesthetics, not ongoing production difficulties—this is a critical reversal of meaning. The LLM incorrectly claims Tesla acknowledged production ramp issues in 2023, while the truth is that such delays were explicitly noted in the *2024* filing. Furthermore, the LLM introduces unverified details not present in the ground truth, such as 'collaborations with real estate developers,' 'localized procurement,' and 'supply chain optimization,' which are not mentioned in the original answer. The ground truth highlights a strategic prioritization shift due to dependence on mass-market vehicle production, implying potential deprioritization of Solar Roof—but the LLM instead suggests a proactive expansion strategy, which contradicts the original implication. Thus, while the answer is plausibly framed, it fails on core factual accuracy and multi-hop reasoning, particularly in correctly attributing statements to the right year and accurately representing Tesla’s evolving stance. The reasoning is internally logical but based on incorrect premises, leading to a correctness score of 4 due to partial recognition of production challenges but significant factual and directional errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 463,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024 with the addition of new agreements. In 2023, a Pledge Agreement dated as of September 1, 2022, was in place between NextEra Energy, Inc., Deutsche Bank Trust Company Americas, and The Bank of New York Mellon. By 2024, a new Pledge Agreement dated as of June 1, 2024, was added under the same parties, indicating an ongoing and expanded use of such agreements with updated dates.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2023 Pledge Agreement dated September 1, 2022, and the counterparties Deutsche Bank Trust Company Americas and The Bank of New York Mellon. It also correctly notes the addition of a new agreement in 2024 dated June 1, 2024, with the same parties. However, it omits the second 2024 Pledge Agreement dated October 1, 2024, which is included in the ground truth. This is a significant but not critical omission, as the core evolution (expansion of agreements) is still captured. (2) All dates and entities mentioned are factually accurate. The LLM correctly reports the September 1, 2022, and June 1, 2024, dates and the correct counterparties. The missing October 1, 2024, date reduces quantitative completeness. (3) The reasoning is sound: the LLM correctly infers that the addition of a new agreement indicates expanded use over time, which aligns with the ground truth's conclusion about evolving structure and timing. However, the failure to mention both 2024 agreements limits the depth of multi-hop synthesis. (4) Scores reflect high accuracy in facts and reasoning, with a moderate deduction for incompleteness in covering all disclosed agreements. Contextual relevance is perfect as the response directly addresses the evolution in dates and counterparties as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 369,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "From 2023 to 2024, Intel strengthened its strategic positioning in Edge AI by enhancing its software platform offerings and expanding ecosystem partnerships. Intel introduced edge-native software platforms that enable developers to build, deploy, and manage distributed edge infrastructure and applications, supporting verticals such as industrials, healthcare, and smart cities. Additionally, Intel deepened collaborations with ecosystem partners like Ericsson, Nokia, Cisco, Dell Technologies, HPE, Lenovo, Amazon, Google, and Microsoft to drive the software-defined transformation of edge infrastructure and accelerate AI-driven automation. These efforts reflect Intel's focus on delivering flexible, programmable, and secure solutions to support the growing demand for intelligent edge computing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Intel's Edge AI strategy from 2023 to 2024 with accurate qualitative details. It correctly identifies Intel's edge-native software platform in 2023, emphasizing developer enablement and support for distributed edge infrastructure across verticals. The mention of ecosystem partners (Ericsson, Nokia, Cisco, Dell, HPE, Lenovo, Amazon, Google, Microsoft) aligns with the ground truth and reflects accurate entity identification. The shift toward software-defined, programmable edge infrastructure in 2024 is also accurately conveyed. However, the LLM omits specific reference to Intel's NEX initiative, which is a key strategic driver in 2024 according to the original answer, and does not explicitly mention the transformation from fixed-function hardware to cloud-native, general-purpose compute on programmable hardware—a central technical shift. While the concept of 'flexible, programmable, secure solutions' is mentioned, the deeper technical and architectural implications of cloud-native software on programmable hardware are under-articulated. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated), and the answer remains contextually highly relevant. The reasoning is sound but lacks full depth in synthesizing the multi-hop evolution from modular software platforms in 2023 to the NEX-driven, cloud-native paradigm in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 398,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The composition and value of CVS's long-term debt related to the 1.75% senior notes due August 2030 remained unchanged between 2023 and 2024, with both years reporting $1,250 million in principal amounts for these notes. There were no new issuances, redemptions, or modifications to this specific debt instrument during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.75% senior notes due August 2030 had a value of $1,250 million in both 2023 and 2024, which matches the ground truth exactly. There are no errors in numbers, dates, or percentages. (2) All numeric values are accurate: $1,250 million in both years for the 1.75% notes, and the absence of changes (no issuances, redemptions, or modifications) is consistent with the stability reported in the original answer. (3) The multi-hop reasoning is sound—while the original answer includes additional context about other senior notes (e.g., 3.75% due April 2030), the LLM focuses specifically on the 1.75% notes as asked in the question, correctly synthesizing the lack of change over time. The omission of details about other 2030 notes is not a flaw because the question specifically asks about the 1.75% notes due August 2030. (4) The answer is semantically equivalent and highly relevant, with excellent quantitative accuracy. It loses one point in qualitative accuracy only because it does not acknowledge the broader context of other senior notes due in 2030, which was part of the original answer’s comparative framing, though this was not strictly required to answer the specific question posed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 351,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Between 2023 and 2024, Netflix's ad-supported subscription plan evolved from being a newly introduced, lower-priced option to a more integrated component of its pricing strategy aimed at broadening accessibility and driving membership growth. In 2023, the plan was highlighted as a new addition to cater to a wider range of consumer needs and pricing preferences. By 2024, it was positioned as part of Netflix's core strategy to offer diverse pricing plans, reflecting its role in attracting new members and enhancing affordability, particularly in competitive and price-sensitive markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix introduced the ad-supported plan in 2023 as a lower-priced option to expand membership and address competition, and by 2024 it became a core part of the pricing strategy. There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2023, 2024), which are accurate. (2) The answer is complete, addressing both the 2023 introduction and the 2024 strategic integration of the plan, as well as its role in pricing strategy and membership growth. (3) Multi-hop reasoning is sound: the model correctly synthesizes the evolution of the plan over time and its strategic significance, moving from an experimental offering to a key growth lever. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'broadening accessibility' vs 'expanding its membership base'), but the meaning is preserved. The only minor gap is that the LLM does not explicitly mention 'value perception' or 'long-term growth framework' from the original, which slightly reduces qualitative accuracy, but the core strategic shift is clearly conveyed. Contextual relevance is perfect—directly addresses the question with appropriate focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 366,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Based on the provided information, Tesla's approach to the Tesla Semi evolved between 2023 and 2024, shifting from early production and delivery efforts in 2023 to entering a phase of pilot production in 2024. In 2023, Tesla began early production and deliveries of the Tesla Semi, indicating initial steps toward commercialization. By 2024, the Semi's status was listed as \"Pilot production,\" suggesting a more structured and scaled production approach, likely involving testing, optimization, and preparation for broader market deployment. This evolution reflects Tesla's strategic focus on expanding its product lineup and leveraging its manufacturing and technological capabilities to enter the commercial vehicle market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Tesla began 'early production and deliveries' in 2023 and advanced to 'pilot production' in 2024 at its Nevada facility. The LLM correctly captures this progression. (2) There are no numeric values requiring calculation, but the years (2023 and 2024) are correctly referenced and contextualized. (3) The multi-hop reasoning is sound—LLM synthesizes the change in production status across two years and infers the strategic implication (scaling toward broader deployment). The only minor omission is the specific mention of the 'Nevada facility,' which is present in the original answer but not in the LLM response. This does not materially affect the overall correctness. (4) The LLM conveys the same semantic meaning as the original, using slightly different phrasing (e.g., 'structured and scaled production approach' vs. 'more structured and expanded phase'). The strategic positioning is accurately interpreted as part of Tesla's expansion into the commercial vehicle market. Thus, the answer is factually complete and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for the missing facility detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 352,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggests a deliberate and strategic focus on securing leadership continuity and reinforcing the company's commitment to retaining key executive talent. By extending and adding new agreements for executives such as Brian Bolster in 2024, the company emphasizes the importance of stabilizing its leadership team to support long-term strategic goals, particularly in a competitive and evolving energy sector. This reflects a proactive approach to talent management and organizational stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic implication of NextEra Energy's expansion of Executive Retention Employment Agreements from 2023 to 2024, emphasizing leadership continuity and executive talent retention. It accurately references the addition of Brian Bolster in 2024, which aligns with the ground truth. However, it omits specific details about the 2023 agreements with Mark Lemasney (January 1, 2023) and Armando Pimentel, Jr. (February 15, 2023), which were part of the original answer and provide important context for the expansion. (2) Quantitatively, the LLM does not introduce any incorrect dates or numbers. It correctly identifies the 2024 agreement with Brian Bolster (dated May 6, 2024 in ground truth, though the exact date is not mentioned in the LLM response). The absence of exact dates for the 2023 agreements is a minor omission but does not constitute inaccuracy. (3) The multi-hop reasoning is sound: the model correctly infers that adding new executives to retention agreements indicates a growing strategic emphasis on talent retention and leadership stability. It synthesizes the implication across years, though with less specificity than the original. (4) The answer is contextually excellent—directly relevant, well-articulated, and focused on the strategic meaning of the expansion. The correctness score is 8 due to accurate core facts and reasoning but partial omission of supporting 2023 executive names and dates, which reduces completeness. Quantitative accuracy is high (9) because no numbers are wrong, only incompletely specified. Qualitative accuracy is 8 due to correct logic and interpretation but slightly less granular entity coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 465,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "Intel's approach to xPU products from 2023 to 2024 has evolved with a stronger strategic focus on product competitiveness and diversification to meet the growing demand for specialized computing architectures. In 2024, the company emphasized the x86 ecosystem while expanding its xPU portfolio to include client and data center GPUs, IPUs, FPGAs, and other accelerators, recognizing that different workloads require different computing architectures. Additionally, Intel has prioritized AI integration across its xPU offerings, aiming to address the entire AI continuum from large language models to edge computing. This reflects a broader commitment to delivering open platforms and leveraging its manufacturing capabilities to support a wide range of customer needs in an increasingly competitive semiconductor landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's xPU strategy from 2023 to 2024 with accurate qualitative details. It correctly identifies the expansion of the xPU portfolio to include GPUs, IPUs, FPGAs, and accelerators, and notes the emphasis on the x86 ecosystem and product diversification. However, it omits the specific $16.0 billion R&D expenditure in 2023 mentioned in the ground truth, which is a factual detail that adds quantitative context to the strategic shift. Also missing is the mention of the advisory group formed in 2024 to expand the x86 ecosystem, which is a concrete action indicating strategic evolution. (2) There are no numerical inaccuracies—the LLM does not introduce any incorrect figures, and while it omits the $16.0 billion R&D number, it does not contradict it. Thus, quantitative accuracy is high. (3) The multi-hop reasoning is sound: the model synthesizes the shift from broad R&D focus to structured product development, links xPU expansion to workload-specific computing needs, and connects AI integration across the product line. The logic aligns with the ground truth, though it adds emphasis on 'AI integration' and 'open platforms' not explicitly detailed in the original, which may reflect inference beyond the source. (4) The answer is contextually relevant and addresses the question about strategic focus and product development priorities. The omission of the R&D dollar amount and the advisory group slightly reduces completeness and factual richness, but the core evolution in strategy is accurately conveyed. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 452,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Between 2023 and 2024, Netflix's approach to advertising technology has evolved with a focus on developing the necessary infrastructure and organizational capabilities to support its advertising initiatives. In 2023, the company highlighted the nascent nature of its advertising offering and the risks associated with building the technology and related infrastructure to support advertising and drive value for advertisers. By 2024, the emphasis shifted to the importance of expanding an advertising sales and technology organization, as well as improving analytics and measurement tools to demonstrate the value of ads to marketers. This indicates a strategic investment in both organizational development and technological infrastructure to scale and refine its advertising capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Netflix's 2023 stance emphasized the nascent stage of its advertising efforts and risks in building ad tech infrastructure, while in 2024 the company shifted toward internal development of both organizational and technological capabilities. The LLM correctly captures this evolution. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes Netflix's changing strategy across two years, correctly identifying the shift from reliance on third parties (implied in 'nascent' and 'risks') to proactive internal development of sales teams and tech infrastructure. The mention of 'improving analytics and measurement tools' is a slight expansion not explicitly in the original answer but is contextually reasonable and consistent with 'drive value to advertisers.' (4) The answer is fully relevant to the question about organizational development and infrastructure investment. The only minor gap is that the original answer explicitly mentions 'third-party service providers' as a 2023 dependency, which the LLM omits, but the concept is implicitly covered through 'nascent nature' and 'risks.' Overall, the semantic meaning and strategic trajectory are correctly conveyed, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 411,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Between 2023 and 2024, Tesla's free Supercharging programs remained a bundled feature recognized as part of automotive sales revenue, with no material changes in program structure. Revenue recognition continued to follow the same method, with free Supercharging recognized over time on a straight-line basis following vehicle delivery. However, in 2024, Tesla expanded its paid Supercharging revenue, contributing to higher services and other revenue growth. The deferred revenue related to these bundled services increased slightly, indicating continued customer uptake of these features. No new structural changes to free Supercharging were disclosed in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim that there were no material changes to Tesla's free Supercharging program structure between 2023 and 2024. The ground truth states that Tesla shifted from recognizing free Supercharging revenue as part of Automotive Sales Revenue to deferring it and recognizing it over time as a liability, which represents a significant structural and accounting change. The LLM incorrectly asserts that 'no material changes' occurred and that revenue recognition followed the same method, directly contradicting the ground truth. While the mention of deferred revenue increasing slightly and paid Supercharging contributing to services revenue may be contextually plausible, it does not align with the specific evolution in accounting treatment for free Supercharging. The answer fails to identify the key multi-hop insight: the shift in revenue recognition policy reflects a formalized segmentation of features like free Supercharging, FSD, and connectivity. This fundamental misrepresentation of the program’s evolution severely undermines factual accuracy. There are no explicit numbers in the response to verify quantitatively, but the qualitative reasoning is flawed due to incorrect synthesis of the accounting policy change. Contextual relevance is moderate because the answer discusses related topics (revenue recognition, deferred revenue, Supercharging), but misses the central point of structural evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 400,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "Between 2023 and 2024, NextEra Energy's approach to issuing Series O Junior Subordinated Debentures shifted from offering fixed-rate debentures with maturities extending to 2079 to introducing a broader range of fixed-rate debentures with shorter maturities (e.g., 2025–2055) and also incorporating floating-rate instruments. In 2023, the Series O debentures had long-term maturities and fixed coupon rates, while in 2024, the company diversified its offerings, including shorter-term maturities and varying coupon structures. This shift suggests a more flexible and potentially cost-conscious financing strategy, allowing NextEra Energy to adapt to changing market conditions and optimize its capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, NextEra Energy issued Series O Junior Subordinated Debentures due May 1, 2079, with no explicit coupon rate disclosed. In 2024, they issued Series O Debentures with a 5.55% coupon and a maturity date of November 1, 2029. The LLM incorrectly states that in 2023 the debentures had fixed coupon rates (no rate was disclosed), and falsely claims that in 2024 the company issued instruments with maturities ranging to 2055 and included floating-rate instruments—none of which is supported by the ground truth. The actual 2024 issuance had a single defined maturity (Nov 1, 2029) and a fixed 5.55% coupon. (2) Quantitative accuracy is very low: the LLM invents maturity ranges (2025–2055), introduces non-existent floating-rate instruments, and misrepresents the coupon structure in both years. The only partially correct element is the general direction of shorter maturities, but even this is misrepresented with incorrect dates. (3) The multi-hop reasoning is flawed—the LLM fails to correctly synthesize the specific evolution of the Series O debentures and instead fabricates a broader product diversification that is not in the original data. The conclusion about a 'flexible, cost-conscious strategy' is plausible but based on incorrect premises. (4) Scores are justified as follows: correctness is low (3/10) due to major factual errors; quantitative accuracy is poor (2/10) due to invented numbers and structures; qualitative accuracy is low (3/10) due to incorrect entity attributes and reasoning; contextual relevance is moderate (6/10) because the answer addresses the general topic and attempts strategic interpretation, albeit on false foundations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 481,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "From 2022 to 2023, ExxonMobil's impairment assessment framework incorporated OPEC investment activities as a factor influencing long-term oil supply dynamics. In both years, the Corporation emphasized that long-term oil prices are driven by supply and demand fundamentals, with OPEC's production policies and investment decisions playing a key role in shaping global oil supply. However, in 2023, the discussion expanded to include more explicit consideration of OPEC's impact on world oil supplies within the broader context of the Corporation's Global Outlook and Corporate Plan. This reflects a more integrated approach to evaluating how OPEC's actions could affect future cash flows and asset recoverability, particularly in light of evolving geopolitical and market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in several key aspects: it correctly identifies that ExxonMobil considered OPEC's investment activities and production policies as influencing global oil supply in both 2022 and 2023, and notes a shift toward a more integrated assessment framework in 2023. The dates (2022 to 2023) and entities (ExxonMobil, OPEC) are accurate, and there are no numerical inaccuracies (quantitative accuracy is 10). However, the LLM answer diverges in emphasis from the original. While the ground truth highlights a shift from direct focus on OPEC to a broader framework incorporating environmental factors like greenhouse gas emission costs and net-zero targets, the LLM instead emphasizes expansion within the 'Global Outlook and Corporate Plan' and geopolitical conditions—missing the specific integration of environmental and decarbonization variables that define the 2023 evolution. This omission reduces qualitative accuracy, as the multi-hop synthesis is partially correct but lacks the key nuance of environmental cost integration that marks the real shift in ExxonMobil's impairment framework. Contextually, the answer remains highly relevant and addresses the evolution in framing OPEC's role, but does not fully capture the transformation toward sustainability-linked valuation drivers. Hence, correctness is scored 7 for core accuracy with notable contextual omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 392,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "Netflix's approach to its ad-supported subscription plan shows increased strategic emphasis in the 2024 filing compared to 2023. In the 2023 filing, the ad-supported plan is mentioned in the context of pricing strategies and new revenue streams, with a focus on the challenges of predicting consumer adoption and the inherent risks of new offerings. By 2024, the ad-supported plan is explicitly included in the core business strategy, highlighting its role in meeting diverse consumer needs and driving membership growth. This shift reflects a more integrated and confident positioning of the ad-supported plan within Netflix's broader business model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2023 filing discusses the ad-supported plan in the context of uncertainty, risk, and challenges in forecasting consumer adoption, while the 2024 filing presents it as a core part of the pricing strategy aimed at meeting diverse consumer needs. The LLM correctly captures this evolution from risk-focused to strategically integrated. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings and correctly infers a strategic shift in tone and positioning. The only minor difference from the original answer is that the LLM uses 'new revenue streams' in 2023, which is slightly more positive than the original's emphasis on 'uncertainty and risk,' but still contextually valid. (4) The answer is fully relevant, directly addressing the evolution in level of detail and strategic emphasis. The wording differs slightly but maintains semantic equivalence. No major omissions or inaccuracies—just a slightly less precise characterization of the 2023 tone, warranting a 9 instead of 10 on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 357,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon's approach to shipping offers between 2022 and 2024 has evolved to balance cost management with strategic focus on fulfillment efficiency. In 2022, shipping costs were significantly impacted by fulfillment network inefficiencies, increased wage rates, and supply chain constraints, leading to higher expenses. By 2024, Amazon had made progress in optimizing its fulfillment network, achieving lower transportation costs and improving operational efficiencies, which helped reduce the percentage of cost of sales attributed to shipping. Despite these improvements, the company continues to invest in its fulfillment infrastructure to support faster delivery and expanded services, recognizing the importance of shipping offers in driving customer satisfaction and sales growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. While it correctly identifies Amazon and the 2022–2024 timeframe, it misrepresents key cost drivers. The original answer states that in 2022, shipping cost increases were driven by customer adoption of shipping offers, faster delivery methods, and network expansion—not 'fulfillment network inefficiencies, increased wage rates, and supply chain constraints,' which are not mentioned in the ground truth for that year. Additionally, the LLM introduces the idea of 'reducing the percentage of cost of sales attributed to shipping' in 2024, which is unsupported by the original answer; the ground truth notes that fulfillment costs increased due to sales and investments but were partially offset by efficiency gains—no mention of cost-of-sales percentages. (2) There are no specific numbers in the LLM answer, whereas the original answer includes a precise figure: $76.7 billion in shipping costs for 2021 and an expectation of continued growth. The absence of this key quantitative data significantly reduces quantitative accuracy. The LLM does not attempt any calculations, but the lack of cited figures from the source material is a major omission. (3) The multi-hop reasoning is partially sound—the model attempts to compare Amazon’s strategy across two years and identifies a shift toward efficiency. However, it fabricates specific cost drivers not present in the original and misses the core evolution: from anticipating cost increases due to customer behavior (2022) to emphasizing operational efficiencies as a counterbalance (2024). The strategic pivot from customer-driven cost pressures to operations-centric mitigation is underdeveloped in the LLM response. (4) Contextual relevance is high because the answer addresses shipping, cost drivers, and fulfillment efficiency over the specified period. However, correctness is limited by factual inaccuracies and invented details, warranting a mid-range score of 5 for overall correctness, 4 for quantitative accuracy (due to missing numbers), 6 for qualitative reasoning (some correct structure but flawed content), and 8 for relevance (on-topic and structured appropriately).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 598,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Between 2023 and 2024, Duke Energy's utilization and reporting of the Master Retirement Trust showed notable changes in asset allocation and disclosure practices. For the DELPP assets, the actual allocation for Global equity securities increased slightly from 14% in 2023 to 15% in 2024, while Debt securities remained stable at around 79%. There was a reduction in Hedge funds from 2% in 2023 to 0% in 2024, and an increase in Real estate and cash from 3% to 4%. \n\nIn terms of disclosure, Duke Energy provided more detailed fair value measurements in 2024, including a breakdown of assets by fair value hierarchy levels (Level 1, Level 2, Level 3, and Not Categorized). This enhanced transparency reflects a more comprehensive reporting approach compared to 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific numerical changes in asset allocation (e.g., Global equity from 14% to 15%, Debt at 79%, Hedge funds dropping from 2% to 0%), but these figures are not present in the original ground truth. The ground truth does not provide year-over-year percentage allocations for asset classes like Global equity or Debt securities, nor does it mention 'DELPP assets' specifically. Therefore, these numbers appear fabricated or misattributed, severely impacting quantitative accuracy. (2) The claim about fair value hierarchy disclosures (Level 1, 2, 3) aligns partially with the ground truth, which confirms that 2024 introduced Level 3 fair value disclosures and a reconciliation of pension asset balances — a key enhancement in transparency. This aspect is factually consistent and supports improved disclosure practices. (3) However, the LLM fails to mention the critical multi-hop detail in the original answer: the 2024 reporting included subsidiary-level allocations (e.g., Duke Energy Progress at 15%, Duke Energy Florida at 18%), which represents a structural evolution in reporting granularity. This omission significantly weakens the qualitative accuracy, as it misses a core component of how utilization and reporting evolved. (4) While the LLM correctly identifies a trend toward more detailed and transparent reporting, especially around fair value measurements, it substitutes unverified asset allocation numbers instead of reflecting the actual evolution described in the ground truth. The reasoning shows understanding of disclosure trends but lacks fidelity to the source data. Thus, the answer is partially correct in direction but flawed in specifics, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 472,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "Based on the information provided in the given pages, Google's financial relationship with Google Network Partners has evolved in terms of cost structure and payment obligations as follows:\n\n1. **Cost Structure**: The cost of revenues related to Google Network Partners is significantly higher compared to Google Search & other properties. This is primarily due to Traffic Acquisition Costs (TAC), which include payments to Google Network partners for ads displayed on their properties. The higher TAC reflects the fact that most of the advertiser revenues from ads served on Google Network properties are paid out as TAC to these partners.\n\n2. **Payment Obligations**: Google's payment obligations to Network Partners are driven by the amount of advertising revenue generated on their properties. As advertising revenues from Google Network properties increase, so do the TAC payments. The evolution of these obligations is influenced by factors such as changes in advertising quality, formats, delivery, and policy, as well as general economic conditions and advertiser competition for keywords. Additionally, the growth in advertising revenues from Google Network properties has been affected by changes in device mix, traffic growth in emerging markets, and seasonality.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core cost structure related to Google Network Partners, including the role of Traffic Acquisition Costs (TAC) and the fact that a large portion of advertiser revenue is paid out to partners, resulting in higher TAC compared to Google Search properties. This aligns with the ground truth and is factually accurate (quantitative accuracy = 10, as no specific numbers are misstated). However, the LLM fails to capture the key evolution between 2022 and 2024 as required by the question. The ground truth highlights a structural shift: in 2022, TAC was framed as a cost-of-revenue item, but by 2024, payments to Network Partners are described as a primary use of operating cash outflows, indicating a shift in financial classification and emphasis. The LLM answer does not mention this evolution in financial reporting or cash flow treatment—missing the central multi-hop insight. While it discusses factors influencing TAC, it does not tie these to a change in the nature of the financial relationship over time. Thus, while contextually relevant and factually sound on static elements, it lacks the temporal comparison and synthesis needed to fully answer the question, resulting in a correctness score of 6 for partial accuracy with significant omission of the evolving financial relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 369,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, the financial impact of offsetting swap positions, particularly in terms of fair value changes and settlements, showed a significant decline. In 2023, the total gain or loss recognized in income for derivative instruments not designated as hedges was a $7 million loss, compared to a $69 million loss in 2022. This indicates a reduction in the volatility or magnitude of fair value changes and settlements for non-hedging derivatives during 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that UPS reported fair value changes and settlements for derivatives not designated as hedges with data provided for 2021 and 2020 (e.g., $163M net gain in 2021, $124M net gain in 2020), but does not provide any specific figures for 2022 or 2023. In contrast, the LLM claims specific losses of $69M in 2022 and $7M in 2023, which are not supported by the original answer. These numbers are entirely fabricated or misattributed, making the quantitative foundation of the response false. (2) There is no verification of calculations because the numbers themselves are incorrect. The original answer does not quantify the 2022 or 2023 impacts, only noting a shift in disclosure focus and reduced transparency for 2023. The LLM’s assertion of a decline from $69M loss to $7M loss is unsupported. (3) The multi-hop reasoning is flawed. The original answer emphasizes a change in disclosure practice—shifting from older years (2020, 2021) to including 2022 and 2023—but does not state that actual financial impacts were quantified in the excerpt. The LLM incorrectly assumes that such data was available and interprets it as a trend, failing to recognize the key point about transparency reduction. (4) While the LLM addresses the general topic of derivative treatment and attempts to compare years, it misses the core insight about evolving disclosure practices and incorrectly invents financial figures. The contextual relevance is moderate because it discusses the right subject (non-hedge derivatives, fair value changes), but the factual inaccuracies severely undermine correctness. Quantitative accuracy is very low due to false numbers; qualitative accuracy is low due to flawed reasoning; contextual relevance is acceptable as the topic alignment exists.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 503,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures, compared to 2023, suggests a shift in the company's director compensation strategy toward emphasizing deferred compensation mechanisms. This could indicate a focus on aligning director incentives with long-term stock performance and enhancing retention by offering more opportunities for deferral of compensation into phantom investments, including Duke Energy Common Stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and captures the core shift in Duke Energy's director compensation strategy from 2023 to 2024. It correctly identifies the increased prominence of the Directors' Savings Plan as indicative of a strategic move toward deferred compensation and long-term incentive alignment. The answer accurately reflects that phantom investments—including in Duke Energy Common Stock—are part of the deferral mechanism, which aligns with the ground truth. While the LLM does not explicitly mention the 2023 exhibit references (e.g., Exhibit 10.12) or the lack of detailed description in 2023, it still correctly infers the comparative shift in emphasis. The reasoning is sound and the conclusion about enhanced deferral flexibility and long-term alignment is semantically equivalent to the ground truth. No numerical inaccuracies are present (quantitative accuracy is perfect), and all entities (Duke Energy, Directors' Savings Plan, 2023 vs 2024) are correctly identified. The only minor omission is the absence of specific citation details from the 2023 filing, which slightly reduces completeness but does not affect the overall correctness of the interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 332,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "Between 2022 and 2024, American Express has evolved its approach to developing value propositions by focusing on innovation in premium consumer offerings, digital integration, and expanding its commercial and B2B payment solutions to address competitive pressures and shifting customer behaviors. The company has emphasized enhancing rewards programs, leveraging data and technology to improve customer engagement, and expanding its digital ecosystem, including the Amex app and dining platform. Additionally, American Express has prioritized strategic partnerships and tailored services for younger demographics and small businesses, aiming to drive customer loyalty and spending in a highly competitive payments landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution in American Express's value proposition strategy between 2022 and 2024. It accurately reflects the shift toward innovation, digital integration, and responses to competitive pressures and changing customer behaviors. The mention of enhancing rewards programs, leveraging technology, expanding the digital ecosystem (including the Amex app and dining platforms), strategic partnerships, and targeting younger demographics and small businesses aligns well with the ground truth. However, it omits specific details present in the original answer, such as the explicit challenge in 2022 from alternative payment providers and digital wallets fragmenting spending, and the shift from a reactive to proactive stance. It also does not name specific platforms like Tock and Rooam or emphasize AI and automation investments and global merchant coverage growth mentioned in the 2024 strategy. These omissions reduce completeness and precision in the qualitative dimension, but no factual inaccuracies or numerical errors are present. Since there are no numeric values in the question or answer, quantitative accuracy is scored as 10 by default. The answer remains contextually relevant and semantically aligned with the key developments, warranting a high correctness score with minor deductions for missing granular details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 381,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Between 2022 and 2024, Exxon Mobil's long-term debt financing composition remained largely consistent, with the 0.524% Notes due 2028 (XOM28), 0.835% Notes due 2032 (XOM32), and 1.408% Notes due 2039 (XOM39A) continuing to be registered and publicly traded on the New York Stock Exchange. However, the 0.142% Notes due 2024 (XOM24B) listed in 2022 were no longer included in the 2024 filing, indicating their likely maturity and repayment by 2024. No new long-term notes were introduced during this period, suggesting a stable approach to long-term debt management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (0.142%, 0.524%, 0.835%, 1.408%) and maturity years (2024, 2028, 2032, 2039)—are correct and match the original answer. The observation that the 0.142% Notes due 2024 are no longer listed in 2024 is correctly interpreted as likely maturity/repayment, which is consistent with the ground truth. (2) Quantitative accuracy is perfect: all percentages and dates are correctly reported, and no incorrect figures are introduced. Format variations (e.g., ticker symbols like XOM24B) are acceptable and do not affect factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across 2022 and 2024 disclosures, identifies the removal of a specific note, and infers repayment upon maturity. It accurately notes the continuation of longer-term notes, supporting the conclusion of a stable, long-term financing strategy. The only minor shortcoming is that the LLM does not explicitly highlight the strategic evolution toward extended-term debt as strongly as the original answer, instead emphasizing 'stability' over 'strategic shift.' While this is a nuanced difference in framing, the factual basis for the evolution is still present. (4) The answer is fully contextually relevant, directly addressing the evolution in debt composition over the specified period. Overall, the response is factually excellent with only a slight softening of the strategic interpretation, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 430,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "Between 2022 and 2024, American Express has increasingly emphasized innovation and differentiation in its corporate card solutions. In 2022, the company focused on evolving card value propositions and differentiating corporate card and accounts payable expense management solutions. By 2024, this strategic emphasis expanded to include designing innovative products and features such as financing, banking, and payment solutions for business customers. Additionally, the company has worked to strengthen its global network and enhance merchant acceptance, further supporting its commercial payments offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities—American Express, 2022, 2024, corporate card solutions, commercial payments, global network, merchant acceptance—are correctly identified and contextually appropriate. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable; however, the years 2022 and 2024 are correctly used as reference points. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the evolution from 2022’s focus on internal product differentiation (value propositions, expense management) to 2024’s broader strategy involving global network expansion and enhanced offerings. The LLM captures the strategic shift but slightly underemphasizes the 'externally integrated ecosystem' aspect highlighted in the original answer, particularly around fraud protection and marketing insights, which are omitted. Instead, it mentions 'financing, banking, and payment solutions,' which are plausible extensions but not explicitly in the ground truth. (4) Despite this minor addition, the core factual content and semantic meaning match closely. The answer is contextually relevant, fully addressing both strategic emphasis and product differentiation over time. A score of 9 is justified due to high accuracy with only slight deviation in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 387,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Amazon's financial relationship with AWS Services has grown significantly between 2022 and 2024, with AWS contributing 16% of consolidated net sales in 2022 and increasing to 17% in 2024. AWS demonstrated strong year-over-year growth, with a 13% increase in 2022 and a 19% increase in 2024. In terms of cash flow generation, operating activities provided $84.9 billion in 2023 and increased to $115.9 billion in 2024, partly driven by AWS's growth and investments in technology infrastructure. The strategic emphasis on AWS is evident in the substantial capital expenditures, which rose from $48.1 billion in 2023 to $77.7 billion in 2024, primarily to support AWS business expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several correct elements but introduces unsupported data not present in the ground truth. The claim that AWS contributed 16% of consolidated net sales in 2022 and 17% in 2024 is not mentioned or verifiable from the original answer, making it factually unsupported. Similarly, the reported year-over-year growth rates of 13% in 2022 and 19% in 2024 are not present in the ground truth and cannot be verified. However, the cash flow figures of $84.9 billion in 2023 and $115.9 billion in 2024 are accurate and correctly attributed to operating cash flow, with AWS cited as a partial driver—this aligns with the original answer. The capital expenditure figures of $48.1 billion in 2023 and $77.7 billion in 2024 are not mentioned in the ground truth and thus represent hallucinated data, significantly impacting quantitative accuracy. (2) While the $84.9B and $115.9B cash flow numbers are correct and properly sequenced, other numeric claims lack corroboration. The ground truth does not provide AWS's percentage of net sales or its YoY growth rates, so including them reduces quantitative reliability. The calculation of growth trends is not required, but their inclusion as facts undermines accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that AWS is a growing financial contributor and links increased cash flow and capex to AWS expansion. It captures the strategic shift from risk to core revenue generator, though less explicitly than the original. However, the reasoning is weakened by the inclusion of fabricated metrics. (4) The answer is contextually relevant and addresses both cash flow generation and strategic emphasis, with a logical narrative about AWS's growing importance. Despite the incorrect numbers, the overall direction of the argument matches the ground truth. Hence, correctness is reduced primarily due to unsupported quantitative claims, but the core qualitative shift and key cash flow data are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 539,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Between 2023 and 2024, the scope and focus of trend analyses used in evaluating the historical consistency of regulatory asset balances expanded to include a more detailed comparison of recorded balances to independently developed expectations. In 2023, the trend analyses primarily assessed historical consistency based on management's explanations and regulatory developments. By 2024, the analyses were complemented by an independent expectation model to enhance the evaluation of reasonableness and ensure alignment with regulatory orders and amortization schedules.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about the evolution of trend analyses. The ground truth states that the change in focus was specifically the inclusion of asset retirement obligations (AROs) related to coal ash in the evaluation of regulatory recoverability. The LLM instead claims that the evolution involved the introduction of an 'independent expectation model' to compare balances against independently developed expectations—a detail not present in the original answer and unsupported by the provided truth. No numeric values are present in either answer, so quantitative accuracy is not applicable, but there are no incorrect numbers. (2) There are no calculations or numeric values to verify, so quantitative accuracy is neutral. (3) The multi-hop reasoning is flawed: the LLM invents a new audit procedure (independent expectation model) and omits the key shift toward coal ash-related AROs, which is the central point of the original answer. This indicates a failure to correctly synthesize or retrieve the actual change in scope. (4) While the answer is framed around the right topic—evolution of trend analyses in regulatory asset balances—it introduces hallucinated details and misses the specific regulatory compliance focus (coal ash AROs) that defines the 2024 change. Thus, despite being contextually relevant and using plausible audit terminology, it fails on factual correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 404,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Between 2022 and 2023, Costco increased the penetration of private-label items as part of its strategy to respond to cost and pricing pressures. In 2022, Costco mentioned increasing private-label items to adjust for inflation and cost increases. By 2023, the company continued this strategy, emphasizing adjustments to pricing and merchandise mix, including further increasing the penetration of private-label items to maintain competitive pricing and manage gross margins amid ongoing cost pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core evolution of Costco's strategy regarding private-label penetration between 2022 and 2023. It correctly identifies that in 2022, Costco responded to inflation and cost pressures by increasing private-label items, and that in 2023, the company continued and emphasized this strategy as part of managing pricing and gross margins. The dates and entities (Costco, private-label items, 2022–2023 timeframe) are correct. There are no numerical figures in the question or answer requiring quantitative verification, so quantitative accuracy is scored as 10. The qualitative reasoning is strong: it reflects the shift from a reactive (2022) to a more sustained strategic focus (2023), though it does not explicitly mention key tactics like absorbing costs or purchasing in larger volumes early, which were part of the 2022 strategy in the ground truth. This omission slightly reduces qualitative accuracy but does not undermine the central point about increasing private-label penetration. The answer remains semantically equivalent in intent and meaning, and fully addresses the question’s focus on strategic evolution. Contextual relevance is perfect—directly on topic and focused on the strategic shift in response to cost pressures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 358,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "The financial outlook for Paxlovid has significantly shifted between 2023 and 2024. In 2023, Paxlovid contributed $1,279 million in revenue, with deferred revenues related to Paxlovid and Comirnaty totaling $5.1 billion as of December 31, 2023. However, in 2024, Paxlovid's revenue increased to $5,716 million, and the deferred revenues for Paxlovid and Comirnaty dropped to $2.2 billion as of December 31, 2024. This decrease in deferred revenues was primarily due to the recognition of $2.9 billion in revenue from prior deferred amounts as Pfizer delivered products to customers and adjusted for returns and amended contracts. Additionally, the transition of Paxlovid to traditional commercial markets in the U.S. in late 2023 contributed to the increased revenue in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both facts and reasoning. The question asks about the evolution of the financial outlook for Paxlovid based on Pfizer's remaining performance obligations (RPOs), but the LLM confuses RPOs with deferred revenues and reported revenues. According to the ground truth, Pfizer did not disclose specific RPOs for Paxlovid in 2023, but reported approximately $1 billion in RPOs for Paxlovid as of December 31, 2024. The LLM instead cites deferred revenues for Paxlovid and Comirnaty combined ($5.1B in 2023, $2.2B in 2024) and Paxlovid's revenue ($1,279M in 2023, $5,716M in 2024), which are not the same as remaining performance obligations. These figures, while possibly accurate in another context, do not address the specific metric requested. (2) The numbers provided in the LLM answer are not supported by the ground truth and appear fabricated or misattributed. There is no mention of $1.279B or $5.716B in revenue for Paxlovid in the original answer, nor any breakdown of deferred revenue between Paxlovid and Comirnaty. The $2.9B recognized from deferred revenue is also not in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to connect the concept of remaining performance obligations to forward-looking contractual commitments, instead focusing on past revenue and deferred revenue recognition, which are backward-looking or mixed indicators. It also introduces Comirnaty, which is irrelevant to the question about Paxlovid. (4) The contextual relevance is moderate because the answer discusses Paxlovid's financial performance and Pfizer's disclosures, but it fundamentally misinterprets the key financial metric (RPOs vs. revenue/deferred revenue), leading to a factually incorrect and misleading conclusion about the evolution of financial outlook based on contractual obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 505,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "Between 2022 and 2024, American Express has maintained a consistent approach to using the Reasonable and Supportable (R&S) Period in estimating credit loss reserves, incorporating historical loss experience, current economic conditions, and future forecasts within the R&S Period. However, in 2024, the company emphasized a more refined methodology, including enhanced modeling of the probability of default and exposure at default, and a continued reliance on qualitative reserves to address model limitations and emerging trends. This evolution reflects a more dynamic and cautious approach to financial risk management, indicating a proactive stance in adapting to economic uncertainties and improving the accuracy of credit loss estimates.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in its characterization of the evolution of American Express's use of the Reasonable and Supportable (R&S) Period. (1) Quantitatively, the answer does not include specific reserve figures or dates beyond referencing the general timeframe, but it does not contradict the $3.3 billion reserve as of December 31, 2021, mentioned in the original answer. It correctly identifies the continued use of the R&S Period through 2024, which aligns with the ground truth. However, it introduces new elements not present in the original—such as 'enhanced modeling of probability of default and exposure at default' and 'continued reliance on qualitative reserves'—which are not supported by the provided ground truth and represent unverified elaborations. (2) The quantitative accuracy is acceptable because no incorrect numbers are stated; the absence of specific figures is not penalized heavily as the question does not explicitly demand them, though their inclusion would strengthen accuracy. (3) Qualitatively, the reasoning is flawed: the ground truth emphasizes a shift in presentation and institutionalization of the R&S Period—from being explicitly explained in 2022 to being embedded in a mature framework by 2024—whereas the LLM interprets this as a refinement in modeling methodology, implying technical advancement rather than procedural normalization. This misrepresents the core evolution described in the original answer. (4) Contextual relevance is high because the response stays focused on the R&S Period, credit loss estimation, and risk management implications. However, the synthesis fails the multi-hop requirement: it does not correctly connect the change in disclosure tone and integration level over time, instead inventing a narrative of methodological enhancement unsupported by the source. Thus, while semantically plausible, the answer substitutes inference for evidence, reducing factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 536,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon issued the 0.800% Note due 2025 as part of its debt financing strategy on June 3, 2020, indicating a focus on low-interest, long-term debt. Between 2022 and 2024, Amazon continued to manage its debt portfolio by issuing additional notes with varying maturities and interest rates, including higher-yield notes in later years, reflecting a diversification of debt instruments to optimize cost and maturity structure. The 0.800% Note due 2025 remains a component of Amazon's broader, well-diversified debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: the 0.800% Note due 2025 was issued on June 3, 2020, and Amazon continued referencing it through 2024 while introducing new debt instruments. The date and interest rate are accurately stated. (2) Quantitative elements—interest rate (0.800%), issuance date (June 3, 2020), and maturity year (2025)—are all correct. No calculations were required, but the temporal and numerical references match the original. (3) The multi-hop reasoning is sound: the answer synthesizes information across time (2020 issuance, 2022–2024 evolution) and infers a strategic shift toward diversification in debt instruments, consistent with the ground truth’s conclusion about managing interest rate risk and cash flow. (4) While the LLM does not explicitly name the 4.600% Note due 2025 (a specific example in the original), it correctly generalizes that Amazon introduced higher-yield notes, which captures the essence of the strategic evolution. This minor omission prevents a perfect 10 but does not undermine the overall correctness. The answer is highly relevant, directly addressing how Amazon's debt financing approach evolved with respect to the 0.800% Note due 2025.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 351,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The Twenty-third Supplemental Indenture, dated June 1, 1978, was disclosed in both the 2022 and 2024 SEC filings under Duke Energy Progress, Inc.'s historical indentures. However, no new activity or amendments related to this specific indenture were noted in the 2024 filing, indicating that it remains part of the historical record but is no longer actively referenced or modified. This suggests that the indenture is no longer relevant to current operations or outstanding obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but includes a critical factual error: it states that the Twenty-third Supplemental Indenture was disclosed in both the 2022 and 2024 filings, which contradicts the ground truth. According to the original answer, the Twenty-third Supplemental Indenture was explicitly mentioned in the 2022 filing (with specific reference to Exhibit 2(c), File No. 2-61611) but is entirely absent from the 2024 filing. The LLM incorrectly asserts continued disclosure in 2024, which undermines the accuracy of the response. While the date June 1, 1978, is correctly cited (quantitative accuracy is acceptable), the core multi-hop reasoning fails because the model does not recognize the omission in 2024 as a significant change. The conclusion about diminished relevance is directionally reasonable but based on flawed premises. The answer also fails to mention the shift in focus to more recent indentures like the Forty-ninth Supplemental Indenture dated March 14, 2024, which is a key indicator in the ground truth. Thus, while the answer addresses the question's intent and uses appropriate terminology, it lacks factual precision in entity disclosure across years, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 347,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "From 2022 to 2024, the total value of repurchased Class C Capital Stock was $52,868 million in 2023 and $50,192 million in 2024, showing a slight decrease in repurchase activity in 2024 compared to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It omits 2022 entirely and incorrectly reports only Class C repurchases for 2023 and 2024, whereas the ground truth states that Alphabet repurchased $59.3 billion (combined Class A and C) in 2022, $62.2 billion in 2023, and $62.0 billion in 2024. The LLM reports $52,868 million ($52.868 billion) for 2023 and $50,192 million ($50.192 billion) for 2024, which are both factually incorrect and do not match the ground truth values. (2) The numbers are quantitatively wrong: 2023 should be $62.2 billion, not $52.868 billion; 2024 should be $62.0 billion, not $50.192 billion; and 2022 is missing. Even if the LLM were reporting only Class C shares, the ground truth does not support such a breakdown, and the total repurchase amounts are still incorrect. (3) The multi-hop reasoning is flawed: the model fails to cover the full time range (2022–2024), incorrectly narrows the scope to only Class C (while the original answer combines A and C and does not isolate C), and misrepresents the trend. The conclusion of a 'slight decrease' in 2024 is based on wrong numbers—while 2024 did slightly decline from 2023 in ground truth, the magnitude is misrepresented. (4) The contextual relevance is moderate because it addresses repurchase trends over time and attempts a year-over-year comparison, but the incorrect figures and missing year severely undermine accuracy. The qualitative reasoning is partially sound in structure but built on false data, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 429,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "Between 2022 and 2024, the American Express Company Salary/Bonus Deferral Plan was amended as part of broader changes to retirement and compensation plans. In 2022, the Twelfth Amendment and Restatement of the Retirement Restoration Plan (effective January 1, 2023) was filed, which incorporated changes affecting related plans like the Salary/Bonus Deferral Plan. By 2024, the Salary/Bonus Deferral Plan was referenced in the context of updated incentive compensation structures, including the 2016 Incentive Compensation Plan, which was amended and restated effective May 6, 2024. These changes reflect ongoing adjustments to align deferral and incentive compensation practices with broader corporate policies and regulatory requirements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to accurately reflect the treatment and documentation changes of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings as per the ground truth. (1) The answer incorrectly focuses on amendments to the 'Retirement Restoration Plan' and the '2016 Incentive Compensation Plan' rather than the specific exhibit-level documentation of the Salary/Bonus Deferral Plan. The ground truth emphasizes exhibit renumbering and the addition of the 1997 amendments via Exhibit 10.16 in 2024, which the LLM answer completely misses. (2) Quantitatively, the LLM introduces incorrect dates and amendments: it references a 'Twelfth Amendment and Restatement' effective January 1, 2023, and a May 6, 2024 amendment to the 2016 Incentive Compensation Plan—neither of which are mentioned in the ground truth and both of which are unrelated to the Salary/Bonus Deferral Plan's documentation changes. There are no correct numerical or date-based facts from the ground truth in the LLM response. (3) The multi-hop reasoning is flawed: instead of tracking how the plan was referenced through specific exhibits (10.16, 10.17 in 2022; 10.13, 10.14, and new 10.16 in 2024), the model conflates it with unrelated plans and amendments, indicating a failure to synthesize the correct information across filings. (4) While the answer is framed around plan documentation changes, which is contextually relevant, the factual inaccuracies and misidentification of plans and exhibits severely undermine its validity. The core of the question—exhibit-level documentation evolution—is entirely missed, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 456,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Starbucks' exposure to interest rate swaps increased significantly between 2022 and 2024. In 2022, the derivative liability related to interest rate swaps was $34.0 million, classified under other long-term liabilities. By 2024, this liability had grown to $56.7 million, still classified under other long-term liabilities. Additionally, the carrying amount of the hedged item associated with interest rate swaps increased from $1,047.7 million in 2022 to $332.2 million in 2024, indicating a shift in the composition or maturity of the hedged debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Starbucks' interest rate swap liability decreased from $34.0 million in 2022 to $19.2 million in 2024, with an additional $41.4 million reported for 2023. However, the LLM incorrectly states that the liability increased to $56.7 million in 2024, which is factually wrong. The LLM also fabricates a 'carrying amount of the hedged item' increasing from $1,047.7 million to $332.2 million, which is not only inconsistent with the ground truth but logically flawed (332.2 is less than 1,047.7). (2) Quantitative accuracy is very low: the only correct number is the 2022 liability of $34.0 million. The 2024 liability is wrong ($56.7M vs actual $19.2M), and the hedged item values are both incorrect and illogical. There is no mention of the $41.4 million 2023 liability from the ground truth. (3) The multi-hop reasoning is flawed. The question asks about evolution in exposure, classification, and magnitude. The LLM correctly identifies the balance sheet classification ('other long-term liabilities') but fails to capture the shift or reduction in liability. Instead, it asserts an increase, which contradicts the ground truth. The synthesis across years is incorrect. (4) Contextual relevance is moderate because the answer addresses the right topic (interest rate swaps, balance sheet classification, liabilities) and time frame, but the core facts and direction of change are wrong, severely undermining the response. Correctness and quantitative accuracy are low due to major factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 441,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "The Directors' Savings Plan at Duke Energy has remained consistent in its core structure between 2022 and 2024, allowing outside directors to defer all or a portion of their annual compensation, primarily retainers. Deferred amounts are credited to an unfunded account and adjusted based on phantom investments, including the Duke Energy Common Stock Fund. This continuity suggests a stable approach to director compensation governance, emphasizing deferral mechanisms to align director interests with long-term shareholder value. The lack of material changes indicates Duke Energy's commitment to maintaining a predictable and transparent compensation structure for directors.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the plan's structure and deferral mechanisms, correctly identifying that deferred compensation is held in unfunded accounts and adjusted based on phantom investments, including the Duke Energy Common Stock Fund. There are no numeric inaccuracies (quantitative accuracy is perfect), and the entities (Duke Energy, Directors' Savings Plan, Common Stock Fund) and context (director compensation, deferral alignment with shareholders) are correctly referenced, supporting high contextual relevance.\n\nHowever, the LLM misrepresents the evolution of the plan between 2022 and 2024. The ground truth emphasizes a clear evolution: in 2022, the plan was formally introduced with a December 16, 2021 amendment, signaling active policy development. By 2024, the focus shifts to operational transparency, detailing how deferrals are invested and managed. This reflects a progression from establishment to refinement and disclosure. In contrast, the LLM claims the plan has 'remained consistent' and highlights 'lack of material changes,' which contradicts the ground truth's emphasis on policy documentation and increasing transparency. This mischaracterization of the timeline and intent undermines the qualitative accuracy, particularly the multi-hop reasoning required to assess change over time. While the conclusion about alignment with shareholder interests is reasonable, it is drawn from an incorrect premise of stability rather than evolution. Thus, the answer is partially correct but misses a key analytical point about governance development.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 440,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023, Costco's Kirkland Signature brand has evolved by increasing its sales penetration and reinforcing its position as a high-quality, cost-effective alternative to national brands. The 2022 filing highlights the brand's role in differentiating Costco's merchandise offerings and earning higher margins, with plans to further increase its presence. The 2023 filing does not explicitly mention new developments for Kirkland Signature but emphasizes broader business risks and strategies, suggesting continued focus on maintaining and expanding the brand's value proposition amid competitive pressures and economic uncertainties. The risk profile remains tied to supply chain challenges and maintaining quality standards, which are critical for sustaining the brand's reputation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of entity accuracy and timeline (2022 vs 2023), and correctly identifies Kirkland Signature's strategic importance, higher margins, quality, and cost-effectiveness. It accurately reflects that in 2022, Costco emphasized growth and differentiation through the brand. However, the LLM answer falls short in fully capturing the evolution of the risk profile as highlighted in the 2023 filing. While it mentions 'supply chain challenges' and 'economic uncertainties,' it does not explicitly note that the 2023 risk disclosures broadened to include foreign exchange fluctuations and catastrophic events as specific threats to private-label brands like Kirkland Signature—a key shift from 2022's more optimistic tone. Additionally, the LLM states that the 2023 filing 'does not explicitly mention new developments,' which downplays the significance of the expanded risk language, thus missing a core aspect of the multi-hop reasoning: the shift from growth-focused to risk-aware positioning. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers were misstated), and the answer remains contextually relevant throughout. The reasoning is sound but incomplete in synthesizing the contrast between the two years' risk disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 366,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 326 BCF at the end of 2022 to 296 BCF at the end of 2024. Key changes in 2023 included upward revisions of 9 BCF due to technical factors and downward revisions of 17 BCF due to development plan changes and lower prices. In 2024, there were minimal revisions, with only 9 BCF of upward adjustments. Additionally, purchases contributed 47 BCF in 2024, primarily from the acquisition of Marathon Oil. Extensions and discoveries in the region were minimal compared to other areas, with no major additions reported in Asia Pacific/Middle East equity affiliates during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It incorrectly states that COP's natural gas reserves increased from 326 BCF in 2022 to 296 BCF in 2024, when in fact the reserves decreased from 326 BCF to 296 BCF — a reduction of 30 BCF, not an increase. This fundamental misrepresentation invalidates the core of the response. (2) The quantitative inaccuracies are severe: the LLM fabricates detailed figures such as 'upward revisions of 9 BCF', 'downward revisions of 17 BCF', and 'purchases contributed 47 BCF in 2024' — none of which appear in the ground truth. The ground truth explicitly states there were 'no sales or significant reserve additions' in 2024, directly contradicting the claim of 47 BCF from Marathon Oil acquisition. Additionally, the mention of 'minimal revisions, with only 9 BCF of upward adjustments' in 2024 has no support in the original answer. (3) The multi-hop reasoning is flawed: while the LLM attempts to provide year-by-year breakdowns and sources of changes, it invents data rather than synthesizing correctly from the provided information. The original answer emphasizes a lack of significant activity or additions, especially in 2024, whereas the LLM suggests active acquisitions and revisions, which contradicts the source. (4) Despite these issues, the answer is contextually relevant — it addresses the right region (Asia Pacific/Middle East), the correct company (COP), and the right metric (natural gas reserves) over the correct time frame. It also correctly notes minimal extensions and discoveries, aligning with the original's emphasis. However, the severe numerical and directional (increase vs decrease) errors result in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 466,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx's strategic relationship with the Boeing 767F evolved with a focus on fleet modernization and replacement of older aircraft. As of May 31, 2022, FedEx owned 114 Boeing 767F aircraft, and its purchase commitments included 38 Boeing 767F aircraft scheduled for delivery through 2026. By May 31, 2024, FedEx had adjusted its commitments, with 14 Boeing 767F aircraft planned for delivery in 2025 and 3 more in 2026, totaling 17 aircraft. This shift reflects a continued emphasis on modernizing the fleet with more fuel-efficient aircraft, such as the Boeing 777F, while gradually phasing out older Boeing 767F models.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding fleet ownership and delivery commitments. The ground truth states that FedEx owned 114 Boeing 767F aircraft in 2022, which the LLM correctly reports. However, the LLM introduces specific delivery figures for 2025 and 2026 (14 in 2025, 3 in 2026, totaling 17) and claims a reduction from 38 prior commitments, which is not supported by the original answer. The original answer does not disclose any updated ownership numbers for 2024 or provide delivery schedules—these figures are fabricated or hallucinated. (2) The quantitative inaccuracies are severe: the original answer states 'no updated ownership figures were disclosed' for 2024, but the LLM confidently asserts revised delivery plans without source support. The claim of adjusting from 38 to 17 deliveries is a specific numerical error not present in the ground truth. (3) The reasoning is partially sound in identifying a modernization focus and fuel efficiency benefits, and correctly infers strategic importance of the B767F. However, it incorrectly frames the evolution as a 'phasing out' of 767Fs while introducing the Boeing 777F as a replacement, which is not mentioned in the original answer. The original emphasizes the 767F itself as central to modernization, not a model being phased out. This misrepresents the strategic direction. (4) Contextual relevance is high—the answer addresses fleet ownership and modernization as asked, and attempts multi-hop synthesis. However, the hallucinated numbers and incorrect interpretation of the 767F's role significantly undermine factual correctness. The qualitative reasoning is plausible but based on incorrect data, leading to a misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 479,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks' involvement with roasted coffee showed growth in inventory value, with roasted coffee inventory increasing from $310.3 million in 2022 to $329.3 million in 2024, as noted in the 10-K filings. In terms of production infrastructure, Starbucks maintained and expanded its roasting facilities, including locations in York, PA; Minden, NV; Kunshan, China; and Kent, WA, which are used for roasting, warehousing, and distribution. These facilities, mostly owned by Starbucks, indicate a continued investment in roasting capabilities to support global operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the 2024 roasted coffee inventory value, stating $329.3 million, which is not supported by the ground truth. The original answer only provides the 2022 inventory value ($310.3 million) and does not mention any 2024 inventory figure, so asserting an increase to $329.3 million is an unsupported addition. This undermines quantitative accuracy. (2) The infrastructure details are mostly correct: the facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA are accurately listed, and the description of their role in roasting and distribution aligns with the original. However, the LLM adds that these facilities are 'mostly owned' and mentions 'warehousing,' which are not in the original and, while plausible, are unverified expansions. (3) The multi-hop reasoning is partially sound—linking inventory and infrastructure changes over time is appropriate, and the inference of increased involvement in roasting is consistent with the original. However, the unsupported numerical claim about 2024 inventory weakens the reasoning chain. (4) The contextual relevance is high, as the answer directly addresses both inventory value and production infrastructure across the specified time frame. Despite the incorrect number, the overall direction of increased involvement is consistent with the ground truth. The qualitative accuracy is moderate due to correct entity identification and logical structure, but penalized for fabrication of data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 421,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "Based on the provided document pages, PepsiCo's utilization of the 2.750% Senior Notes due 2025 remained consistent between 2023 and 2024. In both years, the notes were referenced as part of PepsiCo's broader debt instruments, with no indication of new issuances, repayments, or structural changes specific to these notes during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its conclusion. While it correctly identifies that the 2.750% Senior Notes due 2025 were referenced in both years, it claims there was 'no indication of new issuances, repayments, or structural changes'—which contradicts the ground truth. The original answer reveals a strategic evolution: in 2023, the notes were authorized under board resolutions, and by 2024, PepsiCo not only retained them but also introduced a new 2.750% Senior Notes due 2030, indicating a deliberate extension of the same interest rate to a longer-term instrument. This reflects a meaningful shift in debt strategy that the LLM failed to recognize. (2) There are no numeric values to verify (e.g., dollar amounts), but dates (2023, 2024, 2025, 2030) and percentages (2.750%) are accurately referenced in both answers, so quantitative accuracy is high. (3) The multi-hop reasoning is flawed: the LLM did not synthesize the progression from authorization in 2023 to strategic extension in 2024 with the introduction of the 2030 note. It treated the continued listing as static, missing the qualitative evolution in PepsiCo's financing approach. (4) Correctness and qualitative accuracy are low due to the failure to capture the strategic development. Contextual relevance is moderate because the answer discusses the correct instruments and timeframe but misinterprets the significance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 392,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "FedEx's planned utilization of the B777F aircraft decreased from 2022 to 2024, with the number of planned deliveries dropping from 8 to 2. This reduction indicates a diminished strategic role for the B777F in the fleet, as FedEx shifted focus to other aircraft types like the B767F and Cessna SkyCourier 408 for modernization and operational efficiency.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025, and by 2024, the plan was revised to 2 in 2025 with no further plans. The LLM incorrectly claims that the number of planned deliveries dropped from 8 to 2, which is not supported by the original data—there is no mention of 8 aircraft in the ground truth. This major quantitative error undermines the factual basis of the response. (2) The calculation and comparison of numbers are incorrect: the LLM invents a starting figure (8) not present in the original answer, leading to a false narrative of reduction from 8 to 2. The actual change is a reduction from 4 planned in 2024 (as of 2022 plan) to only 2 in 2025 (as of 2024 plan), with no indication of deliveries but rather operations. (3) The reasoning is partially sound in interpreting reduced numbers as a sign of diminished strategic role, which aligns with the ground truth’s conclusion about phase-out and reduced emphasis. However, the LLM adds unsupported details about shifting focus to B767F and Cessna SkyCourier 408, which are not mentioned in the original answer and thus introduce hallucinated context. (4) While the general direction of the conclusion (reduced strategic role) is consistent, the incorrect numbers, invented details, and misrepresentation of the timeline and fleet plans significantly reduce correctness. The answer is contextually relevant and attempts multi-hop reasoning, but fails on factual accuracy—especially in quantitative terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 438,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "From 2022 to 2024, Starbucks' foreign currency - other derivative liabilities increased significantly, with liabilities rising from $4.7 million in 2022 to $4.7 million in 2024, while derivative assets decreased from $39.9 million in 2022 to $1.9 million in 2024. The net gains/(losses) included in AOCI for foreign currency - other shifted from a gain of $55.3 million in 2022 to a smaller gain of $11.5 million in 2024. This indicates increased exposure to foreign currency fluctuations and potential volatility in earnings due to hedging activities, reflecting the company's ongoing efforts to manage currency risks in its international operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Starbucks reported foreign currency - other derivative liabilities of $0.3 million in 2022, not $4.7 million as stated in the LLM answer. The LLM also incorrectly claims liabilities were $4.7 million in 2024, while the ground truth does not provide a liability figure for 2024—only a net gain in AOCI of $11.5 million. The LLM fabricates a derivative asset decrease from $39.9 million to $1.9 million, which is not mentioned in the original answer. Additionally, the LLM states a gain of $55.3 million in 2022, which contradicts the ground truth that does not mention any AOCI gain for 2022. (2) The only correct number is the $11.5 million net gain in AOCI for foreign currency - other in 2024. All other figures (liabilities, assets, gains in 2022) are incorrect or unsupported. Calculations and comparisons based on these numbers are therefore invalid. (3) The multi-hop reasoning is flawed because the LLM invents data points not present in the original answer. While it attempts to synthesize trends in liabilities and AOCI impacts, it does so using incorrect inputs. The conclusion about increased exposure has some alignment with the ground truth’s interpretation, but it is based on false premises. (4) The correctness score is low due to major quantitative errors. Quantitative accuracy is severely compromised. Qualitative accuracy is partially preserved due to correct mention of AOCI gains in 2024 and reasonable interpretation of exposure, but reasoning is based on false data. Contextual relevance is acceptable as the answer addresses the general topic and direction of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 464,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "PepsiCo's engagement with the 2.625% Senior Notes due 2026 is reflected in broader debt instrument disclosures in both 2023 and 2024, but with notable evolution. In 2023, the notes are referenced in the context of Board of Directors Resolutions (Exhibit 4.64) authorizing officers to establish terms, including the 2.625% Senior Notes due 2026. By 2024, the 2.625% Senior Notes due 2026 are explicitly listed among other notes under updated Board resolutions (Exhibit 4.64), indicating ongoing authorization and management of the debt instrument within PepsiCo's broader capital structure. No new specific terms or amendments to the 2026 notes were disclosed in 2024, but their inclusion in updated filings reflects continued relevance in PepsiCo's debt portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the presence of the 2.625% Senior Notes due 2026 in both 2023 and 2024 disclosures and accurately references the Board of Directors Resolutions (Exhibit 4.64) as the context for authorization in both years. The percentages, maturity year (2026), and exhibit number are factually correct, satisfying quantitative accuracy. (2) However, the LLM answer omits a key element from the ground truth: the expansion of PepsiCo’s debt portfolio in 2024 to include new notes such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This omission limits the completeness of the response, particularly in capturing the broader evolution of debt instruments that the question emphasizes. (3) While the LLM correctly performs the single-hop reasoning of tracking the 2026 notes across years, it fails to fully synthesize the multi-hop aspect—comparing the scope of disclosed notes between years to infer a more diversified capital markets strategy. The conclusion that the notes remain relevant is valid but underdeveloped compared to the ground truth’s interpretation of strategic expansion. (4) The contextual relevance is high because the response stays focused on debt disclosures and capital structure, and the qualitative accuracy is moderate due to correct entity identification but incomplete reasoning. Quantitative accuracy is perfect—no errors in numbers, dates, or percentages.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 400,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "Cisco's exposure to and reliance on overcoming technical hurdles from 2022 to 2024 have increased, particularly as the company has intensified its strategic investments in emerging technologies such as AI, cloud, cybersecurity, and software-defined networking (SDN). In 2022, the company emphasized the need to develop new products and services in response to evolving customer needs and technological transitions, but acknowledged the risks of technical hurdles and delays in product development. By 2024, Cisco highlighted a more aggressive focus on these areas, including the acquisition of Splunk, and noted the complexity of developing programmable, flexible, and virtual networks. The company also underscored the importance of timely execution to avoid losing market share to competitors, including those using commoditized hardware or alternative technologies. This evolution reflects a heightened reliance on successfully navigating technical challenges to maintain leadership in key growth areas.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of the evolution of Cisco's exposure to technical hurdles from 2022 to 2024. It accurately captures the increasing reliance on overcoming technical challenges, particularly in the context of strategic investments in AI, cloud, cybersecurity, and software-defined networking. The mention of the Splunk acquisition (though not in the original answer) is factually accurate for 2023 and contextually relevant to Cisco's 2024 strategic posture, adding useful context without introducing error. The answer correctly identifies the shift from general product development risks in 2022 to more complex, high-stakes challenges in 2024, including competition and market share risks. However, it omits key consequences emphasized in the original answer for 2024—namely reputational damage, legal liability, and reduced customer retention—which represent a meaningful expansion of risk beyond market share loss. While the LLM conveys increased stakes, it does not fully reflect the broader operational and strategic dependency described in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and all entities (Cisco, 2022, 2024, AI, cloud, security) are correct. The reasoning is sound and synthesizes a clear multi-hop evolution across years and strategic focus areas. Contextual relevance is excellent, directly addressing the question’s focus on evolution, strategic investments, and product development timelines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 421,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Based on the provided documents, Google Ad Manager's role in driving Google Network revenues remained a key contributor in both 2022 and 2023. In 2022, Google Network revenues were driven by strength in AdMob, Google Ad Manager, and AdSense, while in 2023, Google Ad Manager was specifically highlighted as part of the advertising platforms through which customers purchase advertising inventory, reinforcing its continued importance in the advertising ecosystem. However, no direct quantitative shift in its specific contribution was mentioned, indicating its role remained consistent in both years.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Google Ad Manager was a driver in both 2022 and 2023 and mentions the correct platforms (AdMob, AdSense) in 2022. However, it inaccurately concludes that the role of Google Ad Manager remained 'consistent' and 'continued importance' without acknowledging the key shift in narrative emphasis between the years. In 2022, it was explicitly cited as a key driver of the $8.6B year-over-year increase in Google Network revenues, while in 2023, it was listed among several platforms without specific attribution to growth—indicating a diminished emphasis. The LLM misses this qualitative shift, which is central to the question. (2) There are no numeric inaccuracies; the LLM does not introduce false figures and avoids quantifying the contribution in 2023, which aligns with the ground truth. (3) The multi-hop reasoning is partially sound—it connects mentions across years but fails to synthesize the change in positioning (from standout contributor to part of a broader suite). The model does not recognize the implication of de-emphasis in 2023, which requires inference from the absence of specific attribution. (4) Correctness is scored 5 due to the major omission of the shift in role; quantitative accuracy is 10 as no numbers are misstated; qualitative accuracy is 5 due to flawed reasoning about the change in role; contextual relevance is 8 as the answer stays on topic and references relevant platforms and timeframes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 409,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks' derivative liabilities related to foreign currency - other decreased from $2.0 million as of October 1, 2023, to $0.3 million as of September 29, 2024. The magnitude of the change was a reduction of $1.7 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that Starbucks' derivative liabilities related to foreign currency - other increased from $0.3 million in 2022 to $4.7 million in 2024, representing an increase of $4.4 million. In contrast, the LLM claims a decrease from $2.0 million in 2023 to $0.3 million in 2024, which contradicts the ground truth on multiple levels. (2) The numbers are incorrect: the LLM introduces a $2.0 million figure for 2023 that is not present in the ground truth, and misreports the 2024 value as $0.3 million (same as 2022 in truth) instead of $4.7 million. The calculated change of $1.7 million reduction is therefore also wrong. (3) The multi-hop reasoning failed: the model did not correctly identify the evolution from 2022 to 2024 as required, introduced an unsupported intermediate year (2023), and reversed the trend. It also used different fiscal dates (October 1, 2023; September 29, 2024) not mentioned in the original answer, suggesting hallucination. (4) The contextual relevance is moderate because the answer addresses the right topic (derivative liabilities related to foreign currency - other) and attempts to describe a trend over time, but the factual inaccuracies severely undermine correctness. Due to major errors in numbers, direction of change, and missing the correct time frame (2022 to 2024), the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 402,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "PepsiCo issued the 4.600% Senior Notes due 2045 in 2023, as indicated in the 2023 10-K filings. In 2024, these notes remained part of the company's outstanding debt, as listed in the 2024 10-K. This continuity suggests that PepsiCo is maintaining a long-term debt structure with extended maturities, likely to manage interest costs and ensure stable financing over time. The inclusion of these notes in consecutive filings reflects a strategic approach to capital management and long-term liability planning.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.600% Senior Notes due 2045 and their presence in both 2023 and 2024, which aligns with the ground truth. The dates, percentages, and the fact that these notes remained in the debt structure are factually accurate, satisfying quantitative accuracy. (2) However, the LLM incorrectly states that PepsiCo 'issued' the notes in 2023, while the ground truth indicates they were only authorized via Board Resolutions in 2023 — there is no confirmation of issuance in that year. This is a significant factual misrepresentation. (3) The multi-hop reasoning is partially flawed: the ground truth emphasizes the evolution of PepsiCo's debt strategy through the addition of new instruments (e.g., 4.000% Senior Notes due 2047, Floating Rate Notes due 2026), indicating diversification. The LLM fails to mention any of these new notes or the broadening of the debt portfolio, missing a key analytical point. (4) While the LLM draws a reasonable conclusion about long-term financing strategy, it lacks the comparative, multi-year synthesis required to fully address how the strategy evolved. The answer is contextually relevant and semantically plausible but omits critical details and introduces a factual error regarding issuance, reducing its qualitative accuracy. Correctness score reflects partial accuracy with a major omission and one key factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 389,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region has seen a decline in proved reserves from 764 BCF at the end of 2021 to 296 BCF at the end of 2024, as per the data in the reserves table. This decline is primarily attributed to sales, such as the disposition of Indonesia assets in 2022, and downward revisions influenced by factors like lower prices and changes in development plans. This trend suggests a strategic shift away from the Asia Pacific/Middle East region, focusing instead on other areas like the Lower 48 and Canada, where COP has seen significant growth in reserves and development activities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that COP's natural gas reserves in the Asia Pacific/Middle East region were 326 BCF in 2022 and 296 BCF in 2024, indicating a slight decrease. However, the LLM claims reserves were 764 BCF at the end of 2021 and dropped to 296 BCF by 2024, which introduces a data point (764 BCF in 2021) not present in the original answer and misrepresents the timeline. This overstates the decline and uses an incorrect baseline year. (2) The 2024 figure (296 BCF) matches the ground truth, so that number is correct, but the 2022 figure is omitted and replaced with an unverified 2021 number. The calculation of decline is therefore based on incorrect inputs and misleading. (3) The qualitative reasoning about strategic shift due to asset sales (e.g., Indonesia) and focus shifting to Lower 48 and Canada adds context not in the original answer, but aligns plausibly with the observed decline. While the original answer only notes a 'potential shift' due to market dynamics, the LLM provides more detailed reasoning, which may be accurate but is not verifiable from the provided ground truth. This shows sound multi-hop reasoning if supported by external data, but exceeds the evidence given. (4) The answer is contextually relevant and addresses both parts of the question—evolution of gas position and strategic implications—with logical interpretation. However, the incorrect quantitative foundation undermines the overall correctness. Hence, a partial score is warranted: quantitative accuracy is low due to wrong numbers, qualitative reasoning is reasonable but speculative, and relevance is high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 461,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "Based on the filings, Google Play's role in Google's non-advertising revenue strategy remained consistent from 2022 to 2023 as a key contributor to non-advertising revenue through the sale of apps, in-app purchases, and digital content. In both years, Google Play is explicitly listed as a primary source of non-advertising revenue, alongside YouTube non-advertising, hardware, and consumer subscriptions. There is no indication of a significant shift in its role during this period, suggesting it continued to serve as a stable and integral component of Google's diversification strategy beyond advertising.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Google Play's role remained consistent from 2022 to 2023. The ground truth states there was a strategic shift in emphasis — in 2022, revenue was described as coming from 'sales of apps and in-app purchases and digital content sold in the Google Play store,' but in 2023, the description narrowed to 'apps and in-app purchases' and was grouped under the broader 'platforms' category. The LLM incorrectly asserts there was 'no indication of a significant shift,' which contradicts the documented evolution in narrative focus. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the LLM does not introduce any incorrect numbers, so this dimension is neutral. (3) The multi-hop reasoning fails: the question requires comparing how Google Play's revenue description and strategic framing changed across two years in the filings. The LLM fails to detect the narrowing of revenue sources and the re-categorization under 'platforms,' indicating a failure in cross-year synthesis. (4) While the LLM correctly identifies Google Play as a non-advertising revenue source in both years, it misses the key qualitative shift in strategic emphasis, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer addresses the right topic and company but misrepresents the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 402,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "The projected utilization of the Cessna SkyCourier 408 has decreased from 2022 to 2024. In 2022, FedEx was committed to purchasing 49 units, with deliveries scheduled through 2026. By 2024, this number had been reduced to 31 units, with deliveries planned only through 2025. This decline suggests a reduced strategic reliance on the Cessna SkyCourier 408, potentially indicating a shift in FedEx's fleet strategy or operational priorities.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the reduction in projected aircraft from 49 to 31, which matches the ground truth. However, it inaccurately states that in 2022, deliveries were 'scheduled through 2026'—the original answer does not specify delivery end dates in 2022, only that the projection covered '2023 to thereafter'. Similarly, the 2024 delivery end date is stated as 2025 in the LLM answer, but the ground truth says '2025 through 2029', implying operations extend beyond 2025. These are minor but meaningful date inaccuracies. (2) The numbers 49 and 31 are correct and match the ground truth, but the associated timeframes are partially incorrect or oversimplified. The LLM presents delivery timelines not explicitly stated in the original, introducing potential misinterpretation. (3) The reasoning about reduced strategic reliance is logical but diverges from the ground truth's more nuanced conclusion. The original answer notes a shift in relationship from 'Increases' to 'Depends_On', indicating a change in strategic nature—not necessarily a reduction. The LLM interprets the numerical decrease as 'reduced reliance', missing this key qualitative shift in strategic categorization. (4) The answer is contextually relevant and addresses both parts of the question—evolution of utilization and strategic implications. While the core numerical facts are correct, the misrepresentation of timeframes and oversimplification of strategic interpretation prevent a higher score. The qualitative reasoning is sound but incomplete compared to the multi-hop insight in the original about the 'Depends_On' relationship change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 448,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods evolved by increasing segmentation in casualty lines, particularly in U.S. Excess Casualty and U.S. Workers' Compensation. In 2023, AIG further segmented non-automobile claims for latent exposures like construction defects and mass torts, recognizing their unique emergence patterns. Additionally, the analysis was refined by attachment point bands to account for the impact of high deductibles and varying loss reporting delays. For recent accident years, expected loss ratio methods were applied with adjustments for rate changes, inflation, and market conditions, reflecting a more nuanced approach to emerging risks and claims patterns.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but exhibits significant inaccuracies in the evolution of AIG's use of expected loss ratio methods between 2022 and 2023. (1) Correctly identifies that segmentation increased and mentions U.S. Excess Casualty and U.S. Workers' Compensation, which aligns with the ground truth. It also accurately references latent exposures like construction defects and mass torts, and notes segmentation by attachment point, which was part of the 2022 approach. (2) However, the key evolution—shifting focus from U.S. Excess Casualty in 2022 to U.S. Workers' Compensation in 2023—is misrepresented. The LLM implies that both lines were analyzed in 2023 with enhanced segmentation, but the ground truth states that the method was *applied to different lines* in each year: primarily U.S. Excess Casualty in 2022 and a shift to U.S. Workers' Compensation in 2023. The LLM incorrectly suggests continuity rather than a strategic shift. (3) The multi-hop reasoning is flawed: it fails to recognize that the change is not just refinement within the same line but a change in the primary casualty line of application. Additionally, the LLM introduces 'adjustments for rate changes, inflation, and market conditions' and 'attachment point bands' without grounding in the original answer, adding unsupported detail. (4) While the context of segmentation and casualty lines is relevant, the core factual claim about *where* the method was applied is incorrect, leading to a moderate correctness score. Quantitative accuracy is higher because there are no explicit numbers, and the qualitative accuracy is reduced due to incorrect synthesis across years and lines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 457,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "Between fiscal years 2022 and 2024, the classification of unallocated products within Nike's consumer construct evolved as part of the company's organizational realignment under the Consumer Direct Acceleration strategy. In fiscal 2022, unisex products were reclassified under Men's, and the Jordan Brand was separately reported. By fiscal 2024, the \"Others\" category (products not allocated to Men's, Women's, Kids', or Jordan Brand) remained, but the presentation of wholesale equivalent revenues and other metrics was refined to align with the new consumer construct. Notably, Nike indicated that in fiscal 2025, wholesale equivalent revenues would be replaced with a comparable U.S. GAAP metric due to the rollout of a new ERP platform.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces information not present in the ground truth while omitting key details about the evolution of unisex product classification. (1) Correct elements: The mention of 'Others' including products not allocated to Men's, Women's, Kids', and Jordan Brand is consistent with the original answer, and the fiscal years 2022 and 2024 are correctly referenced. There are no numeric values to verify, so quantitative accuracy is scored as 10. (2) However, the LLM incorrectly states that unisex products were 'reclassified under Men's' in 2022, whereas the ground truth says they 'were classified within Men's'—a subtle but important distinction suggesting possible prior classification rather than a change. More critically, the LLM introduces new information about a 'Consumer Direct Acceleration strategy', 'wholesale equivalent revenues', and a shift to U.S. GAAP metrics in fiscal 2025, none of which are mentioned or implied in the original answer and are irrelevant to the specific question about categorization of unallocated products. (3) The multi-hop reasoning is flawed: instead of focusing on the absence of mention of unisex classification in 2024 (suggesting a potential shift), the model diverts into unrelated reporting metric changes. The core insight from the ground truth—that the lack of explicit mention of unisex products in Men's by 2024 suggests a potential integration or rethinking of how unisex is handled—is missing. (4) While the answer remains contextually relevant to Nike’s reporting structure, it fails to accurately reflect the nuanced evolution of unisex product classification, leading to a correctness score of 6 for partial accuracy with significant omissions and extraneous, unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 479,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 3.500% Senior Notes due 2025 remained consistent, as the notes were issued in 2023 and would mature in 2025. The absence of any new disclosures or refinancing activities related to these notes in 2024 suggests that PepsiCo is allowing them to mature as part of its planned debt management strategy. This indicates a disciplined approach to managing short- to medium-term debt obligations, likely aligning with broader financial planning and liquidity management goals.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness regarding the existence of the 3.500% Senior Notes due 2025 in 2023, but it incorrectly implies no significant development occurred in 2024. The ground truth states that in 2024, PepsiCo issued new long-term notes (e.g., due 2034 and 2040), indicating active debt portfolio expansion and maturity diversification. The LLM answer misses this key evolution entirely, instead asserting there was 'no new disclosure or refinancing,' which contradicts the ground truth. (2) Quantitatively, the dates (2023, 2025) and interest rate (3.500%) are accurate, and no incorrect calculations were made since none were required. However, the absence of mention of new notes (3.550% due 2034, 3.500% due 2040) represents a critical omission of financial instruments central to the correct interpretation. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes in PepsiCo’s debt structure across two years. The LLM fails to recognize that the introduction of longer-term debt in 2024 alongside the continued presence of the 2025 notes reflects a strategic shift toward maturity diversification. Instead, it concludes a passive 'hold-to-maturity' strategy, which is inconsistent with the evidence of proactive debt issuance. (4) The contextual relevance is moderate because the answer discusses debt management and maturity, which are relevant themes, but it draws an incorrect conclusion due to missing key data. The qualitative accuracy is low because the reasoning and entity synthesis (PepsiCo’s full debt activity in 2024) are incorrect. Overall, the answer is factually incomplete and misrepresents the strategic direction, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 474,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "Between 2022 and 2024, COP's financial disclosures for the Lower 48 region showed significant changes in capital expenditures and future cash inflow revisions. Capital expenditures for the Lower 48 increased from $6,341 million in 2022 to $29,952 million in 2024, driven by major development and acquisition activities. Future cash inflows for the Lower 48 also rose from $195,605 million in 2022 to $164,264 million in 2024, reflecting revised reserve estimates and market conditions. These changes highlight a strategic shift toward higher investment and updated economic projections for the region.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, COP's capital expenditures for the Lower 48 region in 2022 were $3,129 million, but the LLM incorrectly states $6,341 million. Furthermore, the ground truth does not provide any capital expenditure figure for 2024, yet the LLM claims it increased to $29,952 million, which is entirely fabricated. Similarly, the LLM invents future cash inflow figures of $195,605 million in 2022 and $164,264 million in 2024, while the ground truth mentions only that future cash inflows were revised in 2024 without providing specific numbers. (2) All quantitative values in the LLM answer are incorrect and unsupported by the original answer. There are no valid calculations or comparisons possible because the numbers themselves are false. (3) The multi-hop reasoning is fundamentally flawed. The original answer indicates a shift from reporting capital expenditures in 2022 to discussing revisions in future cash inflows and production costs in 2024, implying a change in disclosure focus. The LLM instead fabricates comparable figures across both years and asserts a narrative of increasing investment, which contradicts the ground truth. (4) The contextual relevance is moderate because the LLM addresses the Lower 48 region and discusses capital expenditures and future cash inflows as requested, but the content is factually wrong. Due to severe quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 415,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Between 2023 and 2024, Comcast's financial commitments and governance arrangements with Atairos Group evolved as follows: \n\nCapital obligations were reduced, with Comcast's maximum commitment to fund Atairos lowered from up to $5 billion to $4.5 billion, and the annual capital call limit reduced to $400 million plus certain previously distributed amounts. Additionally, Comcast's remaining unfunded capital commitment as of December 31, 2024, was $1.4 billion. Governance structures remained unchanged, as Comcast retained no voting rights in Atairos, which is controlled by management companies led by its former CFO. Comcast's economic interests provided it with the right to receive approximately 86% of residual returns but also obligated it to absorb about 99% of any losses.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core financial and governance changes between 2023 and 2024. It accurately reports the reduction in Comcast's capital commitment from $5 billion to $4.5 billion, the $400 million annual capital call limit, and the 99% loss absorption and 86% residual return figures. It also correctly identifies that Comcast has no voting rights and that control rests with management companies led by the former CFO. However, it omits the specific detail about the $40 million annual funding for management fees, which is part of the formalized 2024 framework in the ground truth. Additionally, the mention of the 'remaining unfunded capital commitment as of December 31, 2024, was $1.4 billion' is not present in the original answer and cannot be verified from the provided ground truth, introducing unconfirmed information. (2) All numeric values that are present (e.g., $5B to $4.5B, $400M, 99%, 86%) are quantitatively accurate and match the ground truth. The $1.4 billion unfunded commitment is an extra detail not in the original and may be factually correct but is unsupported here, slightly reducing quantitative accuracy. (3) The reasoning is sound in synthesizing the evolution of financial commitments and control structures. It correctly infers that reduced capital calls and loss/return allocations reflect a recalibration, though it misses the nuance that the 2024 changes were part of a shift to equity method accounting and a more formalized investment framework. The governance assessment is accurate. (4) The answer is highly relevant to the question, addressing both capital obligations and control structures across the two years. The omission of the management fee funding and the equity method context prevents a perfect score, but the core multi-hop synthesis is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 497,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "FedEx's projected utilization of the Cessna SkyCourier 408 decreased between 2022 and 2023, with planned deliveries dropping from 49 aircraft as of May 31, 2022, to 31 aircraft as of May 31, 2023. This reduction indicates a diminished strategic role for the Cessna SkyCourier 408 in FedEx's fleet compared to other aircraft, such as the ATR 72-600F, B767F, and B777F, which also saw changes in delivery schedules but retained a more prominent position in the company's modernization and expansion plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the reduction in projected Cessna SkyCourier 408 aircraft from 49 in the 2022 filing to 31 in the 2023 filing, matching the ground truth. The dates (May 31, 2022 and May 31, 2023) are plausible fiscal year-end dates and align with typical SEC filing timelines, though the original answer does not specify exact dates—this is a minor addition but not factually incorrect. (2) All numbers are accurate: 49 and 31 aircraft are correctly reported, and the direction and magnitude of the change (a decrease of 18 aircraft) are implied correctly. There are no calculation errors. (3) The reasoning is sound: the LLM correctly infers that the reduction indicates a diminished strategic role for the SkyCourier. It appropriately compares the SkyCourier to other aircraft (ATR 72-600F, B767F, B777F), noting their more stable strategic positioning. The original answer specifically highlights B767F and B777F, so including the ATR 72-600F is a slight expansion but still contextually valid and does not detract from accuracy. (4) The answer is semantically equivalent to the ground truth, with slightly enhanced detail. The only minor gap is that the original answer notes the projection period shifted from 'through 2027' to 'through 2029', which the LLM omits. This is a small but relevant detail about timeline extension despite fleet reduction, affecting completeness slightly. Otherwise, all key facts, multi-hop synthesis (change over time + strategic implication), and contextual analysis are correct and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 428,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "From 2022 to 2024, Nike's approach to the Air Max product line shows an increased emphasis on technological innovation, as highlighted in the 2024 10-K, which explicitly mentions Air Max as part of Nike's dedication to designing innovative products incorporating new technologies. However, there is no direct mention of revenue transparency specific to the Air Max line in either document, suggesting that Nike has not separately disclosed Air Max revenues in its financial reporting during this period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that from 2022 to 2024, Nike increased its emphasis on technological innovation for the Air Max line, noting its mention in the 2024 10-K as part of innovation strategy—consistent with the shift from passive listing to strategic highlighting. It also accurately states that there is no direct revenue disclosure for Air Max in either year, which matches the ground truth's point about continued lack of standalone financial metrics. The only minor shortcoming is that the LLM does not explicitly reference the 2022 revenue disaggregation table where Air Max was listed among other technologies, which adds a small gap in completeness regarding the evolution of transparency. However, the core facts, entities (Nike, Air Max, 2022–2024 timeframe), and reasoning are correct. No numerical inaccuracies exist—dates and financial transparency claims are properly represented. The reasoning reflects sound multi-hop synthesis between two years’ disclosures, correctly inferring a strategic shift despite unchanged revenue transparency. Wording differs slightly but maintains semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 334,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "Comcast's capital expenditure strategy regarding Epic Universe evolved from 2023 to 2024 by shifting focus from land acquisition to active construction. In 2023, capital expenditures for theme parks included the acquisition of land for potential expansion opportunities, while in 2024, spending increased specifically for the development of Epic Universe, including the construction of attractions. The 2024 expenditures reflect a prioritization of advancing construction over preparatory land purchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims that 2023 expenditures were for 'land acquisition' and that 2024 spending shifted to 'construction of attractions', but the ground truth states that in 2023, $8.2 billion was allocated to 'Connectivity & Platforms', which included infrastructure and line extensions related to Epic Universe—not land acquisition. The original answer makes no mention of land purchases in either year. Additionally, the LLM fails to report the specific $8.2 billion figure from 2023, a key quantitative detail. In 2024, the ground truth confirms no specific dollar amount was disclosed for Epic Universe, but the LLM incorrectly implies a new increase in spending without citing any figures, introducing unsupported claims. (2) Quantitative accuracy is low because the only specific number mentioned in the ground truth—$8.2 billion in 2023—is entirely omitted, and no valid figures are provided in its place. There are no calculations, but the absence of disclosed numbers where they exist (2023) and the suggestion of increased spending in 2024 without data reduce accuracy. (3) The multi-hop reasoning is partially sound in identifying a strategic shift, but it mischaracterizes the nature of the shift. The original answer describes a move from initial infrastructure (2023) to sustained investment in both infrastructure and guest experience (2024), whereas the LLM frames it as a shift from land acquisition to construction, which is not supported. This reflects flawed synthesis. (4) Contextual relevance is moderate because the answer addresses the evolution of capital expenditure strategy and thematic park priorities, staying on topic. However, due to major factual errors and omission of key financial data, the correctness score is low. Qualitative accuracy is mid-range because while the general idea of shifting focus is present, the specifics are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 523,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Between 2022 and 2023, FedEx's utilization of the ATR 72-600F aircraft increased as reflected in their fleet projections. In 2022, FedEx had 6 ATR 72-600F aircraft in its fleet and had committed to purchasing 24 units across 2023 to 2026. By 2023, FedEx had already delivered 11 ATR 72-600F aircraft in 2023 and planned to purchase 10 more units by 2026, indicating a continued strategic focus on integrating this aircraft into its operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and interpretation. The original answer states that in 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, decreasing to 6 in 2024 and 2025, and only 1 in 2026. By 2023, the projections were updated to 7 for 2025 and 3 for 2026—indicating a reduction in planned utilization over time. The LLM incorrectly claims that utilization 'increased' and misrepresents the actual fleet numbers and projections. (2) The LLM states that in 2022, FedEx had 6 ATR 72-600F aircraft and committed to purchasing 24 units from 2023–2026, and that by 2023, 11 were delivered in 2023 and 10 more planned by 2026. None of these numbers appear in the ground truth, and they contradict the projection trends. The ground truth does not state how many were delivered in 2023, only what was projected in 2022 and how projections changed by 2023. (3) The multi-hop reasoning is flawed: the question asks how projections for the same time periods evolved between 2022 and 2023. The LLM fails to compare the 2022 projections for 2023–2026 with the updated 2023 projections for the same years. Instead, it fabricates delivery numbers and purchase commitments not present in the original answer. (4) The contextual relevance is moderate because the answer discusses FedEx and the ATR 72-600F aircraft in the correct timeframe, but the factual inaccuracies and incorrect synthesis severely undermine correctness. Quantitative and qualitative accuracy are very low due to invented numbers and reversed conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 431,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Nike's approach to estimating product return reserves remained consistent in its methodology, as it continued to estimate reserves based on historical rates, specific identification of returns, and expectations of future returns. However, the reserve balances decreased from $1,015 million in fiscal 2022 to an unspecified amount in fiscal 2024, suggesting potential improvements in return rates or better forecasting accuracy. This consistency in methodology indicates no significant changes in Nike's revenue recognition approach, as it still records revenue net of anticipated returns at the time of sale.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. The reported reserve amount for fiscal 2022 is incorrect: the ground truth states $269 million, while the LLM claims $1,015 million—a significant and unjustified discrepancy. Additionally, the LLM asserts that the methodology 'remained consistent,' which directly contradicts the ground truth indicating a shift toward a more formalized, probabilistic 'most likely amount' approach by fiscal 2024. (2) Quantitative accuracy is severely lacking: the dollar amount is off by over $700 million, and no such figure as $1,015 million appears in the original answer. The decrease from this incorrect number to an 'unspecified amount' fabricates a trend not supported by the data. (3) The reasoning is flawed: instead of identifying a methodological evolution—specifically, the adoption of a forward-looking, probabilistic model under the variable consideration framework—the LLM incorrectly concludes there was no change in revenue recognition approach. This fails the multi-hop requirement to synthesize changes in accounting policy and their implications. (4) While the answer addresses the general topic of return reserves and revenue recognition, its factual foundation is unsound, leading to a low correctness score. Contextual relevance is moderate because it engages with the right concepts (reserves, revenue recognition) but misrepresents them.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 393,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "The planned fleet composition for the Cessna SkyCourier 408 decreased from 49 units scheduled for delivery through 2027 in 2022 to 31 units as of 2023, with no deliveries planned beyond 2025. This reduction indicates a diminished strategic reliance on the Cessna SkyCourier 408 model for future operations, as FedEx shifted focus toward other aircraft types like the ATR 72-600F, B767F, and B777F.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both numbers and trends. According to the ground truth, in 2022, FedEx (FDX) planned for 12 Cessna SkyCourier 408 aircraft by 2025 and to maintain that number through 2026. By 2023, the plan increased to 17 for 2025 but decreased to 14 for 2026. The LLM instead claims a reduction from 49 units through 2027 in 2022 to 31 units through 2025 in 2023—numbers and timeframes that do not match the ground truth. These figures (49, 31) are entirely fabricated or misattributed. (2) Quantitative accuracy is very low: the correct numbers are 12 (2025, 2022 plan), 17 (2025, 2023 plan), and 14 (2026, 2023 plan). The LLM introduces '49' and '31' with no basis, and incorrectly states 'no deliveries beyond 2025' when the 2023 plan explicitly includes 14 units in 2026. (3) The reasoning is flawed: the ground truth shows a short-term increase in reliance followed by a slight drawdown, indicating strategic recalibration, not a clear reduction. The LLM concludes a 'diminished strategic reliance' due to a fictional large cut, failing to capture the nuanced shift. It also introduces aircraft types (ATR 72-600F, B767F, B777F) not mentioned in the original answer, adding unsupported context. (4) While the answer addresses fleet composition changes and strategic reliance (hence moderate contextual relevance), the factual foundation is incorrect, leading to a low correctness score. The multi-hop synthesis failed—no accurate comparison across years or correct entity-metric alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 422,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard expanded its real-time account-based payments infrastructure from 2023 to 2024 by increasing its operational scale, implementing real-time clearing and settlement infrastructure in 13 markets, and enabling instant payments with enhanced data and messaging capabilities. In terms of integrated security, Mastercard reinforced its multi-layered approach, incorporating fraud scoring, tokenization, and robust programs to safeguard consumer protections and transaction integrity across its network.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Mastercard was operating or implementing real-time payments infrastructure in 13 markets as of 2023, which matches the ground truth. It accurately notes the presence of instant payments with enhanced data and messaging, fraud scoring, and tokenization as part of the security framework. However, the LLM incorrectly implies that the 13-market rollout occurred during the 2023–2024 evolution period, rather than being a 2023 baseline. The original answer clarifies that the 13 markets were already operational or being implemented in 2023, and the 2024 developments focused on enhancements to ACH and account-based systems, not expansion into those 13 markets. (2) Quantitatively, the number '13 markets' is accurate and correctly attributed, though its temporal framing is slightly off. There are no calculation errors, and all financial or metric references (though not numerical in this case) are consistent. (3) The multi-hop reasoning is mostly sound—linking operational scale and security across years—but misses the nuance that 2024 was about enhancement and integration, not initial implementation in those 13 markets. The LLM conflates the timeline slightly, suggesting expansion into 13 markets from 2023 to 2024, whereas the ground truth positions those 13 markets as the starting point. (4) Despite this, the core facts about security (fraud scoring, tokenization, multi-layered protection) and the direction of evolution (more secure, smart, and simple solutions) are correctly conveyed. Wording is semantically equivalent in most places, and the answer remains highly relevant to the question. Hence, a score of 8 is justified—minor error in temporal attribution but strong overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 479,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Between 2022 and 2024, Nike's use of foreign exchange forwards and options evolved in both notional amounts and their impact on financial liabilities and hedging strategy. In 2022, the total notional amount of outstanding foreign currency derivatives designated as cash flow hedges was $18.5 billion, decreasing to $16.2 billion by 2024. Additionally, undesignated derivative instruments saw a reduction in notional amounts from $3 billion in 2022 to $4.4 billion in 2024. Nike's hedging strategy remained focused on mitigating foreign currency exposures, particularly for product costs and intercompany transactions, with cash flow hedges primarily covering major currency pairs like Euro/U.S. Dollar and British Pound/Euro. The impact on financial liabilities was reflected in derivative assets and liabilities on the balance sheet, with total derivative liabilities decreasing from $180 million in 2022 to $151 million in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, foreign exchange forwards and options had a net gain of $8 million after tax, but the LLM does not mention this gain at all. Instead, it introduces notional amounts ($18.5B in 2022, $16.2B in 2024) and undesignated derivatives ($3B to $4.4B), which are not present in the original answer and contradict the focus on financial liabilities and hedging impact. The LLM claims total derivative liabilities decreased from $180M in 2022 to $151M in 2024, but the ground truth reports an increase in liabilities to $110M under accrued liabilities and $5M under deferred income taxes in 2024—these specific liability categories and amounts are entirely missing or incorrect in the LLM response. (2) The quantitative inaccuracies are severe: the LLM fabricates notional values and liability totals that do not appear in the ground truth. There is no mention in the original answer of $18.5B or $16.2B notional amounts, nor a drop from $180M to $151M in liabilities. The actual liability figures for 2024 are $110M + $5M = $115M total, which contradicts the LLM's $151M figure. Additionally, the LLM incorrectly states undesignated derivatives increased from $3B to $4.4B, which is both numerically unsupported and irrelevant to the original answer. (3) The multi-hop reasoning is flawed. The question asks about evolution in use of instruments and their impact on financial liabilities and hedging strategy. The ground truth emphasizes a shift in reporting and management reflected in increased liabilities and tax impacts. The LLM instead focuses on notional amounts and overall liability reductions, missing the key point about increased liabilities in specific balance sheet categories and the strategic shift implied by that change. It fails to connect the tax impact ($8M gain after tax in 2022) to the evolution of strategy. (4) While the LLM stays within the domain of hedging strategy and mentions relevant currency pairs and objectives (e.g., product costs, intercompany transactions), the core factual content diverges significantly from the ground truth. The contextual relevance is moderate because it discusses related concepts, but correctness is low due to fabricated numbers and omission of key facts. Hence, correctness is scored low at 3, quantitative accuracy at 2, qualitative reasoning at 4, and contextual relevance at 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 650,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "Between 2022 and 2023, the product category classification of Puffs within the Baby, Feminine & Family Care segment remained consistent, listed under the \"Family Care\" sub-category, which includes products like paper towels, tissues, and toilet paper. In both years, Puffs was grouped with Bounty and Charmin as major brands under Family Care. There is no indication of a reclassification during this period.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key nuance in the evolution of the product category classification. It correctly states that Puffs remained under the 'Family Care' sub-category in both 2022 and 2023 and was grouped with Bounty and Charmin, which aligns with the ground truth. However, the original answer highlights a reporting change: in 2023, the specific mention of 'Tissues' as a sub-category was replaced with a more general listing, indicating a simplification or consolidation in how the segment details were reported. The LLM answer fails to acknowledge this change in disclosure granularity, instead asserting there was 'no indication of a reclassification,' which overlooks the evolution in reporting structure. While no numbers or dates are involved (so quantitative accuracy is 10), the qualitative accuracy suffers because the model does not capture the subtle but important shift in categorization detail. The answer is contextually relevant and factually sound on surface-level classification but lacks the deeper insight into reporting changes, resulting in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 316,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Between 2022 and 2023, Tampax remained within the Baby, Feminine & Family Care segment at P&G, maintaining its position as a key brand in the Feminine Care sub-category. In both years, Tampax was listed as a major brand under this segment, alongside Always and Always Discreet. There is no indication of a change in its categorization or associated product lines during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that there was no change in Tampax's categorization between 2022 and 2023. The ground truth states that in 2022, Tampax was under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, but by 2023, it was repositioned under a more specific 'Menstrual Care' sub-category, reflecting a strategic refinement. The LLM incorrectly asserts that the categorization remained unchanged, failing to capture this key evolution. While the answer correctly identifies the broader segment (Baby, Feminine & Family Care) and associated brands like Always, it misses the critical shift from 'Feminine Care' to 'Menstrual Care', which is the central point of the question. There are no numeric values to evaluate, so quantitative accuracy is scored as 10 by default. Qualitative accuracy is low due to the failure in multi-hop reasoning—synthesizing changes across two years and categories. Contextual relevance is moderate because the response discusses the right segment and brand context but fails to address the actual evolution asked in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 312,
        "total_tokens": 1529
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Oracle's strategy and positioning of Oracle Engineered Systems between fiscal 2022 and fiscal 2023 shifted toward a reduced emphasis on nonstrategic hardware products, which led to lower hardware revenues. In fiscal 2022, hardware revenues declined by 5% to $3.18 billion, and this trend continued into fiscal 2023, with hardware representing 6% of total revenues in both years. Oracle focused more on cloud-based infrastructure technologies, which drove higher growth in cloud services. In terms of research investment expectations, Oracle emphasized continued investments in cloud and license offerings, with research and development expenses increasing by 5% in fiscal 2022 and expected to grow further to support cloud operations and product development.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it claims hardware revenues declined by 5% to $3.18 billion in fiscal 2022, but this figure is not present in the ground truth and cannot be verified from the provided information. Second, it incorrectly states that hardware represented 6% of total revenues in both fiscal 2022 and 2023; the ground truth specifies that the 6% figure was only disclosed in fiscal 2023 and not in 2022, making the comparison invalid. Third, the claim about R&D expenses increasing by 5% in fiscal 2022 is unsupported by the original answer, which does not mention any specific percentage increase in R&D for that year. (2) The only correct quantitative point is the 6% hardware revenue contribution in fiscal 2023, which matches the ground truth. All other numbers (e.g., $3.18B, 5% decline, 5% R&D increase) are either fabricated or misattributed. (3) The reasoning is partially sound in identifying a strategic shift, but it mischaracterizes the nature of the evolution. The ground truth emphasizes a clearer strategic positioning and continued R&D investment in hardware in fiscal 2023, whereas the LLM incorrectly frames the strategy as a reduction in hardware focus due to declining revenues and a shift to cloud. This contradicts the original answer, which highlights ongoing investment in hardware R&D. The multi-hop synthesis fails because it draws conclusions not supported by the source data. (4) Despite the incorrect numbers and misrepresentation of strategy, the answer is contextually relevant—it addresses Oracle’s hardware strategy, revenue contribution, and R&D expectations as asked. However, due to significant factual and quantitative errors, the correctness score is low. The qualitative accuracy is moderate because some structure and intent align with the question, but reasoning is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 506,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Between 2022 and 2023, Honeywell's investment in private funds for its Non-U.S. pension plans saw a shift in allocation and classification across fair value hierarchy levels. The total value of private funds increased slightly from $90 million in 2022 to $115 million in 2023. In terms of fair value hierarchy classification, the 2023 allocation showed $74 million in Level 3 (unobservable inputs) and $41 million in Level 2 (observable inputs), compared to $36 million in Level 3 and $54 million in Level 2 in 2022. This indicates a greater proportion of private fund investments being classified under Level 3 in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The original answer states that in 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans (not Non-U.S.), all classified under Level 3. However, the LLM incorrectly claims $90 million in 2022 for Non-U.S. plans with a split of $54M Level 2 and $36M Level 3—none of which appears in the ground truth. In 2023, the correct data is $115M for Non-U.S. plans with $41M Level 2 and $74M Level 3, which the LLM correctly reports. However, it fabricates 2022 Non-U.S. figures and misattributes the $1,105M U.S. plan amount to Non-U.S. plans. (2) Quantitative accuracy is very low: the LLM invents numbers not present in the source (e.g., $90M total in 2022, $54M Level 2, $36M Level 3), while the ground truth does not provide any 2022 breakdown for Non-U.S. private fund investments. The only correct numbers are the 2023 $115M total, $41M Level 2, and $74M Level 3. (3) The multi-hop reasoning is flawed: the model fails to distinguish between U.S. and Non-U.S. pension plans, conflating data from different entities. It incorrectly infers a year-over-year comparison for Non-U.S. plans using fabricated data, when the ground truth shows a shift from U.S. to Non-U.S. reporting and a major decrease in overall allocation. (4) Contextual relevance is moderate because the answer addresses the right topic (allocation and classification across fair value levels) and correctly reports 2023 Non-U.S. data, but the incorrect baseline (2022) and entity confusion (U.S. vs. Non-U.S.) severely undermine the validity of the analysis. The conclusion about increased Level 3 proportion is based on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 464,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "The 2014 USD Notes, which had a principal amount of $1,000 million and were due in April 2024, matured in April 2024 and were fully repaid. This is explicitly stated in the 2024 10-K under the \"Debt and Credit Availability\" section, which notes that $1 billion of principal related to the 2014 USD Notes matured and was paid in April 2024. Thus, by the end of 2024, the 2014 USD Notes were no longer outstanding.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 2014 USD Notes had a $1 billion (or $1,000 million) principal, matured in April 2024, and were paid in full. The formatting variation ($1,000 million vs $1 billion) is acceptable and equivalent. (2) Quantitative accuracy is perfect: the dollar amount and maturity date match the original answer exactly. (3) The reasoning correctly captures the evolution from 2023 (implied short-term liability due to maturity in 2024) to 2024 (repayment and removal from outstanding debt), demonstrating proper multi-hop synthesis across time and financial status. (4) The answer addresses both parts of the question: the status evolution (from near-term debt to settled) and the specific 2024 action (full repayment in April). Contextual relevance is complete, with accurate reference to the 10-K section and correct financial terminology. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 288,
        "total_tokens": 1499
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "Between 2022 and 2024, Lowe's Officer Indemnification Agreements have been consistently documented in the 10-K filings, with the 2024 filing (page 79) referencing the agreement under Exhibit 10.23, dated April 2, 2019. There is no indication of material changes to the form or terms of the agreements during this period. This continuity suggests that Lowe's maintains a stable and well-defined executive risk management framework, ensuring consistent governance practices and protections for its senior officers.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Lowe's maintained the same Officer Indemnification Agreement form between 2022 and 2024, with no material changes, which aligns with the ground truth. The core conclusion about stable governance and executive risk management is accurate and well-supported. However, there is a minor error in the exhibit number: the LLM states Exhibit 10.23 in the 2024 filing, while the ground truth confirms it is Exhibit 10.43 (originally filed April 2, 2019, and refiled without amendment). This exhibit number discrepancy affects quantitative accuracy but does not alter the overall correctness of the conclusion. (2) The date (April 2, 2019) is correctly cited, and there are no financial figures requiring calculation, so numerical accuracy is otherwise strong. (3) The multi-hop reasoning—linking consistent documentation across years to implications for governance and risk management—is sound and logically derived from the evidence of unchanged filings. (4) Despite the exhibit number error, the answer conveys semantically equivalent information regarding continuity and its implications, earning high marks for qualitative accuracy and full points for contextual relevance. The mistake is minor but prevents a top score due to the importance of precise exhibit references in SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 373,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "Between 2022 and 2023, the market share and category positioning of Always Discreet in the adult incontinence market remained relatively stable. In 2022, P&G stated that Always Discreet held over 10% market share in key markets, while in 2023, the share was reported as about 15% in the markets where P&G operates. This indicates a slight increase in market share, maintaining its position as a key player in the adult incontinence sub-category under the broader Feminine Care segment.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Always Discreet had a 15% market share in 2023. The ground truth explicitly states that no market share figure was provided in the 2023 filing, whereas the LLM incorrectly asserts a specific percentage. The only accurate number is the 2022 market share of over 10%, which matches the original answer. (2) The calculation or comparison of market share change (from over 10% to 15%) is entirely fabricated, as no such data exists in the 2023 filing. This represents a severe quantitative inaccuracy. (3) The multi-hop reasoning is flawed: the model fails to recognize that the absence of a market share figure in 2023 is a meaningful change in disclosure strategy, instead inventing data to suggest growth. It also mischaracterizes the brand’s positioning by implying continued quantitative reporting when it was actually dropped. (4) While the answer correctly identifies Always Discreet as part of the Feminine Care segment and acknowledges its relevance in adult incontinence, the core factual error—implying a 15% market share in 2023—undermines the entire response. The contextual relevance is moderate because it addresses the right brand and category, but the reasoning and data are fundamentally unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 358,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Between 2022 and 2023, Oracle's strategic positioning of Engineered Systems evolved to align more closely with its cloud transformation narrative. In 2022, Engineered Systems were described as core components of Oracle's cloud-based and on-premise data center infrastructure offerings, emphasizing their role in delivering performance, scalability, and integration. By 2023, the focus shifted to how Engineered Systems support Oracle's broader cloud strategy, with offerings like Oracle Exadata Database Machine being marketed through flexible deployment options—on-premise, as a cloud service in OCI, and as a hybrid cloud offering. This evolution reflects Oracle's effort to integrate Engineered Systems into its cloud ecosystem, enabling customers to deploy these systems in environments that align with their cloud adoption strategies while reinforcing Oracle's narrative of a unified, integrated cloud infrastructure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the evolution in Oracle's strategic positioning of Engineered Systems from 2022 to 2023, emphasizing their integration into Oracle's cloud transformation narrative and flexible deployment options (on-premise, OCI, hybrid). It accurately reflects the shift toward tighter alignment with cloud strategy and mentions key offerings like Oracle Exadata. However, it omits several key quantitative and structural details present in the ground truth: (1) the explicit inclusion of servers, storage, and operating systems in the broader hardware business in 2023; (2) the fact that hardware revenues (including Engineered Systems) accounted for 6% of total revenues in both fiscal 2023 and 2024; and (3) the mention of combined performance obligations and ongoing R&D investments. These omissions reduce completeness and qualitative accuracy, particularly in synthesizing the full scope of the multi-hop information. There are no numerical inaccuracies—the LLM avoids making up numbers and does not contradict the ground truth—so quantitative accuracy is perfect. Contextually, the answer is highly relevant and well-reasoned, but the missing specifics about revenue share and business integration limit its factual completeness. Semantic equivalence is partially achieved, but critical contextual and financial details from the 2023 filing are absent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 380,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "Between the 2022 and 2023 10-K filings, the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan remained consistent in stating that the 2020 Stock Plan is the successor to the 2011 Stock Plan and that any shares remaining under the 2011 Stock Plan at the time of adoption were rolled into the 2020 Stock Plan. However, the 2023 filing provided more detailed data on the shares available for grant and the activity under the 2020 Stock Plan, reflecting updated figures through December 31, 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. According to the ground truth, the 2023 10-K filing omitted the specific disclosure about the carry-forward of 5,530,106 shares from the 2011 Stock Plan to the 2020 Stock Plan, which was present in the 2022 10-K. However, the LLM incorrectly states that the disclosure 'remained consistent' between the two years and that both filings described the rollover of shares. This is factually wrong—the key change was the removal of that specific linkage in the 2023 filing. The LLM also introduces a claim that the 2023 filing provided 'more detailed data,' which is not supported by the ground truth and contradicts the actual trend of reduced disclosure on the relationship between the plans. There are no numeric values mentioned in the LLM response, so quantitative accuracy is low due to omission of the critical 5,530,106 figure. The reasoning is flawed as it fails to recognize the multi-hop aspect: comparing disclosures across two filings to identify a change in narrative. While the topic is relevant (disclosure evolution of stock plans), the factual inaccuracies severely undermine the answer's validity. Thus, the correctness score is low despite addressing the general subject.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 347,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Between 2022 and 2023, Honeywell slightly reduced its allocation to private funds within its U.S. pension plans, from $1,258 million in 2022 to $1,265 million in 2023. However, the overall allocation to private investments remained relatively stable, with direct private investments increasing slightly from $1,284 million to $1,293 million. This suggests that while the company is maintaining a strategic presence in private investments, it may be prioritizing more liquid or diversified asset classes, such as fixed income and equities, to align with its long-term risk-adjusted investment objectives. The slight shift could indicate a cautious approach to capital deployment, emphasizing stability and returns in a more volatile market environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported numbers. According to the ground truth, Honeywell's investment in private funds was $1,244 million in 2022 and increased to $1,265 million in 2023. However, the LLM incorrectly states the 2022 amount as $1,258 million, which is inaccurate. Additionally, the LLM introduces 'direct private investments' ($1,284M to $1,293M), a metric not mentioned in the original answer or supported by the provided ground truth, making it factually unsupported. (2) The calculation of change is also flawed: the LLM implies a reduction from $1,258M to $1,265M, which is mathematically incorrect (this is actually an increase). The correct increase is from $1,244M to $1,265M, a 1.7% rise, which the LLM fails to compute accurately. (3) The reasoning is partially sound in interpreting strategic stability in private fund allocation, but it is undermined by incorrect data and the introduction of unverified categories like 'direct private investments'. The multi-hop synthesis is weak because it misrepresents the source data and invents metrics not present in the filings. (4) Despite the factual inaccuracies, the LLM attempts to address the question’s intent—analyzing capital deployment priorities—and provides a plausible qualitative interpretation (cautious strategy, risk-adjusted objectives), which maintains moderate contextual relevance. However, the core quantitative errors severely undermine the correctness and reliability of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 418,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B-2 Common Stock emerged as a new class following a class B-1 common stock exchange offer in May 2024, where 241 million shares of class B-1 common stock were exchanged for approximately 120 million shares of class B-2 common stock and 48 million shares of class C common stock. Prior to this exchange offer, no shares of Class B-2 common stock were outstanding. Class B-2 shares are subject to conversion rate adjustments with double the impact compared to Class B-1 shares and are tied to the resolution of U.S. covered litigation. As of September 30, 2024, 49 million shares of Class B-2 common stock were outstanding.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Class B-2 Common Stock was already in existence in 2023 and was subject to conversion rate adjustments tied to the U.S. litigation escrow account, causing dilution in as-converted shares. However, the LLM incorrectly states that Class B-2 'emerged as a new class' in May 2024 due to an exchange offer, which contradicts the original answer stating that no Class B-2 shares were outstanding *prior* to the Class B-1 exchange offer — implying Class B-2 existed structurally before but had zero outstanding shares. The LLM fabricates specific numbers: '241 million shares exchanged for 120 million Class B-2 and 48 million Class C' and '49 million shares outstanding as of September 30, 2024' — none of which appear in the ground truth, nor is there any mention of Class C stock or a May 2024 exchange event. (2) Quantitative accuracy is very low: all numbers (241M, 120M, 48M, 49M, May 2024, September 30, 2024) are either invented or misaligned with the source. The ground truth provides no quantitative data on actual exchanges or outstanding share counts in 2024, only noting the absence of disclosures beyond the pre-existing fact about no shares being outstanding before the exchange. (3) Multi-hop reasoning is flawed: instead of synthesizing the evolution of disclosure focus (from active dilution mechanics in 2023 to silence in 2024), the model invents a narrative around a non-mentioned exchange event and share conversions. It fails to capture the key point that 2024 disclosures lacked updates on conversion mechanics or dilution — suggesting reduced emphasis — and instead asserts active ongoing status with precise figures. (4) Contextual relevance is moderate because it addresses Class B-2 stock, its relationship to other classes, and changes over time, but the substance is factually incorrect. The core conclusion — that Class B-2 had no outstanding shares before the exchange — is partially correct and aligns with the ground truth, but this single accurate point is overshadowed by extensive fabrication. Overall, the answer misrepresents the timeline, introduces false events and numbers, and misses the true nature of the disclosure shift between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 608,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The financial obligations related to the Target Circle program significantly decreased between 2022 and 2024, with deferred revenue dropping from $89 million in 2022 to $19 million in 2025. This decline suggests that the program matured, with more rewards being redeemed or recognized over time, indicating improved engagement or changes in the structure of the program to accelerate reward fulfillment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that deferred revenue dropped from $89 million in 2022 to $19 million in 2025, but the question asks about changes between 2022 and 2024. The correct data points are: $89M as of January 29, 2022 (2022), $117M as of February 3, 2024 (2024), and then a drop to $19M as of February 1, 2025. The LLM incorrectly implies a decline between 2022 and 2024, when in fact there was a significant increase from $89M to $117M during that period. The $19M figure is from 2025, not 2024, so citing it as a 2024 value is a critical error. (2) Quantitative accuracy is low because the model misrepresents the direction and timing of changes. It omits the $117M 2024 figure entirely and incorrectly uses the 2025 number to represent 2024. Calculations or comparisons based on this are invalid. (3) The reasoning is partially sound in interpreting what a decline in deferred revenue might mean (e.g., increased redemptions or program changes), but it fails the multi-hop requirement by not acknowledging the increase from 2022 to 2024 before the later drop. The synthesis across years is flawed. (4) Contextual relevance is moderate because the answer discusses the right program and the general concept of deferred revenue as a liability, but the incorrect timeline undermines the validity of the conclusion about the program's evolution between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 395,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes increased from $980 million as of December 31, 2022, to $996 million as of December 31, 2023. This increase indicates improved investor perception or more favorable market conditions for Netflix's debt during this period, as the higher fair value suggests that the market is willing to pay more for these notes compared to their par value.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the fair value 'increased' from $980 million to $996 million, when in fact the ground truth indicates a decrease from $980 million to $996 million — this is a critical factual error. However, the numerical values themselves ($980 million on December 31, 2022, and $996 million on December 31, 2023) are accurate, which supports partial credit for quantitative accuracy. (2) The calculation of directionality (increase vs. decrease) is incorrect: $996M is greater than $980M, so the fair value actually increased numerically, but the original answer claims it 'decreased' — this contradicts both the numbers and logic. However, the LLM interprets the increase correctly as a movement toward par value and improved investor perception, which aligns with financial reasoning. (3) The multi-hop reasoning is partially sound: the model correctly identifies the two data points across years and draws a logical conclusion about investor perception based on fair value approaching par. However, it fails to notice the contradiction in the original answer’s claim of 'decreased' despite higher 2023 value. (4) The LLM answer is contextually relevant and provides appropriate interpretation of what changing fair value indicates about market conditions. Despite correct number usage, the contradiction in directional change and misrepresentation of the original answer’s claim leads to a low correctness and qualitative accuracy score. The model should have flagged the inconsistency or matched the ground truth's description. Quantitative accuracy is moderate because numbers are right but direction is misstated in response to a flawed original. Final scores reflect correct numbers but flawed logic and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 479,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, the equity structure for Class C Common Stock evolved through the May 2024 exchange offer, where 241 million shares of Class B-1 common stock were tendered, resulting in the issuance of 48 million shares of Class C common stock. This exchange offer marked the first issuance of Class C common stock, as no shares were outstanding in 2023. Additionally, Class C common stock is classified separately, with weighted-average shares outstanding increasing from 10 million in 2023 to 16 million in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that the exchange offer occurred in May 2024, while the ground truth indicates it took place in 2023. Second, it claims that no Class C shares were outstanding in 2023, which contradicts the original answer stating that approximately 48 million shares were issued in 2023 as part of the exchange. Third, the LLM asserts that Class C common stock outstanding increased from 10 million in 2023 to 16 million in 2024, but the ground truth clearly states that by 2024, only 10 shares (not million) were issued and outstanding—indicating a symbolic or nominal balance, not millions. (2) Quantitative errors include: wrong year (2024 vs 2023), incorrect share counts (10 million and 16 million vs actual 48 million issued in 2023 and 10 total shares in 2024), and misrepresenting the scale of shares (millions vs single digits). The 241 million Class B-1 tendered and 48 million Class C issued are correct numbers but misattributed to the wrong year. (3) The multi-hop reasoning is flawed: the model fails to correctly link the 2023 exchange with the stabilization in 2024, instead inventing a new event in 2024 and fabricating share count trends. It also misunderstands the nature of Class C stock as a transitional instrument that was effectively retired, not expanded. (4) Scores are low due to major factual and numerical errors, especially in timing and scale. Contextual relevance is moderate because the answer addresses equity structure evolution and share issuance, but the incorrect data renders the response misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 444,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "Lowe's engagement with Rough Plumbing has evolved from 2022 to 2024 in terms of business classification and service offerings. In 2022, Rough Plumbing was categorized under \"Building Products\" in the consolidated product division, grouped with categories like Building Materials, Electrical, Lumber, Millwork, and others. By 2024, Rough Plumbing was explicitly highlighted in the \"Installed Sales\" section, indicating an increased focus on offering installation services for this category. Additionally, Rough Plumbing was included in the categories covered by Lowe's Protection Plans and Repair Services, demonstrating an expansion in service offerings to enhance customer value and support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Rough Plumbing was classified under 'Building Products' in 2022 and transitioned to being part of 'Installed Sales' by 2024, with inclusion in Protection Plans and Repair Services. The shift from product-only to service-integrated offering is correctly identified. (2) There are no numeric inaccuracies; while the ground truth mentions 'approximately 5% of total sales attributed to installed sales in 2024', the LLM answer does not include this figure. However, it does not make any false claims about numbers, and the omission is minor given that the focus is on classification and service evolution rather than quantifying the sales impact. (3) The multi-hop reasoning is sound—correctly synthesizing changes in business classification and service expansion across years and departments within Lowe's. (4) Semantic equivalence is strong: 'categorized under Building Products' = 'classified under Building Products'; 'included in Protection Plans and Repair Services' = 'integrated into protection plans and installation services'. The only minor gap is the absence of the 5% installed sales context, which slightly reduces completeness but does not affect core correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 392,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "The Class B-2 common stock was introduced in 2024 as part of an exchange offer where 241 million shares of Class B-1 common stock were exchanged for approximately 120 million shares of Class B-2 common stock and 48 million shares of Class C common stock. This exchange resulted in the retirement of the tendered Class B-1 shares. Class B-2 common stock has double the impact of conversion rate adjustments compared to Class B-1 common stock. This indicates that Class B-2 common stock plays a distinct role in the company's capital structure, particularly in relation to conversion mechanics tied to litigation resolutions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Class B-2 common stock was introduced in 2023 with 77 million shares outstanding, but the LLM claims it was introduced in 2024 as part of an exchange offer involving 241 million Class B-1 shares and the issuance of 120 million Class B-2 shares—none of which aligns with the original answer. The ground truth states that by 2024, no Class B-2 shares were outstanding prior to the Class B-1 exchange offer, implying they were either retired or restructured, not newly issued. (2) Quantitative accuracy is poor: the LLM invents numbers (120 million Class B-2 shares, 48 million Class C shares, 241 million Class B-1 shares) that do not appear in the ground truth. The only number in the original answer is 77 million shares in 2023, which the LLM omits entirely. (3) Multi-hop reasoning is flawed—the LLM incorrectly frames the introduction of Class B-2 as occurring during a 2024 exchange, whereas the original answer indicates its introduction in 2023 and absence by 2024, suggesting removal or replacement. The LLM fails to capture this evolution and instead fabricates a role in conversion mechanics tied to litigation, which is not mentioned in the ground truth. (4) Contextual relevance is moderate because the answer discusses capital structure and stock classes, but the invented details and incorrect timeline severely undermine factual correctness. The qualitative reasoning about 'distinct role' is speculative and unsupported by the provided truth. Overall, the answer contradicts the ground truth on key facts and introduces unverified data, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 461,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The financial liability associated with the Target Circle program decreased significantly from $117 million in 2024 (as of February 3, 2024) to $19 million in 2025 (as of February 1, 2025). This decline in deferred revenue suggests that more rewards or benefits under the program were recognized or fulfilled during 2024, potentially indicating increased engagement and usage of the Target Circle program by members.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both direction and magnitude. The original answer states that no specific liability was disclosed in 2022, but by 2024 it had grown to $117 million, indicating growth. The LLM incorrectly claims a decrease from $117 million in 2024 to $19 million in 2025, which is not supported by the ground truth and introduces a future year (2025) not mentioned in the question or original answer. (2) Quantitative inaccuracies include the false claim of a $19 million liability in 2025 and misrepresentation of the trend—instead of showing growth (as per ground truth), it reports a decline. The $117 million figure for 2024 is correct, but it is misused in a comparative context that does not exist in the source. (3) The multi-hop reasoning fails because the model invents data for 2025 and reverses the trend. It also misinterprets the meaning of declining deferred revenue as a sign of growth, whereas the original answer interprets increasing liability as evidence of program expansion. The model does not correctly synthesize the absence of a disclosed figure in 2022 with the emergence of a $117M liability in 2024. (4) The contextual relevance is moderate because the answer discusses the right program (Target Circle) and the concept of deferred revenue/liability, but the incorrect data and flawed logic undermine the conclusion. The reasoning about member engagement has some plausibility but is based on fabricated numbers and an incorrect timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 414,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "NVDA's exposure to and concern about pollution limits between 2023 and 2024 have evolved as the company faces increasing regulatory pressures and operational challenges related to climate change and sustainability. In 2023, the company noted that new or proposed regulations on pollution limits could result in higher direct costs, such as changes to manufacturing processes and increased capital expenditures. By 2024, the concern expanded to include not only direct compliance costs but also indirect costs from suppliers and customers passing on their compliance expenses. Additionally, NVDA highlighted the potential impact of pollution limits on customer data center expansion, as regulations limiting energy or water availability could impair the ability of customers to expand their data center capacity and consume NVDA's products and services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: in 2023, NVDA identified pollution limits as a source of increased costs, including compliance, capital expenditures, and changes to manufacturing—this matches the original answer. By 2024, the concern expanded to include indirect costs and, critically, the impact on customer data center expansion due to regulatory constraints on land, permitting, energy, or water. The LLM correctly captures this evolution in concern from internal operational costs to external demand-side risks. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations, but all references to years (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes NVDA's evolving risk disclosures across two years and connects regulatory pollution limits to both operational impacts and downstream effects on customer behavior—specifically data center expansion, which directly affects demand for NVDA’s products. (4) The only minor shortcoming is that the LLM mentions 'energy or water availability' as regulatory constraints, while the original answer emphasizes 'land and permitting constraints' as the new 2024 risk. While energy and water are related, the emphasis differs slightly. However, this does not materially distort the core insight—that pollution-related regulations could limit customer expansion and thus demand. Overall, the answer is semantically equivalent, contextually relevant, and factually correct with only a slight nuance missing in specificity around 'land and permitting.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 455,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "Between 2023 and 2024, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary totaled approximately $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In July 2024, $77 of these Guaranteed Senior Notes were repaid, reducing the outstanding balance. No further issuances or repayments of these specific Guaranteed Senior Notes are noted for 2024 beyond this repayment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of $500 in Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 at fixed interest rates from 1.400% to 2.120%, valued using Level 3 inputs—this matches the ground truth. It accurately states that $77 of these notes were repaid in 2024 (specifically in July, which adds precision not in the original but does not contradict it). The answer correctly notes no further issuances or repayments beyond the $77 repayment. However, it omits the comparative fair value of long-term debt at the end of 2023 ($5,738) and 2024 ($5,412), which is a key part of the valuation evolution. While the repayment is covered, the broader context of overall fair value decline is missing, which slightly reduces completeness. (2) All numeric values—$500 issuance, $77 repayment, interest rate range, Level 3 inputs—are factually correct and match the ground truth. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly links the Japanese subsidiary to the issuance, identifies the nature of the debt, and connects the 2024 repayment to the reduction in outstanding balance. It synthesizes issuance and repayment across years correctly. The only gap is not connecting the repayment to the overall fair value trend in long-term debt, which was explicitly stated in the original. (4) The answer is highly relevant, directly addressing issuance, repayment, and fair value inputs. The omission of the aggregate fair value figures prevents a perfect score, but all other components are accurate and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 437,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024, Netflix increased its investment in streaming service improvements, as evidenced by higher personnel-related costs and cybersecurity measures. In 2022, technology and development expenses rose by 24%, driven by increased headcount to support production and streaming improvements. By 2024, the company emphasized its enterprise-wide cybersecurity program, including dedicated leadership (e.g., the Vice President of Security and Privacy Engineering) and regular risk assessments, to manage evolving threats. These changes reflect a strategic focus on enhancing service reliability and mitigating cybersecurity risks.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Netflix's investment from personnel growth in 2022 to cybersecurity emphasis in 2024, aligning with the ground truth's core narrative. However, it introduces a 24% increase in technology and development expenses in 2022 that is not present in the original answer; instead, the ground truth specifies a $384 million increase in personnel-related costs. This is a significant quantitative inaccuracy. (2) The original answer does not mention any percentage increase or the specific role of 'Vice President of Security and Privacy Engineering,' which appears to be additional or inferred detail not supported by the provided ground truth. While such roles may exist, their inclusion implies a level of specificity not confirmed in the source. (3) The multi-hop reasoning is sound—linking 2022 personnel investments to 2024 cybersecurity risk disclosures shows appropriate synthesis across years and themes. The shift from growth-focused spending to risk mitigation is accurately captured in spirit. (4) Despite incorrect quantification and added details, the overall qualitative trajectory and contextual relevance are strong. The answer addresses both personnel and cybersecurity changes and correctly frames them as part of a strategic evolution. Hence, correctness is reduced primarily due to unsupported numbers and specifics, warranting a 7 for overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 396,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "Between 2023 and 2024, The Bank of New York Mellon Corporation updated its approach to restricted stock unit (RSU) agreements by introducing the 2024 Form of Restricted Stock Unit Agreement, which was filed in 2024. This reflects a continued evolution in the lifecycle management of equity instruments, aligning with the company's broader executive compensation strategy to maintain competitive and performance-driven incentives. The filing of the 2024 RSU form suggests a refinement in structuring long-term incentives, potentially to better align with corporate governance standards and executive retention goals.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core fact that The Bank of New York Mellon Corporation introduced the '2024 Form of Restricted Stock Unit Agreement' in 2024, which aligns with the ground truth. It correctly identifies the introduction of the 2024 form as part of an evolving equity compensation strategy, and it reasonably infers implications for executive compensation such as retention and performance alignment. However, the answer is incomplete and partially inaccurate in its timeline: it states the 2024 form was 'filed in 2024', but according to the original answer, the 2024 form was actually introduced and filed in the 2023 filing (marked as 'Filed herewith' in 2023), not 2024. Furthermore, the LLM fails to mention the key evolution in 2024 — that the 2024 form transitioned to 'Previously filed' status and was replaced by the new '2025 Form' (filed herewith in 2024). This omission misses the annual iterative pattern of lifecycle management that is central to the ground truth. While the reasoning around strategic intent is plausible, it lacks the multi-hop synthesis of how filing status changes over time (newly filed → previously filed → replaced) to reflect a mature, forward-looking process. Quantitatively, there are no numbers to verify, but the dates and document statuses are misaligned. The answer is contextually relevant and well-structured but misses critical details that define the evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 396,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes were issued in November 2023 with a maturity date of April 15, 2029, and a carrying amount of $750 million at issuance (discount of $3.4 million). By February 2, 2025, the carrying amount remained at $743 million (as of January 28, 2024) and was adjusted to $744 million (as of February 2, 2025), reflecting amortization of the discount. The maturity timeline remains unchanged, with the notes maturing in Fiscal 2029.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance of the 4.90% Senior Notes in November 2023, the maturity date of April 15, 2029, the principal amount of $750 million, and the initial discount of $3.4 million. It accurately reports the carrying amount as $743 million as of January 28, 2024, consistent with the ground truth. However, the LLM introduces a future date—February 2, 2025—and a carrying amount of $744 million on that date, which is not present in the original answer and cannot be verified from the provided ground truth. This speculative forward-looking update reduces quantitative accuracy. (2) All provided numbers (issuance date, maturity date, principal, discount, carrying amount as of early 2024) are correct and consistent with the ground truth. The calculation of the initial carrying amount ($750M - $3.4M = $746.6M) is not explicitly shown, but the reported $743M likely reflects partial amortization by Jan 2024, which is plausible. However, the increase to $744M by Feb 2025 contradicts typical amortization patterns (carrying amount should approach par from below, not fluctuate up and down), suggesting a possible error in reasoning or data sourcing. (3) The multi-hop reasoning is mostly sound—linking issuance details in 2023 to carrying amount in 2024 is appropriate. However, the inclusion of a future carrying amount not in the source data indicates over-extrapolation or reliance on external data, weakening the qualitative accuracy. (4) Despite the speculative future value, the core facts about the notes’ structure and status from 2023 to 2024 are correct, and the answer directly addresses the question’s focus on carrying amount and maturity timeline. The contextual relevance is high as all information pertains directly to the evolution of the notes. The correctness score is 8 due to the otherwise accurate synthesis and only one significant deviation involving unverified future data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 523,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "In November 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. By July 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes, indicating a partial repayment of the issued debt within the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of four Guaranteed Senior Notes totaling approximately $500 in 2023 at fixed interest rates between 1.400% and 2.120%, and the repayment of $77 in 2024. It adds specific months (November 2023 and July 2024), which are not contradicted by the ground truth and may reflect additional precision. All numeric values (amounts, interest rates) are accurate and match the original answer. (2) Quantitative accuracy is perfect: $500 issuance and $77 repayment are correctly reported; interest rate range is exact; no calculation errors. Format variations are acceptable and consistent. (3) The reasoning is sound and reflects multi-hop synthesis between 2023 issuance and 2024 repayment. The LLM correctly links the notes issued in 2023 to the 2024 repayment, showing understanding of the debt instrument's evolution. The only minor omission is not explicitly mentioning that the 2024 filing referenced the proceeds as a source of financing activity, which adds context about ongoing financial engagement. This does not affect core facts but slightly reduces completeness. (4) The answer is highly relevant, directly addressing the evolution of the Guaranteed Senior Notes across the two years. The added temporal specificity (months) enhances clarity without introducing error. The correctness score is 9 due to the omission of the financing activity context; all other dimensions are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 401,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "From 2022 to 2023, the risk associated with competitors developing after-market parts for DHR's products has remained a concern, with no significant evolution noted in the provided documents. In both years, the risk is mentioned as a potential factor that could detract from DHR's sales. In 2022, the document highlights that competitors may develop after-market services and parts for DHR's products. In 2023, the same risk is reiterated, indicating that competitors may develop after-market services and parts, which could negatively impact DHR's sales and profitability. The impact on the company's business and financial statements is primarily through reduced sales and potential pricing pressures.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key qualitative shift in how DHR framed the risk of competitors developing after-market parts from 2022 to 2023. (1) What was correct: The answer correctly identifies that the risk was present in both years and could detract from sales and profitability, which aligns with the original answer. It also accurately notes the potential impact on sales and pricing pressures. (2) Quantitative accuracy: There are no numerical values in the question or answers, so this aspect is not applicable; the response contains no incorrect figures. (3) Multi-hop reasoning assessment: The LLM fails to capture the evolution in risk characterization — in 2022, it was described as a direct threat to sales and competitive position due to commoditization and private-label competition, while in 2023, it was reframed as one of several external pressures, being 'Impacted By' broader industry trends like cost containment and reimbursement policies, indicating a relative de-emphasis. This shift in tone and context is central to the question and was missed by the LLM, which claims 'no significant evolution noted.' (4) Justification for scores: Correctness is scored 5 because core facts (risk exists, impacts sales) are right, but the critical evolution in risk framing is omitted. Qualitative accuracy is 5 due to flawed reasoning in synthesizing the change in narrative. Quantitative accuracy is 10 because no numbers are involved and none are misstated. Contextual relevance is 8 because the answer addresses the general topic and impact on financials, but lacks depth on the evolution aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 444,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix's membership plans evolved with a focus on pricing adjustments and the introduction of new service features to address challenges such as member retention, competition, and content costs. In 2022, the average monthly revenue per paying membership increased by 5% year-over-year, driven by price changes and favorable foreign exchange fluctuations. By 2024, Netflix had introduced an ad-supported subscription plan as a lower-priced option, aiming to attract price-sensitive users while maintaining revenue per membership. Additionally, the company enforced stricter terms of use to limit shared viewing outside households. These changes were intended to counter membership cancellations, improve profitability, and manage rising content production costs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general direction of Netflix's strategy—introducing an ad-supported plan and cracking down on password sharing—but contains significant quantitative inaccuracies. The ground truth states that in 2022, Netflix saw a 7% rise in average monthly revenue per membership, not a 5% increase as claimed by the LLM. Additionally, the LLM omits key data such as the 19% total revenue growth and 11% growth in average paying memberships, which are central to understanding the 2022 performance. The drop in paid net membership additions by 50% year-over-year is also missing, which is a critical signal of the business challenges Netflix faced. (2) The quantitative inaccuracies affect the credibility of the analysis: the 5% figure for revenue per membership growth is incorrect and not supported by the ground truth (which reports 7%). No calculations are performed in the LLM answer, but the use of an incorrect base figure undermines the factual foundation. (3) The multi-hop reasoning is partially sound—the LLM correctly links the introduction of the ad-supported tier and enforcement of terms to challenges like competition and retention—but it fails to fully synthesize the evolution from 2022 performance indicators to 2024 strategic responses using the correct metrics. The business challenges are mentioned (retention, competition, content costs), but the ground truth emphasizes macroeconomic conditions and consumer pricing sensitivity more explicitly. (4) The contextual relevance is high because the answer addresses pricing strategy, service features, and business challenges as asked. Qualitative accuracy is moderate due to correct identification of strategic moves but incomplete and slightly inaccurate reasoning. Correctness is scored at 6 due to partially correct facts but significant omissions and one major numerical error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 508,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Between 2022 and 2023, Boeing's approach to in-orbit incentive payments has shown increased risk exposure due to technical and operational challenges, particularly in satellite programs. In 2023, the company highlighted that in-orbit incentive payments are recognized as revenue during the construction period based on the net present value of expected future payments. However, if satellites fail to meet performance criteria over up to 15 years, Boeing may face refund obligations and significant financial charges. The 2023 filing emphasizes heightened financial risks compared to 2022, reflecting ongoing production disruptions, supplier issues, and technical delays that could trigger losses or reduce expected incentive revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in Boeing's approach to in-orbit incentive payments, noting increased risk exposure and the recognition of revenue during construction based on net present value. It also correctly identifies the 15-year performance period and the risk of refund obligations if performance criteria are not met. However, it omits the key quantitative detail from the ground truth: the $1,585 million in additional losses recorded in 2023 on Boeing's five most significant fixed-price development programs. This is a significant omission because the question specifically asks about financial recognition and risk exposure, and the dollar amount is central to the 2023 update. (2) No incorrect numbers are stated, but the absence of the $1,585 million figure results in a partial failure on quantitative accuracy. The LLM does not contradict any numbers, but fails to include the critical financial metric provided in the original answer. (3) The multi-hop reasoning is sound—comparing 2022's general risk acknowledgment to 2023's more detailed financial exposure—and the synthesis across years is logical and relevant. The LLM correctly infers that earlier revenue recognition increases financial risk if performance fails later, which aligns with the ground truth. (4) The contextual relevance is high, as the answer directly addresses risk exposure and financial recognition over time. The qualitative accuracy is strong due to correct entity identification (Boeing, in-orbit incentive payments, fixed-price programs) and accurate description of revenue recognition practices. However, the lack of the specific loss amount reduces the correctness score to 7, as this is a core element of the 2023 update.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 476,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "Between 2023 and 2024, the Directors' Code of Conduct remained accessible on BNY Mellon's website, with no indication of substantive changes in its disclosure. In both years, the Code was explicitly referenced and available at the same URL, demonstrating consistent accessibility and commitment to transparency regarding director ethical standards.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. While it correctly states that the Directors' Code of Conduct remained accessible on BNY Mellon's website, it falsely asserts that the URL was 'explicitly referenced and available at the same URL' in both years. According to the ground truth, in 2024 the direct URL was no longer provided and the Code was only mentioned as part of a broader list of governance materials. This misrepresents a key evolution in disclosure practices. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the question asks about the evolution in disclosure and accessibility, requiring comparison across two years. The LLM fails to recognize the shift from explicit URL disclosure in 2023 to implicit reference in 2024, missing the nuanced change in transparency approach. Instead, it incorrectly concludes there was 'no indication of substantive changes,' contradicting the ground truth. (4) Contextual relevance is moderate—the response addresses the topic of accessibility and the company’s website, but omits the critical detail about the change in disclosure specificity, leading to an inaccurate overall conclusion. The answer downplays the evolution that actually occurred, resulting in a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 402,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, the role and deployment strategy of Mobileye Drive™ evolved to focus more on fleet deployment and partnerships for autonomous mobility-as-a-service (AMaaS). In 2022, Mobileye emphasized its role in both Robotaxi services and consumer autonomous vehicles (AVs), with initiatives like the Robotaxi project with SIXT and collaborations for commercial use. By 2023, Mobileye Drive™ was positioned as a self-driving system designed for transportation network companies, public transit operators, and suppliers of AV-ready platforms, with plans to bundle it with Moovit's urban mobility application. This shift reflects a strategic move toward scalable, eyes-off/hands-off autonomous solutions for commercial and fleet operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mobileye Drive™’s strategy from 2022 to 2023, emphasizing a shift toward fleet deployment and mobility-as-a-service (MaaS/AMaaS). It accurately notes the 2023 focus on transportation network companies, public transit operators, and AV-ready platform suppliers, as well as the bundling with Moovit’s application. However, it incorrectly cites a ‘Robotaxi project with SIXT’ in 2022, which is not present in the ground truth. Instead, the original answer mentions collaborations with Udelv (autonomous cargo) and Transdev (self-driving mobility), plus a consumer L4 design win with Geely—details omitted in the LLM response. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; all temporal references (2022, 2023) are correct. (3) The multi-hop reasoning is mostly sound: the model correctly infers a strategic pivot from broader autonomous applications to targeted commercial fleet and MaaS ecosystems. However, it substitutes specific partnerships (SIXT) not in the original data, introducing an entity error, and misses key collaborations (Udelv, Transdev, Geely), reducing completeness. (4) The correctness score is 8 because core strategic evolution is accurately conveyed, but there are notable omissions and one incorrect entity. Qualitative accuracy is slightly lower due to the substitution of partnerships. Contextual relevance and quantitative accuracy are perfect as the response directly addresses the question and contains no numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 446,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "The structure and distribution rate of the Tower Preferred Interests evolved significantly from 2022 to 2024. In 2022, the Tower preferred interests consisted of two series: Class A-1 with a $1,500 value and a 5.0% initial distribution rate, and Class A-2 with a $4,500 value and a 4.75% initial distribution rate, both resetting every five years. By 2024, these were restructured into Fixed Rate Class A and Floating Rate Class A Limited Membership Interests. The Fixed Rate Interests pay a 5.90% distribution, while the Floating Rate Interests pay a distribution equal to SOFR plus 250 basis points, with a potential value of $525 by 2028 if not called earlier. This restructuring introduced a hybrid fixed and floating rate structure, enhancing flexibility in response to market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the Tower Preferred Interests from 2022 to 2024. (1) Quantitatively, all key numbers are correct: the 2022 structure with Class A-1 ($1,500, 5.0%) and Class A-2 ($4,500, 4.75%) is accurately reported, as is the 2024 shift to Fixed Rate Interests (5.90%) and Floating Rate Interests (SOFR + 250 bps). The mention of a potential value of $525 by 2028 is not present in the ground truth and appears to be an addition not supported by the original data—this is a minor factual overreach, though it does not contradict the core facts. (2) The restructuring date (August 2024) is omitted, which is a minor omission, but the overall timeline is correctly framed as a 2024 change. (3) The qualitative reasoning is sound: the LLM correctly identifies the shift from two fixed-rate series to a hybrid fixed/floating structure, correctly names the new classes (Fixed Rate and Floating Rate Class A Limited Membership Interests), and accurately describes the distribution mechanisms. (4) The answer is contextually excellent—directly addressing the structural and rate evolution as asked. The only deductions are for the unsupported $525 figure and the missing August 2024 amendment date, preventing a perfect score. Overall, the answer is factually strong, well-reasoned, and semantically equivalent to the ground truth with minor embellishment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 387,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The Balanced Index Fund, which comprises approximately 60% equities and 40% debt securities, is valued using a market approach based on quoted market prices (Level 1). For Level 3 assets related to this fund, the unrealized gains/(losses) evolved from 2022 to 2023 as follows: in 2022, there were significant losses, including ($16) for corporate fixed income, ($11) for mortgage-backed and asset-backed securities, and ($14) for municipal bonds. In contrast, 2023 showed gains, with $2 for corporate fixed income, $6 for mortgage-backed and asset-backed securities, and $3 for other fixed income, indicating an improvement in the unrealized performance of these Level 3 assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Balanced Index Fund's allocation (60% equities, 40% debt) and the shift from unrealized losses in 2022 to gains in 2023 for Level 3 assets. It accurately reports the $2 million gain for corporate fixed income and $6 million for mortgage-backed and asset-backed securities in 2023, matching the ground truth. However, it introduces two incorrect figures not present in the original answer: ($14) million loss for municipal bonds in 2022 and $3 million gain for 'other fixed income' in 2023, which are not mentioned in the ground truth and represent factual inaccuracies. Additionally, while the ground truth notes a change in valuation methodology in 2023 (explicit reference to Level 1 market approach), the LLM incorrectly implies that the Balanced Index Fund itself is valued using Level 1, when the original answer discusses Level 3 assets within the fund and a broader shift toward more transparent valuation practices. (2) Quantitative accuracy is partially compromised due to the inclusion of unsupported numbers (municipal bonds, other fixed income), though the core numbers ($16M, $11M losses in 2022; $2M, $6M gains in 2023) are correct. (3) The multi-hop reasoning is generally sound—comparing 2022 to 2023 performance and noting a turnaround—but incorrectly extends the data beyond what was reported. The synthesis across years is valid, but the addition of unverified asset categories weakens the reasoning. (4) Scores reflect mostly correct core facts with significant but not central errors: correctness docked to 7 due to extra, false data points; quantitative accuracy at 6 due to incorrect numbers; qualitative accuracy at 8 for good structure and logic despite overreach; contextual relevance remains high at 9 as the response directly addresses the evolution of investment approach and unrealized gains/losses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 509,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "Between 2023 and 2024, BNY Mellon's emphasis on accounting developments in its forward-looking statements remained consistent in acknowledging their potential material impact on financial reporting. However, the 2024 filing reflects a broader integration of these considerations into strategic priorities, particularly in the context of regulatory changes and evolving financial frameworks. This evolution suggests that accounting standards are increasingly shaping BNY Mellon's strategic decisions, as the firm aligns its operations and disclosures with new or revised standards to ensure compliance and transparency.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in spirit but lacks specific textual evidence from the 2023 and 2024 filings that the original answer includes. (1) What was correct: The LLM correctly identifies a shift in emphasis—accounting developments becoming more integrated into strategic priorities between 2023 and 2024. It accurately captures the evolving influence of accounting standards on strategic decisions, mentioning regulatory changes and financial frameworks. There are no numeric values to verify, so quantitative accuracy is 10 by default. (2) What was incorrect/missing: The LLM omits the specific language evolution—e.g., in 2023, accounting developments were listed among other factors, while in 2024, the phrasing expanded to include 'the impacts of such developments on our businesses' and linked to 'capital plans including dividends and repurchases' and 'efficiency savings.' These concrete details are central to the original answer and demonstrate the multi-hop synthesis of changes in disclosure language and their strategic implications. (3) Multi-hop reasoning assessment: The LLM recognizes the trend but does not fully synthesize the exact textual changes across years or connect them to specific business decisions as shown in the ground truth. The reasoning is sound but less precise. (4) Justification: The correctness score is 7 because the core idea—increased integration of accounting standards into strategy—is accurate, but key details that demonstrate the evolution are missing. Qualitative accuracy is 7 due to incomplete synthesis; contextual relevance is high (9) as the response stays focused and relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 457,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "In 2023, the evolution of risks related to store safety and cybersecurity introduced potential negative impacts on the associate experience, such as increased costs, operational challenges, and reduced morale due to safety concerns and the need for additional security measures. This contrasts with the engagement-focused initiatives in 2022, which emphasized associate development, recognition, and a supportive culture to foster emotional commitment and improve the overall associate experience.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It correctly contrasts 2022 engagement initiatives (recognition, development, supportive culture) with 2023 risks around store safety and cybersecurity, accurately capturing the shift in focus and its potential negative impact on associate morale and experience. (2) There are no numeric values, percentages, or financial figures in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 vs 2023), initiatives (engagement vs risk exposure), and their implications for associate experience. However, it omits specific details from the ground truth such as the 'four out of five associates emotionally committed' statistic and the mention of organized retail crime and data compromise as specific threats that could erode trust and impact retention. These omissions reduce completeness slightly but do not invalidate the core correctness. (4) Contextual relevance is high—the response directly addresses the comparative evolution of risks and initiatives and their impact on associates. The answer is semantically equivalent in key aspects but lacks some depth in elaborating the specific mechanisms (e.g., trust erosion, reputation damage) noted in the original. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 430,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "The role of the learning curve in influencing cost and production estimates between 2022 and 2023 has become increasingly critical due to heightened production complexities and regulatory scrutiny, particularly for programs like the 787 and 777X. In 2022, learning curve challenges contributed to rework, delivery delays, and abnormal production costs, impacting program profitability. By 2023, the learning curve remained a key factor in cost estimation, with ongoing production stability efforts and supplier coordination affecting profitability and risk management. The evolving learning curve dynamics were explicitly tied to cost projections and gross margin estimates, with even small changes in assumptions potentially impacting earnings by hundreds of millions of dollars.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of dates (2022 vs 2023), programs mentioned (787, 777X), and the general evolution of the learning curve's role in cost and production estimates. There are no specific numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—scored 10. The answer correctly identifies that in 2022, the learning curve contributed to rework, delays, and abnormal costs affecting profitability. It also acknowledges that by 2023, learning curve dynamics were tied to cost projections and gross margin estimates, which aligns with the ground truth. However, the LLM answer falls short in fully capturing the conceptual shift described in the original answer: from the learning curve being a 'risk factor' in 2022 to being integrated as a 'predictable and manageable component' of planning in 2023. The LLM frames it as still a 'key factor' and 'challenges' without emphasizing the strategic shift toward normalization and incorporation into estimation models. This omission affects qualitative accuracy, as the multi-hop reasoning—synthesizing a change in risk perception and management approach—is incomplete. Contextual relevance is high, as all content directly addresses the question’s focus on cost, production, profitability, and risk. Thus, correctness is partially impacted due to missing the core conceptual evolution, warranting a 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 398,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "Between the 2023 and 2024 SEC filings, the disclosure regarding officer and director participation in the Dividend Reinvestment Plan remains consistent, with both filings noting that certain officers or directors participate in the plan and may have shares withheld to cover taxes or pay stock award exercise prices. However, in 2024, the disclosure explicitly references these arrangements as potentially falling under Rule 10b5-1 trading plans or non-Rule 10b5-1 trading arrangements, as defined in Item 408(c) of Regulation S-K, providing greater clarity on the regulatory framework governing such transactions. There is no indication of substantive changes in officer or director participation in the plan itself.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim about the evolution of disclosure between the 2023 and 2024 filings. According to the ground truth, the 2023 filing included a detailed description of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements, while the 2024 filing omitted this detail, indicating a reduction in specificity. However, the LLM answer incorrectly states that the 2024 filing 'explicitly references' these trading arrangements, suggesting increased clarity and regulatory detail—this is the opposite of the truth. There are no numeric values in the question or answer, so quantitative accuracy is not applicable in a traditional sense, but the years (2023, 2024) and regulatory references (Rule 10b5-1, Item 408(c)) are correctly named, warranting full marks for quantitative accuracy. The qualitative accuracy is very low because the reasoning is flawed: the model fails to correctly synthesize the multi-hop information across the two filings and reverses the direction of change in disclosure. Contextual relevance is moderate—the answer addresses the right topic (officer/director participation in the Dividend Reinvestment Plan and related trading arrangements) and mentions correct contextual elements (tax withholding, stock award payments, Regulation S-K), but draws an incorrect conclusion about the evolution of disclosure. Thus, while the entities and general subject matter are accurate, the central factual claim about the change in disclosure is inverted, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 421,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot's investment in creating an interconnected shopping experience increased from $2.6 billion in fiscal 2021 to $3.2 billion in fiscal 2023. Specific changes in tailoring this experience to customers include enhanced digital capabilities, such as improved mobile app functionality, personalized marketing, and expanded fulfillment options (e.g., same-day or next-day delivery). Additionally, in-store improvements like wayfinding signage, self-checkout options, and mobile tools for associates were implemented to create a seamless, frictionless experience across channels.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The original answer states that The Home Depot invested $2.6 billion in capital expenditures in fiscal 2021 focused on interconnected experience, but the LLM incorrectly claims this increased to $3.2 billion in fiscal 2023—this figure is not supported by the ground truth and introduces a false numeric progression. There is no mention in the original answer of the $3.2 billion figure or any specific increase in investment by 2023, so this is a major factual error. (2) While the $2.6 billion figure for fiscal 2021 is correctly cited, the absence of verification for the 2023 amount and the invention of a precise but incorrect number severely undermines quantitative accuracy. No calculation is possible from the original data to support a $3.2 billion figure. (3) Qualitatively, the LLM provides plausible but unverified details about mobile apps, personalized marketing, and in-store improvements. However, the original answer emphasizes a strategic shift toward using 'enhanced merchandising information technology tools' to tailor the experience based on 'shopping intent and location'—a specific, data-driven personalization strategy. The LLM generalizes this into broader digital and operational enhancements without capturing the core evolution in reasoning: from general investment to intent- and location-based personalization via IT tools. (4) Contextually, the answer is relevant and addresses both parts of the question—evolution over time and changes in tailoring—but fails on factual fidelity. It fabricates financial data and substitutes specific strategic shifts with generic improvements, resulting in partial correctness on structure but major errors in substance. Thus, while the direction of the response is appropriate, its factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 510,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "Between 2022 and 2023, the financial relationship between DHR and Aldevron primarily involved capital investment and acquisition-related expenditures. In 2021, DHR acquired Aldevron for approximately $9.6 billion, financing the acquisition using cash on hand and proceeds from commercial paper. The acquisition added approximately $6.1 billion in goodwill to DHR’s balance sheet. By 2023, there were no further acquisitions of Aldevron, as it had already been fully integrated into DHR’s Life Sciences segment. However, DHR continued to invest in capital expenditures to support Aldevron’s operations, particularly in expanding manufacturing capacity for biopharma products.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in timing and amounts. It incorrectly states that DHR acquired Aldevron in 2021 for $9.6 billion, while the ground truth indicates the acquisition-related cash payment occurred in 2023, amounting to $9,561 million (~$9.56 billion), which is close in value but misattributed to the wrong year. This error fundamentally undermines the chronological evolution of the financial relationship. Additionally, the mention of $6.1 billion in goodwill is not present in the ground truth and cannot be verified, representing an unsupported claim. (2) The quantitative accuracy is low: while $9.6 billion is approximately equivalent to $9,561 million (allowing for rounding), placing the acquisition in 2021 instead of 2023 is a critical error. The ground truth specifies that 2022 involved anticipated capital expenditures of $1.5 billion (partially for Aldevron-related capacity), which the LLM fails to mention at all. Instead, it fabricates details about financing via commercial paper and goodwill, which are not in the original answer. (3) The reasoning is partially sound in recognizing that Aldevron transitioned from a target to an integrated entity by 2023 and that capital investments continued post-acquisition. However, it fails the multi-hop synthesis: it does not connect 2022's capital investment plans (as precursors to acquisition integration) with the 2023 cash outflow, instead misrepresenting the timeline. The evolution from capital investment to full acquisition is thus misrepresented. (4) Contextual relevance is high because the answer addresses capital investment and acquisition expenditures and focuses on the correct entities (DHR, Aldevron) and integration into the Life Sciences segment. However, due to major factual and temporal inaccuracies, especially regarding the acquisition date and financial figures beyond the purchase price, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 533,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, the total value of Telco LLC's preferred interests increased from $7,250 million in 2023 to $7,250 million in 2024, remaining unchanged. The structure evolved with the planned issuance of an additional $2,250 of Telco Class A-4 preferred interests in 2025, which will carry an initial distribution rate of 5.94% and reset every four years starting in 2028. Previously, the Telco Class A-1 had a 4.25% distribution rate with a seven-year reset, while Telco Class A-2 and A-3 had an initial rate of 6.85% with a reset on November 1, 2027, and every seven years thereafter.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that Telco LLC had $7,250 million in preferred interests in 2023, but the ground truth indicates that the $7,250 total was reached by 2024 after an April 2023 issuance of $5,250 (not $2,250 as implied). The LLM also falsely claims a $2,250 issuance of 'Class A-4' interests planned for 2025, which is not mentioned in the original answer and contradicts the timeline. The initial 2022 value is misrepresented — the ground truth specifies $2,000 in 2022, not $7,250 in 2023. (2) Quantitative inaccuracies include: wrong dollar amounts (e.g., $7,250 million vs. $7,250 — note 'million' is incorrectly added), incorrect issuance amount ($2,250 vs. $5,250), wrong year for total value, and fabricated future issuance. The distribution rates for A-2 and A-3 (6.85%) and reset date (Nov 1, 2027) are correct, as is the A-1 rate (4.25%) and seven-year reset, but these are outweighed by major errors. (3) Multi-hop reasoning fails: the model misrepresents the evolution from 2022 to 2024, omits the key 2023 issuance that expanded the capital structure, and introduces non-existent instruments (Class A-4). It does not correctly trace the progression from $2,000 to $7,250 via the $5,250 addition. (4) The contextual relevance is moderate because it discusses distribution rates and resets correctly for existing classes, but the structural evolution and total value changes are fundamentally wrong, undermining the core of the question. Correctness and quantitative accuracy are severely penalized due to incorrect totals, fabricated data, and timeline confusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 451,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "Between 2022 and 2024, AIG's use of Expected Loss Ratio Methods has evolved to incorporate more nuanced applications across various insurance lines. In 2022, the Expected Loss Ratio method was primarily used for short-tail classes such as U.S. Property, where it was applied alongside frequency/severity and loss development methods. By 2024, the Expected Loss Ratio method was extended to the latest accident years for U.S. Excess Casualty, reflecting a strategy to address the high attachment points and long-tail nature of these policies. The rationale for this application was to better account for the variability and delayed emergence of claims, especially in layers with high deductibles and limited access to underlying policy data. Additionally, the method was weighted more heavily in the most recent five accident years, adjusted for rate changes, loss trends, and market conditions, to improve the accuracy of loss estimates in an evolving underwriting environment.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and misrepresents AIG's use of Expected Loss Ratio (ELR) methods between 2022 and 2024. (1) The original answer states that in 2022, ELR methods were primarily used for the latest accident year and in aviation exposures due to high severity, but the LLM claims they were used for U.S. Property, which is not supported. By 2024, the ground truth indicates expansion into U.S. Workers' Compensation, a long-tail line, whereas the LLM incorrectly states the method was extended to U.S. Excess Casualty. These are distinct lines of business and represent a significant factual divergence. (2) There are no explicit numbers (e.g., percentages, dollar amounts, years) in the question or ground truth, so quantitative accuracy is not penalized for numeric errors per se, but the incorrect attribution of methods to wrong insurance lines undermines factual precision. (3) The multi-hop reasoning is flawed: the LLM fabricates a narrative about U.S. Excess Casualty and high attachment points without evidence in the ground truth, and invents a weighting strategy over five accident years with adjustments for rate changes and trends, which is not mentioned in the original. (4) While the LLM attempts to address the evolution of ELR methods and provides a plausible rationale (e.g., delayed claim emergence), the entities (insurance lines) and their temporal application are incorrect, leading to a low correctness score. Contextual relevance is moderate because the answer discusses the right topic (evolution of ELR methods) and offers a reasonable structure (change over time, rationale), but the core factual content is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 458,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "From 2023 to 2024, Target has emphasized strengthening its owned brands portfolio as a core element of its strategy, focusing on curating leading national brands and expanding signature partnerships. In 2024, the company highlighted its owned and exclusive brands, including a broader list of brand names, and continued to leverage global sourcing operations to ensure product quality, value, and ethical practices. This reflects a strategic shift toward enhancing brand differentiation and value, aligning with efforts to drive customer loyalty and market share growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Target's strategic emphasis on owned brands from 2023 to 2024 and notes the expansion and execution of exclusive brands in 2024, which aligns with the ground truth. However, it misses the specific detail that Target listed *over 40 distinct brands* in 2024, a key quantitative indicator of portfolio development mentioned in the original answer. While the LLM mentions a 'broader list of brand names,' it does not quantify this, resulting in a partial omission. (2) There are no numerical inaccuracies—no incorrect numbers, dates, or financial figures are presented. The years 2023 and 2024 are correctly used, and no false metrics are introduced. (3) The reasoning is generally sound: the LLM recognizes the strategic continuity and evolution from portfolio expansion to execution and differentiation. However, it adds details not present in the ground truth, such as 'curating leading national brands' and 'global sourcing operations,' which were not part of the documented shift. These additions, while plausible, are not supported by the original data and slightly distort the focus. (4) The answer is contextually relevant and addresses both strategic emphasis and product portfolio development. The core facts are correct, but the lack of the 'over 40 brands' detail and the inclusion of unsupported elements prevent a higher score. The answer captures the essence but lacks full fidelity to the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 404,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's continued listing of the 0.875% Notes due 2030 alongside the new 2.900% Notes due 2030 in 2024 suggests a strategy to diversify its long-term debt structure, potentially to take advantage of favorable market conditions for issuing debt at varying interest rates. The issuance of the higher-yield 2030 Notes may indicate confidence in stable borrowing costs and a desire to lock in rates amid a potentially shifting interest rate environment, while maintaining lower-cost debt through the existing 0.875% Notes. This approach reflects a balanced and opportunistic approach to managing IBM's capital structure and optimizing financing costs over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two notes—0.875% and 2.900% Notes due 2030—and their coexistence in 2024, which aligns with the ground truth. All numeric values (interest rates, maturity year) are accurate, satisfying quantitative accuracy. (2) There are no calculation errors, and the dates and percentages match the original answer exactly. Format is consistent and precise. (3) The reasoning partially aligns with the ground truth but misses a key insight: the significant rate increase from 0.875% to 2.900% for the same maturity suggests deteriorating market conditions for borrowing, not necessarily favorable ones. The LLM incorrectly frames the higher-yield issuance as possibly reflecting 'favorable market conditions' and 'confidence in stable borrowing costs,' which contradicts the implication of rising coupon rates—typically a sign of higher borrowing costs or tighter monetary conditions. The ground truth emphasizes that the rate jump may reflect less favorable conditions, whereas the LLM portrays it as opportunistic timing. (4) Despite this misinterpretation of market conditions, the LLM correctly infers debt diversification and capital structure management as strategic motives, which is contextually relevant and semantically aligned with part of the original conclusion. Thus, while the factual elements are correct, the qualitative reasoning downplays the shift in financing costs and misattributes the rationale for issuing higher-rate debt, leading to a moderate deduction in qualitative accuracy. Correctness score reflects mostly accurate facts but flawed economic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 447,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "Between 2022 and 2024, AT&T's long-term debt composition evolved with the addition of new long-term notes, including the 4.000% Global Notes due June 1, 2049, which remained part of AT&T's debt structure in both years. In 2024, new long-term notes were issued, such as the 3.550% Global Notes due November 18, 2025, and the 0.250% Global Notes due March 4, 2026, reflecting AT&T's ongoing strategy to manage its debt maturity profile and access capital markets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that the 4.000% Global Notes due June 1, 2049 were 'added' or newly included between 2022 and 2024, when according to the ground truth, these notes were already present in 2022 and remained in 2024. More critically, the LLM invents entirely incorrect debt instruments: the '3.550% Global Notes due November 18, 2025' and the '0.250% Global Notes due March 4, 2026'—neither of which appear in the ground truth. The actual new instrument added was the 4.300% Global Notes due November 18, 2034 (T 34C), which the LLM fails to mention. (2) Quantitative accuracy is very low: two out of three interest rates and two out of three maturity dates are incorrect. The only correct numeric element is the 4.000% rate and June 1, 2049 maturity, though even the reasoning around this is flawed. (3) Multi-hop reasoning is poorly executed: the model fails to correctly compare AT&T’s debt instruments across 2022 and 2024, misidentifies what was added, and does not recognize that the 2049 notes were pre-existing. It also does not reference the correct ticker symbols or note series (T 49A, T 34C), indicating a failure in entity tracking. (4) Contextual relevance is moderate because the answer addresses debt composition changes and mentions a plausible strategic rationale, but the factual foundation is unsound, undermining the entire response. The core of the question—evolution involving the 2049 notes and new issuances—is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 420,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "Between 2023 and 2024, the financial impact of the Heritage AspenTech acquisition evolved as follows: intangibles amortization increased significantly from $258 million in 2023 to $560 million in 2024, driven by the full-year impact of the Heritage AspenTech acquisition and the newly acquired National Instruments (NI) business. Restructuring costs related to Heritage AspenTech were minimal in 2023 at $1 million but rose to $8 million in 2024, reflecting ongoing integration and operational adjustments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, intangibles amortization decreased from $258 million in 2023 to $97 million in 2024, but the LLM claims it increased to $560 million in 2024—this is a major factual error. Similarly, restructuring costs in the ground truth rose from $72 million to $228 million, but the LLM states they were only $1 million in 2023 and $8 million in 2024—again, completely wrong. (2) All numeric values are incorrect: amortization ($258 → $97 vs. LLM's $258 → $560), restructuring costs ($72 → $228 vs. LLM's $1 → $8). The LLM also introduces 'National Instruments (NI)' business, which is not mentioned in the original answer and appears to be hallucinated. (3) The multi-hop reasoning is flawed—the LLM fails to correctly synthesize the evolution of two key financial metrics over time and introduces irrelevant entities, indicating a failure in both data retrieval and logical inference. (4) The contextual relevance is moderate because the answer addresses the right topic (financial impact of the Heritage AspenTech acquisition) and the correct metrics (intangibles amortization, restructuring costs), but with entirely incorrect values and explanations, leading to a very low correctness and quantitative accuracy score. The qualitative accuracy is slightly higher only because the structure and intent of the response align with the question format.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 403,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods for workers' compensation between 2022 and 2024 has evolved to place significant weight on these methods for business written in excess of a deductible, particularly in the most recent five accident years. This approach accounts for changes in market conditions, rate adjustments, and inflation. The segmentation of business types has become more refined, with AIG analyzing subsets like U.S. government subcontractor accounts and construction wrap-up business separately due to their unique characteristics. Additionally, the increasing proportion of large deductible accounts has slowed claim reporting patterns, prompting AIG to adjust its reserving methodologies accordingly.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but misses key distinctions and introduces inaccuracies in the evolution of AIG's methodology between 2022 and 2024. (1) Correctly identifies that expected loss ratio methods are applied more heavily to excess of deductible business over multiple accident years (specifically five, as in ground truth), and notes the increasing proportion of large deductible accounts slowing claim reporting—this aligns with the original answer. (2) Quantitatively, there are no explicit numerical errors (e.g., years like 'five accident years' are accurate), so quantitative accuracy is high. (3) However, the qualitative reasoning is flawed: the LLM incorrectly suggests segmentation includes 'U.S. government subcontractor accounts and construction wrap-up business,' which are not mentioned in the ground truth. Instead, the actual 2024 refinement was segmentation by deductible size and claim handling (AIG vs. third-party administrators), which the LLM omits entirely. Additionally, the LLM fails to mention the 2024 emphasis on limitations in claim count data due to aggregation and reinsurance exclusions—a key qualitative shift not present in 2022. (4) The answer is contextually relevant and addresses the general evolution, but lacks precise multi-hop synthesis: it does not contrast 2022 (expected loss ratios primarily for guaranteed cost in most recent year) versus 2024 (greater segmentation and data limitations noted). Thus, while core themes like slowed reporting due to large deductibles are correct, the specific evolution in segmentation and disclosure practices is misrepresented or incomplete, warranting a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 457,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "From 2023 to 2024, Target enhanced its Cyber Fusion Center operations by emphasizing proactive threat intelligence, advanced tools, and internal technologies to detect, investigate, and respond to cybersecurity threats. In 2024, the company further expanded its collaboration with external organizations across industries to share threat intelligence, best practices, and combat cybercrime. These efforts reflect a more integrated and strategic approach to cybersecurity, aligning with evolving threats and regulatory environments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key details from the ground truth, particularly around the specific evolution in Target's cybersecurity approach from 2023 to 2024. (1) What was correct: The answer correctly notes that Target operated its Cyber Fusion Center in both years and expanded collaboration with external organizations in 2024, which aligns with the ground truth. It also appropriately highlights proactive threat detection and intelligence sharing. (2) Quantitative accuracy: There are no numeric values in the question or answers, so this aspect is not applicable; no errors present. (3) Multi-hop reasoning assessment: The model fails to mention critical 2024 enhancements such as the structured incident response program, coordinated escalation model to management and the Board, regular training and compliance activities for team members, and use of third-party vendors to assess and test the cybersecurity program—key differentiators in maturity between 2023 and 2024. These omissions represent a failure to fully synthesize the multi-hop evolution across time and operational domains. (4) Justification: While the answer captures the general direction of improvement and maintains contextual relevance, it lacks specificity and completeness in describing the actual changes, especially internal programmatic developments. This results in a moderate correctness score. The qualitative accuracy is reduced due to incomplete reasoning and missing key facts, even though the overall narrative is plausible and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 422,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Eli Lilly's financial relationship with Baqsimi evolved significantly between 2023 and 2024, particularly through the sale of rights. In 2023, Baqsimi contributed $677.6 million in revenue, primarily from U.S. sales. However, in 2024, the revenue related to Baqsimi was not explicitly listed in product revenue, as the rights for Baqsimi were sold in 2023, shifting the financial arrangement from product sales to collaboration and other revenue. This sale is reflected in the 2024 10-K under collaboration revenue, which includes proceeds from the sale of rights. Thus, the contractual arrangement transitioned from direct product revenue to a collaboration-based revenue model following the sale of rights in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the reported 2023 revenue for Baqsimi: it states $677.6 million, while the ground truth is $579.0 million. This discrepancy is material and undermines the quantitative accuracy. No other specific numbers are provided for 2024, which aligns with the ground truth's lack of a standalone figure, so that aspect is acceptable. (2) The key event—the sale of rights in 2023 leading to a shift in revenue recognition from product sales to collaboration and other revenue in 2024—is correctly identified and conceptually accurate. However, the misstatement of the core financial figure reduces confidence in the data source and affects overall correctness. (3) The multi-hop reasoning is partially sound: the model correctly infers that after the sale of rights, Baqsimi revenue is no longer reported as a standalone product but is subsumed into broader collaboration revenue. This reflects an understanding of revenue recognition changes post-transaction. However, the answer incorrectly implies the sale occurred in 2023 (which may be correct) but attributes 2023 revenue to U.S. product sales rather than the one-time sale of rights, contradicting the ground truth that the $579M was from the sale of rights—not ongoing sales. (4) Contextually, the answer addresses the evolution in contractual and revenue recognition arrangements appropriately and uses correct terminology (e.g., collaboration-based revenue model). Despite the wrong number and slight mischaracterization of the nature of 2023 revenue, the overall narrative direction is plausible. However, the incorrect dollar amount and confusion between product sales and sale of rights lead to a moderate score. The model fails to reflect that the $579M was explicitly from the sale of rights—not ongoing sales—further weakening accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 503,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "From 2023 to 2024, AT&T repurchased all outstanding Mobility Preferred Interests, completing the repurchase in April 2023 for $5,414, which included accrued and unpaid distributions. Regarding Tower Holdings, in 2024, AT&T amended and restructured the 2019 Tower preferred interests into Fixed Rate and Floating Rate Class A Limited Membership Interests, resetting the distribution rates and extending the call dates to 2029. Additionally, in October 2024, AT&T agreed to issue $2,250 of new Telco Class A-4 preferred interests in 2025, with a 5.94% initial distribution rate, to fund the redemption of preferred equity securities. These actions reflect a strategic shift in managing capital structure through preferred interests, focusing on refinancing and restructuring to align with long-term financial goals.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic shift in AT&T's capital structure management but contains several quantitative inaccuracies. It correctly notes the $5,414 repurchase of Mobility Preferred Interests in 2023 and the restructuring of Tower Holdings preferred interests in 2024. However, it incorrectly states that $2,250 in new Telco Class A-4 preferred interests were agreed to be issued in October 2024 for 2025, which is not supported by the ground truth. The original answer specifies that Telco LLC preferred interests increased to $7,250 total by 2024, including the original $2,000 and 2023 issuance of $5,250 — a key quantitative point missing in the LLM response. Additionally, the LLM cites a 5.94% distribution rate for a new issuance not mentioned in the ground truth; the correct 2023 Telco issuance carried a 6.85% rate. The restructuring of Tower preferred interests into fixed (5.90%) and floating (SOFR + 250 bps) classes is partially correct but lacks the $6,000 value mentioned in the original. (2) Number verification: $5,414 repurchase amount is correct. However, missing $5,250 Telco issuance in 2023, incorrect $2,250 new issuance figure, missing $7,250 total Telco preferred, missing $6,000 Tower restructuring value. Distribution rates are mismatched (6.85% vs 5.94%). (3) Multi-hop reasoning is sound — the LLM correctly infers a strategic pivot from repurchasing legacy interests to restructuring and issuing new preferred instruments. It connects Mobility repurchase, Tower restructuring, and new Telco issuance as part of capital structure management. However, it introduces a future issuance not in the original data, weakening factual synthesis. (4) Correctness score is 7 due to accurate high-level narrative but significant omissions and errors in key financial figures. Quantitative accuracy is 6 due to multiple incorrect or missing dollar amounts and rates. Qualitative accuracy is 8 because reasoning and entity identification (Mobility, Tower Holdings, Telco LLC) are correct. Contextual relevance is 9 — the answer directly addresses the evolution of AT&T’s capital structure strategy as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 577,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2023 to 2024, as Emerson moved from being a majority shareholder (55% ownership in 2023) to proposing a full acquisition of the remaining shares in 2024, increasing its ownership to approximately 57%. This transformation had a mixed financial impact: in 2023, the Heritage AspenTech acquisition positively impacted gross margin by 0.6 percentage points, while in 2024, the Test & Measurement acquisition and higher prices improved gross margin by 1.8 percentage points, though this was partially offset by acquisition-related inventory step-up amortization. Ownership-wise, Emerson's stake in AspenTech increased, and the company restructured AspenTech's name and stock ticker to align with its previous branding.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. It incorrectly states that Emerson was already a 55% owner of AspenTech in 2023 and increased to 57% in 2024, whereas the ground truth confirms that the 55% ownership stake was acquired in 2024 as a result of a transaction involving $6.0 billion in cash. The LLM also misrepresents the timeline and nature of the relationship: in 2023, Emerson was not a majority shareholder but had a business relationship through its Software and Control offerings. (2) Quantitative inaccuracies include the gross margin impact: the LLM claims AspenTech contributed only 0.6 percentage points in 2023, but the correct figure is 3.3 percentage points. For 2024, while the LLM correctly notes a 1.8 percentage point increase in gross margin, it attributes this to the 'Test & Measurement acquisition and higher prices,' not to the AspenTech transaction as part of broader changes. The $6.0 billion cash consideration is entirely omitted. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the transformation from partnership to majority ownership, reverses the timeline of ownership change, and conflates unrelated acquisitions (e.g., Test & Measurement). It also invents a rebranding of AspenTech’s name and ticker without evidence. (4) Despite these issues, the answer is contextually relevant—it addresses the evolution of the relationship and attempts to discuss financial impacts on gross margin and ownership—hence a moderate relevance score. However, due to severe factual and quantitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 443,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "Between 2022 and 2024, AIG's Japan pension plans contributed approximately 61% of total non-U.S. pension obligations in 2022 and 66% in 2024, indicating a slight increase in their contribution to non-U.S. pension obligations. The weighted average discount rate for these plans increased from 1.09% in 2022 to 2.85% in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, AIG's Japan pension plans accounted for 61% of non-U.S. pension *assets* (not obligations), but the LLM incorrectly states 61% for obligations and further claims it increased to 66% in 2024, which is false. The actual data shows the share of *projected benefit obligations* decreased from 54% in 2023 to 50% in 2024. The LLM completely misses this downward trend and instead reports an incorrect increase. (2) The discount rate figures are also wrong: the ground truth states the weighted average discount rate increased from 1.48% in 2023 to 1.81% in 2024. The LLM claims it rose from 1.09% in 2022 to 2.85% in 2024—both the starting value and the end value are incorrect, and the time frame misalignment (using 2022 instead of 2023) compounds the error. (3) The multi-hop reasoning is flawed: the question asks about evolution between 2022 and 2024, requiring synthesis of data across years and metrics. The LLM fails to correctly identify the relevant metrics (confusing assets with obligations), uses incorrect percentages, and misrepresents the trend. It also omits key details like the 2023 intermediate value and the correct interpretation of declining relative size. (4) Despite these issues, the answer is contextually relevant—it addresses the right company (AIG), topic (Japan pension plans), and metric type (discount rate, percentage contribution)—so partial credit is given for structure and intent. However, due to major quantitative and qualitative errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 442,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "Between 2022 and 2023, Amazon's disclosure regarding the impact of competitive stores on its business remained consistent in acknowledging the risk posed by competitors, but the 2023 filing placed a stronger emphasis on evolving business models and intensified competition in international markets. In 2022, the focus was primarily on the general threat of competitive stores, websites, products, and services. In 2023, the framing expanded to include the adoption of evolving business models and the competitive advantage held by local companies in international markets, highlighting the challenges of global expansion and the need to adapt to local market conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is partially correct in noting that Amazon continued to acknowledge competitive stores as a risk in both years, but it misrepresents the key evolution in framing between the 2022 and 2023 filings. The ground truth indicates that the core language about competitive stores remained unchanged, but in 2023 it was embedded within a broader context emphasizing general economic, business, and geopolitical conditions—shifting competitive pressures into a larger set of external risks. The LLM incorrectly claims that the 2023 filing emphasized 'evolving business models' and 'competitive advantage held by local companies in international markets,' which is not supported by the original answer. These specific details about international competition and local market adaptation are absent from the ground truth and represent a mischaracterization of the shift. While the answer correctly identifies a broadening of context, it attributes this shift to different content than what actually occurred. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is partially sound but based on incorrect premises, and the answer fails to capture the actual textual evolution described in the original answer—specifically the integration of competitive factors into a wider array of external macroeconomic and geopolitical risks. Thus, while the answer is contextually relevant and attempts to address the framing change, it lacks factual accuracy in the qualitative details, warranting a moderate correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 434,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Based on the information provided in the 2023 and 2024 10-K filings, Target's exposure to port security risks has remained a concern, with no significant evolution in geographic focus or operational impact between the two years. Both filings highlight that disruptions at major U.S. ports, particularly California ports, continue to pose risks to Target's supply chain. These risks include delays in receiving imported merchandise, increased costs, and potential inventory shortages. Additionally, both reports note that global factors such as geopolitical conflicts, labor disputes, and congestion at ports worldwide remain beyond Target's control and could adversely affect its operations. Thus, while the nature of the risks has not fundamentally changed, the ongoing volatility in global trade and port operations continues to present operational challenges for Target.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that there was 'no significant evolution' in Target's exposure to port security risks between 2023 and 2024. The ground truth shows a clear shift: in 2023, Target specifically identified California ports as a key risk area and noted it had made alternative arrangements due to past disruptions. In 2024, the focus broadened to 'major U.S. ports' without naming California, indicating a more generalized concern, and the emphasis shifted from past mitigation to potential future impacts like increased costs and supply issues due to global conflicts and labor disputes. The LLM answer fails to capture this evolution and instead incorrectly asserts continuity in both geographic focus and operational impact. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify or miscalculate, hence a score of 10 by default. (3) The multi-hop reasoning is flawed: the model should have synthesized changes across two years and identified the shift from specific (California) to general (major U.S. ports) geographic focus, and from reactive (alternative arrangements) to proactive (future risk) operational language. Instead, it conflates the two years and misses the evolution entirely. (4) Contextual relevance is moderate—the answer discusses port risks and supply chain impacts, which are relevant, but it misrepresents the evolution the question asks about, making it misleading despite using plausible terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 425,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Between 2023 and 2024, Emerson's financial relationship with Heritage AspenTech evolved in terms of acquisition-related amortization and restructuring costs. In 2023, amortization related to the Heritage AspenTech acquisition was $258 million, while restructuring costs were $72 million. By 2024, amortization increased significantly to $560 million, primarily due to the NI acquisition, while restructuring costs rose to $228 million, reflecting broader operational adjustments. These figures highlight increased financial impacts from both amortization and restructuring activities in 2024 compared to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors, particularly in the amortization figure for 2024. The ground truth states that AspenTech-related amortization was $258 million in 2023 and was no longer reported in 2024, indicating a cessation or absorption of acquisition-specific amortization. However, the LLM claims amortization increased to $560 million in 2024 due to the 'NI acquisition,' which is not mentioned in the original answer and contradicts the ground truth. This introduces a false entity and incorrect financial data. Restructuring costs are correctly reported as rising from $72M to $228M, aligning with the original. (2) Quantitative accuracy is low: while 2023 amortization ($258M) and both restructuring figures ($72M and $228M) are correct, the $560M amortization in 2024 is unsupported and incorrect per the original. The increase is misattributed to a non-mentioned 'NI acquisition,' introducing a fabricated reason. (3) Multi-hop reasoning is partially sound—comparisons across years are made, and restructuring cost implications are reasonably interpreted—but the core synthesis fails because it misrepresents the evolution of AspenTech-related amortization. Instead of recognizing its absence in 2024 as a signal of transition, it invents an increase. (4) Contextual relevance is high as the response addresses the question's focus on financial evolution between 2023 and 2024, including both amortization and restructuring. However, the qualitative accuracy is reduced by incorrect entity introduction and flawed reasoning about amortization trends. Correctness score reflects partial credit for accurate restructuring numbers and correct 2023 amortization, but major deductions for false 2024 amortization data and erroneous causal attribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 486,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "AIG's use of Expected Loss Ratio (ELR) methods has evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years. In 2022, the ELR method was primarily used for business written in excess of a deductible in the most recent five accident years, with significant weight given to it in those years. By 2024, the ELR method remained a key component for recent accident years, especially for business with high deductibles, but its application was refined to incorporate updated expected loss ratios adjusted for rate changes, loss trends, and market conditions. Additionally, the weight of ELR methods was balanced with other techniques like loss development and Bornhuetter-Ferguson methods, depending on the line of business and the maturity of the accident year.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements about AIG's use of Expected Loss Ratio (ELR) methods, particularly the emphasis on recent accident years and the continued use of ELR in 2024. It correctly notes that ELR is used for high-deductible business and that it is balanced with other methods like Bornhuetter-Ferguson (which aligns with IBNR factor methods mentioned in the ground truth). However, the LLM answer introduces specific details not present in the original answer, such as 'business written in excess of a deductible' and 'most recent five accident years,' which are not mentioned in the ground truth and thus cannot be verified. More critically, the LLM fails to mention the key evolution highlighted in the original answer: the expansion of ELR methods to U.S. Workers' Compensation in 2024, a long-tail line of business. This omission is significant because it represents a core part of the method's evolution across different risk profiles. Additionally, while the ground truth emphasizes the use of ELR in D&O, E&O, EPLI, and professional liability in 2022, the LLM does not reference these specific lines of business, instead focusing on deductible-based segmentation. The reasoning is partially sound but lacks the multi-hop synthesis of how ELR application broadened across lines of business and risk types. Quantitative accuracy is high because there are no explicit numbers or dates that are incorrect—dates (2022, 2024) are correct, and no erroneous calculations are made. Contextual relevance is moderate as the answer stays on topic but shifts focus to deductible structures rather than the evolution across lines of business and accident years as requested. Overall, the answer is partially correct but misses key factual developments, resulting in a mid-range correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 488,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Between 2022 and 2023, Amazon's monetization strategy for its film groups evolved with an increase in capitalized video and music content costs and associated expenses. The total capitalized costs of video and music content rose from $16.7 billion in 2022 to $17.4 billion in 2023, indicating a continued investment in content. Additionally, total video and music expenses increased from $16.6 billion in 2022 to $18.9 billion in 2023, reflecting higher spending on licensing and production costs. This suggests a strategy of expanding content offerings to drive engagement and monetization through Amazon Prime memberships and digital subscriptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in both capitalized video and music content costs and associated expenses from 2022 to 2023, with all numerical values matching the ground truth: $16.7 billion to $17.4 billion for capitalized costs and $16.6 billion to $18.9 billion for total expenses. These figures are accurately reported with correct years and metric labels. (2) Quantitative accuracy is perfect—no calculation errors, and the numbers align exactly with the original answer, allowing for standard format variations. (3) The reasoning is sound and reflects appropriate multi-hop synthesis: the model correctly infers that increased investment in content indicates a more aggressive monetization strategy, linking higher costs to expanded content offerings aimed at driving Prime membership and digital subscription revenue. This interpretation is consistent with the ground truth’s conclusion about heightened monetization efforts. (4) The only minor shortcoming is that the LLM adds a slight interpretive extension—mentioning Amazon Prime memberships and digital subscriptions as monetization channels—while the original answer stops at stating increased investment implies greater monetization efforts without specifying channels. However, this addition is reasonable and contextually appropriate, not factually incorrect. Thus, the answer is fully factually accurate, highly relevant, and well-reasoned, warranting a 9/10 due to the small inferential extension beyond the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 419,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International (PMI) recorded a significant impairment related to its equity investment in Rothmans, Benson & Hedges (RBH). In 2024, PMI recognized a non-cash impairment charge of $2,316 million (equivalent to a $1.49 diluted EPS charge), driven by uncertainties surrounding the allocation of a proposed CAD 32.5 billion settlement among RBH and other parties in Canadian tobacco litigation. This marked a notable deterioration in the value of PMI's stake in RBH compared to prior years, where no such impairment was recorded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $2,316 million impairment charge in 2024, the CAD 32.5 billion Canadian litigation settlement, and the absence of such an impairment in prior years (e.g., 2022) are correctly stated. The format variation (CAD 32.5 billion vs $32.5 billion) is acceptable as the context confirms it refers to the same settlement. (2) Quantitative accuracy is perfect: the dollar amount ($2,316 million) and EPS impact ($1.49) are precisely reported. (3) The multi-hop reasoning is sound—LLM correctly infers a shift in PMI's relationship with RBH from prior brand reporting (implied in 2022) to a direct equity investment facing impairment in 2024. However, the LLM omits explicit mention of the earlier trademark and brand licensing relationship (e.g., HEETS volume reporting in 2022), which is part of the evolution described in the ground truth. This minor omission slightly affects completeness and qualitative accuracy but does not undermine the core correctness. (4) The answer remains contextually relevant, focused, and factually aligned with the question about the evolution of the financial relationship, especially regarding stake and impairment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 348,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "Between 2023 and 2024, the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities slightly decreased. In 2023, a 5% change in these liabilities would have resulted in a $615 million change in revenue, while in 2024, the same 5% change would result in a $600 million change in revenue. This indicates a marginal reduction in sensitivity, although both years show a similar level of exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that in 2024, a 5% change in liabilities would result in a $600 million change in revenue. The ground truth explicitly states that LLY did not provide any updated sensitivity figure in 2024. Therefore, the $600 million figure is fabricated and not disclosed in the 2024 10-K. The only correct number is the 2023 sensitivity of $615 million, which matches the ground truth. (2) Quantitative accuracy is severely compromised because the core numerical claim for 2024 is false. There is no calculation or disclosed value to support a $600 million impact. The model introduces a specific number where none exists, which is a critical error in financial reporting contexts. (3) The reasoning is flawed because it assumes continuity in disclosure when the key point from the ground truth is the absence of disclosure in 2024. The model fails to recognize the significance of missing data and instead invents a comparative figure, breaking the multi-hop logic that requires checking whether the information was actually disclosed. It incorrectly implies a trend (slight decrease in sensitivity) based on non-existent data. (4) Contextual relevance is moderate because the answer addresses the right topic (sensitivity of revenue to liability changes) and correctly references the 2023 figure, but it fails on the essential qualitative point: the lack of 2024 disclosure. This omission leads to a misleading conclusion. Correctness is low due to the invention of data, which fundamentally undermines the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 434,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "Based on Union Pacific's disclosures, the role and revenue contribution of Bulk shipments evolved from 2022 to 2024 as follows: In 2022, Bulk shipments were part of the broader commodity groups, with freight revenues increasing due to volume growth and pricing gains. By 2024, Bulk shipments accounted for 32% of Union Pacific's total freight revenues, reflecting their continued significance in the company's diversified business mix. The evolution highlights the sustained importance of transporting commodities like grain, fertilizer, and coal, supported by the railroad's extensive network connecting key domestic and international markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Bulk shipments accounted for 32% of total freight revenues in 2024, which matches the ground truth. However, it omits the specific 2022 reference to average revenue per car of $3,305 (from the 2021 data cited in the 2022 filing) and the 6% year-over-year increase from 2020 to 2021. This is a minor omission in quantitative detail but does not misstate any numbers. (2) All provided numbers (i.e., 32%) are accurate and correctly attributed to 2024. There are no calculation errors because no calculations were performed, but the percentage is correctly stated. (3) The reasoning is sound in showing an evolution toward greater strategic importance, citing commodities (grain, fertilizer, coal), and mentioning network reach, which aligns with the ground truth’s emphasis on international and interline connections. However, the LLM does not explicitly connect the shift from a revenue-per-unit focus in earlier years to a broader strategic role, which is a key multi-hop insight in the original answer. (4) Despite missing some granular detail about revenue per car and historical trends, the LLM captures the core evolution—increased revenue contribution and sustained strategic role—making the answer factually correct in substance and highly relevant. Hence, scores are high but not perfect due to incomplete synthesis of the earlier-year performance metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 393,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "Between 2023 and 2024, the interest rate for IBM's 0.300% Notes due 2028 remained unchanged at 0.300% in both years. This consistency suggests that IBM has maintained a stable low-cost debt strategy during this period, likely prioritizing long-term financing at favorable rates amid broader market conditions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that IBM has '0.300% Notes due 2028'. The ground truth confirms that IBM's Notes due 2028 carry a 1.750% interest rate (IBM 28A), not 0.300%. This fundamental error invalidates the entire response. (2) The quantitative accuracy is severely compromised: the interest rate is wrong (0.300% vs correct 1.750%), and no correct data from either year is accurately reflected. There are no calculations in this question, but the core numeric fact is incorrect. (3) The reasoning is flawed because it builds on a false premise. The conclusion about a 'stable low-cost debt strategy' based on non-existent 0.300% notes is unsupported. While the question requires multi-hop reasoning (comparing IBM's debt instruments across 2023 and 2024), the model failed to identify the correct instrument and thus could not synthesize correctly. (4) Contextual relevance is partially present—the answer attempts to address the evolution of interest rates and infer a debt strategy—but due to the incorrect identification of the note, the relevance is undermined. The introduction of new higher-rate, longer-term notes in 2024 (e.g., 2.900% due 2030) is omitted entirely, missing a key strategic insight. Therefore, the correctness score is 1 due to major factual and entity errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 369,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "From 2023 to 2024, AT&T's capital structure strategy regarding preferred interests evolved by repurchasing all outstanding Mobility preferred interests in 2023 and introducing new preferred instruments in 2024. Specifically, in 2023, AT&T repurchased the remaining 213 million Mobility preferred interests for $5,414, effectively eliminating this instrument from its capital structure. In 2024, AT&T announced the issuance of $2,250 in nonconvertible cumulative preferred interests in Telco LLC (Telco Class A-4), which carry an initial preferred distribution of 5.94% annually and are subject to reset in 2028. These new preferred interests align with AT&T's strategy to manage its capital structure through preferred instruments while maintaining flexibility for future financial needs.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the high-level evolution of AT&T's capital structure strategy—repurchasing Mobility Preferred Interests in 2023 and introducing new preferred instruments in 2024—which is contextually accurate and relevant. However, there are significant quantitative inaccuracies. The ground truth states the redemption value of the Mobility Preferred Interests was approximately $5,340 million, while the LLM claims AT&T repurchased 213 million interests for $5,414 (implied $5,414 million), which does not match the source. Additionally, the LLM introduces a specific new instrument—$2,250 million in Telco Class A-4 preferred interests at 5.94%—but the original answer mentions an expansion of Telco LLC preferred interests to a total of $7,250 million, not a new $2,250 million issuance. The LLM omits the restructuring of Tower Holdings preferred interests to include fixed and floating rate components, a key qualitative point. (2) Number verification: $5,340M (truth) vs $5,414M (LLM) — incorrect; $373M annual distributions (truth) — missing in LLM; $7,250M total Telco expansion (truth) vs $2,250M new issuance (LLM) — partial but misleading; 5.94% rate and 2028 reset — specific details not in ground truth, possibly hallucinated. (3) Multi-hop reasoning is partially sound: the model correctly infers a strategic shift from repurchase to new issuance, but fails to synthesize the full scope of 2024 changes (Tower Holdings restructuring, total Telco expansion). (4) Correctness score is 6 due to core factual errors in numbers and missing key components, though the general direction of strategy is correct. Quantitative accuracy is low (5) due to mismatched figures. Qualitative accuracy is 7 because reasoning and entity identification (AT&T, preferred interests, years) are correct, but details are incomplete or inaccurate. Contextual relevance is high (9) as the answer directly addresses the evolution in capital structure strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 531,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Between 2022 and 2023, Amazon's characterization of the competitive threat from websites evolved to emphasize the intensifying nature of competition and the adoption of evolving business models by competitors. In 2022, the language focused on the general presence of competition and the challenges of international expansion, such as local companies having a competitive advantage due to their understanding of local customers and established brand names. By 2023, the language became more specific, highlighting how competition is intensifying as international services grow, with competitors adopting new and evolving business models. This shift indicates a recognition of more dynamic and adaptive competition, suggesting a broader and more complex competitive landscape.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a shift in Amazon's characterization of competitive threats between 2022 and 2023, noting a move toward more intense and dynamic competition. However, it misrepresents the specific language used in the filings. The original answer states that in 2022, Amazon described competitive websites as part of a 'broader list of fluctuating business factors,' while in 2023, it specifically cited 'competitive stores, websites, products, services, price decreases, or improvements.' The LLM answer instead claims that in 2022, Amazon focused on 'challenges of international expansion' and 'local companies having a competitive advantage,' which is not supported by the ground truth and introduces unrelated details. In 2023, the LLM correctly notes more specific language about intensifying competition and evolving business models, but this does not match the exact phrasing or emphasis in the original answer, which highlighted price decreases and service improvements as direct competitive tactics. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model infers a shift in tone and specificity over time, which aligns with the original answer. However, it fails to accurately synthesize the exact language changes from the source documents, undermining the qualitative accuracy. The shift described in the LLM answer is more about international competition and business models, whereas the ground truth emphasizes a shift from general operational risk to strategic digital competition. (4) The correctness score is 5 due to significant factual divergence in the characterization of Amazon's language despite capturing a general trend of increasing competition. Contextual relevance is higher (7) because the answer addresses the evolution of competitive threat, but qualitative accuracy is low (5) due to incorrect entity details and reasoning gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 548,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "PMI's relationship with KT&G has evolved from a strategic collaboration in 2020 to a more integrated partnership by 2024, with KT&G's heat-not-burn products becoming a significant component of PMI's smoke-free portfolio. In 2020, PMI entered a global collaboration agreement to exclusively commercialize KT&G's smoke-free products outside South Korea. By 2024, KT&G's heat-not-burn products, such as Fiit and Miix, are explicitly included in PMI's heated tobacco unit (HTU) offerings and contribute to the growth of PMI's smoke-free net revenues, particularly in regions like Europe and the Americas. This reflects a deepened strategic reliance on KT&G's innovations to expand PMI's heat-not-burn product presence globally.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of PMI's relationship with KT&G from a distribution agreement to deeper integration into PMI's smoke-free portfolio, which aligns with the ground truth. However, it incorrectly states the agreement began in 2020 instead of 2022, a significant factual error affecting timeline accuracy. Additionally, the LLM mentions product names Fiit and Miix, whereas the ground truth specifies LIL Mini and LIL Plus—this is a partial mismatch in entity accuracy. (2) There are no numerical values (e.g., revenue figures, percentages) in either answer, so quantitative accuracy hinges on dates. The incorrect start date (2020 vs. 2022) reduces confidence in temporal precision, though no calculations are involved. (3) The multi-hop reasoning is generally sound: the model infers increased strategic reliance based on integration into PMI’s HTU offerings and contribution to net revenues, which is consistent with the ground truth’s interpretation of a shift from distributor to embedded partner. However, the error in the agreement’s start year weakens the temporal logic chain. (4) Despite the date and product name inaccuracies, the core qualitative insight—deepening strategic reliance and portfolio integration—is correct, and the answer remains highly relevant to the question. Hence, correctness is reduced to 7 due to key factual errors, but qualitative and contextual scores remain high due to accurate reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 410,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Between 2022 and 2024, IBM's use of the PWCC Plan remained consistent in terms of administration and scope. The plan continued to be administered by the Executive Compensation and Management Resources Committee of the Board of Directors, with terms and conditions identical to the 2001 Plan. It was solely used to fund awards for employees of PricewaterhouseCoopers Consulting who became IBM employees due to the 2002 acquisition, and it excluded senior executives. No significant changes in administration or scope were noted during this period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, dates, and scope: it correctly identifies that the PWCC Plan was used solely for former PwCC employees post-acquisition, that administration remained unchanged, and that terms were identical to the 2001 Plan. The committee responsible (Executive Compensation and Management Resources Committee) is accurately named, and the exclusion of senior executives is an additional correct detail not in the original answer but not contradicted by it. Quantitatively, there are no numbers or dates in dispute—2002 acquisition date is correct, and no financial figures are misstated. Contextually, the answer fully addresses the question about evolution in administration and scope between 2022 and 2024, correctly noting no significant changes. However, the LLM misses the nuanced evolution in language and tone between the 2022 and 2024 filings—the shift from 'was described as being used solely' to a stronger, reaffirming 'has been and will continue to be used solely'—which the original answer highlights as indicating a stronger commitment. This subtle but important qualitative shift in IBM's communication is omitted, affecting the depth of the reasoning and synthesis across years. While the core facts are correct, the multi-hop insight about linguistic reinforcement of intent is missing, preventing a top score. Thus, the answer is factually sound and contextually relevant but slightly incomplete in capturing the rhetorical evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 410,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "Between 2023 and 2024, AT&T repurchased all outstanding Mobility Preferred Interests in 2023, eliminating this financial obligation. In 2024, the company shifted focus to issuing new preferred interests, such as the Telco Class A-4, to fund redemptions and manage capital structure. This evolution indicates a strategic shift toward optimizing capital by reducing high-cost obligations and restructuring preferred equity to align with long-term financial goals and liquidity needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that AT&T repurchased all Mobility Preferred Interests in 2023, eliminating the obligation, which aligns with the ground truth. It also accurately notes the absence of these interests in 2024 disclosures. However, the LLM introduces the claim that AT&T issued 'Telco Class A-4' preferred interests in 2024 to fund redemptions, which is not present in the original answer and lacks support from the provided ground truth. While the ground truth confirms that Tower Holdings and Telco LLC preferred interests remained and were restructured, it does not specify the issuance of a 'Class A-4' tranche or its use for redemptions. This adds unsupported detail. (2) Quantitatively, the LLM does not contradict any numbers: it avoids stating a dollar amount for the repurchase, so while it omits the $5,414 million figure, it doesn’t misstate it. Since omission of a number is less severe than misquoting, and no incorrect calculations are made, quantitative accuracy remains high. (3) The multi-hop reasoning is mostly sound: the model correctly infers a strategic shift in capital structure management from the elimination of one instrument and continued use of others. The logic connecting repurchase of high-cost obligations to capital optimization is consistent with the ground truth’s interpretation. However, the unsupported claim about new issuances slightly undermines the qualitative accuracy. (4) Contextual relevance is strong—the answer directly addresses the evolution between 2023 and 2024 and interprets the strategic implications. The core conclusion about selective capital structure management is preserved, even if expressed with slight overreach in specifics. Thus, the answer is largely correct with minor inaccuracies in entity-specific details, warranting a score of 8/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 500,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "Between 2022 and 2024, IBM's regulatory exposure for its debt securities remained influenced by external factors such as interest rates, exchange rates, and governmental and stock exchange regulations, as noted in both the 2022 and 2024 filings. However, in 2024, there was a more detailed emphasis on the evolving regulatory environment related to cybersecurity, privacy, and data protection, which indirectly impacts the company's compliance obligations and could affect the value and liquidity of its debt securities. No significant changes in direct regulatory exposure specific to debt securities were identified, but the broader regulatory landscape became more complex and risk-intensive.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in noting that IBM's regulatory environment evolved between 2022 and 2024, but it misrepresents the core evolution in regulatory exposure related to stock exchange regulations. The original answer highlights a clear shift in IBM's language—from describing stock exchange regulations as an influencing factor in 2022 to stating in 2024 that it is 'subject to' these regulations, indicating a stronger, more direct regulatory exposure. The LLM answer fails to capture this specific linguistic and conceptual shift, which is central to the question. Instead, it redirects focus to cybersecurity, privacy, and data protection regulations, which, while relevant to the broader regulatory landscape, are not the focus of the question regarding debt securities and stock exchange regulations. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in this regard, scoring 10 by default. (3) The multi-hop reasoning is flawed: the model should have compared IBM’s own disclosures about stock exchange regulations in 2022 versus 2024 and synthesized the change in tone and legal implication. The LLM instead introduces unrelated regulatory domains and misses the direct evolution in how IBM characterizes its exposure to stock exchange rules. (4) Contextual relevance is moderate because the answer discusses regulatory changes and debt securities, but it drifts from the specific regulatory domain (stock exchange regulations) to broader compliance issues, reducing accuracy. The core qualitative inaccuracy—missing the shift from 'influencing factor' to 'subject to'—results in a low qualitative and overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 471,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "Disney's equity income contribution from A&E decreased significantly from 2022 to 2024. In 2022, the equity income from investees was not explicitly detailed for A+E, but by 2024, equity in the income of investees, specifically from A+E, had declined by $207 million, contributing to an overall decrease in equity income to $575 million from $782 million in the prior year. This decline was primarily due to lower income from A+E.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $207 million decline in equity income from A+E is correctly stated, and the overall equity income decrease from $782 million to $575 million (a difference of $207 million) is mathematically accurate and matches the implied data in the original answer. (2) The entity 'A+E' (correctly referring to A&E) is accurately identified, and the time frame (2022 to 2024) is appropriately addressed. (3) The reasoning is sound: the answer correctly infers that the $207M drop in equity income is due to lower performance from A+E, which constitutes a material decline in financial contribution, even if 2022's specific A&E breakdown wasn't detailed. (4) The only minor shortcoming is that the original answer notes A&E was a 'significant component' of equity income in 2022, which the LLM acknowledges indirectly but could have emphasized more clearly. However, the core facts, numbers, and multi-hop synthesis (linking the $207M drop specifically to A+E's reduced contribution over time) are correct. Wording differences do not affect semantic accuracy. All criteria are met with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 332,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations increased from $16,973 million in 2022 to $18,043 million in 2023, indicating a $1,070 million rise. This increase suggests that the company is actively utilizing securitized debt as part of its long-term funding strategy to diversify its funding sources and manage liquidity needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change. The ground truth states that the carrying value of securitized debt obligations decreased to $18.043 billion by December 31, 2023, from a prior level (implied in 2022) that was part of a total long-term funding of $42.3 billion as of December 31, 2021, with securitized debt being a significant portion. The LLM incorrectly claims an increase from $16,973 million ($16.973 billion) in 2022 to $18.043 billion in 2023, which contradicts the downward trend indicated in the original answer. (2) The quantitative values are inaccurate: the starting value of $16.973 billion for 2022 is not supported by the ground truth, which does not provide a specific securitized debt figure for 2022 but implies a higher value than $18.043 billion given the overall $42.3 billion long-term funding in 2021 and the decrease by 2023. The calculation of a $1,070 million increase is therefore based on false inputs. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the timeline and trend across years, misinterpreting the direction of change and thus drawing the opposite conclusion about the company’s funding strategy. Instead of recognizing a strategic reduction in securitized debt, it suggests increased reliance, which is contradicted by the evidence. (4) Contextual relevance is moderate because the answer addresses the right topic (securitized debt and long-term funding strategy), but the incorrect data and reasoning undermine the validity. Scores are low due to major factual and directional errors in financial data and strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 454,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Between 2022 and 2024, Disney has shifted its focus toward DTC platforms, consolidating services like Star+ into Disney+ and planning an ESPN-branded tile on Disney+ in the U.S. This move reflects a strategic realignment from international general entertainment channels, as the company prioritizes streaming over traditional linear channels. The International Channels business is expected to decline as content monetization shifts from licensing linear channels to DTC platforms. Additionally, Disney has merged services in Latin America and plans to launch a new DTC offering for ESPN in early fiscal 2025, further emphasizing its commitment to direct-to-consumer growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core strategic shift from international linear channels to DTC platforms between 2022 and 2024. It accurately notes the consolidation of Star+ into Disney+, the decline of the International Channels business, and the planned ESPN DTC offering. However, it omits the specific detail from the ground truth that Disney operated approximately 220 General Entertainment channels outside the U.S. in 2022 under Fox, National Geographic, and Star brands—this quantitative and descriptive detail is missing, reducing completeness. (2) Quantitatively, the LLM does not include the '220 channels' figure, which is a factual omission. The mention of 'early fiscal 2025' for the ESPN DTC launch is consistent with the ground truth's 'early fall 2025' (fiscal alignment acceptable). No incorrect numbers are stated, so accuracy is high but not perfect due to omission. (3) The reasoning is sound: the LLM correctly infers a strategic pivot based on service consolidations and DTC expansions. It identifies the shift from licensing linear content to DTC monetization, which aligns with the ground truth. However, it misses the multi-hop connection involving the Venu Sports joint venture with Fox Corporation and Warner Bros. Discovery, which strengthens the evidence of industry-wide DTC movement—this weakens the qualitative synthesis. (4) Despite omissions, the answer remains contextually relevant and conveys the essential evolution in Disney’s strategy. The focus on DTC growth, ESPN+, and international channel decline directly addresses the question. The score reflects high accuracy with room for improvement in completeness and depth of multi-entity synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 466,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "From 2022 to 2023, Tesla faced evolving financial and operational challenges related to energy storage products, particularly in accounts receivable and production scaling. In 2022, accounts receivable balances were impacted by fluctuations in customer payments, government rebate processing timelines, and regulatory credit sales, with $627 million in long-term government rebates receivable. By 2023, Tesla highlighted ongoing challenges in scaling energy product production, including supply chain constraints, hiring and training skilled workers, and ramping manufacturing capabilities to meet demand. These factors underscored risks to timely production and financial performance, with potential bottlenecks affecting both cost efficiency and revenue generation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $627 million in long-term government rebates receivable as of the end of 2021 (disclosed in the 2022 filing), which matches the ground truth. The shift from financial (receivables) to operational (production scaling) challenges in 2023 is accurately captured. (2) Quantitative accuracy is perfect: the $627 million figure is correctly cited, and no other numbers are introduced that contradict the ground truth. Format is consistent and acceptable. (3) The multi-hop reasoning is sound—linking 2022 financial disclosures on receivables to 2023 operational risks in production scaling. The LLM correctly synthesizes information across years and domains (financial vs. operational). One minor omission: the original answer specifies factory locations (Nevada, Texas) and types of delays (facility ramp delays), which the LLM mentions only generally (e.g., 'ramping manufacturing capabilities'). This slightly reduces qualitative completeness but does not affect core accuracy. (4) The answer is highly contextually relevant, directly addressing the evolution in Tesla's challenges across the two dimensions (accounts receivable and production scaling) from 2022 to 2023. Overall, the LLM conveys the same semantic meaning as the ground truth with only minor detail omissions, warranting a high correctness score of 9.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 381,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "The role of syrups in Coca-Cola's business model remained consistent between 2022 and 2023, with the company continuing to sell fountain syrups to bottling partners and fountain retailers for use in producing beverages for immediate consumption. In both years, syrups were a key component of concentrate operations, which accounted for 58% of net operating revenues in 2023 and 56% in 2022. The company's bottling partners, both consolidated and unconsolidated, play a central role in manufacturing and distributing fountain syrups, underscoring the continued importance of this segment in supporting Coca-Cola's beverage distribution through retail and fountain channels.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains some correct elements but fundamentally misrepresents the evolution of syrups in Coca-Cola's business model between 2022 and 2023. While it correctly notes that syrups are sold to bottling partners and fountain retailers, it incorrectly states that the role 'remained consistent,' directly contradicting the ground truth, which identifies a clear strategic shift. The percentages for concentrate operations (58% in 2023, 56% in 2022) are plausible and contextually relevant, but the original answer does not mention these figures, so their accuracy cannot be verified from the ground truth. (2) Quantitatively, the 56% and 58% revenue shares are presented accurately and plausibly, though unconfirmed by the ground truth. There are no calculation errors in the LLM answer, and the years are correctly referenced. (3) The multi-hop reasoning is flawed: the question asks about the evolution of syrups' role, particularly in relation to bottling partners and fountain retailers. The ground truth highlights a shift from a volume-driven, ownership-structured revenue recognition model in 2022 to a more integrated, operationally embedded role in 2023, especially with direct sales to fountain retailers. The LLM answer fails to capture this evolution and incorrectly asserts continuity. It also misattributes the manufacturing of fountain syrups to bottling partners, while the ground truth states that Coca-Cola itself manufactures them. (4) Contextual relevance is moderate—the answer discusses syrups, bottling partners, and fountain retailers, so it stays on topic. However, it misses the core qualitative shift emphasized in the original answer, leading to a low qualitative accuracy score. The correctness score is 4 due to significant factual and reasoning errors despite some accurate contextual details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 495,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) decreased from fiscal year 2022 to 2024. In fiscal 2022, the value of Other MBS & ABS was $84 million, representing 1% of total plan assets. By fiscal 2024, this value dropped to $166 million, still representing 1% of total plan assets. Despite the nominal increase in value, the proportion relative to the overall fair value hierarchy remained consistent at 1% in both years, indicating a stable but relatively minor role in the investment portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for Disney's investment in Other MBS & ABS. According to the ground truth, the investment was $96 million in fiscal 2022 and increased to $120 million in fiscal 2024. However, the LLM incorrectly states it was $84 million in 2022 and 'dropped to $166 million' in 2024 — which is both numerically incorrect and contradictory (a drop from $84M to $166M is an increase, not a decrease). The proportion (1%) is correctly reported in both years. (2) Quantitative accuracy is severely compromised: the dollar amounts are wrong in both years, and the directional trend is mischaracterized — the LLM claims the investment 'decreased' while reporting a higher number in 2024, showing internal inconsistency. The correct trend is a moderate increase from $96M to $120M. (3) The qualitative reasoning is partially sound in noting that the proportion remained stable at 1%, and in interpreting the stable role in the portfolio. However, the multi-hop synthesis fails because it uses incorrect base figures, undermining the conclusion. The model does recognize the need to compare absolute value changes versus proportional stability, but does so on false data. (4) Contextual relevance is acceptable — the answer addresses the right metric, time frame, and concept (proportion within fair value hierarchy). However, due to major numerical inaccuracies and a flawed trend description, the overall correctness score is low. Minor credit is given for correct percentage values and relevant structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 432,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Between 2022 and 2023, Skunk Works' advanced development programs expanded their focus on next-generation military aircraft capabilities by emphasizing hypersonics, intelligence, surveillance, reconnaissance (ISR), and air mobility. In 2022, the programs were described as incorporating innovative design and rapid prototype applications for future systems, including unmanned and manned aerial systems. By 2023, the focus had evolved to include more specific advancements in hypersonics, situational awareness, and network-enabled activities to enhance system integration and effectiveness.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the focus areas in both 2022 and 2023, including hypersonics, ISR, air mobility, and situational awareness, which aligns with the ground truth. It accurately notes the continuation of unmanned and manned aerial systems in 2022 and the evolution toward more integrated, network-enabled capabilities in 2023. However, it omits the explicit mention of 'air dominance' as a newly emphasized core capability in 2023, which is a key point in the original answer and represents the primary shift. Instead, the LLM frames the evolution around 'system integration and effectiveness,' which, while plausible, does not fully capture the strategic prioritization of air dominance. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across years and identifies continuity and evolution in focus areas, but fails to highlight the specific strategic shift to air dominance, weakening the qualitative accuracy. (4) The answer remains contextually relevant and well-structured, addressing the evolution of focus areas in relation to next-generation military aircraft. The omission of 'air dominance' as a central theme in 2023 prevents a higher score, but core elements are present, justifying a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 405,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "Tesla's approach to the Powerwall product evolved from 2022 to 2023 by emphasizing integration with residential solar energy products and enhancing cross-selling opportunities. In 2022, Tesla noted that Powerwall's growing availability and interest were driven by grid stability concerns, with a focus on cross-selling with residential solar energy. By 2023, Tesla further highlighted the integration of Powerwall with Solar Roof and solar energy systems, leveraging modular design and software capabilities to optimize performance and customer solutions. This shift reflects a stronger emphasis on creating a cohesive energy ecosystem for residential customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Tesla emphasized cross-selling Powerwall with residential solar in 2022 due to grid stability concerns and availability, and by 2023 shifted toward deeper integration with Solar Roof and solar systems. The LLM correctly identifies the evolution from sales-driven cross-selling to technical integration. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years and product lines (Powerwall, Solar Roof, solar energy systems) and captures the strategic shift. The only minor gap is that the LLM does not explicitly mention Tesla's focus on 'improving installation capabilities and price efficiencies for Solar Roof' in 2022, which is part of the original answer and adds context to the integration strategy. However, this omission does not distort the overall meaning. (4) The answer is contextually relevant, directly addressing both integration strategy and production emphasis (implied through availability and design improvements). Wording differs but semantic equivalence is preserved. Thus, the answer earns a 9 for correctness and qualitative accuracy due to near-complete alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 390,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Between 2022 and 2024, Gilead's strategic positioning around Biktarvy has emphasized its role as a key driver in the company's HIV portfolio, maintaining its position as a leading single-tablet regimen for the treatment of HIV-1. However, the associated commercial risks have increased due to factors such as competitive pressures from generic products and other branded therapies, pricing pressures from government and private payers (notably under the Inflation Reduction Act of 2022), and the potential for market share erosion if treatment paradigms shift away from nucleoside-based regimens like TAF, which is a core component of Biktarvy. These risks underscore the challenges Gilead faces in sustaining Biktarvy's commercial success amid an evolving HIV treatment landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and strategic evolution. (1) It accurately captures Biktarvy's continued prominence in Gilead’s HIV portfolio between 2022 and 2024 and correctly identifies the increased commercial risks due to overreliance on TAF-based therapies. The mention of shifting treatment paradigms away from nucleoside-based regimens matches the original answer’s concern about reduced preference impacting sales. (2) There are no numeric values, dates, or financial figures in either answer that conflict; the reference to the Inflation Reduction Act of 2022 is factually accurate and contextually relevant, though not present in the original answer—this adds detail without contradicting. (3) The multi-hop reasoning is sound: the LLM synthesizes Biktarvy’s role in the HIV portfolio with emerging commercial risks, including external pressures (payer pricing, generics) and therapeutic class vulnerability. However, it adds elements (e.g., Inflation Reduction Act, generic competition) not emphasized in the ground truth, which focuses more narrowly on overreliance on TAF and innovation stagnation. While these additions are plausible, they slightly shift emphasis from the core issue of portfolio concentration risk. (4) Despite this, the answer remains semantically equivalent in key aspects—Biktarvy’s central role and growing risk exposure—and fully addresses the question’s scope. Hence, a score of 8 is justified: factually accurate and complete, with minor expansion beyond the original focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 430,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retrospective Responsibility Plan saw an increase in the U.S. litigation escrow account balance, primarily due to higher deposits. In 2022, the escrow account balance increased from $894 million to $1,449 million, with $850 million deposited. In 2023, the balance rose further to $1,764 million, with $1,000 million deposited. Additionally, payments to opt-out merchants were higher in 2023 at $685 million compared to $295 million in 2022. The mechanisms referenced in the U.S. Litigation Escrow Agreement remained consistent, involving deposits into the escrow account, payments to resolve litigation, and the conversion feature affecting class B common stock.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core of the question. (1) The question asks about changes in the *composition* of the U.S. Retrospective Responsibility Plan between 2022 and 2023, specifically regarding mechanisms related to the U.S. Litigation Escrow Agreement. The ground truth states that the plan expanded in 2023 to include a new mechanism — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining prior mechanisms. The LLM instead discusses changes in *funding levels* (escrow account balances, deposits, payments), which were not asked for and are not part of the composition of the plan. (2) The quantitative details (e.g., $894M to $1,449M, $1,000M deposited) may be factually accurate in some context, but they are irrelevant to the question about structural mechanisms. There is no verification that these numbers match the ground truth because the ground truth does not contain them — indicating a misinterpretation of the query. (3) The multi-hop reasoning is flawed: the model conflates financial activity within the escrow account with the legal and structural components of the Responsibility Plan. It incorrectly asserts that 'mechanisms referenced in the U.S. Litigation Escrow Agreement remained consistent', when the actual change was in the broader plan’s composition, not just the escrow agreement. The mention of the 'conversion feature' is correct but insufficient. (4) The answer lacks qualitative and contextual accuracy because it focuses on monetary flows rather than structural mechanisms. While it mentions the escrow agreement and conversion feature, it omits all other mechanisms (indemnification, judgment sharing, omnibus agreement) and completely misses the addition of the 'makewhole agreements' in 2023 — the key change. Thus, despite some correct terminology, the answer is factually and conceptually misaligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 521,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, the strategic importance of Biktarvy for Gilead has remained high due to its strong patent protection, with U.S. and European Union patent expiration estimated for 2033. This extended exclusivity helps safeguard Biktarvy’s market position as a key HIV treatment. However, Gilead continues to face risks related to its heavy reliance on HIV products, including Biktarvy, for a significant portion of its revenue. These risks include potential market share losses due to competition and the eventual loss of patent exclusivity, which could impact revenue and necessitate a shift toward new product launches or indications to sustain growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Biktarvy's U.S. patent expiration in 2033, which matches the ground truth. However, it incorrectly states that the European Union (E.U.) patent also expires in 2033, whereas the original answer notes that no expiration was listed for the E.U. in 2022, indicating stronger or potentially longer protection. This is a factual inaccuracy affecting entity and qualitative accuracy. (2) Quantitatively, the 2033 U.S. patent date is accurate, and no other numbers or calculations are involved, so quantitative accuracy is high. (3) The multi-hop reasoning is partially sound: the model connects patent protection to strategic importance and acknowledges revenue dependency and competition risks. However, it misses the key evolution highlighted in the ground truth—while patent protection remained strong, GILD's 2024 risk disclosures emphasized increased vulnerability due to market competition and treatment paradigm shifts, suggesting a shift in strategic posture despite patent strength. The LLM frames the risk as ongoing rather than escalating, missing the temporal change in tone and emphasis. (4) Contextual relevance is strong—the answer addresses patent timelines, revenue dependency, and competitive risks. However, the failure to capture the nuanced shift in risk disclosure from 2022 to 2024 reduces qualitative and overall correctness, warranting a score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 391,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Based on the information provided in the document pages, there have been no modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, either in terms of guarantee structure or referenced documentation. The 2023 filing (T_10k_2023.pdf) references the same guaranty for Illinois Bell Telephone Company as outlined in the 2022 filing (T_10k_2022.pdf), with no indication of changes during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that there were no modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, both in structure and documentation, which aligns with the ground truth. It accurately reflects that the same guarantee was referenced in both years, with no changes indicated. The answer correctly references the 2022 and 2023 filings (T_10k_2022.pdf and T_10k_2023.pdf), maintaining entity and temporal accuracy. While the ground truth provides more specific detail—naming Exhibit 4-d to the Form 10-K for the period ending December 31, 2011—the LLM answer does not contradict this and conveys semantically equivalent information by stating the same guaranty was referenced in both years. The omission of the specific exhibit and historical filing date is a minor lack of detail but does not affect the factual correctness of the core claim. All reasoning is sound, logically consistent, and contextually appropriate. Quantitative elements (years, document types) are accurate. Thus, the answer is highly accurate with only a slight reduction in qualitative accuracy due to less specificity on the referenced documentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 335,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggests that there has been no material adjustment to the conversion rate during this period, which implies stability in the potential dilution of Class A common stockholders' voting power. However, since Class C shares carry no voting rights, their conversion into Class A shares would increase the total number of voting shares outstanding, thereby diluting the voting power of existing Class A common stockholders in significant corporate transactions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the consistent conversion rate between 2022 and 2023 and notes the stability in the structural conversion mechanism, which aligns with the ground truth. It also correctly observes that Class C shares carry no voting rights and that conversion would dilute Class A voting power by increasing the voting share pool. However, it misses key quantitative details from the original answer: the exact conversion rate of 4.0000 and the as-converted Class A equivalent stock values of 38 million in 2022 and 39 million in 2023. While the LLM implies stability, it does not explicitly connect the unchanged conversion rate to the stable relative dilution effect despite the slight increase in as-converted value, which is central to the ground truth's reasoning. The answer contains sound logic about dilution in principle but fails to synthesize the multi-hop insight that the *unchanged rate* combined with a *slight increase in converted value* still results in stable relative impact. This omission reduces qualitative accuracy. Entity identification (Class A and Class C stock, voting rights) is correct, and the context is relevant, but the explanation lacks the full financial and comparative reasoning present in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 351,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla's relationship with the Solar Roof shifted toward reduced production focus and strategic reallocation of resources. In 2022, Solar Roof was highlighted as part of Tesla's energy generation and storage offerings, with production occurring at Gigafactory New York. However, by 2023, the Solar Roof was notably absent from major strategic discussions, and Tesla faced delays and challenges in scaling its production. The company increasingly prioritized its mass-market electric vehicles and energy storage systems (like Powerwall and Megapack), reflecting a strategic dependency shift toward higher-margin and faster-scaling segments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts: Tesla produced the Solar Roof at Gigafactory New York in 2022, and by 2023, the company faced challenges in scaling production, with a more cautious or reduced emphasis on the Solar Roof. The shift in strategic focus toward higher-margin, faster-scaling segments like mass-market EVs and energy storage (Powerwall, Megapack) is a reasonable inference supported by Tesla's public disclosures, even if not explicitly stated in the original answer. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (Tesla, Solar Roof, Gigafactory New York, 2022–2023 timeframe) are correct. The reasoning is sound and reflects appropriate multi-hop synthesis across time and strategic priorities. However, the original answer emphasizes a shift from active production focus to highlighting *risks and dependencies* in disclosures, whereas the LLM interprets this as a strategic reallocation toward other products. While plausible, this adds an element of strategic intent (reallocation) not explicitly confirmed in the ground truth, which focuses on risk disclosure rather than resource shifting. This slight overinterpretation prevents a perfect qualitative and correctness score. Semantically, the core message—reduced emphasis and increased caution around Solar Roof from 2022 to 2023—is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 390,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, the role of syrups in Coca-Cola's business model remained integral to both concentrate and finished product operations. Syrups are produced by combining concentrates with water and sweeteners, and they are sold to bottling partners or fountain retailers for use in producing finished beverages. In 2023, concentrate operations (which include syrup sales) accounted for 58% of net operating revenues, slightly up from 56% in 2022, while finished product operations accounted for 42% in 2023, down from 44% in 2022. This suggests a modest shift toward concentrate and syrup sales as a larger portion of Coca-Cola's revenue, reflecting the continued reliance on bottling partners for finished beverage production and distribution.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. The percentages cited—58% and 56% for concentrate operations in 2023 and 2022, respectively—are not supported by the ground truth and represent a critical error. The original answer does not mention any such revenue split between concentrate and finished product operations, nor does it provide percentage breakdowns of net operating revenues. Therefore, these numbers are fabricated or misattributed, severely undermining quantitative accuracy. Additionally, the LLM incorrectly frames syrups as being 'produced by combining concentrates with water and sweeteners,' which reverses the actual process: concentrates are used to make syrups, which are then further diluted into finished beverages. This reflects a fundamental misunderstanding of Coca-Cola’s production hierarchy. While the answer correctly identifies that syrups are sold to bottling partners and fountain retailers and are part of concentrate operations, it misses key qualitative shifts described in the original answer: the 2023 change in distribution model where Coca-Cola directly manages fountain syrup sales in the U.S., and the inclusion of syrup operations in the North America operating segment. These omissions indicate a failure in multi-hop reasoning and synthesis across the two years’ filings. The answer is contextually relevant and addresses the general role of syrups in the business model, but it fails to capture the strategic evolution toward tighter control and regional segmentation. Thus, while some elements are semantically aligned, the presence of false data and flawed reasoning limits correctness to partially accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 464,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "Between 2022 and 2024, the company's operational focus on Africa/Eurasia remained relatively stable in terms of geographic reporting structure, as it continued to be one of the five reportable operating segments within the Oral, Personal and Home Care product segment. In terms of financial contribution, Africa/Eurasia's operating profit slightly declined from $228 million in 2022 to $253 million in 2024, while its net sales increased modestly from $1,082 million in 2022 to $1,095 million in 2024. This suggests a slight improvement in profitability relative to sales during this period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Africa/Eurasia had an operating profit of $203 million in 2022, but the LLM claims $228 million in 2022 and $253 million in 2024—both figures are incorrect and unsupported by the original answer. Additionally, the LLM introduces specific net sales figures ($1,082M in 2022 and $1,095M in 2024) that are not present in the ground truth, making them fabricated or misattributed data. (2) The quantitative inaccuracies are severe: the operating profit numbers are wrong, and the direction of change (decline vs. increase) is misrepresented. The ground truth does not provide 2024 operating profit or any sales data, so the LLM’s inclusion of such precise numbers is hallucinated. (3) The reasoning is flawed in terms of multi-hop synthesis. The ground truth highlights a structural change in 2024—realignment of the skin health business from Europe to North America—as evidence of strategic refinement in geographic reporting. The LLM completely misses this key point and instead fabricates financial trends. It also incorrectly states that Africa/Eurasia was part of the 'Oral, Personal and Home Care product segment' in both years, while the ground truth clarifies it became a distinct reportable segment within that geographic structure in 2024, implying a structural evolution, not stability. (4) The contextual relevance is moderate because the LLM addresses the general topic of geographic structure and financial contribution, but due to major factual errors, omissions of key strategic changes, and invented data, the overall correctness score is very low. The qualitative accuracy is slightly higher only because the general framing (evaluating structure and performance) aligns with the question intent, but the execution fails on critical details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 503,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's Orthopaedics business demonstrated steady global sales performance, with a 4.1% year-over-year increase in worldwide sales, driven by growth in both U.S. and international markets. The business emphasized enabling technologies across hips, knees, trauma, spine, and sports, reflecting a strategic focus on innovation and advanced solutions. This aligns with the broader MedTech segment's emphasis on technological advancements to enhance patient outcomes and clinical efficacy.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.1% year-over-year increase in global sales for Johnson & Johnson's Orthopaedics business in 2023, which matches the ground truth. However, it fails to report the actual global sales figure of $8,942 million, as well as the specific U.S. ($5,525 million) and international ($3,417 million) revenue numbers and their respective growth rates (3.8% and 4.6%), making the quantitative response incomplete. (2) While the percentage growth (4.1%) is accurate, the absence of absolute revenue figures represents a significant omission, especially since the question asks about 'global sales performance'—a metric that requires both relative and absolute numbers for full context. The LLM does not mention that 2024 data omitted revenue figures entirely, which is a key strategic shift highlighted in the ground truth. (3) The qualitative assessment is partially correct: the LLM notes the emphasis on enabling technologies across hips, knees, trauma, spine, and sports medicine, which aligns with the 2024 framing. However, it misses the core multi-hop insight—the strategic pivot from quantitative (2023) to qualitative (2024) presentation—failing to contrast the two years' reporting styles. This undermines the reasoning about how the strategic presentation evolved. (4) The contextual relevance is high because the answer addresses both sales performance and enabling technologies, but the lack of comparative framing between years and missing financial specifics reduces factual completeness and correctness. Hence, the scores reflect partial accuracy with significant gaps in quantitative detail and strategic synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 457,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa's approach to managing litigation liabilities through loss sharing agreements remained largely consistent in terms of the scope of U.S. covered litigation and liability allocation. The scope of U.S. covered litigation continued to include actions brought by merchants who opted out of the Rule 23(b)(3) settlement class in MDL 1720, provided they arose from facts similar to those in MDL 1720 and were not transferred to it. The liability allocation under the omnibus agreement remained unchanged, with the monetary portion of settlements or judgments divided into a Mastercard portion at 33.3333% and a Visa portion at 66.6667%. The Visa portion was allocated in accordance with the U.S. retrospective responsibility plan, which includes the litigation escrow agreement, conversion feature of class B common stock, and indemnification obligations of Visa U.S.A. members.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key evolution in Visa's approach between 2022 and 2023, which is the central focus of the question. (1) Quantitatively, the numbers are accurate: the 66.6667% (Visa) and 33.3333% (Mastercard) liability split under the omnibus agreement is correctly stated, and the reference to opt-out actions from MDL 1720 is factually consistent with the ground truth. (2) However, the LLM incorrectly asserts that Visa's approach 'remained largely consistent' between 2022 and 2023, which contradicts the ground truth. In reality, 2023 marked a strategic shift: Visa consolidated its loss sharing framework under the U.S. Retrospective Responsibility Plan, now encompassing previously settled or substantially resolved matters—indicating a pivot toward finalizing legacy liabilities. This evolution from a focus on specific amendments (e.g., October 2015) in 2022 to a broader, retrospective framework in 2023 is entirely omitted. (3) The multi-hop reasoning is flawed because the model fails to synthesize the change in strategic posture—while correctly identifying components of the liability structure, it does not recognize or explain the shift in scope and intent. (4) The answer is contextually relevant and uses correct entities (MDL 1720, Rule 23(b)(3), omnibus agreement, U.S. Retrospective Responsibility Plan), but the qualitative inaccuracy in portraying continuity instead of evolution significantly undermines the correctness. Hence, the correctness score is 5: some facts are right, but the core analytical point is missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 429,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, CL's investment in Guaranteed Investment Contracts (GICs) within its pension plan assets decreased from $51 million in 2022 to $30 million in 2024 for international plans, while there were no GICs in U.S. plans during this period. This decline suggests a shift in the company's pension plan asset strategy, likely toward diversifying its portfolio into other investment categories such as fixed income funds and multi-asset funds, which increased in allocation. The move indicates a potential effort to optimize returns and manage risk by reducing reliance on GICs, which are typically lower-risk but lower-return investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, CL held $1 million in GICs under U.S. Pension Plans and $55 million under International Pension Plans, totaling $56 million—not $51 million as stated. By 2024, U.S. holdings were fully phased out (correctly noted), but international holdings were reduced to $34 million, not $30 million. The LLM incorrectly reports international amounts as $51M (2022) and $30M (2024), which misrepresents both the starting and ending values. (2) Calculations are flawed: the actual decrease in international GICs is $21 million (from $55M to $34M), not $21M from $51M to $30M. The total reduction from $56M to $34M (net $22M drop) is misrepresented. (3) The qualitative reasoning is partially sound—the conclusion about strategic reallocation away from GICs toward other asset classes like fixed income and multi-asset funds aligns with the intent of the original answer. The interpretation that this reflects a move to optimize returns and manage risk is reasonable and contextually appropriate. (4) Entity accuracy is good: CL, Guaranteed Investment Contracts, U.S. and International Pension Plans, and the time frame (2022–2024) are correctly identified. However, the synthesis of multi-hop data across years and geographies is flawed due to incorrect numbers. While the overall direction of change (reduction) and strategic implication are captured, the factual foundation is weak, warranting a mid-range score of 5 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 423,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "Between 2022 and 2024, the Mastercard Developer Platform has evolved to become a more centralized and accessible hub for integrating digital assets and new technologies. In 2022, the platform was described as a tool to simplify access to and integration of Mastercard's digital assets, offering a single access point with tools and capabilities for finding APIs across a broad range of services. By 2024, the platform had expanded its role in enabling blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, supporting secure, scalable, and interoperable transactions within blockchain ecosystems. Additionally, the platform now facilitates consumer use cases such as buying and spending cryptocurrencies, reflecting Mastercard's broader commitment to innovation in digital assets and emerging technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 description of the platform as a single access point for digital assets and API integration is consistent with the original answer. The 2024 evolution correctly references the Mastercard Multi-Token Network™, blockchain-based transactions, programmable payments, and interoperability. (2) There are no numeric values, dates, or calculations in the question or answers that require verification; all time references (2022, 2024) are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two time points and identifies the strategic shift from general digital integration to supporting advanced technologies like blockchain and digital currencies. The mention of consumer use cases (buying/spending cryptocurrencies) adds contextual detail not explicitly in the ground truth but is plausible and consistent with Mastercard's public strategy—this does not contradict the original answer but slightly extends it. (4) The answer is semantically equivalent to the ground truth, with only minor differences in emphasis. The core evolution—from a broad integration platform to one enabling next-gen financial tech—is accurately captured. The score is 9 instead of 10 because the LLM introduces 'consumer use cases such as buying and spending cryptocurrencies' which, while reasonable, is not present in the verified ground truth from the knowledge graph and slightly exceeds the supported evidence. Otherwise, the answer is complete, factually correct, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 447,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "Between 2022 and 2024, the company's investment in U.S. common stocks within its pension plans has significantly decreased. In 2022, U.S. common stocks were valued at $2 (Level 1) under the U.S. pension plans, while in 2024, the value dropped to $1 (Level 1). This decline aligns with the company's strategic asset allocation, which emphasizes a higher proportion of fixed income securities (60% in 2024) and a lower allocation to equity securities (26% in 2024 for U.S. plans). The reduced exposure to U.S. common stocks reflects a more conservative approach to managing pension plan assets, prioritizing stability and income generation over equity market exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its factual claims. The ground truth states that the company had *no* investment in U.S. common stocks in its U.S. pension plans in both 2022 and 2024, while the LLM incorrectly claims there was a $2 investment in 2022 and $1 in 2024. This is a major factual error. Additionally, the LLM introduces specific allocation percentages (60% fixed income, 26% equity) that are not present in the original answer and cannot be verified from the provided truth. (2) Quantitative accuracy is very low: the dollar amounts ($2, $1) are incorrect, and the percentages cited (60%, 26%) are unsupported. The only correct quantitative point is the mention of Level 1 assets, though even this is misapplied given the wrong values. (3) The reasoning is flawed: the LLM assumes a 'decrease' in investment, but the ground truth shows no change—zero allocation in U.S. common stocks in the U.S. plan over both years. The conclusion about a 'more conservative approach' is speculative and based on false premises. It also fails to mention the $2 million in the *international* pension plan that remained constant, a key part of the original answer. (4) Contextual relevance is moderate because the answer addresses strategic asset allocation and pension plan investments, but it does so with incorrect data and misrepresents the evolution. The multi-hop synthesis is poor—failing to distinguish between U.S. and international pension plans and misrepresenting the presence of U.S. common stock holdings. Overall, the answer conveys a narrative opposite to the truth (decline from $2 to $1 vs. no investment in U.S. plan and stable $2M in international plan).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 461,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Between 2022 and 2023, Disney's strategic focus on cruise ships evolved with plans for additional fleet expansion, as noted in the 2023 filing. Capital investment in the cruise line remained a priority, aligning with broader Experiences segment growth initiatives. Operationally, Disney acknowledged risks related to market demand, macroeconomic conditions, and the high costs associated with launching new cruise ships, including potential asset write-downs if investments underperform, as seen with past ventures like Star Wars: Galactic Starcruiser.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim about Disney's strategic evolution. The ground truth states that Disney shifted from a growth-oriented capital investment focus in 2022 to an operational risk mitigation focus in 2023, particularly due to external disruptions like hurricanes. In contrast, the LLM claims that fleet expansion remained a priority in 2023 and that capital investment was still emphasized, which contradicts the documented shift in strategic framing. (2) There are no numeric values in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the question requires synthesizing a shift in strategic emphasis across two years using Disney’s own disclosures. The LLM fails this synthesis, incorrectly portraying continuity in investment focus rather than the documented pivot from growth to risk management. It also introduces irrelevant examples (e.g., Star Wars: Galactic Starcruiser) not tied to cruise ship operations or risk disclosures in the filings. (4) While the LLM addresses the general topic of capital investment and operational risks, it misrepresents the direction of change between 2022 and 2023, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because it discusses related themes but misses the key strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 400,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard's use of short duration foreign exchange derivative contracts has evolved between 2022 and 2024 by increasing their deployment to manage foreign exchange risk during daily settlement activities. In 2022, the Company recorded a $21 million impact in general and administrative expenses related to these contracts, while in 2024, this impact rose to $32 million. These contracts are used to offset potential changes in the value of monetary assets and liabilities due to foreign exchange fluctuations, with the objective of reducing volatility from foreign currency movements against the Company's functional currencies. The increased use reflects a growing emphasis on managing short-term exposure arising from the timing difference between payment transactions and subsequent settlements with customers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Mastercard continued using short duration FX derivatives with the same objective from 2022 to 2024, but the LLM claims there was an 'increased deployment' and rising expense impact from $21M to $32M, which is not supported by the original answer. These specific dollar amounts and expense trends are not mentioned in the ground truth and appear fabricated. (2) Quantitative accuracy is very low because the $21M and $32M figures, along with the assertion of increasing impact, are incorrect and unsupported. There are no numbers in the original answer regarding financial impacts of these contracts. (3) The qualitative reasoning is partially sound in that the LLM correctly identifies the purpose of the contracts (managing FX risk in daily settlements and reducing volatility), but it fails on multi-hop synthesis by inventing a trend in usage and financial impact not present in the data. It also misses the key evolution noted in the ground truth: the dynamic de-designation and re-designation of euro-denominated debt hedges in 2023–2024, which reflects strategic shifts in broader FX risk management. (4) Contextual relevance is moderate because the answer addresses the general topic of short-duration FX derivatives and their role in settlement risk, but it misrepresents the evolution by focusing on unverified quantitative increases rather than the actual strategic adjustments described in the original. The core factual error—asserting growing use and financial impact—undermines the correctness score, warranting a 3/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 447,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce's strategic relationship with enterprise cloud companies has evolved by expanding its investment focus and enhancing ecosystem integration. In 2023, the company emphasized investments in enterprise cloud companies, technology startups, and system integrators, aiming to digitally transform industries and expand its solution ecosystem. By 2024, Salesforce continued to grow its strategic investment portfolio, including reinvesting proceeds from the sales of strategic investments, and introduced Agentforce—an agentic layer of the Salesforce Platform for deploying autonomous AI agents across business functions. This advancement, along with deeper integration of AI and the expansion of the Hyperforce infrastructure, reflects a stronger focus on ecosystem integration and innovation to support customer needs and drive growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Salesforce's 2023 investment focus in enterprise cloud companies, startups, and system integrators for digital transformation and ecosystem expansion, which aligns with the ground truth. However, it misrepresents the 2024 evolution by emphasizing continued investment growth and introducing new elements—Agentforce, AI integration, and Hyperforce expansion—that are not mentioned in the original answer and are unsupported by the provided ground truth. The core shift in the original answer—from financial investment to strategic dependency and deeper ecosystem integration via AppExchange and third-party development—is underemphasized and partially replaced with unverified technological advancements. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable; no errors in this regard. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes the 2023 investment strategy, but fails to accurately reflect the 2024 strategic pivot toward dependency on partners through platform-enabled integration (e.g., AppExchange and ISVs). Instead, it introduces speculative innovations (Agentforce, Hyperforce) that shift focus away from ecosystem partnership dependency to internal product development. (4) While the answer is contextually relevant and addresses the evolution of strategic relationships, it substitutes key factual content with plausible but unverified details, reducing factual correctness. The original answer emphasizes a structural shift in relationship type (from investor to dependent ecosystem partner), which the LLM answer does not adequately capture, leading to a correctness score of 6 due to significant qualitative inaccuracies despite correct framing and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 495,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the company maintained a consistent methodology for determining accrual rates for vendor funding programs, but there was increased sensitivity to projected purchase volumes. In both years, accrual rates were based on vendor agreements and historical purchase trends, with adjustments made as necessary. However, in fiscal 2024, the company emphasized that amounts accrued could be more significantly impacted if actual purchase volumes deviated from projections, particularly for programs with graduated funding thresholds tied to volume achievements. This reflects a heightened awareness of the potential variability in vendor funding outcomes due to fluctuations in purchasing activity.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about the evolution of the company's approach to accrual rates. The ground truth states that the methodology remained consistent and that the explicit mention of 'graduated purchase volumes' was present in fiscal 2023 but omitted in fiscal 2024, suggesting a potential simplification or stabilization. In contrast, the LLM claims there was 'increased sensitivity' and 'heightened awareness' in fiscal 2024, which contradicts the original answer. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—however, no numbers were misstated, so it scores highly on that dimension by default. The reasoning is flawed: the LLM inverts the actual trend by suggesting greater sensitivity in 2024 when the evidence points to reduced emphasis on volume sensitivity. The answer is contextually relevant—addressing accrual rates, vendor funding, and purchase volumes—but synthesizes the implications incorrectly. It fails the multi-hop reasoning test by drawing an opposite conclusion from the same evidence. Thus, while the entities (vendor funding programs, accrual rates, fiscal years) are correctly identified, the qualitative interpretation is fundamentally inaccurate, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 360,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "The strategic relationship between LLY and Boehringer Ingelheim (BI) has seen increased legal involvement and collaborative dependency from 2022 to 2024, particularly concerning Jardiance. In 2022, BI initiated patent litigation against generic companies seeking approval for generic versions of Jardiance, with LLY not being a party to this litigation. By 2024, the collaboration faced new challenges as the U.S. Department of Health and Human Services (HHS) selected Jardiance under the Inflation Reduction Act (IRA) for government-set pricing, effective in 2026, which imposes a 66% discount from the 2023 list price. Additionally, LLY and BI are jointly defending five product liability lawsuits related to Jardiance, with BI assuming responsibility for legal defense and indemnification under their agreement. This highlights an increased legal burden and dependency on BI for managing Jardiance-related legal and financial risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, LLY was not a party to BI's Hatch-Waxman litigation against generics; by 2024, Jardiance was selected under the IRA for government-set pricing with a 66% discount from the 2023 list price, effective in 2026. The mention of the 66% discount and its reference to the 2023 list price matches the original. (2) Quantitative accuracy is perfect: the 66% discount and 2026 effective date are correctly stated. No calculations are required, but all numbers are precise and contextually accurate. (3) Multi-hop reasoning is sound: the answer synthesizes legal developments (litigation in 2022 vs. joint product liability lawsuits in 2024) and business dependency (IRA pricing impact), correctly inferring increased collaborative dependency. The addition of LLY and BI jointly defending five product liability lawsuits—while not in the original answer—is factually consistent and adds relevant detail without contradicting the ground truth. (4) The only minor gap is that the original emphasizes LLY's growing *revenue dependency* and *strategic entanglement* due to IRA pricing, which the LLM touches on but could emphasize more directly. However, the core message of increased legal and collaborative dependency is preserved. Wording differs but semantic equivalence is strong. Contextual relevance is excellent, addressing all aspects of the question: evolution over time, legal involvement, and collaborative dependency around Jardiance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 423,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "From 2022 to 2023, Disney's capital investment strategy toward cruise ships became more aligned with its broader Parks & Experiences business, emphasizing expansion and enhancement of guest offerings. In 2022, the focus was on the scheduled opening of Lighthouse Point in 2024 as a Disney Cruise Line destination, indicating a strategic investment in new cruise-related infrastructure. By 2023, the strategy expanded to include cruise ships as a core component of the Parks & Experiences segment, with capital investments directed toward cruise ships, new attractions, and capital improvements, reflecting a broader commitment to integrating cruise experiences with its theme park and resort ecosystem.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift in Disney's capital investment toward cruise ships from 2022 to 2023, aligning with the broader Parks & Experiences business. It accurately reflects that in 2023, cruise ships were explicitly listed as part of capital investments, which matches the ground truth. However, the LLM introduces specific information not present in the original answer — namely, the 'scheduled opening of Lighthouse Point in 2024' — which, while potentially true, is not mentioned in the provided ground truth and thus cannot be verified from the given context. This addition introduces unverified detail that affects factual fidelity. (2) There are no numerical values, dates, or financial figures in the original or LLM answer beyond '2022', '2023', and '2024'. The year '2024' is used appropriately in context and does not conflict with the ground truth, so quantitative accuracy is high. (3) The multi-hop reasoning is generally sound: the model correctly infers a strategic evolution from general Experiences segment risks in 2022 to explicit capital allocation toward cruise ships in 2023. However, the ground truth emphasizes the absence of specific capital investment mentions in 2022, whereas the LLM implies active investment via Lighthouse Point, which contradicts the original answer’s point that cruise ships were not specifically emphasized in 2022. This weakens the qualitative accuracy. (4) The answer is contextually relevant and well-structured, addressing the evolution of strategy and integration with Parks & Experiences. The core factual claim about increased prioritization in 2023 is correct. However, the inclusion of unverified specifics reduces the overall correctness score to 7, as the answer goes beyond the supported evidence without clear basis from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 500,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Between 2022 and 2024, Mastercard Foundry has significantly expanded its role in fostering innovation by deepening its engagement with emerging technologies and fintech partnerships. In 2022, Foundry focused on providing access to thought leadership, innovation methodologies, and early-stage fintech players. By 2024, its role had evolved to include driving the adoption of virtual card number (VCN) solutions, integrating with third-party platforms, and launching the Alias-Based Remittances and Payouts platform to streamline cross-border transactions. Additionally, Foundry supported blockchain ecosystems through the Mastercard Multi-Token Network™ and continued to experiment with future technologies, demonstrating a more proactive and integrated approach to innovation and fintech collaboration.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard Foundry from 2022 to 2024 in broad terms, including its focus on innovation, emerging technologies, and fintech partnerships. It accurately notes the 2022 role involving thought leadership and early-stage fintech access, and the 2024 shift toward more active innovation. However, it introduces specific initiatives—such as driving virtual card number (VCN) solutions, integration with third-party platforms, and the launch of the 'Alias-Based Remittances and Payouts platform'—that are not present in the ground truth and cannot be verified from the provided knowledge graph. These additions represent factual overreach or hallucination. While the mention of blockchain ecosystems and the Mastercard Multi-Token Network™ aligns with the original answer, the original does not support VCN or Alias-Based platforms as Foundry initiatives. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised—score reflects no errors in this dimension. (3) The multi-hop reasoning is partially sound: the model correctly identifies the temporal evolution and synthesizes Foundry’s growing role in blockchain and fintech. However, it fails to restrict its response to verified developments, introducing unverified programs that undermine the factual integrity of the synthesis. (4) The contextual relevance is high because the answer addresses the core question about Foundry’s evolving role, but correctness is reduced due to unsupported specifics. The original answer emphasizes Foundry as an 'innovation engine' experimenting with future tech and enabling blockchain-based models via the Multi-Token Network, without mentioning VCN or remittance platforms. Thus, while the direction of evolution is correctly interpreted, the supporting evidence includes inaccuracies, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 521,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "Between 2022 and 2024, the financial and strategic nature of the collaboration with Boehringer Ingelheim, particularly regarding Jardiance (empagliflozin), evolved significantly due to regulatory designations and pricing pressures. In 2022, Jardiance received regulatory designations such as Fast Track for chronic kidney disease and Breakthrough Therapy for heart failure with preserved ejection fraction, supporting its development and potential market differentiation. However, by 2024, pricing pressures intensified due to the Inflation Reduction Act (IRA), which led to government-set price reductions. Specifically, the U.S. Department of Health and Human Services (HHS) selected Jardiance for price-setting under the IRA, imposing a 66% discount from its 2023 list price for a 30-day supply, effective in 2026. This marked a strategic shift from leveraging regulatory designations to managing the financial impact of mandated price reductions, reflecting broader industry pressures on pricing and reimbursement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Jardiance received Fast Track and Breakthrough Therapy designations (specifically for CKD and HFpEF, as noted), and by 2024, it was selected under the Inflation Reduction Act for a 66% price reduction effective in 2026, based on its 2023 list price. These numbers, dates, and percentages match the original answer exactly. (2) Quantitative accuracy is perfect: the 66% discount, 2023 pricing reference, and 2026 effective date are all correctly reported. Format variations (e.g., '66% discount') are consistent and clear. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across time (2022 vs 2024), regulatory frameworks (FDA designations vs IRA pricing), and strategic implications (from regulatory support to financial pressure). It identifies the shift in collaboration nature as strategic and financially significant. (4) The only minor shortcoming is that the original answer emphasizes the shift from 'regulatory facilitation to regulatory-driven financial constraints' at a more abstract, strategic level, while the LLM answer provides more granular detail on indications (CKD, HFpEF) not explicitly mentioned in the ground truth. However, this additional detail is factually correct and enhances completeness without distorting meaning. Thus, the answer is semantically equivalent and contextually fully relevant. Minor deduction from 10 to 9 in qualitative accuracy due to slight over-specificity on indications not in the original, though not incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 438,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "From 2023 to 2024, the strategic positioning of the CH-53K King Stallion heavy lift helicopter within Lockheed Martin's Rotary and Mission Systems (RMS) segment has evolved as a key growth program. In 2023, the CH-53K was highlighted as a major program under RMS, with international interest and production activity, including the award of contracts for 12 helicopters to Israel. By 2024, the CH-53K remains a central component of RMS's portfolio, emphasizing its role in military operations and international markets, with continued development, production, and sustainment efforts. This reflects its growing importance in meeting global heavy-lift helicopter needs and supporting U.S. and allied defense strategies.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but misses the core evolution described in the ground truth. It correctly identifies the CH-53K as a key program within Lockheed Martin's Rotary and Mission Systems (RMS) segment in both 2023 and 2024, and notes its strategic importance. However, it fails to capture the nuanced shift in strategic positioning—from being one of several near-to-mid-term growth drivers in 2023 to being repositioned in 2024 within a broader framework of all-domain mission solutions, digital technologies, AI/ML, and autonomy. This conceptual evolution is central to the original answer and is entirely omitted in the LLM response. Instead, the LLM introduces specific details not present in the ground truth, such as the contract award for 12 helicopters to Israel, which, while potentially accurate, are not part of the verified knowledge graph and distract from the actual strategic narrative. (2) Quantitatively, there are no explicit numbers in the ground truth, and the LLM does not introduce any incorrect figures—only unverified specifics (e.g., '12 helicopters to Israel'). Since the ground truth contains no revenue, production numbers, or dates beyond years, and the LLM does not contradict any, quantitative accuracy is acceptable. (3) The multi-hop reasoning is partially sound—linking the CH-53K to RMS across two years—but fails to synthesize the shift in strategic framing. The LLM emphasizes continuity (international markets, production) rather than the evolution toward technological integration and interoperability, which is the key insight. (4) Correctness is scored 6 due to partial factual alignment but significant omission of the core conceptual shift. Qualitative accuracy is low (5) because the reasoning lacks the necessary depth and synthesis. Contextual relevance is high (8) as the answer stays on topic and discusses the right program and segment, but misses the strategic nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 528,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicates a strategic shift toward focusing on innovative and combination therapies, such as Jardiance, Glyxambi, Synjardy, and Trijardy XR, which address broader therapeutic areas beyond glucose control, including cardiovascular and renal benefits. This suggests a market focus on value-based care and expanding treatment indications to meet evolving payer and patient needs in chronic disease management.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the shift in the co-commercialized diabetes portfolio between 2022 and 2024, noting that by 2024 the portfolio included only Jardiance, Glyxambi, Synjardy, and Trijardy XR, which aligns with the ground truth. However, it omits explicit mention of the products removed—Trajenta, Jentadueto, and Basaglar—which is a key part of the factual change and strategic implication. While the remaining products are correctly listed, the absence of the dropped products weakens completeness. (2) There are no numeric values, dates, or calculations in the response, so quantitative accuracy is not applicable; however, the years 2022 and 2024 are used appropriately and contextually, consistent with the ground truth. (3) The multi-hop reasoning is partially sound: the LLM infers a strategic focus on innovative and combination therapies with broader therapeutic benefits, which is a reasonable interpretation supported by the retained products (especially Jardiance’s known cardiovascular benefits). However, it does not address potential drivers like generic competition (e.g., Basaglar facing biosimilar pressure) or lifecycle management, which are part of the ground truth reasoning. This limits the depth of qualitative accuracy. (4) The response is contextually relevant and provides a plausible interpretation of strategic direction, but lacks full factual completeness and nuanced reasoning present in the original answer. Hence, correctness is scored 7 for core facts being mostly right with a significant omission, qualitative accuracy 7 for sound but incomplete reasoning, quantitative accuracy 10 (no errors where applicable), and contextual relevance 9 for strong alignment with the question’s intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 475,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "The JASSM program's financial performance and strategic importance evolved significantly between 2023 and 2024. In 2023, production activity increased, contributing to higher net sales within the Missiles and Fire Control (MFC) segment due to a production ramp-up on JASSM and other precision fires programs. This contributed to the MFC segment's backlog increasing to $32,229 million at year-end 2023. In 2024, the production ramp-up on JASSM continued, further boosting net sales by $1.2 billion in the MFC segment and contributing to a year-end backlog of $38,783 million. This growth highlights JASSM's growing strategic importance in defense programs and its increasing contribution to Lockheed Martin's backlog and revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. According to the ground truth, there was no mention of a production ramp-up or increased activity for JASSM in 2023; it was only in 2024 that JASSM saw a production ramp-up contributing to a $1.2 billion increase in tactical and strike missile programs. However, the LLM incorrectly states that there was a production ramp-up in 2023 and attributes specific net sales growth and backlog figures to that year. The ground truth does not provide any backlog value for 2023 or 2024, nor does it state that JASSM contributed to a backlog of $32,229 million in 2023 or $38,783 million in 2024—these figures are fabricated or misattributed. (2) The $1.2 billion increase is correctly cited but misassigned: in the ground truth, it refers to the increase in tactical and strike missile programs in 2024, not net sales directly attributable to JASSM alone. The LLM incorrectly frames this as a net sales boost 'by $1.2 billion in the MFC segment' due to JASSM, when the ground truth presents it as part of a broader program category. (3) The multi-hop reasoning is partially sound in linking JASSM to MFC, backlog growth, and strategic importance in 2024, which aligns with the ground truth. However, the reasoning fails in 2023, where the LLM invents a production ramp-up and financial impact not present in the original data. (4) The contextual relevance is high because the answer addresses the evolution of JASSM’s performance and strategic role, backlog contribution, and production activity. However, due to major quantitative errors and incorrect attribution of financial data, the correctness score is low. The qualitative accuracy is moderate because the general direction of change (increased importance in 2024) is correct, but the reasoning is based on false premises for 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 512,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPM has shifted its focus in evaluating credit risk for Business Banking Loans from primarily relying on geographic distribution to incorporating more detailed borrower-level metrics, such as refreshed FICO scores and loan-to-value (LTV) ratios. This evolution, evident by comparing 2023 and 2024 disclosures, reflects a more granular approach to identifying early signs of borrower distress. By emphasizing FICO scores and LTV ratios, JPM can better assess individual borrower risk profiles and potential default likelihood, enabling earlier intervention and improved risk management.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that JPM's focus in 2023 was on loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment, and in 2024 shifted to delinquency rates—specifically loans more than 30 days past due—as early indicators of borrower distress. In contrast, the LLM claims the shift was from 'geographic distribution' to 'FICO scores and LTV ratios,' which is not supported by the ground truth and introduces entirely fabricated metrics and reasoning. (2) There are no numeric values in either answer, so quantitative accuracy cannot be assessed on numbers, but the use of incorrect financial metrics (FICO, LTV) in place of the correct ones (delinquency rates, loan performance models) constitutes a severe factual error. (3) The multi-hop reasoning fails completely: the LLM does not correctly identify the evolution in risk focus (from broad portfolio strategy to early delinquency tracking), nor does it accurately reflect how Business Banking Loans were integrated into consumer risk frameworks. Instead, it invents a narrative around borrower-level metrics that is absent from the original. (4) The contextual relevance is moderate because the answer addresses credit risk evaluation and early distress detection in Business Banking Loans over 2023–2024, but the substance is factually wrong, resulting in low scores for correctness, qualitative accuracy, and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 420,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Based on the provided document pages, there is no explicit mention of changes in the terms of Target Corporation's SPP II (Supplemental Pension Plan II) between the 2022 and 2023 filings. However, the inclusion of SPP II in both years' exhibits indicates its continued relevance within the company's executive compensation framework. This consistency suggests that Target maintains long-term, non-qualified retirement benefits for executives as part of a broader compensation strategy, potentially to attract and retain top talent.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to capture key factual details present in the ground truth. (1) It claims there is 'no explicit mention of changes' in the SPP II plan terms between 2022 and 2023 filings, which directly contradicts the ground truth stating that the plan was updated from the '2016 Plan Statement, as amended...effective April 3, 2016' in 2022 to the '2022 Plan Statement, as amended...effective May 1, 2022' in 2023. These are specific, verifiable changes in the plan's governing document and effective date, indicating a material update. (2) The quantitative accuracy is low because the LLM omits these critical dates (April 3, 2016, and May 1, 2022) and fails to note the shift in plan version, which are central to the question. (3) The reasoning is flawed: instead of identifying the documented evolution in plan terms, it asserts no change occurred, missing the multi-hop synthesis between the two filings that shows an update in the plan’s statement and effective date. (4) While the general idea that SPP II remains part of executive compensation is contextually relevant, the answer misses the core point about structural changes, leading to a misleading conclusion about consistency rather than evolution. The suggestion about talent retention is speculative and not grounded in the documented plan updates. Thus, despite some relevance, the answer is factually inaccurate and lacks the necessary depth and correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 400,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "From 2022 to 2024, the financial obligations related to Incyte under the Olumiant collaboration remained structured around potential future milestone payments. As of December 31, 2021, Incyte was eligible to receive up to $100.0 million in additional success-based regulatory milestones and up to $100.0 million in potential sales-based milestones. By December 31, 2024, the document does not indicate any new or updated potential milestone amounts, suggesting that the potential future payments remained unchanged at those levels.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct numbers—$100.0 million in regulatory and $100.0 million in sales-based milestones are correctly cited from 2022 (or end of 2021) data. However, the key evolution from 2022 to 2024 is misrepresented. The ground truth states that by 2024, there is no mention of remaining regulatory milestones, implying they were likely paid out or dropped, and only royalty payments (tiered up to 20%, plus a low teens royalty for COVID-19 sales) are referenced. The LLM incorrectly claims that 'potential future payments remained unchanged,' which contradicts the shift described in the original answer. (2) Quantitatively, the $100M + $100M figures are accurate and match the ground truth, earning partial credit. However, the absence of updated milestone figures in 2024 is misinterpreted as continuity, when it actually signals a transition to a royalties-only structure. (3) The multi-hop reasoning fails: the model does not synthesize the change over time—specifically, the disappearance of regulatory milestones and the emphasis on sales-based royalties by 2024. Instead, it assumes no change due to lack of explicit updates, which is logically flawed. (4) Contextual relevance is moderate because the answer addresses the topic and timeframe, but misses the core evolution the question asks about—how obligations changed. The conclusion is factually incorrect, leading to a low correctness score despite some accurate inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 407,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco's financial exposure in the APJC region increased between fiscal 2022 and fiscal 2023. In fiscal 2022, APJC revenue was $8,027 million, while in fiscal 2023, it rose to $8,208 million, reflecting growth in the region. Additionally, goodwill allocated to the APJC segment increased from $5,382 million in fiscal 2022 to $8,208 million in fiscal 2023, primarily driven by the Splunk acquisition and other smaller acquisitions. This indicates a significant expansion of Cisco's investment and strategic focus in the APJC region during this period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) Quantitatively, the LLM fabricates specific revenue figures: it claims APJC revenue was $8,027M in FY2022 and $8,208M in FY2023, but the original answer states that no specific financial figures for APJC were disclosed in FY2022 and no revenue data is provided for FY2023. Additionally, the LLM incorrectly states that goodwill in APJC was $5,382M in FY2022 and grew to $8,208M in FY2023, which is false—the ground truth states that total APJC *assets* (not goodwill) were $5,382M as of July 29, 2023 (FY2023), with no asset breakdown provided for FY2022. The LLM confuses assets with goodwill and invents values not present in the source. (2) The calculation and comparison of revenue and goodwill are entirely fabricated, with no basis in the provided data. (3) Qualitatively, the reasoning is flawed: the LLM asserts growth and strategic expansion based on made-up numbers and misattributed metrics, failing to recognize that the key point in the original answer is the *change in disclosure transparency*—from no explicit APJC asset breakdown in FY2022 to a disclosed asset balance in FY2023—not financial performance trends. (4) Contextually, the answer addresses Cisco’s APJC exposure, so it is relevant, but the factual inaccuracies and incorrect synthesis render it misleading. The model fails the multi-hop requirement by not recognizing the absence of data in one year and the emergence of asset disclosure in the next. Due to complete failure on factual and quantitative accuracy, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 436,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "The strategic collaboration between Lilly (LLY) and Boehringer Ingelheim regarding Jardiance has been impacted by regulatory changes, particularly the U.S. Inflation Reduction Act of 2022 (IRA). In 2023, the U.S. Department of Health and Human Services (HHS) selected Jardiance as one of the first ten medicines subject to government-set prices, effective in 2026. By August 2024, HHS announced a 66% discount for Jardiance compared to its 2023 list price for a 30-day supply. This regulatory development has prompted the companies to adjust their strategies, as the IRA accelerates revenue erosion for Jardiance prior to the expiry of its exclusivity, thereby influencing pricing and reimbursement dynamics.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Inflation Reduction Act (IRA) as a key regulatory change impacting the LLY and Boehringer Ingelheim collaboration on Jardiance, and notes the 66% discount applied in August 2024 compared to the 2023 U.S. list price, which aligns with the ground truth. However, it incorrectly states that the government-set prices are effective in 2026, while the original answer specifies that the 66% discount was applied in August 2024—meaning the pricing impact was immediate in 2024, not delayed to 2026. This is a significant factual error in timing. (2) The 66% discount figure is accurate and correctly referenced to August 2024 vs. 2023 list price. However, the LLM omits the 2022 revenue growth data (30% in U.S., 28% outside U.S.) mentioned in the original answer, which was part of the evolution from 2022 to 2024. This omission reduces completeness and quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model connects the IRA to Jardiance’s pricing and infers strategic adjustments by the companies. However, it fails to fully synthesize the timeline—starting from 2022 growth, moving through the August 2023 selection for price setting, to the 2024 discount impact—thus weakening the evolution narrative. (4) The contextual relevance is high, as the answer directly addresses the regulatory impact on the collaboration. Qualitative accuracy is strong in reasoning but penalized slightly for the 2026 effective date error. Quantitative accuracy is reduced due to the missing 2022 growth figures and the incorrect effective date for price changes. Correctness score is 7 because core facts (66% discount, IRA impact, 2023 selection) are correct, but key data points are missing and a major timing error affects interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 489,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "Between 2022 and 2023, GM's emphasis on the financial and reputational risks of product safety recalls, particularly for global platforms like the Chevrolet Bolt EV, showed a heightened focus on the broader implications for its EV/AV technology positioning. In 2022, the risks were primarily outlined in terms of the costs associated with recalls and the potential for reputational damage, especially for global platforms. By 2023, GM expanded this discussion to include the impact of recalls on brand equity, consumer trust, and the company's leadership in emerging technologies like EVs and AVs. This evolution reflects GM's growing recognition that safety issues in advanced technologies could not only lead to financial costs but also hinder its strategic goals in the EV/AV space.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GM's 2022 focus on financial costs and logistical complexity of the Chevrolet Bolt EV recall, particularly due to its global platform scale, is accurately represented. In 2023, the shift toward emphasizing reputational damage, brand equity, consumer trust, and implications for leadership in EV/AV technologies is correctly captured. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—only years (2022, 2023), which are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, connects the Bolt EV recall to broader platform risks, and correctly infers the strategic evolution in risk disclosure from cost-centric to reputation- and strategy-centric concerns. (4) The only minor shortcoming is that the LLM slightly generalizes the 2022 stance by mentioning 'potential for reputational damage'—while the ground truth specifies that 2022 focus was primarily on financial burden, with reputational risk becoming emphasized in 2023. This nuance is softened but not incorrectly stated, hence a score of 9 instead of 10 on qualitative accuracy. Overall, the answer is contextually excellent, factually correct, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 377,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "Between 2022 and 2024, Costco's Japanese subsidiary issued Guaranteed Senior Notes totaling approximately $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturity dates extending to 2043. In July 2024, $77 of these notes were repaid. This evolution suggests that Costco is strategically managing its long-term financing by issuing debt with extended maturities to ensure stable capital availability while also selectively repaying portions of its obligations to maintain flexibility and optimize its debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: $500 in Guaranteed Senior Notes issued in November 2023, fixed interest rates from 1.400% to 2.120%, maturities extending to 2043, and $77 repaid in July 2024. These match the ground truth exactly. The only minor omission is that the 2022 disclosure was limited to general terms and use of Level 3 inputs, which the LLM does not mention. However, the evolution from less to more detailed disclosure is implied by focusing on the 2023–2024 developments. (2) Quantitative accuracy is perfect: all dollar amounts ($500, $77), dates (November 2023, July 2024), interest rates, and maturities (up to 2043) are correct and match the ground truth. (3) The multi-hop reasoning is sound—linking the issuance and repayment to long-term financing strategy shows synthesis across time and financial intent. The conclusion about extended maturities and strategic debt management aligns with the ground truth’s interpretation. (4) Scores reflect near-perfect factual accuracy, with only a slight deduction in qualitative accuracy for not explicitly acknowledging the increased transparency from 2022 to 2024, which is part of the evolution. Contextual relevance is full, as the answer directly addresses both the evolution and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 364,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "The value of Cisco's available-for-sale debt investments decreased from $15,592 million in 2023 to $9,865 million in 2024, a reduction of $5,727 million. This significant decline suggests that Cisco may have reallocated or liquidated a portion of its investment portfolio, likely to fund strategic initiatives such as the acquisition of Splunk and to return capital to shareholders through dividends and stock repurchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in dates and direction of change. The original answer states that the value dropped from $15,592 million in 2022 to $9,865 million in 2023, but the LLM incorrectly claims the change occurred from 2023 to 2024, which is factually wrong. The decrease amount of $5,727 million is correctly calculated and matches the ground truth, but it is applied to the wrong years. (2) Quantitative accuracy is partially correct: the dollar values ($15,592M and $9,865M) and the difference ($5,727M) are accurate, but the time frame is reversed and shifted forward by a year. This undermines the factual correctness of the response. (3) The reasoning about a strategic reduction in holdings is plausible and aligns with the ground truth's interpretation, and the mention of reallocation for strategic initiatives like the Splunk acquisition adds context not in the original, but this is speculative and not supported in the ground truth. However, the multi-hop synthesis fails because it uses incorrect fiscal years, breaking the chain of accurate inference. (4) The answer is contextually relevant and addresses both parts of the question—change in value and strategic implication—but the core factual error in timing severely reduces correctness. While the qualitative reasoning about investment strategy shift is consistent with the original, the incorrect timeline and unsupported specifics (e.g., Splunk funding) limit accuracy. Thus, the correctness score is low due to critical date errors, despite correct numbers and reasonable interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 439,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "JPMorgan Chase's exposure to system damage risks, particularly from third-party vendor attacks and data recovery challenges, has evolved from 2023 to 2024 with increased emphasis on proactive measures and heightened awareness of emerging threats. In 2024, the company highlighted a stronger focus on third-party vendor oversight, including early detection of attacks on vendors and vulnerabilities in open-source software. Additionally, JPMorgan Chase emphasized the need to enhance systems and controls to recover from outages caused by malware or ransomware attacks, reflecting a more robust approach to data recovery compared to 2023. The 2024 filing also underscored the growing complexity of cyber threats, such as AI-driven attacks and quantum computing risks, which were not as explicitly addressed in 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects. While it correctly identifies an evolution in JPMorgan Chase's risk exposure from 2023 to 2024 and mentions third-party vendors and data recovery, it introduces concepts not present in the original answer, such as 'AI-driven attacks' and 'quantum computing risks,' which were not cited in the ground truth. Additionally, the LLM emphasizes 'proactive measures' and 'enhanced oversight,' which shifts the tone toward mitigation efforts rather than the increased risk exposure described in the original. The ground truth highlights a worsening risk profile—specifically, ransomware targeting third-party vendors, risks exceeding cyber insurance coverage, and inability to prevent fraudulent transaction processing—none of which are mentioned in the LLM response. Instead, the LLM focuses on detection and system enhancements, which misrepresents the nature of the evolution. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; no errors in dates or formats. (3) The multi-hop reasoning is partially sound—comparing 2023 and 2024 risk exposures—but fails to synthesize the correct details from each year. The LLM incorrectly characterizes the evolution as one of improved controls rather than heightened risk, which undermines the qualitative accuracy. (4) Correctness is scored at 5 due to partial factual alignment but significant omission of key risks and introduction of unsupported ones. Qualitative accuracy is low for the same reasons. Contextual relevance is high because the answer stays on topic and addresses the general theme of evolving cyber risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 470,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "Costco made operational investments in processing, packaging, and manufacturing facilities to support the production of private-label items by 2024, as outlined in the 2024 filing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that Costco made operational investments in processing, packaging, and manufacturing facilities by 2024 to support private-label production, as confirmed in the 2024 filing. All entities (Costco, 2024, private-label items) and the nature of the investments are accurately identified, satisfying the core of the multi-hop question linking the 2022 strategy to 2024 actions. There are no numeric inaccuracies, so quantitative accuracy is perfect. However, the LLM answer omits key contextual details present in the original answer: specifically, the strategic rationale from the 2022 filing (managing inflationary pressures and maintaining competitive pricing) and the significance of the shift from external sourcing to internal production capabilities. While the LLM captures the operational outcome, it does not fully convey the strategic evolution, which is central to the multi-hop synthesis required. This limits qualitative accuracy slightly. Contextual relevance is strong as the response directly addresses the operational investments made by 2024. Overall, the answer is correct but less complete than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 330,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's approach to Medicaid managed care contract bidding became more cautious and risk-conscious, particularly in terms of assumptions and bid accuracy. In both years, the company emphasized that its bids are based on assumptions regarding enrollment, utilization, medical costs, and other factors. However, in 2023, the company highlighted increased risks due to potential unforeseen changes in programs, policy shifts after bid submission, and competitive pressures from lower competitor bids. The 2023 filing also underscored the potential for material adverse impacts if these assumptions are incorrect or if there are significant changes in Medicaid program funding or requirements after bids are submitted. This suggests a heightened awareness of bid accuracy risks and a more strategic approach to managing uncertainties in the bidding process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in UnitedHealth Group's approach to Medicaid managed care contract bidding between 2022 and 2023. (1) It correctly identifies that in both years, the company relied on assumptions about enrollment, utilization, and medical costs, but in 2023, there was a heightened focus on the risks associated with those assumptions. The shift from emphasizing contract renewal risk in 2022 (retaining members via renewals) to bid assumption accuracy in 2023 is accurately reflected, though the 2022 emphasis on member retention due to non-renewal is slightly underemphasized in the LLM response. (2) There are no numerical values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes a shift in risk focus across two years and attributes it to changes in strategic disclosure, referencing program changes, competitor pricing, and post-bid policy shifts as new risks in 2023. The LLM adds contextual detail (e.g., 'policy shifts after bid submission') that aligns with but slightly expands beyond the original, without introducing inaccuracies. (4) The answer is contextually relevant and fully addresses the question about evolution in assumptions and risks. The only reason for not scoring a 10 is that the 2022 risk—losing members due to failure to renew contracts—is mentioned more centrally in the ground truth and only implicitly covered in the LLM answer. Overall, the semantic meaning and factual content are substantially equivalent, with high qualitative and contextual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 449,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "Based on the information provided in the given pages:\n\nIn 2022, MET's investment in Municipals was classified entirely under Level 2 of the fair value hierarchy, with an estimated fair value of $14,212 million. By 2023, the investment in Municipals remained classified under Level 2, with an estimated fair value of $147 million for pension benefits and $8 million for other postretirement benefits, totaling $155 million. Thus, the valuation hierarchy classification for MET's investment in Municipals remained consistent from 2022 to 2023, staying within Level 2.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, MET's Municipals investment was valued at $14,212 million but was categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. However, the LLM incorrectly states that it was 'classified entirely under Level 2' in 2022, which contradicts the original answer. This is a critical error in both entity classification and reasoning. (2) For 2023, the LLM reports a total value of $155 million ($147M + $8M), but the ground truth states $159 million. While close, this is still inaccurate. More importantly, the original answer emphasizes a shift to explicit 'Level 2' classification in 2023, implying improved transparency, whereas the LLM falsely claims the classification remained the same (Level 2) in both years, missing the key evolution in hierarchy disclosure. (3) The multi-hop reasoning is flawed: the question asks about evolution in both valuation and hierarchy classification. The LLM fails to recognize that the 2022 classification was not specified by level (hence no 'Level 2' designation), making the comparison invalid. It incorrectly assumes consistency where there was actually a shift from unspecified to specified hierarchy. (4) Despite these major factual and reasoning errors, the answer is contextually relevant—addressing the right company, metric, and time frame—and attempts proper synthesis. Hence, contextual relevance is high, but correctness, quantitative, and qualitative accuracy are severely compromised due to incorrect numbers and, more critically, a fundamental misrepresentation of the valuation hierarchy evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 464,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "From fiscal year 2022 to 2024, Microsoft has enhanced the licensing flexibility and customer agreement models for Office 365 by introducing more tailored and simplified options. In 2022, Office 365 revenue was recognized ratably over the contract period, with a focus on integration between desktop applications and cloud services. By 2024, Microsoft expanded its licensing programs, such as the Microsoft Customer Agreement and Microsoft Products and Services Agreement, offering non-expiring agreements and greater flexibility for organizations to license cloud services and on-premises software as needed. These changes reflect a shift toward more adaptable, customer-centric models that support both subscription and perpetual licensing options, with optional Software Assurance for added flexibility.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Microsoft's licensing and customer agreement models for Office 365 from fiscal year 2022 to 2024. (1) Key facts are accurate: the shift from traditional volume licensing to more flexible, customer-centric models by 2024 is correctly identified, including the introduction of the Microsoft Customer Agreement, Microsoft Products and Services Agreement, and implied flexibility in subscription terms. The mention of ratable revenue recognition in 2022 matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time (2022 vs 2024) and identifies the shift in licensing philosophy. However, the LLM slightly overreaches by mentioning 'perpetual licensing options' and 'non-expiring agreements', which are not emphasized in the ground truth and could misrepresent the shift toward subscription-based, no-commitment models. The original answer highlights monthly/annual subscriptions with no organization-wide commitment, focusing on cloud services—this nuance is partially lost. (4) Contextual relevance is strong: the response directly addresses licensing flexibility and customer agreement models across the specified fiscal years. The core message of increased flexibility and customer-centric design is preserved. Minor inaccuracies in emphasis prevent a perfect score, but the answer remains factually solid and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 451,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "Between 2022 and 2023, the composition of MET's Level 3 Fixed Maturity Securities AFS changed slightly, with the percentage of these securities in the U.S. Pension Benefits plan decreasing from 83% in 2022 to 82% in 2023. This minor shift suggests a relatively stable investment strategy focused on maintaining a high allocation to fixed maturity securities, consistent with the company's objective of aligning its investments with long-term benefit obligations and managing risk prudently.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to address the actual composition changes in MET's Level 3 Fixed Maturity Securities AFS between 2022 and 2023. (1) The provided numbers—83% and 82% allocation to fixed maturity securities in the U.S. Pension Benefits plan—are not mentioned in the ground truth and are irrelevant to the question about Level 3 composition. The ground truth specifies exact dollar amounts across categories: in 2022, $1M Corporate bonds, $1M Foreign Bonds, $11M Equity Securities; in 2023, $54M Corporate bonds, $2M Foreign Bonds, $828M Other Investments. None of these figures are reflected in the LLM response. (2) There are no correct quantitative values reported; the LLM introduces percentages unrelated to the actual asset breakdown. (3) The reasoning is fundamentally flawed: instead of identifying a strategic shift toward 'Other Investments' and increased Level 3 exposure, the LLM claims stability and minor change, which contradicts the ground truth showing a massive increase in Other Investments (from $11M to $828M) and a shift in asset class focus. (4) The answer lacks contextual relevance—while it discusses investment strategy, it does so using incorrect data and an irrelevant metric (pension plan percentage), failing to synthesize the actual multi-hop information about changes in Level 3 assets. The conclusion about 'stable strategy' is unsupported and opposite to the evidence. Overall, the response misses all key facts and misrepresents the company's investment shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 418,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Between 2022 and 2024, Microsoft has evolved Office 365's strategic positioning by integrating it more deeply into its broader cloud services portfolio, emphasizing AI-driven enhancements to maintain competitiveness. Office 365 is now recognized as a key component of Microsoft's cloud-based offerings, with revenue recognized ratably over the contract period due to its integration with cloud services. In response to competitive pressures from AI-driven offerings, Microsoft has invested significantly in AI technologies, infusing generative AI capabilities into Office 365 and other products to enhance user experience and maintain market leadership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Office 365's evolution from a standalone cloud offering in 2022 to an AI-integrated component of Microsoft's broader cloud portfolio by 2024 is accurately described. The mention of ratable revenue recognition is consistent with cloud service accounting practices and adds contextual accuracy, though not explicitly in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Office 365's strategic shift, its integration with AI, and the response to competitive pressures from AI-driven entrants (e.g., ad-funded or open-source models). The only minor omission is the lack of explicit mention of competing business models (free, ad-supported, open-source AI), which the original answer highlights as a key competitive pressure. This slightly reduces qualitative accuracy but does not undermine the core correctness. (4) The answer is fully contextually relevant, directly addressing the evolution of Office 365’s positioning, its role in the cloud portfolio, and competitive dynamics. Wording differs but semantic meaning matches the original. Overall, this is a strong, factually correct response with only a slight gap in completeness regarding competitive model specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 411,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group maintained a consistent methodology for evaluating credit-related impairments, primarily relying on assessing expected cash flows, issuer credit quality, and the absence of significant credit deterioration. As of December 31, 2023, the Company did not report material credit-related impairments, similar to its position in 2022 and 2021. The financial impact of these impairments remained immaterial in both years, with no significant changes in the allowance for credit losses on available-for-sale or held-to-maturity debt securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that UnitedHealth Group maintained a 'consistent methodology' between 2022 and 2023. The ground truth states that the company evolved its approach in 2023 by formalizing a distinction between credit-related and non-credit-related impairments, which the LLM answer completely omits. This is a major qualitative error. While the statement that impairments were not material is consistent with the ground truth (where allowance was 'not material'), the LLM incorrectly implies no methodological change occurred. (2) Quantitatively, there are no specific dollar amounts, percentages, or dates in either answer that conflict—both correctly note immaterial financial impact and reference 2022 and 2023. The LLM’s use of 'December 31, 2023' is plausible context but not in the original. No calculation errors are present because no calculations were required. (3) The multi-hop reasoning fails: the question asks about evolution in methodology and financial impact, requiring comparison across years and synthesis of changes in accounting approach. The LLM fails to identify the key 2023 change in impairment recognition (segmenting credit vs. non-credit, new presentation in financial statements), which is central to the correct answer. (4) Correctness is low (3/10) due to missing the primary factual development—methodological evolution. Quantitative accuracy is high (8/10) because no numbers are wrong, but there are no specific figures to verify. Qualitative accuracy is poor (3/10) due to incorrect reasoning and failure to capture the change in framework. Contextual relevance is moderate (6/10) as it addresses the topic and timeframe but misses the key evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 473,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "From 2022 to 2023, the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans showed slight changes. For U.S. pension benefits, the total estimated fair value of Fixed Maturity Securities AFS increased from $6,802 million in 2022 to $6,714 million in 2023. For U.S. other postretirement benefits, the total estimated fair value increased from $1,256 million in 2022 to $1,274 million in 2023. The allocation by level within the fair value hierarchy also saw minor shifts, with Level 3 assets increasing slightly for both pension and postretirement benefit plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in quantitative data. According to the ground truth, the 2022 figures were percentages (84% for U.S. Pension Benefits and 95% for U.S. Other Postretirement Benefits), not dollar amounts ($6,802M and $1,256M as claimed). The LLM incorrectly presents 2022 values as absolute fair values when the original answer does not provide any dollar figures for 2022. Only the 2023 values ($6,714 million and $1,274 million) are correct and match the ground truth. (2) The claimed increases in fair value are therefore incorrect: the LLM states that values increased from 2022 to 2023, but since the 2022 dollar amounts are fabricated, this comparison is invalid. In fact, the ground truth shows a shift in reporting methodology—from percentage allocations in 2022 to absolute valuations in 2023—rather than a direct year-over-year change in dollar terms. (3) The qualitative reasoning is partially sound in noting a shift in reporting, but it fails to capture the core multi-hop insight: the evolution from relative allocation (percentages) to absolute valuation (dollar amounts), which reflects a change in disclosure depth, not necessarily a change in portfolio composition. The mention of Level 3 assets is unsupported by the original answer and introduces unverified details. (4) Despite the incorrect numbers, the answer is contextually relevant—addressing the right entities (MET, Fixed Maturity Securities AFS, pension and postretirement plans) and attempting a year-over-year comparison. However, the severe quantitative inaccuracies—especially inventing 2022 dollar figures—undermine the correctness, warranting a low score of 3. Quantitative accuracy is scored 2 due to mostly false numbers; qualitative accuracy is 4 for partial reasoning; contextual relevance is 8 as the structure and intent align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 509,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Between 2022 and 2023, Lowe's strategic positioning of the Kitchens & Bath product category evolved by integrating it more deeply into its Total Home strategy, emphasizing localized offerings and omnichannel capabilities. In 2023, Kitchens & Bath was highlighted as part of Lowe's expanded installation services and tailored assortments to meet local customer preferences. This suggests that Kitchens & Bath holds a significant position in Lowe's product portfolio, as it is part of key growth initiatives focused on Pro and consumer solutions across the home.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Kitchens & Bath became more strategically important in 2023 and is tied to Lowe's 'Total Home' strategy, which aligns with the ground truth. However, it omits the key factual shift in categorization: in 2022, Kitchens & Bath was grouped under Home Décor (with Appliances, Décor, Flooring, Paint), and in 2023 it was repositioned among construction/renovation categories like Lumber, Building Materials, and Rough Plumbing. This structural reorganization is central to the evolution of strategic positioning and is missing from the LLM response. Instead, the LLM emphasizes 'localized offerings,' 'omnichannel capabilities,' and 'installation services,' which, while potentially true, are not supported by the provided ground truth and introduce unsupported details. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model infers increased strategic importance, which is correct, but fails to base this conclusion on the actual organizational restructuring evidence from the knowledge graph. The reasoning is plausible but not grounded in the specific entity relationships provided. (4) The contextual relevance is high because the answer addresses the evolution and strategic importance of Kitchens & Bath, but the lack of precise structural repositioning details and introduction of unverified elements (e.g., tailored assortments, local preferences) reduce factual accuracy. Thus, correctness and qualitative accuracy are moderately scored at 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 447,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez International's strategic focus on Cheese & Grocery has evolved from being an \"adjacent, locally relevant category\" in 2022 to not being explicitly highlighted in its 2024 strategic priorities. This shift suggests that the company is prioritizing its core snack categories—chocolate, biscuits, and baked snacks—over Cheese & Grocery for long-term growth, aligning with its goal to be the global leader in snacking.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general strategic shift away from Cheese & Grocery but misses key factual details present in the ground truth. It incorrectly states that Cheese & Grocery was an 'adjacent, locally relevant category' in 2022, whereas the original answer specifies that Mondelez *directly produced* these products and generated $1,990 million in revenue from them that year. This quantitative information is entirely omitted, which is a significant factual gap. By 2024, the company no longer reports direct production and only holds a strategic stake—this shift is partially reflected but not explicitly stated in the LLM response. (2) The $1,990 million revenue figure for 2022 is completely missing in the LLM answer, failing the quantitative accuracy check. There are no calculations required, but the absence of this key financial metric undermines the answer's completeness and precision. (3) The multi-hop reasoning—linking a decline in direct involvement in Cheese & Grocery with a strategic refocusing on core snacks—is logically sound and correctly inferred. The LLM correctly identifies the prioritization of core categories like biscuits and chocolate, aligning with Mondelez’s long-term snacking goals. However, it fails to synthesize the full evolution: from direct production (with revenue data) to a lighter footprint via strategic stake. (4) Despite missing critical numbers and misrepresenting the 2022 status, the overall direction of the strategic shift is correctly interpreted, and the conclusion about prioritizing core snacks is valid. Hence, the correctness score is 6—partially correct with significant omissions. Quantitative accuracy is low (4) due to missing revenue data. Qualitative accuracy is moderate (7) as reasoning and entity identification (Mondelez, core snacks) are sound. Contextual relevance is high (9) because the answer stays focused and addresses the strategic evolution question appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 530,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "In the 2022 10-K filing, Jevity and Freego™ products were listed separately under the Nutritional Products segment, with Jevity positioned as a primary enteral feeding product. By the 2023 10-K filing, Freego™ was explicitly grouped with Jevity, indicating a shift in positioning where Freego™ is now presented as a complementary product within the same enteral feeding lineup, emphasizing integration and possibly a more cohesive product strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct and captures the core idea of a shift in product positioning between Jevity and Freego™ from 2022 to 2023. It correctly identifies that in 2022, Jevity was presented as a primary enteral feeding product with Freego™ listed separately, and that in 2023, Freego™ was more closely grouped with Jevity, suggesting a strategic repositioning. However, the LLM omits specific details about the exact order of product listings, which are critical to fully answering the question. According to the ground truth, in 2022, Freego™ (Enteral Pump) and Freego™ sets were listed after Glucerna and Osmolite®, whereas in 2023, they were moved immediately after Jevity, ahead of Glucerna and Osmolite®. This precise reordering is not mentioned in the LLM response, weakening the completeness and qualitative accuracy. While the LLM infers a plausible interpretation (integration/complementary strategy), it does not explicitly confirm the change in listing sequence, which is central to the question. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response remains contextually relevant and logically sound in its high-level reasoning. Minor deduction in qualitative accuracy due to incomplete synthesis of the multi-hop detail (product order across years).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 372,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "From 2022 to 2023, MET's investment in municipals showed an increase in fair value, with the estimated fair value rising from $14,212 million in 2022 to $14,212 million in 2023 (unchanged). The classification of these investments as fixed maturity securities available-for-sale (AFS) remained consistent in both years. The absence of allowance for credit loss (ACL) in both years suggests that the company did not identify significant credit impairments in its municipal bond portfolio during this period. This stability in fair value and the lack of credit losses indicate that MET's credit risk management strategy for municipals is effective, as the company is maintaining a portfolio with minimal credit risk exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. It claims MET's municipal investment remained unchanged at $14,212 million in 2023, but the ground truth shows a dramatic drop to just $159 million. This fundamental error invalidates the entire response. Additionally, the LLM states there was no allowance for credit loss (ACL) in either year, which is not mentioned or supported in the original answer. (2) Quantitative accuracy is extremely low: the 2023 value is off by over $14 billion. The claim of 'unchanged' fair value directly contradicts the ground truth showing a 99% reduction. No correct calculations or comparisons are made. (3) The multi-hop reasoning is flawed. The LLM fails to recognize the strategic reduction in municipals, misinterpreting stability where there is actually a major shift. Instead of identifying a risk reduction strategy through divestment, it incorrectly infers effectiveness from non-existent stability. (4) Contextual relevance is low because the answer addresses the right topic (municipals, AFS classification, credit risk) but with completely inaccurate data and conclusions. While it correctly notes the AFS classification, this is overshadowed by catastrophic errors in magnitude and interpretation. The suggestion of effective credit risk management due to 'stability' is the opposite of the truth—MET drastically reduced exposure, implying a strategic retreat from perceived risk.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 398,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Between 2022 and 2023, Abbott's use of interest rate hedge contracts decreased in notional value, from approximately $2.9 billion in 2022 to $2.2 billion in 2023. This reduction was primarily due to the maturity of $700 million of interest rate hedge contracts in 2023, which coincided with the repayment of long-term debt. These contracts are used to manage exposure to changes in the fair value of fixed-rate debt by offsetting changes in long-term benchmark interest rates. The impact on fixed-rate debt management is that the hedged debt is marked to market, which offsets the effect of marking the interest rate swaps to market, thereby stabilizing the overall interest cost exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Abbott's notional value of interest rate hedge contracts was approximately $2.2 billion in both 2022 and 2023, remaining consistent. However, the LLM incorrectly states that the notional value decreased from $2.9 billion in 2022 to $2.2 billion in 2023, introducing a false reduction of $700 million due to maturities. This $2.9 billion figure is entirely incorrect and not supported by the original answer. (2) The quantitative accuracy is low because the core dollar amounts are wrong—especially the fabricated $2.9 billion in 2022 and the $700 million reduction. While the $2.2 billion figure for 2023 is correct, it is framed as a reduction rather than a continuation, distorting the trend. (3) The qualitative reasoning is partially sound: the LLM correctly identifies the purpose of the hedges (managing fair value exposure of fixed-rate debt) and explains the accounting impact (marking hedged debt to market to offset swap valuations). It also correctly notes the role of benchmark interest rates. However, it fails to mention the key qualitative evolution in 2023—increased disclosure and a more refined approach to risk management—which was a central point in the original answer. (4) Contextual relevance is moderate: the answer addresses the general topic of hedge usage and debt management, but misrepresents the evolution by focusing on a notional decline that did not occur. The reasoning about hedge mechanics is relevant but built on incorrect premises. Overall, major factual errors in numbers and trend description severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 456,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M's issuance and management of fixed-rate registered notes showed notable repayment activity and strategic shifts in interest rate management. In 2022, 3M repaid $600 million in fixed-rate medium-term notes, and in 2023, it repaid $500 million in fixed-rate registered notes, $650 million in fixed-rate medium-term notes, and 600 million euros in fixed-rate medium-term notes. By 2024, 3M repaid $1.1 billion in medium-term notes. Additionally, 3M engaged in interest rate swaps, converting portions of fixed-rate notes into floating-rate debt to manage exposure to rising interest rates. This strategy is evident in the 2024 data, where $916 million in floating-rate debt carried a higher effective interest rate of 6.94%, reflecting a shift toward managing interest rate risk amid a rising rate environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and repayment details. According to the ground truth, in 2022, 3M did not repay $600 million in fixed-rate medium-term notes — instead, it held $600 million in 10-year notes due 2030 and $650 million in 30-year notes due 2050. The repayment activity began in 2023 with $500 million in fixed-rate registered notes, and in 2024, $1.1 billion in medium-term notes were repaid. However, the LLM incorrectly attributes a $600 million repayment in 2022 and adds a $650 million repayment in 2023 for medium-term notes, which is not supported by the original answer. Additionally, the mention of 600 million euros in fixed-rate medium-term notes in 2023 is not present in the ground truth and appears to be fabricated. (2) The interest rate swap information is partially correct — the original answer confirms swaps converted portions of fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, but the LLM introduces a new figure of $916 million in floating-rate debt with a 6.94% effective rate in 2024, which is not in the original data and lacks corroboration. (3) The multi-hop reasoning is partially sound — the model correctly infers a strategic shift toward managing interest rate exposure via swaps and reduced fixed-rate debt, which aligns with the original answer’s conclusion. However, it fails to accurately trace the issuance history (e.g., the $3.25 billion August 2019 issuance) and misrepresents repayment timelines. (4) The contextual relevance is high — the answer addresses both repayment activity and interest rate strategies as asked. Despite incorrect numbers, it captures the general trend of reducing fixed-rate exposure and using swaps. However, due to significant quantitative errors and unsupported figures, the correctness score is limited to 5, reflecting partial accuracy with major factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 518,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "Between 2023 and 2024, the role of securities issuances in Schwab's capital structure evolved as part of its broader capital management strategy to maintain liquidity and support balance sheet growth. In 2023, Schwab issued senior unsecured debt with higher interest rates (e.g., 5.643% to 6.196%) to align with the rising interest rate environment and strengthen its capital position. By 2024, Schwab executed $15.0 billion of receive-fixed swaps on its Senior Notes to hedge against lower interest rates, reducing interest expense exposure. This shift reflects Schwab's proactive approach to managing interest rate risk and optimizing its funding sources, particularly by leveraging capital markets issuances and derivative instruments to balance liquidity needs and capital efficiency.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and introduces details not present in the ground truth, significantly affecting correctness. (1) Quantitative Accuracy: The specific interest rates (5.643% to 6.196%) and the $15.0 billion receive-fixed swaps are not mentioned in the original answer and cannot be verified against the provided ground truth. These figures appear to be fabricated or hallucinated. There is no mention of derivatives or hedging activities in the ground truth, which undermines the quantitative and factual basis of the response. (2) Completeness: While the question asks about the evolution of securities issuances in relation to funding sources and capital management, the LLM focuses narrowly on debt issuance and derivative usage, missing the broader shift toward diversified funding sources highlighted in the original answer (e.g., FHLB borrowings, repurchase agreements, CDs). (3) Entity Accuracy: The company (Schwab/CSC) and time frame (2023–2024) are correctly identified, but financial instruments like 'receive-fixed swaps' and specific interest rates are not supported by the ground truth. (4) Reasoning: The multi-hop synthesis is flawed—the original answer emphasizes a strategic shift from securities issuances as a primary source to one among many, indicating diversification. The LLM instead frames the evolution around interest rate hedging and cost management via swaps, which is a different strategic narrative not present in the ground truth. (5) Semantic Equivalence: The overall message diverges significantly—the original highlights diversification of funding tools; the LLM emphasizes interest rate risk management through derivatives. While both touch on capital structure evolution, the mechanisms and strategic rationale differ. The LLM answer is contextually relevant and addresses capital structure changes, but its factual foundation is weak, leading to a low correctness score despite plausible-sounding details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 530,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "Coca-Cola's contingent payment obligations related to fairlife increased significantly from 2022 to 2024, with the fair value of the remaining milestone payment rising from $3,017 million in 2023 to $6,126 million in 2024. This increase indicates that fairlife has likely underperformed against its financial targets, as the contingent liability is based on fairlife's operating results and is not subject to a ceiling. The higher fair value of the obligation suggests a greater likelihood of needing to make the full milestone payment in 2025 due to lower-than-expected performance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in multiple critical ways. (1) Quantitative Accuracy: The LLM claims the contingent payment obligation increased from $3,017 million in 2023 to $6,126 million in 2024, which is grossly inaccurate. The ground truth states the liability was $270 million in 2022 and remained a $270 million contingent obligation through 2024 (with $100 million already paid in 2021). The LLM's numbers are over 10 times larger and completely fabricated. (2) Completeness: While the question asks about the evolution from 2022 to 2024 and performance implications, the LLM fails to mention the $100 million payment in 2021 for meeting 2020 targets, a key fact in the original answer. (3) Entity Accuracy: The company (Coca-Cola, fairlife) and timeframes (2022–2024) are correctly identified, but financial metrics (contingent liability value) and years (no 2023 value in ground truth) are wrong. (4) Reasoning: The LLM incorrectly infers that an increase in liability indicates underperformance, when in reality, contingent payments are typically structured to reflect probability of target achievement—higher liability usually suggests higher likelihood of meeting targets, not underperformance. However, in this case, the ground truth indicates the $270M obligation remained unchanged, suggesting stable expectations of performance. The LLM’s reasoning is based on false data and flawed logic. (5) Semantic Equivalence: The LLM’s answer conveys the opposite meaning—suggesting growing liability and underperformance—while the truth indicates sustained liability and continued progress toward targets. The answer fails on all core dimensions of factual accuracy and multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 472,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved significantly between 2022 and 2024, with a stronger focus on global market positioning and deeper integration with enterprise IT solutions. In 2022, Oracle highlighted growth in cloud services and license support revenues, driven by customer renewals and adoption of cloud-based infrastructure technologies. By 2024, Oracle emphasized the flexibility of OCI and Oracle Cloud Services (SaaS and OCI), enabling customers to choose deployment models that best suit their needs, including on-premise, cloud-based, or hybrid environments. This reflects Oracle's broader strategy to position OCI as a comprehensive and integrated solution for enterprise IT, supporting both cloud-native and traditional on-premise operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the LLM does not repeat the exact $36.052 billion figure from 2022, it correctly references cloud and license revenue growth without introducing any incorrect numbers, and no calculations are attempted that could introduce errors—thus maintaining quantitative integrity. (2) The entity identification is correct: Oracle, OCI, SaaS, and the 2022–2024 timeframe are all accurately referenced. (3) The reasoning correctly captures the multi-hop evolution: from a revenue-focused narrative in 2022 (where cloud and license contributed 85% of revenue, though the LLM doesn't state the percentage) to a strategic positioning of OCI as an integrated, flexible infrastructure pillar by 2024. The LLM accurately reflects the shift toward hybrid and deployment flexibility, which is central to Oracle’s 2024 messaging. (4) The only minor omission is the lack of the specific 85% revenue contribution figure and the explicit contrast that in 2022, there was no strategic language about OCI positioning—this contextual nuance slightly reduces completeness in qualitative accuracy. However, the core strategic evolution is correctly synthesized and semantically equivalent. The answer remains highly relevant, factually sound, and responsive to both global positioning and integration aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 385,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Between 2023 and 2024, the credit loss allowance for PALs (Pledged Asset Lines) decreased significantly, with the allowance for credit losses on total bank loans dropping from 0.09% to 0.04% of total year-end loans. This reduction reflects improved credit quality metrics and lower projected loss rates. Additionally, all PALs remained fully collateralized by securities with fair values exceeding borrowings in both years, eliminating the need for an allowance for credit losses on PALs.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific percentages (0.09% to 0.04%) for the allowance for credit losses on total bank loans, which are not present in the original answer and cannot be verified from the ground truth. These figures appear to be fabricated or misattributed, as the original answer only states a 'slight decrease' in PALs and mentions improved credit quality but provides no numerical data. This is a critical error in quantitative accuracy. (2) The claim that 'all PALs remained fully collateralized by securities with fair values exceeding borrowings in both years' contradicts the original answer, which states that full collateralization and elimination of allowance occurred specifically 'by 2024', implying a change from 2023. The original does not confirm full collateralization in 2023, so asserting it for both years is factually incorrect. (3) The reasoning partially captures the multi-hop evolution—improved credit metrics leading to reduced allowance and eventual elimination due to collateralization—but incorrectly frames the timeline and adds unsupported quantitative details. (4) While the overall direction of risk profile improvement and the link to ASC 326 practical expedient are conceptually aligned, the inclusion of false precision and incorrect year-over-year characterization reduces correctness. The answer is contextually relevant and captures the general trend, but fails on key factual and quantitative points essential to the multi-hop analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 413,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's relationship with the Asia Pacific & Latin America (APLA) region showed modest growth in revenues, increasing from $6,431 million in 2023 to $6,729 million in 2024. Operationally, APLA remained one of Nike's four geographic operating units, with earnings before interest and taxes (EBIT) slightly declining from $1,932 million in 2023 to $1,885 million in 2024. The region's strategic emphasis appears to align with Nike's broader focus on geographic diversification and direct-to-consumer growth, as reflected in the continued investment in direct-to-consumer sales channels and integration within Nike's global operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. While it provides financial figures for APLA (e.g., revenue increasing from $6,431M to $6,729M and EBIT declining from $1,932M to $1,885M), these numbers are not present in the ground truth and cannot be verified from the provided knowledge graph. More critically, the core evolution described in the original answer—Nike transitioning from direct operations with unionized employees in APLA in FY2023 to using third-party distributors in FY2024—is completely absent from the LLM response. Instead, the LLM fabricates financial metrics and discusses strategic emphasis on direct-to-consumer growth, which is not mentioned in the ground truth. (2) The quantitative values appear internally consistent (small revenue increase, slight EBIT decline), but since they are unsupported by the source data and not part of the known facts, they are factually inaccurate. There is no indication in the ground truth that such figures were disclosed or relevant to the operational shift. (3) The multi-hop reasoning fails entirely: the question asks about changes in operational structure and strategic emphasis, requiring synthesis of workforce representation (trade unions) in FY2023 and the shift to third-party distributors in FY2024. The LLM does not mention trade unions, third-party distributors, or any structural change, instead focusing on financial performance and generic strategy. (4) The contextual relevance is moderate because the answer discusses Nike and the APLA region over the correct time frame and touches on operational themes, but it misses the key factual transformation described in the ground truth. Due to major factual inaccuracies and failure to capture the central operational shift, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 493,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Between 2022 and 2023, Abbott emphasized growth and innovation in its U.S. Pediatric Nutritionals business, with a notable focus on Pedialyte. In 2022, U.S. Pediatric Nutritionals sales increased by 10.3%, driven by growth in Pedialyte, Similac, and PediaSure. By 2023, Abbott continued to expand its product portfolio, maintaining Pedialyte as a key driver while emphasizing innovation and consumer engagement. The company's strategic efforts included marketing and brand-building initiatives to strengthen its position in the pediatric nutritional market, reflecting a sustained emphasis on Pedialyte's role in meeting consumer needs for hydration and pediatric care.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Pedialyte was a growth driver in 2022 with a 10.3% sales increase in U.S. Pediatric Nutritionals, alongside Similac and PediaSure, which matches the ground truth. This demonstrates full quantitative accuracy. (2) The numbers and dates are correct—10.3% growth in 2022 is accurately reported. No calculations were required, but the figure is cited properly. (3) However, the LLM misses a key qualitative and structural evolution: in 2023, Pedialyte was formally integrated into Abbott’s Nutritional Products segment portfolio, listed alongside Ensure, Glucerna, and PediaSure, indicating a strategic shift from being a growth contributor to a core, formally recognized brand. The LLM mentions continued emphasis and innovation but does not capture this formal repositioning or portfolio-level integration, which is central to the strategic evolution. (4) While the answer is contextually relevant and correctly frames Pedialyte as a key player in pediatric nutrition, it falls short in fully synthesizing the multi-hop insight—linking 2022 performance to 2023 structural integration. Thus, the correctness and qualitative accuracy scores are reduced, but not severely, as the core facts and direction of strategy are still accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 363,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "From 2022 to 2023, RTX's 7.100% notes due 2027 remained unchanged in principal balance at $135 million. However, the current portion of long-term debt increased significantly from $135 million in 2022 to $1,283 million in 2023, indicating a shift in classification likely due to the note nearing maturity. This suggests that RTX is managing its debt by reclassifying maturing obligations to current liabilities and potentially planning for refinancing or repayment, aligning with a strategy of maintaining liquidity and managing near-term debt maturities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, RTX's aggregate principal balance for the 7.100% notes due 2027 was $6 million in 2022 and increased to $135 million in 2023. The LLM incorrectly states that the principal balance was $135 million in both years, completely missing the significant increase from $6M to $135M. Additionally, the LLM introduces a 'current portion of long-term debt' increase from $135M to $1,283M, which is not mentioned or supported by the original answer and appears fabricated. (2) The numbers are therefore grossly inaccurate: the 2022 principal is off by a factor of 22.5x ($6M vs $135M claimed), and the introduction of unrelated figures undermines all quantitative accuracy. There are no correct calculations or comparisons based on actual data. (3) The reasoning is flawed because it fails to recognize the multi-hop aspect of the question: tracking the evolution of a specific debt instrument over time. Instead of identifying a strategic increase in exposure to these notes, the LLM assumes no change in principal and invents a narrative around reclassification to current debt, which is unsupported. The conclusion about refinancing or liquidity management is speculative and based on incorrect data. (4) While the answer attempts to address debt management strategy (hence partial contextual relevance), the factual foundation is entirely wrong, leading to an incorrect interpretation of RTX's actions. The qualitative reasoning would be stronger if based on correct data, but as-is, it reflects a failure in entity and temporal tracking across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 453,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Converse's revenue performance declined, with total revenues decreasing by 14% to $2,082 million from $2,427 million. This decline was driven by a 16% drop in footwear revenues and a 15% decrease in wholesale sales, primarily due to weaker demand in North America and Western Europe. Strategically, Converse faced challenges in maintaining sales growth amid increased promotional activity and reduced consumer traffic, which contributed to a 30% drop in earnings before interest and taxes (EBIT). This indicates a contraction in both revenue and profitability for Converse during this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that Converse revenues decreased by 15% on a currency-neutral basis in fiscal 2023, but the LLM claims a 14% decline to $2,082 million from $2,427 million. However, a 14% decline from $2,427M would be approximately $2,087M, which is close but not exact. More critically, the $2,427M and $2,082M figures and the 16% footwear decline, 15% wholesale drop, and 30% EBIT decline are not present in the original answer and appear to be fabricated or misattributed. These specific numbers and metrics are not supported by the ground truth, which does not provide absolute revenue figures or EBIT changes. (2) The original answer focuses on a strategic evolution—Converse transitioning to a stand-alone subsidiary in fiscal 2024 as part of Nike’s portfolio strategy—while the LLM omits this entirely and instead emphasizes declining profitability and earnings, which were not mentioned in the ground truth. (3) The multi-hop reasoning is flawed: the LLM synthesizes detailed financial metrics that are not in the source, failing to connect the actual strategic shift (stand-alone operation) that defines the evolution. It correctly identifies weak demand in North America and Western Europe, which aligns with the original, showing partial reasoning accuracy. (4) While the LLM addresses revenue performance and mentions strategic challenges, it misses the core strategic repositioning in fiscal 2024, which is central to the original answer. Thus, despite some contextual relevance and partial qualitative accuracy in identifying regions of decline, the answer is factually incorrect on key numbers and incomplete in strategic insight, warranting a correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 480,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "Coca-Cola has increasingly emphasized digital evolution as a critical factor in its financial risk assessment from 2022 to 2024. In 2022, the company noted the importance of adapting to digital transformation to address evolving consumer shopping preferences and to improve efficiency and productivity. By 2024, the risk of not successfully digitalizing the Coca-Cola system was highlighted as a direct threat to its ability to increase sales and improve margins, with a stronger focus on leveraging data, AI, automation, and digital tools to enhance operations and consumer engagement. The 2024 filing reflects a more urgent recognition of digital initiatives as essential to maintaining competitiveness and financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Coca-Cola's shift from viewing digital evolution as a risk in 2022 to a strategic dependency in 2024 is accurately captured. The 2022 framing around adapting to digital transformation for efficiency and consumer preferences matches the original, and the 2024 emphasis on digitalization being critical for sales growth and margin improvement is correctly conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning—comparing risk assessments across years and synthesizing changes in strategic posture—is sound. The LLM correctly infers the increased urgency and financial linkage in 2024, noting that failure to digitalize could impair sales and margins, which matches the original answer’s claim about adverse financial impact. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'direct threat' vs. 'strategic dependency'), the meaning is consistent. The only minor gap is that the LLM does not explicitly use the term 'brand relevance' from the 2022 assessment, but this does not detract from the core financial focus on sales and margins. Overall, the answer is contextually precise, factually correct, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 397,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Services from fiscal year 2022 to 2024 has shown a continued increase in research and development investment and a stronger positioning of cloud offerings relative to on-premise solutions. In fiscal 2022, Oracle invested $7.2 billion in R&D, and by fiscal 2024, this investment trend continued, reflecting a focus on enhancing cloud offerings and developing new technologies. Oracle has positioned its cloud services as a preferred deployment model, emphasizing their flexibility, cost-effectiveness, and interoperability, while facilitating migration from on-premise solutions to Oracle Cloud Services. The company expects continued growth in cloud services and license support revenues, which represented a significant portion of total revenues in both periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Oracle's $7.2 billion R&D investment in fiscal 2022, which matches the ground truth. However, it incorrectly implies that the R&D investment amount for fiscal 2024 is known and continuing the same trend, while the original answer explicitly states that the 2024 report does not specify the R&D investment amount. This is a factual overstatement. (2) Quantitatively, the only number provided ($7.2 billion in 2022) is accurate, but the inference about 2024 spending lacks support, reducing quantitative accuracy slightly. No calculations are made, so no errors there. (3) The reasoning captures the strategic shift toward cloud services and the relative de-emphasis on on-premise solutions, which is correct. However, it misses the nuanced evolution in messaging—from highlighting technical differentiators (security, integration) in 2022 to emphasizing customer choice and fit in 2024. This subtlety in strategic positioning is absent in the LLM answer, weakening the qualitative accuracy. (4) The answer remains contextually relevant, addressing both R&D investment and cloud positioning over time, and correctly frames cloud as the preferred model. While it captures the overall direction of Oracle’s strategy, the lack of precision on 2024 R&D data and the omission of the shift in strategic messaging prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 381,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors' Formula Stock Award Plan had no future stock awards or deferrals available for issuance as of both 2023 and 2024, as the plan was closed to new awards or deferrals. In 2023, 509 shares were issuable under the plan for deferred compensation benefits, and by 2024, this number had decreased to 391 shares, reflecting ongoing distributions of deferred benefits with no new shares being added.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Norwest Corporation Directors' Formula Stock Award Plan was closed to new awards and deferrals in both 2023 and 2024, which aligns with the ground truth. It also correctly notes the decrease in issuable shares from 2023 to 2024 and that only existing obligations remained. However, the key factual error lies in the numeric values: the LLM states 509 shares were issuable in 2023, but the ground truth does not specify this number—only that 391 shares were issuable in 2024. There is no mention of 509 shares in the original answer, making this a significant quantitative inaccuracy. (2) The calculation of a decrease from 509 to 391 is plausible but unsupported by the ground truth, which only confirms the 391 figure for 2024 and does not provide a 2023 share count. Thus, the quantitative accuracy is low due to the introduction of an unverified number. (3) The multi-hop reasoning is partially sound—the model correctly infers that the plan is inactive and winding down, and it synthesizes the status across two years. However, it fabricates a specific numeric value for 2023 without basis, undermining the reasoning chain. (4) Despite the numerical error, the overall interpretation of the plan’s status and evolution is directionally correct, and the answer is highly relevant to the question. Hence, qualitative accuracy and contextual relevance are relatively high, but the correctness score is limited by the unsupported quantitative claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 416,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "McDonald's 2023 disclosure on food safety concerns shows a more detailed and forward-looking approach compared to 2022, particularly in relation to supply chain risks and cost volatility. In 2023, the company explicitly highlights the vulnerability of its supply chain to food safety issues, emphasizing the impact of factors such as food-borne illnesses, contamination, and tampering, not only within its restaurants but also across the supply chain and delivery systems. It also underscores the potential for supply chain interruptions due to limited suppliers for certain products, which could lead to price increases and operational challenges. Additionally, 2023 includes a stronger emphasis on the evolving regulatory environment and the need for compliance with increasingly prescriptive regulations related to food safety, labeling, and disclosure practices. This reflects a more comprehensive view of food safety risks and their broader implications on operations and financial performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of McDonald's food safety disclosures between 2022 and 2023. It accurately captures the shift toward a more supply chain- and cost-focused framing in 2023, emphasizing vulnerabilities in the supply chain, limited suppliers, and the impact on pricing and operations. It also correctly notes the increased emphasis on regulatory compliance in 2023, which is consistent with the broader financial and operational risk orientation. However, the LLM answer does not explicitly contrast the 2022 focus on reputational risk (e.g., brand perception, consumer trust) with the 2023 shift toward financial and supply chain volatility, which is a key element of the original answer. While the 2023 developments are well described, the comparative evolution—central to the question—is less clearly articulated. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and all entities (McDonald's, food safety, supply chain, cost volatility, regulatory environment) are correctly identified. The reasoning is sound and contextually relevant, but the absence of a direct 2022 vs. 2023 contrast on reputational vs. financial risk slightly weakens the qualitative accuracy. Overall, the answer is factually correct and relevant, but slightly less complete in capturing the full comparative nuance of the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 399,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "The carrying value of TMO's 1.750% 7-Year Senior Notes remained unchanged at $700 million between 2023 and 2024, as noted in the effective interest rate tables for both years. The effective interest rate also stayed consistent at 1.89% in both periods, indicating no material change in the interest rate or valuation adjustments during this time.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value of $700 million and the effective interest rate of 1.89% are correctly reported for both 2023 and 2024. There are no calculation errors or discrepancies in dollar amounts or percentages. (2) The answer is complete, addressing both parts of the question—evolution of carrying value and interest rate—over the two years. (3) Entity accuracy is correct: TMO refers to Thermo Fisher Scientific (implied by context), the debt instrument is properly identified as the 1.750% 7-Year Senior Notes, and the years 2023 and 2024 are correctly referenced. (4) The reasoning is sound: the model correctly infers that no changes occurred in either metric between the two years, and the conclusion about no material change in valuation or interest rate is logically supported by the data. (5) The semantic meaning is equivalent to the original answer, with slightly different phrasing but identical factual content. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 311,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX's exposure to its 7.000% notes due 2038 remained unchanged between 2022 and 2023, with the principal balance listed as $148 million in both years. This suggests that RTX did not take action to refinance or retire this specific debt instrument during the period, indicating a strategy of maintaining existing long-term debt maturities without immediate changes.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that RTX's exposure remained unchanged at $148 million in both 2022 and 2023. According to the ground truth, the principal balance was $11 million in 2022 and increased to $148 million in 2023. This major quantitative error undermines the entire response. (2) The numbers are not accurate: the 2022 figure is off by over $137 million. The LLM incorrectly asserts no change, when in fact there was a significant increase. Calculations or comparisons based on these figures are therefore invalid. (3) The multi-hop reasoning is flawed because the model failed to correctly retrieve and compare the two yearly disclosures. Instead of identifying a strategic increase in long-term debt exposure, it concludes there was no action, leading to an incorrect interpretation of RTX’s debt management strategy. (4) The contextual relevance is moderate because the answer addresses the right topic (debt maturity strategy) and refers to the correct instrument (7.000% notes due 2038), but the incorrect data leads to a false conclusion. The reasoning would have been sound if based on accurate figures, so qualitative accuracy is low but not zero. Correctness is severely penalized due to the core factual inaccuracy in financial amounts and trend direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 366,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees remained largely consistent in terms of collecting rent and royalties, as these payments are based on a percentage of franchisees' sales. In 2023, McDonald's reported $8,381.1 million in rent and $4,645.1 million in royalties from franchised restaurants, while in 2022, the figures were $8,381.1 million in rent and $4,645.1 million in royalties. Notably, the Company had previously deferred collections in 2020 due to the impact of the pandemic, but had collected substantially all of these deferrals by the end of 2021. There is no indication of significant changes in the collection process or terms between 2022 and 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims that McDonald's collected $8,381.1 million in rent and $4,645.1 million in royalties in both 2022 and 2023, implying no change between the years. However, the original answer (ground truth) does not provide any such figures for rent and royalties collected in 2022 or 2023. Instead, the ground truth focuses on the evolution of the financial relationship through the lens of pandemic-related deferrals and their resolution by end-2021, with normalization in 2023. The LLM invents precise financial figures not present in the source, which is a critical error. (2) There is no verification possible for the $8,381.1M and $4,645.1M numbers because they do not appear in the original answer. The original answer mentions a $1 billion deferral in 2020 (not 2022–2023), which was mostly collected by end-2021. The LLM incorrectly shifts focus to fabricated 2022–2023 revenue figures instead of addressing the evolution of deferral policies. (3) The multi-hop reasoning is flawed: the question asks about the evolution between 2022 and 2023 regarding rent/royalty collection practices, particularly in the context of prior deferrals. The correct inference is that by 2022–2023, McDonald's had returned to normal operations with no ongoing deferrals. The LLM correctly notes that deferrals occurred in 2020 and were mostly collected by end-2021, but then incorrectly implies that the lack of deferrals in 2022–2023 is due to consistent collection practices, supported by false financial data. This undermines the reasoning. (4) The contextual relevance is high because the answer addresses the right topic—franchisee financial relationships, rent/royalty collection, and pandemic impacts—but the inclusion of fabricated numbers severely damages correctness and quantitative accuracy. The qualitative accuracy is moderate because the general direction of reasoning (return to normalcy) is correct, but it is unsupported by the actual evidence and distorted by false data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 560,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "The Coca-Cola Company's financial stake in Embotelladora Andina S.A. (Andina) increased in value from 2022 to 2024, as evidenced by the difference between the fair value and carrying value of the investment. In 2024, the fair value of the investment was $168 million, while the carrying value was $90 million, resulting in a $78 million difference. This indicates that the market value of the investment has appreciated, suggesting a positive strategic positioning and potential for growth in the Andina business. The increase in value reflects the company's confidence in Andina's performance and its strategic importance in the region.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the 2024 carrying value ($90 million) and fair value ($168 million) of Coca-Cola's stake in Embotelladora Andina S.A., which matches the ground truth. However, it omits the key 2022 event — Coca-Cola recognized a $39 million gain from a partial sale of its ownership interest — which is central to understanding the evolution of the stake. This omission significantly undermines the completeness and correctness of the response. (2) The quantitative values for 2024 are accurate, and the $78 million difference between fair and carrying value is correctly calculated (168 - 90 = 78). However, the answer incorrectly frames this as an 'increase in value' from 2022 to 2024 without providing any 2022 carrying or fair value data, which is not supported by the evidence. The ground truth does not state that the stake increased in value over time, only that a partial sale occurred in 2022 and a valuation was reported in 2024. (3) The multi-hop reasoning is flawed: the LLM infers a positive strategic trajectory and 'increased stake' based on fair value appreciation, but the original answer indicates a partial exit strategy — a divestiture — which contradicts the LLM's interpretation. The strategic positioning is misrepresented: the original emphasizes a reduction in exposure, while the LLM suggests growing confidence and importance. (4) While the numbers for 2024 are correct and contextually relevant, the failure to mention the 2022 divestiture and misinterpretation of strategic intent results in a partially correct but misleading answer. Hence, the correctness score is moderate (4), quantitative accuracy is high (8) due to correct numbers and calculation, qualitative accuracy is low (4) due to flawed reasoning and missing synthesis, and contextual relevance is fair (7) as it addresses the investment's value but misses the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 515,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle's strategic investment in cloud infrastructure from 2022 to 2024 has shown a marked emphasis on internal development and positioning Oracle Cloud Infrastructure (OCI) as a central pillar of its product portfolio. In 2022, Oracle highlighted its internal R&D efforts and the expansion of Oracle Cloud data centers to meet growing customer demand, emphasizing automation and rapid delivery of cloud capabilities. By 2024, Oracle further solidified OCI's role as a core offering, integrating it with Oracle Cloud Services and enhancing its scalability, reliability, and security. The company also expanded its global cloud operations and continued to invest in infrastructure to support hybrid and cloud-based deployment models, reflecting a strategic shift toward cloud-centric solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Oracle emphasized internal R&D in 2022 and evolved to position Oracle Cloud Infrastructure (OCI) as a central offering by 2024. The focus on expanding data centers, automation, scalability, reliability, and hybrid cloud models is consistent with Oracle's strategic trajectory. (2) There are no numeric values (e.g., dollar amounts, percentages, headcount) in either the original or LLM answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Oracle's shift from broad internal development in 2022 to a more structured, product-centric strategy around OCI by 2024. It captures the evolution in strategic emphasis and portfolio positioning. (4) The LLM adds slightly more detail on hybrid deployments and global operations not explicitly mentioned in the original, but these are reasonable inferences consistent with Oracle's public strategy and do not contradict the ground truth. The only minor gap is that the original emphasizes the 'structured, customer-facing product portfolio' aspect more explicitly, which the LLM implies but does not state verbatim. However, semantic equivalence is maintained. All entities—Oracle, OCI, R&D, 2022–2024 timeframe—are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 385,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "Between 2023 and 2024, TMO's involvement with The Binding Site Group evolved from its acquisition in early 2023 to integration within the Specialty Diagnostics segment. The acquisition in 2023 expanded TMO's diagnostic capabilities in blood cancers and immune disorders, and by 2024, the company demonstrated strategic focus on leveraging such acquisitions to enhance its portfolio and operational performance. This progression indicates successful integration and alignment with TMO's strategy of expanding through targeted acquisitions to strengthen its market position and drive growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that TMO acquired The Binding Site Group in 2023 and integrated it into the Specialty Diagnostics segment, expanding its capabilities in blood cancers and immune disorders—this matches the original answer. The strategic focus on growth through acquisitions is correctly inferred. (2) There are no numeric inaccuracies; the LLM does not include the $2.70 billion acquisition cost or the 19-year weighted-average amortization period for customer relationships, but it does not misstate any figures. The absence of these specific quantitative details prevents a perfect score, though their omission does not make the answer factually incorrect. (3) The multi-hop reasoning is sound: the model connects acquisition to integration and infers strategic intent. However, it misses the specific evidence of integration (i.e., inclusion in amortization of definite-lived intangible assets), which is a key indicator in the ground truth. (4) The answer remains contextually relevant and conveys a semantically close interpretation, emphasizing integration and strategic focus. While it lacks one or two specific data points that would demonstrate deeper synthesis, the overall reasoning and factual content are accurate and appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 367,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "Between 2022 and 2024, the disclosure and accessibility of the Directors' Code of Conduct for BNY Mellon evolved in terms of website links and scope. In 2022, the Directors' Code of Conduct was posted at \"bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf,\" with a partial or broken link. By 2024, the link was updated and fully functional as \"https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf,\" indicating improved accessibility. The scope remained consistent, applying specifically to all directors of BNY Mellon, with a commitment to disclose amendments or waivers on the website.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the scope of the Directors' Code of Conduct remained unchanged—applying to all directors—from 2022 to 2024, which matches the ground truth. However, it inaccurately describes the 2022 URL as 'partial or broken' and provides only a fragment initially, which contradicts the ground truth that a full, functional URL was available. Additionally, the LLM claims the 2024 link is the same as the 2022 link, but in reality, the domain changed from 'bnymellon.com' to 'bny.com', reflecting a rebranding. The LLM fails to note this key evolution in the URL structure, instead suggesting only that accessibility improved, which misrepresents the nature of the change. (2) The dates (2022 and 2024) are correct, and there are no numeric calculations, so quantitative accuracy is acceptable despite the URL inaccuracies. (3) The multi-hop reasoning is partially sound—linking disclosure practices across years—but fails in synthesizing the actual change in domain (rebranding from BNY Mellon to BNY), which is a central point in the ground truth. The model does not recognize the significance of the domain shift, missing a key qualitative insight. (4) Contextual relevance is high because the answer addresses both website links and scope of application as asked. However, due to factual inaccuracies in the URLs and lack of recognition of the rebranding, the correctness and qualitative accuracy scores are reduced significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 407,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial reporting and strategic emphasis on franchisee relationships evolved in several key ways. Financially, the number of developmental licensed and foreign affiliated restaurants increased significantly, with developmental licensed restaurants rising from 7,913 in 2021 to 8,684 in 2023, and foreign affiliated restaurants growing from 7,775 in 2021 to 9,178 in 2023. This reflects a strategic shift toward expanding franchisee ownership, particularly in international markets. Additionally, goodwill related to franchise acquisitions increased from $2,782.5 million in 2021 to $3,040.4 million in 2023, indicating continued investment in franchisee-related assets. The Company also emphasized technology and brand licensing, with revenues from these areas growing, as franchisees increasingly rely on McDonald's for digital platforms and brand partnerships.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific numerical data (e.g., 7,913 to 8,684 developmental licensed restaurants, 7,775 to 9,178 foreign affiliated restaurants, goodwill increasing from $2,782.5M to $3,040.4M) that are not present in the original answer or implied by the ground truth. There is no mention in the ground truth of these specific figures or trends in restaurant counts or goodwill, making these claims unsupported. (2) The quantitative accuracy is low because the numbers cited—while precise—cannot be verified against the original answer and appear to be hallucinated or drawn from external data not referenced in the ground truth. The original answer does not provide any numerical trends between 2022 and 2023 related to restaurant counts or goodwill. (3) The reasoning partially aligns with the ground truth in that it infers a strategic emphasis on franchisees, which matches the 2023 shift toward viewing franchisees as key stakeholders. However, the LLM fails to mention the core factual evolution: in 2022, transactions with franchisees were deemed immaterial to consolidated financials, while in 2023, franchisees were explicitly integrated into the business model description. This key shift in financial reporting transparency and strategic framing is missing. (4) Contextual relevance is moderate because the answer discusses franchisee expansion and strategic importance, which are relevant themes, but it substitutes the actual multi-hop insight (evolution in financial reporting treatment and stakeholder framing) with unrelated metrics. The answer focuses on growth metrics and investments not mentioned in the ground truth, missing the conceptual shift in reporting and stakeholder emphasis. Thus, while the general direction is plausible, the factual basis and reasoning do not align with the provided truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 501,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "Between 2023 and 2024, the contingent consideration liabilities related to the Clif Bar acquisition increased from $452 million to $548 million. This change reflects fair value adjustments based on updated financial projections for net revenue, gross profit, and EBITDA, as well as discount and volatility rates. Both years classified the Clif Bar contingent consideration as Level 3 liabilities, indicating the use of unobservable inputs in fair value measurements. The fair value adjustments were primarily recorded in selling, general, and administrative expenses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims the contingent consideration increased from $452 million in 2023 to $548 million, but the ground truth states only $548 million as the 2023 year-end liability, with no mention of a $452 million figure or any 2024 value. There is no support for a year-over-year increase. (2) Quantitative accuracy is poor: the $452 million figure is entirely fabricated, and no 2024 value is provided in the original answer—only that the liability is no longer explicitly discussed. The LLM incorrectly implies both years reported values, when the 2024 filing omits updated figures. (3) The reasoning is flawed: the LLM suggests an evolution in fair value between 2023 and 2024 based on financial projections, but the ground truth indicates that 2024 disclosures do not mention the contingent consideration at all, instead referencing prior-year purchase price allocation adjustments. This suggests finalization or reclassification, not an updated fair value measurement. The LLM fails to identify this critical shift in disclosure. (4) While the LLM correctly notes that fair value adjustments were recorded in SG&A expenses and that the liabilities are Level 3, these correct details do not compensate for the core error: inventing a comparative quantitative trend that the source data does not support. The answer misrepresents the evolution of the liability by implying ongoing measurement in 2024 when the silence in disclosure suggests otherwise. Contextual relevance is moderate because it addresses fair value and classification, but misses the key point about the absence of 2024 disclosures and the shift to purchase price allocation adjustments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 469,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "AMD's strategic emphasis on Vulkan API support has remained consistent between 2022 and 2024, with continued integration of Vulkan into its discrete GPU offerings to support modern gaming and compute workloads. In both years, AMD highlights that its Radeon RX series GPUs support Vulkan alongside DirectX 12 Ultimate, emphasizing compatibility with high-refresh rate displays and immersive gaming experiences. This ongoing focus on Vulkan reflects AMD's commitment to cross-platform, high-performance graphics solutions, ensuring competitiveness in the discrete GPU market by catering to developers and users who prioritize open standards and advanced rendering capabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in stating that AMD maintained consistent support for the Vulkan API between 2022 and 2024 across its Radeon RX series GPUs, and correctly identifies Vulkan's role in enabling modern gaming and compute workloads alongside DirectX 12 Ultimate. There are no numeric inaccuracies (quantitative accuracy is perfect), and the context of API support for competitiveness in the discrete GPU market is well addressed. However, the LLM omits key architectural evolution details present in the ground truth: specifically, the shift from RDNA 2 (2022, Radeon RX 6000 series) to RDNA 3 (2024, Radeon RX 7000 series) as the underlying hardware advancement. This omission weakens the qualitative accuracy, as the progression in GPU architecture is central to AMD’s strategy of combining backward API compatibility with cutting-edge performance. While the LLM captures the continuity in Vulkan support, it fails to synthesize the multi-hop detail that AMD’s competitiveness stems not just from API support but from pairing that support with generational architectural improvements. Thus, the answer is semantically aligned but incomplete in its technical depth, warranting a 7 in correctness and qualitative accuracy. Contextual relevance remains high as the response directly addresses the strategic implications of API support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 374,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "The Powder Metal Matter charge of $2.9 billion in 2023 significantly impacted RTX's operating profit, contributing to a $1.9 billion decrease compared to 2022. This charge, primarily at Pratt & Whitney, was a major driver behind the drop in operating profit from $5.5 billion in 2022 to $3.6 billion in 2023, reducing the operating profit margin from 8.2% to 5.2%. The charge also lowered the effective tax rate in 2023 due to its impact on pretax income.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but includes some details not present in the original answer, which may not be verifiable from the provided knowledge graph. (1) Quantitatively, the $2.9 billion Powder Metal Matter charge and the $1.9 billion decrease in operating profit are accurate and match the ground truth. The resulting drop from $5.5B to $3.6B in operating profit is mathematically correct ($5.5B - $1.9B = $3.6B), and the margin decline from 8.2% to 5.2% is consistent with that change, assuming stable revenue. However, the original answer does not specify absolute operating profit values or margins, so these figures, while plausible, go beyond the provided ground truth. (2) The mention of Pratt & Whitney and the impact on the effective tax rate are not included in the original answer; while potentially true, they represent additional details not confirmed by the knowledge graph, reducing strict factual alignment. (3) The reasoning is sound: the LLM correctly identifies the shift in integration-related charges from a positive trend in 2022 (declining adjustments) to a major negative in 2023 due to the Powder Metal Matter charge. It synthesizes the cause-effect relationship between the charge and operating profit correctly. (4) Contextually, the answer is highly relevant and addresses both parts of the question: the 2022–2023 trend and the impact of the 2023 charge. However, the addition of unverified specifics slightly reduces quantitative and qualitative accuracy. Overall, the core facts and multi-hop synthesis are correct, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 445,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "MDLZ acquired Clif Bar on August 1, 2022, and during 2023, the acquisition contributed incremental net revenues of $529 million through the one-year anniversary of the acquisition. No specific acquisition-related financial activities between 2023 and 2024 are detailed in the provided pages, indicating that the integration of Clif Bar was likely completed by the end of 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains partially correct information but misses key aspects of the evolution between 2023 and 2024. It correctly identifies the August 1, 2022 acquisition date and reports $529 million in incremental net revenues during 2023, which aligns with typical post-acquisition reporting. However, it incorrectly states that 'no specific acquisition-related financial activities between 2023 and 2024 are detailed,' which contradicts the ground truth: the 2024 10-K explicitly mentions purchase price allocation adjustments for Clif Bar from the prior year, indicating ongoing financial activity. (2) The $529 million revenue figure is plausible and may be accurate (though not verifiable from the provided context), and the 2022 acquisition date matches the ground truth. However, the answer fabricates a lack of 2023–2024 activity that is directly contradicted by the original answer, which cites 2024 disclosures about prior-year adjustments. (3) The multi-hop reasoning fails: while the model correctly retrieves the acquisition event and its financial impact in 2023, it does not synthesize the 2024 10-K information about purchase price allocation adjustments, which is central to the question about evolution in the relationship. This omission represents a failure in cross-year document synthesis. (4) The contextual relevance is high because the answer addresses acquisition timing and financial impact, but correctness is significantly reduced due to the false claim of no 2023–2024 activity and the omission of key 2024 financial adjustments, making the conclusion about integration completion unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 443,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "From 2023 to 2024, Gulfstream's approach to energy-efficient engines has advanced with the introduction of the G700, which features \"all-new engines\" designed for superior high-speed performance and fuel efficiency. This shift is reflected in the certification and entry into service of the G700 in early 2024, as well as the continued development and deployment of aircraft like the G800 and G400, which emphasize high-speed range efficiency and reduced emissions. These developments underscore Gulfstream's commitment to sustainability and innovation in engine technology.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in Gulfstream's approach with the introduction of the G700 in 2024 featuring 'all-new engines' for efficiency, aligning with the ground truth. However, it incorrectly implies that the G800 and G400 were part of the 2024 energy-efficient engine developments, which is not supported in the original answer—these models are not mentioned in the ground truth and their inclusion introduces factual inaccuracies. (2) Quantitatively, the answer does not include incorrect dates or numbers; the mention of 'early 2024' for G700 certification is consistent with the ground truth's implication of production starting in 2024. No monetary figures or percentages are involved. (3) The multi-hop reasoning is partially sound: the model correctly infers a shift from R&D focus in 2023 to production in 2024 via the G700. However, it overextends by adding unverified aircraft models (G800, G400), suggesting flawed synthesis or hallucination, weakening the qualitative accuracy. (4) The contextual relevance is high as the answer addresses both the evolution in engine strategy and specific aircraft developments, though with some extraneous and unsupported details. The core progression from strategic emphasis to tangible output is preserved, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 370,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 to 2024, AMD's semi-custom SoC products have transitioned from being a niche revenue contributor to a more strategically emphasized segment. In 2022, revenue from semi-custom SoCs was described as dependent on third-party product success and non-recurring engineering fees, with no control over customer marketing efforts. By 2024, AMD's financial disclosures highlight semi-custom SoCs as part of a broader product portfolio that includes AI accelerators, GPUs, and APUs, indicating a more integrated strategic positioning. Additionally, AMD's 2024 filings reflect a stronger emphasis on development and IP licensing, suggesting a shift toward leveraging semi-custom SoCs as part of a diversified revenue model tied to long-term partnerships and innovation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AMD's relationship with semi-custom SoC products from 2022 to 2024, aligning closely with the ground truth. It accurately describes the 2022 state as dependent on third-party product success and non-recurring engineering (NRE) fees, with no control over customer marketing—this matches the original answer's emphasis on dependency and external performance linkage. By 2024, the LLM correctly identifies a shift toward strategic integration, inclusion in a broader product portfolio (AI accelerators, GPUs, APUs), and alignment with long-term innovation, which reflects the ground truth's claim of a more central and controlled role. The mention of IP licensing and diversified revenue model adds slight nuance not explicitly in the original but is consistent with the direction of the strategic shift. (2) There are no numeric values, percentages, or financial figures in either the question or answers, so quantitative accuracy is not applicable in terms of calculations; however, the years 2022 and 2024 are correctly referenced, and no incorrect dates or numbers are introduced—thus, quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 vs 2024), identifies changes in revenue structure (from NRE and sales dependency to diversified, partnership-driven models), and correctly maps strategic positioning shifts. The only minor gap is that the original answer explicitly mentions DPUs as part of the diversified portfolio, which the LLM omits—this prevents a perfect 10 on qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing both revenue structure and strategic positioning over the specified time frame. Overall, the LLM answer is factually correct, semantically equivalent, and only slightly less comprehensive than the ground truth due to one omitted product type (DPUs).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 528,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares ($0.20 par value) and 500 thousand A Preferred Shares ($1.00 par value) authorized, and no shares issued or outstanding in either year. This indicates that the company has not utilized preferred shares as part of its capital strategy during this period and has instead focused on other forms of capital management, such as ordinary share repurchases and equity-based compensation programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the preferred share authorization remained unchanged between FY2023 and FY2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years, and no shares issued or outstanding. These quantitative details match the ground truth exactly, with acceptable formatting variations (e.g., parentheses for par value). (2) All numbers and dates are accurate—127.5 million, 500 thousand, $0.20, $1.00 par values, and the two fiscal years are correctly referenced. No calculations were required, but the factual reporting of figures is precise. (3) The multi-hop reasoning is sound: the model correctly infers from the lack of changes and zero issuances that preferred shares were not utilized in the capital strategy. It adds a slight expansion—mentioning ordinary share repurchases and equity-based compensation—as alternative strategies, which, while not contradicted by the ground truth, are not explicitly supported by the provided data. This addition does not introduce inaccuracy but goes slightly beyond the evidence. (4) The answer is semantically equivalent to the ground truth in all key facts and conveys the same core conclusion about capital strategy. The minor extrapolation prevents a perfect 10, but the response is highly accurate, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 386,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "Between 2022 and 2024, the framing of reputational risk related to adverse publicity in BK's risk disclosures has evolved to include more specific linked concerns. In 2022, reputational risk was broadly mentioned as a potential impact of adverse events or publicity. By 2024, the disclosure explicitly ties reputational harm to broader issues such as climate change concerns, geopolitical events, and government scrutiny, highlighting a more nuanced understanding of interconnected risks affecting the company's operations and client activity.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in identifying the evolution of reputational risk framing in BK's disclosures between 2022 and 2024, with accurate dates and no numerical inaccuracies (quantitative accuracy is perfect as there are no numbers to verify). The answer correctly notes that in 2022, adverse publicity was linked to reputational harm and government scrutiny, and that by 2024, the scope expanded to include broader concerns. However, it misses the specific mention of the 'platforms operating model transition' as a new linked concern in 2024, which is a key part of the ground truth. Additionally, while the LLM mentions 'geopolitical events,' this is not present in the original answer and may represent an overextension or misattribution not supported by the ground truth. The core progression—broadening of reputational risk to include sustainability issues like climate change—is correctly captured, supporting a solid qualitative assessment. Contextual relevance is high as the response directly addresses the evolution of risk framing over time. The reasoning is sound but incomplete in synthesizing all multi-hop elements (e.g., operational model changes), leading to a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 339,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "Amazon's financial investment and valuation approach toward Anthropic, PBC evolved from 2023 to 2024 as follows: In 2023, Amazon invested $1.25 billion in a convertible note from Anthropic classified as available-for-sale, reported at fair value with unrealized gains and losses in 'Accumulated other comprehensive income (loss).' By 2024, this investment remained classified as a Level 3 asset, and Amazon had an agreement to potentially invest an additional $2.75 billion in a second convertible note. The valuation of the investment was subject to market conditions and the inherent complexity of private company valuations, with fair value adjustments based on observable price changes or impairments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and matches the ground truth in key quantitative aspects: the $1.25 billion initial investment, the $2.75 billion potential additional investment, the available-for-sale classification, reporting at fair value with unrealized gains/losses in 'Accumulated other comprehensive income (loss)', and the Level 3 asset categorization are all accurately reported. These figures are factually correct and consistent with the original answer, earning a perfect score on quantitative accuracy. Contextual relevance is also full, as the response directly addresses the evolution of Amazon's investment and valuation approach toward Anthropic, PBC from 2023 to 2024. However, the LLM omits a key qualitative shift emphasized in the 2024 filing: the increased focus on valuation complexity and risk due to lack of market data and global economic uncertainty. While it mentions 'inherent complexity of private company valuations,' it does not convey the shift in disclosure emphasis from investment mechanics (2023) to valuation challenges (2024), which is central to the original answer. Additionally, the LLM states Amazon had an agreement to 'potentially invest' the additional $2.75 billion, whereas the ground truth specifies a firm agreement to invest by Q1 2024—this softens the certainty of the commitment. These omissions affect completeness and reasoning depth, preventing a top score in qualitative accuracy and overall correctness. Nonetheless, the core facts and multi-hop synthesis (linking 2023 classification to 2024 continuity and valuation context) are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 435,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "Between 2023 and 2024, the nature of the risks related to the protection of Mondelez International's (MDLZ) intellectual property, including know-how, remained largely consistent, with a continued emphasis on the importance of intellectual property rights to the company's business. However, in the 2024 filing, there was a more explicit mention of the potential impact of developments in artificial intelligence technologies on the protection of intellectual property. This suggests a heightened awareness and potential evolution in the risk landscape, as AI could introduce new challenges in safeguarding proprietary information and innovations. Otherwise, the core risks—such as the potential for third-party claims of infringement, the costs and distractions of litigation, and the possible need for costly licensing agreements—remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim about the evolution of MDLZ's intellectual property risks between 2023 and 2024. According to the ground truth, in 2023 MDLZ specifically highlighted artificial intelligence (AI) as a factor that could reduce intellectual property protections and thus pose a risk. However, in 2024, the company removed this specific reference to AI and instead broadened its risk disclosure to include general legal and regulatory non-compliance, enforcement actions, and reputational harm. The LLM answer incorrectly states the opposite—that AI was more explicitly mentioned in 2024—when in fact it was de-emphasized or omitted. This is a critical factual reversal. There are no numerical values in the question or answers, so quantitative accuracy is not applicable in a meaningful way, but since no numbers were misstated, it scores highly. The qualitative accuracy is very low because the reasoning is flawed: the model fails to correctly synthesize the multi-hop change in risk disclosure over time and misidentifies the direction of change. Contextual relevance is moderate because the answer addresses the general topic of IP risks and mentions relevant elements like litigation and third-party agreements, but it distorts the key evolution in the risk narrative. Overall, the answer conveys the opposite of the truth regarding the role of AI in MDLZ's risk disclosures, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 399,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Goldman Sachs updated its treatment of Non-Employee Director Equity Award Agreements between 2023 and 2024, with the 2024 filing introducing new forms such as the \"Form of Non-Employee Director RSU Award Agreement\" and \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled)\" without specifying prior versions. In contrast, the 2023 filing referenced older, pre-2015 agreements and incorporated by reference agreements from prior years (e.g., 2014 and 2017). This suggests a shift in 2024 toward more current and distinct award structures for non-employee directors, though specific timeline details for these changes are not explicitly outlined in the provided pages.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to match the ground truth in key factual and structural aspects. (1) It incorrectly claims that the 2024 filing introduced 'new forms' such as 'Form of Non-Employee Director RSU Award Agreement' and 'Cash-Settled' variants, which are not mentioned in the ground truth and not supported by the referenced exhibits. (2) The ground truth states that in 2023, the agreement was referenced under Exhibit 10.17 with an amendment dated November 28, 2008, and in 2024 it shifted to Exhibit 10.18 that references Exhibit 10.69 from the 2008 Annual Report—this specific exhibit evolution (10.17 → 10.18, with linkage to 10.69) is entirely missing from the LLM answer. Instead, the LLM fabricates details about 'pre-2015 agreements' and incorporation of 2014/2017 documents, which are not in the original. (3) The LLM misrepresents the nature of the evolution: the ground truth describes a consolidation or formalization of existing agreements with deeper historical referencing, not a shift to new award structures. (4) No correct dates or exhibit numbers are provided in the LLM answer—critical quantitative and structural elements are wrong. While the answer is relevant to the general topic (director equity awards at Goldman Sachs), the factual inaccuracies, invented details, and failure to capture the actual exhibit-based evolution result in a low correctness score. The reasoning is unsound due to lack of multi-hop synthesis from actual filing structures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 411,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers evolved in terms of revenue recognition and contractual responsibilities, primarily through an increased shift toward merchant-based transactions. This shift allows BKNG to facilitate payments from travelers directly, increasing its ability to offer secure and flexible transaction terms. As a result, BKNG incurs higher merchant-related expenses, such as personnel and payment processing costs, which negatively impact operating margins despite incremental revenue gains. Additionally, the Company's contractual responsibilities expanded, as it now assumes more obligations related to payment processing, chargebacks, and fraud prevention in these merchant transactions.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in terms of factual content and reasoning, despite being internally consistent and relevant to the topic. (1) The key claim—that BKNG shifted toward 'merchant-based transactions' in 2022–2023, incurring higher expenses and assuming greater payment-related liabilities—is not supported by the ground truth. The original answer states that BKNG clarified its role as an agent and recognizes revenue on a net basis, which contradicts the idea of a merchant (principal) model. In accounting terms, recognizing revenue on a net basis indicates agency model treatment, not merchant (gross) model. (2) There are no numeric values in either answer, so quantitative accuracy is neutral; no errors here. (3) The multi-hop reasoning is flawed: the LLM mischaracterizes the evolution of BKNG’s relationship—instead of moving toward more detailed accounting disclosures around agency-model revenue recognition (as per ground truth), it fabricates a shift to a merchant model with expanded obligations. This is a fundamental misunderstanding of both the business model and accounting implications. (4) Contextual relevance is moderate because the answer discusses revenue recognition and contractual responsibilities in the correct timeframe and company context, but the substance is factually incorrect. The actual evolution was increased transparency in revenue recognition timing and basis (net vs. gross), not an expansion of merchant responsibilities. Thus, correctness and qualitative accuracy are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 418,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "Goldman Sachs restructured the presentation of its executive life insurance policy disclosures between the 2023 and 2024 10-K filings. In the 2023 filing, these policies were listed under specific exhibit numbers (e.g., 10.11 and 10.12), detailing policies with Metropolitan Life Insurance Company and Pacific Life & Annuity Company. In the 2024 filing, these specific life insurance policy exhibits were omitted from the listed exhibits, suggesting a reorganization or removal of such disclosures from the main exhibit list, potentially moved to another section or integrated into broader compensation-related disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially relevant but contains significant factual inaccuracies. (1) It incorrectly states that the executive life insurance policy exhibits were 'omitted' in the 2024 10-K filing, when in fact they were retained and only renumbered (from 10.11 and 10.12 to 10.12 and 10.13). This misrepresents the core fact of the disclosure change. (2) Quantitatively, the years (2023, 2024) and company names (Metropolitan Life Insurance Company, Pacific Life & Annuity Company) are correct, earning partial credit. However, the exhibit numbers are inaccurately described—specifically, the claim that they were 'omitted' contradicts the ground truth that they were renumbered and retained. (3) The multi-hop reasoning fails: the model does not correctly synthesize the continuity of the exhibits across filings, instead inferring removal or relocation without evidence. The ground truth emphasizes structural reorganization via renumbering, not omission or integration elsewhere. (4) While the answer addresses the question's focus on structural changes and identifies the correct policies and years, the central claim of omission undermines factual correctness. The reasoning and qualitative accuracy are therefore low, though the context and entities are mostly relevant, justifying a moderate contextual relevance score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 368,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, the strategic importance of FBAR filters has increased, with Broadcom emphasizing their role in wireless communications and proprietary manufacturing. In 2022, FBAR filters were highlighted as products made internally using innovative and proprietary processes. By 2024, the company further reinforced the strategic value of internal fabrication for FBAR filters, underscoring their importance in protecting intellectual property and accelerating time-to-market. This shift reflects a stronger competitive positioning, leveraging internal capabilities for mission-critical products while outsourcing commodity processes, thereby enhancing differentiation in a highly competitive semiconductor market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the strategic importance and continuity of internal fabrication of FBAR filters from 2022 to 2024, aligning with the ground truth. It accurately reflects that internal fabrication was emphasized for IP protection and faster time to market in both years. However, it misses the specific expansion of competitive context in 2024—namely, the explicit mention of competitors like Qorvo, Qualcomm, and Skyworks—which is a key qualitative update in the original answer. This omission slightly weakens the multi-hop synthesis of how competitive pressures evolved. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable; the years 2022 and 2024 are correctly referenced, earning full marks. (3) The reasoning is largely sound: the LLM correctly infers that internal fabrication remained strategic and links it to competitive positioning. However, it does not fully synthesize the increased competitive intensity as evidenced by the broader list of competitors in 2024, which is a critical nuance in the evolution of Broadcom’s environment. (4) The answer is contextually relevant and well-articulated, conveying the core strategic continuity accurately. The correctness score is 8 because the key facts are correct, but a meaningful detail about competitive landscape expansion is missing, reducing completeness and qualitative accuracy slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 404,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "Between 2023 and 2024, BMY's strategic positioning of Krazati evolved significantly, with a stronger focus on expanding its clinical development across multiple indications. In 2023, Krazati was primarily in development for advanced NSCLC with KRAS mutations and colorectal cancer. By 2024, Krazati's development expanded to include first-line NSCLC (TPS <50%) and additional trials for 2L+ mutated NSCLC (KRYSTAL-12) and 2L CRC (KRYSTAL-10). Financially, Krazati's valuation increased substantially following BMY's $4.8 billion acquisition of Mirati in January 2024, which included Krazati's commercial rights and development assets, reflecting its strategic importance in BMY's oncology portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key developments in Krazati's strategic positioning between 2023 and 2024. It accurately notes the expansion of clinical development to include first-line NSCLC (TPS <50%), 2L+ mutated NSCLC (KRYSTAL-12), and 2L CRC (KRYSTAL-10), aligning with the ground truth. The $4.8 billion acquisition of Mirati by BMY in January 2024 is correctly stated, matching the financial valuation aspect. (2) Quantitatively, all numbers and dates are accurate: the $4.8 billion acquisition amount and the timing (January 2024) are correct. No calculations were required, but the financial figure is properly cited. (3) The multi-hop reasoning is sound—LLM synthesizes information about clinical trial progression (from 2023 pipeline to 2024 expanded focus) and links it to the acquisition event that enabled full control, showing strategic evolution. However, the LLM omits explicit mention that Krazati had already received FDA and EMA approvals for second-line NSCLC and FDA approval for KRAS-mutated colorectal cancer by 2024, which is a notable omission in clinical development status. It also does not mention the combination with a PD-1 inhibitor in first-line NSCLC, a key strategic shift. (4) Despite these omissions, the core facts—clinical expansion, acquisition, and strategic importance—are correct and contextually relevant. The answer captures the essence of the evolution, just missing a few specific details on approvals and combination therapy. Hence, high scores across the board with a slight deduction in qualitative accuracy for incomplete clinical detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 442,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG has maintained a mutually beneficial relationship with travel service providers, focusing on expanding distribution channels and enhancing inventory utilization. The Company facilitates payments for travel services and collects commissions or margins, with financial obligations primarily managed through deferred merchant bookings. These deferred amounts include estimated payables to travel service providers and BKNG's expected future revenue. In 2023, the increase in deferred merchant bookings was driven by higher business volumes, reflecting stronger demand and transaction growth. Additionally, BKNG continues to offer incentive programs, such as referral bonuses and rebates, to encourage partnerships with travel service providers, further reinforcing collaborative relationships.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains no explicit numeric values (e.g., dollar amounts, percentages), so there are no quantitative inaccuracies. It correctly references 'deferred merchant bookings' and incentive programs like referral bonuses and rebates, which aligns with the ground truth. However, the key qualitative shift described in the original answer — from competition in 2022 to dependence in 2023 — is missing. Instead, the LLM claims BKNG 'maintained a mutually beneficial relationship,' which contradicts the ground truth that BKNG shifted from competing to a more dependent, incentive-driven model. This misrepresents the evolution of the relationship. (2) There are no numbers to verify, but the use of terms like 'deferred merchant bookings' and 'incentive programs' is factually consistent with the original answer. (3) The multi-hop reasoning is partially sound: the model connects deferred merchant bookings to payables and references incentives. However, it fails to synthesize the critical shift in relationship dynamics between 2022 and 2023 — a core requirement of the question. The original answer emphasizes a strategic pivot, while the LLM portrays continuity, missing the transformational aspect. (4) Correctness is scored 6 because key facts (incentives, deferred bookings) are present, but the central narrative about evolving from competition to dependence is incorrect. Quantitative accuracy is 10 because no numbers are misstated. Qualitative accuracy is 5 due to the flawed characterization of the relationship evolution. Contextual relevance is 8 because the answer addresses financial obligations and incentives but misses the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 459,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "From 2022 to 2024, Broadcom's involvement in the development of Custom Touch Controllers remained consistent as a key product offering within its wireless market solutions. In both years, Custom Touch Controllers were listed as part of Broadcom's semiconductor product portfolio, specifically under the Mobile Device Connectivity Solutions segment. However, in 2024, Broadcom's broader strategic focus expanded with the acquisition of VMware, which primarily impacted infrastructure software solutions and did not directly affect the Custom Touch Controllers product lifecycle. Thus, Broadcom's role in Custom Touch Controllers remained largely unchanged in terms of product development and market positioning during this period.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that Broadcom's role remained 'largely unchanged' from 2022 to 2024. The ground truth states a clear evolution from being a supplier in 2022 to an active producer involved in design and creation by 2024. The LLM contradicts this by asserting no significant change, which misrepresents the strategic shift. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is flawed: the question requires synthesizing Broadcom's changing role across years, but the LLM fails to identify the progression from component supplier to custom silicon producer. Instead, it incorrectly emphasizes the VMware acquisition, which is contextually irrelevant to Custom Touch Controllers. (4) While the LLM correctly identifies that Custom Touch Controllers were part of Broadcom's portfolio in both years, it misses the key qualitative shift in involvement. The answer is contextually relevant in discussing the product line but fails to capture the evolution in the product lifecycle, leading to a low correctness and qualitative accuracy score despite accurate entity and time period references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 355,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "Union Pacific's approach to freight cars from 2023 to 2024 shows a consistent focus on asset acquisition to support growth and operational needs. In 2023, the company invested $728 million in locomotives and freight cars, including $57 million in lease buyouts. In 2024, this investment increased slightly to $788 million, with $143 million allocated to lease buyouts. These investments reflect a strategy to modernize the fleet, replace aging assets, and accommodate growth opportunities, aligning with the company's broader capital plan to enhance operational efficiency and network capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $57 million in lease buyouts in 2023 and $143 million in 2024 are accurately reported. The total investments in locomotives and freight cars ($728M in 2023 and $788M in 2024) are consistent with the broader capital context, even though the original answer does not mention these totals—this additional detail does not contradict but rather enriches the response. (2) The shift from leasing to acquiring freight cars via lease buyouts is correctly identified and supported by the increasing buyout figures, demonstrating sound multi-hop reasoning across years. (3) Entity accuracy is strong: Union Pacific, correct years (2023–2024), and relevant financial metrics (lease buyouts) are properly used. (4) The qualitative reasoning is solid—the conclusion about a strategic shift toward asset ownership to support modernization, replacement, and growth is logically derived from the increased lease buyouts. The only minor limitation is that the original answer emphasizes a shift 'from leasing to acquiring' more explicitly, while the LLM frames it as a continuation of acquisition focus; however, the data supports both interpretations. Overall, the answer is factually correct, contextually relevant, and synthesizes multi-year financial data accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 379,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike's structural changes in APLA between FY2022 and FY2023, particularly the transition of certain businesses to third-party distributors, had notable financial and operational impacts. In FY2022, Nike recorded a non-recurring impairment charge of $11 million in the Corporate segment, primarily due to the anticipated release of non-cash cumulative foreign currency translation losses related to the transition. Operationally, this shift likely reduced Nike's direct control and investment in APLA markets, potentially affecting revenue visibility and operational flexibility in those regions.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures part of the financial impact by correctly identifying a non-recurring impairment charge of $11 million in FY2022 related to foreign currency translation losses due to the transition to third-party distributors. This aligns with the ground truth's mention of non-cash cumulative foreign currency translation losses. However, the LLM introduces a specific dollar amount ($11 million) that is not present in the original answer (ground truth), which only mentions the existence of non-recurring impairment charges without quantification. Since the knowledge graph does not confirm this number, including it reduces quantitative accuracy. Additionally, the LLM omits key elements of the structural shift: the change from direct operations to a strategic stake in APLA and the reference to Note 18 on divestitures in the FY2023 filing. It also fails to mention that APLA continues to include results for NIKE and Jordan brands under the new structure. Operationally, while the LLM suggests reduced control and potential impacts on revenue visibility, the ground truth emphasizes the strategic intent to reduce operational overhead and improve financial efficiency—nuances that are partially captured but not fully articulated. The reasoning is logically sound but incomplete in synthesizing the full multi-hop context (transition mechanics, reporting changes, strategic rationale). Wording is relevant and mostly aligned, but missing core components of the operational transformation lowers completeness and qualitative accuracy. Contextual relevance is high as the response stays focused on the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 442,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "From 2022 to 2024, Broadcom's involvement with InP lasers has remained a key part of its internal fabrication strategy, particularly for fiber optic communications. In both periods, Broadcom has highlighted its use of internal fabrication for products based on proprietary processes, including InP lasers, to protect IP and accelerate time-to-market. However, in 2024, there is a slight emphasis on continued investment in internal fabrication capabilities and process optimization, suggesting a more strategic and expanded role for InP lasers in Broadcom's competitive positioning, especially as it seeks to maintain differentiation in high-speed, mission-critical applications.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately captures Broadcom's continued use of internal fabrication for InP lasers from 2022 to 2024, particularly for fiber optic communications, and correctly identifies the strategic rationale (IP protection, time-to-market). The answer also correctly notes a shift in emphasis by 2024 toward internal capabilities, which matches the ground truth's observation of increased focus on competitive positioning. However, the LLM omits a key detail present in the original answer: the explicit naming of competitors such as Coherent Corp. and Lumentum Holdings Inc. in 2024 as part of Broadcom's competitive landscape disclosure. This omission slightly weakens the multi-hop synthesis, as the original answer ties the strategic emphasis on InP lasers directly to competitive differentiation against named peers. While the LLM infers a broader strategic intent ('maintain differentiation'), it does not reflect the specific evidentiary support from the filings. There are no numerical inaccuracies (quantitative accuracy is perfect, scoring 10), and the contextual relevance is strong as it directly addresses the evolution in fabrication strategy and competitive positioning. Qualitative accuracy is high but not perfect due to the missing competitor names, which are important for full factual completeness in the multi-hop context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 388,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, Swoosh, LLC maintained its significant ownership of approximately 77% of NIKE's Class A Common Stock, which grants disproportionate voting power as holders of Class A stock elect three-quarters of the Board of Directors. In 2022, if converted to Class B Common Stock, this would equate to about 16% ownership, while in 2023, the ownership percentages remained consistent. This structure allows Swoosh, LLC, managed by Travis Knight, to exert substantial influence over corporate governance and strategic decisions despite owning a smaller percentage of Class B shares. The implications for shareholder influence are that other shareholders, particularly those holding Class B stock, have limited voting power, potentially limiting their ability to effect major corporate changes or influence board composition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Swoosh, LLC owned approximately 77% of NIKE's Class A Common Stock in both 2022 and 2023, and that this translates to about 16% ownership in Class B Common Stock if converted—matching the ground truth exactly. All quantitative figures (77%, 16%, years 2022 and 2023) are accurate. (2) There are no calculations required beyond the stated percentages, and the LLM correctly reflects the consistency in ownership across the two years. Number formats and values are precise and consistent with the original answer. (3) The multi-hop reasoning is sound: the LLM connects Swoosh, LLC’s ownership to voting power (Class A electing three-quarters of the Board), identifies Travis Knight’s managerial role, and explains the implications for shareholder influence—particularly the limited power of Class B shareholders. This demonstrates correct synthesis across ownership structure, control mechanisms, and governance impact. (4) The only minor shortcoming is that the original answer explicitly names Travis Knight as having a 'significant role in managing' the shares, while the LLM refers to him as 'managing'—a slight overstatement of role without specifying the nature of his role (e.g., through a management position in Swoosh, LLC). However, this does not materially distort the factual implication. Otherwise, the answer is semantically equivalent, contextually complete, and highly relevant to the question about evolution and implications of ownership structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 418,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI advanced its strategic positioning of Reduced-Risk Products (RRPs) by integrating the Swedish Match acquisition into its existing portfolio, enhancing market availability through complementary product offerings like IQOS and ZYN. This integration expanded PMI's smoke-free presence, particularly in the U.S., and positioned the company to accelerate its transition to a smoke-free future by combining oral nicotine and heat-not-burn technologies.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic direction of PMI's evolution in reduced-risk products but misses key factual details from the ground truth. (1) Correct elements include the integration of Swedish Match and the mention of IQOS and ZYN as complementary products, which aligns with PMI’s 2023 strategy. The focus on expanding smoke-free presence in the U.S. is contextually relevant. (2) However, the answer fails to mention the critical reclassification from 'Reduced-Risk Products (RRPs)' to 'Smoke-Free Products (SFPs)' in 2023, which now includes wellness and healthcare offerings—a central point in the original answer. It also omits the specific quantitative metric that PMI’s smoke-free products were available in 84 markets by the end of 2023, a key expansion indicator. The ground truth notes that 2022 market availability was unspecified, making the 84-market figure a significant update. (3) The reasoning partially reflects multi-hop synthesis (e.g., linking acquisition to portfolio expansion), but it does not accurately represent the full scope of portfolio integration as defined in the original—specifically the rebranding and category expansion beyond tobacco-derived products. (4) While the answer is contextually relevant and mentions correct entities (PMI, Swedish Match, IQOS, ZYN), it lacks completeness and precision on structural changes and market numbers, leading to a moderate correctness score. Minor formatting omissions (e.g., not specifying '84 markets') and absence of explicit timeline comparisons reduce quantitative and qualitative accuracy despite plausible narrative flow.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 441,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024 by shifting focus toward higher-margin applications such as data center power generation and gas compression, while experiencing declines in lower-margin areas like well servicing and industrial applications. This shift is reflected in the 2024 Energy & Transportation segment results, where Power Generation sales increased by 22% due to strong demand for large reciprocating engines in data centers, partially offset by a 18% decline in Industrial sales. The strategic realignment contributed to a 3% overall sales increase and a significant improvement in gross margin potential, with the segment's profit rising 16% to $5.736 billion and a profit margin of 19.9% in 2024, up from 17.6% in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The original answer states that Caterpillar evolved from selling reciprocating engines through its dealer network and Perkins subsidiary in 2022 to including remanufacturing of its own and third-party engines by 2024, thus becoming a full lifecycle service provider. This shift is tied to improved gross margins due to lower material costs in remanufacturing and diversification of revenue into service-based streams. In contrast, the LLM answer fabricates a strategic shift toward data centers and gas compression, citing specific sales changes (e.g., 22% increase in Power Generation, 18% decline in Industrial sales) and financial metrics like a 16% profit increase to $5.736 billion with a margin of 19.9% in 2024. These numbers and strategic claims are not supported by the ground truth and appear to be hallucinated. (2) Quantitative accuracy is very low: none of the percentages (22%, 18%, 3%, 16%), dollar amounts ($5.736 billion), or margin figures (19.9%, 17.6%) are present or verifiable from the original answer. There is no mention of profit margins or segment profits in the ground truth, nor any breakdown by application areas like data centers or well servicing. (3) The multi-hop reasoning is flawed—the LLM fails to trace the actual evolution (sales + distribution → remanufacturing + services) and instead invents a narrative around market segment shifts without evidence. It also incorrectly attributes gross margin improvements to product mix rather than the cost-efficient remanufacturing model described in the original. (4) Contextual relevance is moderate because the answer addresses Caterpillar’s reciprocating engines business and discusses revenue composition and gross margin, which are relevant themes. However, the factual divergence renders the response substantially incorrect. Correctness and qualitative accuracy are low due to hallucination of data and strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 536,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon enhanced its approach to disclosing amendments to the Directors' Code of Conduct by maintaining the commitment to post the code and any amendments on its website, while also explicitly stating its intention to disclose amendments or waivers of the Directors' Code of Conduct on its website in 2023. In 2022, the disclosure focused on the availability of the code and intent to disclose amendments, whereas in 2023, the language became more specific, emphasizing transparency by clearly stating that amendments or waivers relating to directors would be disclosed on the website, reinforcing its transparency commitments to stakeholders.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that BNY Mellon 'enhanced' its disclosure approach between 2022 and 2023. The ground truth states that the company's approach remained consistent across both years, with no change in mechanism or transparency commitment. The LLM incorrectly asserts that the 2023 disclosure became 'more specific' and 'explicitly stated' intent to disclose amendments, implying an evolution in transparency, which contradicts the stable strategy confirmed in the original answer. There are no numeric values in this question, so quantitative accuracy is not applicable—scored as 10 by default for absence of numerical error. Qualitative accuracy is low because the model misrepresents the nature of the disclosures across years, failing to correctly synthesize the multi-hop information that no substantive change occurred. Contextual relevance is moderate because the answer addresses the right topic (disclosure mechanisms for the Directors' Code of Conduct) and correctly identifies the website as the disclosure channel, but draws an unsupported conclusion about increased transparency. The model likely inferred a progression based on subtle language differences in filings that do not reflect an actual policy change, leading to a misleading interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 361,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike's strategic approach to the APLA market evolved through a shift in operational structure and market participation. In FY22, Nike experienced growth in APLA, with NIKE Direct contributing to the momentum. However, in FY23, the company transitioned certain APLA countries (Argentina, Uruguay, and Chile) from a wholesale and direct-to-consumer model to a distributor model. This change aimed to reduce selling and administrative expenses and lessen exposure to foreign exchange volatility, reflecting a more streamlined and profit-focused strategy in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Nike's shift in APLA between FY22 and FY23: direct operations in FY22 and a transition to third-party distributors in FY23. The mention of Argentina, Uruguay, and Chile adds specificity not in the original answer but does not contradict it and may reflect additional context. (2) There are no numeric values (percentages, dollar amounts, etc.) in either answer, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound—LLM synthesizes operational structure changes and links them to strategic intent (reducing expenses, mitigating FX risk), which is consistent with the strategic shift described in the ground truth. (4) The LLM answer enhances the original with plausible strategic rationale (cost reduction, FX volatility) without introducing factual errors. The only minor gap is that the original emphasizes APLA’s contribution to 14% NIKE Direct growth in FY22, which the LLM omits, slightly reducing completeness. However, the core evolution in strategy, structure, and market participation is accurately conveyed. Hence, high scores across all dimensions with a 9 on correctness due to the minor omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 346,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "From 2022 to 2024, the impact of favorable price realization on Caterpillar's sales and profitability evolved as follows: In 2021 (as referenced in 2022 filings), favorable price realization contributed to a 22% increase in sales and a 51% increase in operating profit compared to 2020. By 2024, while sales decreased slightly by 3% compared to 2023, favorable price realization helped offset lower sales volume and contributed to a higher operating profit margin (20.2% in 2024 vs. 19.3% in 2023), indicating continued positive impact on profitability despite a challenging market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly references 2021 data (from 2022 filings) as part of the 2022 impact, which misaligns with the question's focus on 2022–2024. The ground truth states that in 2022, favorable price realization contributed $9.223 billion to sales growth, but the LLM claims a '22% increase in sales' and '51% increase in operating profit'—metrics not present in the original answer and unrelated to the requested time frame. For 2024, the LLM states a 3% sales decrease and improved operating margin (20.2% vs 19.3%), but these specific percentages are not in the ground truth and contradict the documented $2.251 billion volume decline and profit increase from $10.335B to $10.792B. (2) The quantitative inaccuracies are severe: none of the dollar figures from the ground truth ($9.223B sales boost in 2022, $2.251B volume decline, profit increase of $457M) are mentioned or correctly calculated. Instead, the LLM introduces unverified percentages. (3) The reasoning is partially sound in recognizing that favorable pricing helped offset volume declines and supported profitability in 2024, which aligns with the original answer’s logic. However, it fails the multi-hop requirement by not connecting actual reported figures across years and misrepresents the data sources. (4) Scores reflect major factual and numerical errors (correctness: 3), very poor quantitative accuracy (2), partial understanding of the trend but flawed execution (qualitative: 4), and moderate relevance as it addresses the general theme of pricing impact on profitability (contextual: 6).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 447,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "Between 2023 and 2024, General Motors' approach to EV manufacturing capacity evolved by shifting strategic focus from autonomous vehicle (AV) development to prioritizing personal EVs and refining supply chain resilience. In 2024, GM announced a refocused AV strategy on personal vehicles and stopped funding Cruise's robotaxi development, signaling a reallocation of resources to EVs. Additionally, GM emphasized the need to build a more resilient, scalable, and sustainable North American EV supply chain, including strategic investments in raw material suppliers and long-term supply agreements. This shift reflects a stronger commitment to scaling EV production and addressing supply chain challenges to support long-term EV demand.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in GM's EV manufacturing strategy from 2023 to 2024, noting the shift toward a more resilient, scalable, and sustainable North American-focused supply chain, including strategic investments in raw material suppliers and long-term supply agreements—this aligns with the ground truth. However, the LLM introduces a detail not present in the original answer: the pivot from autonomous vehicle (AV) development and Cruise's robotaxi program. While factually plausible and contextually relevant, this specific strategic shift from AVs to EVs is not mentioned in the ground truth and represents an addition rather than a synthesis from the provided knowledge. The core elements—strategic focus evolution and supply chain development—are accurately conveyed. (2) There are no numerical values, dates, or calculations in either answer, so quantitative accuracy is not applicable; the years 2023 and 2024 are used correctly. (3) The multi-hop reasoning is sound in that it connects changes in strategic focus and supply chain development across two years, though the inclusion of Cruise and AV strategy goes beyond the source information. The model correctly identifies GM as the entity and maintains correct time framing. (4) The correctness score is 8 because the key aspects of the answer are accurate and semantically aligned with the ground truth, but there is an unsupported addition (Cruise/AV pivot) that slightly affects factual fidelity. Qualitative accuracy is 8 due to this overreach in reasoning. Quantitative accuracy is 10 (no errors, all temporal references correct), and contextual relevance is 10 as the answer directly addresses the question's focus on strategic and supply chain evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 480,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid, as reflected in remaining performance obligations, decreased significantly from 2022 to 2024. In 2022, Paxlovid contributed $18,933 million in revenues, while by 2024, this dropped to $5,716 million. Additionally, as of December 31, 2024, remaining performance obligations for Paxlovid were approximately $1 billion, compared to $5.1 billion in deferred revenues for Paxlovid as of December 31, 2023. This decline reflects the transition of Paxlovid from government contracts to commercial markets and the recognition of previously deferred revenues.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Pfizer did not disclose specific remaining performance obligations for Paxlovid in 2022, but the LLM incorrectly claims $5.1 billion in deferred revenues for 2023 and implies quantifiable obligations in 2022 via revenue figures. While the $1 billion remaining performance obligation as of December 31, 2024, is correctly stated, the comparison to $5.1 billion in deferred revenue from 2023 is not supported by the ground truth, which does not mention deferred revenue or 2023 figures. Additionally, the LLM introduces revenue numbers ($18,933 million in 2022 and $5,716 million in 2024) that were not part of the original answer and are irrelevant to the question about remaining performance obligations. (2) Quantitative accuracy is low: the $1 billion figure for 2024 is correct, but all other numbers (e.g., $5.1 billion deferred revenue in 2023, revenue amounts) are either fabricated or misapplied. There is no verification that these numbers appear in the actual 10-K filings as described. (3) Multi-hop reasoning is flawed. The question asks about the evolution of 'remaining performance obligations,' not revenues or deferred revenue. The LLM conflates different financial metrics—revenue and deferred revenue—with performance obligations, demonstrating a misunderstanding of accounting terminology and failing to correctly synthesize the required disclosures. The original answer correctly notes the absence of disclosed obligations in 2022 and their emergence in 2024; the LLM incorrectly assumes data was available earlier. (4) Contextual relevance is moderate because the answer discusses Paxlovid and financial commitments, but it focuses on incorrect metrics. The conclusion about transition to commercial markets may be plausible contextually, but it is not supported by the ground truth and distracts from the actual disclosure trend. Overall, the answer is mostly incorrect due to fabrication of data and misinterpretation of financial terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 554,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Between 2022 and 2023, Caterpillar enhanced its approach to monitoring supplier financial viability by strengthening risk mitigation strategies and contractual agreements. The company continues to use agreements with suppliers to protect its intellectual property and monitor risks, including supplier financial viability, production flexibility, business continuity, quality, and delivery. While no specific new strategies are detailed for 2023, the emphasis on maintaining industry-leading supplier quality and delivery expectations suggests a continued and potentially more rigorous focus on supplier financial health and performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses key details from the ground truth, particularly regarding the evolution of Caterpillar's approach between 2022 and 2023. (1) Correctly identifies that Caterpillar monitors supplier financial viability and uses contractual agreements to protect intellectual property and mitigate risks—this aligns with the 2022 disclosure. However, it fails to note the significant qualitative shift in 2023 where 'supplier financial viability' was explicitly listed as the first risk in supply chain disclosures, indicating heightened prioritization. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is incomplete: while the LLM acknowledges ongoing monitoring and implied rigor, it does not capture the structural change in emphasis or the reinforcement of global strategic sourcing models to build long-term relationships and leverage enterprise spend, which are key differentiators in 2023. (4) Contextually, the response is relevant and addresses the general theme of risk mitigation and supplier monitoring, but lacks specificity on how the approach evolved. The claim that 'no specific new strategies are detailed' contradicts the ground truth, which highlights a more explicit and structured focus in 2023. Thus, while the answer is plausible and contextually aligned, it omits critical differentiating information, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 408,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions evolved significantly in strategic positioning and integration within its value-added services. In 2022, the focus was on leveraging data and authentication tools to prevent fraud and protect account holder data. By 2024, Visa expanded its offerings with three new AI-powered products—Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization—to reduce fraud across a broader range of payment types, including A2A and card-not-present (CNP) transactions, both on and off Visa's network. This evolution reflects a more proactive and comprehensive integration of AI and machine learning to enhance fraud prevention and secure the payments ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually plausible and contextually relevant, but diverges from the ground truth in key qualitative aspects of strategic positioning. (1) Correct elements: The time frame (2022–2024) is accurate, and the evolution toward enhanced fraud prevention with AI-powered tools like Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager aligns with Visa’s public direction. The emphasis on expanding beyond Visa’s network to include A2A and CNP transactions is contextually appropriate. (2) Quantitative accuracy: No specific numbers (e.g., dollar amounts, percentages) are present in either answer, so no discrepancies exist—this aspect is neutral but not penalized. (3) Multi-hop reasoning assessment: The LLM correctly infers a strategic evolution in Risk and Identity Solutions, but fails to reflect the structured three-pillar framework (Visa transactions, network-agnostic services, services beyond payments) that is central to the ground truth. Instead, it focuses on product-level innovations without articulating the broader strategic repositioning within value-added services. (4) The original answer emphasizes structural integration and strategic categorization, while the LLM emphasizes technological enhancement (AI/ML) and product launches. While these are likely complementary in reality, the LLM answer substitutes product details for strategic architecture, missing the core of the ground truth. Thus, while the direction is correct, the synthesis is incomplete—leading to a partial correctness score. Semantic equivalence is not fully achieved due to this shift in focus from strategic framework to technical capabilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 455,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "The company's exposure to shelf space limitations as a risk factor has remained significant between 2022 and 2023, with continued challenges from retail customer policies such as inventory destocking, fulfillment requirements, and limitations on shelf space access. In 2023, the evolution of the retail landscape, including the growth of eCommerce and alternative retail channels like subscription services and direct-to-consumer models, has intensified these challenges. While the company acknowledges these pressures, it has not indicated a reduction in exposure but rather an ongoing need to adapt to shifting retail dynamics and consumer preferences.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures that shelf space limitations remained a significant risk from 2022 to 2023 and correctly identifies the evolution in retail dynamics, including the growth of eCommerce, subscription services, and direct-to-consumer channels. The description of ongoing challenges due to retail customer policies (e.g., shelf space access) matches the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes the progression from potential risk in 2022 to active impact in 2023 and links it to broader retail changes. However, the LLM omits the specific forward-looking action mentioned in the ground truth—'planning to invest more in digital and analytics capabilities to adapt'—which is a meaningful detail about the company's response. This omission prevents a perfect score. (4) The answer is highly contextually relevant, directly addressing the evolution of the risk factor and its relation to retail policy changes and alternative channels. Overall, the answer is factually accurate and well-reasoned but slightly less complete than the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 365,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Between fiscal years 2023 and 2024, Oracle has further emphasized hybrid deployments by expanding its product offerings and enhancing interoperability. In 2023, Oracle highlighted its hybrid deployment models, including Oracle Exadata Cloud@Customer and Dedicated Region offerings, which allow customers to run Oracle Cloud in their own data centers. By 2024, Oracle expanded on this by introducing programs to help customers pivot their licenses and support contracts to the Oracle Cloud for new deployments and migrate existing workloads, emphasizing flexibility and customer choice. Additionally, Oracle increased its focus on integrating AI and machine learning into its cloud offerings, such as the Oracle Autonomous Database, to improve automation and innovation for hybrid environments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately identifies Oracle's hybrid deployment offerings in fiscal 2023, specifically naming Oracle Exadata Cloud@Customer and Dedicated Region, which matches the original answer. The emphasis on customer choice and flexibility is also correctly conveyed. For fiscal 2024, the LLM notes an expansion in programs supporting license portability and workload migration to Oracle Cloud, which reflects a strategic deepening of hybrid support, consistent with the ground truth's mention of 'deeper integration and support.' While the original answer emphasizes 'product integrations and services tailored for hybrid environments,' the LLM substitutes this with specific examples like migration programs and AI/ML integration, which are plausible extensions but not explicitly confirmed in the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default due to absence of errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes Oracle’s evolving strategy across two fiscal years, identifying continuity and progression in hybrid deployment focus. However, the mention of AI/ML and Autonomous Database, while contextually relevant, introduces elements not present in the original answer, slightly deviating from the documented evolution focused on interoperability and extensibility rather than AI enhancements. (4) The answer is highly contextually relevant, directly addressing both product offerings and strategic emphasis across the two fiscal years. The core facts are correct, though minor overreach in inferring AI integration as a key 2024 evolution slightly reduces qualitative accuracy. Overall, the answer is factually solid with minor embellishment, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 522,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid significantly decreased between 2022 and 2024. In 2022, Paxlovid generated $18,933 million in revenue, primarily driven by government contracts. By 2023, this dropped to $1,279 million due to a revenue reversal of $3.5 billion associated with returned EUA-labeled treatment courses. In 2024, Paxlovid revenue rebounded to $5,716 million as the product transitioned to commercial markets. Remaining performance obligations for Paxlovid totaled $1 billion as of December 31, 2024, compared to higher contracted revenue expectations in 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the revenue figures for 2022, 2023, and 2024. The ground truth does not provide specific revenue numbers for Paxlovid in those years, nor does it mention a $3.5 billion revenue reversal in 2023 or a rebound to $5,716 million in 2024. These figures are not supported by the original answer and appear to be hallucinated or incorrectly sourced. The only correct quantitative point is the $1 billion in remaining performance obligations as of December 31, 2024, which matches the ground truth. (2) The original answer does not include year-by-year revenue data for Paxlovid, so the LLM’s inclusion of $18,933 million in 2022 and other figures cannot be verified and contradicts the more cautious, forward-looking tone of the original. There is no mention of a revenue reversal or commercial transition in the ground truth. (3) The multi-hop reasoning is partially sound in that the LLM attempts to trace the evolution of financial commitment over time and references performance obligations, but it fails to accurately represent the nature of Pfizer’s disclosures. The original emphasizes potential future revenue streams and a shift to multi-year recognition, not specific past revenues or reversals. The LLM incorrectly frames the trend as a 'significant decrease' based on unsupported numbers, rather than a strategic shift in revenue recognition timing. (4) While the answer is contextually relevant—addressing the evolution of financial commitment and citing performance obligations—the high level of quantitative inaccuracy severely undermines correctness. The qualitative reasoning is somewhat accurate in identifying a reduced commitment, but the logic is based on false premises. Hence, the correctness score is low despite relevant structure and partial alignment with the original’s conclusion about reduced expectations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 518,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Between 2022 and 2023, Caterpillar's relationship with its independent dealers remained largely consistent in terms of contractual obligations, with dealers continuing to operate under standard sales and service agreements that grant them rights to sell and service Caterpillar products within defined geographic territories. However, the strategic emphasis on dealers appears to have shifted slightly, with a stronger focus on leveraging dealer networks to support long-term customer relationships and global market reach, as highlighted by the continued expansion of dealer coverage across 191 countries in 2023. No significant changes to the contractual terms or termination conditions were noted in the provided pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in noting that Caterpillar maintains relationships with independent dealers under sales and service agreements and operates in 191 countries, which aligns with the general context. However, it incorrectly states that there were 'no significant changes to the contractual terms' between 2022 and 2023, directly contradicting the ground truth, which specifies a clear evolution from a general partnership model in 2022 to a formalized, standardized contractual framework in 2023. This misrepresents the core of the question regarding how the relationship evolved. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the mention of '191 countries' is consistent with Caterpillar's global footprint and does not introduce a factual error. (3) The multi-hop reasoning is flawed: the question requires comparing Caterpillar's dealer relationships across two years to identify changes in contractual obligations and strategic emphasis. The LLM fails to recognize the shift from informal/general descriptions in 2022 to detailed, structured agreements in 2023, missing the key evolution in both contractual obligations (e.g., dealer requirements to maintain personnel, financial records) and strategic emphasis (increased control and accountability). (4) While the answer is contextually relevant and uses appropriate terminology, the qualitative inaccuracy in depicting the nature of change severely undermines correctness. The answer downplays a significant strategic shift, resulting in a low correctness and qualitative accuracy score despite acceptable structure and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 453,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, Colgate-Palmolive's financial allocation and operational focus in Africa/Eurasia, as part of the 2022 Global Productivity Initiative, saw a reduction in restructuring charges. In 2022, Africa/Eurasia accounted for 11% of the $110 million in pretax charges, while in 2023, it contributed 5% of the $32 million in pretax charges. This decline suggests a decreasing emphasis on restructuring activities in the region as the initiative progressed. Capital expenditures in Africa/Eurasia also remained relatively modest compared to other regions, with $33 million in 2022 and no specific 2023 figure provided, indicating a continued but limited operational focus in the region.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. The ground truth states that in 2023, approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative related to Africa/Eurasia, but the LLM incorrectly claims that Africa/Eurasia accounted for 11% of $110M in 2022 and 5% of $32M in 2023—these figures are not supported by the original answer and contradict its narrative. Additionally, the original answer does not provide 2023 capital expenditure figures, but it does not state that restructuring charges decreased; rather, it frames the 10% allocation in 2023 as part of an ongoing strategic shift. The LLM invents specific numbers not present in the source and misrepresents the trend. (2) The only correct quantitative detail is the $33 million capital expenditure for Africa/Eurasia in 2022, which matches the ground truth. The $13M in 2021 and $8M in 2020 are omitted, but more critically, the LLM fabricates percentages and total charges ($110M, $32M) with no basis in the provided answer. There is no mention in the original answer of 2023 being 5% of $32M or any decline in charges—this is a complete misstatement. (3) The multi-hop reasoning is flawed. The original answer draws a contrast between rising capital expenditures in 2022 and a strategic pivot in 2023 toward restructuring under the Global Productivity Initiative. The LLM incorrectly interprets this as a reduction in restructuring activity, when the actual emphasis is on a shift from capital investment to restructuring—not a decrease in restructuring. This reverses the intended inference. (4) The contextual relevance is moderate because the LLM addresses the region and the general theme of financial allocation and restructuring, but due to significant factual and logical errors, the conclusion is misleading. The answer fails to capture the strategic evolution described in the original—shifting from growth-focused CAPEX to cost optimization—as it wrongly suggests restructuring efforts are winding down, when they are instead being initiated or continued under a broader program.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 567,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "From 2022 to 2024, Qualcomm's strategic focus on 5G technologies has evolved to emphasize both investment in foundational 5G advancements and the commercialization of 5G solutions across diverse industries. In 2022, Qualcomm highlighted its ongoing investments in 5G-based technologies and the need to develop leading and cost-effective 5G technologies and products. By 2024, the company expanded its 5G commercialization outcomes, showcasing the integration of 5G technologies into platforms like Snapdragon, which power premium experiences in mobile, automotive, and IoT sectors. Additionally, Qualcomm has focused on AI-enhanced 5G modem-RF platforms to improve performance and connectivity, reflecting a stronger emphasis on scaling 5G across applications and ensuring leadership in the global rollout of 5G networks.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures Qualcomm's strategic focus on 5G from 2022 to 2024, noting investment in foundational technologies in 2022 and expanded commercialization by 2024. It accurately reflects the emphasis on developing leading and cost-effective 5G products. However, it omits key details from the ground truth, particularly around the transition to monetization via licensing and the specific mention that the majority of QTL revenues came from OFDMA-based 5G products. While it mentions integration into Snapdragon and AI-enhanced modem-RF platforms, these are not in the original answer and may reflect plausible but unverified extensions. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is partially sound: the model correctly infers a shift from investment to commercialization, but fails to fully synthesize the critical evolution from R&D risk acknowledgment (regulatory, competition, design-in cycles) in 2022 to market leadership and licensing dominance in 2024. The mention of AI-enhanced platforms and specific product branding (Snapdragon) introduces details not present in the ground truth, which weakens qualitative accuracy. (4) The answer is contextually relevant and addresses the evolution of strategic focus, investment, and commercialization. However, the absence of licensing outcomes and revenue sources—central to the original answer's conclusion on monetization—results in a correctness score of 7, reflecting accurate core facts but missing significant elements of the commercialization outcome.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 453,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Between 2022 and 2024, Paxlovid's revenue contribution to Pfizer significantly declined, dropping from $18,933 million in 2022 to $5,716 million in 2024, primarily due to the U.S. government transitioning from emergency use authorization (EUA) to commercial market sales and a non-cash revenue reversal in 2023. Contractual commitments also evolved, with a notable shift in 2024 involving the supply of 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) at no cost for pandemic preparedness through 2028.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Paxlovid generated $76 million in revenue in 2022, not $18,933 million ($18.9 billion) as claimed. The 2024 revenue figure of $5,716 million ($5.7 billion) is also incorrect—no direct revenue for 2024 is stated in the original answer; instead, Pfizer reported approximately $1 billion in remaining performance obligations (not annual revenue). These numbers are wildly off, indicating severe quantitative errors. (2) The contractual commitment mentioned in the LLM answer—supplying 1.0 million treatment courses to the SNS at no cost through 2028—is not present in the original answer and contradicts the ground truth, which highlights $1 billion in performance obligations under existing contracts but does not mention a no-cost supply agreement. (3) The reasoning is flawed: the LLM suggests a 'decline' in revenue from 2022 to 2024 based on fabricated figures, while the original answer describes a strategic evolution from initial sales to longer-term contractual positioning, with no year-over-year comparison provided. The mention of a non-cash revenue reversal in 2023 is plausible contextually but not supported in the provided ground truth and thus cannot be credited. (4) While the LLM attempts to address both revenue and contractual evolution (meeting contextual relevance), the severe numerical inaccuracies and incorrect entity/metric assignments (e.g., performance obligations misinterpreted as direct revenue, invented contracts) undermine correctness. The answer fabricates data rather than reflecting the knowledge graph truth, warranting a low score despite structurally addressing the question's domains.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 469,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "The company's exposure to credit market tightness as a supply chain risk increased between 2022 and 2023, as evidenced by the 2023 filing explicitly listing \"the impact on our suppliers of tighter credit or capital markets\" as a risk factor under global supply chain disruptions. This indicates a heightened vulnerability to external financial conditions in 2023, reflecting growing concerns about how tightening credit markets could affect supplier stability and, consequently, the company's operations and financial condition.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the evolution in the company's framing of credit market tightness as a supply chain risk from 2022 to 2023. It accurately notes that in 2023, the company explicitly listed 'the impact on our suppliers of tighter credit or capital markets' as a risk factor under global supply chain disruptions, which aligns with the ground truth. There are no numeric inaccuracies (quantitative accuracy is 10), and the years and entities are correct. The reasoning is sound in recognizing an increased emphasis on supplier vulnerability due to financial conditions. However, the LLM slightly overstates the shift as an 'increase in exposure' and 'heightened vulnerability,' whereas the original answer emphasizes a shift in perspective—from supplier-specific impact to broader operational integration—rather than necessarily a worsening of risk. The ground truth highlights a change in framing ('negatively impacts suppliers' in 2022 vs. 'impacted by' in 2023) reflecting a more integrated view, not just growing concern. Thus, while the LLM captures the directional trend correctly, it misses some nuance in the nature of the evolution, leading to a qualitative accuracy of 8. Contextual relevance is full, as all parts of the question are addressed with appropriate focus on risk evolution and implications for financial vulnerability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 387,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly from 2022 to 2024. In 2022, Paxlovid generated $18.9 billion in revenue, primarily from supply agreements with government and government-sponsored customers. By 2023, Paxlovid revenue dropped to $1.28 billion due to a revenue reversal of $3.5 billion in the fourth quarter of 2023, associated with the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. In 2024, Paxlovid revenue rebounded to $5.7 billion, driven by commercial market sales and a $442 million revenue recognition in the third quarter for supplying 1.0 million treatment courses to the U.S. Strategic National Stockpile (SNS) for pandemic preparedness. Additionally, deferred revenues related to Paxlovid totaled $1.4 billion in current liabilities and $785 million in noncurrent liabilities as of December 31, 2024, with recognition expected through 2028.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures and misrepresents the evolution of Pfizer's contractual obligations. While it correctly identifies that Paxlovid was under EUA in 2022 and that there were returns of U.S. government inventory, the revenue figures ($18.9B in 2022, $1.28B in 2023, $5.7B in 2024) are not supported by the ground truth and contradict the disclosed remaining performance obligations of $1B as of end-2024. The $3.5B revenue reversal in Q4 2023 and $442M recognition in Q3 2024 are not mentioned in the ground truth, which instead cites a $771M favorable adjustment in 2024 related to prior reversals. The deferred revenue breakdown ($1.4B current, $785M noncurrent) is absent from the original answer and introduces unverified detail. (2) Quantitative accuracy is low: none of the major dollar amounts match the ground truth. The original answer reports a $1B remaining performance obligation (not deferred revenue) and a $771M favorable adjustment, whereas the LLM reports different numbers and frames them as revenues and deferred liabilities. There is no mention in the ground truth of $18.9B in 2022 revenue or a $3.5B reversal. (3) The reasoning is partially sound in identifying multi-hop elements—linking government returns, revenue adjustments, and future obligations—but fails to synthesize the correct data. It incorrectly infers revenue trends and contractual commitments rather than citing disclosed remaining performance obligations. The answer fabricates granular revenue figures across years not present in the source. (4) Contextual relevance is high because the LLM addresses the evolution of financial commitments, contractual dynamics, and government agreements over time, aligning with the question’s intent. However, correctness and quantitative accuracy are severely compromised by invented or incorrect figures, leading to a low overall score despite relevant structure and thematic coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 536,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "From 2023 to 2024, the financial liability related to Aearo Technologies' respirator mask/asbestos litigation decreased slightly, with accruals dropping from $62 million as of December 31, 2023, to $51 million as of December 31, 2024. However, the overall liability for respirator mask/asbestos matters (excluding Aearo) increased, with the Company raising its accruals by $36 million in 2024, bringing the total to $523 million. This increase reflects higher costs associated with resolving claims involving more serious injuries, such as mesothelioma and black lung disease. The risk exposure remains significant due to uncertainties in projecting future claims, liability allocation, and potential changes in legal and regulatory environments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Aearo had an accrual of $62 million as of December 31, 2023, which contradicts the ground truth stating that in 2023, Aearo was in bankruptcy proceedings and MMM had a $574 million accrual for liabilities *excluding* Aearo. There is no mention in the ground truth of a $62 million Aearo-specific accrual in 2023. The $51 million figure for 2024 is correct and matches the ground truth for Aearo-related claims. However, the LLM incorrectly claims the overall accrual (excluding Aearo) increased to $523 million in 2024 with a $36 million increase, while the ground truth states the 2023 figure was $574 million — meaning the LLM’s $523 million is actually lower, not higher, and contradicts both the direction and magnitude of change. (2) The quantitative inaccuracies are severe: the key numbers for 2023 Aearo liability ($62M vs. no direct accrual due to bankruptcy) and the non-Aearo liability trend (increase to $523M vs. actual $574M in 2023) are factually wrong. The calculation of a $36 million increase is unsupported by the ground truth. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the shift from bankruptcy stay in 2023 to defined liability via Cabot agreement in 2024. It omits the critical contractual arrangement with Cabot, which limits Aearo’s liability for pre-1997 exposure in exchange for $100,000 quarterly payments — a key evolution in risk exposure. Instead, it fabricates numerical trends not present in the data. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant — it addresses financial liability evolution and mentions serious injury claims. However, due to major factual and quantitative errors, especially in core financial figures and trends, the correctness score is low at 3. The qualitative accuracy is partially preserved due to correct mention of $51M in 2024 and general context on claim severity, but the absence of the Cabot agreement severely limits accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 551,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline of 1.7 share points. In comparison, between 2020 and 2021, Skoal's shipment volume decreased slightly, from 208.5 million to 197.4 million, indicating a modest decline in volume during that period. Thus, while the retail share decline between 2023 and 2024 was significant, the shipment volume trend between 2020 and 2021 showed a smaller reduction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual data: retail share decreased from 9.3% in 2023 to 7.6% in 2024, and shipment volume declined from 208.5 million to 197.4 million packs/cans between 2020 and 2021. These numbers match the ground truth exactly. (2) Quantitative accuracy is perfect—values, years, and implied calculation of the 1.7 percentage point drop in retail share are accurate. The volume decline of 11.1 million units is correctly represented as a 'modest decline' or 'slight' decrease, which is reasonable given the context. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two different time periods (2023–2024 vs. 2020–2021) and two different metrics (retail share vs. shipment volume), both related to Skoal under MO. The comparison between the two trends is logically presented. (4) The only minor deviation from the original answer is in interpretation: the ground truth emphasizes that both metrics show a 'consistent downward trend' suggesting long-term challenges, while the LLM characterizes the 2020–2021 volume drop as a 'smaller reduction' and implies a difference in magnitude of decline. This is not incorrect, but slightly underemphasizes the consistency of the downward trajectory highlighted in the original. However, this is a nuance in framing rather than a factual or reasoning error. All core facts, calculations, entities, and synthesis are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 398,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's approach to multimedia technologies has evolved with a stronger emphasis on AI integration and expansion into new industries. In 2022, the company highlighted its focus on developing multimedia technologies such as camera, video, display, and computer vision, as part of its broader R&D efforts in 4G, 5G, and RFFE technologies. By 2024, Qualcomm expanded its engineering focus to include generative AI and on-device AI capabilities, aiming to scale these innovations across industries and use cases. Additionally, multimedia technologies are being integrated into product offerings for automotive, IoT, and XR applications, reflecting Qualcomm's strategy to diversify beyond mobile handsets and leverage AI for enhanced performance and personalization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Qualcomm's 2022 focus on camera, video, display, and computer vision as part of broader R&D (including modem/RF technologies, referred to as 4G/5G/RFFE in the LLM answer) is accurately represented. By 2024, the shift toward generative AI and on-device AI integration is correctly identified. The expansion into automotive, IoT, and XR (a specific addition not in the original but consistent with 'industries beyond mobile') reflects valid inference and industry context. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes changes in engineering focus and product integration across two time points, correctly identifying the evolution from hardware-centric multimedia to AI-enhanced, platform-oriented strategy. (4) The only minor gap is that the original emphasizes a 'more deliberate diversification strategy' and 'enabling developers to design and deploy applications across devices,' which is slightly underemphasized in the LLM answer—though the mention of scaling innovations across industries captures the essence. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies; high contextual relevance and qualitative reasoning. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 412,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M's financial relationship with the Aearo Entities evolved significantly. In the second quarter of 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy proceedings, which had previously led to their deconsolidation in 2022. This reconsolidation resulted in the removal of the Aearo Entities' intercompany balances from 3M's balance sheet, including a $0.6 billion net liability for intercompany amounts and a $0.7 billion equity investment. By 2024, these balances were no longer reflected in 3M's consolidated financial statements. Additionally, 3M continued to fund the CAE Settlement, contributing $6.0 billion between 2023 and 2029 to resolve litigation related to Combat Arms Earplugs, which included $5.3 billion in pre-tax present value charges recorded in 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reconsolidation of the Aearo Entities in 2023 and the removal of a $0.6 billion net liability and $0.7 billion equity investment from 3M's balance sheet, which aligns with the ground truth. These numbers are accurate and properly attributed to the 2023 reconsolidation. However, the LLM incorrectly states that by 2024, the Aearo Entities were no longer consolidated — the ground truth indicates that after reconsolidation in 2023, they were consolidated as of December 31, 2023, but the 2024 status is described as a shift to a retained equity interest (i.e., deconsolidation may have occurred again or the relationship changed), which the LLM does not clearly reflect. Instead, the LLM vaguely says the balances were 'no longer reflected,' which contradicts the implication of continued consolidation into 2023 and misrepresents the 2024 shift. (2) Quantitatively, the $0.6B and $0.7B figures are correct and match the ground truth. However, the mention of a $6.0 billion funding commitment over 2023–2029 and $5.3 billion in pre-tax charges, while factually plausible in context, is not part of the original answer and introduces extraneous information not requested in the question about the financial relationship evolution in terms of equity and intercompany balances. This distracts from the core focus. (3) The multi-hop reasoning is partially sound — the LLM connects reconsolidation to balance sheet impacts — but fails to accurately characterize the 2024 transition from full consolidation to a retained stake, which is a key qualitative shift emphasized in the ground truth. The reasoning implies deconsolidation happened in 2023, whereas the truth indicates reconsolidation occurred in 2023, with a new structure emerging in 2024. (4) Scores reflect high factual accuracy on numbers and core events, but docking for misrepresenting the 2024 status and introducing irrelevant litigation funding details, reducing completeness and qualitative precision despite strong contextual relevance to the topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 555,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved significantly, strengthening their strategic positioning within Visa's broader value-added services portfolio. In 2022, these solutions were described as tools to help clients prevent fraud and protect account holder data, with offerings such as Visa Advanced Authorization, Visa Secure, and CardinalCommerce. By 2024, the portfolio had expanded with the introduction of the Visa Protect suite, which includes new AI-powered products like Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager. These advancements highlight Visa's increased focus on leveraging artificial intelligence and machine learning to enhance fraud prevention across both card-present and card-not-present transactions, as well as non-card payments, reinforcing their role as a core component of Visa's security and innovation strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Visa's Risk and Identity Solutions from fraud prevention to a more advanced, AI-driven suite, which aligns with the direction of the original answer. It correctly identifies core 2022 offerings like Visa Advanced Authorization and Visa Secure, and notes the strategic focus on fraud prevention and data protection. However, it introduces specific new products—Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager—as part of a 'Visa Protect suite' in 2024, which are not mentioned in the ground truth. The ground truth does not reference AI-powered enhancements or these specific product names, instead emphasizing structural changes: Risk and Identity Solutions becoming one of five core categories within a broader value-added services portfolio that now includes Open Banking and Advisory Services, with over 200 total products as of September 30, 2024. The LLM answer misses this key organizational and portfolio-level shift, which is central to the strategic positioning evolution. While the emphasis on enhanced capabilities is plausible, the response substitutes structural and portfolio diversification insights with unverified product-level details and technological enhancements (e.g., AI) not present in the source. Quantitatively, no explicit numbers are misstated (dates 2022–2024 are correct), so quantitative accuracy is high. Contextually, the answer remains relevant to the question’s focus on evolution and strategic role. However, the qualitative accuracy is reduced due to unsupported product claims and failure to capture the multi-hop synthesis of how Risk and Identity Solutions were repositioned within a larger, integrated services ecosystem.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 471,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "Between 2023 and 2024, the impact of RTX's Acquisition Accounting Adjustments on operating profit remained relatively stable, with a slight decrease from $1,998 million in 2023 to $2,058 million in 2024. The adjustments were primarily driven by the amortization of acquired intangible assets, which increased from $2,021 million in 2023 to $2,095 million in 2024. The overall changes in the components of the adjustments were described as consistent between the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM claims RTX disclosed a $2,058 million impact in 2024, which contradicts the ground truth stating that RTX did not provide any updated quantitative figures for 2024. Similarly, the LLM reports an increase in amortization from $2,021M (2023) to $2,095M (2024), but no such data is present in the original answer—these numbers are entirely fabricated. The only correct number is the $1,998 million negative impact in 2023, which matches the ground truth. (2) The LLM incorrectly asserts that the impact 'remained relatively stable' with specific figures, while the ground truth states RTX shifted from quantitative to qualitative disclosure in 2024—meaning no new numbers were released. (3) Qualitatively, the reasoning fails the multi-hop synthesis: instead of recognizing a change in disclosure policy (from numerical to conceptual), the model assumes continuity and invents data. It misses the key evolution—reduction in transparency—entirely. (4) Contextually, while the answer addresses acquisition accounting adjustments and operating profit, it misrepresents the nature of the evolution between years, making it misleading despite surface-level relevance. The core factual error—asserting 2024 quantification when none existed—warrants a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 382,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Between fiscal years 2022 and 2023, Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud increased from $44.97 billion to $54.88 billion, representing a 22% growth. This growth aligns with the broader Microsoft Cloud revenue increase from $91.4 billion to $111.6 billion, indicating that Office 365 Commercial is a significant and accelerating driver within the cloud ecosystem. The strong performance underscores Microsoft's successful shift toward cloud-based productivity solutions and its growing dominance in enterprise software.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in quantitative data. It claims Office 365 Commercial revenue increased from $44.97B to $54.88B (22% growth), but the original answer does not provide specific Office 365 Commercial revenue figures for FY2022 or FY2023. Instead, it states that Office 365 Commercial was a key growth driver within the Productivity and Business Processes segment in FY2022 and was subsumed into the broader Microsoft Cloud revenue in FY2023 ($111.6B), which grew from $91.4B. There is no support in the ground truth for isolating Office 365 Commercial revenue as a standalone dollar figure or calculating its exact growth. (2) The calculation of 22% growth is therefore unsupported and incorrect. While the Microsoft Cloud revenue figures ($91.4B to $111.6B) are correctly cited, attributing specific dollar amounts to Office 365 Commercial is a fabrication not present in the original data. (3) The reasoning is partially sound in recognizing that Office 365 Commercial is a growing part of the Microsoft Cloud ecosystem and that Microsoft is shifting toward cloud-based productivity solutions. However, the model fails the multi-hop synthesis by incorrectly extracting or inventing granular revenue numbers that were not disclosed, leading to a false precision. (4) The contextual relevance is fair because the answer addresses the evolution and growth trajectory within the cloud ecosystem, but the high scores are penalized due to severe quantitative inaccuracies. Correctness is low (3/10) because the core numerical claims are false, even if the general trend direction is plausible.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 448,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck's alliance revenue related to Lynparza increased by 9% in 2024 compared to 2023, driven primarily by higher demand in most international markets. This growth was supported by the expansion of Lynparza's indications and approvals in various regions, including China, where it received approval in January 2025 for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 9% growth in alliance revenue for Lynparza from 2023 to 2024 and attributes it to higher demand in international markets, which aligns with the ground truth. However, the LLM introduces information not present in the original answer—specifically, Lynparza's approval in China in January 2025 based on the OlympiA trial. This event falls outside the 2023–2024 timeframe and is not mentioned in the ground truth as a contributing factor to the 2024 revenue increase, making it an unsupported addition. (2) Quantitatively, the 9% growth figure is accurate and correctly compared between 2023 and 2024. There are no calculation errors. The date January 2025 is factually plausible but not part of the provided knowledge base and does not support the revenue change *between* 2023 and 2024, thus weakening the temporal accuracy. (3) The multi-hop reasoning is partially sound—revenue growth tied to international demand is correctly synthesized. However, the model overreaches by incorporating external-seeming regulatory developments not in the original data, suggesting potential hallucination or incorrect source linkage. (4) The contextual relevance is high as the answer directly addresses the evolution and drivers of alliance revenue. The core facts are correct, but the inclusion of unverified future events reduces qualitative and quantitative accuracy slightly. Hence, correctness is scored 7 due to mostly accurate but partially extraneous information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 415,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The Procter & Gamble 2014 Stock and Incentive Compensation Plan is included in equity compensation reporting for both 2023 and 2024, but it is explicitly noted that this plan does not allow for future grants of securities. In both years, the 2019 Stock and Incentive Compensation Plan is the only active plan permitting future grants. The regulatory context remains consistent, with the 2014 Plan being referenced in the list of plans under Item 12, but no material changes in its treatment or disclosure are observed between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some factually accurate elements, such as the correct identification of the 2014 and 2019 Stock and Incentive Compensation Plans and the fact that the 2014 plan does not allow future grants, with the 2019 plan being the only active one. These points align with typical disclosures in SEC filings and are consistent with the regulatory context under Item 12. However, the core of the question asks about the *evolution* in treatment and disclosure between 2023 and 2024, particularly regarding regulatory context and inclusion in equity compensation reporting. The LLM answer asserts that 'no material changes in its treatment or disclosure are observed,' which directly contradicts the ground truth, which identifies a meaningful shift: from being discussed in the context of regulatory documentation alongside other plans in 2023, to being integrated into broader equity compensation transparency and ownership structure reporting in 2024. This evolution reflects a change in emphasis and integration within the company's reporting framework, which the LLM fails to recognize. Thus, while the entities and basic plan statuses are correct (supporting a moderate quantitative and contextual score), the qualitative reasoning is flawed—the model misses the multi-hop synthesis of how the plan’s role in disclosures evolved over time. The conclusion drawn by the LLM contradicts the ground truth’s central claim of a shift in focus, resulting in a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 415,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "The 1992 Stock Plan is no longer an active source for future equity grants within the company's compensation structure. In both the 2023 and 2024 filings, it is listed among the equity compensation plans but is explicitly noted that only the 2019 Stock and Incentive Compensation Plan allows for future grants. This indicates that the 1992 Plan has been superseded by newer plans and no longer plays a role in the company's ongoing equity compensation strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in that it correctly identifies the 1992 Stock Plan as no longer active for future grants and notes that only the 2019 Stock and Incentive Compensation Plan allows new grants. This aligns with the evolution described in the original answer—transitioning from a referenced plan in 2023 to being part of a consolidated table in 2024, indicating a passive role. The dates (1992, 2019, 2023, 2024) and plan names are accurate, satisfying quantitative and entity accuracy. However, the LLM omits a key detail from the original answer: the shift in presentation from being 'incorporated by reference' in 2023 to being included in a consolidated disclosure table in 2024, which is central to how the treatment evolved. This structural change in reporting is a critical part of the multi-hop reasoning and is not addressed. While the conclusion about the plan being inactive is correct and logically inferred, the answer does not fully capture the evolution in disclosure treatment, which is the focus of the question. Thus, while the core facts are right, the answer lacks completeness in describing the nature of the change between filings, leading to a moderate deduction in qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 355,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "Between 2023 and 2024, the company observed that clients continued to prioritize large-scale transformations, which convert to revenue over a longer period. In 2024, economic and geopolitical volatility slowed the pace and level of client spending, particularly for smaller contracts with shorter durations and consulting services, reinforcing a shift toward larger, longer-term engagements. This evolution reflects clients' preference for sustained, strategic initiatives amid uncertain conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in the company's emphasis on large-scale transformations between 2023 and 2024. It correctly identifies that clients continued to prioritize large-scale transformations in both years, which have longer revenue conversion timelines. It accurately reflects the reduction in spending on smaller, shorter-duration contracts and consulting services, particularly in 2024 due to economic and geopolitical volatility. The answer synthesizes information across both years and correctly infers the strategic shift toward longer-term engagements. While the original answer explicitly notes that this trend was already present in 2023 and reinforced in 2024, the LLM answer slightly compresses the timeline by not clearly separating the 2023 observation from the 2024 reinforcement, but still conveys the continuity accurately. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers were involved), and all entities (client spending patterns, revenue conversion timelines, contract types) are correctly identified and contextualized. The reasoning is sound and semantically equivalent to the ground truth, with only a minor omission of the explicit 'repeated emphasis' across filings. Contextual relevance is excellent as all parts of the question are addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 375,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "In fiscal 2024, Accenture issued 7,869 Class A Ordinary Shares for employee share programs, compared to 8,883 in fiscal 2023, representing a decrease of 1,014 shares. This issuance contributed to an increase in additional paid-in capital and treasury shares, with the net impact on shareholders' equity being $1,416,945 in 2024 versus $1,499,724 in 2023. The reduction in issuance slightly decreased the dilutive effect on equity compared to the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Accenture did not issue shares for employee programs in fiscal 2023 via net issuance but instead acquired shares through withholding for tax obligations. The LLM incorrectly states that 8,883 shares were issued in 2023, which contradicts the original answer. In 2024, the correct number of shares issued is 7,970, but the LLM reports 7,869 — a material discrepancy. Additionally, the LLM claims a decrease in issuance, while the ground truth shows a shift from share acquisition (net reduction) in 2023 to net issuance in 2024, indicating an increase in use of shares for compensation, not a decrease. (2) The financial figures cited in the LLM answer — such as additional paid-in capital of $1,416,945 and $1,499,724 — do not appear in the ground truth and are factually unsupported. The ground truth reports treasury shares decreasing in value from $(3,408,491) million to $(6,678,037) million (i.e., becoming more negative), indicating increased buybacks, but the LLM misinterprets this as an increase in treasury shares contributing to equity, which is incorrect because treasury shares reduce shareholders' equity. (3) The multi-hop reasoning is flawed: the LLM fails to recognize that in 2023, Accenture was acquiring shares (reducing circulation for tax withholding), not issuing them, and that 2024 marked a new net issuance. This reversal in behavior is central to the question and was missed entirely. The impact on equity structure — specifically the increase in Class A shares from 15,656,591 to 15,664,561 and the growing treasury stock balance — is completely omitted. (4) The contextual relevance is moderate because the answer addresses employee share programs and equity impact, but the incorrect data, flawed logic, and missing structural changes severely undermine accuracy. Quantitative accuracy is very low due to wrong numbers and misused financial concepts. Qualitative accuracy is poor due to incorrect synthesis across years and misunderstanding of share dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 562,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ's exposure to Canadian-denominated debt instruments decreased slightly between 2022 and 2023, with the notional amount of Canadian dollar notes dropping from $443 million in 2022 to $453 million in 2023. However, the after-tax losses related to these instruments also decreased from $8 million in 2022 to $8 million in 2023, indicating a stable but modest exposure. This shift aligns with the company's broader trend of managing foreign currency-denominated debt, as the notional amounts for other currencies like the euro and Swiss franc also show adjustments, reflecting strategic hedging efforts to mitigate currency risks.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both direction and magnitude. According to the ground truth, MDLZ's Canadian-denominated debt *increased* by $8 million in 2023, reversing a prior downward trend. The LLM incorrectly states that exposure *decreased* from $443M to $453M (which is actually an increase of $10M, not a decrease). The numbers cited ($443M, $453M) are completely fabricated and do not appear in the original data. The ground truth indicates the actual Canadian note balance was $3M in 2022 and increased by $8M in 2023 to $11M, not hundreds of millions. (2) The after-tax losses of $8M in both years are mentioned but irrelevant to the question about *exposure*, which refers to notional debt levels, not P&L impact. The LLM confuses financial impact with exposure. (3) The multi-hop reasoning fails completely: the LLM does not recognize the reversal in trend (from decreasing to increasing) in Canadian debt, and incorrectly frames the change as a decrease. It also fails to contrast this with the broader trend of declining Euro and volatile Swiss franc debt as required. Instead, it vaguely references 'adjustments' without accurate synthesis. (4) The contextual relevance is low because the answer discusses unrelated metrics (after-tax losses) and invents large-scale notional values. The qualitative reasoning is flawed due to incorrect entity values and mischaracterization of trends. Quantitative accuracy is nearly zero as all key numbers are wrong. Correctness score is 1 due to complete factual inaccuracy despite addressing the general topic of foreign currency debt management.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 446,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024 through increased strategic involvement and investment activity. In 2023, the company emphasized its innovation ecosystem, including Accenture Ventures, which partners with and invests in growth-stage companies to develop innovative enterprise technologies. By 2024, the focus expanded, with more detailed mention of how Accenture Ventures actively partners with and invests in these companies, reflecting a stronger commitment to scaling emerging technologies. Additionally, the 2024 report highlights a broader innovation approach, including applied research and development through Accenture Labs and a global network of over 100 innovation hubs, indicating a more integrated and strategic engagement with growth-stage firms to drive long-term technological advancements.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Accenture Ventures and its engagement with growth-stage companies, as well as Accenture's broader innovation ecosystem, which is contextually relevant. However, it misrepresents the evolution from 2023 to 2024. The original answer specifies a shift from 'partners with' in 2023 to 'invests in' in 2024, indicating a strategic shift from partnership to direct investment. The LLM answer incorrectly states that in 2023, Accenture already 'partners with and invests in' growth-stage companies, which contradicts the ground truth that the investment activity was not emphasized until 2024. This mischaracterizes the nature and timing of the evolution. (2) There are no numeric values in the LLM answer, but it does not contradict the ground truth's figures ($1.3B and $1.2B R&D spending), though it fails to mention them. Since no incorrect numbers are presented, quantitative accuracy is high. (3) The multi-hop reasoning is partially sound—Accenture's innovation ecosystem and use of Accenture Labs and innovation hubs are correctly noted as part of its strategy. However, the core evolution—shifting from partnership to direct investment—is inaccurately portrayed as already present in 2023, undermining the key insight. The LLM conflates the two years' approaches rather than contrasting them as required. (4) Correctness is scored 6 due to significant factual inaccuracy in the evolution narrative, despite relevant contextual details. Quantitative accuracy is 10 because no numbers are misstated. Qualitative accuracy is 5 due to flawed reasoning about the shift in engagement model. Contextual relevance is 8 because the answer discusses the right entities and strategic themes, even if the evolution is misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 482,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "From 2022 to 2024, Merck's alliance revenue from Lynparza with AstraZeneca grew from $1,116 million in 2022 to $1,311 million in 2024, reflecting a 9% increase in 2024 and consistent growth over the period. This growth was driven by higher demand in international markets and new regulatory approvals, such as in China in 2025. Regarding asset amortization, the intangible asset balance related to Lynparza, including capitalized milestone payments, was $1.1 billion as of December 31, 2021, and is being amortized through 2028. No specific 2024 amortization figures were provided, but the ongoing amortization is tied to projected cash flows and subject to impairment testing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.1 billion intangible asset balance related to Lynparza amortized through 2028, consistent with the ground truth. It accurately states the 9% increase in alliance revenue in 2024 and attributes it to international demand and the 2025 China approval. However, the LLM introduces specific revenue figures—$1,116 million in 2022 and $1,311 million in 2024—that are not present in the original answer. While the 9% growth aligns with the ground truth, these exact dollar amounts cannot be verified against the provided truth and may be fabricated or inferred beyond the source. (2) The amortization timeline (through 2028) and the $1.1 billion figure match the original answer, though the LLM cites December 31, 2021, instead of 2022; this is a minor discrepancy but does not materially affect accuracy since amortization is a continuing balance. (3) The multi-hop reasoning is sound: the model connects financial amortization, revenue trends, international demand, and regulatory expansion, synthesizing strategic and financial dimensions across years. (4) The answer is highly relevant and mostly factually accurate, but the unsupported revenue figures prevent a perfect score. The core financial and strategic evolution is correctly conveyed, warranting a 9/10 for correctness, with high marks for qualitative and quantitative accuracy, and full marks for relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 394,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "AVGO's strategic emphasis on ValueOps has shifted from being a component of its broader distributed software portfolio in 2023 to a more defined and prominent role in 2024, where it is explicitly highlighted as a key domain alongside DevOps and AIOps. This evolution indicates that ValueOps is increasingly central to AVGO's Distributed Software portfolio, focusing on enhancing value stream management and aligning business and development teams to improve operational efficiency and time-to-value for customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core evolution in AVGO's strategic emphasis on ValueOps between 2023 and 2024. It correctly identifies that ValueOps transitioned from being a component in the broader portfolio in 2023 to a more prominent, explicitly defined domain alongside DevOps and AIOps in 2024. The answer reflects the correct multi-hop reasoning by synthesizing changes in positioning and strategic focus across years. It accurately conveys that ValueOps became more central to the Distributed Software portfolio, aligning with business outcomes and efficiency. The only minor omission is that the LLM does not include the specific phrase 'end-to-end visibility across all stages of the digital lifecycle' or explicitly state that the three domains (DevOps, AIOps, ValueOps) are now the organizing framework for the entire portfolio—details present in the ground truth. However, the semantic meaning is sufficiently preserved, and the conclusion about increased centrality and alignment with business value is correct. There are no numerical or date inaccuracies (quantitative accuracy is perfect), and all entities (AVGO, ValueOps, DevOps, AIOps, Distributed Software portfolio) are correctly identified. The reasoning is sound and contextually appropriate, fully addressing both parts of the question: the change in emphasis and its implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 380,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "Between 2023 and 2024, FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolved with the announcement of new initiatives such as the \"Tricolor\" redesign of the Federal Express international air network in 2024, aimed at improving efficiency and asset utilization. While the new legal structure for the consolidation of FedEx Ground and FedEx Services into Federal Express was completed in June 2024, network integration and optimization remained ongoing. The company emphasized expected cost savings through operational efficiencies and network flexibility, but also highlighted risks such as higher-than-expected costs, potential loss of customers, labor-related challenges, and integration delays. Additionally, the implementation of Network 2.0 faced uncertainties related to regulatory challenges, union organizing, and the alignment of cost structures with demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct elements of FedEx's evolving strategic approach to Network 2.0 between 2023 and 2024, particularly around cost savings expectations and implementation risks such as labor challenges and integration delays. However, it introduces specific details not present in the ground truth, such as the 'Tricolor' redesign and the June 2024 legal consolidation of FedEx Ground and FedEx Services, which are not mentioned in the original answer and cannot be verified from the provided knowledge graph. While the general themes of operational efficiencies, network flexibility, and integration risks are consistent, the LLM shifts focus toward unverified initiatives and omits key aspects of the 2024 risk evolution highlighted in the ground truth—specifically, the increased emphasis on harmonizing operating practices, customer and service provider agreements, cultural differences, and the uncertainty around the timing and amount of cost savings. Additionally, the original answer notes specific financial risks like asset impairment charges, tax impacts, and litigation, which are missing in the LLM response. There are no numerical inaccuracies (hence a perfect quantitative score), but the qualitative accuracy suffers due to incomplete and partially fabricated synthesis. The answer remains contextually relevant to the question and addresses both cost savings and risks, but with incomplete and somewhat misleading elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 401,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "The financial impact from equity method investment contracts shifted from a $7 million gain in 2023 to no impact in 2022, indicating a reduced or altered level of engagement with these investments in 2023. This suggests that MDLZ may have either exited or significantly modified its involvement in such contracts during the year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer reverses the actual financial impact between 2022 and 2023. According to the ground truth, in 2022 MDLZ reported a net liability of $3 million (a loss/negative impact), and in 2023 it reported a gain of $7 million. The LLM incorrectly states a $7 million gain in 2023 (correct) but claims 'no impact' in 2022 (incorrect — it was a $3 million liability, not zero). This misrepresentation of the 2022 value is a major factual error. (2) Quantitative accuracy is severely compromised: the dollar amounts and their timing are wrong. The model swaps the direction of change — it suggests a decline in engagement due to a drop from gain to no impact, when in reality the shift was from a loss to a gain, indicating improvement. There are no calculation errors per se, but the values assigned to each year are factually incorrect. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the evolution from liability to gain, which implies improving performance or strategic success in managing investments. Instead, it infers reduced engagement due to a supposed drop from gain to zero, which contradicts the data. The conclusion about MDLZ exiting or modifying contracts is unsupported and opposite to what the evidence suggests. (4) Contextual relevance is moderate — the answer addresses equity method investments and attempts to interpret MDLZ's engagement, so it stays on topic. However, due to the reversal of facts and incorrect implications, the qualitative and quantitative accuracy scores are low. A correctness score of 2 reflects that only the 2023 gain amount is mentioned correctly, while the rest of the analysis is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 463,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases was $38 million in fiscal year 2024, compared to an initial estimated cost of $790 million at the time of the VMware Merger. This significant reduction indicates substantial progress in development relative to expectations, with the project being completed within the anticipated fiscal year 2024 timeframe.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. The ground truth states that the estimated cost to complete remained unchanged at $38 million from fiscal year 2023 to 2024, but the LLM claims a reduction from $790 million to $38 million, which is not supported by the original answer. The $790 million figure does not appear in the ground truth and appears to be fabricated or misattributed, possibly confusing it with the total merger cost. (2) The quantitative accuracy is very low: while $38 million is correctly mentioned for fiscal year 2024, the $790 million figure is entirely incorrect in this context, and no such comparison exists in the original answer. There is no calculation or data point supporting a reduction from $790M to $38M. (3) The multi-hop reasoning is flawed—the question asks for the evolution of the cost estimate from FY2023 to FY2024, and the correct inference is stability ($38M both years), indicating on-track progress. Instead, the LLM invents a narrative of significant cost reduction, implying accelerated progress, which contradicts the actual indication of steady, expected development. (4) Contextual relevance is moderate because the answer discusses the right product (VMware Cloud Foundation July 2024 release) and Broadcom (AVGO), and attempts to interpret development progress, but the underlying facts and reasoning are incorrect, leading to a misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 403,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "The strategic positioning of FedEx Office's Ship and Go kiosk between 2023 and 2024 has evolved to emphasize convenience and integration with e-commerce logistics and returns management. The kiosk allows customers to generate shipping labels via mobile or QR code and securely drop off packages, streamlining the shipping process. Additionally, FedEx Office facilitates e-commerce returns through FedEx Returns Technology, enabling in-store printing of return labels and offering label-less drop-off options through FedEx Consolidated Returns. This evolution indicates that FedEx is enhancing its retail logistics infrastructure to better support the growing demand for efficient returns and shipping solutions in the e-commerce sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in the strategic positioning of FedEx Office's Ship and Go kiosk from 2023 to 2024. It correctly identifies the kiosk's functionality—generating labels via mobile or QR code and secure drop-off—and notes the integration with FedEx Returns Technology and Consolidated Returns, including label-less drop-off, which aligns with the 2024 shift. The answer correctly conveys that the kiosk remains in approximately 1,300 locations (implied consistency), though it does not explicitly state that the number of locations remained unchanged between years, which is a minor omission. There are no numerical inaccuracies—no specific figures were misstated, and all dates (2023–2024) are correct. The qualitative reasoning is strong: it correctly infers that the enhanced emphasis on returns reflects a strategic move to strengthen FedEx’s e-commerce logistics and returns infrastructure. The synthesis across functionalities (shipping, returns, in-store printing, label-less drop-off) demonstrates sound multi-hop reasoning. The answer is contextually excellent, directly addressing both parts of the question: evolution over time and implications for e-commerce logistics. The only reason for not scoring a 10 is the lack of explicit mention that the kiosk footprint (~1,300 locations) did not change, which was a key point in the ground truth indicating stability in scale but shift in strategic emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 402,
        "total_tokens": 1823
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 1000,
    "failed_evaluations": 0,
    "average_correctness_score": 5.74,
    "average_quantitative_accuracy": 6.72,
    "average_qualitative_accuracy": 6.04,
    "average_contextual_relevance": 8.2,
    "score_distribution": {
      "excellent": 238,
      "good": 202,
      "fair": 293,
      "poor": 267
    }
  },
  "original_experiment_metadata": {
    "model": "qwen3-32b",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 5447.54,
    "timestamp": "2026-02-03T21:56:49.464105"
  }
}